,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC004496-42,"October 01, 2018 -  September 30, 2019",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI","Takashi  Furusawa|Ravikanth  Nanduri; PhD|Yuri  Postnikov; MD, PhD|Shaofei  Zhang",NULL,Joost J Oppenheim; MD (Cancer Inflammation Program),David  Landsman; PhD (NLM),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108240
1,BC004504-47,"October 01, 2018 -  September 30, 2019",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Christophe  Cataisson|Luowei  Li|Wendy  Weinberg,NULL,Giorgio  Trinchieri (Cancer Inflammation Program),Maria Irene Morasso; PhD (NIAMS),"1. Li L, Cataisson C, Flowers B, Fraser E, Sanchez V, Day CP, Yuspa SH (2019). Topical Application of a Dual ABC Transporter Substrate and NF-κB Inhibitor Blocks Multiple Sources of Cutaneous Inflammation in Mouse Skin. J Invest Dermatol  139, 1506-1515.e7.   https://doi.org/10.1016/j.jid.2018.12.026",https://intramural.nih.gov/search/searchview.taf?ipid=108241
2,BC004517-43,"October 01, 2018 -  September 30, 2019",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Laila Abdulkareem Al-Eryani|John  Digiovanna|Sikandar  Khan|Xiaoling  Zhou|Maxwell P Lee; PhD,"Steffen  Emmert|Vera  Price (Univ of California, SF)|Alain  Sarasin|Allen  Lehmann (Genome Damage and Stability Centre, Univ of Sussex)|Shin Ichi  Moriwaki (Dermatology, Osaka Medical School)|Chikako  Nishigori (Dermatology, Kobe Univ School of Medicine)|Show all 12",Margaret Anne Tucker (Human Genetics Program)|Alisa  Goldstein; PhD (Clinical Genetics Branch)|Michael  Bustin; PhD (Laboratory of Metabolism)|Mark  Raffeld; MD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology),"Vilhelm A Bohr; MD, PhD (NIA) |Brian Patrick Brooks; MD, PhD (NEI) |Melissa A Merideth (NHGRI) |Carmen Crowell Brewer; PhD (NIDCD) |Andrew J Griffith; MD, PhD (NIDCD) |Eirini  Manoli; MD, MSc (NHGRI)","1. Armenta AM, Massey PR, Khan SG, Tamura D, Levy ML, DiGiovanna JJ, Kraemer KH, Fox MC (2018). Variant subtype of xeroderma pigmentosum diagnosed in a 77-year-old woman. JAAD Case Rep  4, 1074-1076.   https://doi.org/10.1016/j.jdcr.2018.08.013|2. Kraemer KH, Tamura D, Khan SG (2018). Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers. Br J Dermatol  178, 1009.   https://doi.org/10.1111/bjd.16525|3. Levoska MA, Cohen JI, Manoli I, Richard Lee CC, Ching SST, Shand J, Tamura D, Kraemer KH, DiGiovanna JJ (2018). Recurrent scarring papulovesicular lesions on sun-exposed skin in a 22-year-old man. J Am Acad Dermatol  78, 637-642.   https://doi.org/10.1016/j.jaad.2017.08.005|4. Pugh J, Khan SG, Tamura D, Goldstein AM, Landi MT, DiGiovanna JJ, Kraemer KH (2019). Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population. JAMA Dermatol  155, 72-78.   https://doi.org/10.1001/jamadermatol.2018.4473|5. Randall G, Kraemer KH, Pugh J, Tamura D, DiGiovanna JJ, Khan SG, Oetjen KA (2019). Mortality-associated immunological abnormalities in trichothiodystrophy: correlation of reduced levels of immunoglobulin and neutrophils with poor patient survival. Br J Haematol  185, 752-754.   https://doi.org/10.1111/bjh.15598|6. Shanbhag NM, Geschwind MD, DiGiovanna JJ, Groden C, Godfrey R, Yousefzadeh MJ, Wade EA, Niedernhofer LJ, Malicdan MCV, Kraemer KH, Gahl WA, Toro C (2018). Neurodegeneration as the presenting symptom in 2 adults with xeroderma pigmentosum complementation group F. Neurol Genet  4, e240.   https://doi.org/10.1212/NXG.0000000000000240|7. Wang Y, Masaki T, Khan SG, Tamura D, Kuschal C, Rogers M, DiGiovanna JJ, Kraemer KH (2018). Four-dimensional, dynamic mosaicism is a hallmark of normal human skin that permits mapping of the organization and patterning of human epidermis during terminal differentiation. PLoS One  13, e0198011.   https://doi.org/10.1371/journal.pone.0198011",https://intramural.nih.gov/search/searchview.taf?ipid=108242
3,BC005093-41,"October 01, 2018 -  September 30, 2019",Growth-Differentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,Harold  Lovvorn (Vanderbilt University)|Mark  de Caestecker (Vanderbilt University),James  Lautenberger; PhD (Basic Research Laboratory)|George  Nelson (Office of the Director)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|Mark B Lewandoski (Genetics of Vertebrate Development Section)|Melinda  Hollingshead (Biological Testing Branch),NULL,"1. Yun K, Hurwitz AA, Perantoni AO (2018). Constitutive metanephric mesenchyme-specific expression of interferon-gamma causes renal dysplasia by regulating Sall1 expression. PLoS One  13, e0197356.   https://doi.org/10.1371/journal.pone.0197356",https://intramural.nih.gov/search/searchview.taf?ipid=108243
4,BC005268-32,"October 01, 2018 -  September 30, 2019",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Jasvinder  Singh; PhD|Matan  Cohen|Catherine Scarlett Harvey|Anura Gokul Shodhan; PhD|Martin  Xaver; PhD,Alastair  Goldman (University of Sheffield)|Akira  Shinohara (Osaka University)|Soni  Lacefield (Indiana University)|Jack  Griffith; PhD (University of North Carolina),NULL,NULL,"1. Hunt LJ, Ahmed EA, Kaur H, Ahuja JS, Hulme L, Chou TC, Lichten M, Goldman ASH (2019). S. cerevisiae Srs2 helicase ensures normal recombination intermediate metabolism during meiosis and prevents accumulation of Rad51 aggregates. Chromosoma  128, 249-265.   https://doi.org/10.1007/s00412-019-00705-9|2. Kaur H, Ahuja JS, Lichten M (2018). Methods for Controlled Protein Depletion to Study Protein Function during Meiosis. Methods Enzymol  601, 331-357.   https://doi.org/10.1016/bs.mie.2017.11.032|3. Shodhan A, Medhi D, Lichten M (2019). Noncanonical Contributions of MutLγ to VDE-Initiated Crossovers During Saccharomyces cerevisiae Meiosis. G3 (Bethesda)  9, 1647-1654.   https://doi.org/10.1534/g3.119.400150",https://intramural.nih.gov/search/searchview.taf?ipid=108245
5,BC005271-28,"October 01, 2018 -  September 30, 2019",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Nima Michael Assad|Sreejana  Ray|Desiree Christine Tillo|Aniekanabasi Ime Ufot,Tim  Hughes (University of Toronto)|Matthew T Weirauch (University of Toronto)|John  Stamatoyannopoulos (University of Washington)|Andrew  Smith (University of Southern California)|Jussi  Taipale (Karolinska Institute),Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Michael  Bustin; PhD (Laboratory of Metabolism)|Peter C Fitzgerald (Office of the Director)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Shioko  Kimura; PhD (Endocrinology Section),Ann  Dean; PhD (NIDDK) |Kai  Ge; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108247
6,BC005445-35,"October 01, 2018 -  September 30, 2019",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Heba Khair Al Khamici|Brandi Lynn Carofino; PhD|Vanesa Cecilia Sanchez; PhD|Ji  Luo|Kent W Hunter; PhD,NULL,Christina M Annunziata (Womens Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108248
7,BC005450-36,"October 01, 2018 -  September 30, 2019",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Gregory Philippe M Fettweis; PhD|Saori  Fujiwara|David Alejandro Garcia Grisales|Thomas A Johnson|Sohyoung  Kim|Show all 12,Dan  Theodorescu (University of Colorado)|Lars  Grontved|Jeremy  Gunawardena (Harvard Medical School)|Ruth  Ashery-Padan (Laboratory Of Receptor Biology & Gene Expression)|Ville Juhani Paakinaho; PhD (Laboratory Of Receptor Biology & Gene Expression)|Diego Martin Presman; PhD,Michael L Nickerson (Laboratory Translational Genomics)|Vassiliki  Saloura; MD (Thoracic and GI Malignancies Branch)|Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling)|Carol J Thiele (Pediatric Oncology Branch)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch),"Jay H Chung; MD, PhD (NHLBI) |David Johannes Clark; PhD (NICHD) |Iain  Fraser (NIAID) |Myong-Hee  Sung (NIA)","1. Fujiwara S, Baek S, Varticovski L, Kim S, Hager GL (2019). High Quality ATAC-Seq Data Recovered from Cryopreserved Breast Cell Lines and Tissue. Sci Rep  9, 516.   https://doi.org/10.1038/s41598-018-36927-7|2. Goldstein I, Hager GL (2018). Dynamic enhancer function in the chromatin context. Wiley Interdiscip Rev Syst Biol Med  10.   https://doi.org/10.1002/wsbm.1390|3. Goldstein I, Hager GL (2018). The Three Ds of Transcription Activation by Glucagon: Direct, Delayed, and Dynamic. Endocrinology  159, 206-216.   https://doi.org/10.1210/en.2017-00521|4. Johnson TA, Chereji RV, Stavreva DA, Morris SA, Hager GL, Clark DJ (2018). Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo. Nucleic Acids Res  46, 203-214.   https://doi.org/10.1093/nar/gkx1044|5. Paakinaho V, Johnson TA, Presman DM, Hager GL (2019). Glucocorticoid receptor quaternary structure drives chromatin occupancy and transcriptional outcome. Genome Res  29, 1223-1234.   https://doi.org/10.1101/gr.244814.118|6. Saloura V, Vougiouklakis T, Sievers C, Burkitt K, Nakamura Y, Hager G, van Waes C (2018). The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck. Oral Oncol  81, 100-108.   https://doi.org/10.1016/j.oraloncology.2018.04.014|7. Swinstead EE, Paakinaho V, Hager GL (2018). Chromatin reprogramming in breast cancer. Endocr Relat Cancer  25, R385-R404.   https://doi.org/10.1530/ERC-18-0033",https://intramural.nih.gov/search/searchview.taf?ipid=108249
8,BC005522-32,"October 01, 2018 -  September 30, 2019",Stem-Progenitor Cells and Carcinogenesis of Thyroid,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Henrique Bregolin Dias|Yo-Taro  Shirai,NULL,NULL,NULL,"1. Iwadate M, Takizawa Y, Shirai YT, Kimura S (2018). An in vivo model for thyroid regeneration and folliculogenesis. Lab Invest  98, 1126-1132.   https://doi.org/10.1038/s41374-018-0068-x|2. Kimura S, Glover A (2018). Editorial - Endocrine Tumor. Mol Cell Endocrinol  469, 1-2.   https://doi.org/10.1016/j.mce.2018.04.017|3. Ock S, Ahn J, Lee SH, Kim HM, Kang H, Kim YK, Kook H, Park WJ, Kim S, Kimura S, Jung CK, Shong M, Holzenberger M, Abel ED, Lee TJ, Cho BY, Kim HS, Kim J (2018). Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation. Int J Cancer  143, 2458-2469.   https://doi.org/10.1002/ijc.31779|4. Tata PR, Chow RD, Saladi SV, Tata A, Konkimalla A, Bara A, Montoro D, Hariri LP, Shih AR, Mino-Kenudson M, Mou H, Kimura S, Ellisen LW, Rajagopal J (2018). Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity. Dev Cell  44, 679-693.e5.   https://doi.org/10.1016/j.devcel.2018.02.024",https://intramural.nih.gov/search/searchview.taf?ipid=108250
9,BC005562-32,"October 01, 2018 -  September 30, 2019",Xenobiotic receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Chad Nicholas Brocker|Linda G Byrd|Kristopher W Krausz|Yuhong  Luo|Lulu  Sun|Shogo  Takahashi|Show all 8,Jeffrey  Peters (NCI)|Jeffrey  Idle (University of Bern)|Andrew  Patterson (Pennsylvania State University)|Yatrik  Shah|Changtao  Jiang|Moshe  Levi (University of Colorado School of Medicine)|Show all 8,NULL,Oksana  Gavrilova; PhD (NIDDK),"1. Aibara D, Matsusue K, Takiguchi S, Gonzalez FJ, Yamano S (2018). Fat-specific protein 27 is a novel target gene of liver X receptor α. Mol Cell Endocrinol  474, 48-56.   https://doi.org/10.1016/j.mce.2018.02.006|2. Battistelli C, Sabarese G, Santangelo L, Montaldo C, Gonzalez FJ, Tripodi M, Cicchini C (2019). The lncRNA HOTAIR transcription is controlled by HNF4α-induced chromatin topology modulation. Cell Death Differ  26, 890-901.   https://doi.org/10.1038/s41418-018-0170-z|3. Borland MG, Kehres EM, Lee C, Wagner AL, Shannon BE, Albrecht PP, Zhu B, Gonzalez FJ, Peters JM (2018). Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells. Toxicology  404-405, 25-32.   https://doi.org/10.1016/j.tox.2018.05.003|4. Brocker CN, Patel DP, Velenosi TJ, Kim D, Yan T, Yue J, Li G, Krausz KW, Gonzalez FJ (2018). Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice. J Lipid Res  59, 2140-2152.   https://doi.org/10.1194/jlr.M088419|5. Caratti G, Iqbal M, Hunter L, Kim D, Wang P, Vonslow RM, Begley N, Tetley AJ, Woodburn JL, Pariollaud M, Maidstone R, Donaldson IJ, Zhang Z, Ince LM, Kitchen G, Baxter M, Poolman TM, Daniels DA, Stirling DR, Brocker C, Gonzalez F, Loudon AS, Bechtold DA, Rattray M, Matthews LC, et al. [1 more author] (2018). REVERBa couples the circadian clock to hepatic glucocorticoid action. J Clin Invest  128, 4454-4471.   https://doi.org/10.1172/JCI96138|6. Choi S, Neequaye P, French SW, Gonzalez FJ, Gyamfi MA (2018). Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice. J Biol Chem  293, 1-17.   https://doi.org/10.1074/jbc.M117.815217|7. Domínguez-Acosta O, Vega L, Estrada-Muñiz E, Rodríguez MS, Gonzalez FJ, Elizondo G (2018). Activation of aryl hydrocarbon receptor regulates the LPS/IFNγ-induced inflammatory response by inducing ubiquitin-proteosomal and lysosomal degradation of RelA/p65. Biochem Pharmacol  155, 141-149.   https://doi.org/10.1016/j.bcp.2018.06.016|8. Ghosh J, Chowdhury AR, Srinivasan S, Chattopadhyay M, Bose M, Bhattacharya S, Raza H, Fuchs SY, Rustgi AK, Gonzalez FJ, Avadhani NG (2018). Cigarette Smoke Toxins-Induced Mitochondrial Dysfunction and Pancreatitis Involves Aryl Hydrocarbon Receptor Mediated Cyp1 Gene Expression: Protective Effects of Resveratrol. Toxicol Sci  166, 428-440.   https://doi.org/10.1093/toxsci/kfy206|9. Gonzalez FJ, Xie C, Jiang C (2018). The role of hypoxia-inducible factors in metabolic diseases. Nat Rev Endocrinol  15, 21-32.   https://doi.org/10.1038/s41574-018-0096-z|10. Hayashi Y, Ito Y, Naito H, Tamada H, Yamagishi N, Kondo T, Ishikawa T, Gonzalez FJ, Nakajima T (2019). In utero exposure to di(2-ethylhexyl)phthalate suppresses blood glucose and leptin levels in the offspring of wild-type mice. Toxicology  415, 49-55.   https://doi.org/10.1016/j.tox.2019.01.008|11. Hua H, Yang J, Lin H, Xi Y, Dai M, Xu G, Wang F, Liu L, Zhao T, Huang J, Gonzalez FJ, Liu A (2018). PPARα-independent action against metabolic syndrome development by fibrates is mediated by inhibition of STAT3 signalling. J Pharm Pharmacol  70, 1630-1642.   https://doi.org/10.1111/jphp.13014|12. Jiang Y, Feng D, Ma X, Fan S, Gao Y, Fu K, Wang Y, Sun J, Yao X, Liu C, Zhang H, Xu L, Liu A, Gonzalez FJ, Yang Y, Gao B, Huang M, Bi H (2019). Pregnane X Receptor Regulates Liver Size and Liver Cell Fate by Yes-Associated Protein Activation in Mice. Hepatology  69, 343-358.   https://doi.org/10.1002/hep.30131|13. Kim D, Brocker CN, Takahashi S, Yagai T, Kim T, Xie G, Wang H, Qu A, Gonzalez FJ (2019). Keratin 23 Is a Peroxisome Proliferator-Activated Receptor Alpha-Dependent, MYC-Amplified Oncogene That Promotes Hepatocyte Proliferation. Hepatology  70, 154-167.   https://doi.org/10.1002/hep.30530|14. Konstandi M, Sotiropoulos I, Matsubara T, Malliou F, Katsogridaki A, Andriopoulou CE, Gonzalez FJ (2019). Adrenoceptor-stimulated inflammatory response in stress-induced serum amyloid A synthesis. Psychopharmacology (Berl)  236, 1687-1699.   https://doi.org/10.1007/s00213-018-5149-4|15. Lalwani A, Warren J, Liuwantara D, Hawthorne WJ, O'Connell PJ, Gonzalez FJ, Stokes RA, Chen J, Laybutt DR, Craig ME, Swarbrick MM, King C, Gunton JE (2019). β Cell Hypoxia-Inducible Factor-1α Is Required for the Prevention of Type 1 Diabetes. Cell Rep  27, 2370-2384.e6.   https://doi.org/10.1016/j.celrep.2019.04.086|16. Li G, Brocker CN, Xie C, Yan T, Noguchi A, Krausz KW, Xiang R, Gonzalez FJ (2018). Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643. J Gastroenterol Hepatol  33, 1138-1145.   https://doi.org/10.1111/jgh.14046|17. Li G, Brocker CN, Yan T, Xie C, Krausz KW, Xiang R, Gonzalez FJ (2018). Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha. Mol Metab  7, 80-89.   https://doi.org/10.1016/j.molmet.2017.10.011|18. Lu Y, Harada M, Kamijo Y, Nakajima T, Tanaka N, Sugiyama E, Kyogashima M, Gonzalez FJ, Aoyama T (2019). Peroxisome proliferator-activated receptor α attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice. Arch Toxicol  93, 149-161.   https://doi.org/10.1007/s00204-018-2335-4|19. Malliou F, Andreadou I, Gonzalez FJ, Lazou A, Xepapadaki E, Vallianou I, Lambrinidis G, Mikros E, Marselos M, Skaltsounis AL, Konstandi M (2018). The olive constituent oleuropein, as a PPARα agonist, markedly reduces serum triglycerides. J Nutr Biochem  59, 17-28.   https://doi.org/10.1016/j.jnutbio.2018.05.013|20. Moreno-Marín N, Merino JM, Alvarez-Barrientos A, Patel DP, Takahashi S, González-Sancho JM, Gandolfo P, Rios RM, Muñoz A, Gonzalez FJ, Fernández-Salguero PM (2018). Aryl Hydrocarbon Receptor Promotes Liver Polyploidization and Inhibits PI3K, ERK, and Wnt/β-Catenin Signaling. iScience  4, 44-63.   https://doi.org/10.1016/j.isci.2018.05.006|21. Muthusamy S, Jeong JJ, Cheng M, Bonzo JA, Kumar A, Gonzalez FJ, Borthakur A, Dudeja PK, Saksena S, Malakooti J (2018). Hepatocyte nuclear factor 4α regulates the expression of intestinal epithelial Na+/H+ exchanger isoform 3. Am J Physiol Gastrointest Liver Physiol  314, G14-G21.   https://doi.org/10.1152/ajpgi.00225.2017|22. Ou-Yang Q, Lin XM, Zhu YJ, Zheng B, Li L, Yang YC, Hou GJ, Chen X, Luo GJ, Huo F, Leng QB, Gonzalez FJ, Jiang XQ, Wang HY, Chen L (2018). Distinct role of nuclear receptor corepressor 1 regulated de novo fatty acids synthesis in liver regeneration and hepatocarcinogenesis in mice. Hepatology  67, 1071-1087.   https://doi.org/10.1002/hep.29562|23. Patel D, Roy A, Kundu M, Jana M, Luan CH, Gonzalez FJ, Pahan K (2018). Aspirin binds to PPARα to stimulate hippocampal plasticity and protect memory. Proc Natl Acad Sci U S A  115, E7408-E7417.   https://doi.org/10.1073/pnas.1802021115|24. Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD, Gonzalez FJ, Chiang JYL (2018). Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology  68, 1574-1588.   https://doi.org/10.1002/hep.29857|25. Peters JM, Kim DJ, Bility MT, Borland MG, Zhu B, Gonzalez FJ (2019). Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer. Mol Carcinog  58, 1612-1622.   https://doi.org/10.1002/mc.23033|26. Sasaki S, Urabe M, Maeda T, Suzuki J, Irie R, Suzuki M, Tomaru Y, Sakaguchi M, Gonzalez FJ, Inoue Y (2018). Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ. Mol Cell Biol  38.   https://doi.org/10.1128/MCB.00213-18|27. Sun L, Xie C, Wang G, Wu Y, Wu Q, Wang X, Liu J, Deng Y, Xia J, Chen B, Zhang S, Yun C, Lian G, Zhang X, Zhang H, Bisson WH, Shi J, Gao X, Ge P, Liu C, Krausz KW, Nichols RG, Cai J, Rimal B, Patterson AD, et al. [3 more authors] (2018). Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med  24, 1919-1929.   https://doi.org/10.1038/s41591-018-0222-4|28. Takahashi S, Tanaka N, Fukami T, Xie C, Yagai T, Kim D, Velenosi TJ, Yan T, Krausz KW, Levi M, Gonzalez FJ (2018). Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development. Hepatol Commun  2, 1567-1582.   https://doi.org/10.1002/hep4.1263|29. Thakur A, Wong JCH, Wang EY, Lotto J, Kim D, Cheng JC, Mingay M, Cullum R, Moudgil V, Ahmed N, Tsai SH, Wei W, Walsh CP, Stephan T, Bilenky M, Fuglerud BM, Karimi MM, Gonzalez FJ, Hirst M, Hoodless PA (2019). Hepatocyte Nuclear Factor 4-Alpha Is Essential for the Active Epigenetic State at Enhancers in Mouse Liver. Hepatology  70, 1360-1376.   https://doi.org/10.1002/hep.30631|30. Wang BL, Zhang CW, Wang L, Tang KL, Tanaka N, Gonzalez FJ, Xu Y, Fang ZZ (2019). Lipidomics reveal aryl hydrocarbon receptor (Ahr)-regulated lipid metabolic pathway in alpha-naphthyl isothiocyanate (ANIT)-induced intrahepatic cholestasis. Xenobiotica  49, 591-601.   https://doi.org/10.1080/00498254.2018.1467065|31. Wang XX, Wang D, Luo Y, Myakala K, Dobrinskikh E, Rosenberg AZ, Levi J, Kopp JB, Field A, Hill A, Lucia S, Qiu L, Jiang T, Peng Y, Orlicky D, Garcia G, Herman-Edelstein M, D'Agati V, Henriksen K, Adorini L, Pruzanski M, Xie C, Krausz KW, Gonzalez FJ, Ranjit S, et al. [3 more authors] (2018). FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity. J Am Soc Nephrol  29, 118-137.   https://doi.org/10.1681/ASN.2017020222|32. Xie G, Yin S, Zhang Z, Qi D, Wang X, Kim D, Yagai T, Brocker CN, Wang Y, Gonzalez FJ, Wang H, Qu A (2019). Hepatocyte Peroxisome Proliferator-Activated Receptor α Enhances Liver Regeneration after Partial Hepatectomy in Mice. Am J Pathol  189, 272-282.   https://doi.org/10.1016/j.ajpath.2018.10.009|33. Yang XN, Liu XM, Fang JH, Zhu X, Yang XW, Xiao XR, Huang JF, Gonzalez FJ, Li F (2018). PPARα Mediates the Hepatoprotective Effects of Nutmeg. J Proteome Res  17, 1887-1897.   https://doi.org/10.1021/acs.jproteome.7b00901|34. Zhang SY, Dong YQ, Wang P, Zhang X, Yan Y, Sun L, Liu B, Zhang D, Zhang H, Liu H, Kong W, Hu G, Shah YM, Gonzalez FJ, Wang X, Jiang C (2018). Adipocyte-derived Lysophosphatidylcholine Activates Adipocyte and Adipose Tissue Macrophage Nod-Like Receptor Protein 3 Inflammasomes Mediating Homocysteine-Induced Insulin Resistance. EBioMedicine  31, 202-216.   https://doi.org/10.1016/j.ebiom.2018.04.022|35. Zhang Y, Yan T, Sun D, Xie C, Zheng Y, Zhang L, Yagai T, Krausz KW, Bisson WH, Yang X, Gonzalez FJ (2018). Structure-Activity Relationships of the Main Bioactive Constituents of Euodia rutaecarpa on Aryl Hydrocarbon Receptor Activation and Associated Bile Acid Homeostasis. Drug Metab Dispos  46, 1030-1040.   https://doi.org/10.1124/dmd.117.080176|36. Zhao Q, Liu F, Cheng Y, Xiao XR, Hu DD, Tang YM, Bao WM, Yang JH, Jiang T, Hu JP, Gonzalez FJ, Li F (2019). Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling. Mol Cell Proteomics  18, 520-533.   https://doi.org/10.1074/mcp.RA118.000817",https://intramural.nih.gov/search/searchview.taf?ipid=108251
10,BC005598-30,"October 01, 2018 -  September 30, 2019",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Fatima Ghazanfar Ali-Rahmani|Sachi  Horibata|Lyn Ann J Mickley|Crystal Chari Cole Lipsey|Rajalakshm L Padmanabhan|Ruchi Pramod Patel|Show all 8,"JeanPierre  Gillet (University of Namur)|Bates  Susan (Columbia University)|Antonio  Fojo; MD, PhD (NCI)","Suresh V Ambudkar; PhD (Viral Epidemiology Br)|Sadhana  Jackson (Neuro-Oncology Branch)|Di S Xia; PhD, MS, BS (Crystallography Section)",Matthew David Hall (NCATS) |Christopher Simon Hourigan (NHLBI) |Kevin G Chen; MD (NINDS),"1. Baglo Y, Liang BJ, Robey RW, Ambudkar SV, Gottesman MM, Huang HC (2019). Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells. Cancer Lett  457, 110-118.   https://doi.org/10.1016/j.canlet.2019.04.037|2. Chen KG, Mallon BS, Park K, Robey PG, McKay RDG, Gottesman MM, Zheng W (2018). Pluripotent Stem Cell Platforms for Drug Discovery. Trends Mol Med  24, 805-820.   https://doi.org/10.1016/j.molmed.2018.06.009|3. Horibata S, Gui G, Lack J, DeStefano CB, Gottesman MM, Hourigan CS (2019). Heterogeneity in refractory acute myeloid leukemia. Proc Natl Acad Sci U S A  116, 10494-10503.   https://doi.org/10.1073/pnas.1902375116|4. Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM (2018). Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer  18, 452-464.   https://doi.org/10.1038/s41568-018-0005-8|5. Robinson AN, Tebase BG, Francone SC, Huff LM, Kozlowski H, Cossari D, Lee JM, Esposito D, Robey RW, Gottesman MM (2019). Coexpression of ABCB1 and ABCG2 in a Cell Line Model Reveals Both Independent and Additive Transporter Function. Drug Metab Dispos  47, 715-723.   https://doi.org/10.1124/dmd.118.086181",https://intramural.nih.gov/search/searchview.taf?ipid=108252
11,BC005599-29,"October 01, 2018 -  September 30, 2019","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Sharlyn  Mazur; PhD|Daniel James Schilling|Jonathan Lawrence Smisson|Harichandra Dnyaneshwar Tagad; PhD,Robert Taylor Ripley; MD|Veronica  Veschi (PEDIATRIC ONCOLOGY BRANCH),Stewart  Durell (Laboratory of Cell Biology)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108253
12,BC005645-30,"October 01, 2018 -  September 30, 2019",Role of the HTLV-1A and HTLV1-C inflammatory profile in disease,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Veronica  Galli|Corrado  Gurgo|Ramona  Moles|Sarkis  Sarkis; PhD|Robyn M Washington Parks,"Vincenzo  Ciminale (Department of Oncology and Surgical Sciences, University of Padova)|Damian  Purcell (University Of Melbourne)|Mark Niccolo Polizzotto; MD|Anthony  Kelleher (University Of New South Wales)|Dinny  Graham (University Of Sydney School Of Medicine)|Anthony  Cunningham|Show all 11",Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Cynthia  Masison (Office of the Director)|David J Venzon; PhD (Biostatistics and Data Management Section),Steven J Jacobson; PhD (NINDS),"1. Galli V, Nixon CC, Strbo N, Artesi M, de Castro-Amarante MF, McKinnon K, Fujikawa D, Omsland M, Washington-Parks R, Romero L, Caruso B, Durkin K, Brown S, Karim B, Vaccari M, Jacobson S, Zack JA, Van den Broeke A, Pise-Masison C, Franchini G (2019). Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice. J Virol  93.   https://doi.org/10.1128/JVI.00565-19",https://intramural.nih.gov/search/searchview.taf?ipid=108254
13,BC005708-28,"October 01, 2018 -  September 30, 2019","Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers",Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Chad Nicholas Brocker|Linda G Byrd|Kristopher W Krausz|Shogo  Takahashi|Thomas John Velenosi|Vikas Chandra Akkaraju,"Jeffrey  Idle (University of Bern)|Andrew  Patterson (Pennsylvania State University)|Huichang  Bi (Sun Yat-sen University)|Zhong-Ze  Fang|John  Chiang (Northeast Ohio Medical University)|Fei  Li (Kunming Institute Of Botany,)|Show all 10",Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Shioko  Kimura; PhD (Endocrinology Section)|James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Chen Y, Golla S, Garcia-Milian R, Thompson DC, Gonzalez FJ, Vasiliou V (2019). Hepatic metabolic adaptation in a murine model of glutathione deficiency. Chem Biol Interact  303, 1-6.   https://doi.org/10.1016/j.cbi.2019.02.015|2. Dai M, Hua H, Lin H, Xu G, Hu X, Li F, Gonzalez FJ, Liu A, Yang J (2018). Targeted Metabolomics Reveals a Protective Role for Basal PPARα in Cholestasis Induced by α-Naphthylisothiocyanate. J Proteome Res  17, 1500-1508.   https://doi.org/10.1021/acs.jproteome.7b00838|3. Li S, Xu J, Yao Z, Hu L, Qin Z, Gao H, Krausz KW, Gonzalez FJ, Yao X (2018). The roles of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated proteins (MRPs/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells. Chem Biol Interact  296, 45-56.   https://doi.org/10.1016/j.cbi.2018.09.001|4. Lu D, Xue L, Feng C, Jin Y, Wu C, Xie C, Gonzalez FJ, Wang G, Zhou Z (2019). A systemic workflow for profiling metabolome and lipidome in tissue. J Chromatogr A  1589, 105-115.   https://doi.org/10.1016/j.chroma.2018.12.061|5. Mukherjee K, Song CY, Estes AM, Dhodi AN, Ormseth BH, Shin JS, Gonzalez FJ, Malik KU (2018). Cytochrome P450 1B1 Is Critical for Neointimal Growth in Wire-Injured Carotid Artery of Male Mice. J Am Heart Assoc  7, e010065.   https://doi.org/10.1161/JAHA.118.010065|6. Nair SG, Patel DP, Gonzalez FJ, Patel BM, Singhal P, Chaudhary DV (2018). Simultaneous determination of etonogestrel and ethinyl estradiol in human plasma by UPLC-MS/MS and its pharmacokinetic study. Biomed Chromatogr  32, e4165.   https://doi.org/10.1002/bmc.4165|7. Patterson AD, Gonzalez FJ, Perdew GH, Peters JM (2018). Molecular Regulation of Carcinogenesis: Friend and Foe. Toxicol Sci  165, 277-283.   https://doi.org/10.1093/toxsci/kfy185|8. Peters JM, Gonzalez FJ (2018). The Evolution of Carcinogenesis. Toxicol Sci  165, 272-276.   https://doi.org/10.1093/toxsci/kfy184|9. Qin Z, Li S, Yao Z, Hong X, Xu J, Lin P, Zhao G, Gonzalez FJ, Yao X (2018). Metabolic profiling of corylin in vivo and in vitro. J Pharm Biomed Anal  155, 157-168.   https://doi.org/10.1016/j.jpba.2018.03.047|10. Qin Z, Zhang B, Yang J, Li S, Xu J, Yao Z, Zhang X, Gonzalez FJ, Yao X (2019). The Efflux Mechanism of Fraxetin-O-Glucuronides in UGT1A9-Transfected HeLa Cells: Identification of Multidrug Resistance-Associated Proteins 3 and 4 (MRP3/4) as the Important Contributors. Front Pharmacol  10, 496.   https://doi.org/10.3389/fphar.2019.00496|11. Shehu AI, Lu J, Wang P, Zhu J, Wang Y, Yang D, McMahon D, Xie W, Gonzalez FJ, Ma X (2019). Pregnane X receptor activation potentiates ritonavir hepatotoxicity. J Clin Invest  129, 2898-2903.   https://doi.org/10.1172/JCI128274|12. Tu MJ, Ho PY, Zhang QY, Jian C, Qiu JX, Kim EJ, Bold RJ, Gonzalez FJ, Bi H, Yu AM (2019). Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models. Cancer Lett  442, 82-90.   https://doi.org/10.1016/j.canlet.2018.10.038|13. Wang H, Ge C, Zhou J, Guo Y, Cui S, Huang N, Yan T, Cao L, Che Y, Zheng Q, Zheng X, Gonzalez FJ, Wang G, Hao H (2018). Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis. EBioMedicine  37, 322-333.   https://doi.org/10.1016/j.ebiom.2018.10.028|14. Wang L, Hong X, Yao Z, Dai Y, Zhao G, Qin Z, Wu B, Gonzalez FJ, Yao X (2018). Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes. Xenobiotica  48, 357-367.   https://doi.org/10.1080/00498254.2017.1323139|15. Wang Y, Chen Y, Guan L, Zhang H, Huang Y, Johnson CH, Wu Z, Gonzalez FJ, Yu A, Huang P, Wang Y, Yang S, Chen P, Fan X, Huang M, Bi H (2018). Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming. Cell Death Differ  25, 735-748.   https://doi.org/10.1038/s41418-017-0013-3|16. Wang YK, Yang XN, Liang WQ, Xiao Y, Zhao Q, Xiao XR, Gonzalez FJ, Li F (2019). A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice. Xenobiotica  49, 655-670.   https://doi.org/10.1080/00498254.2018.1489167|17. Xie C, Gao X, Sun D, Zhang Y, Krausz KW, Qin X, Gonzalez FJ (2018). Metabolic Profiling of the Novel Hypoxia-Inducible Factor 2α Inhibitor PT2385 In Vivo and In Vitro. Drug Metab Dispos  46, 336-345.   https://doi.org/10.1124/dmd.117.079723|18. Yan T, Wang H, Cao L, Wang Q, Takahashi S, Yagai T, Li G, Krausz KW, Wang G, Gonzalez FJ, Hao H (2018). Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation. Drug Metab Dispos  46, 1310-1319.   https://doi.org/10.1124/dmd.118.082008|19. Zhang B, Yang J, Qin Z, Li S, Xu J, Yao Z, Zhang X, Gonzalez FJ, Yao X (2019). Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1. PLoS One  14, e0217695.   https://doi.org/10.1371/journal.pone.0217695|20. Zhang T, Zhao Q, Xiao X, Yang R, Hu D, Zhu X, Gonzalez FJ, Li F (2019). Modulation of Lipid Metabolism by Celastrol. J Proteome Res  18, 1133-1144.   https://doi.org/10.1021/acs.jproteome.8b00797|21. Zhao J, Xie C, Mu X, Krausz KW, Patel DP, Shi X, Gao X, Wang Q, Gonzalez FJ (2018). Metabolic alterations in triptolide-induced acute hepatotoxicity. Biomed Chromatogr  32, e4299.   https://doi.org/10.1002/bmc.4299|22. Zhao Q, Li XM, Liu HN, Gonzalez FJ, Li F (2018). Metabolic map of osthole and its effect on lipids. Xenobiotica  48, 285-299.   https://doi.org/10.1080/00498254.2017.1306660|23. Zhao Q, Zhang T, Xiao XR, Huang JF, Wang Y, Gonzalez FJ, Li F (2019). Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity. Br J Pharmacol  176, 2162-2178.   https://doi.org/10.1111/bph.14664",https://intramural.nih.gov/search/searchview.taf?ipid=108255
14,BC005785-25,"October 01, 2018 -  September 30, 2019",TGF-betas in breast cancer progression,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Daniel  Grun|Nellie  Moshkovich; BS|Humberto  Ochoa|Binwu  Tang|Jing  Huang|Steven David Cappell|Show all 8,John  Condeelis (Albert Einstein College of Medicine)|Maja  Oktay (Albert Einstein College of Medicine),Dominic  Esposito; PhD (Office Of The Director)|Patricia  Steeg; PhD (Womens Malignancies Branch)|Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling)|Jinqiu  Chen (Office of the Director)|Noemi  Kedei (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108256
15,BC005793-25,"October 01, 2018 -  September 30, 2019",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Marshonna J Forgues|Curtis  Harris; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108257
16,BC006150-38,"October 01, 2018 -  September 30, 2019","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Shar-Yin Naomi Huang|Ukhyun  Jo|Evgeny Anatolyevich Kiselev; PhD|Laetitia  Marzi|Ann  Orr|Show all 13,"Mark  Cushman (Medicinal Chemistry, Purdue University)|Gary  Olson (Provid Pharma)|Yuk  Sham (University of Minnesota)|ZhengQuiang  Wang (University of Minnesota)|Sherif  El-Khamisy (University of Sussex)|Keith  Caldecott (University of Sussex)|Show all 13","David S Waugh; PhD (Protein Engineering Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Beverly Ann Teicher (Molecular Pharmocology Branch)|George T Lountos (Macromolecular Crystallography Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Xue Zhi  Zhao (Chemical Biology Laboratory)",NULL,"1. Kawale AS, Akopiants K, Valerie K, Ruis B, Hendrickson EA, Huang SN, Pommier Y, Povirk LF (2018). TDP1 suppresses mis-joining of radiomimetic DNA double-strand breaks and cooperates with Artemis to promote optimal nonhomologous end joining. Nucleic Acids Res  46, 8926-8939.   https://doi.org/10.1093/nar/gky694|2. Rehman I, Basu SM, Das SK, Bhattacharjee S, Ghosh A, Pommier Y, Das BB (2018). PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexes. Nucleic Acids Res  46, 5601-5617.   https://doi.org/10.1093/nar/gky291|3. Ribeiro CJA, Kankanala J, Shi K, Kurahashi K, Kiselev E, Ravji A, Pommier Y, Aihara H, Wang Z (2018). New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2). Eur J Pharm Sci  118, 67-79.   https://doi.org/10.1016/j.ejps.2018.03.021|4. Yu LM, Hu Z, Chen Y, Ravji A, Lopez S, Plescia CB, Yu Q, Yang H, Abdelmalak M, Saha S, Agama K, Kiselev E, Marchand C, Pommier Y, An LK (2018). Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2). Eur J Med Chem  151, 777-796.   https://doi.org/10.1016/j.ejmech.2018.04.024",https://intramural.nih.gov/search/searchview.taf?ipid=108258
17,BC006161-36,"October 01, 2018 -  September 30, 2019",DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Andrea Simone Baechler|Valentina  Factor|Shar-Yin Naomi Huang|Evgeny Anatolyevich Kiselev; PhD|Ann  Orr|Show all 12,"Mark  Cushman (Medicinal Chemistry, Purdue University)|Takehiro  Yasukawa (University College of London)|Linkun  An (LABORATORY OF MOLECULAR PHARMACOLOGY)|Keith  Caldecott (University of Sussex)|Sherif  El-Khamisy (University of Sussex)|William  Gmeiner (PHARMACOLOGY, WAKE FOREST UNIVERSITY)|Show all 9",Melinda  Hollingshead (Biological Testing Branch)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Beverly Ann Teicher (Molecular Pharmocology Branch),"Keir Cajal Neuman; BA, PhD (NHLBI) |Thomas Anthony Kunkel; PhD (NIEHS) |Weidong  Wang; PhD (NIA)","1. Hegedüs É, Kókai E, Nánási P, Imre L, Halász L, Jossé R, Antunovics Z, Webb MR, El Hage A, Pommier Y, Székvölgyi L, Dombrádi V, Szabó G (2018). Endogenous single-strand DNA breaks at RNA polymerase II promoters in Saccharomyces cerevisiae. Nucleic Acids Res  46, 10649-10668.   https://doi.org/10.1093/nar/gky743|2. Lee HM, Clark EP, Kuijer MB, Cushman M, Pommier Y, Philpot BD (2018). Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome. Mol Autism  9, 45.   https://doi.org/10.1186/s13229-018-0228-2|3. Marzi L, Agama K, Murai J, Difilippantonio S, James A, Peer CJ, Figg WD, Beck D, Elsayed MSA, Cushman M, Pommier Y (2018). Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors. Mol Cancer Ther  17, 1694-1704.   https://doi.org/10.1158/1535-7163.MCT-18-0028",https://intramural.nih.gov/search/searchview.taf?ipid=108259
18,BC006198-30,"October 01, 2018 -  September 30, 2019",Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Sarah Danielle Altman|Ramesh Maruthi Chingle|Kohei  Tsuji|Xue Zhi  Zhao|John Stephen Schneekloth|Joel Patrick Schneider; PhD,"Michael  Yaffe (Massachusetts Institute of Technology)|Christoph  Rader; PhD|Robert  Ulrich (Molecular Immunology, USAMRIID)|Noriko  Takahashi (Hoshi University)",Kyung  Lee; PhD (Laboratory of Metabolism)|David S Waugh; PhD (Protein Engineering Section)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Ruth  Nussinov; PhD (Cancer Inflammation Program),NULL,"1. Hymel D, Grant RA, Tsuji K, Yaffe MB, Burke TR (2018). Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors. Bioorg Med Chem Lett  28, 3202-3205.   https://doi.org/10.1016/j.bmcl.2018.08.018|2. Lountos GT, Raran-Kurussi S, Zhao BM, Dyas BK, Burke TR, Ulrich RG, Waugh DS (2018). High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design. Acta Crystallogr D Struct Biol  74, 1015-1026.   https://doi.org/10.1107/S2059798318011919|3. Zhao XZ, Tsuji K, Hymel D, Burke TR (2019). Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors. Molecules  24.   https://doi.org/10.3390/molecules24081488",https://intramural.nih.gov/search/searchview.taf?ipid=108260
19,BC007333-28,"October 01, 2018 -  September 30, 2019",Pharmacology of HIV Viral DNA and Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Evgeny Anatolyevich Kiselev; PhD|Azhar A Ravji,NULL,Terrence R Burke; PhD (Chemical Biology Laboratory)|Xue Zhi  Zhao (Chemical Biology Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108261
20,BC007363-25,"October 01, 2018 -  September 30, 2019",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Pankaj Shantaram Mahajan; PhD|Xue Zhi  Zhao,"Peter  Cherepanov (Imperial College London)|Arnold  Edward (Rutgers University)|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)|Dmitry  Lyumkis (Salk Institute For Biological Sciences)|Goedele  Maertens (Imperial College London)",Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),Robert  Craigie; PhD (NIDDK),"1. Zhao XZ, Métifiot M, Kiselev E, Kessl JJ, Maddali K, Marchand C, Kvaratskhelia M, Pommier Y, Burke TR (2018). HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence. Molecules  23.   https://doi.org/10.3390/molecules23081858",https://intramural.nih.gov/search/searchview.taf?ipid=108262
21,BC007365-25,"October 01, 2018 -  September 30, 2019",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Olivia Louise Feehan-Nelson|Anjelika  Gasilina|Katie Elizabeth Hebron; PhD|Xiaoying  Jian; PhD|Ruibai  Luo|Neeladri Sekhar Roy; PhD|Show all 7,Elizabeth  Sztul (University of Alabama)|Robert  Kalb|Thomas  Abrams (University of Maryland School of Medicine),"Robert Andrew Byrd (Structural Biophysics Laboratory)|Marielle Elizabeth Yohe (Pediatric Oncology Branch)|Di S Xia; PhD, MS, BS (Crystallography Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|John Frederick Shern (Pediatric Oncology Branch)|Ira  Daar; PhD (Cancer and Developmental Biology Laboratory)",James  Gruschus; PhD (NHLBI) |James Robert Sellers; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108263
22,BC008382-36,"October 01, 2018 -  September 30, 2019",Computational Approaches for RNA Structure and Function Determination,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Eckart  Bindewald|Kazimierz Wojcieck Kasprzak|Tae Jin  Kim|Shuo  Gu|Mikhail V Kashlev,NULL,Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling)|Yun Xing M Wang (Structural Biophysics Laboratory)|Stuart F J Le Grice; PhD (Basic Research Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108264
23,BC008710-42,"October 01, 2018 -  September 30, 2019",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"DNA Molecular Biology Section, NCI",Shannon M Doyle|Audrey Lynne Heffner|Joel R Hoskins|Jui-Yun R Liao|Thu-Lan Lily Nguyen,George  Stan (University of Cincinnati)|Jill  Johnson (University Of Idaho)|Alexandra Monica Deaconescu (BIOCHEMISTRY & BIOPHYSICS CENTER),Leonard  Neckers; PhD (Urologic Oncology Branch)|Susan  Gottesman; PhD (Biochemical Genetics Section),NULL,"1. Balasubramanian A, Markovski M, Hoskins JR, Doyle SM, Wickner S (2019). Hsp90 of E. coli modulates assembly of FtsZ, the bacterial tubulin homolog. Proc Natl Acad Sci U S A  116, 12285-12294.   https://doi.org/10.1073/pnas.1904014116|2. Doyle SM, Hoskins JR, Kravats AN, Heffner AL, Garikapati S, Wickner S (2019). Intermolecular Interactions between Hsp90 and Hsp70. J Mol Biol  431, 2729-2746.   https://doi.org/10.1016/j.jmb.2019.05.026|3. Genest O, Wickner S, Doyle SM (2019). Hsp90 and Hsp70 chaperones: Collaborators in protein remodeling. J Biol Chem  294, 2109-2120.   https://doi.org/10.1074/jbc.REV118.002806|4. Hoskins JR, Wickner S, Doyle SM (2018). Bacterial Hsp90 ATPase Assays. Methods Mol Biol  1709, 199-207.   https://doi.org/10.1007/978-1-4939-7477-1_15|5. Kravats AN, Hoskins JR, Reidy M, Johnson JL, Doyle SM, Genest O, Masison DC, Wickner S (2018). Functional and physical interaction between yeast Hsp90 and Hsp70. Proc Natl Acad Sci U S A  115, E2210-E2219.   https://doi.org/10.1073/pnas.1719969115",https://intramural.nih.gov/search/searchview.taf?ipid=108236
24,BC008714-42,"October 01, 2018 -  September 30, 2019",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Jiandong  Chen|Francois  De Mets|Kumari  Kavita|Nadim  Majdalani|Teppi  Morita|Song  Tong|Show all 7,"Sarah  Woodson (Department of Biophysics, Johns Hopkins University)|Aurelia  Battesti|Teppei  Morita (Suzuka University Of Medical Sciences)|Laurence  Van Melderen (Universit� Libre De Bruxelles)",NULL,"Gisela  Storz; PhD (NICHD) |Susan K Buchanan (NIDDK) |Karen Moore Frank; MD, PhD (CC) |Matthew David Hall (NCATS) |Herbert  Tabor; MD (NIDDK)","1. Chen J, Morita T, Gottesman S (2019). Regulation of Transcription Termination of Small RNAs and by Small RNAs: Molecular Mechanisms and Biological Functions. Front Cell Infect Microbiol  9, 201.   https://doi.org/10.3389/fcimb.2019.00201|2. De Mets F, Van Melderen L, Gottesman S (2019). Regulation of acetate metabolism and coordination with the TCA cycle via a processed small RNA. Proc Natl Acad Sci U S A  116, 1043-1052.   https://doi.org/10.1073/pnas.1815288116|3. Fröhlich KS, Gottesman S (2018). Small Regulatory RNAs in the Enterobacterial Response to Envelope Damage and Oxidative Stress. Microbiol Spectr  6.   https://doi.org/10.1128/microbiolspec.RWR-0022-2018|4. Kavita K, de Mets F, Gottesman S (2018). New aspects of RNA-based regulation by Hfq and its partner sRNAs. Curr Opin Microbiol  42, 53-61.   https://doi.org/10.1016/j.mib.2017.10.014",https://intramural.nih.gov/search/searchview.taf?ipid=108265
25,BC008751-39,"October 01, 2018 -  September 30, 2019",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Sabina  Gudmundsson|Phuoc  Le|Dale  Lewis; PhD|Subhash C Verma|Xiaoli  Weng,Szabolcs  Semsey|Michal  Hammel (Lawrence Berkeley National Laboratory),Victor  Zhurkin; PhD (Laboratory of Cell Biology)|David  Levens; PhD (Laboratory of Pathology),NULL,"1. Wang X, N MPA, Jeon HJ, Lee Y, He J, Adhya S, Lim HM (2019). Processing generates 3' ends of RNA masking transcription termination events in prokaryotes. Proc Natl Acad Sci U S A  116, 4440-4445.   https://doi.org/10.1073/pnas.1813181116",https://intramural.nih.gov/search/searchview.taf?ipid=108266
26,BC008752-39,"October 01, 2018 -  September 30, 2019",Thyroid Hormone Nuclear Receptors in Health and Disease,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Cho Rong  Han|Sunmi  Park|Li  Zhao|Xuguang  Zhu,"G.R.  Williams (Imperial College London, Imperial College London)|Paul M Yen; MD (NIDDK)|Anita  Boelen (Laboratory Of Endocrinology)|Frdric  Flamant (Ecole Normale Sup�rieure De Lyon)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Paul Saiho Liu; PhD (Pharmaceutical Resources Branch)",Yun-Bo  Shi; PhD (NICHD),"1. Bao L, Roediger J, Park S, Fu L, Shi B, Cheng SY, Shi YB (2019). Thyroid Hormone Receptor Alpha Mutations Lead to Epithelial Defects in the Adult Intestine in a Mouse Model of Resistance to Thyroid Hormone. Thyroid  29, 439-448.   https://doi.org/10.1089/thy.2018.0340|2. Freudenthal B, Shetty S, Butterfield NC, Logan JG, Han CR, Zhu X, Astapova I, Hollenberg AN, Cheng SY, Bassett JHD, Williams GR (2019). Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha. Thyroid  29, 726-734.   https://doi.org/10.1089/thy.2018.0399|3. Lee J, Yi S, Chang JY, Kim JT, Sul HJ, Park KC, Zhu X, Cheng SY, Kero J, Kim J, Shong M (2019). Loss of Primary Cilia Results in the Development of Cancer in the Murine Thyroid Gland. Mol Cells  42, 113-122.   https://doi.org/10.14348/molcells.2018.0430|4. Thakur S, Daley B, Gaskins K, Vasko VV, Boufraqech M, Patel D, Sourbier C, Reece J, Cheng SY, Kebebew E, Agarwal S, Klubo-Gwiezdzinska J (2018). Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo. Clin Cancer Res  24, 4030-4043.   https://doi.org/10.1158/1078-0432.CCR-17-3167",https://intramural.nih.gov/search/searchview.taf?ipid=108267
27,BC008753-37,"October 01, 2018 -  September 30, 2019",Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Richard A Beers|Tapan K Bera|Alexander  Chan|Noah Lejiang Chen|Dominique N Daly|Wenlong  Liu|Show all 13,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|Satoshi  Nagata (Sanford Research/USD)|Ulrich  Brinkmann (NCI)|Mascha  Binder (Universit�tsklinikum Hamburg Eppendorf)|Bruce  Molitoris (Indiana University School Of Medicine)|Francis Jay Mussai|Show all 8","David J Fitzgerald; PhD (Biotherapy Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Raffit  Hassan (Thoracic and GI Malignancies Branch)|Hisataka  Kobayashi (Molecular Imaging Program)|Serguei V Kozlov (Office of the Director)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)",NULL,"1. Bera TK, Abe Y, Ise T, Oberle A, Gallardo D, Liu XF, Nagata S, Binder M, Pastan I (2018). Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients. Leukemia  32, 569-572.   https://doi.org/10.1038/leu.2017.315|2. Chandramohan V, Bao X, Yu X, Parker S, McDowall C, Yu YR, Healy P, Desjardins A, Gunn MD, Gromeier M, Nair SK, Pastan IH, Bigner DD (2019). Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations. J Immunother Cancer  7, 142.   https://doi.org/10.1186/s40425-019-0614-0|3. Kaplan G, Mazor R, Lee F, Jang Y, Leshem Y, Pastan I (2018). Improving the In Vivo Efficacy of an Anti-Tac (CD25) Immunotoxin by Pseudomonas Exotoxin A Domain II Engineering. Mol Cancer Ther  17, 1486-1493.   https://doi.org/10.1158/1535-7163.MCT-17-1041|4. King EM, Mazor R, Çuburu N, Pastan I (2018). Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin. J Immunol  200, 2038-2045.   https://doi.org/10.4049/jimmunol.1701430|5. Leshem Y, King EM, Mazor R, Reiter Y, Pastan I (2018). SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma Tumors. Toxins (Basel)  10.   https://doi.org/10.3390/toxins10110470|6. Leshem Y, Pastan I (2019). Pseudomonas Exotoxin Immunotoxins and Anti-Tumor Immunity: From Observations at the Patient's Bedside to Evaluation in Preclinical Models. Toxins (Basel)  11.   https://doi.org/10.3390/toxins11010020|7. Müller F, Cunningham T, Beers R, Bera TK, Wayne AS, Pastan I (2018). Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia. Toxins (Basel)  10.   https://doi.org/10.3390/toxins10050210|8. Mayer K, Mundigl O, Kettenberger H, Birzele F, Stahl S, Pastan I, Brinkmann U (2019). Diphthamide affects selenoprotein expression: Diphthamide deficiency reduces selenocysteine incorporation, decreases selenite sensitivity and pre-disposes to oxidative stress. Redox Biol  20, 146-156.   https://doi.org/10.1016/j.redox.2018.09.015|9. Mazor R, King E, Pastan I (2018). Anti-drug antibodies to LMB-100 are enhanced by mAbs targeting OX40 and CTLA4 but not by mAbs targeting PD1 or PDL-1. Cell Immunol  334, 38-41.   https://doi.org/10.1016/j.cellimm.2018.08.016|10. Mazor R, King EM, Onda M, Cuburu N, Addissie S, Crown D, Liu XF, Kishimoto TK, Pastan I (2018). Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity. Proc Natl Acad Sci U S A  115, E733-E742.   https://doi.org/10.1073/pnas.1717063115|11. Mazor R, King EM, Pastan I (2018). Strategies to Reduce the Immunogenicity of Recombinant Immunotoxins. Am J Pathol  188, 1736-1743.   https://doi.org/10.1016/j.ajpath.2018.04.016|12. Onda M, Kobayashi K, Pastan I (2019). Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity. Proc Natl Acad Sci U S A  116, 4575-4582.   https://doi.org/10.1073/pnas.1820388116|13. Shancer Z, Liu XF, Nagata S, Zhou Q, Bera TK, Pastan I (2019). Anti-BCMA immunotoxins produce durable complete remissions in two mouse myeloma models. Proc Natl Acad Sci U S A  116, 4592-4598.   https://doi.org/10.1073/pnas.1821733116|14. Shancer Z, Williams M, Igelman A, Nagata S, Ise T, Pastan I, Bera TK (2018). Preclinical development of anti-BCMA immunotoxins targeting multiple myeloma. Antib Ther  1, 19-25.   https://doi.org/10.1093/abt/tby004|15. Wei J, Bera TK, Liu XF, Zhou Q, Onda M, Ho M, Tai CH, Pastan I (2018). Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity. Proc Natl Acad Sci U S A  115, E3501-E3508.   https://doi.org/10.1073/pnas.1721780115|16. Yu X, Dobrikov M, Keir ST, Gromeier M, Pastan IH, Reisfeld R, Bigner DD, Chandramohan V (2019). Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors. PLoS One  14, e0210608.   https://doi.org/10.1371/journal.pone.0210608",https://intramural.nih.gov/search/searchview.taf?ipid=108268
28,BC008756-32,"October 01, 2018 -  September 30, 2019",Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kerrie Leanne Marie|Helen Thompson Michael|Antonella  Sassano|Yanlin  Yu,"Edward  De Fabo (GWU)|Hitoshi  Takagi (First Dept of Internal Medicien, Gunma University School of Medicine)|Thomas  Tuting (Dermatology, University of Bonn)|Dot  Bennett (St. George's Hospital Medical School)|Ron  DePinho (Dana Farber, Harvard)|Chris  Counter (Duke University)|Show all 9","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Margaret Anne Tucker (Human Genetics Program)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Curtis  Henrich (Molecular Targets Laboratory)|Norman Edward Sharpless; MD (Office Of The Director)|Howard A Young; PhD (Cancer Inflammation Program)",Heinz  Arnheiter; MD (NINDS) |William James Pavan; PhD (NHGRI),"1. Harris ML, Fufa TD, Palmer JW, Joshi SS, Larson DM, Incao A, Gildea DE, Trivedi NS, Lee AN, Day CP, Michael HT, Hornyak TJ, Merlino G, NISC Comparative Sequencing Program, Pavan WJ (2018). A direct link between MITF, innate immunity, and hair graying. PLoS Biol  16, e2003648.   https://doi.org/10.1371/journal.pbio.2003648|2. Huang L, Qin Y, Zuo Q, Bhatnagar K, Xiong J, Merlino G, Yu Y (2018). Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma. Int J Cancer  142, 1652-1663.   https://doi.org/10.1002/ijc.31196|3. Marie KL, Merlino G (2019). Something Old, Something New: The Tumor Microenvironment Comes of Age. Cancer Discov  9, 19-21.   https://doi.org/10.1158/2159-8290.CD-18-1320|4. Yu Y, Dai M, Lu A, Yu E, Merlino G (2018). PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation. Oncogene  37, 2225-2236.   https://doi.org/10.1038/s41388-017-0061-7|5. Zuo Q, Liu J, Huang L, Qin Y, Hawley T, Seo C, Merlino G, Yu Y (2018). AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma. Oncogene  37, 3275-3289.   https://doi.org/10.1038/s41388-018-0205-4",https://intramural.nih.gov/search/searchview.taf?ipid=108269
29,BC008757-32,"October 01, 2018 -  September 30, 2019",Bio-Therapies for the Treatment of Cancer,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Biotherapy Section, NCI","Antonella  Antignani; BS, PhD",NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Christine Campo Alewine (Laboratory of Molecular Biology)|Ira H Pastan; MD (Molecular Biology Section)|Raffit  Hassan (Thoracic and GI Malignancies Branch)",Massimo Giulio Gadina; PhD (NIAMS) |Michael J Iadarola; PhD (CC) |Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108270
30,BC008905-38,"October 01, 2018 -  September 30, 2019",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Meghan Faith Anderman|Luciarita  Boccuzzi|Marian E Durkin|Sarah  Eng|Alexander G Papageorge|Xiaolan  Qian; MD, PhD|Show all 9",Steven J Carr|Igor  Barsukov (University of Liverpool),NULL,NULL,"1. Çuburu N, Kim R, Guittard GC, Thompson CD, Day PM, Hamm DE, Pang YS, Graham BS, Lowy DR, Schiller JT (2019). A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8+ Memory T Cells. J Immunol  202, 1250-1264.   https://doi.org/10.4049/jimmunol.1800219|2. Ashraf S, Kudo H, Rao J, Kikuchi A, Widmeier E, Lawson JA, Tan W, Hermle T, Warejko JK, Shril S, Airik M, Jobst-Schwan T, Lovric S, Braun DA, Gee HY, Schapiro D, Majmundar AJ, Sadowski CE, Pabst WL, Daga A, van der Ven AT, Schmidt JM, Low BC, Gupta AB, Tripathi BK, et al. [40 more authors] (2018). Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment. Nat Commun  9, 1960.   https://doi.org/10.1038/s41467-018-04193-w|3. Sánchez-Martín D, Otsuka A, Kabashima K, Ha T, Wang D, Qian X, Lowy DR, Tosato G (2018). Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression. J Natl Cancer Inst  110, 390-399.   https://doi.org/10.1093/jnci/djx219",https://intramural.nih.gov/search/searchview.taf?ipid=108271
31,BC009052-30,"October 01, 2018 -  September 30, 2019",Understanding Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Nicolas  Cuburu; PhD|Patricia  Day; PhD|Rhonda C Kines|Yuk Ying S Pang|Cynthia D Thompson|Douglas  Lowy; MD,Richard  Roden (Johns Hopkins University)|Bryce  Chackerian (University of New Mexico)|Elisabet  de los Pinos (Aura Biosciences Inc.)|Ali  Salanti (University of Copenhagen)|Gert  Scheper (Crucell/Johnson&Johnson),Ligia  Pinto (Infection & Immunoepidemiology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Aimee Rebecca Kreimer (Infection & Immunoepidemiology Branch)|Peter L Choyke; MD (Molecular Imaging Program),"Barney S Graham; MD, PhD (NIAID) |Jeffrey  Cohen; MD (NIAID) |Alan T Remaley; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108272
32,BC009265-37,"October 01, 2018 -  September 30, 2019",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Farrah Ali Alkhaleel|Sofia Io Celli|Ying  Lu|Masashi  Watanabe|Paul A Roche; PhD,"Gail  Bishop (University of Iowa)|Rafi  Ahmed; PhD (Emory Vacine Center, Emory University)",Louis  Staudt; MD (Lymphoid Malignancies Branch),"Nan-Ping  Weng; MD, PhD (NIA)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108273
33,BC009273-32,"October 01, 2018 -  September 30, 2019",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Jennifer Marie Ashe|Mohamedelsherif G Gadelhaq Badr|Abhisek  Bhattacharya; PhD|Terry I Guinter|Yasuko Mary Mano|Show all 13,"Batu M Erman|Deitmar  Kappes (Immunology, Fox Chase Cancer Center)|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)|Ed  Palmer (University of Basel)|Gunter  Bernhardt (Hannover Medical School)",Naomi  Taylor (Pediatric Oncology Branch),"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108274
34,BC009281-33,"October 01, 2018 -  September 30, 2019",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Farrah Ali Alkhaleel|Yungping  Chiang|Ying  Lu|Masashi  Watanabe|Ray  Zhang|Paul A Roche; PhD,NULL,NULL,Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108276
35,BC009283-35,"October 01, 2018 -  September 30, 2019",Consequences of chronic Interferon-gamma expression on the host,Howard A Young; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI","Cara Elizabeth Fliegel|Megan Marie Hess|Tomoaki  Hoshino; MD, PhD|Morgan Brianna Johnson|Michael E Sanford|Aleena  Shahab|Show all 12",Monika  Wolkers (Sanquin)|M  Gershwin (University of Califernia at Davis)|Zia  Rahman (Penn State Univ. College of Medicine),Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Danielle A Springer; VMD (NHLBI) |Miles  Herkenham; PhD (NIMH) |Michael N Sack; MD (NHLBI) |Ethan M Shevach; MD (NIAID),"1. Bae HR, Hodge DL, Yang GX, Leung PSC, Chodisetti SB, Valencia JC, Sanford M, Fenimore JM, Rahman ZSM, Tsuneyama K, Norman GL, Gershwin ME, Young HA (2018). The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex-biased autoimmunity. Hepatology  67, 1408-1419.   https://doi.org/10.1002/hep.29524|2. Baez NS, Cerbán F, Savid-Frontera C, Hodge DL, Tosello J, Acosta-Rodriguez E, Almada L, Gruppi A, Viano ME, Young HA, Rodriguez-Galan MC (2019). Thymic expression of IL-4 and IL-15 after systemic inflammatory or infectious Th1 disease processes induce the acquisition of ""innate"" characteristics during CD8+ T cell development. PLoS Pathog  15, e1007456.   https://doi.org/10.1371/journal.ppat.1007456|3. Braffett BH, Rice MM, Young HA, Lachin JM (2019). Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes. PLoS One  14, e0210367.   https://doi.org/10.1371/journal.pone.0210367|4. Goedhart M, Cornelissen AS, Kuijk C, Geerman S, Kleijer M, van Buul JD, Huveneers S, Raaijmakers MHGP, Young HA, Wolkers MC, Voermans C, Nolte MA (2018). Interferon-Gamma Impairs Maintenance and Alters Hematopoietic Support of Bone Marrow Mesenchymal Stromal Cells. Stem Cells Dev  27, 579-589.   https://doi.org/10.1089/scd.2017.0196|5. Kuppusamy B, Young HA (2019). Partners in Crime: Fledgling Tumors Hijack Inflammation. J Interferon Cytokine Res  39, 1-5.   https://doi.org/10.1089/jir.2018.29011.bku|6. Menk AV, Scharping NE, Moreci RS, Zeng X, Guy C, Salvatore S, Bae H, Xie J, Young HA, Wendell SG, Delgoffe GM (2018). Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions. Cell Rep  22, 1509-1521.   https://doi.org/10.1016/j.celrep.2018.01.040|7. O'Brien TR, Young HA, Donnelly RP, Prokunina-Olsson L (2019). Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential. J Interferon Cytokine Res  39, 586-591.   https://doi.org/10.1089/jir.2019.0018|8. Salerno F, Engels S, van den Biggelaar M, van Alphen FPJ, Guislain A, Zhao W, Hodge DL, Bell SE, Medema JP, von Lindern M, Turner M, Young HA, Wolkers MC (2018). Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells. Nat Immunol  19, 828-837.   https://doi.org/10.1038/s41590-018-0155-6|9. Salerno F, Guislain A, Freen-Van Heeren JJ, Nicolet BP, Young HA, Wolkers MC (2019). Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells. Oncoimmunology  8, e1532762.   https://doi.org/10.1080/2162402X.2018.1532762|10. Tanaka A, Leung PSC, Young HA, Gershwin ME (2018). Therapeutic and immunological interventions in primary biliary cholangitis: from mouse models to humans. Arch Med Sci  14, 930-940.   https://doi.org/10.5114/aoms.2017.70995|11. Young HA, Gaylor CM, de Kerckhove D, Watkins H, Benton D (2019). Interoceptive accuracy moderates the response to a glucose load: a test of the predictive coding framework. Proc Biol Sci  286, 20190244.   https://doi.org/10.1098/rspb.2019.0244",https://intramural.nih.gov/search/searchview.taf?ipid=108277
36,BC009287-35,"October 01, 2018 -  September 30, 2019",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Julie  Hixon|Wenqing  Li|Hila  Winer Yanai; PhD,Joao  Barata (U.Lisbon)|Richard  Hotchkiss (Wash U)|Scott  Walsh (University of Maryland)|Terry J Fry (NCI),Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Peter D Aplan; MD (Cancer Genetics Branch),NULL,"1. Akkapeddi P, Fragoso R, Hixon JA, Ramalho AS, Oliveira ML, Carvalho T, Gloger A, Matasci M, Corzana F, Durum SK, Neri D, Bernardes GJL, Barata JT (2019). A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia. Leukemia  33, 2155-2168.   https://doi.org/10.1038/s41375-019-0434-8|2. Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmelé T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS (2018). Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight  3.   https://doi.org/10.1172/jci.insight.98960|3. Marchitto MC, Dillen CA, Liu H, Miller RJ, Archer NK, Ortines RV, Alphonse MP, Marusina AI, Merleev AA, Wang Y, Pinsker BL, Byrd AS, Brown ID, Ravipati A, Zhang E, Cai SS, Limjunyawong N, Dong X, Yeaman MR, Simon SI, Shen W, Durum SK, O'Brien RL, Maverakis E, Miller LS (2019). Clonal Vγ6+Vδ4+ T cells promote IL-17-mediated immunity against Staphylococcus aureus skin infection. Proc Natl Acad Sci U S A  116, 10917-10926.   https://doi.org/10.1073/pnas.1818256116|4. Senkevitch E, Li W, Hixon JA, Andrews C, Cramer SD, Pauly GT, Back T, Czarra K, Durum SK (2018). Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations. Oncotarget  9, 22605-22617.   https://doi.org/10.18632/oncotarget.25194",https://intramural.nih.gov/search/searchview.taf?ipid=108278
37,BC009369-29,"October 01, 2018 -  September 30, 2019",Studies of Receptor Interactions and Effects of Alarmins,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Md Masud Alam|Xiao-Qing  Li|Anna Lee  Trivett|De  Yang|Sean Matthew Hannifin|Imene  Jridi; PhD|Show all 11,Feng  Wei|Oystein  Rekdal (Lytix Biopharma)|W  Wu (University of Maryland)|Richard  Jewell (University of Maryland)|Xin  Chen (University Of Macao)|Michael  Zasloff (Georgetown University)|Show all 10,Michael  Bustin; PhD (Laboratory of Metabolism)|Joseph John Barchi (Chemical Biology Laboratory)|Bruce Allen Shapiro; PhD (Rna Biology Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory)|Lino  Tessarollo (Mouse Cancer Genetics Program),NULL,"1. Arts RJW, Huang PK, Yang, Joosten LAB, van der Meer JWM, Oppenheim JJ, Netea MG, Cheng SC (2018). High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells. Front Immunol  9, 526.   https://doi.org/10.3389/fimmu.2018.00526|2. Chen CY, Ueha S, Ishiwata Y, Yokochi S, Yang, Oppenheim JJ, Ogiwara H, Shichino S, Deshimaru S, Shand FHW, Shibayama S, Matsushima K (2019). Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice. J Immunother Cancer  7, 21.   https://doi.org/10.1186/s40425-019-0503-6|3. Oppenheim JJ (2018). The Future of the Cytokine Discipline. Cold Spring Harb Perspect Biol  10.   https://doi.org/10.1101/cshperspect.a028498|4. Yang, Han Z, Alam MM, Oppenheim JJ (2018). High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin. Semin Immunol  38, 49-53.   https://doi.org/10.1016/j.smim.2018.02.012",https://intramural.nih.gov/search/searchview.taf?ipid=108279
38,BC009392-27,"October 01, 2018 -  September 30, 2019",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Martha Iveth Garcia; PhD|Jennifer B Mariano|Meredith Boyle Metzger; PhD|Claudia Isabella Meyer|Christopher Edward Smith|Yien-Che  Tsai|Show all 8,Joseph  Roitelman|Mickael  Cohen (IBPC)|Jeffrey  Brodsky (University of Pittsburgh)|Christopher  Lima (Sloan Kettering Cancer Center),Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,"1. Hann ZS, Metzger MB, Weissman AM, Lima CD (2019). Crystal structure of the Schizosaccharomyces pombe U7BR E2-binding region in complex with Ubc7. Acta Crystallogr F Struct Biol Commun  75, 552-560.   https://doi.org/10.1107/S2053230X19009786",https://intramural.nih.gov/search/searchview.taf?ipid=108230
39,BC009404-25,"October 01, 2018 -  September 30, 2019",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Joanna Marta Bandola-Simon; PhD|Kyung Jin  Cho|Karis  Faust|Sunil  Kaul|Hei Jung  Kim|Even  Walseng,"Lisa  Denzin (Immunology Program, Sloan-Kettering Institute)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|James  Drake (NCI)|Laurence  Eisenlohr (University of Pennsylvania)|J  Blander (Icahn School of Medicine at Mount Sinai)|Show all 7",NULL,NULL,"1. Bhagwandin C, Ashbeck EL, Whalen M, Bandola-Simon J, Roche PA, Szajman A, Truong SM, Wertheim BC, Klimentidis YC, Ishido S, Renquist BJ, Lybarger L (2018). The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner. PLoS One  13, e0204898.   https://doi.org/10.1371/journal.pone.0204898|2. Jung HS, Cho KJ, Seol Y, Takagi Y, Dittmore A, Roche PA, Neuman KC (2018). Polydopamine encapsulation of fluorescent nanodiamonds for biomedical applications. Adv Funct Mater  28.   https://doi.org/10.1002/adfm.201801252|3. Kaul S, Mittal SK, Roche PA (2018). A major isoform of the E3 ubiquitin ligase March-I in antigen-presenting cells has regulatory sequences within its gene. J Biol Chem  293, 4478-4485.   https://doi.org/10.1074/jbc.RA118.001775|4. Lei L, Bandola-Simon J, Roche PA (2018). Ubiquitin-conjugating enzyme E2 D1 (Ube2D1) mediates lysine-independent ubiquitination of the E3 ubiquitin ligase March-I. J Biol Chem  293, 3904-3912.   https://doi.org/10.1074/jbc.RA117.001322",https://intramural.nih.gov/search/searchview.taf?ipid=108280
40,BC009405-25,"October 01, 2018 -  September 30, 2019",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Joseph Byung Hoon An|Yungping  Chiang|Karen  Hathcock|Max F Xu,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch),"Francis S Collins; MD, PhD (OD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108281
41,BC010001-24,"October 01, 2018 -  September 30, 2019",Molecular-Cellular Regulation of Hematopoietic Stem Cells,Jonathan  Keller; PhD,NULL,"Mouse Cancer Genetics Program, NCI",Brad Lamar Jakubison; PhD|Tanmoy  Sarkar; PhD|Shweta  Singh; PhD|Kathrin  Muegge; MD|Lino  Tessarollo,NULL,"Laura  Schmidt (Urologic Oncology Branch)|Jairaj K Acharya; MBBS, PhD (Cancer and Developmental Biology Laboratory)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108282
42,BC010006-24,"October 01, 2018 -  September 30, 2019",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Jerlin  Garo|Yoo-Seok  Hwang|Moonsup  Lee|Jian  Sun; PhD|Jaeho  Yoon; PhD,Sally  Moody (George Washington University Medical Center)|Hee Jun  Cho; PhD|Peter  Nemes (University Of Maryland-college Park),NULL,NULL,"1. Lee M, Hwang YS, Yoon J, Sun J, Harned A, Nagashima K, Daar IO (2019). Developmentally regulated GTP-binding protein 1 modulates ciliogenesis via an interaction with Dishevelled. J Cell Biol  218, 2659-2676.   https://doi.org/10.1083/jcb.201811147",https://intramural.nih.gov/search/searchview.taf?ipid=108283
43,BC010008-24,"October 01, 2018 -  September 30, 2019",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Vincent Keith Hughitt|Kathleen Connolly Jevtich|Patricia Ann Wiley|Ke  Zhang|Shuling  Zhang; MD, PhD|Robert Mark Simpson; DVM, PhD",NULL,NULL,NULL,"1. Gearhart PJ, Mock BA, Casellas R, Cancro MP (2018). The Reign of Antibodies: A Celebration of and Tribute to Michael Potter and His Homogeneous Immunoglobulin Workshops. J Immunol  200, 23-26.   https://doi.org/10.4049/jimmunol.1701516",https://intramural.nih.gov/search/searchview.taf?ipid=108284
44,BC010013-24,"October 01, 2018 -  September 30, 2019",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Cancer Inflammation Program, NCI","Frederick Joseph Goodson-Gregg|Hong-Chuan  Li|Paul  Wright|Mary  Carrington; MS, PhD|Daniel  McVicar; PhD",Jeffrey  Miller (University of Minnesota Cancer Center)|Taku  Kambayashi (University of Pennsylvania)|Martin  Ivarsson (Karolinska)|Aharon  Freud (Ohio State University Comprehensive Cancer Center)|Savan  Ram (University of Washington)|Michael  Verneris (University of Minnesota),NULL,NULL,"1. Anderson SK (2018). Molecular evolution of elements controlling HLA-C expression: Adaptation to a role as a killer-cell immunoglobulin-like receptor ligand regulating natural killer cell function. HLA  92, 271-278.   https://doi.org/10.1111/tan.13396|2. Johnson JK, Wright PW, Li H, Anderson SK (2018). Identification of trophoblast-specific elements in the HLA-C core promoter. HLA  92, 288-297.   https://doi.org/10.1111/tan.13404|3. Li H, Anderson SK (2018). Association of TNFRSF1B Promoter Polymorphisms with Human Disease: Further Studies Examining T-Regulatory Cells Are Required. Front Immunol  9, 443.   https://doi.org/10.3389/fimmu.2018.00443|4. Li H, Ivarsson MA, Walker-Sperling VE, Subleski J, Johnson JK, Wright PW, Carrington M, Björkström NK, McVicar DW, Anderson SK (2018). Identification of an elaborate NK-specific system regulating HLA-C expression. PLoS Genet  14, e1007163.   https://doi.org/10.1371/journal.pgen.1007163|5. Lou H, Li H, Ho KJ, Cai LL, Huang AS, Shank TR, Verneris MR, Nickerson ML, Dean M, Anderson SK (2019). The Human TET2 Gene Contains Three Distinct Promoter Regions With Differing Tissue and Developmental Specificities. Front Cell Dev Biol  7, 99.   https://doi.org/10.3389/fcell.2019.00099",https://intramural.nih.gov/search/searchview.taf?ipid=108286
45,BC010014-24,"October 01, 2018 -  September 30, 2019",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Mouse Cancer Genetics Program, NCI",Yafeng  He|Kai  Ni; PhD|Andrew James Schwader|Xiaoping  Xu,NULL,Margaret  Cam; PhD (Office of the Director)|Richard Phillip Finney (Office of the Director),NULL,"1. Yan B, Liu S, Shi Y, Liu N, Chen L, Wang X, Xiao D, Liu X, Mao C, Jiang Y, Lai W, Xin X, Tang CE, Luo D, Tan T, Jia J, Liu Y, Yang R, Huang J, Zhou H, Cheng Y, Cao Y, Yu W, Muegge K, Tao Y (2018). Activation of AhR with nuclear IKKα regulates cancer stem-like properties in the occurrence of radioresistance. Cell Death Dis  9, 490.   https://doi.org/10.1038/s41419-018-0542-9",https://intramural.nih.gov/search/searchview.taf?ipid=108287
46,BC010015-24,"October 01, 2018 -  September 30, 2019",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Keqiang  Chen|Wang Hua  Gong|Weiwei  Liang,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,NULL,"1. Chen K, Bao Z, Tang P, Gong W, Yoshimura T, Wang JM (2018). Chemokines in homeostasis and diseases. Cell Mol Immunol  15, 324-334.   https://doi.org/10.1038/cmi.2017.134|2. Chen X, Zhuo S, Zhu T, Yao P, Yang M, Mei H, Li N, Ma F, Wang JM, Chen S, Ye RD, Li Y, Le Y (2019). Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization. Diabetes  68, 1130-1142.   https://doi.org/10.2337/db18-0469|3. Ji C, Yang L, Yi W, Xiang D, Wang Y, Zhou Z, Qian F, Ren Y, Cui W, Zhang X, Zhang P, Wang JM, Cui Y, Bian X (2018). Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/β-catenin pathway. Oncogene  37, 3953-3966.   https://doi.org/10.1038/s41388-018-0226-z|4. Kim SY, Zhang F, Gong W, Chen K, Xia K, Liu F, Gross R, Wang JM, Linhardt RJ, Cotten ML (2018). Copper regulates the interactions of antimicrobial piscidin peptides from fish mast cells with formyl peptide receptors and heparin. J Biol Chem  293, 15381-15396.   https://doi.org/10.1074/jbc.RA118.001904|5. Tang P, Wang JM (2018). Chemokines: the past, the present and the future. Cell Mol Immunol  15, 295-298.   https://doi.org/10.1038/cmi.2018.9|6. Wang Q, Jiang J, Ying G, Xie XQ, Zhang X, Xu W, Zhang X, Song E, Bu H, Ping YF, Yao XH, Wang B, Xu S, Yan ZX, Tai Y, Hu B, Qi X, Wang YX, He ZC, Wang Y, Wang JM, Cui YH, Chen F, Meng K, Wang Z, et al. [1 more author] (2018). Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells. Cell Res  28, 336-358.   https://doi.org/10.1038/cr.2018.15|7. Wen X, Xu X, Sun W, Chen K, Pan M, Wang JM, Bolland SM, Jin T (2019). G-protein-coupled formyl peptide receptors play a dual role in neutrophil chemotaxis and bacterial phagocytosis. Mol Biol Cell  30, 346-356.   https://doi.org/10.1091/mbc.E18-06-0358",https://intramural.nih.gov/search/searchview.taf?ipid=108288
47,BC010017-24,"October 01, 2018 -  September 30, 2019","Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Shayla Elizabeth Hesse; MD|Joy Christine Johnson|Phuoc  Le|Manoj  Rajaure,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108289
48,BC010020-24,"October 01, 2018 -  September 30, 2019",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Barbara  Debrah|Sonya C Duke,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|Alan S Wayne; MD","Christine Campo Alewine (Laboratory of Molecular Biology)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Raffit  Hassan (Thoracic and GI Malignancies Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Nirali Niranjan Shah (Pediatric Oncology Branch)",NULL,"1. Bokori-Brown M, Metz J, Petrov PG, Mussai F, De Santo C, Smart NJ, Saunders S, Knight B, Pastan I, Titball RW, Winlove CP (2018). Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy. Front Oncol  8, 553.   https://doi.org/10.3389/fonc.2018.00553|2. Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Karlin L, Robak T, Gladstone DE, le Coutre P, Dietrich S, Gotic M, Larratt L, Offner F, Schiller G, Swords R, Bacon L, Bocchia M, Bouabdallah K, Breems DA, Cortelezzi A, Dinner S, Doubek M, Gjertsen BT, Gobbi M, Hellmann A, Lepretre S, et al. [18 more authors] (2018). Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia. Leukemia  32, 1768-1777.   https://doi.org/10.1038/s41375-018-0210-1",https://intramural.nih.gov/search/searchview.taf?ipid=108290
49,BC010021-24,"October 01, 2018 -  September 30, 2019",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Corinne A Boulanger-Espeut|Jabril Rahim Johnson|Kimberly Stephanie Meza|Lauren Elizabeth Ragle,Cathrin  Brisken (ISREC/EPFL)|Robert D Bruno|Brian  Booth,NULL,Justin Britt Lack (NIAID),"1. Johnson JR, Boulanger CA, Hudson T, Savage E, Smith GH (2019). Microarray and pathway analysis of two COMMA-Dβ derived clones reveal important differences relevant to their developmental capacity in-vivo. Oncotarget  10, 2118-2135.   https://doi.org/10.18632/oncotarget.26655|2. Ragle LE, Bruno RD, Boulanger CA, Smith GH (2019). Long-label-retaining mammary epithelial cells are created early in ductal development and distributed throughout the branching ducts. Mech Dev  159, 103565.   https://doi.org/10.1016/j.mod.2019.103565|3. Smith GH, Medina D (2018). Does the Mouse Mammary Gland Arise from Unipotent or Multipotent Mammary Stem/Progenitor Cells? J Mammary Gland Biol Neoplasia  23, 1-3.   https://doi.org/10.1007/s10911-018-9394-2",https://intramural.nih.gov/search/searchview.taf?ipid=108291
50,BC010022-24,"October 01, 2018 -  September 30, 2019",Genetics of Complex Diseases and Health Disparities,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI","Elizabeth  Binns-Roemer|Sungkweon  Cho; MD, PhD|Victor A David|Sophie Mh Limou",Rajendra  Bhimma (University of KwaZulu-Natal)|Michael  Lipkowitz (Georgetown University)|Rakhi  Naik (Johns Hopkins University)|Saraladevi  Naicker (University of the Witwatersrand)|Frederick  Kaskel (Albert Einstein College of Medicine)|Carmen  Peralta (University of California at San Francisco)|Show all 14,George  Nelson (Office of the Director)|Stephen J Lockett; PhD (Office Of The Director)|Randall C Johnson (Office Of The Director)|Frank  Maldarelli (Host Virus Interaction Branch),Jeffrey Burnett Kopp; MD (NIDDK),"1. Asharam K, Bhimma R, David VA, Coovadia HM, Qulu WP, Naicker T, Gillies CE, Vega-Warner V, Johnson RC, Limou S, Kopp JB, Sampson M, Nelson GW, Winkler CA (2018). NPHS2 V260E Is a Frequent Cause of Steroid-Resistant Nephrotic Syndrome in Black South African Children. Kidney Int Rep  3, 1354-1362.   https://doi.org/10.1016/j.ekir.2018.07.017|2. Chacón-Duque JC, Adhikari K, Fuentes-Guajardo M, Mendoza-Revilla J, Acuña-Alonzo V, Barquera R, Quinto-Sánchez M, Gómez-Valdés J, Everardo Martínez P, Villamil-Ramírez H, Hünemeier T, Ramallo V, Silva de Cerqueira CC, Hurtado M, Villegas V, Granja V, Villena M, Vásquez R, Llop E, Sandoval JR, Salazar-Granara AA, Parolin ML, Sandoval K, Peñaloza-Espinosa RI, Rangel-Villalobos H, et al. [25 more authors] (2018). Latin Americans show wide-spread Converso ancestry and imprint of local Native ancestry on physical appearance. Nat Commun  9, 5388.   https://doi.org/10.1038/s41467-018-07748-z|3. Cho SK, Winkler CA, Lee SJ, Chang Y, Ryu S (2019). The Prevalence of Hyperuricemia Sharply Increases from the Late Menopausal Transition Stage in Middle-Aged Women. J Clin Med  8.   https://doi.org/10.3390/jcm8030296|4. David VA, Binns-Roemer EA, Winkler CA (2019). Taqman Assay for Genotyping CKD-Associated APOL1 SNP rs60910145: A Cautionary Note. Kidney Int Rep  4, 184-185.   https://doi.org/10.1016/j.ekir.2018.09.018|5. Doshi MD, Ortigosa-Goggins M, Garg AX, Li L, Poggio ED, Winkler CA, Kopp JB (2018). APOL1 Genotype and Renal Function of Black Living Donors. J Am Soc Nephrol  29, 1309-1316.   https://doi.org/10.1681/ASN.2017060658|6. Douce DR, Soliman EZ, Naik R, Hyacinth HI, Cushman M, Winkler CA, Howard G, Lange EM, Lange LA, Irvin MR, Zakai NA (2019). Association of sickle cell trait with atrial fibrillation: The REGARDS cohort. J Electrocardiol  55, 1-5.   https://doi.org/10.1016/j.jelectrocard.2019.04.010|7. Franceschini N, Kopp JB, Barac A, Martin LW, Li Y, Qian H, Reiner AP, Pollak M, Wallace RB, Rosamond WD, Winkler CA (2018). Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women. JAMA Cardiol  3, 712-720.   https://doi.org/10.1001/jamacardio.2018.1827|8. Gutiérrez OM, Irvin MR, Chaudhary NS, Cushman M, Zakai NA, David VA, Limou S, Pamir N, Reiner AP, Naik RP, Sale MM, Safford MM, Hyacinth HI, Judd SE, Kopp JB, Winkler CA (2018). APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults. Circ Genom Precis Med  11, e002098.   https://doi.org/10.1161/CIRCGEN.117.002098|9. Gutiérrez OM, Limou S, Lin F, Peralta CA, Kramer HJ, Carr JJ, Bibbins-Domingo K, Winkler CA, Lewis CE, Kopp JB (2018). APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults. Kidney Int  93, 727-732.   https://doi.org/10.1016/j.kint.2017.08.019|10. Hughson MD, Hoy WE, Mott SA, Bertram JF, Winkler CA, Kopp JB (2018). APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death. Kidney Int Rep  3, 89-98.   https://doi.org/10.1016/j.ekir.2017.08.007|11. Hyacinth HI, Carty CL, Seals SR, Irvin MR, Naik RP, Burke GL, Zakai NA, Wilson JG, Franceschini N, Winkler CA, David VA, Kopp JB, Judd SE, Adams RJ, Longstreth WT, Egede L, Lackland DT, Taylor H, Manson JE, Howard V, Allison M, Gee BE, Correa A, Safford MM, Arnett DK, et al. [3 more authors] (2018). Association of Sickle Cell Trait With Ischemic Stroke Among African Americans: A Meta-analysis. JAMA Neurol  75, 802-807.   https://doi.org/10.1001/jamaneurol.2018.0571|12. Kopp JB, Winkler CA (2018). Genetics, Genomics, and Precision Medicine in End-Stage Kidney Disease. Semin Nephrol  38, 317-324.   https://doi.org/10.1016/j.semnephrol.2018.05.002|13. Mak ACY, White MJ, Eckalbar WL, Szpiech ZA, Oh SS, Pino-Yanes M, Hu D, Goddard P, Huntsman S, Galanter J, Wu AC, Himes BE, Germer S, Vogel JM, Bunting KL, Eng C, Salazar S, Keys KL, Liberto J, Nuckton TJ, Nguyen TA, Torgerson DG, Kwok PY, Levin AM, Celedón JC, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, et al. [28 more authors] (2018). Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma. Am J Respir Crit Care Med  197, 1552-1564.   https://doi.org/10.1164/rccm.201712-2529OC|14. Reidy KJ, Hjorten RC, Simpson CL, Rosenberg AZ, Rosenblum SD, Kovesdy CP, Tylavsky FA, Myrie J, Ruiz BL, Haque S, Mozhui K, Nelson GW, David VA, Yang X, Suzuki M, Jacob J, Reznik SE, Kaskel FJ, Kopp JB, Winkler CA, Davis RL (2018). Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry. Am J Hum Genet  103, 367-376.   https://doi.org/10.1016/j.ajhg.2018.08.002|15. Spear ML, Hu D, Pino-Yanes M, Huntsman S, Eng C, Levin AM, Ortega VE, White MJ, McGarry ME, Thakur N, Galanter J, Mak ACY, Oh SS, Ampleford E, Peters SP, Davis A, Kumar R, Farber HJ, Meade K, Avila PC, Serebrisky D, Lenoir MA, Brigino-Buenaventura E, Cintron WR, Thyne SM, et al. [13 more authors] (2019). A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma. Pharmacogenomics J  19, 249-259.   https://doi.org/10.1038/s41397-018-0042-4|16. Tin A, Nadkarni G, Evans AM, Winkler CA, Bottinger E, Rebholz CM, Sarnak MJ, Inker LA, Levey AS, Lipkowitz MS, Appel LJ, Arking DE, Coresh J, Grams ME (2018). Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression. J Am Soc Nephrol  29, 1939-1947.   https://doi.org/10.1681/ASN.2017101064|17. Wojcik GL, Graff M, Nishimura KK, Tao R, Haessler J, Gignoux CR, Highland HM, Patel YM, Sorokin EP, Avery CL, Belbin GM, Bien SA, Cheng I, Cullina S, Hodonsky CJ, Hu Y, Huckins LM, Jeff J, Justice AE, Kocarnik JM, Lim U, Lin BM, Lu Y, Nelson SC, Park SL, et al. [61 more authors] (2019). Genetic analyses of diverse populations improves discovery for complex traits. Nature  570, 514-518.   https://doi.org/10.1038/s41586-019-1310-4",https://intramural.nih.gov/search/searchview.taf?ipid=108292
51,BC010027-25,"October 01, 2018 -  September 30, 2019",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Thomas A Johnson,NULL,Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology),NULL,"1. Oh KS, Gottschalk RA, Lounsbury NW, Sun J, Dorrington MG, Baek S, Sun G, Wang Z, Krauss KS, Milner JD, Dutta B, Hager GL, Sung MH, Fraser IDC (2018). Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene Expression. J Immunol  201, 757-771.   https://doi.org/10.4049/jimmunol.1800158|2. Stavreva DA, Garcia DA, Fettweis G, Gudla PR, Zaki GF, Soni V, McGowan A, Williams G, Huynh A, Palangat M, Schiltz RL, Johnson TA, Presman DM, Ferguson ML, Pegoraro G, Upadhyaya A, Hager GL (2019). Transcriptional Bursting and Co-bursting Regulation by Steroid Hormone Release Pattern and Transcription Factor Mobility. Mol Cell  75, 1161-1177.e11.   https://doi.org/10.1016/j.molcel.2019.06.042",https://intramural.nih.gov/search/searchview.taf?ipid=108293
52,BC010030-24,"October 01, 2018 -  September 30, 2019",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Transport Biochemistry Section, NCI",Biebele  Abel|Sabrina  Lusvarghi|Megumi  Murakami|Andaleeb  Sajid|Khurts  Shilagardi,"Zhe-Sheng  Chen (Pharmaceutical Sciences, St. John's University)|Tanaji  Tallele (St. Johns University)|Michael  Mayer (University of Michigan)|Chung-Pu  Wu (Chang Gung University)|John E Golin|Sriram  Subramaniam; PhD","Stewart  Durell (Laboratory of Cell Biology)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Di S Xia; PhD, MS, BS (Crystallography Section)","Kenneth A Jacobson; BA, MS, PhD (NIDDK)","1. Cui Q, Cai CY, Gao HL, Ren L, Ji N, Gupta P, Yang Y, Shukla S, Ambudkar SV, Yang DH, Chen ZS (2019). Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells. Front Oncol  9, 313.   https://doi.org/10.3389/fonc.2019.00313|2. Hsiao SH, Murakami M, Yeh N, Li YQ, Hung TH, Wu YS, Ambudkar SV, Wu CP (2018). The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines. Cancer Lett  434, 81-90.   https://doi.org/10.1016/j.canlet.2018.07.022|3. Nandigama K, Lusvarghi S, Shukla S, Ambudkar SV (2019). Large-scale purification of functional human P-glycoprotein (ABCB1). Protein Expr Purif  159, 60-68.   https://doi.org/10.1016/j.pep.2019.03.002|4. Patel BA, Abel B, Barbuti AM, Velagapudi UK, Chen ZS, Ambudkar SV, Talele TT (2018). Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein. J Med Chem  61, 834-864.   https://doi.org/10.1021/acs.jmedchem.7b01340|5. Sajid A, Lusvarghi S, Chufan EE, Ambudkar SV (2018). Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1). PLoS One  13, e0204693.   https://doi.org/10.1371/journal.pone.0204693|6. Sugisawa N, Ohnuma S, Ueda H, Murakami M, Sugiyama K, Ohsawa K, Kano K, Tokuyama H, Doi T, Aoki J, Ishida M, Kudoh K, Naitoh T, Ambudkar SV, Unno M (2018). Novel Potent ABCB1 Modulator, Phenethylisoquinoline Alkaloid, Reverses Multidrug Resistance in Cancer Cell. Mol Pharm  15, 4021-4030.   https://doi.org/10.1021/acs.molpharmaceut.8b00457|7. Wu CP, Lusvarghi S, Wang JC, Hsiao SH, Huang YH, Hung TH, Ambudkar SV (2019). Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines. Mol Pharm  16, 3040-3052.   https://doi.org/10.1021/acs.molpharmaceut.9b00274|8. Wu CP, Murakami M, Hsiao SH, Liu TC, Yeh N, Li YQ, Hung TH, Wu YS, Ambudkar SV (2018). SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines. Cancer Lett  433, 259-272.   https://doi.org/10.1016/j.canlet.2018.07.004",https://intramural.nih.gov/search/searchview.taf?ipid=108294
53,BC010277-22,"October 01, 2018 -  September 30, 2019",Mechanisms of Chromosome Maintenance in Bacteria,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Soniya  Chatterjee|Alexander Eric Doan|Roopa  Kothapalli,"Johan  Paulsson (Appl Math and Theoretical Physics, U of Cambridge)|Elliott  Crooke (Georgetown University Medical Center)|Ling Chin  Hwang|Heon M Lim",Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Lisa Marie Jenkins (Laboratory of Cell Biology),Aravind L Iyer; PhD (NLM) |Rodolfo  Ghirlando; PhD (NIDDK),"1. Ciaccia PN, Ramachandran R, Chattoraj DK (2018). A Requirement for Global Transcription Factor Lrp in Licensing Replication of Vibrio cholerae Chromosome 2. Front Microbiol  9, 2103.   https://doi.org/10.3389/fmicb.2018.02103|2. Das B, Chattoraj DK (2019). Commentary: Functionality of Two Origins of Replication in Vibrio cholerae Strains With a Single Chromosome. Front Microbiol  10, 1314.   https://doi.org/10.3389/fmicb.2019.01314|3. Ramachandran R, Ciaccia PN, Filsuf TA, Jha JK, Chattoraj DK (2018). Chromosome 1 licenses chromosome 2 replication in Vibrio cholerae by doubling the crtS gene dosage. PLoS Genet  14, e1007426.   https://doi.org/10.1371/journal.pgen.1007426",https://intramural.nih.gov/search/searchview.taf?ipid=108295
54,BC010278-22,"October 01, 2018 -  September 30, 2019",Imaging cellular assemblies with three-dimensional electron microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Reinhard Karl Grisshammer; PhD|Lisa M. Hartnell,Chris  Szakal (NIST)|Primal  de Lanerolle (University of Illinois at Chicago),Jeffrey D Lifson; MD (Office Of The Director)|Kumaran S Ramamurthi (Laboratory of Molecular Biology),Donald F Bliss (NLM) |Luigi  Ferrucci; MD (NIA),"1. Earl LA, Falconieri V, Subramaniam S (2018). Microbiology catches the cryo-EM bug. Curr Opin Microbiol  43, 199-207.   https://doi.org/10.1016/j.mib.2018.02.012",https://intramural.nih.gov/search/searchview.taf?ipid=108296
55,BC010283-22,"October 01, 2018 -  September 30, 2019",DNA repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Maria Elsa  Callen Moreu|Yaakov  Maman|Jacob J Paiano|Nicholas Franklin Sciascia; BS|Kenta  Shinoda|Anthony T Tubbs|Show all 13,Chuna  Choudhary (University Of Copenhagen)|Olivier  Hyrien (Cnrs)|Manuela  Pellegrini|Derrick  Rossi; MD (Harvard University/Chidren's Hospital)|Solomon  Snyder (Johns Hopkins University School Of Medicine)|Scott  Armstrong (Harvard Medical School)|Show all 11,Yves  Pommier; PhD (Developmental Therapeutics Branch),Rafael Cristian Casellas; PhD (NIAMS) |Kai  Ge; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108297
56,BC010292-22,"October 01, 2018 -  September 30, 2019",Enzymes and Substrates of the Ubiquitin Conjugating System,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Martha Iveth Garcia; PhD|Loren Joy Kozar|Jennifer B Mariano|Meredith Boyle Metzger; PhD|Claudia Isabella Meyer|Christopher Edward Smith|Show all 9,"Karen H Vousden|David  Fushman (Biochemistry, University of Maryland)|George  Oyler (JHU)|Sina  Bavari (-, USAMRIID)|Danny  Huang (Beatson Institute)|Charles B Shoemaker; PhD (Veterinary Medicine, Tufts University)|Show all 7",Robert Andrew Byrd (Structural Biophysics Laboratory)|Jordan Leslie Meier; PhD (Chemical Biology Laboratory)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Whitcomb EA, Tsai YC, Basappa J, Liu K, Le Feuvre AK, Weissman AM, Taylor A (2019). Stabilization of p27Kip1/CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control. FASEB J  33, 1235-1247.   https://doi.org/10.1096/fj.201800960R",https://intramural.nih.gov/search/searchview.taf?ipid=108231
57,BC010297-22,"October 01, 2018 -  September 30, 2019",Identification of Genetic Factors Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Victor A David|Sophie Mh Limou,Gregory D Kirk|William  Wester (Vanderbilt University School of Medicine)|Rajendra  Bhimma (University of KwaZulu-Natal)|Saraladevi  Naicker (University of the Witwatersrand)|Frederick  Kaskel (Albert Einstein College of Medicine)|Frank  Post (Kings College)|Show all 7,Charles  Rabkin (Infection & Immunoepidemiology Branch),Jeffrey Burnett Kopp; MD (NIDDK),"1. Aliyu MH, Wudil UJ, Ingles DJ, Shepherd BE, Gong W, Musa BM, Muhammad H, Sani MU, Abdu A, Nalado AM, Atanda A, Ahonkhai AA, Ikizler TA, Winkler CA, Kopp JB, Kimmel PL, Wester CW (2019). Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction ""R3"" Trial): protocol and study design. Trials  20, 341.   https://doi.org/10.1186/s13063-019-3436-y|2. An P, Kirk GD, Limou S, Binns-Roemer E, Kopp JB, Winkler CA (2019). Impact of APOL1 Genetic Variants on HIV-1 Infection and Disease Progression. Front Immunol  10, 53.   https://doi.org/10.3389/fimmu.2019.00053|3. An P, Xu J, Yu Y, Winkler CA (2018). Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma. Front Genet  9, 261.   https://doi.org/10.3389/fgene.2018.00261|4. An P, Zeng Z, Winkler CA (2018). The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression. J Infect Dis  218, 1404-1410.   https://doi.org/10.1093/infdis/jiy355|5. Liao X, Wang X, Huang K, Han C, Deng J, Yu T, Yang C, Huang R, Liu X, Yu L, Zhu G, Su H, Qin W, Zeng X, Han B, Han Q, Liu Z, Zhou X, Gong Y, Liu Z, Huang J, Winkler CA, O'Brien SJ, Ye X, Peng T (2019). Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma. J Cancer  10, 3267-3283.   https://doi.org/10.7150/jca.29986|6. Luo L, An P, Jia X, Yue X, Zheng S, Liu S, Chen Y, An W, Winkler CA, Duan Z (2018). Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study. Front Genet  9, 662.   https://doi.org/10.3389/fgene.2018.00662|7. Swanepoel CR, Atta MG, D'Agati VD, Estrella MM, Fogo AB, Naicker S, Post FA, Wearne N, Winkler CA, Cheung M, Wheeler DC, Winkelmayer WC, Wyatt CM, Conference Participants (2018). Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int  93, 545-559.   https://doi.org/10.1016/j.kint.2017.11.007|8. Yang C, Su H, Liao X, Han C, Yu T, Zhu G, Wang X, Winkler CA, O'Brien SJ, Peng T (2018). Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma. Cancer Manag Res  10, 679-696.   https://doi.org/10.2147/CMAR.S162595|9. Zhao X, Li J, Winkler CA, An P, Guo JT (2018). IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections. Front Microbiol  9, 3228.   https://doi.org/10.3389/fmicb.2018.03228",https://intramural.nih.gov/search/searchview.taf?ipid=108298
58,BC010298-22,"October 01, 2018 -  September 30, 2019",Growth Regulation Section,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",NULL,Taiji  Matsusaka (Tokyo Medical & Dental University)|Iekuni  Ichikawa (Vanderbilt University School of Medicine)|Namiko  Kobayashi (University of Tsukaba)|Francesco  Beguinot (Federico Ii University Of Naples; National Research Council)|Tetsu  Hayashida (Keio University School Of Medicine)|Michio  Nagata (University Of Tsukuba)|Show all 7,"Di S Xia; PhD, MS, BS (Crystallography Section)",NULL,"1. Okabe M, Motojima M, Miyazaki Y, Pastan I, Yokoo T, Matsusaka T (2019). Global polysome analysis of normal and injured podocytes. Am J Physiol Renal Physiol  316, F241-F252.   https://doi.org/10.1152/ajprenal.00115.2018|2. Tsuchida Y, Zhong J, Otsuka T, Dikalova A, Pastan I, Anantharamaiah GM, Linton MF, Yancey PG, Ikizler TA, Fogo AB, Yang H, Kon V (2019). Lipoprotein modulation of proteinuric renal injury. Lab Invest  99, 1107-1116.   https://doi.org/10.1038/s41374-019-0253-6|3. Zoshima T, Hara S, Yamagishi M, Pastan I, Matsusaka T, Kawano M, Nagata M (2019). Possible role of complement factor H in podocytes in clearing glomerular subendothelial immune complex deposits. Sci Rep  9, 7857.   https://doi.org/10.1038/s41598-019-44380-3",https://intramural.nih.gov/search/searchview.taf?ipid=108299
59,BC010300-22,"October 01, 2018 -  September 30, 2019",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Marieli  Gonzalez-Cotto|Erika Mariana Palmieri; PhD|Jeffrey J Subleski|Jessica Frances Walls|Jonathan  Weiss,"Valance  Washington (Anatomy and Cell biology, Universidad Central del Caribe)|James  Finke (Cleveland Clinic)|Philip  Taylor (Cardiff University)|Selinda Jane Orr|Andrew  Lane (U. of Louisville)|Teresa  Fan (University of Louisville)|Show all 7",William Marston Linehan; MD (Urologic Oncology Branch)|Tim Friedrich Greten (Thoracic and GI Malignancies Branch),Doug B Kuhns; PhD (NIAID) |Leslie Glenn Biesecker; MD (NHGRI),"1. Davies LC, Rice CM, McVicar DW, Weiss JM (2019). Diversity and environmental adaptation of phagocytic cell metabolism. J Leukoc Biol  105, 37-48.   https://doi.org/10.1002/JLB.4RI0518-195R|2. Tong WH, Maio N, Zhang DL, Palmieri EM, Ollivierre H, Ghosh MC, McVicar DW, Rouault TA (2018). TLR-activated repression of Fe-S cluster biogenesis drives a metabolic shift and alters histone and tubulin acetylation. Blood Adv  2, 1146-1156.   https://doi.org/10.1182/bloodadvances.2018015669|3. Weiss JM, Davies LC, Karwan M, Ileva L, Ozaki MK, Cheng RY, Ridnour LA, Annunziata CM, Wink DA, McVicar DW (2018). Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. J Clin Invest  128, 3794-3805.   https://doi.org/10.1172/JCI99169",https://intramural.nih.gov/search/searchview.taf?ipid=108300
60,BC010301-22,"October 01, 2018 -  September 30, 2019",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",Evgeny  Arons|Lacey Renee James|Hong  Zhou,Arthur  Frankel (Texas A&M)|Tadeusz  Robak (University of Lodz)|Martin  Tallman (Memorial Sloan Kettering Cancer Center)|Farhad  Ravandi (MD Anderson)|Michael  Grever (Ohio State Universithy)|Jan  Burger (MD Anderson)|Show all 7,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Constance M Yuan (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Ira H Pastan; MD (Molecular Biology Section)|David J Fitzgerald; PhD (Biotherapy Section)|Masanori  Onda (Molecular Biology Section)",NULL,"1. Feurtado J, Kreitman RJ (2019). Moxetumomab Pasudotox: Clinical Experience in Relapsed/Refractory Hairy Cell Leukemia. Clin J Oncol Nurs  23, E52-E59.   https://doi.org/10.1188/19.CJON.E52-E59|2. Kreitman RJ, Arons E (2018). Update on hairy cell leukemia. Clin Adv Hematol Oncol  16, 205-215.|3. Subbiah V, Kreitman RJ, Wainberg ZA, Cho JY, Schellens JHM, Soria JC, Wen PY, Zielinski C, Cabanillas ME, Urbanowitz G, Mookerjee B, Wang D, Rangwala F, Keam B (2018). Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer. J Clin Oncol  36, 7-13.   https://doi.org/10.1200/JCO.2017.73.6785|4. Vallera DA, Kreitman RJ (2018). Immunotoxins Targeting B cell Malignancy-Progress and Problems With Immunogenicity. Biomedicines  7.   https://doi.org/10.3390/biomedicines7010001",https://intramural.nih.gov/search/searchview.taf?ipid=108301
61,BC010304-21,"October 01, 2018 -  September 30, 2019",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Lakshmi  Balagopalan|Grace Alice Bugos|Ana Maria Dios Esponera|Joseph Anthony Garvey|Wenmei  Li; PhD|Asit Kumar Manna; PhD|Show all 10,NULL,Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Ettore  Appella; MD (Laboratory of Cell Biology),Peter W Schuck; PhD (NIBIB),"1. Balagopalan L, Yi J, Nguyen T, McIntire KM, Harned AS, Narayan K, Samelson LE (2018). Plasma membrane LAT activation precedes vesicular recruitment defining two phases of early T-cell activation. Nat Commun  9, 2013.   https://doi.org/10.1038/s41467-018-04419-x|2. Dios-Esponera A, Melis N, Subramanian BC, Weigert R, Samelson LE (2019). Pak1 Kinase Promotes Activated T Cell Trafficking by Regulating the Expression of L-Selectin and CCR7. Front Immunol  10, 370.   https://doi.org/10.3389/fimmu.2019.00370|3. Manna A, Zhao H, Wada J, Balagopalan L, Tagad HD, Appella E, Schuck P, Samelson LE (2018). Cooperative assembly of a four-molecule signaling complex formed upon T cell antigen receptor activation. Proc Natl Acad Sci U S A  115, E11914-E11923.   https://doi.org/10.1073/pnas.1817142115|4. Yi J, Balagopalan L, Nguyen T, McIntire KM, Samelson LE (2019). TCR microclusters form spatially segregated domains and sequentially assemble in calcium-dependent kinetic steps. Nat Commun  10, 277.   https://doi.org/10.1038/s41467-018-08064-2",https://intramural.nih.gov/search/searchview.taf?ipid=108302
62,BC010307-20,"October 01, 2018 -  September 30, 2019",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Kelli Taylor Czarra|Ariana Maria Vitale,"Naoto  Ueno (National Institute for Basic Biology)|Wendy  Woodward (The University of Texas MD Anderson Cancer Center)|Savitri  Krishnamurthy (The University of Texas MD Anderson Cancer Center)|Michael  Lewis (Lester and Sue Smith Breast Center, Baylor College of Medicine)|Mary  Alpaugh (Rowan University)",Philip Jeffrey Tofilon (Radiation Oncology Branch)|Bruce Allen Shapiro; PhD (Rna Biology Laboratory)|Ruth  Nussinov; PhD (Cancer Inflammation Program)|Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,"1. Balamurugan K, Mendoza-Villanueva D, Sharan S, Summers GH, Dobrolecki LE, Lewis MT, Sterneck E (2019). C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes. Oncogene  38, 3765-3780.   https://doi.org/10.1038/s41388-018-0516-5",https://intramural.nih.gov/search/searchview.taf?ipid=108238
63,BC010308-21,"October 01, 2018 -  September 30, 2019",In vivo Imaging Analysis of Steroid-Nuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Razi  Raziuddin|Diana  Stavreva|Lyuba  Varticovski,Luke  Iwanowicz (USGS-BRD)|Michael  Collins (Center for Natural Capital)|Patricia  Bright (U.S. Geological Survey)|Adali  Pecci (Ciudad Universitaria)|Arpita  Upadhyaya (University of Maryland/Maryland Nanocenter)|Diego  Alvarez De La Rosa Rodriguez (Molecular Neurophysiology Section)|Show all 7,"Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108305
64,BC010309-21,"October 01, 2018 -  September 30, 2019",Nuclear Architecture and Disease,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Hesam  Babahosseini; PhD|Elizabeth  Finn|Kelsey Lillian Gallant|Arturo Gerardo Garza-Gongora|Stephen A Mabon|Karen J Meaburn|Show all 12,Job  Dekker; PhD (University of Massachusetts)|Dan  Levy (University of Wyoming),Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,"1. Babahosseini H, Misteli T, DeVoe DL (2018). Active or Passive On-Demand Droplet Merging in a Microfluidic Valve-Based Trap. Conf Proc IEEE Eng Med Biol Soc  2018, 5350-5353.   https://doi.org/10.1109/EMBC.2018.8513481|2. Babahosseini H, Misteli T, DeVoe DL (2019). Microfluidic on-demand droplet generation, storage, retrieval, and merging for single-cell pairing. Lab Chip  19, 493-502.   https://doi.org/10.1039/c8lc01178h|3. Baranes-Bachar K, Levy-Barda A, Oehler J, Reid DA, Soria-Bretones I, Voss TC, Chung D, Park Y, Liu C, Yoon JB, Li W, Dellaire G, Misteli T, Huertas P, Rothenberg E, Ramadan K, Ziv Y, Shiloh Y (2018). The Ubiquitin E3/E4 Ligase UBE4A Adjusts Protein Ubiquitylation and Accumulation at Sites of DNA Damage, Facilitating Double-Strand Break Repair. Mol Cell  69, 866-878.e7.   https://doi.org/10.1016/j.molcel.2018.02.002|4. Hamczyk MR, Villa-Bellosta R, Quesada V, Gonzalo P, Vidak S, Nevado RM, Andrés-Manzano MJ, Misteli T, López-Otín C, Andrés V (2019). Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells. EMBO Mol Med  11.   https://doi.org/10.15252/emmm.201809736|5. Serebryannyy L, Misteli T (2018). Protein sequestration at the nuclear periphery as a potential regulatory mechanism in premature aging. J Cell Biol  217, 21-37.   https://doi.org/10.1083/jcb.201706061|6. Serebryannyy LA, Misteli T (2019). HiPLA: High-throughput imaging proximity ligation assay. Methods  157, 80-87.   https://doi.org/10.1016/j.ymeth.2018.11.004|7. Shen Y, Kubben N, Candia J, Morozov AV, Misteli T, Losert W (2018). RefCell: multi-dimensional analysis of image-based high-throughput screens based on 'typical cells'. BMC Bioinformatics  19, 427.   https://doi.org/10.1186/s12859-018-2454-1",https://intramural.nih.gov/search/searchview.taf?ipid=108306
65,BC010313-21,"October 01, 2018 -  September 30, 2019",Molecular signatures for liver cancer diagnosis and treatment stratification,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI","Anuradha Samantha Budhu|Julian Marcelo Candia|Dana Andrew Dominguez|Marshonna J Forgues|Sophia  Franck|Man Hsin  Hung; MD, PhD|Show all 14","Zhao-You  Tang (Liver Cancer Institute)|Christoffer  Loffredo (Georgetown University)|Mathuros  Ruchirawat (Chulabhorn Research Institute)|Dean  Felsher (Division of Oncology, Stanford University School of Medicine)|Scott  Lowe (Cold Spring Harbor Laboratory)|JuSeog  Lee (University of Texas MD Anderson Cancer Center)|Show all 9",Eytan  Ruppin (Cancer Data Science Laboratory)|Tim Friedrich Greten (Thoracic and GI Malignancies Branch)|E. Michael  Gertz (Cancer Data Science Laboratory)|Alejandro Alberto Schaffer; PhD (Cancer Data Science Laboratory)|Bradford J Wood; MD (Office of the Director),NULL,"1. Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G, Gouw A, Kagen A, Klimstra D, Komuta M, Kondo F, Miksad R, Nakano M, Nakanuma Y, Ng I, Paradis V, Nyun Park Y, Quaglia A, Roncalli M, Roskams T, Sakamoto M, Saxena R, Sempoux C, Sirlin C, Stueck A, et al. [9 more authors] (2018). cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. Hepatology  68, 113-126.   https://doi.org/10.1002/hep.29789|2. Liu J, Dang H, Wang XW (2018). The significance of intertumor and intratumor heterogeneity in liver cancer. Exp Mol Med  50, e416.   https://doi.org/10.1038/emm.2017.165",https://intramural.nih.gov/search/searchview.taf?ipid=108308
66,BC010319-21,"October 01, 2018 -  September 30, 2019",Structural Basis of Biological Membrane Protein Functions and Drug Resistance,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Xiaoyun  Bai|Lothar  Esser|Fei  Zhou,Min  Chen (University Of Massachusetts Amherst)|Zhaohai  Qin (Chinese Agriculture University),Suresh V Ambudkar; PhD (Viral Epidemiology Br)|Michael Marc Gottesman; MD (Laboratory of Cell Biology),Joseph  Shiloach; PhD (NIDDK) |Mario J Borgnia; PhD (NIEHS),"1. Esser L, Zhou F, Yu CA, Xia D (2019). Crystal structure of bacterial cytochrome bc1 in complex with azoxystrobin reveals a conformational switch of the Rieske iron-sulfur protein subunit. J Biol Chem  294, 12007-12019.   https://doi.org/10.1074/jbc.RA119.008381|2. Liu WC, Zhou F, Xia D, Shiloach J (2019). Expression of multidrug transporter P-glycoprotein in Pichia pastoris affects the host's methanol metabolism. Microb Biotechnol  12, 1226-1236.   https://doi.org/10.1111/1751-7915.13420|3. Xia D, Zhou F, Esser L (2019) Emerging consensus on the mechanism of poly specific substrate recognition by the multi drug reasnporter P-glycoprotein. Caner Drug Resistance, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=108309
67,BC010326-20,"October 01, 2018 -  September 30, 2019","Biomolecular Structure and Mechanism, Structure-Based Drug Design",Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Biomolecular Structure Section, NCI",Sudhaker  Dharavath; PhD|Lan  Jin|Joshua Steven Rose; PhD|Gary X Shaw|Genbin  Shi|He  Song|Show all 7,Honggao  Yan|Sherif  Abou Elela (University of Sherbrooke)|Allen  Nicholson (Temple University)|Shivendra  Singh (University of Pittsburgh),David S Waugh; PhD (Protein Engineering Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Joseph Edward Tropea (Macromolecular Crystallography Laboratory)|Yun Xing M Wang (Structural Biophysics Laboratory)|Shuo  Gu (Rna Biology Laboratory),NULL,"1. Abou Elela S, Ji X (2019). Structure and function of Rnt1p: An alternative to RNAi for targeted RNA degradation. Wiley Interdiscip Rev RNA  10, e1521.   https://doi.org/10.1002/wrna.1521|2. Singh KB, Ji X, Singh SV (2018). Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer. Mol Cancer Ther  17, 2079-2090.   https://doi.org/10.1158/1535-7163.MCT-18-0117|3. Song H, Ji X (2019). The mechanism of RNA duplex recognition and unwinding by DEAD-box helicase DDX3X. Nat Commun  10, 3085.   https://doi.org/10.1038/s41467-019-11083-2|4. Wang C, Shi G, Ji X (2018). Design, synthesis, and anticancer activity evaluation of irreversible allosteric inhibitors of the ubiquitin-conjugating enzyme Ube2g2. Medchemcomm  9, 1818-1825.   https://doi.org/10.1039/c8md00320c",https://intramural.nih.gov/search/searchview.taf?ipid=108310
68,BC010328-20,"October 01, 2018 -  September 30, 2019",Role of C-EBP transcription factors in cell growth and tumorigenesis,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Srikanta  Basu; PhD|Linshan  Hu|Nancy C Martin|Sweta  Misra; PhD|Jacqueline  Salotti; PhD|Karen Lynn Saylor|Show all 7,NULL,Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),NULL,"1. Basu SK, Basu S, Johnson PF (2019). Localized RAS signaling drives cancer. Oncoscience  6, 298-300.   https://doi.org/10.18632/oncoscience.479|2. Basu SK, Gonit M, Salotti J, Chen J, Bhat A, Gorospe M, Viollet B, Claffey KP, Johnson PF (2018). A RAS-CaMKKβ-AMPKα2 pathway promotes senescence by licensing post-translational activation of C/EBPβ through a novel 3'UTR mechanism. Oncogene  37, 3528-3548.   https://doi.org/10.1038/s41388-018-0190-7|3. Wang ZH, Gong K, Liu X, Zhang Z, Sun X, Wei ZZ, Yu SP, Manfredsson FP, Sandoval IM, Johnson PF, Jia J, Wang JZ, Ye K (2018). C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease. Nat Commun  9, 1784.   https://doi.org/10.1038/s41467-018-04120-z",https://intramural.nih.gov/search/searchview.taf?ipid=108311
69,BC010329-20,"October 01, 2018 -  September 30, 2019",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",David Ellis Durrant|Hsiao Chi Alice  Hsu|Daniel A Ritt|Russell Spencer Smith|Elizabeth Mclean Terrell,"Channing J Der (Department of Pharmacology, University of North Carolina at Chapel Hill)|John  Porco (Boston University)|Arvin  Dar (Ichan School Of Medicine At Mount Sinai)|John  Hancock (University Of Texas Health Science Center At Houston)|Robert L Kortum",Andrew G Stephen (Office Of The Director)|Ping  Zhang (Structural Biophysics Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Dominic  Esposito; PhD (Office Of The Director),NULL,"1. Durrant DE, Morrison DK (2018). Targeting the Raf kinases in human cancer: the Raf dimer dilemma. Br J Cancer  118, 3-8.   https://doi.org/10.1038/bjc.2017.399|2. Terrell EM, Morrison DK (2019). Ras-Mediated Activation of the Raf Family Kinases. Cold Spring Harb Perspect Med  9.   https://doi.org/10.1101/cshperspect.a033746",https://intramural.nih.gov/search/searchview.taf?ipid=108312
70,BC010331-20,"October 01, 2018 -  September 30, 2019",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI",Kenneth Min Kim|Kunduri  Govind; PhD,"Pedro  Labarca (Arturo Prat 514, Centro de Estudios Cientificos)|Usha  Acharya (University of Mass. Medical School)|joost  holthuis (University of Utrecht)|Vivek  Jayaraman (HHMI Janelia Farms Research Campus)",NULL,NULL,"1. Kunduri G, Turner-Evans D, Konya Y, Izumi Y, Nagashima K, Lockett S, Holthuis J, Bamba T, Acharya U, Acharya JK (2018). Defective cortex glia plasma membrane structure underlies light-induced epilepsy in cpes mutants. Proc Natl Acad Sci U S A  115, E8919-E8928.   https://doi.org/10.1073/pnas.1808463115",https://intramural.nih.gov/search/searchview.taf?ipid=108313
71,BC010334-20,"October 01, 2018 -  September 30, 2019",Conserved Element DNA Vaccine,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Jenifer L Bear|Xintao  Hu|Zhongyan  Lu|Bethany Anne Nagy|Robert  Burns|George N Pavlakis; MD, PhD","John  Eldridge (Wyeth Lederle Vaccines)|Deborah  Fuller (University of Washington)|Drew  Hannaman (Ichor Medical Systems, Inc.)|Sylvie  Le Gall (Massachusetts General Hospital)|Harriett L Robinson|James  Mullins; PhD (Microbiology, University of Washington)|Show all 16",Stuart F J Le Grice; PhD (Basic Research Laboratory),"Richard A Koup; MD (NIAID) |Lucio  Gama; PhD (NIAID) |John R Mascola; MD (NIAID) |Bernard  Moss; MD, PhD (NIAID)","1. Hu X, Lu Z, Valentin A, Rosati M, Broderick KE, Sardesai NY, Marx PA, Mullins JI, Pavlakis GN, Felber BK (2018). Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques. Hum Vaccin Immunother  14, 2163-2177.   https://doi.org/10.1080/21645515.2018.1489949|2. Hu X, Valentin A, Cai Y, Dayton F, Rosati M, Ramírez-Salazar EG, Kulkarni V, Broderick KE, Sardesai NY, Wyatt LS, Earl PL, Moss B, Mullins JI, Pavlakis GN, Felber BK (2018). DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination. Hum Gene Ther  29, 1029-1043.   https://doi.org/10.1089/hum.2018.065|3. Munson P, Liu Y, Bratt D, Fuller JT, Hu X, Pavlakis GN, Felber BK, Mullins JI, Fuller DH (2018). Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection. Hum Vaccin Immunother  14, 1820-1831.   https://doi.org/10.1080/21645515.2018.1448328",https://intramural.nih.gov/search/searchview.taf?ipid=108314
72,BC010336-20,"October 01, 2018 -  September 30, 2019",Lambda Genetic Networks and Lambda Red-Mediated Recombination,Donald L Court; PhD|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Nina C Costantino|Carolyn B McGill|Xintian  Li|Alison J Rattray|Lynn C Thomason|Mikhail V Kashlev,"Max  Gottesman (Institute of Cancer Research, Columbia University)|William  Margolin (Microbiology and Molecular Genetics, University of Texas Medical School)|Joel  Stavans (Physics of Complex Systems, Weizmann Institute of Science)",Sankar  Adhya; PhD (Developmental Genetics Section)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Saxena S, Myka KK, Washburn R, Costantino N, Court DL, Gottesman ME (2018). Escherichia coli transcription factor NusG binds to 70S ribosomes. Mol Microbiol  108, 495-504.   https://doi.org/10.1111/mmi.13953",https://intramural.nih.gov/search/searchview.taf?ipid=108315
73,BC010338-20,"October 01, 2018 -  September 30, 2019",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Michael Graham Stanley Boylan|Cynthia M Elder|Salvia  Misaghian,"Trevor  Williams (University of Colarado)|David M Ornitz; MD (Department of Developmental Biology, Washington University, School of Medicine)|Ryoichiro  Kageyama (Institute for Virus Research, Kyoto University)|Anna-katerina  Hadjantonakis (Memorial Sloan Kettering Cancer Center)|Ernestina  Schipani (University Of Michigan)",Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108316
74,BC010345-20,"October 01, 2018 -  September 30, 2019",The Role of Wnt Genes in Vertebrate Development and Cancer,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cell Signaling in Vertebrate Development Section, NCI",Ravindra Babu  Chalamalasetty|Melissa Suh Hee Kim|Matthew John Koury|Nikolaos Panagiotis Mandalos|Sara E Parkin,NULL,Mark B Lewandoski (Genetics of Vertebrate Development Section)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108318
75,BC010348-20,"October 01, 2018 -  September 30, 2019",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",Alla E Gustchina|Maria  Miller|Pawel  Strzelczyk|Di  Zhang,NULL,Zbigniew  Dauter (Synchrotron Radiation Research Section),NULL,"1. Lubkowski J, Chan W, Wlodawer A (2019). Opportunistic complexes of E. coli L-asparaginases with citrate anions. Sci Rep  9, 11070.   https://doi.org/10.1038/s41598-019-46432-0|2. Lubkowski J, Sonmez C, Smirnov SV, Anishkin A, Kotenko SV, Wlodawer A (2018). Crystal Structure of the Labile Complex of IL-24 with the Extracellular Domains of IL-22R1 and IL-20R2. J Immunol  201, 2082-2093.   https://doi.org/10.4049/jimmunol.1800726|3. Mishra V, Rathore I, Arekar A, Sthanam LK, Xiao H, Kiso Y, Sen S, Patankar S, Gustchina A, Hidaka K, Wlodawer A, Yada RY, Bhaumik P (2018). Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights. FEBS J  285, 3077-3096.   https://doi.org/10.1111/febs.14598|4. Raczynska JE, Shabalin IG, Minor W, Wlodawer A, Jaskolski M (2018). A close look onto structural models and primary ligands of metallo-β-lactamases. Drug Resist Updat  40, 1-12.   https://doi.org/10.1016/j.drup.2018.08.001|5. Rotanova TV, Andrianova AG, Kudzhaev AM, Li M, Botos I, Wlodawer A, Gustchina A (2019). New insights into structural and functional relationships between LonA proteases and ClpB chaperones. FEBS Open Bio  9, 1536-1551.   https://doi.org/10.1002/2211-5463.12691",https://intramural.nih.gov/search/searchview.taf?ipid=108319
76,BC010350-20,"October 01, 2018 -  September 30, 2019",Prevention of AIDS,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Jenifer L Bear|Cristina  Bergamaschi|Santhi  Devasundaram|Zhongyan  Lu|Bethany Anne Nagy|Robert  Burns|Show all 10,"Bart  Haynes (Duke Human Vaccine Institute)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|David C Montefiori; PhD (Department of Surgery, NIAID)|Rafick-Pierre  Sekaly (Centre de Recherche du Centre Hospitalier de l'Universite de Montreal)|David A Zaharoff|Ira  Berkower|Show all 33","Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director)|Jacob D Estes (Office Of The Director)|Brandon Frank Keele (Office Of The Director)|David J Venzon; PhD (Biostatistics and Data Management Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",Konstantinos  Petrovas (NIAID) |Mario  Roederer; PhD (NIAID) |Malcolm A Martin; MD (NIAID) |Vanessa  Hirsch (NIAID) |Merlin L Robb (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108320
77,BC010378-20,"October 01, 2018 -  September 30, 2019",Macromolecular Crystallography Research with Synchrotron Radiation,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Synchrotron Radiation Research Section, NCI",Sergei V Pletnev|Milosz Jacek Ruszkowski; PhD|Bartosz  Sekula,"Andrzej  Joachimiak (Biosciences, Argonne Natl. Lab.)|Wladek  Minor|Zbyszek  Otwinowski (Biomedical Sciences, Southwestern Medical School)|Mariusz  Jaskolski (University of  Poznan)|Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Dauter Z (2019). Sulfur-SAD phasing from microcrystals utilizing low-energy X-rays. IUCrJ  6, 503-504.   https://doi.org/10.1107/S2052252519008698|2. Dauter Z, Jaskolski M (2018). On the helical arrangements of protein molecules. Protein Sci  27, 643-652.   https://doi.org/10.1002/pro.3356|3. Dauter Z, Wlodawer A (2018). Crystallographically correct but confusing presentation of structural models deposited in the Protein Data Bank. Acta Crystallogr D Struct Biol  74, 939-945.   https://doi.org/10.1107/S2059798318009828|4. Li M, Srp J, Gustchina A, Dauter Z, Mares M, Wlodawer A (2019). Crystal structures of the complex of a kallikrein inhibitor from Bauhinia bauhinioides with trypsin and modeling of kallikrein complexes. Acta Crystallogr D Struct Biol  75, 56-69.   https://doi.org/10.1107/S2059798318016492|5. Muslinkina L, Roldán-Salgado A, Gaytán P, Juárez-González VR, Rudiño E, Pletneva N, Pletnev V, Dauter Z, Pletnev S (2019). Structural Factors Enabling Successful GFP-Like Proteins with Alanine as the Third Chromophore-Forming Residue. J Mol Biol  431, 1397-1408.   https://doi.org/10.1016/j.jmb.2019.02.013|6. Ruszkowska A, Ruszkowski M, Dauter Z, Brown JA (2018). Structural insights into the RNA methyltransferase domain of METTL16. Sci Rep  8, 5311.   https://doi.org/10.1038/s41598-018-23608-8|7. Ruszkowski M, Sekula B, Ruszkowska A, Dauter Z (2018). Chloroplastic Serine Hydroxymethyltransferase From Medicago truncatula: A Structural Characterization. Front Plant Sci  9, 584.   https://doi.org/10.3389/fpls.2018.00584|8. Sekula B, Dauter Z (2019). Spermidine Synthase (SPDS) Undergoes Concerted Structural Rearrangements Upon Ligand Binding - A Case Study of the Two SPDS Isoforms From Arabidopsis thaliana. Front Plant Sci  10, 555.   https://doi.org/10.3389/fpls.2019.00555|9. Sekula B, Dauter Z (2019). Structural Study of Agmatine Iminohydrolase From Medicago truncatula, the Second Enzyme of the Agmatine Route of Putrescine Biosynthesis in Plants. Front Plant Sci  10, 320.   https://doi.org/10.3389/fpls.2019.00320|10. Sekula B, Ruszkowski M, Dauter Z (2018). Structural Analysis of Phosphoserine Aminotransferase (Isoform 1) From Arabidopsis thaliana- the Enzyme Involved in the Phosphorylated Pathway of Serine Biosynthesis. Front Plant Sci  9, 876.   https://doi.org/10.3389/fpls.2018.00876|11. Wlodawer A, Dauter Z, Porebski PJ, Minor W, Stanfield R, Jaskolski M, Pozharski E, Weichenberger CX, Rupp B (2018). Detect, correct, retract: How to manage incorrect structural models. FEBS J  285, 444-466.   https://doi.org/10.1111/febs.14320",https://intramural.nih.gov/search/searchview.taf?ipid=108321
78,BC010379-20,"October 01, 2018 -  September 30, 2019",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI","Yuba Raj Bhandari; PhD|Jienyu  Ding|Yun-Tzai  Lee; PhD|Saminathan  Ramakrishnan; PhD|Jason R Stagno|Ping  Yu; MD, PhD",NULL,Alan  Rein; PhD (Retroviral Replication Laboratory),NULL,"1. Watts NR, Eren E, Zhuang X, Wang YX, Steven AC, Wingfield PT (2018). A new HIV-1 Rev structure optimizes interaction with target RNA (RRE) for nuclear export. J Struct Biol  203, 102-108.   https://doi.org/10.1016/j.jsb.2018.03.011",https://intramural.nih.gov/search/searchview.taf?ipid=108322
79,BC010387-20,"October 01, 2018 -  September 30, 2019",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",Suhas Sampat Kharat; PhD|Arun Prakash Mishra,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108323
80,BC010390-20,"October 01, 2018 -  September 30, 2019",Role of Neurotrophins in the Development of the Mammalian Nervous System,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Colleen A Barrick|Jodi L Becker|Andie Kealohi Sato Conching|Gianluca  Fulgenzi|Zhenyi  Hong; PhD|Mary Ellen  Palko|Show all 7,"Italo  Mocchetti (Pharmacology, Georgetown University)|Juan Carlos  Arevalo (University of Salamanca)|Barbara  Hempstead (Cornell University)|Ted  Dawson (Johns Hopkins University)|Valina  Dawson (Johns Hopkins University)",NULL,NULL,"1. Brahmachari S, Lee S, Kim S, Yuan C, Karuppagounder SS, Ge P, Shi R, Kim EJ, Liu A, Kim D, Quintin S, Jiang H, Kumar M, Yun SP, Kam TI, Mao X, Lee Y, Swing DA, Tessarollo L, Ko HS, Dawson VL, Dawson TM (2019). Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease. Brain  142, 2380-2401.   https://doi.org/10.1093/brain/awz172|2. López-Benito S, Sánchez-Sánchez J, Brito V, Calvo L, Lisa S, Torres-Valle M, Palko ME, Vicente-García C, Fernández-Fernández S, Bolaños JP, Ginés S, Tessarollo L, Arévalo JC (2018). Regulation of BDNF Release by ARMS/Kidins220 through Modulation of Synaptotagmin-IV Levels. J Neurosci  38, 5415-5428.   https://doi.org/10.1523/JNEUROSCI.1653-17.2018|3. López-Erauskin J, Tadokoro T, Baughn MW, Myers B, McAlonis-Downes M, Chillon-Marinas C, Asiaban JN, Artates J, Bui AT, Vetto AP, Lee SK, Le AV, Sun Y, Jambeau M, Boubaker J, Swing D, Qiu J, Hicks GG, Ouyang Z, Fu XD, Tessarollo L, Ling SC, Parone PA, Shaw CE, Marsala M, et al. [3 more authors] (2018). ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS. Neuron  100, 816-830.e7.   https://doi.org/10.1016/j.neuron.2018.09.044|4. Ling SC, Dastidar SG, Tokunaga S, Ho WY, Lim K, Ilieva H, Parone PA, Tyan SH, Tse TM, Chang JC, Platoshyn O, Bui NB, Bui A, Vetto A, Sun S, McAlonis-Downes M, Han JS, Swing D, Kapeli K, Yeo GW, Tessarollo L, Marsala M, Shaw CE, Tucker-Kellogg G, La Spada AR, et al. [3 more authors] (2019). Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. Elife  8.   https://doi.org/10.7554/eLife.40811|5. Xiong Y, Neifert S, Karuppagounder SS, Liu Q, Stankowski JN, Lee BD, Ko HS, Lee Y, Grima JC, Mao X, Jiang H, Kang SU, Swing DA, Iacovitti L, Tessarollo L, Dawson TM, Dawson VL (2018). Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice. Proc Natl Acad Sci U S A  115, 1635-1640.   https://doi.org/10.1073/pnas.1712648115",https://intramural.nih.gov/search/searchview.taf?ipid=108324
81,BC010391-20,"October 01, 2018 -  September 30, 2019",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Colleen A Barrick|Jodi L Becker|Gianluca  Fulgenzi|Mary Ellen  Palko|Zhenyi  Hong; PhD|Sudhirkumar U Yanpallewar,Barbara  Hempstead (Cornell University)|Gianluca  Fulgenzi,NULL,Oksana  Gavrilova; PhD (NIDDK) |Hans Jurgen  Wess; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108325
82,BC010411-20,"October 01, 2018 -  September 30, 2019",Initiation of DNA Replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Adrian M Baris|Haiqing  Fu|Sangmin  Jang|Christophe  Redon|Bhushan L Thakur|Yves  Pommier; PhD|Show all 7,"Eric  Bouhassira (hematology, Albert Einstein College of Medicine)|Jean-Marc  Lemaitre (Institute of Functional Genomics)|lizhao  wu (Rutgers New Jersey Medical School Cancer Center)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Patricia  Steeg; PhD (Womens Malignancies Branch)",Karen P Usdin; PhD (NIDDK),"1. Fu H, Baris A, Aladjem MI (2018). Replication timing and nuclear structure. Curr Opin Cell Biol  52, 43-50.   https://doi.org/10.1016/j.ceb.2018.01.004|2. Jang SM, Redon CE, Aladjem MI (2018). Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy. Front Mol Biosci  5, 19.   https://doi.org/10.3389/fmolb.2018.00019|3. Jang SM, Zhang Y, Utani K, Fu H, Redon CE, Marks AB, Smith OK, Redmond CJ, Baris AM, Tulchinsky DA, Aladjem MI (2018). The replication initiation determinant protein (RepID) modulates replication by recruiting CUL4 to chromatin. Nat Commun  9, 2782.   https://doi.org/10.1038/s41467-018-05177-6|4. Redmond CJ, Fu H, Aladjem MI, McBride AA (2018). Human Papillomavirus Integration: Analysis by Molecular Combing and Fiber-FISH. Curr Protoc Microbiol  51, e61.   https://doi.org/10.1002/cpmc.61|5. Utani K, Aladjem MI (2018). Extra View: Sirt1 Acts As A Gatekeeper Of Replication Initiation To Preserve Genomic Stability. Nucleus  9, 261-267.   https://doi.org/10.1080/19491034.2018.1456218|6. Warburton A, Redmond CJ, Dooley KE, Fu H, Gillison ML, Akagi K, Symer DE, Aladjem MI, McBride AA (2018). HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression. PLoS Genet  14, e1007179.   https://doi.org/10.1371/journal.pgen.1007179|7. Xu X, Chen E, Mo L, Zhang L, Shao F, Miao K, Liu J, Su SM, Valecha M, Chan UI, Zheng H, Chen M, Chen W, Chen Q, Fu H, Aladjem MI, He Y, Deng CX (2019). BRCA1 represses DNA replication initiation through antagonizing estrogen signaling and maintains genome stability in parallel with WEE1-MCM2 signaling during pregnancy. Hum Mol Genet  28, 842-857.   https://doi.org/10.1093/hmg/ddy398",https://intramural.nih.gov/search/searchview.taf?ipid=108326
83,BC010412-20,"October 01, 2018 -  September 30, 2019",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Alan Anthony Merk,NULL,NULL,NULL,"1. Bartesaghi A, Aguerrebere C, Falconieri V, Banerjee S, Earl LA, Zhu X, Grigorieff N, Milne JLS, Sapiro G, Wu X, Subramaniam S (2018). Atomic Resolution Cryo-EM Structure of β-Galactosidase. Structure  26, 848-856.e3.   https://doi.org/10.1016/j.str.2018.04.004",https://intramural.nih.gov/search/searchview.taf?ipid=108327
84,BC010413-19,"October 01, 2018 -  September 30, 2019",Human Artificial Chromosomes for Cancer Research and Functional Genomics,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Jung-Hyun  Kim|Hee-Sheung  Lee|Mikhail A Liskovykh|Vladimir  Noskov; PhD|Nikolai S Petrov|Yves  Pommier; PhD,"Mitsuo  Oshimura (Tottori University)|William  Earnshaw (Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)|Hiroshi  Masumoto (NCI)|Phil  Hieter (University of British Columbia)|Marie-paule  Teulade-fichou (Institute Curie)|Alexey  Tomilin (Institute Of Cytology)",NULL,Danny L Sackett; PhD (NICHD) |David  Schlessinger; PhD (NIA) |Adam Michael Phillippy (NHGRI),"1. Kim JH, Dilthey AT, Nagaraja R, Lee HS, Koren S, Dudekula D, Wood Iii WH, Piao Y, Ogurtsov AY, Utani K, Noskov VN, Shabalina SA, Schlessinger D, Phillippy AM, Larionov V (2018). Variation in human chromosome 21 ribosomal RNA genes characterized by TAR cloning and long-read sequencing. Nucleic Acids Res  46, 6712-6725.   https://doi.org/10.1093/nar/gky442|2. Kouprina N, Larionov V (2019). TAR Cloning: Perspectives for Functional Genomics, Biomedicine, and Biotechnology. Mol Ther Methods Clin Dev  14, 16-26.   https://doi.org/10.1016/j.omtm.2019.05.006|3. Kouprina N, Petrov N, Molina O, Liskovykh M, Pesenti E, Ohzeki JI, Masumoto H, Earnshaw WC, Larionov V (2018). Human Artificial Chromosome with Regulated Centromere: A Tool for Genome and Cancer Studies. ACS Synth Biol  7, 1974-1989.   https://doi.org/10.1021/acssynbio.8b00230|4. Kouprina N, Pommier Y, Larionov V (2018). Novel screen for anti-cancer drugs that elevate chromosome instability (CIN) using human artificial chromosome (HAC). Oncotarget  9, 36833-36835.   https://doi.org/10.18632/oncotarget.26406|5. Ohzeki J, Larionov V, Earnshaw WC, Masumoto H (2019). De novo formation and epigenetic maintenance of centromere chromatin. Curr Opin Cell Biol  58, 15-25.   https://doi.org/10.1016/j.ceb.2018.12.004|6. Sinenko SA, Skvortsova EV, Liskovykh MA, Ponomartsev SV, Kuzmin AA, Khudiakov AA, Malashicheva AB, Alenina N, Larionov V, Kouprina N, Tomilin AN (2018). Transfer of Synthetic Human Chromosome into Human Induced Pluripotent Stem Cells for Biomedical Applications. Cells  7.   https://doi.org/10.3390/cells7120261",https://intramural.nih.gov/search/searchview.taf?ipid=108239
85,BC010419-20,"October 01, 2018 -  September 30, 2019",Molecular Mechanisms of TGF-beta Signaling Pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Birendra  Kc; PhD|Jee-Hye  Shin; PhD|Christina  Stuelten|Liuya  Tang|Roberto  Weigert; MSc Chemistry, PhD","Steven  Cheng (Nanjing Medical University)|Hans  Clevers (Hubrecht Laboratory and Centre for Biomedical Genetics, Netherlands Institute for Developmental Biology)|Rik  Derynck (University Of California San Francisco)|Jianyuan  Luo (Peking University Health Science Center)|Farhad  Parhami (Max Biopharma Inc.)",Lisa Marie Jenkins (Laboratory of Cell Biology),"Sushil Gopal Rane; MS, PhD (NIDDK)","1. Tripathi V, Shin JH, Stuelten CH, Zhang YE (2019). TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance. Oncogene  38, 3185-3200.   https://doi.org/10.1038/s41388-018-0655-8|2. Tu E, Chia CPZ, Chen W, Zhang D, Park SA, Jin W, Wang D, Alegre ML, Zhang YE, Sun L, Chen W (2018). T Cell Receptor-Regulated TGF-β Type I Receptor Expression Determines T Cell Quiescence and Activation. Immunity  48, 745-759.e6.   https://doi.org/10.1016/j.immuni.2018.03.025|3. Zhang YE (2018). Mechanistic insight into contextual TGF-β signaling. Curr Opin Cell Biol  51, 1-7.   https://doi.org/10.1016/j.ceb.2017.10.001",https://intramural.nih.gov/search/searchview.taf?ipid=108328
86,BC010425-20,"October 01, 2018 -  September 30, 2019",Strategies for Cancer Immunotherapy Clinical Trials,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Renee Nicole Donahue|Caroline Mikaela Maria Jochems; PhD|Samuel Troy Pellom; PhD|Martine  Policard|Claire Alison Smalley|Angela Mae Schwab|Show all 9,"Paul  Chaplin (Bavarian Nordic, Inc.)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|Frank E Jones; PhD (Tulane School of Medicine)|Shahrooz  Rabizadeh (Nantbioscience/nantomics)|Helen B Sabzevari|Patrick  Soon-shiong (Nantbioscience)|Show all 7","Seth M Steinberg; PhD (Office Of The Clinical Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic and GI Malignancies Branch)",Clint Tanner Allen (NIDCD) |Andrew Lee Mammen (NIAMS),"1. Schlom J, Gulley JL (2018). Vaccines as an Integral Component of Cancer Immunotherapy. JAMA  320, 2195-2196.   https://doi.org/10.1001/jama.2018.9511",https://intramural.nih.gov/search/searchview.taf?ipid=108329
87,BC010440-18,"October 01, 2018 -  September 30, 2019","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Emine  Guven-Maiorov; PhD|Hyunbum  Jang|Tsung-Jen  Liao|Buyong  Ma|Chung  Tsai|Mingzhen  Zhang; PhD|Show all 9,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Ratnesh  Lal (Medical School, University of Chicago)|Bruce  Kagan (UCLA)|Show all 20",Kyung  Lee; PhD (Laboratory of Metabolism)|Terrence R Burke; PhD (Chemical Biology Laboratory),"Carter  Van Waes; MD, PhD (NIDCD) |David Barry Sacks (CC)","1. Cheng F, Liang H, Butte AJ, Eng C, Nussinov R (2019). Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health. Pharmacol Rev  71, 1-19.   https://doi.org/10.1124/pr.118.016253|2. Cheng F, Nussinov R (2018). KRAS Activating Signaling Triggers Arteriovenous Malformations. Trends Biochem Sci  43, 481-483.   https://doi.org/10.1016/j.tibs.2018.04.007|3. Huang Y, Fang J, Lu W, Wang Z, Wang Q, Hou Y, Jiang X, Reizes O, Lathia J, Nussinov R, Eng C, Cheng F (2019). A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling. Cell Chem Biol  26, 1143-1158.e6.   https://doi.org/10.1016/j.chembiol.2019.05.004|4. Kuzu G, Keskin O, Nussinov R, Gursoy A (2018). PRISM-EM: template interface-based modelling of multi-protein complexes guided by cryo-electron microscopy density maps. Corrigendum. Acta Crystallogr D Struct Biol  74, 65-66.   https://doi.org/10.1107/S2059798317017739|5. Lei J, Qi R, Tang Y, Wang W, Wei G, Nussinov R, Ma B (2019). Conformational stability and dynamics of the cancer-associated isoform Δ133p53β are modulated by p53 peptides and p53-specific DNA. FASEB J  33, 4225-4235.   https://doi.org/10.1096/fj.201801973R|6. Li X, Dong X, Wei G, Margittai M, Nussinov R, Ma B (2018). The distinct structural preferences of tau protein repeat domains. Chem Commun (Camb)  54, 5700-5703.   https://doi.org/10.1039/c8cc01263f|7. Liao TJ, Jang H, Fushman D, Nussinov R (2018). Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles. Biophys J  115, 629-641.   https://doi.org/10.1016/j.bpj.2018.07.016|8. Nussinov R, Jang H, Tsai CJ, Cheng F (2019). Precision medicine review: rare driver mutations and their biophysical classification. Biophys Rev  11, 5-19.   https://doi.org/10.1007/s12551-018-0496-2|9. Nussinov R, Jang H, Tsai CJ, Cheng F (2019). Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers. PLoS Comput Biol  15, e1006658.   https://doi.org/10.1371/journal.pcbi.1006658|10. Nussinov R, Tsai CJ, Jang H (2018). Oncogenic Ras Isoforms Signaling Specificity at the Membrane. Cancer Res  78, 593-602.   https://doi.org/10.1158/0008-5472.CAN-17-2727|11. Nussinov R, Tsai CJ, Jang H (2019). Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant? Semin Cancer Biol  54, 114-120.   https://doi.org/10.1016/j.semcancer.2018.01.002|12. Nussinov R, Tsai CJ, Jang H (2019). Oncogenic KRas mobility in the membrane and signaling response. Semin Cancer Biol  54, 109-113.   https://doi.org/10.1016/j.semcancer.2018.02.009|13. Nussinov R, Tsai CJ, Jang H (2019). Protein ensembles link genotype to phenotype. PLoS Comput Biol  15, e1006648.   https://doi.org/10.1371/journal.pcbi.1006648|14. Nussinov R, Tsai CJ, Shehu A, Jang H (2019). Computational Structural Biology: Successes, Future Directions, and Challenges. Molecules  24.   https://doi.org/10.3390/molecules24030637|15. Nussinov R, Zhang M, Tsai CJ, Jang H (2018). Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers. Biochim Biophys Acta Mol Basis Dis  1864, 2304-2314.   https://doi.org/10.1016/j.bbadis.2017.10.032|16. Nussinov R, Zhang M, Tsai CJ, Liao TJ, Fushman D, Jang H (2018). Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention. Biophys Rev  10, 1263-1282.   https://doi.org/10.1007/s12551-018-0461-0|17. Ozdemir ES, Jang H, Gursoy A, Keskin O, Li Z, Sacks DB, Nussinov R (2018). Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2. J Biol Chem  293, 3685-3699.   https://doi.org/10.1074/jbc.RA117.001596|18. Ozdemir ES, Nussinov R, Gursoy A, Keskin O (2019). Developments in integrative modeling with dynamical interfaces. Curr Opin Struct Biol  56, 11-17.   https://doi.org/10.1016/j.sbi.2018.10.007|19. Peng H, Zeng X, Zhou Y, Zhang D, Nussinov R, Cheng F (2019). A component overlapping attribute clustering (COAC) algorithm for single-cell RNA sequencing data analysis and potential pathobiological implications. PLoS Comput Biol  15, e1006772.   https://doi.org/10.1371/journal.pcbi.1006772|20. Qi R, Wei G, Ma B, Nussinov R (2018). Replica Exchange Molecular Dynamics: A Practical Application Protocol with Solutions to Common Problems and a Peptide Aggregation and Self-Assembly Example. Methods Mol Biol  1777, 101-119.   https://doi.org/10.1007/978-1-4939-7811-3_5|21. Qian Z, Zou Y, Zhang Q, Chen P, Ma B, Wei G, Nussinov R (2018) Atomistic-level study of the interactions between hIAPP protofibrils and membranes: Influence of pH and lipid composition. Biochim Biophys Acta Biomembr, in press (e-pub ahead of print)  https://doi.org/10.1016/j.bbamem.2018.02.005|22. Rangarajan S, He Y, Chen Y, Kerzic MC, Ma B, Gowthaman R, Pierce BG, Nussinov R, Mariuzza RA, Orban J (2018). Peptide-MHC (pMHC) binding to a human antiviral T cell receptor induces long-range allosteric communication between pMHC- and CD3-binding sites. J Biol Chem  293, 15991-16005.   https://doi.org/10.1074/jbc.RA118.003832|23. Ren B, Hu R, Zhang M, Liu Y, Xu L, Jiang B, Ma J, Ma B, Nussinov R, Zheng J (2018). Experimental and Computational Protocols for Studies of Cross-Seeding Amyloid Assemblies. Methods Mol Biol  1777, 429-447.   https://doi.org/10.1007/978-1-4939-7811-3_27|24. Song NY, Zhu F, Wang Z, Willette-Brown J, Xi S, Sun Z, Su L, Wu X, Ma B, Nussinov R, Xia X, Schrump DS, Johnson PF, Karin M, Hu Y (2018). IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways. Proc Natl Acad Sci U S A  115, E812-E821.   https://doi.org/10.1073/pnas.1717520115|25. Tsai CJ, Nussinov R (2018). Allosteric activation of RAF in the MAPK signaling pathway. Curr Opin Struct Biol  53, 100-106.   https://doi.org/10.1016/j.sbi.2018.07.007|26. Tsai CJ, Nussinov R (2019). Emerging Allosteric Mechanism of EGFR Activation in Physiological and Pathological Contexts. Biophys J  117, 5-13.   https://doi.org/10.1016/j.bpj.2019.05.021|27. Wang G, Zhang M, Jang H, Lu S, Lin S, Chen G, Nussinov R, Zhang J, Gaponenko V (2018). Interaction of Calmodulin with the cSH2 Domain of the p85 Regulatory Subunit. Biochemistry  57, 1917-1928.   https://doi.org/10.1021/acs.biochem.7b01130|28. Wang M, Zhu D, Zhu J, Nussinov R, Ma B (2018). Local and global anatomy of antibody-protein antigen recognition. J Mol Recognit  31, e2693.   https://doi.org/10.1002/jmr.2693|29. Weismiller HA, Murphy R, Wei G, Ma B, Nussinov R, Margittai M (2018). Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms. J Biol Chem  293, 17336-17348.   https://doi.org/10.1074/jbc.RA118.005316|30. Wodak SJ, Paci E, Dokholyan NV, Berezovsky IN, Horovitz A, Li J, Hilser VJ, Bahar I, Karanicolas J, Stock G, Hamm P, Stote RH, Eberhardt J, Chebaro Y, Dejaegere A, Cecchini M, Changeux JP, Bolhuis PG, Vreede J, Faccioli P, Orioli S, Ravasio R, Yan L, Brito C, Wyart M, et al. [14 more authors] (2019). Allostery in Its Many Disguises: From Theory to Applications. Structure  27, 566-578.   https://doi.org/10.1016/j.str.2019.01.003|31. Wu D, Wang W, Chen W, Lian F, Lang L, Huang Y, Xu Y, Zhang N, Chen Y, Liu M, Nussinov R, Cheng F, Lu W, Huang J (2018). Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells. Haematologica  103, 1472-1483.   https://doi.org/10.3324/haematol.2018.188185|32. Yang YA, Lee S, Zhao J, Thompson AJ, McBride R, Tsogtbaatar B, Paulson JC, Nussinov R, Deng L, Song J (2018). In vivo tropism of Salmonella Typhi toxin to cells expressing a multiantennal glycan receptor. Nat Microbiol  3, 155-163.   https://doi.org/10.1038/s41564-017-0076-4|33. Zeng X, Zhu S, Liu X, Zhou Y, Nussinov R, Cheng F (2019) deepDR: A network-based deep learning approach to in silico drug repositioning. Bioinformatics, in press (e-pub ahead of print)  https://doi.org/10.1093/bioinformatics/btz418|34. Zhang M, Jang H, Nussinov R (2019). The mechanism of PI3Kα activation at the atomic level. Chem Sci  10, 3671-3680.   https://doi.org/10.1039/c8sc04498h|35. Zhang M, Jang H, Nussinov R (2019). The structural basis for Ras activation of PI3Kα lipid kinase. Phys Chem Chem Phys  21, 12021-12028.   https://doi.org/10.1039/c9cp00101h|36. Zhang M, Li Z, Wang G, Jang H, Sacks DB, Zhang J, Gaponenko V, Nussinov R (2018). Calmodulin (CaM) Activates PI3Kα by Targeting the ""Soft"" CaM-Binding Motifs in Both the nSH2 and cSH2 Domains of p85α. J Phys Chem B  122, 11137-11146.   https://doi.org/10.1021/acs.jpcb.8b05982|37. Zhao J, Nussinov R, Ma B (2019). Antigen binding allosterically promotes Fc receptor recognition. MAbs  11, 58-74.   https://doi.org/10.1080/19420862.2018.1522178|38. Zhao J, Zhang B, Zhu J, Nussinov R, Ma B (2018). Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients. Biochim Biophys Acta Mol Basis Dis  1864, 2294-2303.   https://doi.org/10.1016/j.bbadis.2017.12.009",https://intramural.nih.gov/search/searchview.taf?ipid=108303
88,BC010441-18,"October 01, 2018 -  September 30, 2019",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Emine  Guven-Maiorov; PhD|Hyunbum  Jang|Buyong  Ma|Emine Sila Ozdemir|Amarda  Shehu|Chung  Tsai|Show all 9,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Ratnesh  Lal (Medical School, University of Chicago)|Bruce  Kagan (UCLA)|Show all 17",Kyung  Lee; PhD (Laboratory of Metabolism)|Terrence R Burke; PhD (Chemical Biology Laboratory),"Carter  Van Waes; MD, PhD (NIDCD) |David Barry Sacks (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108304
89,BC010442-18,"October 01, 2018 -  September 30, 2019",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI","Emine  Guven-Maiorov; PhD|Amarda  Shehu|Chung  Tsai|Yinling  Hu|Mary  Carrington; MS, PhD|Giorgio  Trinchieri","Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Ratnesh  Lal (Medical School, University of Chicago)|Bruce  Kagan (UCLA)|Show all 17",Kyung  Lee; PhD (Laboratory of Metabolism)|Terrence R Burke; PhD (Chemical Biology Laboratory),"Carter  Van Waes; MD, PhD (NIDCD) |David Barry Sacks (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108307
90,BC010449-18,"October 01, 2018 -  September 30, 2019",Role of Novel Cytokine Secretoglobin (SCGB) 3A2 in Lung,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Richard Scott Clayton|Henrique Bregolin Dias|Shun  Nakayama,Taketomo  Kido|Aprile  Pilon (Therabron Therapeutics),Raul Eduardo Cachau (Office Of The Director)|Xu  Naizhen (Laboratory of Pathology),NULL,"1. Naizhen X, Kido T, Yokoyama S, Linnoila RI, Kimura S (2019). Spatiotemporal Expression of Three Secretoglobin Proteins, SCGB1A1, SCGB3A1, and SCGB3A2, in Mouse Airway Epithelia. J Histochem Cytochem  67, 453-463.   https://doi.org/10.1369/0022155419829050|2. Ostrin EJ, Little DR, Gerner-Mauro KN, Sumner EA, Ríos-Corzo R, Ambrosio E, Holt SE, Forcioli-Conti N, Akiyama H, Hanash SM, Kimura S, Huang SXL, Chen J (2018). β-Catenin maintains lung epithelial progenitors after lung specification. Development  145.   https://doi.org/10.1242/dev.160788|3. Yokoyama S, Cai Y, Murata M, Tomita T, Yoneda M, Xu L, Pilon AL, Cachau RE, Kimura S (2018). A novel pathway of LPS uptake through syndecan-1 leading to pyroptotic cell death. Elife  7.   https://doi.org/10.7554/eLife.37854",https://intramural.nih.gov/search/searchview.taf?ipid=108330
91,BC010451-18,"October 01, 2018 -  September 30, 2019",Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Kevin Roland Trabbic; PhD|Jeffrey  Gildersleeve,"Philip  Deshong (University of Maryland, College Park)|David  Cheresh (University of California San Diego)",NULL,NULL,"1. Trabbic KR, Whalen K, Abarca-Heideman K, Xia L, Temme JS, Edmondson EF, Gildersleeve JC, Barchi JJ (2019). A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide. Sci Rep  9, 5662.   https://doi.org/10.1038/s41598-019-42076-2",https://intramural.nih.gov/search/searchview.taf?ipid=108380
92,BC010453-18,"October 01, 2018 -  September 30, 2019",Genetics and Molecular Mechanisms of Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Cindy Huong-Bich Chau|Martina Arnett Knechel|Douglas K Price|William Laurence Dahut; MD|Ravi  Madan,"Ian Abban Thompson; MD|Robin  Leach (UT Health Science Center San Antonio)|Phyllis  Goodman (Fred Hutchinson Cancer Research Center)|Ashraful  Hoque (MD Anderson Cancer Center)|Elizabeth  Platz; PhD (School of Public Health, Johns Hopkins University)|Catherine  Tangen (Fred Hutchinson Cancer Research Center)|Show all 12",Howard  Parnes (Prostate and Urologic Cancer Research Group)|Tim Friedrich Greten (Thoracic and GI Malignancies Branch)|Heidi H Kong (Office of the Director)|Seth M Steinberg; PhD (Office Of The Clinical Director)|Anish  Thomas; MD (Developmental Therapeutics Branch)|David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Chau CH, Figg WD (2018). Revisiting 5α-reductase inhibitors and the risk of prostate cancer. Nat Rev Urol  15, 400-401.   https://doi.org/10.1038/s41585-018-0018-9|2. Huang PA, Price DK, Figg WD (2018). Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance. Cancer Biol Ther  19, 869-870.   https://doi.org/10.1080/15384047.2018.1449618|3. McCrea EM, Lee DK, Sissung TM, Figg WD (2018). Precision medicine applications in prostate cancer. Ther Adv Med Oncol  10, 1758835918776920.   https://doi.org/10.1177/1758835918776920|4. Petrovics G, Price DK, Lou H, Chen Y, Garland L, Bass S, Jones K, Kohaar I, Ali A, Ravindranath L, Young D, Cullen J, Dorsey TH, Sesterhenn IA, Brassell SA, Rosner IL, Ross D, Dahut W, Ambs S, Figg WD, Srivastava S, Dean M (2019). Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population. Prostate Cancer Prostatic Dis  22, 406-410.   https://doi.org/10.1038/s41391-018-0114-1|5. Tang L, Platek ME, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JKV, Santella RM, Hsing A, Figg WD, Lippman SM, Thompson IM, Ambrosone CB (2018). Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis  39, 125-133.   https://doi.org/10.1093/carcin/bgx144",https://intramural.nih.gov/search/searchview.taf?ipid=108331
93,BC010476-17,"October 01, 2018 -  September 30, 2019",Time Domian Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Jeffrey Robert Brender|Nallathamby  Devasahayam|Shun Kishimoto Kishimoto|Yu  Saida|Kazutoshi  Yamamoto; PhD|James B Mitchell; PhD,Robert  Gillies (Moffitt Cancer Center)|Charles  Hart (Threshold Pharmaceuticals),NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS) |Thomas J Pohida; MS (CIT),"1. Dewhirst MW, Mowery YM, Mitchell JB, Cherukuri MK, Secomb TW (2019). Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies. J Clin Invest  129, 489-491.   https://doi.org/10.1172/JCI126044|2. Enomoto A, Qian C, Devasahayam N, Kishimoto S, Oshima N, Blackman B, Swenson RE, Mitchell JB, Koretsky AP, Krishna MC (2018). Wireless implantable coil with parametric amplification for in vivo electron paramagnetic resonance oximetric applications. Magn Reson Med  80, 2288-2298.   https://doi.org/10.1002/mrm.27185|3. Kishimoto S, Krishna MC, Khramtsov VV, Utsumi H, Lurie DJ (2018). In Vivo Application of Proton-Electron Double-Resonance Imaging. Antioxid Redox Signal  28, 1345-1364.   https://doi.org/10.1089/ars.2017.7341|4. Kishimoto S, Matsumoto KI, Saito K, Enomoto A, Matsumoto S, Mitchell JB, Devasahayam N, Krishna MC (2018). Pulsed Electron Paramagnetic Resonance Imaging: Applications in the Studies of Tumor Physiology. Antioxid Redox Signal  28, 1378-1393.   https://doi.org/10.1089/ars.2017.7391|5. Kishimoto S, Oshima N, Yamamoto K, Munasinghe J, Ardenkjaer-Larsen JH, Mitchell JB, Choyke PL, Krishna MC (2018). Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes. Free Radic Biol Med  116, 1-10.   https://doi.org/10.1016/j.freeradbiomed.2017.12.034|6. Matsumoto KI, Hyodo F, Mitchell JB, Krishna MC (2018). Effect of body temperature on the pharmacokinetics of a triarylmethyl-type paramagnetic contrast agent used in EPR oximetry. Magn Reson Med  79, 1212-1218.   https://doi.org/10.1002/mrm.27008|7. Matsumoto KI, Mitchell JB, Krishna MC (2018). Comparative studies with EPR and MRI on the in vivo tissue redox status estimation using redox-sensitive nitroxyl probes: influence of the choice of the region of interest. Free Radic Res  52, 248-255.   https://doi.org/10.1080/10715762.2018.1427235|8. Matsuo M, Kawai T, Kishimoto S, Saito K, Munasinghe J, Devasahayam N, Mitchell JB, Krishna MC (2018). Co-imaging of the tumor oxygenation and metabolism using electron paramagnetic resonance imaging and 13-C hyperpolarized magnetic resonance imaging before and after irradiation. Oncotarget  9, 25089-25100.   https://doi.org/10.18632/oncotarget.25317|9. Naz S, Kishimoto S, Mitchell JB, Krishna MC (2019). Imaging Metabolic Processes to Predict Radiation Responses. Semin Radiat Oncol  29, 81-89.   https://doi.org/10.1016/j.semradonc.2018.10.004|10. Pursley R, Enomoto A, Wu H, Brender JR, Pohida T, Subramanian S, Krishna MC, Devasahayam N (2019). Towards reduction of SAR in scaling up in vivo pulsed EPR imaging to larger objects. J Magn Reson  299, 42-48.   https://doi.org/10.1016/j.jmr.2018.12.011|11. Takakusagi Y, Kishimoto S, Naz S, Matsumoto S, Saito K, Hart CP, Mitchell JB, Krishna MC (2018). Radiotherapy Synergizes with the Hypoxia-Activated Prodrug Evofosfamide: In Vitro and In Vivo Studies. Antioxid Redox Signal  28, 131-140.   https://doi.org/10.1089/ars.2017.7106",https://intramural.nih.gov/search/searchview.taf?ipid=108341
94,BC010477-17,"October 01, 2018 -  September 30, 2019",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Jeffrey Robert Brender|Nallathamby  Devasahayam|Shun Kishimoto Kishimoto|Yu  Saida|Kazutoshi  Yamamoto; PhD|James B Mitchell; PhD,NULL,NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS),"1. Brender JR, Kishimoto S, Merkle H, Reed G, Hurd RE, Chen AP, Ardenkjaer-Larsen JH, Munasinghe J, Saito K, Seki T, Oshima N, Yamamoto K, Choyke PL, Mitchell J, Krishna MC (2019). Dynamic Imaging of Glucose and Lactate Metabolism by 13C-MRS without Hyperpolarization. Sci Rep  9, 3410.   https://doi.org/10.1038/s41598-019-38981-1|2. Read GH, Miura N, Carter JL, Kines KT, Yamamoto K, Devasahayam N, Cheng JY, Camphausen KA, Krishna MC, Kesarwala AH (2018). Three-dimensional alginate hydrogels for radiobiological and metabolic studies of cancer cells. Colloids Surf B Biointerfaces  171, 197-204.   https://doi.org/10.1016/j.colsurfb.2018.06.018",https://intramural.nih.gov/search/searchview.taf?ipid=108340
95,BC010481-17,"October 01, 2018 -  September 30, 2019",HIV-1 Reverse Transcriptase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Paul L Boyer|Patrick K Clark|Linda L Dunn|Andrea L Ferris|Steven J Smith,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",Terrence R Burke; PhD (Chemical Biology Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Gary T Pauly (Chemical Biology Laboratory),NULL,"1. Boyer PL, Melody K, Smith SJ, Dunn LL, Kline C, Fischer DK, Dwivedi R, Clark P, Hughes SH, Ambrose Z (2019). Two Coselected Distal Mutations in HIV-1 Reverse Transcriptase (RT) Alter Susceptibility to Nonnucleoside RT Inhibitors and Nucleoside Analogs. J Virol  93.   https://doi.org/10.1128/JVI.00224-19|2. Boyer PL, Smith SJ, Zhao XZ, Das K, Gruber K, Arnold E, Burke TR, Hughes SH (2018). Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase. J Virol  92.   https://doi.org/10.1128/JVI.02203-17",https://intramural.nih.gov/search/searchview.taf?ipid=108337
96,BC010484-17,"October 01, 2018 -  September 30, 2019",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",James Michael Dunleavey; PhD|Yang  Feng|Steven  Seaman|Daeho  So,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries)|Gary  DeCrescenzo (BioMed Valley Discoveries)|Dean  Welsch (BioMed Valley Discoveries)|Dimiter Stanchev Dimitrov; PhD (NCI),Nancy J Emenaker (Nutritional Science Research Group),NULL,"1. Evans DJ, Wasinger AM, Brey RN, Dunleavey JM, St Croix B, Bann JG (2018). Seneca Valley Virus Exploits TEM8, a Collagen Receptor Implicated in Tumor Growth. Front Oncol  8, 506.   https://doi.org/10.3389/fonc.2018.00506|2. Szot C, Saha S, Zhang XM, Zhu Z, Hilton MB, Morris K, Seaman S, Dunleavey JM, Hsu KS, Yu GJ, Morris H, Swing DA, Haines DC, Wang Y, Hwang J, Feng Y, Welsch D, DeCrescenzo G, Chaudhary A, Zudaire E, Dimitrov DS, St Croix B (2018). Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release. J Clin Invest  128, 2927-2943.   https://doi.org/10.1172/JCI120481|3. Wallace J, Lutgen V, Avasarala S, St Croix B, Winn RA, Al-Harthi L (2018). Wnt7a induces a unique phenotype of monocyte-derived macrophages with lower phagocytic capacity and differential expression of pro- and anti-inflammatory cytokines. Immunology  153, 203-213.   https://doi.org/10.1111/imm.12830",https://intramural.nih.gov/search/searchview.taf?ipid=108346
97,BC010487-17,"October 01, 2018 -  September 30, 2019",The role of CPSF6 in HIV-1 infection,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Kyeongeun  Lee|Sorin Ophelie Miller|Sekou-Tidiane T Yoda|Szu-Wei  Huang; PhD,"Alan  Engelman; PhD (Dana-Farber, Harvard University)|Thomas  Hope (Northwestern University)|Richard  Sutton|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)|Irene  Pedersen (University of California - Irvine)",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Xiaolin  Wu; PhD (Office Of The Director),NULL,"1. Bochnakian A, Zhen A, Zisoulis DG, Idica A, KewalRamani VN, Neel N, Daugaard I, Hamdorf M, Kitchen S, Lee K, Pedersen IM (2019). Interferon-Inducible MicroRNA miR-128 Modulates HIV-1 Replication by Targeting TNPO3 mRNA. J Virol  93.   https://doi.org/10.1128/JVI.00364-19",https://intramural.nih.gov/search/searchview.taf?ipid=108338
98,BC010488-17,"October 01, 2018 -  September 30, 2019",HIV-1 passage through the nuclear pore complex,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Szu-Wei  Huang; PhD|Kyeongeun  Lee|Sorin Ophelie Miller|Sekou-Tidiane T Yoda,"Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Jeremy  Luban (Columbia University)|Filipe  Diaz-griffero (Albert Einstein College Of Medicine)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108339
99,BC010493-17,"October 01, 2018 -  September 30, 2019",Nucleic Acid Footprinting and development of small molecule antagonists,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Samantha Beatrice Gacasan|Stefano  Ginocchio|Jennifer T Miller|Jason William Rausch|Chringma  Sherpa,"David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|Marie-Louise  Hammarskjold (University of Virginia)|John  Tavis (Saint Louis University)|Peter  Stockley (University of Leeds)",John Stephen Schneekloth (Chemical Biology Laboratory)|Denise  Whitby (Office Of The Director),NULL,"1. Okamoto K, Rausch JW, Wakashin H, Fu Y, Chung JY, Dummer PD, Shin MK, Chandra P, Suzuki K, Shrivastav S, Rosenberg AZ, Hewitt SM, Ray PE, Noiri E, Le Grice SFJ, Hoek M, Han Z, Winkler CA, Kopp JB (2018). APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R. Commun Biol  1, 188.   https://doi.org/10.1038/s42003-018-0188-2|2. Sherpa C, Jackson PEH, Gray LR, Anastos K, Le Grice SFJ, Hammarskjold ML, Rekosh D (2019). Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time. J Virol  93.   https://doi.org/10.1128/JVI.02102-18|3. Sherpa C, Rausch JW, Le Grice SF (2018). Structural characterization of maternally expressed gene 3 RNA reveals conserved motifs and potential sites of interaction with polycomb repressive complex 2. Nucleic Acids Res  46, 10432-10447.   https://doi.org/10.1093/nar/gky722|4. Sztuba-Solinska J, Le Grice SFJ (2018). The ""Topological Train Ride"" of a viral long non-coding RNA. RNA Biol  15, 13-16.   https://doi.org/10.1080/15476286.2017.1391442",https://intramural.nih.gov/search/searchview.taf?ipid=108343
100,BC010494-17,"October 01, 2018 -  September 30, 2019",Small molecule targeting viral nucleotidyltransferases,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Ellen Elizabeth Bak|Jennifer T Miller,"Graziella  Tocco (University of Cagliari)|John  Tavis (Saint Louis University)|Ryan  Murelli (Brooklyn College)|Lynda  Morrison (St. Louis University)|Blossom  Damania (University of North Carolina, Chapel Hill, NC)",John A Beutler (Molecular Targets Laboratory),NULL,"1. Dehghanpir SD, Birkenheuer CH, Yang K, Murelli RP, Morrison LA, Le Grice SFJ, Baines JD (2018). Broad anti-herpesviral activity of α-hydroxytropolones. Vet Microbiol  214, 125-131.   https://doi.org/10.1016/j.vetmic.2017.12.016",https://intramural.nih.gov/search/searchview.taf?ipid=108342
101,BC010499-17,"October 01, 2018 -  September 30, 2019",Maryland Prostate Cancer Case-Control Study,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Maeve Kiely Bailey-Whyte|Tiffany Marie Howe|Tsion Zewdu Minas|Wei  Tang; PhD,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Carlos  Casiano (Loma Linda University School of Medicine)|Clayton  Yates (Tuskegee University)",Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108332
102,BC010504-17,"October 01, 2018 -  September 30, 2019","Understanding Retroviral Reverse Transcription, Recombination, and Replication",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Alice Ann Duchon; PhD|Yang  Liu; PhD|Olga A Nikolaitchik|Jonathan Mark Olivares Rawson|Chijioke Nkemjika Umunnakwe|Saurabh  Shakya; PhD|Show all 9,Karin  Musier-forsyth (Ohio State University)|Leor  Weinberger (University Of California San Francisco)|Bin  Wu (Johns Hopkins University),Brandon Frank Keele (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108336
103,BC010506-17,"October 01, 2018 -  September 30, 2019","Defining Mechanisms of HIV1 RNA Trafficking, Virus Assembly and Virion Structure",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Alice Ann Duchon; PhD|Yang  Liu; PhD|Olga A Nikolaitchik|Jonathan Mark Olivares Rawson|Chijioke Nkemjika Umunnakwe|Show all 12,NULL,Robert  Gorelick (Office Of The Director)|Eric O Freed; PhD (HIV Drug Resistance Program),Jiji  Chen (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108335
104,BC010511-17,"October 01, 2018 -  September 30, 2019",Retrovirus Assembly and Maturation,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Tomas  Kroupa; PhD|Banhi  Biswas|Constance Irene Rink|Wei-Shau  Hu; PhD,"Bogdan  Dragnea (University of Indiana)|Adam  Zlotnick; PhD (Biochemistry and Molecular Biology, University of Oklahoma)|Volker  Vogt (Cornell University)|John  Briggs (European Molecular Biology Laboratory)|Monica  Roth (Robert Wood Johnson Medical School, University of Medicine and Dentistry)|Robert  Dick (Cornell University)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Kunio  Nagashima (Office of the Director)|Thorkell  Andresson (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Eric O Freed; PhD (HIV Drug Resistance Program)|Yun Xing M Wang (Structural Biophysics Laboratory),Peter W Schuck; PhD (NIBIB),"1. Comas-Garcia M, Kroupa T, Datta SA, Harvin DP, Hu WS, Rein A (2018). Efficient support of virus-like particle assembly by the HIV-1 packaging signal. Elife  7.   https://doi.org/10.7554/eLife.38438|2. Qu K, Glass B, Doležal M, Schur FKM, Murciano B, Rein A, Rumlová M, Ruml T, Kräusslich HG, Briggs JAG (2018). Structure and architecture of immature and mature murine leukemia virus capsids. Proc Natl Acad Sci U S A  115, E11751-E11760.   https://doi.org/10.1073/pnas.1811580115|3. Rein A (2019). RNA Packaging in HIV. Trends Microbiol  27, 715-723.   https://doi.org/10.1016/j.tim.2019.04.003",https://intramural.nih.gov/search/searchview.taf?ipid=108344
105,BC010512-17,"October 01, 2018 -  September 30, 2019",Interactions of Retroviral Proteins with Nucleic Acids,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Tomas  Kroupa; PhD|Banhi  Biswas|Constance Irene Rink|Wei-Shau  Hu; PhD,Karin  Musier-Forsyth (Ohio State University)|Raveen  Parboosing (University Of Kwazulu-natal),Stephen J Lockett; PhD (Office Of The Director),Peter W Schuck; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108345
106,BC010516-17,"October 01, 2018 -  September 30, 2019",Gated Optical Detectors-Dose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Barbara Chin Arora|Jason Yulin Cheng; PhD|Peter  Guion|Holly  Ning|Ying  Zhuge,"Wei  Chen (University Of Texas)|Chang-Ming  Ma (Radiation Oncology Department, Fox Chase Cancer Center)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108349
107,BC010518-17,"October 01, 2018 -  September 30, 2019",Role of BMP and FGF signaling during limb development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Christian Louis Bonatto Paese; MSC|Michael Graham Stanley Boylan|Cynthia M Elder|Salvia  Misaghian,Trevor  Williams (University of Colarado)|Miguel Humberto Torres,Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,"1. Gao B, Ajima R, Yang W, Li C, Song H, Anderson MJ, Liu RR, Lewandoski MB, Yamaguchi TP, Yang Y (2018). Coordinated directional outgrowth and pattern formation by integration of Wnt5a and Fgf signaling in planar cell polarity. Development  145.   https://doi.org/10.1242/dev.163824",https://intramural.nih.gov/search/searchview.taf?ipid=108352
108,BC010523-17,"October 01, 2018 -  September 30, 2019",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Vanivilasini  Balachandran|Jothy  Dhakshnamoorthy|Amber Rae Cutter|Hernan Diego Folco|Brent Joseph Groubert|Sahana  Holla|Show all 15,NULL,Thorkell  Andresson (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108232
109,BC010524-17,"October 01, 2018 -  September 30, 2019",HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach,"Vladimir  Poroikov (Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)|Chenzhong  Liao|Karen  Buckheit (ImQuest Biosciences)",Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108350
110,BC010525-17,"October 01, 2018 -  September 30, 2019",Immune Reconstitution,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Catherine Virginia Bare|Don Eugene Farthing|Francis  Flomerfelt; PhD|Christopher Nelson Johns|Hye Kyung  Kim|Ruifeng  Teng,NULL,Jung-Hyun  Park (Experimental Immunology Branch),NULL,"1. Williams KM, Holter-Chakrabarty J, Lindenberg L, Duong Q, Vesely SK, Nguyen CT, Havlicek JP, Kurdziel K, Gea-Banacloche J, Lin FI, Avila DN, Selby G, Kanakry CG, Li S, Scordino T, Adler S, Bollard CM, Choyke P, Gress RE (2018). Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study. Lancet Haematol  5, e44-e52.   https://doi.org/10.1016/S2352-3026(17)30215-6",https://intramural.nih.gov/search/searchview.taf?ipid=108334
111,BC010538-17,"October 01, 2018 -  September 30, 2019",Molecular Analysis of Breast Cancer Metastasis to the Brain,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Brunilde M Gril|Anurag Narasimha Paranjape|Debbie  Wei|Stanley  Lipkowitz; MD, PhD|Alexandra Dos Santos Zimmer","Quentin  Smith; PhD (Dept. of Pharmacy, Texas Technical University)|Jacek  Jassem (Medical University of Gdansk)|Renata  Duchnowska (Military Institute of Medicine,)|Priscilla  Brastianos (MGH)|Scott  Carter (Dana-Farber Cancer Center)|Philippe  Metellus (Aix-marseille Universit�)|Show all 8",Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|William Douglas Figg Ii (Genitourinary Malignancies Branch)|Simone  Difilippantonio (Office Of The Director)|Terri Sue Armstrong; PhD (Neuro-Oncology Branch),Rolf Eric Swenson; PhD (NHLBI),"1. Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L, Peters S, Arvold ND, Harsh GR, Steeg PS, Chang SD (2019). Brain metastases. Nat Rev Dis Primers  5, 5.   https://doi.org/10.1038/s41572-018-0055-y|2. Contreras-Zárate MJ, Day NL, Ormond DR, Borges VF, Tobet S, Gril B, Steeg PS, Cittelly DM (2019). Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases. Oncogene  38, 4685-4699.   https://doi.org/10.1038/s41388-019-0756-z",https://intramural.nih.gov/search/searchview.taf?ipid=108347
112,BC010547-17,"October 01, 2018 -  September 30, 2019",Drug Development for Prostate Cancer and other Metastatic Processes,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Cindy Huong-Bich Chau|Martina Arnett Knechel|Douglas K Price|James L Gulley; MD, PhD|William Laurence Dahut; MD|Ravi  Madan|Show all 7",Neil  Vargesson; PhD (University of Aberdeen)|Christopher  Schofield (University of Oxford)|Wooin  Lee (Seoul National University)|Walter  Jager (University of Vienna)|Michael  Gutschow (University of Bonn)|Donald  McDonnel (Duke University School of Medicine),Howard  Parnes (Prostate and Urologic Cancer Research Group)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Tim Friedrich Greten (Thoracic and GI Malignancies Branch)|Heidi H Kong (Office of the Director)|Seth M Steinberg; PhD (Office Of The Clinical Director)|Anish  Thomas; MD (Developmental Therapeutics Branch),Craig Joseph Thomas (NCATS),"1. Alyamani M, Emamekhoo H, Park S, Taylor J, Almassi N, Upadhyay S, Tyler A, Berk MP, Hu B, Hwang TH, Figg WD, Peer CJ, Chien C, Koshkin VS, Mendiratta P, Grivas P, Rini B, Garcia J, Auchus RJ, Sharifi N (2018). HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer. J Clin Invest  128, 3333-3340.   https://doi.org/10.1172/JCI98319|2. Karakunnel JJ, Bui N, Palaniappan L, Schmidt KT, Mahaffey KW, Morrison B, Figg WD, Kummar S (2018). Reviewing the role of healthy volunteer studies in drug development. J Transl Med  16, 336.   https://doi.org/10.1186/s12967-018-1710-5|3. Schmidt KT, Madan RA, Figg WD (2018). Expanding the use of abiraterone in prostate cancer: Is earlier always better? Cancer Biol Ther  19, 97-100.   https://doi.org/10.1080/15384047.2017.1394555|4. Szmulewitz RZ, Peer CJ, Ibraheem A, Martinez E, Kozloff MF, Carthon B, Harvey RD, Fishkin P, Yong WP, Chiong E, Nabhan C, Karrison T, Figg WD, Stadler WM, Ratain MJ (2018). Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer. J Clin Oncol  36, 1389-1395.   https://doi.org/10.1200/JCO.2017.76.4381",https://intramural.nih.gov/search/searchview.taf?ipid=108333
113,BC010578-16,"October 01, 2018 -  September 30, 2019",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Christopher Michael Dower|James Michael Dunleavey; PhD|Yang  Feng|Steven  Seaman|Liping  Yang; PhD|Kuo-Sheng Frank Hsu,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries)|Gary  DeCrescenzo (BioMed Valley Discoveries)|Dean  Welsch (BioMed Valley Discoveries)|Dimiter Stanchev Dimitrov; PhD (NCI),NULL,NULL,"1. Byrd TT, Fousek K, Pignata A, Szot C, Samaha H, Seaman S, Dobrolecki L, Salsman VS, Oo HZ, Bielamowicz K, Landi D, Rainusso N, Hicks J, Powell S, Baker ML, Wels WS, Koch J, Sorensen PH, Deneen B, Ellis MJ, Lewis MT, Hegde M, Fletcher BS, St Croix B, Ahmed N (2018). TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res  78, 489-500.   https://doi.org/10.1158/0008-5472.CAN-16-1911",https://intramural.nih.gov/search/searchview.taf?ipid=108235
114,BC010579-16,"October 01, 2018 -  September 30, 2019",Papillomavirus Virion Proteins and Vaccines,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Meghan Faith Anderman|Luciarita  Boccuzzi|Marian E Durkin|Sarah  Eng|Alexander G Papageorge|Xiaolan  Qian; MD, PhD|Show all 11",NULL,Ligia  Pinto (Infection & Immunoepidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch),NULL,"1. Çuburu N, Khan S, Thompson CD, Kim R, Vellinga J, Zahn R, Lowy DR, Scheper G, Schiller JT (2018). Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins. Int J Cancer  142, 1467-1479.   https://doi.org/10.1002/ijc.31166|2. Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, Pinto LA, Hildesheim A, Gonzalez P, Costa Rica HPV Vaccine Trial (CVT) Group (2018). Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine  36, 4774-4782.   https://doi.org/10.1016/j.vaccine.2017.12.078|3. Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, Gonzalez P, Pinto LA, Kreimer AR, Costa Rica HPV Vaccine Trial (CVT) Group (2018). Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. J Natl Cancer Inst  110.   https://doi.org/10.1093/jnci/djx158",https://intramural.nih.gov/search/searchview.taf?ipid=108359
115,BC010580-16,"October 01, 2018 -  September 30, 2019",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108353
116,BC010595-16,"October 01, 2018 -  September 30, 2019",Structure and Function of Vif and APOBEC3 (A3) Proteins,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Krista A Delviks-Frankenberry|Belete Ayele Desimmie|Shruti Hiren Shah|Wei-Shau  Hu; PhD,"Yong  Xiong (Yale University)|Eric  Barklis (University of Oregon)|Reuben  Harris (Biochemistry, University of Minnesota)|Welkin  Johnson; PhD (Dept of Microbiology and Mol Genetics, Harvard Medical School)|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)|Bruce  Torbett (The Scripps Research Institute)",Mary  Kearney (Host Virus Interaction Branch)|Frank  Maldarelli (Host Virus Interaction Branch)|Brandon Frank Keele (Office Of The Director)|Hiroshi  Matsuo; PhD (Basic Research Laboratory)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Ziegler SJ, Liu C, Landau M, Buzovetsky O, Desimmie BA, Zhao Q, Sasaki T, Burdick RC, Pathak VK, Anderson KS, Xiong Y (2018). Insights into DNA substrate selection by APOBEC3G from structural, biochemical, and functional studies. PLoS One  13, e0195048.   https://doi.org/10.1371/journal.pone.0195048",https://intramural.nih.gov/search/searchview.taf?ipid=108361
117,BC010598-16,"October 01, 2018 -  September 30, 2019",Human Immune Responses to Tumor Antigens for Cancer Immunotherapy,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Renee Nicole Donahue|Caroline Mikaela Maria Jochems; PhD|Samuel Troy Pellom; PhD|Martine  Policard|Claire Alison Smalley|Angela Mae Schwab|Show all 10,"Paul  Chaplin (Bavarian Nordic, Inc.)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Frank E Jones; PhD (Tulane School of Medicine)|Shahrooz  Rabizadeh (Nantbioscience/nantomics)|Helen B Sabzevari|Show all 8","Seth M Steinberg; PhD (Office Of The Clinical Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic and GI Malignancies Branch)",Clint Tanner Allen (NIDCD) |Andrew Lee Mammen (NIAMS),"1. McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM (2018). Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys  101, 1259-1270.   https://doi.org/10.1016/j.ijrobp.2018.04.038|2. Morillon YM, Su Z, Schlom J, Greiner JW (2019). Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12. J Immunother Cancer  7, 150.   https://doi.org/10.1186/s40425-019-0620-2",https://intramural.nih.gov/search/searchview.taf?ipid=108234
118,BC010600-16,"October 01, 2018 -  September 30, 2019","AAA Proteins, Their Functions and Related Diseases","Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Lothar  Esser|Dong  Lin,NULL,NULL,Yihong  Ye (NIDDK),"1. Tang WK, Odzorig T, Jin W, Xia D (2019). Structural Basis of p97 Inhibition by the Site-Selective Anticancer Compound CB-5083. Mol Pharmacol  95, 286-293.   https://doi.org/10.1124/mol.118.114256|2. Ye Y, Xia D (2019) A spiral path to unfold. Nature Structural Molecular Biology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=108354
119,BC010607-16,"October 01, 2018 -  September 30, 2019",Ras-mediated signals in human epithelial cell transformation and metastasis,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Aian Neil Seno Alilin|Juanjuan  Yin|Lechen  Li,NULL,Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108358
120,BC010624-16,"October 01, 2018 -  September 30, 2019",The Molecular Profile of Prostate Tumors in African-American Men,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Maeve Kiely Bailey-Whyte|Francine Shernette Baker|Tiffany Marie Howe|Tsion Zewdu Minas|Margaret Saira Pichardo|Wei  Tang; PhD,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Nagireddy  Putluri (Baylor College of Medicine)|Clayton  Yates (Tuskegee University)|Carlos  Casiano (Loma Linda University School of Medicine)",Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Karunasinghe N, Ambs S, Wang A, Tang W, Zhu S, Dorsey TH, Goudie M, Masters JG, Ferguson LR (2018). Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts. PLoS One  13, e0199122.   https://doi.org/10.1371/journal.pone.0199122|2. Pichardo MS, Smith CJ, Dorsey TH, Loffredo CA, Ambs S (2018). Association of Anthropometric Measures with Prostate Cancer among African American Men in the NCI-Maryland Prostate Cancer Case-Control Study. Cancer Epidemiol Biomarkers Prev  27, 936-944.   https://doi.org/10.1158/1055-9965.EPI-18-0242|3. Smith CJ, Minas TZ, Ambs S (2018). Analysis of Tumor Biology to Advance Cancer Health Disparity Research. Am J Pathol  188, 304-316.   https://doi.org/10.1016/j.ajpath.2017.06.019|4. Tang W, Wallace TA, Yi M, Magi-Galluzzi C, Dorsey TH, Onabajo OO, Obajemu A, Jordan SV, Loffredo CA, Stephens RM, Silverman RH, Stark GR, Klein EA, Prokunina-Olsson L, Ambs S (2018). IFNL4-ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer. Clin Cancer Res  24, 5471-5481.   https://doi.org/10.1158/1078-0432.CCR-18-1060",https://intramural.nih.gov/search/searchview.taf?ipid=108364
121,BC010627-16,"October 01, 2018 -  September 30, 2019",Clinical Pharmacogenetics,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Roberto Hugo Barbier|Sheryl A Gere|Emily Noel Risdon|Tristan  Sissung|Jonathan Dale Strope|Seth M Steinberg; PhD,C  Landgren (Memorial Sloan Kettering Cancer Center)|Susan  Bates; MD (NCI)|John F Deeken,"Peter L Choyke; MD (Molecular Imaging Program)|David J Venzon; PhD (Biostatistics and Data Management Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Richard Lawrence Piekarz (Investigational Drug Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)",NULL,"1. Sissung T, Figg W (2019) UGT1A1 Polymorphisms and Mutations Affect Anticancer Drug Therapy, in Handbook of Therapeutic Biomarkers in Cancer, in press.|2. Peer CJ, Hall OM, Sissung TM, Piekarz R, Balasubramaniam S, Bates SE, Figg WD (2018). A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat. Cancer Chemother Pharmacol  82, 565-570.   https://doi.org/10.1007/s00280-018-3631-7",https://intramural.nih.gov/search/searchview.taf?ipid=108355
122,BC010632-16,"October 01, 2018 -  September 30, 2019",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Rna Biology Laboratory, NCI",Yixiong  Chen; PhD|Carmen  Mata Martin; PhD|Zhe  Sun|Yan Ning H Zhou|Mikhail V Kashlev|Thomas Dana Schneider; PhD|Show all 7,NULL,Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Mata Martin C, Sun Z, Zhou YN, Jin DJ (2018). Extrachromosomal Nucleolus-Like Compartmentalization by a Plasmid-Borne Ribosomal RNA Operon and Its Role in Nucleoid Compaction. Front Microbiol  9, 1115.   https://doi.org/10.3389/fmicb.2018.01115|2. Sun Z, Cagliero C, Izard J, Chen Y, Zhou YN, Heinz WF, Schneider TD, Jin DJ (2019). Density of σ70 promoter-like sites in the intergenic regions dictates the redistribution of RNA polymerase during osmotic stress in Escherichia coli. Nucleic Acids Res  47, 3970-3985.   https://doi.org/10.1093/nar/gkz159",https://intramural.nih.gov/search/searchview.taf?ipid=108357
123,BC010646-16,"October 01, 2018 -  September 30, 2019",Chromatin Remodeling Proteins,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Thomas A Johnson|Rodney Louis Schiltz; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108356
124,BC010654-15,"October 01, 2018 -  September 30, 2019",Lymphatic Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI","Stephen Scott Adler|Gary Leonard Griffiths; BSc, PhD|Paula  Jacobs|Elaine Marie Jagoda; MS|Ilhan  Lim|Timothy Eli Phelps",NULL,Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Koerber SA, Stach G, Kratochwil C, Haefner MF, Rathke H, Herfarth K, Kopka K, Holland-Letz T, Choyke PL, Will L, Haberkorn U, Debus J, Giesel FL (2019) Lymph node involvement in treatment-naïve prostate cancer patients - correlation of PSMA-PET/CT imaging and Roach formula in 280 men in the Radiotherapeutic management. J Nucl Med, in press (e-pub ahead of print)  https://doi.org/10.2967/jnumed.119.227637|2. Mehralivand S, van der Poel H, Winter A, Choyke PL, Pinto PA, Turkbey B (2018). Sentinel lymph node imaging in urologic oncology. Transl Androl Urol  7, 887-902.   https://doi.org/10.21037/tau.2018.08.23",https://intramural.nih.gov/search/searchview.taf?ipid=108366
125,BC010655-15,"October 01, 2018 -  September 30, 2019",Prostate Cancer Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI","Dagane  Daar|Philip Charles Eclarinal|Alicia Nicole Forest|Gary Leonard Griffiths; BSc, PhD|Stephanie Anne Harmon|Paula  Jacobs|Show all 20",Anwar  Padhani (Mt Vernon Hospital)|Jeff  Weinreb (Yale New Haven Hospital)|Francois  Cornud (Hopital Neckers)|Art  Rastinehed (Long Island Jewish Hospital)|Martin G Pomper|Jelle  Barentsz (Nijmegen University)|Show all 10,William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Murali  Krishna; PhD (Radiation Biology Branch)|Deborah E Citrin (Radiation Oncology Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch),"Ronald M Summers; MD, PhD (CC) |Rolf Eric Swenson; PhD (NHLBI)","1. Azizi S, Van Woudenberg N, Sojoudi S, Li M, Xu S, Abu Anas EM, Yan P, Tahmasebi A, Kwak JT, Turkbey B, Choyke P, Pinto P, Wood B, Mousavi P, Abolmaesumi P (2018). Toward a real-time system for temporal enhanced ultrasound-guided prostate biopsy. Int J Comput Assist Radiol Surg  13, 1201-1209.   https://doi.org/10.1007/s11548-018-1749-z|2. Barrett T, Rajesh A, Rosenkrantz AB, Choyke PL, Turkbey B (2019). PI-RADS version 2.1: one small step for prostate MRI. Clin Radiol  74, 841-852.   https://doi.org/10.1016/j.crad.2019.05.019|3. Bjurlin MA, Turkbey B, Rosenkrantz AB, Gaur S, Choyke PL, Taneja SS (2018). Imaging the High-risk Prostate Cancer Patient: Current and Future Approaches to Staging. Urology  116, 3-12.   https://doi.org/10.1016/j.urology.2017.12.001|4. Borofsky S, George AK, Gaur S, Bernardo M, Greer MD, Mertan FV, Taffel M, Moreno V, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2018). What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate. Radiology  286, 186-195.   https://doi.org/10.1148/radiol.2017152877|5. Bouchelouche K, Choyke PL (2018). Advances in prostate-specific membrane antigen PET of prostate cancer. Curr Opin Oncol  30, 189-196.   https://doi.org/10.1097/CCO.0000000000000439|6. Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, Sarkaria JN, Sondel PM, Tran PT, Wilson GD, Willers H, Wong RKS, Harari PM (2018). Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. Lancet Oncol  19, e240-e251.   https://doi.org/10.1016/S1470-2045(18)30096-2|7. Cheng R, Lay N, Roth HR, Turkbey B, Jin D, Gandler W, McCreedy ES, Pohida T, Pinto P, Choyke P, McAuliffe MJ, Summers RM (2019). Fully automated prostate whole gland and central gland segmentation on MRI using holistically nested networks with short connections. J Med Imaging (Bellingham)  6, 024007.   https://doi.org/10.1117/1.JMI.6.2.024007|8. Choyke PL (2018). Quantitative MRI or Machine Learning for Prostate MRI: Which Should You Use? Radiology  289, 138-139.   https://doi.org/10.1148/radiol.2018181304|9. Czarniecki M, Mena E, Lindenberg L, Cacko M, Harmon S, Radtke JP, Giesel F, Turkbey B, Choyke PL (2018). Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents. Transl Androl Urol  7, 831-843.   https://doi.org/10.21037/tau.2018.08.03|10. Gaur S, Harmon S, Gupta RT, Margolis DJ, Lay N, Mehralivand S, Merino MJ, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B (2019). A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI). Acad Radiol  26, 5-14.   https://doi.org/10.1016/j.acra.2018.03.024|11. Gaur S, Harmon S, Mehralivand S, Bednarova S, Calio BP, Sugano D, Sidana A, Merino MJ, Pinto PA, Wood BJ, Shih JH, Choyke PL, Turkbey B (2018). Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer. J Magn Reson Imaging  48, 1326-1335.   https://doi.org/10.1002/jmri.26025|12. Gaur S, Lay N, Harmon SA, Doddakashi S, Mehralivand S, Argun B, Barrett T, Bednarova S, Girometti R, Karaarslan E, Kural AR, Oto A, Purysko AS, Antic T, Magi-Galluzzi C, Saglican Y, Sioletic S, Warren AY, Bittencourt L, Fütterer JJ, Gupta RT, Kabakus I, Law YM, Margolis DJ, Shebel H, et al. [7 more authors] (2018). Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation. Oncotarget  9, 33804-33817.   https://doi.org/10.18632/oncotarget.26100|13. Giesel FL, Knorr K, Spohn F, Will L, Maurer T, Flechsig P, Neels O, Schiller K, Amaral H, Weber WA, Haberkorn U, Schwaiger M, Kratochwil C, Choyke P, Kramer V, Kopka K, Eiber M (2019). Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy. J Nucl Med  60, 362-368.   https://doi.org/10.2967/jnumed.118.212233|14. Harmon SA, Bergvall E, Mena E, Shih JH, Adler S, McKinney Y, Mehralivand S, Citrin DE, Couvillon A, Madan RA, Gulley JL, Mease RC, Jacobs PM, Pomper MG, Turkbey B, Choyke PL, Lindenberg ML (2018). A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer. J Nucl Med  59, 1665-1671.   https://doi.org/10.2967/jnumed.117.207373|15. Harmon SA, Mena E, Shih JH, Adler S, McKinney Y, Bergvall E, Mehralivand S, Sowalsky AG, Couvillon A, Madan RA, Gulley JL, Eary J, Mease RC, Pomper MG, Dahut WL, Turkbey B, Lindenberg L, Choyke PL (2018). A comparison of prostate cancer bone metastases on 18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion. Oncotarget  9, 37676-37688.   https://doi.org/10.18632/oncotarget.26481|16. Harmon SA, Tuncer S, Sanford T, Choyke PL, Türkbey B (2019). Artificial intelligence at the intersection of pathology and radiology in prostate cancer. Diagn Interv Radiol  25, 183-188.   https://doi.org/10.5152/dir.2019.19125|17. Li R, Xu S, Bakhutashvili I, Turkbey IB, Choyke P, Pinto P, Wood B, Tse ZTH (2019). Template for MR Visualization and Needle Targeting. Ann Biomed Eng  47, 524-536.   https://doi.org/10.1007/s10439-018-02167-z|18. Lindenberg L, Turkbey B, Choyke P (2018). Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally Advanced, Recurrent, and Metastatic Prostate Cancer-Reply. JAMA Oncol  4, 749-750.   https://doi.org/10.1001/jamaoncol.2017.5340|19. Mehralivand S, Shih JH, Harmon S, Smith C, Bloom J, Czarniecki M, Gold S, Hale G, Rayn K, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2019). A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI. Radiology  290, 709-719.   https://doi.org/10.1148/radiol.2018181278|20. Mehralivand S, Shih JH, Rais-Bahrami S, Oto A, Bednarova S, Nix JW, Thomas JV, Gordetsky JB, Gaur S, Harmon SA, Siddiqui MM, Merino MJ, Parnes HL, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2018). A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification. JAMA Oncol  4, 678-685.   https://doi.org/10.1001/jamaoncol.2017.5667|21. Mena E, Lindenberg LM, Choyke PL (2019). New Targets for PET Molecular Imaging of Prostate Cancer. Semin Nucl Med  49, 326-336.   https://doi.org/10.1053/j.semnuclmed.2019.02.001|22. Morales-Kastresana A, Musich TA, Welsh JA, Telford W, Demberg T, Wood JCS, Bigos M, Ross CD, Kachynski A, Dean A, Felton EJ, Van Dyke J, Tigges J, Toxavidis V, Parks DR, Overton WR, Kesarwala AH, Freeman GJ, Rosner A, Perfetto SP, Pasquet L, Terabe M, McKinnon K, Kapoor V, Trepel JB, et al. [11 more authors] (2019). High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer. J Extracell Vesicles  8, 1597603.   https://doi.org/10.1080/20013078.2019.1597603|23. Smith CP, Harmon SA, Barrett T, Bittencourt LK, Law YM, Shebel H, An JY, Czarniecki M, Mehralivand S, Coskun M, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B (2019). Intra- and interreader reproducibility of PI-RADSv2: A multireader study. J Magn Reson Imaging  49, 1694-1703.   https://doi.org/10.1002/jmri.26555|24. Smith CP, Laucis A, Harmon S, Mena E, Lindenberg L, Choyke PL, Turkbey B (2019). Novel Imaging in Detection of Metastatic Prostate Cancer. Curr Oncol Rep  21, 31.   https://doi.org/10.1007/s11912-019-0780-8|25. Sumathipala Y, Lay N, Turkbey B, Smith C, Choyke PL, Summers RM (2018). Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks. J Med Imaging (Bellingham)  5, 044507.   https://doi.org/10.1117/1.JMI.5.4.044507|26. Thai JN, Narayanan HA, George AK, Siddiqui MM, Shah P, Mertan FV, Merino MJ, Pinto PA, Choyke PL, Wood BJ, Turkbey B (2018). Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer. Radiology  288, 485-491.   https://doi.org/10.1148/radiol.2018170425|27. To MNN, Vu DQ, Turkbey B, Choyke PL, Kwak JT (2018). Deep dense multi-path neural network for prostate segmentation in magnetic resonance imaging. Int J Comput Assist Radiol Surg  13, 1687-1696.   https://doi.org/10.1007/s11548-018-1841-4|28. Turkbey B, Choyke PL (2018). Future Perspectives and Challenges of Prostate MR Imaging. Radiol Clin North Am  56, 327-337.   https://doi.org/10.1016/j.rcl.2017.10.013|29. Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC (2019). Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol  76, 340-351.   https://doi.org/10.1016/j.eururo.2019.02.033|30. Valle LF, Greer MD, Shih JH, Barrett T, Law YM, Rosenkrantz AB, Shebel H, Muthigi A, Su D, Merino MJ, Wood BJ, Pinto PA, Krauze AV, Kaushal A, Choyke PL, Türkbey B, Citrin DE (2018). Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy. Diagn Interv Radiol  24, 46-53.   https://doi.org/10.5152/dir.2018.17285|31. van Houdt PJ, Agarwal HK, van Buuren LD, Heijmink SWTPJ, Haack S, van der Poel HG, Ghobadi G, Pos FJ, Peeters JM, Choyke PL, van der Heide UA (2018). Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T2 mapping across multiple systems. Magn Reson Med  79, 1586-1594.   https://doi.org/10.1002/mrm.26816|32. van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR, Brausi MA, Choyke PL, Cooperberg MR, Eggener S, Feller JF, Frauscher F, George AK, Hindley RG, Jenniskens SFM, Klotz L, Kovacs G, Lindner U, Loeb S, Margolis DJ, Marks LS, May S, Mcclure TD, Montironi R, Nour SG, et al. [13 more authors] (2019). Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project. World J Urol  37, 2147-2153.   https://doi.org/10.1007/s00345-019-02636-7",https://intramural.nih.gov/search/searchview.taf?ipid=108367
126,BC010656-15,"October 01, 2018 -  September 30, 2019",Growth Factor Imaging and Photoimmunotherapy,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI","Gary Leonard Griffiths; BSc, PhD|Yutaka  Kurebayashi; MD, PhD|Noriko  Sato; PhD|Karen J Wong",NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Peter A Pinto; MD (Urologic Oncology Branch),Joshua  Farber; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108368
127,BC010657-15,"October 01, 2018 -  September 30, 2019",Cellular In vivo Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Philip Charles Eclarinal|Alicia Nicole Forest|Michael  Green|Noriko  Sato; PhD|Jurgen  Seidel; PhD|Show all 8,NULL,Christian S Hinrichs (Experimental Transplantation and Immunology Branch),Joshua  Farber; MD (NIAID) |Richard  Childs; MD (NHLBI),"1. Czarniecki M, Gautam R, Choyke PL, Turkbey B (2018). Imaging findings of hereditary renal tumors, a review of what the radiologist should know. Eur J Radiol  101, 8-16.   https://doi.org/10.1016/j.ejrad.2018.01.026|2. Lindenberg L, Mena E, Choyke PL, Bouchelouche K (2019). PET imaging in renal cancer. Curr Opin Oncol  31, 216-221.   https://doi.org/10.1097/CCO.0000000000000518|3. Strongin A, Heller T, Doherty D, Glass IA, Parisi MA, Bryant J, Choyke P, Turkbey B, Daryanani K, Yildirimli D, Vemulapalli M, Mullikin JC, Malicdan MC, Vilboux T, Gahl WA, Gunay-Aygun M, NISC Comparative Sequencing Program (2018). Characteristics of Liver Disease in 100 Individuals With Joubert Syndrome Prospectively Evaluated at a Single Center. J Pediatr Gastroenterol Nutr  66, 428-435.   https://doi.org/10.1097/MPG.0000000000001816",https://intramural.nih.gov/search/searchview.taf?ipid=108369
128,BC010661-15,"October 01, 2018 -  September 30, 2019",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Kellsye Paula Fabian|Sarah Elizabeth Franks; PhD|Sofia Ribeiro Gameiro|Kristen  Solocinski|Marion G Taylor|Benjamin Robert Wolfson|Show all 7,NULL,NULL,NULL,"1. Fenerty KE, Padget M, Wolfson B, Gameiro SR, Su Z, Lee JH, Rabizadeh S, Soon-Shiong P, Hodge JW (2018). Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition. J Immunother Cancer  6, 133.   https://doi.org/10.1186/s40425-018-0445-4|2. Friedman J, Morisada M, Sun L, Moore EC, Padget M, Hodge JW, Schlom J, Gameiro SR, Allen CT (2018). Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies. J Immunother Cancer  6, 59.   https://doi.org/10.1186/s40425-018-0374-2|3. Fujii R, Jochems C, Tritsch SR, Wong HC, Schlom J, Hodge JW (2018). An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression. Cancer Immunol Immunother  67, 675-689.   https://doi.org/10.1007/s00262-018-2121-4|4. Fujii R, Schlom J, Hodge JW (2018). A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab. J Neurosurg  128, 1419-1427.   https://doi.org/10.3171/2017.1.JNS162610|5. Hicks KC, Fantini M, Donahue RN, Schwab A, Knudson KM, Tritsch SR, Jochems C, Clavijo PE, Allen CT, Hodge JW, Tsang KY, Schlom J, Gameiro SR (2018). Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types. Oncoimmunology  7, e1466018.   https://doi.org/10.1080/2162402X.2018.1466018",https://intramural.nih.gov/search/searchview.taf?ipid=108379
129,BC010666-15,"October 01, 2018 -  September 30, 2019",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",Houssein  Abdul Sater|Amy Rosenberg Hankin|Fatima Hafiz Karzai; MD|Ariel Elan Marciscano; MD|Jennifer L Marte|Alanvin D Orpia|Show all 12,"John  Marshall|Paul  Chaplin (Bavarian Nordic, Inc.)",William Marston Linehan; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter A Pinto; MD (Urologic Oncology Branch)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch),Andrew Lee Mammen (NIAMS),"1. Boyiadzis MM, Kirkwood JM, Marshall JL, Pritchard CC, Azad NS, Gulley JL (2018). Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease. J Immunother Cancer  6, 35.   https://doi.org/10.1186/s40425-018-0342-x|2. Collins JM, Gulley JL (2019). Product review: avelumab, an anti-PD-L1 antibody. Hum Vaccin Immunother  15, 891-908.   https://doi.org/10.1080/21645515.2018.1551671|3. Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, Gravekamp C, Gulley JL, Gunn H, Hoffman RM, Kaur B, Liu K, Lyerly HK, Marciscano AE, Moradian E, Ruppel S, Saltzman DA, Tattersall PJ, Thorne S, Vile RG, Zhang HH, Zhou S, McFadden G (2018). White paper on microbial anti-cancer therapy and prevention. J Immunother Cancer  6, 78.   https://doi.org/10.1186/s40425-018-0381-3|4. Gulley JL, Borre M, Vogelzang NJ, Ng S, Agarwal N, Parker CC, Pook DW, Rathenborg P, Flaig TW, Carles J, Saad F, Shore ND, Chen L, Heery CR, Gerritsen WR, Priou F, Langkilde NC, Novikov A, Kantoff PW (2019). Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol  37, 1051-1061.   https://doi.org/10.1200/JCO.18.02031|5. Keilholz U, Mehnert JM, Bauer S, Bourgeois H, Patel MR, Gravenor D, Nemunaitis JJ, Taylor MH, Wyrwicz L, Lee KW, Kasturi V, Chin K, von Heydebreck A, Gulley JL (2019). Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial. J Immunother Cancer  7, 12.   https://doi.org/10.1186/s40425-018-0459-y|6. Kelly K, Infante JR, Taylor MH, Patel MR, Wong DJ, Iannotti N, Mehnert JM, Loos AH, Koch H, Speit I, Gulley JL (2018). Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials. Cancer  124, 2010-2017.   https://doi.org/10.1002/cncr.31293|7. Le Tourneau C, Hoimes C, Zarwan C, Wong DJ, Bauer S, Claus R, Wermke M, Hariharan S, von Heydebreck A, Kasturi V, Chand V, Gulley JL (2018). Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial. J Immunother Cancer  6, 111.   https://doi.org/10.1186/s40425-018-0424-9|8. Monge C, Maeng H, Brofferio A, Apolo AB, Sathya B, Arai AE, Gulley JL, Bilusic M (2018). Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report. J Immunother Cancer  6, 150.   https://doi.org/10.1186/s40425-018-0473-0|9. Strauss J, Heery CR, Kim JW, Jochems C, Donahue RN, Montgomery AS, McMahon S, Lamping E, Marté JL, Madan RA, Bilusic M, Silver MR, Bertotti E, Schlom J, Gulley JL (2019). First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors. Clin Cancer Res  25, 99-109.   https://doi.org/10.1158/1078-0432.CCR-18-1512",https://intramural.nih.gov/search/searchview.taf?ipid=108378
130,BC010668-15,"October 01, 2018 -  September 30, 2019",Instrumentation for microSPECT and microPET imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Jorge Amilcar Carrasquillo|Philip Charles Eclarinal|Michael  Green|Elaine Marie Jagoda; MS|Timothy Eli Phelps|Show all 8,NULL,NULL,Thomas J Pohida; MS (CIT),"1. Asiedu KO, Ferdousi M, Ton PT, Adler SS, Choyke PL, Sato N (2018). Bone marrow cell homing to sites of acute tibial fracture: 89Zr-oxine cell labeling with positron emission tomographic imaging in a mouse model. EJNMMI Res  8, 109.   https://doi.org/10.1186/s13550-018-0463-8|2. Basuli F, Zhang X, Blackman B, White ME, Jagoda EM, Choyke PL, Swenson RE (2019). Fluorine-18 Labeled Fluorofuranylnorprogesterone ([18F]FFNP) and Dihydrotestosterone ([18F]FDHT) Prepared by ""Fluorination on Sep-Pak"" Method. Molecules  24.   https://doi.org/10.3390/molecules24132389|3. Basuli F, Zhang X, Jagoda EM, Choyke PL, Swenson RE (2018). Rapid synthesis of maleimide functionalized fluorine-18 labeled prosthetic group using ""radio-fluorination on the Sep-Pak"" method. J Labelled Comp Radiopharm  61, 599-605.   https://doi.org/10.1002/jlcr.3623|4. Basuli F, Zhang X, Williams MR, Seidel J, Green MV, Choyke PL, Swenson RE, Jagoda EM (2018). One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging. Nucl Med Biol  62-63, 63-70.   https://doi.org/10.1016/j.nucmedbio.2018.05.004|5. Jagoda EM, Vasalatiy O, Basuli F, Opina ACL, Williams MR, Wong K, Lane KC, Adler S, Ton AT, Szajek LP, Xu B, Butcher D, Edmondson EF, Swenson RE, Greiner J, Gulley J, Eary J, Choyke PL (2019). Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab. Mol Imaging  18, 1536012119829986.   https://doi.org/10.1177/1536012119829986|6. Kurdziel KA, Mena E, McKinney Y, Wong K, Adler S, Sissung T, Lee J, Lipkowitz S, Lindenberg L, Turkbey B, Kummar S, Milenic DE, Doroshow JH, Figg WD, Merino MJ, Paik CH, Brechbiel MW, Choyke PL (2019). First-in-human phase 0 study of 111In-CHX-A""-DTPA trastuzumab for HER2 tumor imaging. J Transl Sci  5.   https://doi.org/10.15761/JTS.1000269|7. Roy J, Kuo F, Basuli F, Williams MR, Wong K, Green MV, Seidel J, Adler SS, Xu B, Choyke PL, Jagoda EM (2019). The Distribution Volume of 18F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy. Cancer Biother Radiopharm  34, 238-244.   https://doi.org/10.1089/cbr.2018.2656|8. Young CR, Adler S, Eary JF, Lindenberg ML, Jacobs PM, Collins J, Kummar S, Kurdziel KA, Choyke PL, Mena E (2019). Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid Tumors. J Nucl Med  60, 492-496.   https://doi.org/10.2967/jnumed.118.216994",https://intramural.nih.gov/search/searchview.taf?ipid=108365
131,BC010670-15,"October 01, 2018 -  September 30, 2019",Radiation-induced molecular targets,Norman Norman Coleman; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Molykutty J Aryankalayil|Sunita  Chopra; PhD|Iris Regina Eke; MD|Shannon Elizabeth Martello|Deborah E Citrin,Emanuel  Petricoin (George Mason University)|Lance  Liotta (George Mason University)|Sylvia  Formenti (NYU)|Sandra  Demaria (Weill Cornell Medical School)|Rocco  Cassagrande (Gryphon Scientific),James B Mitchell; PhD (Radiation Biology Branch)|Mansoor Mukhtar Ahmed; PhD (Radiotherapy Development Branch)|Murali  Krishna; PhD (Radiation Biology Branch),NULL,"1. Aryankalayil MJ, Chopra S, Levin J, Eke I, Makinde A, Das S, Shankavaram U, Vanpouille-Box C, Demaria S, Coleman CN (2018). Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation. Radiat Res  189, 251-263.   https://doi.org/10.1667/RR14891.1|2. Falls KC, Sharma RA, Lawrence YR, Amos RA, Advani SJ, Ahmed MM, Vikram B, Coleman CN, Prasanna PG (2018). Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15-18 October 2017; Cancun, Mexico. Radiat Res  190, 350-360.   https://doi.org/10.1667/RR15121.1|3. George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, Wu C, Coleman CN, Vikram B, Ahmed MM (2019). National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer. Cancer  125, 2732-2746.   https://doi.org/10.1002/cncr.32150|4. McClelland S, Leberknight J, Guadagnolo BA, Coleman CN, Petereit DG (2018). The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States, part 2: American Indian patients. Adv Radiat Oncol  3, 3-7.   https://doi.org/10.1016/j.adro.2017.08.010|5. Zakeri K, Coleman CN, Vikram B (2018). Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't! Front Oncol  8, 130.   https://doi.org/10.3389/fonc.2018.00130|6. Zakeri K, Narayanan D, Vikram B, Evans G, Coleman CN, Prasanna PGS (2019). Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts. Int J Radiat Oncol Biol Phys  104, 188-196.   https://doi.org/10.1016/j.ijrobp.2018.12.027",https://intramural.nih.gov/search/searchview.taf?ipid=108363
132,BC010671-15,"October 01, 2018 -  September 30, 2019",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Mariah Sarahjane Balmaceno-Criss|Laura Beth Chopp|Thomas  Ciucci|Yayi  Gao|Smriti  Kanangat|Assaf Yosef Magen|Show all 9,"Marc  Jenkins|Wilfried  Ellmeier (Immunology, University of Vienna)|Georg  Hollander (University of Oxford)|Hai-Hui  Xue; MD, PhD (University of Iowa)|Yi  Zhang (Temple University)|Jonathan  Kaye (Cedars Sinai Medical Center)|Show all 9","Charles  Vinson; PhD (Nucleic Acids Section)|Avinash  Bhandoola; MD, PhD (Laboratory Of Genome Integrity)|Richard J Hodes; MD (Experimental Immunology Branch)|Bao D Quoe  Tran (Office of the Director)|Michael Christopher Kelly; PhD (Office of the Director)|Lino  Tessarollo (Mouse Cancer Genetics Program)","Paul E Love; MD, PhD (NICHD) |Dorian  McGavern (NINDS) |Yasmine  Belkaid; PhD (NIAID) |John J O'Shea; MD (NIAMS) |Alan  Sher; PhD (NIAID) |Ulrich K Siebenlist; PhD (NIAID)","1. Bosselut R (2019). Control of Intra-Thymic αβ T Cell Selection and Maturation by H3K27 Methylation and Demethylation. Front Immunol  10, 688.   https://doi.org/10.3389/fimmu.2019.00688",https://intramural.nih.gov/search/searchview.taf?ipid=108362
133,BC010675-15,"October 01, 2018 -  September 30, 2019",Development of a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",David W Farnsworth|Joel Sebastian Temme; BS|Joseph John Barchi,Beat  Ernst (University Of Basel)|Catherine  Grimes (University Of Delaware)|Xuefei  Huang (Michigan State University)|Raja  Mazumder (George Washington University)|Rene  Ranzinger (University Of Georgia),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108371
134,BC010677-15,"October 01, 2018 -  September 30, 2019",NADPH Oxidases as Novel Targets for Cancer Therapy,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Guojian  Jiang; MD|Agnes  Juhasz|Jiamo  Lu; MD, MPH, MHS|Jennifer Lynn Meitzler|Yongzhong  Wu",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108370
135,BC010681-15,"October 01, 2018 -  September 30, 2019",Development of inhibitors targeting Plk1 polo-box domain,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Celeste Natalie Alverez|Yaozong  Chen,Michael  Yaffe (Massachusetts Institute of Technology)|Jeong Kyu Bang,Terrence R Burke; PhD (Chemical Biology Laboratory),"Kenneth A Jacobson; BA, MS, PhD (NIDDK)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108375
136,BC010683-15,"October 01, 2018 -  September 30, 2019",Role of FH loss in development of HLRCC heriditary kidney cancer,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Frank James Echtenkamp; PhD|Ryo  Ishida|Genesis Mayliz Rivera-Marquez|William Marston Linehan; MD|Piyush Kumar Agarwal; MD|Show all 8,Sunil  Sudarshan|Didier  Picard (University of Geneva)|Victor  Darley-Usmar (University of Alabama-Birmingham)|Richard  Wooster (Wellcome Trust Sanger Inst)|Robert Taylor Ripley; MD,Yves  Pommier; PhD (Developmental Therapeutics Branch)|Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Moses MA, Kim YS, Rivera-Marquez GM, Oshima N, Watson MJ, Beebe KE, Wells C, Lee S, Zuehlke AD, Shao H, Bingman WE, Kumar V, Malhotra SV, Weigel NL, Gestwicki JE, Trepel JB, Neckers LM (2018). Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer. Cancer Res  78, 4022-4035.   https://doi.org/10.1158/0008-5472.CAN-17-3728|2. Shao H, Li X, Moses MA, Gilbert LA, Kalyanaraman C, Young ZT, Chernova M, Journey SN, Weissman JS, Hann B, Jacobson MP, Neckers L, Gestwicki JE (2018). Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70). J Med Chem  61, 6163-6177.   https://doi.org/10.1021/acs.jmedchem.8b00583|3. Sourbier C, Liao PJ, Ricketts CJ, Wei D, Yang Y, Baranes SM, Gibbs BK, Ohanjanian L, Spencer Krane L, Scroggins BT, Keith Killian J, Wei MH, Kijima T, Meltzer PS, Citrin DE, Neckers L, Vocke CD, Marston Linehan W (2018). Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers. Oncotarget  9, 10723-10733.   https://doi.org/10.18632/oncotarget.24112",https://intramural.nih.gov/search/searchview.taf?ipid=108377
137,BC010696-15,"October 01, 2018 -  September 30, 2019",Study of Hereditary Renal and Other Familial Syndromes,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Xu  Naizhen|Rafael Santiago Parra Medina|David D Roberts; PhD|Jennifer Clare Jones; MD, PhD",NULL,"Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Mark Wayne Ball (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108376
138,BC010707-14,"October 01, 2018 -  September 30, 2019",Role of T Regulatory Cell Suppression in Autoimmunity and Cancer,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Xin  Chen|Anna Lee  Trivett|De  Yang|Debra  Tross|Tianzhen  He,Xin  Chen (University of Macao)|Dimiter Stanchev Dimitrov; PhD (NCI),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108382
139,BC010709-14,"October 01, 2018 -  September 30, 2019",Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108391
140,BC010717-14,"October 01, 2018 -  September 30, 2019",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Christopher Joseph Melani|Saleema  Osman|Louis  Staudt; MD,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108392
141,BC010719-14,"October 01, 2018 -  September 30, 2019",Randomized Phase II study of borteozmib-EPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Christopher Joseph Melani|Saleema  Osman,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108393
142,BC010725-14,"October 01, 2018 -  September 30, 2019",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Keqiang  Chen|Wang Hua  Gong|Weiwei  Liang,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Gert  Schmid-Schonbein (Whitaker Institute, UC San Diego)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,"Ronald N Germain; MD, PhD (NIAID) |Yasmine  Belkaid; PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108385
143,BC010728-14,"October 01, 2018 -  September 30, 2019",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Christopher Joseph Melani|Saleema  Osman|Louis  Staudt; MD,"Myron  Czuczman (Oncology, Roswell Park Cancer Institute)|Bruce Allan Chabner|Andrew  Zelenetz (Medicine, MSKCC)|Bruce  Cheson (NCI)",Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108394
144,BC010736-14,"October 01, 2018 -  September 30, 2019",Unraveling the function of CD276,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Yang  Feng|Steven  Seaman|Liping  Yang; PhD,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries)|Gary  DeCrescenzo (BioMed Valley Discoveries)|Dean  Welsch (BioMed Valley Discoveries)|Dimiter Stanchev Dimitrov; PhD (NCI),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108390
145,BC010738-14,"October 01, 2018 -  September 30, 2019","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging",Steven X Hou|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Poonam  Aggarwal|Cristopher Eduardo Aguilar Ortiz|Chunmei  Shi|Hyunhee  Shin|Shree Ram  Singh|Guohao  Wang,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program),Wanjun  Chen; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108387
146,BC010740-14,"October 01, 2018 -  September 30, 2019",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Alexander Jacob Bahnick|Noela Mbaka Botaka|Dorothy Leeann Ackerman|Molly Day Congdon|Jennifer Aude Crainic|Andrew Tyler Delaitsch|Show all 11,"James  Fleckenstein (Washington University School of Medicine, St. Louis)|Hanping  Feng (University of Maryland)|Paul  Lampe (Fred Hutchinson Cancer Research Center)|Raquel  Ruiz (University Of Maryland)|Laura  Walker (Adimab)",Jacek Tadeusz Lubkowski (Macromolecular Crystallography Laboratory)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM (2018). Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity. J Clin Invest  128, 3298-3311.   https://doi.org/10.1172/JCI97659",https://intramural.nih.gov/search/searchview.taf?ipid=108386
147,BC010749-14,"October 01, 2018 -  September 30, 2019",Immunotherapeutic Approaches for AIDS,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Bhabadeb S Chowdhury; PhD|Hrishikesh Shrinivas Pandit|Margherita  Rosati|Antonio L Valentin|Bethany Anne Nagy|Marjorie  Robert-Guroff; PhD|Show all 9,"David C Montefiori; PhD (Department of Surgery, NIAID)|James  Mullins; PhD (Microbiology, University of Washington)|Sylvie  Le Gall (Massachusetts General Hospital)|John  Eldridge (Wyeth Lederle Vaccines)|Drew  Hannaman (Ichor Medical Systems, Inc.)|Bart  Haynes (Duke Human Vaccine Institute)|Show all 26",Jeffrey D Lifson; MD (Office Of The Director)|Brandon Frank Keele (Office Of The Director)|David J Venzon; PhD (Biostatistics and Data Management Section),"Richard A Koup; MD (NIAID) |Lucio  Gama; PhD (NIAID) |John R Mascola; MD (NIAID) |Bernard  Moss; MD, PhD (NIAID) |Vanessa  Hirsch (NIAID)","1. Ferrando-Martinez S, Moysi E, Pegu A, Andrews S, Nganou Makamdop K, Ambrozak D, McDermott AB, Palesch D, Paiardini M, Pavlakis GN, Brenchley JM, Douek D, Mascola JR, Petrovas C, Koup RA (2018). Accumulation of follicular CD8+ T cells in pathogenic SIV infection. J Clin Invest  128, 2089-2103.   https://doi.org/10.1172/JCI96207",https://intramural.nih.gov/search/searchview.taf?ipid=108383
148,BC010750-14,"October 01, 2018 -  September 30, 2019",Heterodimeric IL-15 in Cancer Immunotherapy,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Bhabadeb S Chowdhury; PhD|Konstantinos  Dimas; MD|Sevasti  Karaliota|Bethany Anne Nagy|Hrishikesh Shrinivas Pandit|Dimitrios  Stellas|Show all 10,"Karen  Gaensler (University of California)|Rafick-Pierre  Sekaly (Centre de Recherche du Centre Hospitalier de l'Universite de Montreal)|Morten  Thaysen-Andersen (Macquarie University)|Bernard  Fox (Oregon Cancer Center)|Francois  Villinger (New Iberia Research Center, University of Louisiana at Lafayette)|Louis  Picker (Vaccine And Gene Therapy Institute)|Show all 11","Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Kevin Charles Conlon (Lymphoid Malignancies Branch)|Jacob D Estes (Office Of The Director)|David J Venzon; PhD (Biostatistics and Data Management Section)",Konstantinos  Petrovas (NIAID) |Mario  Roederer; PhD (NIAID) |Thomas Arthur Fleisher; MD (CC) |Xiaoyuan  Chen; PhD (NIBIB),"1. Shi Y, Dincheva-Vogel L, Ayemoba CE, Fung JP, Bergamaschi C, Pavlakis GN, Farzaneh F, Gaensler KML (2018). IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice. Blood Adv  2, 3177-3192.   https://doi.org/10.1182/bloodadvances.2018019026",https://intramural.nih.gov/search/searchview.taf?ipid=108384
149,BC010759-14,"October 01, 2018 -  September 30, 2019",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sarah Faith Clatterbuck Soper; PhD|Sean Richard Davis; MD, PhD|Arthur A Glatfelter; MS|Yuan  Jiang; MD|John E Lueders|Sanjit  Mukherjee|Show all 11","Ching  Lau (Ped Heme/Onc, Texas Children's Hospital)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Ashok  Venkitaraman (University of Cambridge)|Lee Jay Helman; MD (NCI)",Sharon Ann Savage (Clinical Genetics Branch)|Lisa  Mirabello (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108388
150,BC010763-14,"October 01, 2018 -  September 30, 2019",Building on the success of the adoptive immunotherapy of cancer,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Devikala  Gurusamy|Amanda Nicole Henning|Rigel Joseph Kishton|Ping-Hsien  Lee; PhD|Douglas  Palmer|Madhusudhanan  Sukumar|Show all 12,Paul  Antony (Univeristy of Maryland)|Vincenzo  Bronte,Giorgio  Trinchieri (Cancer Inflammation Program),NULL,"1. Henning AN, Klebanoff CA, Restifo NP (2018). Silencing stemness in T cell differentiation. Science  359, 163-164.   https://doi.org/10.1126/science.aar5541|2. Henning AN, Roychoudhuri R, Restifo NP (2018). Epigenetic control of CD8+ T cell differentiation. Nat Rev Immunol  18, 340-356.   https://doi.org/10.1038/nri.2017.146|3. Johnson MO, Wolf MM, Madden MZ, Andrejeva G, Sugiura A, Contreras DC, Maseda D, Liberti MV, Paz K, Kishton RJ, Johnson ME, de Cubas AA, Wu P, Li G, Zhang Y, Newcomb DC, Wells AD, Restifo NP, Rathmell WK, Locasale JW, Davila ML, Blazar BR, Rathmell JC (2018). Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism. Cell  175, 1780-1795.e19.   https://doi.org/10.1016/j.cell.2018.10.001|4. Kanellopoulou C, George AB, Masutani E, Cannons JL, Ravell JC, Yamamoto TN, Smelkinson MG, Jiang PD, Matsuda-Lennikov M, Reilley J, Handon R, Lee PH, Miller JR, Restifo NP, Zheng L, Schwartzberg PL, Young M, Lenardo MJ (2019). Mg2+ regulation of kinase signaling and immune function. J Exp Med  216, 1828-1842.   https://doi.org/10.1084/jem.20181970|5. Lin CC, Kurashige M, Liu Y, Terabayashi T, Ishimoto Y, Wang T, Choudhary V, Hobbs R, Liu LK, Lee PH, Outeda P, Zhou F, Restifo NP, Watnick T, Kawano H, Horie S, Prinz W, Xu H, Menezes LF, Germino GG (2018). A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed. Sci Rep  8, 2743.   https://doi.org/10.1038/s41598-018-20856-6|6. Wei J, Kishton RJ, Angel M, Conn CS, Dalla-Venezia N, Marcel V, Vincent A, Catez F, Ferré S, Ayadi L, Marchand V, Dersh D, Gibbs JS, Ivanov IP, Fridlyand N, Couté Y, Diaz JJ, Qian SB, Staudt LM, Restifo NP, Yewdell JW (2019). Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance. Mol Cell  73, 1162-1173.e5.   https://doi.org/10.1016/j.molcel.2018.12.020",https://intramural.nih.gov/search/searchview.taf?ipid=108389
151,BC010774-13,"October 01, 2018 -  September 30, 2019",T Cell Alternative p38 Activation Pathway,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Muhammad Shamsul Alam|Bei  Dong,Al  Fornace (Georgetown University)|Matthias Martin Gaida,Ettore  Appella; MD (Laboratory of Cell Biology),"David Harvey Margulies; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108395
152,BC010778-13,"October 01, 2018 -  September 30, 2019",HIV-1 Maturation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",Sherimay  Ablan|Phuong Nhat Pham|Alexander Baptiste Kleinpeter,Tatyana  Polenova; PhD (University of Delaware)|Feng  Li; PhD|Ritu  Gaur|Carl  Wild (Panacos Pharmaceuticals)|-  Hetero Drugs (Hetero Research Foundation)|Mark  Yeager,Alan  Rein; PhD (Retroviral Replication Laboratory),Alasdair C Steven; PhD (NIAMS),"1. Urano E, Timilsina U, Kaplan JA, Ablan S, Ghimire D, Pham P, Kuruppu N, Mandt R, Durell SR, Nitz TJ, Martin DE, Wild CT, Gaur R, Freed EO (2019). Resistance to Second-Generation HIV-1 Maturation Inhibitors. J Virol  93.   https://doi.org/10.1128/JVI.02017-18|2. Zheng Z, Lan K, Freed E, Shi Z (2019). Preface to special issue of Virologica Sinica commemorating the first joint SKLV NIH Virology Symposium. Virol Sin  34, 117-118.",https://intramural.nih.gov/search/searchview.taf?ipid=108401
153,BC010782-13,"October 01, 2018 -  September 30, 2019",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Jing-Xin  Feng|Brittney Sophia Harrington|Hidetaka  Ohnuki|Michael Joseph Diprima|Douglas  Lowy; MD,Frederick  Wang (Harvard Univ)|Maria  Cid (Univ. of Barcelona Medical School)|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst),"Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David  Levens; PhD (Laboratory of Pathology)|Roberto  Weigert; MSc Chemistry, PhD (Laboratory of Cellular and Molecular Biology)|Ira  Daar; PhD (Cancer and Developmental Biology Laboratory)",Yosuke  Mukoyama; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108403
154,BC010783-13,"October 01, 2018 -  September 30, 2019","Inflammation, Macrophage Differentiation, and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Jin Young  Baik|Swati Suresh Choksi|Hyung Joon  Kwon; PhD|Zhao-Shan  Liu|Jiong  Yan,"Brian  Rowan (School of Medicine, Tulane University)|Jennifer  Yu (Cleveland Clinic)|Tao  Li (National Center Of Biomedical Analysis)",Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics),Chengyu  Liu; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108404
155,BC010788-13,"October 01, 2018 -  September 30, 2019",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Sukriti  Bagchi|Deblina  Banerjee|Zhihui  Liu|Ming  Sun|Man  Xu|John Frederick Shern|Show all 7,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Cheryl  Arrowsmith (University of Toronto)|Jian  Jin (Icahn School of Medicine at Mt. Sinai)|Kimberly  Stegmaier (Dana-Farber Cancer Institute)",Javed  Khan; MD (Cancer Genetics Branch)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Ettore  Appella; MD (Laboratory of Cell Biology)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Chunhua  Yan (Cancer Informatics Branch),NULL,"1. Bhaskaran N, Liu Z, Saravanamuthu SS, Yan C, Hu Y, Dong L, Zelenka P, Zheng L, Bletsos V, Harris R, Harrington B, Weinberg A, Thiele CJ, Ye F, Pandiyan P (2018). Identification of Casz1 as a Regulatory Protein Controlling T Helper Cell Differentiation, Inflammation, and Immunity. Front Immunol  9, 184.   https://doi.org/10.3389/fimmu.2018.00184|2. Chen L, Alexe G, Dharia NV, Ross L, Iniguez AB, Conway AS, Wang EJ, Veschi V, Lam N, Qi J, Gustafson WC, Nasholm N, Vazquez F, Weir BA, Cowley GS, Ali LD, Pantel S, Jiang G, Harrington WF, Lee Y, Goodale A, Lubonja R, Krill-Burger JM, Meyers RM, Tsherniak A, et al. [8 more authors] (2018). CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2. J Clin Invest  128, 446-462.   https://doi.org/10.1172/JCI90793|3. Souza BK, da Costa Lopez PL, Menegotto PR, Vieira IA, Kersting N, Abujamra AL, Brunetto AT, Brunetto AL, Gregianin L, de Farias CB, Thiele CJ, Roesler R (2018). Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma. Mol Neurobiol  55, 7242-7258.   https://doi.org/10.1007/s12035-018-0874-6",https://intramural.nih.gov/search/searchview.taf?ipid=108405
156,BC010789-13,"October 01, 2018 -  September 30, 2019",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Sukriti  Bagchi|Zhihui  Liu|Javier Alberto Padial|Ming  Sun,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)|Zhijie  Li (China Medical University)",Seth M Steinberg; PhD (Office Of The Clinical Director),NULL,"1. Hua Z, Zhan Y, Zhang S, Dong Y, Jiang M, Tan F, Liu Z, Thiele CJ, Li Z (2018). P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB). Apoptosis  23, 408-419.   https://doi.org/10.1007/s10495-018-1467-6|2. Jiang M, Hua Z, Dong Y, Liu Z, Thiele CJ, Li Z (2018). Quantitative ubiquitylome analysis and crosstalk with proteome/acetylome analysis identified novel pathways and targets of perifosine treatment in neuroblastoma. Transl Cancer Res  7, 1548-1560.   https://doi.org/10.21037/tcr.2018.11.30|3. Xu N, Hua Z, Ba G, Zhang S, Liu Z, Thiele CJ, Li Z (2019). The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo. J Exp Clin Cancer Res  38, 118.   https://doi.org/10.1186/s13046-019-1107-1",https://intramural.nih.gov/search/searchview.taf?ipid=108406
157,BC010791-13,"October 01, 2018 -  September 30, 2019","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Cancer Inflammation Program, NCI",Marjan  Akdag|Arman A Bashirova|Xiaojiang  Gao|Amir  Horowitz|Zhansong  Lin|Maureen P Martin|Show all 12,"Chloe  Thio (University Medicine, Johns Hopkins University)|David  Thomas (Johns Hopkins University)|Michael  Knowles (Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)|Bruce  Walker (Harvard Medical School)|Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|Show all 24","James Jerome Goedert; MD (Epidemiology and Biostatistics Program)|Denise  Whitby (Office Of The Director)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)",Daniel C Douek; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108399
158,BC010792-13,"October 01, 2018 -  September 30, 2019",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Cancer Inflammation Program, NCI",Marjan  Akdag|Arman A Bashirova|Xiaojiang  Gao|Amir  Horowitz|Zhansong  Lin|Maureen P Martin|Show all 13,"John  Trowsdale (University of Cambridge)|Richard  Single (University of Vermont)|Kenneth  Kidd (Yale University)|Bruce  Walker (Harvard Medical School)|Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Judith  Kidd (Yale University)|Show all 11",NULL,NULL,"1. Adland E, Hill M, Lavandier N, Csala A, Edwards A, Chen F, Radkowski M, Kowalska JD, Paraskevis D, Hatzakis A, Valenzuela-Ponce H, Pfafferott K, Williams I, Pellegrino P, Borrow P, Mori M, Rockstroh J, Prado JG, Mothe B, Dalmau J, Martinez-Picado J, Tudor-Williams G, Frater J, Stryhn A, Buus S, et al. [15 more authors] (2018). Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection. J Virol  92.   https://doi.org/10.1128/JVI.01685-17|2. Arora J, McLaren PJ, Chaturvedi N, Carrington M, Fellay J, Lenz TL (2019). HIV peptidome-wide association study reveals patient-specific epitope repertoires associated with HIV control. Proc Natl Acad Sci U S A  116, 944-949.   https://doi.org/10.1073/pnas.1812548116|3. Bachtel ND, Umviligihozo G, Pickering S, Mota TM, Liang H, Del Prete GQ, Chatterjee P, Lee GQ, Thomas R, Brockman MA, Neil S, Carrington M, Bwana B, Bangsberg DR, Martin JN, Kallas EG, Donini CS, Cerqueira NB, O'Doherty UT, Hahn BH, Jones RB, Brumme ZL, Nixon DF, Apps R (2018). HLA-C downregulation by HIV-1 adapts to host HLA genotype. PLoS Pathog  14, e1007257.   https://doi.org/10.1371/journal.ppat.1007257|4. Boelen L, Debebe B, Silveira M, Salam A, Makinde J, Roberts CH, Wang ECY, Frater J, Gilmour J, Twigger K, Ladell K, Miners KL, Jayaraman J, Traherne JA, Price DA, Qi Y, Martin MP, Macallan DC, Thio CL, Astemborski J, Kirk G, Donfield SM, Buchbinder S, Khakoo SI, Goedert JJ, et al. [4 more authors] (2018). Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1. Sci Immunol  3.   https://doi.org/10.1126/sciimmunol.aao2892|5. Kinloch NN, Lee GQ, Carlson JM, Jin SW, Brumme CJ, Byakwaga H, Muzoora C, Bwana MB, Cobarrubias KD, Hunt PW, Martin JN, Carrington M, Bangsberg DR, Harrigan PR, Brockman MA, Brumme ZL (2019). Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity. J Virol  93.   https://doi.org/10.1128/JVI.01502-18|6. Leaton LA, Shortt J, Kichula KM, Tao S, Nemat-Gorgani N, Mentzer AJ, Oppenheimer SJ, Deng Z, Hollenbach JA, Gignoux CR, Guethlein LA, Parham P, Carrington M, Norman PJ (2019). Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates. Front Immunol  10, 24.   https://doi.org/10.3389/fimmu.2019.00024|7. Li JZ, Segal FP, Bosch RJ, Lalama CM, Roberts-Toler C, Delagreverie H, Getz R, Garcia-Broncano P, Kinslow J, Tressler R, Van Dam CN, Keefer M, Carrington M, Lichterfeld M, Kuritzkes D, Yu XG, Landay A, Sax PE, AIDS Clinical Trials Group Study A5308 Team (2019) ART reduces T cell activation and immune exhaustion markers in HIV controllers. Clin Infect Dis, in press (e-pub ahead of print)  https://doi.org/10.1093/cid/ciz442|8. Manolio TA, Hutter CM, Avigan M, Cibotti R, Davis RL, Denny JC, Grenade L, Wheatley LM, Carrington MN, Chantratita W, Chung WH, Dalton AD, Hung SI, Lee MTM, Leeder JS, Lertora JJL, Mahasirimongkol S, McLeod HL, Mockenhaupt M, Pacanowski M, Phillips EJ, Pinheiro S, Pirmohamed M, Sung C, Suwankesawong W, et al. [5 more authors] (2018). Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis. Clin Pharmacol Ther  103, 390-394.   https://doi.org/10.1002/cpt.890|9. McMichael AJ, Carrington M (2019). Topological perspective on HIV escape. Science  364, 438-439.   https://doi.org/10.1126/science.aax4989|10. Mori M, Leitman E, Walker B, Ndung'u T, Carrington M, Goulder P (2019). Impact of HLA Allele-KIR Pairs on HIV Clinical Outcome in South Africa. J Infect Dis  219, 1456-1463.   https://doi.org/10.1093/infdis/jiy692|11. Wang SS, Carrington M, Berndt SI, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Smedby KE, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, Nieters A, de Sanjose S, Cozen W, Brown EE, Turner J, Spinelli JJ, Zheng T, Birmann BM, Flowers CR, Becker N, et al. [58 more authors] (2018). HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res  78, 4086-4096.   https://doi.org/10.1158/0008-5472.CAN-17-2900",https://intramural.nih.gov/search/searchview.taf?ipid=108398
159,BC010793-13,"October 01, 2018 -  September 30, 2019","Role of inflammation, innate resistance, and immunity in carcinogenesis",Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Sharon A Bargo|Pramita  Chatterjee|Amiran  Dzutsev; PhD|April Michele Huang|John Anthony McCulloch; PhD|Soumen  Roy; PhD|Show all 12,"Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Sergei A. Nedospasov; PhD, DSc|Sergey  Grivennikov (Fox Chase Cancer Center)",Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),Yasmine  Belkaid; PhD (NIAID),"1. Nguyen-Lefebvre AT, Ajith A, Portik-Dobos V, Horuzsko DD, Arbab AS, Dzutsev A, Sadek R, Trinchieri G, Horuzsko A (2018). The innate immune receptor TREM-1 promotes liver injury and fibrosis. J Clin Invest  128, 4870-4883.   https://doi.org/10.1172/JCI98156",https://intramural.nih.gov/search/searchview.taf?ipid=108407
160,BC010795-13,"October 01, 2018 -  September 30, 2019",Mechanisms of transcription pausing and fidelity in prokaryotes and eukaryotes,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Mikhail G Bubunenko|Sara Catherine Husher|Lucyna E Lubkowska|Alexander Victorovich Yakhnin|Donald L Court; PhD|Thomas Dana Schneider; PhD|Show all 7,Michelle  Wang (Cornell University)|Paul  Babitzke (Penn State University),NULL,NULL,"1. KIreeva M, Trang C, Matevosyan G, Turek-Herman J, Chasov V, Lubkowska L, Kashlev M (2018). RNA-DNA and DNA-DNA base-pairing at the upstream edge of the transcription bubble regulate translocation of RNA polymerase and transcription rate. Nucleic Acids Res  46, 5764-5775.   https://doi.org/10.1093/nar/gky393",https://intramural.nih.gov/search/searchview.taf?ipid=108408
161,BC010801-13,"October 01, 2018 -  September 30, 2019",Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Julia Wanda Cohen|Eva  Dombi|Andrea Michelle Gross; MD|Kara Suzanne Heisey|Souvik  Karmakar|Robert F Murphy|Show all 11,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Bruce  Korf (University of Alabama)|Victor  Mautner (Genetics, Hamburg University)|Nancy  Ratner (Division of Experimental Hematology, Children's Hospital Medical Center)|Ludwine  Messiaen; PhD (Dept of Genetics, University of Alabama)|Jaishri  Blakeley (Johns Hopkins)|Show all 13","Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Alice Pinting Chen (Office of the Director)|Markku Martti Miettinen (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Seth M Steinberg; PhD (Office Of The Clinical Director)","Constantine Argyrios Stratakis; MD, DSc (NICHD) |Scott Mitchell Paul; MD (CC) |Edmond Joseph Fitzgibbon; MD (NEI) |Leslie Glenn Biesecker; MD (NHGRI) |Dominique C Pichard (NIAMS) |Prashant  Chittiboina; MD (NINDS)","1. Ferner RE, Bakker A, Elgersma Y, Evans DGR, Giovannini M, Legius E, Lloyd A, Messiaen LM, Plotkin S, Reilly KM, Schindeler A, Smith MJ, Ullrich NJ, Widemann B, Sherman LS (2019). From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis. Am J Med Genet A  179, 1098-1106.   https://doi.org/10.1002/ajmg.a.61112|2. Huang V, Bergner AL, Halpin C, Merker VL, Sheridan MR, Widemann BC, Blakeley JO, Plotkin SR (2018). Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2. Otol Neurotol  39, 632-638.   https://doi.org/10.1097/MAO.0000000000001781|3. Isakson SH, Rizzardi AE, Coutts AW, Carlson DF, Kirstein MN, Fisher J, Vitte J, Williams KB, Pluhar GE, Dahiya S, Widemann BC, Dombi E, Rizvi T, Ratner N, Messiaen L, Stemmer-Rachamimov AO, Fahrenkrug SC, Gutmann DH, Giovannini M, Moertel CL, Largaespada DA, Watson AL (2018). Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1. Commun Biol  1, 158.   https://doi.org/10.1038/s42003-018-0163-y|4. Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, Darling TN, Burton-Akright J, Bagheri M, Dombi E, Gruber A, Jarosinski PF, Martin S, Nathan N, Paul SM, Savage RE, Wolters PL, Schwartz B, Widemann BC, Biesecker LG (2019). Pharmacodynamic Study of Miransertib in Individuals with Proteus Syndrome. Am J Hum Genet  104, 484-491.   https://doi.org/10.1016/j.ajhg.2019.01.015|5. Nelson C, Dombi E, Rosenblum J, Miettinen M, Lehky T, Whitcomb P, Hayes C, Scott G, Benzo S, Widemann B, Chittiboina P (2019) Safe marginal surgical resections of atypical neurofibromas in NF1. Journal of Neurosurgery, in press.|6. Parker VER, Keppler-Noreuil KM, Faivre L, Luu M, Oden NL, De Silva L, Sapp JC, Andrews K, Bardou M, Chen KY, Darling TN, Gautier E, Goldspiel BR, Hadj-Rabia S, Harris J, Kounidas G, Kumar P, Lindhurst MJ, Loffroy R, Martin L, Phan A, Rother KI, Widemann BC, Wolters PL, Coubes C, PROMISE Working Group, et al. [6 more authors] (2019). Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum. Genet Med  21, 1189-1198.   https://doi.org/10.1038/s41436-018-0297-9|7. Rauen KA, Schoyer L, Schill L, Stronach B, Albeck J, Andresen BS, Cavé H, Ellis M, Fruchtman SM, Gelb BD, Gibson CC, Gripp K, Hefner E, Huang WYC, Itkin M, Kerr B, Linardic CM, McMahon M, Oberlander B, Perlstein E, Ratner N, Rogers L, Schenck A, Shankar S, Shvartsman S, et al. [12 more authors] (2018). Proceedings of the fifth international RASopathies symposium: When development and cancer intersect. Am J Med Genet A  176, 2924-2929.   https://doi.org/10.1002/ajmg.a.40632",https://intramural.nih.gov/search/searchview.taf?ipid=108409
162,BC010802-13,"October 01, 2018 -  September 30, 2019",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Supreet  Agarwal|Aian Neil Seno Alilin|Sonam  Raj; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108410
163,BC010806-13,"October 01, 2018 -  September 30, 2019",Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Berkley Eric Gryder|Robert George Hawley|Jeetendra  Kumar|Sivasish  Sindiri|Young K Song|Jun S Wei,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Lee Jay Helman; MD (NCI)|Dimiter  Dimitrov (University Of Pittsburgh)|Rimas Jonas Orentas",Carol J Thiele (Pediatric Oncology Branch)|Mitchell  Ho (Laboratory of Molecular Biology)|Brigitte  Widemann; MD (Pediatric Oncology Branch),Craig Joseph Thomas (NCATS) |Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108411
164,BC010808-13,"October 01, 2018 -  September 30, 2019",Chromatin structure and dynamics,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hanqiao  Feng|Bing-Rui  Zhou,NULL,Ping  Zhang (Structural Biophysics Laboratory)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Victor  Zhurkin; PhD (Laboratory of Cell Biology),Rodolfo  Ghirlando; PhD (NIDDK) |Jiansheng  Jiang; PhD (NIAID),"1. Fyodorov DV, Zhou BR, Skoultchi AI, Bai Y (2018). Emerging roles of linker histones in regulating chromatin structure and function. Nat Rev Mol Cell Biol  19, 192-206.   https://doi.org/10.1038/nrm.2017.94|2. Zhou BR, Bai Y (2019). Chromatin structures condensed by linker histones. Essays Biochem  63, 75-87.   https://doi.org/10.1042/EBC20180056|3. Zhou BR, Jiang J, Ghirlando R, Norouzi D, Sathish Yadav KN, Feng H, Wang R, Zhang P, Zhurkin V, Bai Y (2018). Revisit of Reconstituted 30-nm Nucleosome Arrays Reveals an Ensemble of Dynamic Structures. J Mol Biol  430, 3093-3110.   https://doi.org/10.1016/j.jmb.2018.06.020|4. Zhou BR, Yadav KNS, Borgnia M, Hong J, Cao B, Olins AL, Olins DE, Bai Y, Zhang P (2019). Atomic resolution cryo-EM structure of a native-like CENP-A nucleosome aided by an antibody fragment. Nat Commun  10, 2301.   https://doi.org/10.1038/s41467-019-10247-4",https://intramural.nih.gov/search/searchview.taf?ipid=108396
165,BC010814-13,"October 01, 2018 -  September 30, 2019",Elucidating the Regulation of HIV RNA Functions and Genome Packaging,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Alice Ann Duchon; PhD|Yang  Liu; PhD|Olga A Nikolaitchik|Jonathan Mark Olivares Rawson|Chijioke Nkemjika Umunnakwe|Show all 12,"David  Grnwald (Technical University of Delft)|Jeffrey  Chao (Friedrich Miescher Institute for Biomedical Research)|Kevin  Weeks (University of North Carolina, Chapel Hill)|Madhu  Lal Nag (Food And Drug Administration)|Karin  Musier-forsyth (Ohio State University)|Leor  Weinberger (University Of California San Francisco)|Show all 7",Robert  Gorelick (Office Of The Director)|Brandon Frank Keele (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108412
166,BC010816-13,"October 01, 2018 -  September 30, 2019","Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies",Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Romi  Biswas|Qun  Jiang|Mana Kamana Kamana Khanal|Vikram Alexander Misra|Betsy J Morrow|Jingli  Zhang,NULL,Ira H Pastan; MD (Molecular Biology Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Mark  Raffeld; MD (Laboratory of Pathology)|Markku Martti Miettinen (Laboratory of Pathology),NULL,"1. Ghafoor A, Thomas A, Hassan R (2018). Targeting mesothelin in ovarian cancer. Oncotarget  9, 36050-36051.   https://doi.org/10.18632/oncotarget.26350|2. Mendoza TR, Williams LA, Keating KN, Siegel J, Elbi C, Nowak AK, Hassan R, Cuffel B, Cleeland CS (2019). Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). J Patient Rep Outcomes  3, 34.   https://doi.org/10.1186/s41687-019-0122-5|3. Nicolaides NC, Schweizer C, Somers EB, Wang W, Fernando S, Ross EN, Grasso L, Hassan R, Kline JB (2018). CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients. Cancer Biol Ther  19, 622-630.   https://doi.org/10.1080/15384047.2018.1449614",https://intramural.nih.gov/search/searchview.taf?ipid=108413
167,BC010819-13,"October 01, 2018 -  September 30, 2019",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Jennifer Marie Bell|Zehava  Grossman; PhD|Pamela Jo Harris|Shawn A Hill|Kristi  Huik; PhD|Kristen Rosalie Kent|Show all 10,John W Mellors|Zandrea  Ambrose (University of Pittsburgh)|Michael  Jordan (Tufts University)|John  Coffin (Tufts University),Paul L Boyer (Retroviral Replication Laboratory)|Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Eric O Freed; PhD (HIV Drug Resistance Program)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Cheryl Ann Winkler (Basic Research Laboratory),Henry  Masur; MD (CC) |Caryn G Morse; MD (CC) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID) |Joseph A Kovacs; MD (CC) |Alice K Pau; PharmD (NIAID),"1. Gibson KM, Steiner MC, Kassaye S, Maldarelli F, Grossman Z, Pérez-Losada M, Crandall KA (2019). A 28-Year History of HIV-1 Drug Resistance and Transmission in Washington, DC. Front Microbiol  10, 369.   https://doi.org/10.3389/fmicb.2019.00369|2. Grossman Z, Rico SV, Cone K, Shao W, Rehm C, Jones S, Bozzi G, Dean S, Dewar R, Rehman T, Purdy J, Hadigan C, Pau AK, Maldarelli F (2018). Early Presence of HIV-1 Subtype C in Washington, D.C. AIDS Res Hum Retroviruses  34, 680-684.   https://doi.org/10.1089/AID.2018.0041",https://intramural.nih.gov/search/searchview.taf?ipid=108414
168,BC010822-13,"October 01, 2018 -  September 30, 2019",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au|Jessica Rose Eisenstatt|Pushkar  Malakar|Prashant  Mishra|Kentaro  Ohkuni|Roshan Lal Shrestha|Show all 13,"Grant  Hartzog (MCD Biology, Univ. of California, Santa Cruz)|Richard  Baker (Univ. of Massachusetts, Amherst)|Charles  Boone (NCI)|Dan  Foltz (Univ. of VA)|Kerry  Bloom (University of North Carolina (UNC) @ Chapel HIll)|Brenda  Andrews; PhD (University of Toronto)|Show all 10",Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression)|Gianluca  Pegoraro (Laboratory of Receptor Biology and Gene Expression)|Thorkell  Andresson (Office Of The Director),David  Landsman; PhD (NLM) |David Johannes Clark; PhD (NICHD),"1. Mishra PK, Basrai MA (2019). Protein kinases in mitotic phosphorylation of budding yeast CENP-A. Curr Genet  65, 1325-1332.   https://doi.org/10.1007/s00294-019-00997-5|2. Mishra PK, Olafsson G, Boeckmann L, Westlake TJ, Jowhar ZM, Dittman LE, Baker RE, D'Amours D, Thorpe PH, Basrai MA (2019). Cell cycle-dependent association of polo kinase Cdc5 with CENP-A contributes to faithful chromosome segregation in budding yeast. Mol Biol Cell  30, 1020-1036.   https://doi.org/10.1091/mbc.E18-09-0584|3. Mishra PK, Thapa KS, Chen P, Wang S, Hazbun TR, Basrai MA (2018). Budding yeast CENP-ACse4 interacts with the N-terminus of Sgo1 and regulates its association with centromeric chromatin. Cell Cycle  17, 11-23.   https://doi.org/10.1080/15384101.2017.1380129|4. Ohkuni K, Levy-Myers R, Warren J, Au WC, Takahashi Y, Baker RE, Basrai MA (2018). N-terminal Sumoylation of Centromeric Histone H3 Variant Cse4 Regulates Its Proteolysis To Prevent Mislocalization to Non-centromeric Chromatin. G3 (Bethesda)  8, 1215-1223.   https://doi.org/10.1534/g3.117.300419|5. Ohkuni K, Pasupala N, Peek J, Holloway GL, Sclar GD, Levy-Myers R, Baker RE, Basrai MA, Kerscher O (2018). SUMO-Targeted Ubiquitin Ligases (STUbLs) Reduce the Toxicity and Abnormal Transcriptional Activity Associated With a Mutant, Aggregation-Prone Fragment of Huntingtin. Front Genet  9, 379.   https://doi.org/10.3389/fgene.2018.00379",https://intramural.nih.gov/search/searchview.taf?ipid=108397
169,BC010824-13,"October 01, 2018 -  September 30, 2019",Molecular structures of membrane protein assemblies,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Reinhard Karl Grisshammer; PhD|Lisa M. Hartnell,Frank  McCormick (UCSF School of Medicine)|Eduardo  Perozo (University of Chicago)|John  Kuriyan (UC Berkeley),Suresh V Ambudkar; PhD (Viral Epidemiology Br),"Bernard R Brooks; PhD (NHLBI) |Mark Lee Mayer; BSc, PhD (NINDS) |Kenton J Swartz; PhD (NINDS) |Sanjay Arvind Desai; MD, PhD (NIAID)","1. Matthies D, Bae C, Toombes GE, Fox T, Bartesaghi A, Subramaniam S, Swartz KJ (2018). Single-particle cryo-EM structure of a voltage-activated potassium channel in lipid nanodiscs. Elife  7.   https://doi.org/10.7554/eLife.37558",https://intramural.nih.gov/search/searchview.taf?ipid=108415
170,BC010825-13,"October 01, 2018 -  September 30, 2019",HIV neutralization and mechanisms of cellular entry,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Reinhard Karl Grisshammer; PhD|Lisa M. Hartnell,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Michael  Rossman (Purdue University)|Peter  Palese (Mount Sinai School of Medicine)|Judith  White (University of Virginia)|Florian  Krammer (Mt. Sinai School of Medicine)|Raghavan  Varadarajan (Indian Institute of Science)",Jeffrey D Lifson; MD (Office Of The Director),Donald F Bliss (NLM),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108416
171,BC010826-13,"October 01, 2018 -  September 30, 2019",Technology Development for 3D Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Reinhard Karl Grisshammer; PhD|Lisa M. Hartnell,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Frank  McCormick (UCSF School of Medicine)|Michael  Rossman (Purdue University)|Miljan  Simonovic (University of Illinois at Chicago)",Suresh V Ambudkar; PhD (Viral Epidemiology Br)|Kumaran S Ramamurthi (Laboratory of Molecular Biology)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),Bernard R Brooks; PhD (NHLBI) |Xiongwu  Wu; PhD (NHLBI),"1. Glancy B, Hartnell LM, Combs CA, Femnou A, Sun J, Murphy E, Subramaniam S, Balaban RS (2018). Power Grid Protection of the Muscle Mitochondrial Reticulum. Cell Rep  23, 2832.   https://doi.org/10.1016/j.celrep.2018.05.055",https://intramural.nih.gov/search/searchview.taf?ipid=108417
172,BC010827-13,"October 01, 2018 -  September 30, 2019",Structural Studies of Metabolic Enzymes and Their Regulation,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Alan Anthony Merk,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108418
173,BC010830-13,"October 01, 2018 -  September 30, 2019",Mechanisms of non-classical multidrug resistance in cancer,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Fatima Ghazanfar Ali-Rahmani|Aaron Andrew Bickert|Sachi  Horibata|Lyn Ann J Mickley|Crystal Chari Cole Lipsey|Edna Akinyi Ooko; PhD|Show all 13,NULL,"Yves  Pommier; PhD (Developmental Therapeutics Branch)|Jung-Min  Lee (Womens Malignancies Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",Thomas J Pohida; MS (CIT) |Nicole Yen-I Morgan; PhD (NIBIB) |Raman  Sood; PhD (NHGRI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108419
174,BC010832-13,"October 01, 2018 -  September 30, 2019",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ulf  Ryde (Lund University)|Alberto  Podjarny (IGBMC),Raul Eduardo Cachau (Office Of The Director)|Jianghai  Zhu (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108420
175,BC010833-13,"October 01, 2018 -  September 30, 2019",Global consequences of aneuploidy on gene expression and nuclear architecture,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Markus Alexander Brown|Bernard N Chen|Wei-Dong  Chen|Reinhard  Ebner|Yue  Hu|Adihe Rachel Lokanga; BS|Show all 8,"Michael  Ghadimi (Surgery, U. of Goettingen)|Daniel Paul Rosenberg|Indika  Rajapakse (University of Michigan)|Stephen  Smale (University Of California, Berkeley)|Jens  Habermann",Thomas A Misteli; PhD (Office of the Director),Keji  Zhao; PhD (NHLBI),"1. Wangsa D, Quintanilla I, Torabi K, Vila-Casadesús M, Ercilla A, Klus G, Yuce Z, Galofré C, Cuatrecasas M, Lozano JJ, Agell N, Cimini D, Castells A, Ried T, Camps J (2018). Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness. FASEB J  32, 3502-3517.   https://doi.org/10.1096/fj.201700247RR",https://intramural.nih.gov/search/searchview.taf?ipid=108421
176,BC010834-13,"October 01, 2018 -  September 30, 2019",Intratumor heterogeneity and tumor evolution,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Reinhard  Ebner|Kerstin  Heselmeyer|Yue  Hu|Yueh Hwa Chien Tong|Damrong M Wangsa|Show all 7,Gert  Auer|Daniel  Rosenberg (University Of Connecticut)|Jens  Habermann|Russell  Schwartz|(Department of Biological Sciences)|Timo  Gaiser|Philipp  Stroebel (Georg August University GÃ¶ttingen),Alejandro Alberto Schaffer; PhD (Cancer Data Science Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108422
177,BC010837-13,"October 01, 2018 -  September 30, 2019",Disease prognostication and treatment response in rectal cancer patients,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Markus Alexander Brown|Bernard N Chen|Reinhard  Ebner|Yue  Hu|Damrong M Wangsa|Darawalee  Wangsa,"Michael  Ghadimi (Surgery, U. of Goettingen)|Gert  Auer|Daniel  Rosenberg (University Of Connecticut)|Timo  Gaiser",NULL,Danny L Sackett; PhD (NICHD),"1. Fiedler D, Heselmeyer-Haddad K, Hirsch D, Hernandez LS, Torres I, Wangsa D, Hu Y, Zapata L, Rueschoff J, Belle S, Ried T, Gaiser T (2019). Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence. Int J Cancer  144, 1561-1573.   https://doi.org/10.1002/ijc.31869|2. Hu Y, Gaedcke J, Emons G, Beissbarth T, Grade M, Jo P, Yeager M, Chanock SJ, Wolff H, Camps J, Ghadimi BM, Ried T (2018). Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery. Genes Chromosomes Cancer  57, 140-149.   https://doi.org/10.1002/gcc.22512|3. Póti Á, Berta K, Xiao Y, Pipek O, Klus GT, Ried T, Csabai I, Wilcoxen K, Mikule K, Szallasi Z, Szüts D (2018). Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts. Br J Cancer  119, 1392-1400.   https://doi.org/10.1038/s41416-018-0312-6|4. Torabi K, Erola P, Alvarez-Mora MI, Díaz-Gay M, Ferrer Q, Castells A, Castellví-Bel S, Milà M, Lozano JJ, Miró R, Ried T, Ponsa I, Camps J (2019). Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers. Int J Cancer  144, 513-524.   https://doi.org/10.1002/ijc.31936",https://intramural.nih.gov/search/searchview.taf?ipid=108424
178,BC010844-13,"October 01, 2018 -  September 30, 2019",DNA Folding in Chromatin at the Supra-nucleosome Level,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Tatiana Vladimirovna Nikitina|Seyed Davood  Norouzi; PhD,"Wilma  Olson (Wright-Rieman Laboratories, Rutgers University)|Sergei  Grigoryev (Pennsylvania State University College of Medicine)|Feng  Cui (Rochester Institute of Technology)|Vladimir  Teif (University Of Essex, Colchester, Co4 3sq, Uk)",Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Sankar  Adhya; PhD (Developmental Genetics Section),David Johannes Clark; PhD (NICHD),"1. Bass MV, Nikitina T, Norouzi D, Zhurkin VB, Grigoryev SA (2019). Nucleosome spacing periodically modulates nucleosome chain folding and DNA topology in circular nucleosome arrays. J Biol Chem  294, 4233-4246.   https://doi.org/10.1074/jbc.RA118.006412|2. Ghosh RP, Shi Q, Yang L, Reddick MP, Nikitina T, Zhurkin VB, Fordyce P, Stasevich TJ, Chang HY, Greenleaf WJ, Liphardt JT (2019). Satb1 integrates DNA binding site geometry and torsional stress to differentially target nucleosome-dense regions. Nat Commun  10, 3221.   https://doi.org/10.1038/s41467-019-11118-8|3. Norouzi D, Zhurkin VB (2018). Dynamics of Chromatin Fibers: Comparison of Monte Carlo Simulations with Force Spectroscopy. Biophys J  115, 1644-1655.   https://doi.org/10.1016/j.bpj.2018.06.032",https://intramural.nih.gov/search/searchview.taf?ipid=108425
179,BC010845-13,"October 01, 2018 -  September 30, 2019",p53-induced Regulation of Transcription in the Chromatin Context,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Tatiana Vladimirovna Nikitina|Seyed Davood  Norouzi; PhD,Sergei  Grigoryev (Pennsylvania State University College of Medicine)|Feng  Cui,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108402
180,BC010850-13,"October 01, 2018 -  September 30, 2019",Mechanisms of Normal Tissue Toxicity From Irradiation,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Seok Joo  Kwon; PhD|Bradley T Scroggins|Ayla Oksuz White|Hong G Zhang; PhD,NULL,James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. He Y, Thummuri D, Zheng G, Okunieff P, Citrin DE, Vujaskovic Z, Zhou D (2019). Cellular senescence and radiation-induced pulmonary fibrosis. Transl Res  209, 14-21.   https://doi.org/10.1016/j.trsl.2019.03.006|2. Liu Q, Gheorghiu L, Drumm M, Clayman R, Eidelman A, Wszolek MF, Olumi A, Feldman A, Wang M, Marcar L, Citrin DE, Wu CL, Benes CH, Efstathiou JA, Willers H (2018). PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. Oncogene  37, 2793-2805.   https://doi.org/10.1038/s41388-018-0130-6",https://intramural.nih.gov/search/searchview.taf?ipid=108426
181,BC010852-13,"October 01, 2018 -  September 30, 2019",Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Begum Han Horuluoglu; MSC|Neslihan  Turan|Debra  Tross|Nadya I Tarasova; PhD|Joost J Oppenheim; MD|Howard A Young; PhD|Show all 7,Ihsan  Gursel|Jay  Hooper (USAMRIID)|Sven  Klaschik|Masuhiro  Takahashi (Niigata University)|John  Vasilakos (3M Corporation)|Christian Hans Bode; MD|Show all 9,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",Igal  Gery; PhD (NEI),"1. Sato T, Shimosato T, Klinman DM (2018). Silicosis and lung cancer: current perspectives. Lung Cancer (Auckl)  9, 91-101.   https://doi.org/10.2147/LCTT.S156376",https://intramural.nih.gov/search/searchview.taf?ipid=108430
182,BC010853-13,"October 01, 2018 -  September 30, 2019",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Begum Han Horuluoglu; MSC|Neslihan  Turan|Debra  Tross|Joost J Oppenheim; MD|Giorgio  Trinchieri,Sven  Klaschik|Takashi  Sato,NULL,Igal  Gery; PhD (NEI),"1. Steinhagen F, Zillinger T, Peukert K, Fox M, Thudium M, Barchet W, Putensen C, Klinman D, Latz E, Bode C (2018). Suppressive oligodeoxynucleotides containing TTAGGG motifs inhibit cGAS activation in human monocytes. Eur J Immunol  48, 605-611.   https://doi.org/10.1002/eji.201747338",https://intramural.nih.gov/search/searchview.taf?ipid=108431
183,BC010870-12,"October 01, 2018 -  September 30, 2019",Hematopoietic Stem Cell Transplant for GATA2 Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree|Julia  Scheiermann|Laura M Tuschong|Robert R West|Daniele N Avila|Sarah  Waheed; MD,NULL,NULL,Steven M Holland; MD (NIAID),"1. Galera P, Hsu AP, Wang W, Droll S, Chen R, Schwartz JR, Klco JM, Arai S, Maese L, Zerbe C, Parta MJ, Young NS, Holland SM, Hickstein DD, Calvo KR (2018). Donor-derived MDS/AML in families with germline GATA2 mutation. Blood  132, 1994-1998.   https://doi.org/10.1182/blood-2018-07-861070|2. Jung M, Cordes S, Zou J, Yu SJ, Guitart X, Hong SG, Dang V, Kang E, Donaires FS, Hassan SA, Albitar M, Hsu AP, Holland SM, Hickstein DD, Townsley D, Dunbar CE, Winkler T (2018). GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells. Blood Adv  2, 3553-3565.   https://doi.org/10.1182/bloodadvances.2018017137|3. McReynolds LJ, Yang Y, Yuen Wong H, Tang J, Zhang Y, Mulé MP, Daub J, Palmer C, Foruraghi L, Liu Q, Zhu J, Wang W, West RR, Yohe ME, Hsu AP, Hickstein DD, Townsley DM, Holland SM, Calvo KR, Hourigan CS (2019). MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations. Leuk Res  76, 70-75.   https://doi.org/10.1016/j.leukres.2018.11.013|4. Parta M, Shah NN, Baird K, Rafei H, Calvo KR, Hughes T, Cole K, Kenyon M, Schuver BB, Cuellar-Rodriguez J, Zerbe CS, Holland SM, Hickstein DD (2018). Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen. Biol Blood Marrow Transplant  24, 1250-1259.   https://doi.org/10.1016/j.bbmt.2018.01.030|5. Zolton JR, Parikh TP, Hickstein DD, Holland SM, Hill MJ, DeCherney AH, Wolff EF (2018). Oocyte cryopreservation for women with GATA2 deficiency. J Assist Reprod Genet  35, 1201-1207.   https://doi.org/10.1007/s10815-018-1146-0",https://intramural.nih.gov/search/searchview.taf?ipid=108464
184,BC010876-12,"October 01, 2018 -  September 30, 2019",The role of cancer stem cells in liver cancer heterogeneity and subtypes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Julian Marcelo Candia|Ching Wen  Chang|Marshonna J Forgues|Subreen Adel Khatib|Shiqi  Shen; BSM|Amanda Jean Craig|Show all 7,Zhao-You  Tang (Liver Cancer Institute)|Yamashita  Taro (Kanazawa University Graduate School of Medical Science),Mitchell  Ho (Laboratory of Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108502
185,BC010877-12,"October 01, 2018 -  September 30, 2019",The identification of human hepatocellular carcinoma metastasis genes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Ching Wen  Chang|Marshonna J Forgues|Amanda Jean Craig|Limin  Wang; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108501
186,BC010881-12,"October 01, 2018 -  September 30, 2019",Development of TGF-beta antagonists for cancer therapy,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yu-an  Yang|Binwu  Tang|Kent W Hunter; PhD|Maxwell P Lee; PhD|Howard H Yang,Amer  Mirza (XOMA (US) LLC)|Caroline  Hill (Francis Crick Institute)|Maureen  O'Connor-McCourt (Formation Biologics Inc),Patricia  Steeg; PhD (Womens Malignancies Branch),"Sushil Gopal Rane; MS, PhD (NIDDK) |Ashok Balkrishna Kulkarni; PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108499
187,BC010885-12,"October 01, 2018 -  September 30, 2019",Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI","David A Davis; MD|Kathryn Anne Lurain; MD, MPH|Ramya Meenakshi Ramaswami|Prabha  Shrestha; PhD|Alexandra Joyce Stream|Victoria Y Wang|Show all 10","Rolf  Renne (Case Western Reserave University, Cleveland, OH)|Robert  Newton (University Of York)|Ting-ting  Wu (University Of California Los Angeles)","Denise  Whitby (Office Of The Director)|Stefania  Pittaluga (Laboratory of Pathology)|Christopher  Buck (Laboratory of Cellular Oncology)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108508
188,BC010886-12,"October 01, 2018 -  September 30, 2019",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Wei  Tang; PhD,NULL,Ashish Kumar Lal (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108434
189,BC010887-12,"October 01, 2018 -  September 30, 2019",Novel Markers for Disease Outcome in Breast Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Maeve Kiely Bailey-Whyte|Francine Shernette Baker|Tiffany Marie Howe|Tsion Zewdu Minas|Gatikrushna  Panigrahi; PhD|Wei  Tang; PhD,Arun  Sreekumar (Baylor College of Medicine)|Olufunmilayo  Olopade (University of Chicago)|Nagireddy  Putluri (Baylor College of Medicine)|Clayton  Yates (Tuskegee University),Ashish Kumar Lal (Cancer Genetics Branch)|David Anderson Wink (Cancer Inflammation Program)|Michael  Bustin; PhD (Laboratory of Metabolism)|Eytan  Ruppin (Cancer Data Science Laboratory),NULL,"1. Mishra P, Tang W, Putluri V, Dorsey TH, Jin F, Wang F, Zhu D, Amable L, Deng T, Zhang S, Killian JK, Wang Y, Minas TZ, Yfantis HG, Lee DH, Sreekumar A, Bustin M, Liu W, Putluri N, Ambs S (2018). ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming. J Clin Invest  128, 323-340.   https://doi.org/10.1172/JCI93815|2. Walter KR, Ford ME, Gregoski MJ, Kramer RM, Knight KD, Spruill L, Nogueira LM, Krisanits BA, Phan V, La Rue AC, Lilly MB, Ambs S, Chan K, Turner TF, Varner H, Singh S, Uribarri J, Garrett-Mayer E, Armeson KE, Hilton EJ, Clair MJ, Taylor MH, Abbott AM, Findlay VJ, Peterson LL, et al. [2 more authors] (2019). Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat  173, 559-571.   https://doi.org/10.1007/s10549-018-4992-7|3. Wang S, Huo D, Kupfer S, Alleyne D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Zheng Y (2018). Genetic variation in the vitamin D related pathway and breast cancer risk in women of African ancestry in the root consortium. Int J Cancer  142, 36-43.   https://doi.org/10.1002/ijc.31038|4. Wang S, Huo D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Zheng Y (2018). Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry. Mol Carcinog  57, 1311-1318.   https://doi.org/10.1002/mc.22845|5. Wang S, Qian F, Zheng Y, Ogundiran T, Ojengbede O, Zheng W, Blot W, Nathanson KL, Hennis A, Nemesure B, Ambs S, Olopade OI, Huo D (2018). Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry. Breast Cancer Res Treat  168, 703-712.   https://doi.org/10.1007/s10549-017-4638-1|6. Wang S, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Huo D (2018). Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry. Cancer Epidemiol Biomarkers Prev  27, 116-118.   https://doi.org/10.1158/1055-9965.EPI-17-0755",https://intramural.nih.gov/search/searchview.taf?ipid=108435
190,BC010888-12,"October 01, 2018 -  September 30, 2019",Clinical Trials of Patients with AIDS-Related Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI","David A Davis; MD|Kathryn Anne Lurain; MD, MPH|Ramya Meenakshi Ramaswami|Victoria Y Wang|Joseph M Ziegelbauer",Mac  Cheever (Fred Hutchinson Cancer Research Center)|Shou-Jiang  Gao (University of Texas)|Robert  Newton (University Of York)|Thomas  Uldrick (Fred Hutchinson Cancer Center),Denise  Whitby (Office Of The Director)|Stefania  Pittaluga (Laboratory of Pathology)|Christopher  Buck (Laboratory of Cellular Oncology)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology),Amir Hossein Gandjbakhche; PhD (NICHD) |Irina  Maric; MD (CC) |Irini  Sereti; MD (NIAID) |Corina M Millo; MD (CC) |Joseph A Kovacs; MD (CC),"1. Lurain K, Yarchoan R, Ramaswami R (2019). The Changing Face of HIV-Associated Malignancies: Advances, Opportunities, and Future Directions. Am Soc Clin Oncol Educ Book  39, 36-40.   https://doi.org/10.1200/EDBK_100017|2. Lurain K, Yarchoan R, Uldrick TS (2018). Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease. Hematol Oncol Clin North Am  32, 75-88.   https://doi.org/10.1016/j.hoc.2017.09.007|3. Manion M, Uldrick T, Polizzotto MN, Sheikh V, Roby G, Lurain K, Metzger D, Mican JM, Pau A, Lisco A, Laidlaw E, Hammoud DA, Whitby D, Yarchoan R, Sereti I (2018). Emergence of Kaposi's Sarcoma Herpesvirus-Associated Complications Following Corticosteroid Use in TB-IRIS. Open Forum Infect Dis  5, ofy217.   https://doi.org/10.1093/ofid/ofy217|4. Nalwoga A, Cose S, Nash S, Miley W, Asiki G, Kusemererwa S, Yarchoan R, Labo N, Whitby D, Newton R (2018). Relationship Between Anemia, Malaria Coinfection, and Kaposi Sarcoma-Associated Herpesvirus Seropositivity in a Population-Based Study in Rural Uganda. J Infect Dis  218, 1061-1065.   https://doi.org/10.1093/infdis/jiy274|5. Yarchoan R, Uldrick TS (2018). HIV-Associated Cancers and Related Diseases. N Engl J Med  378, 1029-1041.   https://doi.org/10.1056/NEJMra1615896|6. Yarchoan R, Uldrick TS (2018). HIV-Associated Cancers and Related Diseases. N Engl J Med  378, 2145.   https://doi.org/10.1056/NEJMc1804812",https://intramural.nih.gov/search/searchview.taf?ipid=108507
191,BC010891-12,"October 01, 2018 -  September 30, 2019",Development of new antibody-based cancer therapies,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Holly E Holden|Ying  Fu|Jessica Diana Hong|Aarti  Kolluri|Dan  Li|Nan  Li|Show all 7,NULL,"Ira H Pastan; MD (Molecular Biology Section)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Tim Friedrich Greten (Thoracic and GI Malignancies Branch)|Martin John Schnermann; PhD (Chemical Biology Laboratory)|Freddy Enrique Escorcia; MD, PhD (Molecular Imaging Program)",Matthew David Hall (NCATS),"1. Fu Y, Ho M (2018). DNA damaging agent-based antibody-drug conjugates for cancer therapy. Antib Ther  1, 33-43.   https://doi.org/10.1093/abt/tby007|2. Kim H, Ho M (2018). Isolation of Antibodies to Heparan Sulfate on Glypicans by Phage Display. Curr Protoc Protein Sci  94, e66.   https://doi.org/10.1002/cpps.66|3. Li N, Gao W, Zhang YF, Ho M (2018). Glypicans as Cancer Therapeutic Targets. Trends Cancer  4, 741-754.   https://doi.org/10.1016/j.trecan.2018.09.004|4. Li N, Wei L, Liu X, Bai H, Ye Y, Li D, Li N, Baxa U, Wang Q, Lv L, Chen Y, Feng M, Lee B, Gao W, Ho M (2019). A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice. Hepatology  70, 1231-1245.   https://doi.org/10.1002/hep.30646",https://intramural.nih.gov/search/searchview.taf?ipid=108465
192,BC010898-12,"October 01, 2018 -  September 30, 2019",Redox Mechanism Process of Angiogenesis and Wound Healing,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Debashree  Basudhar|Lisa Ann Ridnour|Veena  Somasundaram|Howard A Young; PhD|Giorgio  Trinchieri,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Murali  Krishna; PhD (Radiation Biology Branch)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|David D Roberts; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108504
193,BC010899-12,"October 01, 2018 -  September 30, 2019",Inflammation and cancer treatment,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Debashree  Basudhar|Luiz Gonzaga De Franca Lopes|Lisa Ann Ridnour|Howard A Young; PhD|Giorgio  Trinchieri,"Bruce  King (Department of Chemistry, Wake Forest University)|Micheal  Vitek (Neurology, Duke Uniuversity Medical School)",Murali  Krishna; PhD (Radiation Biology Branch)|David D Roberts; PhD (Laboratory of Pathology),NULL,"1. Thomas K, Moody TW, Jensen RT, Tong J, Rayner CL, Barnett NL, Fairfull-Smith KE, Ridnour LA, Wink DA, Bottle SE (2018). Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs. Eur J Med Chem  147, 34-47.   https://doi.org/10.1016/j.ejmech.2018.01.077",https://intramural.nih.gov/search/searchview.taf?ipid=108505
194,BC010914-12,"October 01, 2018 -  September 30, 2019",Gene Expression Profiling and Clinical Characterization of Phototoxicity,Heidi H Kong|IRP Faculty Profile,NULL,"Office of the Director, NCI",Jay Hyun  Jo; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108516
195,BC010938-12,"October 01, 2018 -  September 30, 2019",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,Heidi H Kong|IRP Faculty Profile,NULL,"Office of the Director, NCI",Iryna Leonidivna Chub|Valentina Shobhana Pillai; CRNP|Nicole Helen Schwardt|Monica Elizabeth Taylor|Keisuke  Nagao,Carsten  Flohr (St. John's College)|Lora  Hooper (UT Southwestern)|Lloyd  Miller (Johns Hopkins),NULL,"Julia A Segre; PhD (NHGRI) |Alexandra  Freeman (NIAID) |Steven M Holland; MD (NIAID) |Niki  Moutsopoulos; DDS, PhD (NIDCR)","1. Glatz M, Jo JH, Kennedy EA, Polley EC, Segre JA, Simpson EL, Kong HH (2018). Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis. PLoS One  13, e0192443.   https://doi.org/10.1371/journal.pone.0192443|2. Harris TA, Gattu S, Propheter DC, Kuang Z, Bel S, Ruhn KA, Chara AL, Edwards M, Zhang C, Jo JH, Raj P, Zouboulis CC, Kong HH, Segre JA, Hooper LV (2019). Resistin-like Molecule α Provides Vitamin-A-Dependent Antimicrobial Protection in the Skin. Cell Host Microbe  25, 777-788.e8.   https://doi.org/10.1016/j.chom.2019.04.004",https://intramural.nih.gov/search/searchview.taf?ipid=108517
196,BC010940-12,"October 01, 2018 -  September 30, 2019",Cutaneous Adverse Drug Reactions,Heidi H Kong|IRP Faculty Profile,NULL,"Office of the Director, NCI",Valentina Shobhana Pillai; CRNP|Edward W Cowen,NULL,"Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|Alice Pinting Chen (Office of the Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108515
197,BC010944-12,"October 01, 2018 -  September 30, 2019",Strategies for Cancer Immunotherapy Development: Preclinical Studies,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Lajuan  Chase|Garland M Davis|Bertina L Gibbs|John  Greiner; PhD|Duane Howard Hamilton|Kristin Caroline Hicks|Show all 15,"Mario  Roselli (Oncology, Tor Vergata)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Frank E Jones; PhD (Tulane School of Medicine)|Shahrooz  Rabizadeh (Nantbioscience/nantomics)|Dean  Maeda (Syntrix Pharmaceuticals, Inc.)|Peter  Ordentlich (Syndax Pharmaceuticals, Inc.)|Show all 11",Christian S Hinrichs (Experimental Transplantation and Immunology Branch),NULL,"1. Friedman J, Padget M, Lee J, Schlom J, Hodge J, Allen C (2019). Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells. Oral Oncol  90, 38-44.   https://doi.org/10.1016/j.oraloncology.2019.01.017|2. Jochems C, Tritsch SR, Knudson KM, Gameiro SR, Rumfield CS, Pellom ST, Morillon YM, Newman R, Marcus W, Szeto C, Rabizadeh S, Wong HC, Soon-Shiong P, Schlom J (2019). The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex. Oncoimmunology  8, e1532764.   https://doi.org/10.1080/2162402X.2018.1532764|3. Knudson KM, Hicks KC, Alter S, Schlom J, Gameiro SR (2019). Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy. J Immunother Cancer  7, 82.   https://doi.org/10.1186/s40425-019-0551-y",https://intramural.nih.gov/search/searchview.taf?ipid=108475
198,BC010945-12,"October 01, 2018 -  September 30, 2019",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",Houssein  Abdul Sater|Amy Rosenberg Hankin|Fatima Hafiz Karzai; MD|Sunnie S Kim|Ariel Elan Marciscano; MD|Jennifer L Marte|Show all 13,"Douglas  McNeel (University of Wisconsin)|Paul  Chaplin (Bavarian Nordic, Inc.)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|John  Lee (Nantkwest)|John  Marshall|Zhen  Su (EMD Serono-Merck)","William Marston Linehan; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Jennifer Clare Jones; MD, PhD (Laboratory of Pathology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)",NULL,"1. Collins JM, Redman JM, Gulley JL (2018). Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy. Expert Rev Vaccines  17, 697-705.   https://doi.org/10.1080/14760584.2018.1506332",https://intramural.nih.gov/search/searchview.taf?ipid=108461
199,BC010946-12,"October 01, 2018 -  September 30, 2019",Protection against Radiation-Induced Carcinogenesis,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|Sangeeta  Gohain|Anastasia L Sowers|Murali  Krishna; PhD,NULL,Frank Jess Gonzalez; PhD (Laboratory of Metabolism),NULL,"1. Cook JA, Naz S, Anver MR, Sowers AL, Fabre K, Krishna MC, Mitchell JB (2018). Cancer Incidence in C3H Mice Protected from Lethal Total-Body Radiation after Amifostine. Radiat Res  189, 490-496.   https://doi.org/10.1667/RR14987.1",https://intramural.nih.gov/search/searchview.taf?ipid=108532
200,BC010958-12,"October 01, 2018 -  September 30, 2019","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",Ira  Daar; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Jerlin  Garo|Yoo-Seok  Hwang|Jaeho  Yoon; PhD,Hee Jun  Cho; PhD|Peter  Nemes (University Of Maryland-college Park),NULL,NULL,"1. Cho HJ, Hwang YS, Yoon J, Lee M, Lee HG, Daar IO (2018). EphrinB1 promotes cancer cell migration and invasion through the interaction with RhoGDI1. Oncogene  37, 861-872.   https://doi.org/10.1038/onc.2017.386|2. Yoon J, Hwang YS, Lee M, Sun J, Cho HJ, Knapik L, Daar IO (2018). TBC1d24-ephrinB2 interaction regulates contact inhibition of locomotion in neural crest cell migration. Nat Commun  9, 3491.   https://doi.org/10.1038/s41467-018-05924-9",https://intramural.nih.gov/search/searchview.taf?ipid=108448
201,BC010959-12,"October 01, 2018 -  September 30, 2019",Relationship between DNA damage detection and signaling,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Maria Elsa  Callen Moreu|Yaakov  Maman|Jacob J Paiano|Nicholas Franklin Sciascia; BS|Kenta  Shinoda|Raphael Souza Pavani; PhD|Show all 13,Solomon  Snyder (Johns Hopkins University School Of Medicine)|Chuna  Choudhary (University Of Copenhagen)|Derrick  Rossi; MD (Harvard University/Chidren's Hospital)|Manuela  Pellegrini|Olivier  Hyrien (Cnrs)|Scott  Armstrong (Harvard Medical School)|Show all 11,Yves  Pommier; PhD (Developmental Therapeutics Branch),Rafael Cristian Casellas; PhD (NIAMS) |Kai  Ge; PhD (NIDDK),"1. Chu SH, Song EJ, Chabon JR, Minehart J, Matovina CN, Makofske JL, Frank ES, Ross K, Koche RP, Feng Z, Xu H, Krivtsov A, Nussenzweig A, Armstrong SA (2018). Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by Mll-Af4 and activated Ras. Blood Adv  2, 2478-2490.   https://doi.org/10.1182/bloodadvances.2018021592|2. Das P, Veazey KJ, Van HT, Kaushik S, Lin K, Lu Y, Ishii M, Kikuta J, Ge K, Nussenzweig A, Santos MA (2018). Histone methylation regulator PTIP is required to maintain normal and leukemic bone marrow niches. Proc Natl Acad Sci U S A  115, E10137-E10146.   https://doi.org/10.1073/pnas.1806019115|3. Di Siena S, Campolo F, Gimmelli R, Di Pietro C, Marazziti D, Dolci S, Lenzi A, Nussenzweig A, Pellegrini M (2018). Atm reactivation reverses ataxia telangiectasia phenotypes in vivo. Cell Death Dis  9, 314.   https://doi.org/10.1038/s41419-018-0357-8|4. Gutierrez-Martinez P, Hogdal L, Nagai M, Kruta M, Singh R, Sarosiek K, Nussenzweig A, Beerman I, Letai A, Rossi DJ (2018). Diminished apoptotic priming and ATM signalling confer a survival advantage onto aged haematopoietic stem cells in response to DNA damage. Nat Cell Biol  20, 413-421.   https://doi.org/10.1038/s41556-018-0054-y|5. Nacson J, Krais JJ, Bernhardy AJ, Clausen E, Feng W, Wang Y, Nicolas E, Cai KQ, Tricarico R, Hua X, DiMarcantonio D, Martinez E, Zong D, Handorf EA, Bellacosa A, Testa JR, Nussenzweig A, Gupta GP, Sykes SM, Johnson N (2018). BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. Cell Rep  24, 3513-3527.e7.   https://doi.org/10.1016/j.celrep.2018.08.086|6. Sasanuma H, Tsuda M, Morimoto S, Saha LK, Rahman MM, Kiyooka Y, Fujiike H, Cherniack AD, Itou J, Callen Moreu E, Toi M, Nakada S, Tanaka H, Tsutsui K, Yamada S, Nussenzweig A, Takeda S (2018). BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes. Proc Natl Acad Sci U S A  115, E10642-E10651.   https://doi.org/10.1073/pnas.1803177115|7. Tubbs A, Sridharan S, van Wietmarschen N, Maman Y, Callen E, Stanlie A, Wu W, Wu X, Day A, Wong N, Yin M, Canela A, Fu H, Redon C, Pruitt SC, Jaszczyszyn Y, Aladjem MI, Aplan PD, Hyrien O, Nussenzweig A (2018). Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse. Cell  174, 1127-1142.e19.   https://doi.org/10.1016/j.cell.2018.07.011|8. van Wietmarschen N, Nussenzweig A (2018). Mechanism for Synthetic Lethality in BRCA-Deficient Cancers: No Longer Lagging Behind. Mol Cell  71, 877-878.   https://doi.org/10.1016/j.molcel.2018.08.045|9. Zong D, Adam S, Wang Y, Sasanuma H, Callén E, Murga M, Day A, Kruhlak MJ, Wong N, Munro M, Ray Chaudhuri A, Karim B, Xia B, Takeda S, Johnson N, Durocher D, Nussenzweig A (2019). BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation. Mol Cell  73, 1267-1281.e7.   https://doi.org/10.1016/j.molcel.2018.12.010",https://intramural.nih.gov/search/searchview.taf?ipid=108538
202,BC010960-12,"October 01, 2018 -  September 30, 2019",ETIB Clinical Trials,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Judy Liliana Baruffaldi|Tracey N Chinn|Megan Irene Kenyon|Eun Soo  Paek|Lauren R Skeffington|Jennifer Sproul Wilder,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108460
203,BC010975-12,"October 01, 2018 -  September 30, 2019",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Kellsye Paula Fabian|Sarah Elizabeth Franks; PhD|Sofia Ribeiro Gameiro|Kristen  Solocinski|Marion G Taylor|Benjamin Robert Wolfson|Show all 7,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,"1. Carrasquillo J, Hodge J (2019) Radiation and immunotherapy: implications for neuroendocrine yumors, in Current Diagnostic and Therapeutic Approaches in Nuclear Endocrinology, in press.|2. Guha C, Dicker A, Padget M, Hodge J (2019) Integrating immunotherapy modalities with radiation therapy, in Perez  Brady's Principles and Practice of Radiation Oncology, in press.|3. Morisada M, Clavijo PE, Moore E, Sun L, Chamberlin M, Van Waes C, Hodge JW, Mitchell JB, Friedman J, Allen CT (2018). PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation. Oncoimmunology  7, e1395996.   https://doi.org/10.1080/2162402X.2017.1395996",https://intramural.nih.gov/search/searchview.taf?ipid=108509
204,BC010977-12,"October 01, 2018 -  September 30, 2019",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Silvano Rakeem Daniels|Donna M Voeller|David J Wisniewski,Steven  Jay (University Of Maryland)|Rachel  Klevit (University Of Washington),Anand S Merchant (Cancer Diagnosis Program)|Richard J Hodes; MD (Experimental Immunology Branch)|Barry R O'Keefe (Molecular Targets Laboratory)|Udayan  Guha (Thoracic and GI Malignancies Branch),Richard  Childs; MD (NHLBI),"1. Daniels SR, Liyasova M, Kales SC, Nau MM, Ryan PE, Green JE, Lipkowitz S (2019). Loss of function Cbl-c mutations in solid tumors. PLoS One  14, e0219143.   https://doi.org/10.1371/journal.pone.0219143|2. Schardt JS, Noonan-Shueh M, Oubaid JM, Pottash AE, Williams SC, Hussain A, Lapidus RG, Lipkowitz S, Jay SM (2019). HER3-Targeted Affibodies with Optimized Formats Reduce Ovarian Cancer Progression in a Mouse Xenograft Model. AAPS J  21, 48.   https://doi.org/10.1208/s12248-019-0318-x",https://intramural.nih.gov/search/searchview.taf?ipid=108525
205,BC010982-12,"October 01, 2018 -  September 30, 2019",Collaborative Pathways that Lead to Leukemia,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Yang-Jo  Chung|Toshihiro  Matsukawa|Vijay  Negi|Mianmian  Yin|Paul S Meltzer; MD, PhD",Trang  Hoang (U. Montreal)|Donald  Small (Johns Hopkins University School of Medicine)|Steven  Pruitt (Rpci)|Ben  Ebert (Brigham Hospital)|Terry J Fry (NCI)|Margaret  Goodell (Baylor College Of Medicine),Scott K Durum; PhD (Cancer Inflammation Program),NULL,"1. Peng L, Guo H, Ma P, Sun Y, Dennison L, Aplan PD, Hess JL, Friedman AD (2019). HoxA9 binds and represses the Cebpa +8 kb enhancer. PLoS One  14, e0217604.   https://doi.org/10.1371/journal.pone.0217604|2. Yin M, Chung YJ, Lindsley RC, Walker RL, Zhu YJ, Ebert BL, Meltzer PS, Aplan PD (2019). Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background. Blood  133, 2610-2614.   https://doi.org/10.1182/blood.2018864173",https://intramural.nih.gov/search/searchview.taf?ipid=108437
206,BC010983-12,"October 01, 2018 -  September 30, 2019",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Yang-Jo  Chung|Sara  Hazaveh; BA,Donald  Small (Johns Hopkins University School of Medicine)|JP  Issa (MD Anderson)|Chris  Slape (Monash University)|Laura  Schuettpelz (Washington University)|Amit  Verma (Alberrt Einstein)|Terry J Fry (NCI)|Show all 7,NULL,NULL,"1. Chung YJ, Khawaja G, Wolcott KM, Aplan PD (2018). Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome. J Vis Exp  .  https://doi.org/10.3791/58140|2. Lau BW, Huh K, Madero-Marroquin R, De Marchi F, Lim Y, Wang Q, Lobo F, Marchionni L, Smith DB, DeZern A, Levis MJ, Aplan PD, Matsui W, Gondek LP (2019). Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity. Oncogene  38, 687-698.   https://doi.org/10.1038/s41388-018-0431-9|3. Monlish DA, Bhatt ST, Duncavage EJ, Greenberg ZJ, Keller JL, Romine MP, Yang W, Aplan PD, Walter MJ, Schuettpelz LG (2018). Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS. Blood  131, 1032-1035.   https://doi.org/10.1182/blood-2017-08-801944",https://intramural.nih.gov/search/searchview.taf?ipid=108438
207,BC010984-12,"October 01, 2018 -  September 30, 2019",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Gal  Cafri|Drew Caldwell Deniger; PhD|Stephanie  Goff|Vid  Leko|Frank Joseph Lowery; PhD|Richard  Sherry; MD|Show all 11,NULL,NULL,NULL,"1. Ahmadzadeh M, Pasetto A, Jia L, Deniger DC, Stevanović S, Robbins PF, Rosenberg SA (2019). Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity. Sci Immunol  4.   https://doi.org/10.1126/sciimmunol.aao4310|2. Cafri G, Yossef R, Pasetto A, Deniger DC, Lu YC, Parkhurst M, Gartner JJ, Jia L, Ray S, Ngo LT, Jafferji M, Sachs A, Prickett T, Robbins PF, Rosenberg SA (2019). Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients. Nat Commun  10, 449.   https://doi.org/10.1038/s41467-019-08304-z|3. Goff SL, Rosenberg SA (2019). BRAF Inhibition: Bridge or Boost to T-cell Therapy? Clin Cancer Res  25, 2682-2684.   https://doi.org/10.1158/1078-0432.CCR-19-0286|4. Kalaora S, Wolf Y, Feferman T, Barnea E, Greenstein E, Reshef D, Tirosh I, Reuben A, Patkar S, Levy R, Quinkhardt J, Omokoko T, Qutob N, Golani O, Zhang J, Mao X, Song X, Bernatchez C, Haymaker C, Forget MA, Creasy C, Greenberg P, Carter BW, Cooper ZA, Rosenberg SA, et al. [8 more authors] (2018). Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma. Cancer Discov  8, 1366-1375.   https://doi.org/10.1158/2159-8290.CD-17-1418|5. Lo W, Parkhurst M, Robbins PF, Tran E, Lu YC, Jia L, Gartner JJ, Pasetto A, Deniger D, Malekzadeh P, Shelton TE, Prickett T, Ray S, Kivitz S, Paria BC, Kriley I, Schrump DS, Rosenberg SA (2019). Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer. Cancer Immunol Res  7, 534-543.   https://doi.org/10.1158/2326-6066.CIR-18-0686|6. Mehta GU, Malekzadeh P, Shelton T, White DE, Butman JA, Yang JC, Kammula US, Goff SL, Rosenberg SA, Sherry RM (2018). Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases. J Immunother  41, 241-247.   https://doi.org/10.1097/CJI.0000000000000223|7. Qutob N, Masuho I, Alon M, Emmanuel R, Cohen I, Di Pizio A, Madore J, Elkahloun A, Ziv T, Levy R, Gartner JJ, Hill VK, Lin JC, Hevroni Y, Greenberg P, Brodezki A, Rosenberg SA, Kosloff M, Hayward NK, Admon A, Niv MY, Scolyer RA, Martemyanov KA, Samuels Y (2018). RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells. Sci Rep  8, 653.   https://doi.org/10.1038/s41598-017-18851-4|8. Yossef R, Tran E, Deniger DC, Gros A, Pasetto A, Parkhurst MR, Gartner JJ, Prickett TD, Cafri G, Robbins PF, Rosenberg SA (2018). Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy. JCI Insight  3.   https://doi.org/10.1172/jci.insight.122467",https://intramural.nih.gov/search/searchview.taf?ipid=108473
208,BC010985-12,"October 01, 2018 -  September 30, 2019",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI","Drew Caldwell Deniger; PhD|Vid  Leko|Yong-Chen  Lu; PhD|Richard  Sherry; MD|James Chung-Yin Yang; MD, PhD|Nicholas Phillip Restifo; MD|Show all 9",NULL,NULL,NULL,"1. Goff SL, Morgan RA, Yang JC, Sherry RM, Robbins PF, Restifo NP, Feldman SA, Lu YC, Lu L, Zheng Z, Xi L, Epstein M, McIntyre LS, Malekzadeh P, Raffeld M, Fine HA, Rosenberg SA (2019). Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma. J Immunother  42, 126-135.   https://doi.org/10.1097/CJI.0000000000000260|2. Sana G, Madigan JP, Gartner JJ, Fourrez M, Lin J, Qutob N, Narayan J, Shukla S, Ambudkar SV, Xia D, Rosenberg SA, Gottesman MM, Samuels Y, Gillet JP (2019). Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities. J Invest Dermatol  139, 1985-1992.e10.   https://doi.org/10.1016/j.jid.2019.01.036",https://intramural.nih.gov/search/searchview.taf?ipid=108472
209,BC010998-12,"October 01, 2018 -  September 30, 2019",Identification of Novel Mutations In Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Andrew Scott Brohl|Igor Borisovich Kuznetsov|Sivasish  Sindiri|Young K Song|Jun S Wei|Xinyu  Wen|Show all 7,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Stephen  Skapek (The University of Chicago)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Lee Jay Helman; MD (NCI)",Carol J Thiele (Pediatric Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108513
210,BC010999-12,"October 01, 2018 -  September 30, 2019","Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma",Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Berkley Eric Gryder|Sivasish  Sindiri|Young K Song|Jun S Wei|Xinyu  Wen,Daniel  Catchpoole (The Children's Hospital at Westmead)|Terry J Fry (NCI)|Crystal L. Mackall; MD (NCI),Brigitte  Widemann; MD (Pediatric Oncology Branch)|Mitchell  Ho (Laboratory of Molecular Biology)|Christian S Hinrichs (Experimental Transplantation and Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108514
211,BC011002-12,"October 01, 2018 -  September 30, 2019",Bioinformatics: Systems Biology of Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Andrew Scott Brohl|Igor Borisovich Kuznetsov|Sivasish  Sindiri|Jun S Wei|Xinyu  Wen|Paul S Meltzer; MD, PhD",NULL,NULL,NULL,"1. Machiela MJ, Grünewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, Zaidi S, Grossetete-Lalami S, Ballet S, Lapouble E, Laurence V, Michon J, Pierron G, Kovar H, Gaspar N, Kontny U, González-Neira A, Picci P, Alonso J, Patino-Garcia A, Corradini N, Bérard PM, Freedman ND, Rothman N, et al. [28 more authors] (2018). Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. Nat Commun  9, 3184.   https://doi.org/10.1038/s41467-018-05537-2|2. McBride MJ, Pulice JL, Beird HC, Ingram DR, D'Avino AR, Shern JF, Charville GW, Hornick JL, Nakayama RT, Garcia-Rivera EM, Araujo DM, Wang WL, Tsai JW, Yeagley M, Wagner AJ, Futreal PA, Khan J, Lazar AJ, Kadoch C (2018). The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma. Cancer Cell  33, 1128-1141.e7.   https://doi.org/10.1016/j.ccell.2018.05.002|3. Rajbhandari P, Lopez G, Capdevila C, Salvatori B, Yu J, Rodriguez-Barrueco R, Martinez D, Yarmarkovich M, Weichert-Leahey N, Abraham BJ, Alvarez MJ, Iyer A, Harenza JL, Oldridge D, De Preter K, Koster J, Asgharzadeh S, Seeger RC, Wei JS, Khan J, Vandesompele J, Mestdagh P, Versteeg R, Look AT, Young RA, et al. [5 more authors] (2018). Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. Cancer Discov  8, 582-599.   https://doi.org/10.1158/2159-8290.CD-16-0861|4. Tricoli JV, Boardman LA, Patidar R, Sindiri S, Jang JS, Walsh WD, McGregor PM, Camalier CE, Mehaffey MG, Furman WL, Bahrami A, Williams PM, Lih CJ, Conley BA, Khan J (2018). A mutational comparison of adult and adolescent and young adult (AYA) colon cancer. Cancer  124, 1070-1082.   https://doi.org/10.1002/cncr.31136|5. Wei JS, Kuznetsov IB, Zhang S, Song YK, Asgharzadeh S, Sindiri S, Wen X, Patidar R, Najaraj S, Walton A, Auvil JMG, Gerhard DS, Yuksel A, Catchpoole D, Hewitt SM, Sondel PM, Seeger R, Maris JM, Khan J (2018). Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma. Clin Cancer Res  24, 5673-5684.   https://doi.org/10.1158/1078-0432.CCR-18-0599|6. Yohe ME, Heske CM, Stewart E, Adamson PC, Ahmed N, Antonescu CR, Chen E, Collins N, Ehrlich A, Galindo RL, Gryder BE, Hahn H, Hammond S, Hatley ME, Hawkins DS, Hayes MN, Hayes-Jordan A, Helman LJ, Hettmer S, Ignatius MS, Keller C, Khan J, Kirsch DG, Linardic CM, Lupo PJ, et al. [8 more authors] (2019). Insights into pediatric rhabdomyosarcoma research: Challenges and goals. Pediatr Blood Cancer  66, e27869.   https://doi.org/10.1002/pbc.27869",https://intramural.nih.gov/search/searchview.taf?ipid=108512
212,BC011006-12,"October 01, 2018 -  September 30, 2019",Molecular diagnosis and outcome prediction in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Da Wei  Huang|Weihong  Xu|Yandan  Yang; PhD|Wyndham H Wilson; MD, PhD|Mark Jason Roschewski",John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Computational & Systems Biology Branch)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, et al. [28 more authors] (2019). Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood  133, 1313-1324.   https://doi.org/10.1182/blood-2018-09-871418|2. Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, et al. [22 more authors] (2019). Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood  133, 1664-1676.   https://doi.org/10.1182/blood-2018-09-872549|3. Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu F, Ordóñez GR, Rovira J, Clot G, Royo C, Navarro A, Gonzalez-Farre B, Vaghefi A, Castellano G, Rubio-Perez C, Tamborero D, Briones J, Salar A, Sancho JM, Mercadal S, Gonzalez-Barca E, Escoda L, Miyoshi H, Ohshima K, Miyawaki K, et al. [14 more authors] (2018). Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets. Leukemia  32, 675-684.   https://doi.org/10.1038/leu.2017.251|4. Mottok A, Wright G, Rosenwald A, Ott G, Ramsower C, Campo E, Braziel RM, Delabie J, Weisenburger DD, Song JY, Chan WC, Cook JR, Fu K, Greiner T, Smeland E, Holte H, Savage KJ, Glinsmann-Gibson BJ, Gascoyne RD, Staudt LM, Jaffe ES, Connors JM, Scott DW, Steidl C, Rimsza LM (2018). Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens. Blood  132, 2401-2405.   https://doi.org/10.1182/blood-2018-05-851154|5. Wright GW, Wilson WH, Staudt LM (2018). Genetics of Diffuse Large B-Cell Lymphoma. N Engl J Med  379, 493-494.   https://doi.org/10.1056/NEJMc1806191|6. Zhang JP, Song Z, Wang HB, Lang L, Yang YZ, Xiao W, Webster DE, Wei W, Barta SK, Kadin ME, Staudt LM, Nakagawa M, Yang Y (2019). A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening. Blood  134, 171-185.   https://doi.org/10.1182/blood.2019001043",https://intramural.nih.gov/search/searchview.taf?ipid=108489
213,BC011007-12,"October 01, 2018 -  September 30, 2019",RNA interference-based screens for molecular targets in cancer,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Da Wei  Huang|James Daniel Phelan|Zhuo  Wang|Yandan  Yang; PhD|Ryan Matthew Young|Hong  Zhao,NULL,George W Wright (Computational & Systems Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108490
214,BC011008-12,"October 01, 2018 -  September 30, 2019",Oncogenic mechanisms and molecular targets in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Jae Woo  Choi|Da Wei  Huang|Thomas Michael Oellerich|Arthur L Shaffer|James Q Wang|Weihong  Xu|Show all 11,John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Computational & Systems Biology Branch)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Dadashian EL, McAuley EM, Liu D, Shaffer AL, Young RM, Iyer JR, Kruhlak MJ, Staudt LM, Wiestner A, Herman SEM (2019). TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib. Cancer Res  79, 360-371.   https://doi.org/10.1158/0008-5472.CAN-18-0781",https://intramural.nih.gov/search/searchview.taf?ipid=108487
215,BC011010-12,"October 01, 2018 -  September 30, 2019",Oncogenic mechanisms and molecular targets in myeloma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Ryan Matthew Young,NULL,NULL,NULL,"1. Sikora KA, Bennett JR, Vyncke L, Deng Z, Tsai WL, Pauwels E, Layh-Schmitt G, Brundidge A, Navid F, Zaal KJM, Hanson E, Gadina M, Staudt LM, Griffin TA, Tavernier J, Peelman F, Colbert RA (2018). Germline gain-of-function myeloid differentiation primary response gene-88 (MYD88) mutation in a child with severe arthritis. J Allergy Clin Immunol  141, 1943-1947.e9.   https://doi.org/10.1016/j.jaci.2018.01.027",https://intramural.nih.gov/search/searchview.taf?ipid=108488
216,BC011011-12,"October 01, 2018 -  September 30, 2019",The genome-wide function of supercoiling and alternative DNA conformations,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Fedor Edmundovich Kouzine|Lipeng  Wu|Ying  Zheng|Kenneth Dean Aldape; MD,Laura  Baranello|Sabrina  Leslie (Magill University),Yves  Pommier; PhD (Developmental Therapeutics Branch),Keji  Zhao; PhD (NHLBI) |Teresa M Przytycka (NLM) |Rafael Cristian Casellas; PhD (NIAMS) |Craig Joseph Thomas (NCATS),"1. Scott S, Shaheen C, McGuinness B, Metera K, Kouzine F, Levens D, Benham CJ, Leslie S (2019). Single-molecule visualization of the effects of ionic strength and crowding on structure-mediated interactions in supercoiled DNA molecules. Nucleic Acids Res  47, 6360-6368.   https://doi.org/10.1093/nar/gkz408|2. Scott S, Xu ZM, Kouzine F, Berard DJ, Shaheen C, Gravel B, Saunders L, Hofkirchner A, Leroux C, Laurin J, Levens D, Benham CJ, Leslie SR (2018). Visualizing structure-mediated interactions in supercoiled DNA molecules. Nucleic Acids Res  46, 4622-4631.   https://doi.org/10.1093/nar/gky266|3. Vian L, Pękowska A, Rao SSP, Kieffer-Kwon KR, Jung S, Baranello L, Huang SC, El Khattabi L, Dose M, Pruett N, Sanborn AL, Canela A, Maman Y, Oksanen A, Resch W, Li X, Lee B, Kovalchuk AL, Tang Z, Nelson S, Di Pierro M, Cheng RR, Machol I, St Hilaire BG, Durand NC, et al. [8 more authors] (2018). The Energetics and Physiological Impact of Cohesin Extrusion. Cell  173, 1165-1178.e20.   https://doi.org/10.1016/j.cell.2018.03.072|4. Vian L, Pękowska A, Rao SSP, Kieffer-Kwon KR, Jung S, Baranello L, Huang SC, El Khattabi L, Dose M, Pruett N, Sanborn AL, Canela A, Maman Y, Oksanen A, Resch W, Li X, Lee B, Kovalchuk AL, Tang Z, Nelson S, Di Pierro M, Cheng RR, Machol I, St Hilaire BG, Durand NC, et al. [8 more authors] (2018). The Energetics and Physiological Impact of Cohesin Extrusion. Cell  175, 292-294.   https://doi.org/10.1016/j.cell.2018.09.002",https://intramural.nih.gov/search/searchview.taf?ipid=108519
217,BC011028-12,"October 01, 2018 -  September 30, 2019",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Mark Wayne Ball|Daniel  Crooks|Martin  Lang; PhD|Lindsay A. Middelton|Christopher James Ricketts; PhD|Laura  Schmidt|Show all 11,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108523
218,BC011032-12,"October 01, 2018 -  September 30, 2019",Post-translational modifications of Hsp90,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Genesis Mayliz Rivera-Marquez|Wanping  Xu,"Brian  Blagg (Chemistry, University of Kansas)|Laurence  Pearl (University of Sussex)|Matthias  Mayer (University of Heidelberg)|Marc  Cox (University of Texas at El Paso)|Gabriela X Chiosis|Timothy  Haystead (Duke University)|Show all 11",NULL,Daniel C Masison; PhD (NIDDK),"1. Bachman AB, Keramisanou D, Xu W, Beebe K, Moses MA, Vasantha Kumar MV, Gray G, Noor RE, van der Vaart A, Neckers L, Gelis I (2018). Phosphorylation induced cochaperone unfolding promotes kinase recruitment and client class-specific Hsp90 phosphorylation. Nat Commun  9, 265.   https://doi.org/10.1038/s41467-017-02711-w|2. Sager RA, Woodford MR, Neckers L, Mollapour M (2018). Detecting Posttranslational Modifications of Hsp90. Methods Mol Biol  1709, 209-219.   https://doi.org/10.1007/978-1-4939-7477-1_16|3. Xu W, Beebe K, Chavez JD, Boysen M, Lu Y, Zuehlke AD, Keramisanou D, Trepel JB, Prodromou C, Mayer MP, Bruce JE, Gelis I, Neckers L (2019). Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1. Nat Commun  10, 2574.   https://doi.org/10.1038/s41467-019-10463-y|4. Zuehlke AD, Moses MA, Neckers L (2018). Heat shock protein 90: its inhibition and function. Philos Trans R Soc Lond B Biol Sci  373.   https://doi.org/10.1098/rstb.2016.0527",https://intramural.nih.gov/search/searchview.taf?ipid=108537
219,BC011033-12,"October 01, 2018 -  September 30, 2019",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Sunil  Kaul|Hei Jung  Kim,Satoshi  Ishido (Riken Center for Allergy and Immunology)|James  Drake (NCI),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108471
220,BC011035-12,"October 01, 2018 -  September 30, 2019",Regulation of Exocytosis from Immune Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Sunil  Kaul,NULL,NULL,Katherine Walton Roche; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108470
221,BC011038-12,"October 01, 2018 -  September 30, 2019",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Mark Wayne Ball|Daniel  Crooks|Martin  Lang; PhD|Cristiane  Leite|Lindsay A. Middelton|Christopher James Ricketts; PhD|Show all 11,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)","1. Baba M, Furuya M, Motoshima T, Lang M, Funasaki S, Ma W, Sun HW, Hasumi H, Huang Y, Kato I, Kadomatsu T, Satou Y, Morris N, Karim BO, Ileva L, Kalen JD, Wilan Krisna LA, Hasumi Y, Sugiyama A, Kurahashi R, Nishimoto K, Oyama M, Nagashima Y, Kuroda N, Araki K, et al. [7 more authors] (2019). TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease. Mol Cancer Res  17, 1613-1626.   https://doi.org/10.1158/1541-7786.MCR-18-1235|2. Baiocco JA, Ball MW, Pappajohn AK, Rayn KN, Bratslavsky G, Boyle SL, Linehan WM, Metwalli AR (2019). A comparison of outcomes for standard and multiplex partial nephrectomy in a solitary kidney: The National Cancer Institute experience. Urol Oncol  37, 356.e1-356.e7.   https://doi.org/10.1016/j.urolonc.2019.02.015|3. Callahan CL, Moore L, Lenz P, Linehan WM, Nickerson ML, Rothman N, Purdue MP (2019). Differences in Tumor VHL Mutation and Hypoxia-inducible Factor 2α Expression Between African American and White Patients with Clear Cell Renal Cell Carcinoma. Eur Urol  75, 882-884.   https://doi.org/10.1016/j.eururo.2019.01.001|4. Crooks DR, Maio N, Lane AN, Jarnik M, Higashi RM, Haller RG, Yang Y, Fan TW, Linehan WM, Rouault TA (2018). Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells. J Biol Chem  293, 8297-8311.   https://doi.org/10.1074/jbc.RA118.001885|5. Damayanti NP, Budka JA, Khella HWZ, Ferris MW, Ku SY, Kauffman E, Wood AC, Ahmed K, Chintala VN, Adelaiye-Ogala R, Elbanna M, Orillion A, Chintala S, Kao C, Linehan WM, Yousef GM, Hollenhorst PC, Pili R (2018). Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma. Clin Cancer Res  24, 5977-5989.   https://doi.org/10.1158/1078-0432.CCR-18-0269|6. Hasumi H, Furuya M, Tatsuno K, Yamamoto S, Baba M, Hasumi Y, Isono Y, Suzuki K, Jikuya R, Otake S, Muraoka K, Osaka K, Hayashi N, Makiyama K, Miyoshi Y, Kondo K, Nakaigawa N, Kawahara T, Izumi K, Teranishi J, Yumura Y, Uemura H, Nagashima Y, Metwalli AR, Schmidt LS, et al. [3 more authors] (2018). BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes. Hum Mol Genet  27, 2712-2724.   https://doi.org/10.1093/hmg/ddy181|7. Jha A, Ling A, Millo C, Gupta G, Viana B, Lin FI, Herscovitch P, Adams KT, Taïeb D, Metwalli AR, Linehan WM, Brofferio A, Stratakis CA, Kebebew E, Lodish M, Civelek AC, Pacak K (2018). Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population. Eur J Nucl Med Mol Imaging  45, 787-797.   https://doi.org/10.1007/s00259-017-3896-9|8. Kurahashi R, Kadomatsu T, Baba M, Hara C, Itoh H, Miyata K, Endo M, Morinaga J, Terada K, Araki K, Eto M, Schmidt LS, Kamba T, Linehan WM, Oike Y (2019). MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma. Cancer Sci  110, 1897-1908.   https://doi.org/10.1111/cas.14026|9. Linehan WM, Ricketts CJ (2019). The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol  16, 539-552.   https://doi.org/10.1038/s41585-019-0211-5|10. Rathmell WK, Rathmell JC, Linehan WM (2018) Metabolic Pathways in Kidney Cancer: Current Therapies and Future Directions. J Clin Oncol, in press (e-pub ahead of print)  https://doi.org/10.1200/JCO.2018.79.2309|11. Sager RA, Woodford MR, Backe SJ, Makedon AM, Baker-Williams AJ, DiGregorio BT, Loiselle DR, Haystead TA, Zachara NE, Prodromou C, Bourboulia D, Schmidt LS, Linehan WM, Bratslavsky G, Mollapour M (2019). Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90. Cell Rep  26, 1344-1356.e5.   https://doi.org/10.1016/j.celrep.2019.01.018|12. Sapp JC, Johnston JJ, Driscoll K, Heidlebaugh AR, Miren Sagardia A, Dogbe DN, Umstead KL, Turbitt E, Alevizos I, Baron J, Bönnemann C, Brooks B, Donkervoort S, Jee YH, Linehan WM, McMahon FJ, Moss J, Mullikin JC, Nielsen D, Pelayo E, Remaley AT, Siegel R, Su H, Zarate C, NISC Comparative Sequencing Program, Manolio TA, et al. [2 more authors] (2018). Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing Pilot. Am J Hum Genet  103, 358-366.   https://doi.org/10.1016/j.ajhg.2018.07.018|13. Schmidt LS, Linehan WM (2018). FLCN: The causative gene for Birt-Hogg-Dubé syndrome. Gene  640, 28-42.   https://doi.org/10.1016/j.gene.2017.09.044|14. Tirosh A, Journy N, Folio LR, Lee C, Leite C, Yao J, Kovacs W, Linehan WM, Malayeri A, Kebebew E, Berrington de González A (2019). Cumulative Radiation Exposures from CT Screening and Surveillance Strategies for von Hippel-Lindau-associated Solid Pancreatic Tumors. Radiology  290, 116-124.   https://doi.org/10.1148/radiol.2018180687|15. Tirosh A, Sadowski SM, Linehan WM, Libutti SK, Patel D, Nilubol N, Kebebew E (2018). Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease. JAMA Oncol  4, 124-126.   https://doi.org/10.1001/jamaoncol.2017.3428|16. Vocke CD, Ricketts CJ, Ball MW, Schmidt LS, Metwalli AR, Middelton LA, Killian JK, Khan J, Meltzer PS, Simonds WF, Merino MJ, Linehan WM (2019). CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors. Urology  124, 91-97.   https://doi.org/10.1016/j.urology.2018.11.013|17. Xu Y, Taylor P, Andrade J, Ueberheide B, Shuch B, Glazer PM, Bindra RS, Moran MF, Linehan WM, Neel BG (2018). Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma. Cancer Res  78, 6539-6548.   https://doi.org/10.1158/0008-5472.CAN-18-0901",https://intramural.nih.gov/search/searchview.taf?ipid=108524
222,BC011043-12,"October 01, 2018 -  September 30, 2019",Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Mark Wayne Ball|Daniel  Crooks|Martin  Lang; PhD|Lindsay A. Middelton|Christopher James Ricketts; PhD|Laura  Schmidt|Show all 10,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108520
223,BC011053-12,"October 01, 2018 -  September 30, 2019",TMPRSS2-ERG chromosomal translocations and prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Aian Neil Seno Alilin|Juanjuan  Yin,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108511
224,BC011054-12,"October 01, 2018 -  September 30, 2019",Nuclear Factor-kappaB in Ovarian Cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",David Michael Anderson|Lidia F Hernandez|Yusuke  Shibuya,NULL,George W Wright (Computational & Systems Biology Branch)|Margaret  Cam; PhD (Office of the Director),"Craig Joseph Thomas (NCATS) |Carter  Van Waes; MD, PhD (NIDCD)","1. House CD, Grajales V, Ozaki M, Jordan E, Wubneh H, Kimble DC, James JM, Kim MK, Annunziata CM (2018). IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts. BMC Cancer  18, 595.   https://doi.org/10.1186/s12885-018-4507-2",https://intramural.nih.gov/search/searchview.taf?ipid=108436
225,BC011055-12,"October 01, 2018 -  September 30, 2019",Serum Antibody Profiling with a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Dorothy Leeann Ackerman|Andrew Tyler Delaitsch|Alexander Jacob Bahnick,NULL,"James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Howard A Young; PhD (Cancer Inflammation Program)",NULL,"1. Durbin SV, Wright WS, Gildersleeve JC (2018). Development of a Multiplex Glycan Microarray Assay and Comparative Analysis of Human Serum Anti-Glycan IgA, IgG, and IgM Repertoires. ACS Omega  3, 16882-16891.   https://doi.org/10.1021/acsomega.8b02238|2. Xia L, Gildersleeve JC (2019). Anti-glycan IgM repertoires in newborn human cord blood. PLoS One  14, e0218575.   https://doi.org/10.1371/journal.pone.0218575",https://intramural.nih.gov/search/searchview.taf?ipid=108458
226,BC011058-12,"October 01, 2018 -  September 30, 2019",Development of a Vaccine for HIV-AIDS: Humoral Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Gospel Menakam Enyindah-Asonye|Sabrina  Helmold Hait|Tanya N Hoang|Christopher James Hogge|Ruth Mesfin  Hunegnaw; PhD|Eunju  Ko; PhD|Show all 11,"David C Montefiori; PhD (Department of Surgery, NIAID)|Susan  Zolla-Pazner (NYU Med School)|miroslaw  gorny; PhD (NYU Medical School)|Galit  Alter; PhD (Division of Medical Sciences, Harvard Medical School)|Margaret  Ackerman (Dartmouth University)",David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Enyindah-Asonye G, Nwankwo A, Hogge C, Rahman MA, Helmold Hait S, Hunegnaw R, Ko EJ, Hoang T, Venzon DJ, Robert-Guroff M (2019). A Pathogenic Role for Splenic B1 Cells in SIV Disease Progression in Rhesus Macaques. Front Immunol  10, 511.   https://doi.org/10.3389/fimmu.2019.00511|2. Lewis GK, Ackerman ME, Scarlatti G, Moog C, Robert-Guroff M, Kent SJ, Overbaugh J, Reeves RK, Ferrari G, Thyagarajan B (2019). Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1. Front Immunol  10, 1025.   https://doi.org/10.3389/fimmu.2019.01025|3. Miller-Novak LK, Das J, Musich TA, Demberg T, Weiner JA, Venzon DJ, Mohanram V, Vargas-Inchaustegui DA, Tuero I, Ackerman ME, Alter G, Robert-Guroff M (2018). Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques. J Virol  92.   https://doi.org/10.1128/JVI.00721-18",https://intramural.nih.gov/search/searchview.taf?ipid=108468
227,BC011061-12,"October 01, 2018 -  September 30, 2019",Computational and Experimental RNA Nanobiology,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Eckart  Bindewald|Eric Alexander Fields|Kazimierz Wojcieck Kasprzak|Tae Jin  Kim|Hannah Olympia Prensky|Anu  Puri; PhD|Show all 8,Eliahu  Heldman|Kirill Andreevich Afonin|Kshitij  Gupta|Christopher  Jewell (University of Maryland)|Johnathan  Lovell (University of Buffalo),Marina A Dobrovolskaia (Cancer Imaging Program)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Stephen J Lockett; PhD (Office Of The Director)|Joost J Oppenheim; MD (Cancer Inflammation Program)|Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling),NULL,"1. Puri A, Viard M, Zakrevsky P, Parlea L, Singh K, Shapiro B (2018) Alliance of Lipids with siRNA, in Molecular Medicines for Cancer: Concepts and Applications of Nanotechnology, in press.|2. Lu JS, Bindewald E, Kasprzak WK, Shapiro BA (2018). RiboSketch: versatile visualization of multi-stranded RNA and DNA secondary structure. Bioinformatics  34, 4297-4299.   https://doi.org/10.1093/bioinformatics/bty468|3. Sajja S, Chandler M, Fedorov D, Kasprzak WK, Lushnikov A, Viard M, Shah A, Dang D, Dahl J, Worku B, Dobrovolskaia MA, Krasnoslobodtsev A, Shapiro BA, Afonin KA (2018). Dynamic Behavior of RNA Nanoparticles Analyzed by AFM on a Mica/Air Interface. Langmuir  34, 15099-15108.   https://doi.org/10.1021/acs.langmuir.8b00105|4. Zakrevsky P, Bindewald E, Humbertson H, Viard M, Dorjsuren N, Shapiro BA (2019). A Suite of Therapeutically-Inspired Nucleic Acid Logic Systems for Conditional Generation of Single-Stranded and Double-Stranded Oligonucleotides. Nanomaterials (Basel)  9.   https://doi.org/10.3390/nano9040615",https://intramural.nih.gov/search/searchview.taf?ipid=108477
228,BC011062-12,"October 01, 2018 -  September 30, 2019",Development of a Vaccine for HIV-AIDS: Cellular Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Gospel Menakam Enyindah-Asonye|Sabrina  Helmold Hait|Tanya N Hoang|Christopher James Hogge|Ruth Mesfin  Hunegnaw; PhD|Eunju  Ko; PhD|Show all 7,NULL,David J Venzon; PhD (Biostatistics and Data Management Section)|David Allan Ball (Laboratory of Receptor Biology and Gene Expression)|Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Hunegnaw R, Mushtaq Z, Enyindah-Asonye G, Hoang T, Robert-Guroff M (2019). Alveolar Macrophage Dysfunction and Increased PD-1 Expression During Chronic SIV Infection of Rhesus Macaques. Front Immunol  10, 1537.   https://doi.org/10.3389/fimmu.2019.01537|2. Ko EJ, Helmold Hait S, Enyindah-Asonye G, Rahman MA, Hoang T, Robert-Guroff M (2019). Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses. Front Immunol  10, 779.   https://doi.org/10.3389/fimmu.2019.00779",https://intramural.nih.gov/search/searchview.taf?ipid=108469
229,BC011063-12,"October 01, 2018 -  September 30, 2019",Development of a Vaccine for HIV-AIDS: Translation to the Clinic,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Gospel Menakam Enyindah-Asonye|Sabrina  Helmold Hait|Tanya N Hoang|Christopher James Hogge|Ruth Mesfin  Hunegnaw; PhD|Eunju  Ko; PhD|Show all 12,"Michael  Thomas (Howard University)|Margaret  Ackerman (Dartmouth University)|Galit  Alter; PhD (Division of Medical Sciences, Harvard Medical School)|Mark  Cameron (Case Western Reserve University)|Slim  Fourati (Assistance Publique)|David C Montefiori; PhD (Department of Surgery, NIAID)|Show all 7","Ettore  Appella; MD (Laboratory of Cell Biology)|Brandon Frank Keele (Office Of The Director)|Jennifer Clare Jones; MD, PhD (Laboratory of Pathology)|Colm  Ohuigin (Cancer Inflammation Program)|David J Venzon; PhD (Biostatistics and Data Management Section)",Mark  Connors; MD (NIAID) |Daniel  Appella; PhD (NIDDK),"1. Plank-Bazinet JL, Sampson A, Kornstein SG, Germino GG, Robert-Guroff M, Gilman SE, Wetherington CL, Cook N, Cornelison TL, Begg L, Clayton JA (2018). A Report of the 24th Annual Congress on Women's Health-Workshop on Transforming Women's Health: From Research to Practice. J Womens Health (Larchmt)  27, 115-120.   https://doi.org/10.1089/jwh.2017.29016.orwh|2. Rahman MA, Robert-Guroff M (2019). Accelerating HIV vaccine development using non-human primate models. Expert Rev Vaccines  18, 61-73.   https://doi.org/10.1080/14760584.2019.1557521",https://intramural.nih.gov/search/searchview.taf?ipid=108467
230,BC011064-12,"October 01, 2018 -  September 30, 2019",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Ke  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108534
231,BC011065-12,"October 01, 2018 -  September 30, 2019","Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)",Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Snehal Mahendra Gaikwad|Nana Abena Gyabaah-Kessie|Vincent Keith Hughitt|Tyler John Peat|Ke  Zhang|Shuling  Zhang; MD, PhD|Show all 8",Vinod  Ravi (Md Anderson Cancer Center)|Jing  Zhang (U Of Wisconsin)|Ola Anders Landgren,John Stephen Schneekloth (Chemical Biology Laboratory)|Anish  Thomas; MD (Developmental Therapeutics Branch)|Haobin  Chen (Thoracic & Oncologic Surgery Branch)|Kyung  Lee; PhD (Laboratory of Metabolism),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108535
232,BC011070-12,"October 01, 2018 -  September 30, 2019",Hematopathology Diagnosis,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Jinjun  Cheng|Theresa M Davies Hill|Princess Yah Dorley|Ivo  Francischetti; MD, PhD|Pallavi Kanwar  Galera|Gaurav Kumar Gupta; MD, PhD|Show all 11",NULL,"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)",Jeffrey  Cohen; MD (NIAID),"1. Clot G, Jares P, Giné E, Navarro A, Royo C, Pinyol M, Martín-Garcia D, Demajo S, Espinet B, Salar A, Ferrer A, Muntañola A, Aymerich M, Rauert-Wunderlich H, Jaffe ES, Connors JM, Gascoyne RD, Delabie J, López-Guillermo A, Ott G, Wright GW, Staudt LM, Rosenwald A, Scott DW, Rimsza LM, et al. [2 more authors] (2018). A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome. Blood  132, 413-422.   https://doi.org/10.1182/blood-2018-03-838136|2. Cohen JI, Manoli I, Dowdell K, Krogmann TA, Tamura D, Radecki P, Bu W, Turk SP, Liepshutz K, Hornung RL, Fassihi H, Sarkany RP, Bonnycastle LL, Chines PS, Swift AJ, Myers TG, Levoska MA, DiGiovanna JJ, Collins FS, Kraemer KH, Pittaluga S, Jaffe ES (2019). Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites. Blood  133, 2753-2764.   https://doi.org/10.1182/blood.2018893750|3. Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH (2018). Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. Lancet Haematol  5, e609-e617.   https://doi.org/10.1016/S2352-3026(18)30177-7|4. Egan C, Jaffe ES (2018). Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes. Semin Diagn Pathol  35, 20-33.   https://doi.org/10.1053/j.semdp.2017.11.002|5. Gupta GK, Xi L, Pack SD, Jones JB, Pittaluga S, Raffeld M, Jaffe ES (2019). ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female. Haematologica  104, e534-e536.   https://doi.org/10.3324/haematol.2019.230094|6. Jaffe ES (2019). Diagnosis and classification of lymphoma: Impact of technical advances. Semin Hematol  56, 30-36.   https://doi.org/10.1053/j.seminhematol.2018.05.007|7. Jaffe ES, Quintanilla-Martinez L (2018). t(14;18)-positive B cells: is it seed or soil? Blood  132, 1631-1632.   https://doi.org/10.1182/blood-2018-09-872077|8. Lai C, Roschewski M, Melani C, Pittaluga S, Shovlin M, Steinberg SM, Dunleavy K, Pack S, Jaffe ES, Wilson WH (2018). MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R. Leuk Lymphoma  59, 505-508.   https://doi.org/10.1080/10428194.2017.1339882|9. Li Y, Gupta G, Molofsky A, Xie Y, Shihabi N, McCormick J, Jaffe ES (2018). B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients. Am J Surg Pathol  42, 269-276.   https://doi.org/10.1097/PAS.0000000000000982|10. Marshall VA, Labo N, Hao XP, Holdridge B, Thompson M, Miley W, Brands C, Coalter V, Kiser R, Anver M, Golubeva Y, Warner A, Jaffe ES, Piatak M, Wong SW, Ohlen C, MacAllister R, Smedley J, Deleage C, Del Prete GQ, Lifson JD, Estes JD, Whitby D (2018). Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV. PLoS Pathog  14, e1007130.   https://doi.org/10.1371/journal.ppat.1007130|11. Martín-Garcia D, Navarro A, Valdés-Mas R, Clot G, Gutiérrez-Abril J, Prieto M, Ribera-Cortada I, Woroniecka R, Rymkiewicz G, Bens S, de Leval L, Rosenwald A, Ferry JA, Hsi ED, Fu K, Delabie J, Weisenburger D, de Jong D, Climent F, O'Connor SJ, Swerdlow SH, Torrents D, Beltran S, Espinet B, González-Farré B, et al. [12 more authors] (2019). CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma. Blood  133, 940-951.   https://doi.org/10.1182/blood-2018-07-862151|12. Melani C, Advani R, Roschewski M, Walters KM, Chen CC, Baratto L, Ahlman MA, Miljkovic MD, Steinberg SM, Lam J, Shovlin M, Dunleavy K, Pittaluga S, Jaffe ES, Wilson WH (2018). End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making. Haematologica  103, 1337-1344.   https://doi.org/10.3324/haematol.2018.192492|13. Natkunam Y, Gratzinger D, Chadburn A, Goodlad JR, Chan JKC, Said J, Jaffe ES, de Jong D (2018). Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood  132, 1871-1878.   https://doi.org/10.1182/blood-2018-04-842559|14. Perry AM, Bailey NG, Bonnett M, Jaffe ES, Chan WC (2019). Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract. Int J Surg Pathol  27, 102-107.   https://doi.org/10.1177/1066896918785985|15. Raess PW, Wang HW, Pack SD, Jaffe ES (2019). CD30+ large B cell lymphoma with anaplastic features and complete loss of B cell marker expression arising from follicular lymphoma. Histopathology  75, 602-605.   https://doi.org/10.1111/his.13919|16. Roswarski J, Roschewski M, Lucas A, Melani C, Pittaluga S, Jaffe ES, Steinberg SM, Waldmann TA, Wilson WH (2018). Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas. Leuk Lymphoma  59, 1466-1469.   https://doi.org/10.1080/10428194.2017.1387908|17. Roswarski J, Roschewski M, Melani C, Pittaluga S, Lucas A, Steinberg SM, Jaffe ES, Waldmann TA, Wilson WH (2019). Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas. Leuk Lymphoma  60, 2062-2066.   https://doi.org/10.1080/10428194.2018.1562184|18. Schmidt J, Ramis-Zaldivar JE, Bonzheim I, Steinhilber J, Müller I, Haake A, Yu SC, Raffeld M, Fend F, Salaverria I, Siebert R, Jaffe ES, Quintanilla-Martinez L (2018). CREBBP gene mutations are frequently detected in in situ follicular neoplasia. Blood  132, 2687-2690.   https://doi.org/10.1182/blood-2018-03-837039|19. van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, et al. [17 more authors] (2018). International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood  132, 2115-2124.   https://doi.org/10.1182/blood-2018-07-862334|20. Wagener R, López C, Kleinheinz K, Bausinger J, Aukema SM, Nagel I, Toprak UH, Seufert J, Altmüller J, Thiele H, Schneider C, Kolarova J, Park J, Hübschmann D, Murga Penas EM, Drexler HG, Attarbaschi A, Hovland R, Kjeldsen E, Kneba M, Kontny U, de Leval L, Nürnberg P, Oschlies I, Oscier D, et al. [9 more authors] (2018). IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. Blood  132, 2280-2285.   https://doi.org/10.1182/blood-2018-03-842088|21. Wagener R, Seufert J, Raimondi F, Bens S, Kleinheinz K, Nagel I, Altmüller J, Thiele H, Hübschmann D, Kohler CW, Nürnberg P, Au-Yeung R, Burkhardt B, Horn H, Leoncini L, Jaffe ES, Ott G, Rymkiewicz G, Schlesner M, Russell RB, Klapper W, Siebert R (2019). The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Blood  133, 962-966.   https://doi.org/10.1182/blood-2018-07-864025|22. Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES (2019). The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood  133, 1703-1714.   https://doi.org/10.1182/blood-2018-11-881268|23. Wu D, Lim MS, Jaffe ES (2018). Pathology of Castleman Disease. Hematol Oncol Clin North Am  32, 37-52.   https://doi.org/10.1016/j.hoc.2017.09.004",https://intramural.nih.gov/search/searchview.taf?ipid=108510
233,BC011078-12,"October 01, 2018 -  September 30, 2019",Phase 0-1 Clinical Trials,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Agnes  Juhasz|Yves  Pommier; PhD|Anish  Thomas; MD,Edward  Newman (City of Hope Comprehensive Cancer Center)|Shivaani  Kummar (Stanford University School of Medicine),"Ralph  Parchment (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)|Amy Kathleen Leblanc; DVM (Molecular Imaging Program)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)",NULL,"1. Baker RG, Hoos AX, Adam SJ, Wholley D, Doroshow JH, Lowy DR, Tabak LA, Collins FS (2018). The Partnership for Accelerating Cancer Therapies. Cancer J  24, 111-114.   https://doi.org/10.1097/PPO.0000000000000321|2. Doroshow DB, Doroshow JH (2019). From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development. Cancer J  25, 245-253.   https://doi.org/10.1097/PPO.0000000000000386|3. Doroshow JH (2019). Introduction by the Guest Editor: Oncologic Precision Medicine and the Use of Basket and Umbrella Clinical Trials. Cancer J  25, 243-244.   https://doi.org/10.1097/PPO.0000000000000394|4. Meehan R, Kummar S, Do K, O'Sullivan Coyne G, Juwara L, Zlott J, Rubinstein L, Doroshow JH, Chen AP (2018). A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and Sarcomas. Oncologist  23, 1269-e125.   https://doi.org/10.1634/theoncologist.2018-0203|5. Monks A, Zhao Y, Hose C, Hamed H, Krushkal J, Fang J, Sonkin D, Palmisano A, Polley EC, Fogli LK, Konaté MM, Miller SB, Simpson MA, Voth AR, Li MC, Harris E, Wu X, Connelly JW, Rapisarda A, Teicher BA, Simon R, Doroshow JH (2018). The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel. Cancer Res  78, 6807-6817.   https://doi.org/10.1158/0008-5472.CAN-18-0989|6. Pommier Y, Cushman M, Doroshow JH (2018). Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins. Oncotarget  9, 37286-37288.   https://doi.org/10.18632/oncotarget.26466|7. Speranza G, Anderson L, Chen AP, Do K, Eugeni M, Weil M, Rubinstein L, Majerova E, Collins J, Horneffer Y, Juwara L, Zlott J, Bishop R, Conley BA, Streicher H, Tomaszewski J, Doroshow JH, Kummar S (2018). First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile. Invest New Drugs  36, 230-239.   https://doi.org/10.1007/s10637-017-0495-3|8. Takebe N, Beumer JH, Kummar S, Kiesel BF, Dowlati A, O'Sullivan Coyne G, Piekarz R, Rubinstein L, Fogli LK, Vaishampayan U, Goel S, O'Bryant CL, El-Rayes BF, Chung V, Lenz HJ, Kim R, Belani CP, Tuscano JM, Schelman W, Moore N, Doroshow JH, Chen AP (2019). A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction. Br J Clin Pharmacol  85, 2499-2511.   https://doi.org/10.1111/bcp.14054|9. Wilsker DF, Barrett AM, Dull AB, Lawrence SM, Hollingshead MG, Chen A, Kummar S, Parchment RE, Doroshow JH, Kinders RJ (2019). Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage Markers. Clin Cancer Res  25, 3084-3095.   https://doi.org/10.1158/1078-0432.CCR-18-2523|10. Xia F, Shukla M, Brettin T, Garcia-Cardona C, Cohn J, Allen JE, Maslov S, Holbeck SL, Doroshow JH, Evrard YA, Stahlberg EA, Stevens RL (2018). Predicting tumor cell line response to drug pairs with deep learning. BMC Bioinformatics  19, 486.   https://doi.org/10.1186/s12859-018-2509-3",https://intramural.nih.gov/search/searchview.taf?ipid=108449
234,BC011081-12,"October 01, 2018 -  September 30, 2019",Prostate Section,Peter A Pinto; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Lisa Frances Mowell|Luis Manuel Nunez|Charlotte Sophronia Payne|Nana  Yaqub-Ogun|Donald P Bottaro; PhD|Leonard  Neckers; PhD|Show all 7,Arul Moli Chinnaiyan|Mohummad Minhaj Siddiqui,Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Alan  Rein; PhD (Retroviral Replication Laboratory)|Deborah E Citrin (Radiation Oncology Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch),Sheng  Xu (CC),"1. Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, et al. [45 more authors] (2018). Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol  36, 414-424.   https://doi.org/10.1200/JCO.2017.74.1173",https://intramural.nih.gov/search/searchview.taf?ipid=108542
235,BC011090-12,"October 01, 2018 -  September 30, 2019",Molecular biology of human polyomaviruses,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Anna Katherine Belford|Diana  Pastrana|Mary Louise Piaskowski|Michael Joseph Tisza,Jianxin  You (U Penn)|Ellen  Cahir-McFarland (Biogen),NULL,Alison Anne McBride; PhD (NIAID),"1. Becker M, Dominguez M, Greune L, Soria-Martinez L, Pfleiderer MM, Schowalter R, Buck CB, Blaum BS, Schmidt MA, Schelhaas M (2019). Infectious Entry of Merkel Cell Polyomavirus. J Virol  93.   https://doi.org/10.1128/JVI.02004-18|2. Liu W, Krump NA, Buck CB, You J (2019). Merkel Cell Polyomavirus Infection and Detection. J Vis Exp  .  https://doi.org/10.3791/58950|3. McDermott DH, Pastrana DV, Calvo KR, Pittaluga S, Velez D, Cho E, Liu Q, Trout HH, Neves JF, Gardner PJ, Bianchi DA, Blair EA, Landon EM, Silva SL, Buck CB, Murphy PM (2019). Plerixafor for the Treatment of WHIM Syndrome. N Engl J Med  380, 163-170.   https://doi.org/10.1056/NEJMoa1808575",https://intramural.nih.gov/search/searchview.taf?ipid=108442
236,BC011091-12,"October 01, 2018 -  September 30, 2019",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|Arthur A Glatfelter; MS|John E Lueders|Marbin A Pineda|Robert L Walker; BS|Fan  Yang|Show all 10",Albert  Fornace Jr (Georgetown University)|Jerry  Shay (UT Southwestern)|Electron  Kebebew; MD,"Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Sharon Ann Savage (Clinical Genetics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Sheueyann  Cheng; PhD (Gene Regulation Section)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)",Leslie Glenn Biesecker; MD (NHGRI),"1. Ciftci-Yilmaz S, Au WC, Mishra PK, Eisenstatt JR, Chang J, Dawson AR, Zhu I, Rahman M, Bilke S, Costanzo M, Baryshnikova A, Myers CL, Meltzer PS, Landsman D, Baker RE, Boone C, Basrai MA (2018). A Genome-Wide Screen Reveals a Role for the HIR Histone Chaperone Complex in Preventing Mislocalization of Budding Yeast CENP-A. Genetics  210, 203-218.   https://doi.org/10.1534/genetics.118.301305|2. Kouprina N, Liskovykh M, Lee NCO, Noskov VN, Waterfall JJ, Walker RL, Meltzer PS, Topol EJ, Larionov V (2018). Analysis of the 9p21.3 sequence associated with coronary artery disease reveals a tendency for duplication in a CAD patient. Oncotarget  9, 15275-15291.   https://doi.org/10.18632/oncotarget.24567|3. Lee JS, Das A, Jerby-Arnon L, Arafeh R, Auslander N, Davidson M, McGarry L, James D, Amzallag A, Park SG, Cheng K, Robinson W, Atias D, Stossel C, Buzhor E, Stein G, Waterfall JJ, Meltzer PS, Golan T, Hannenhalli S, Gottlieb E, Benes CH, Samuels Y, Shanks E, Ruppin E (2018). Harnessing synthetic lethality to predict the response to cancer treatment. Nat Commun  9, 2546.   https://doi.org/10.1038/s41467-018-04647-1|4. Moreno-Smith M, Halder JB, Meltzer PS, Gonda TA, Mangala LS, Rupaimoole R, Lu C, Nagaraja AS, Gharpure KM, Kang Y, Rodriguez-Aguayo C, Vivas-Mejia PE, Zand B, Schmandt R, Wang H, Langley RR, Jennings NB, Ivan C, Coffin JE, Armaiz GN, Bottsford-Miller J, Kim SB, Halleck MS, Hendrix MJ, Bornman W, et al. [5 more authors] (2018). ATP11B mediates platinum resistance in ovarian cancer. J Clin Invest  128, 3199.   https://doi.org/10.1172/JCI122301|5. Quan XX, Hawk NV, Chen W, Coupar J, Lee SK, Petersen DW, Meltzer PS, Montemarano A, Braun M, Chen Z, Van Waes C (2018). Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133+ Skin Cancer Stem Cells. Mol Cancer Ther  17, 2034-2048.   https://doi.org/10.1158/1535-7163.MCT-17-0421",https://intramural.nih.gov/search/searchview.taf?ipid=108531
237,BC011095-12,"October 01, 2018 -  September 30, 2019",Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Molly Marie Lee|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD","Irmgard  Irminger (Clinical Development, University Hospitals Geneva HUG)|Brian M Shuch|Jean-Baptiste  Lattouf|Paul  Dent (Virginia Commonwealth University)|Ching-Shih  Chen (The Ohio State University)","Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108440
238,BC011106-12,"October 01, 2018 -  September 30, 2019",Specification of T cell function during development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Jennifer Marie Ashe|Mohamedelsherif G Gadelhaq Badr|Abhisek  Bhattacharya; PhD|Terry I Guinter|Yasuko Mary Mano|Show all 11,"Batu M Erman|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)",NULL,"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108485
239,BC011107-12,"October 01, 2018 -  September 30, 2019",Role of Protein Scaffolds in RTK-Ras-dependent Signal Transduction,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Daniel A Ritt|Elizabeth Mclean Terrell|Christopher John Westlake; PhD,NULL,Peter F Johnson; PhD (Mouse Cancer Genetics Program),NULL,"1. Basu SK, Lee S, Salotti J, Basu S, Sakchaisri K, Xiao Z, Walia V, Westlake CJ, Morrison DK, Johnson PF (2018). Oncogenic RAS-Induced Perinuclear Signaling Complexes Requiring KSR1 Regulate Signal Transmission to Downstream Targets. Cancer Res  78, 891-908.   https://doi.org/10.1158/0008-5472.CAN-17-2353|2. Kota P, Terrell EM, Ritt DA, Insinna C, Westlake CJ, Morrison DK (2019). M-Ras/Shoc2 signaling modulates E-cadherin turnover and cell-cell adhesion during collective cell migration. Proc Natl Acad Sci U S A  116, 3536-3545.   https://doi.org/10.1073/pnas.1805919116",https://intramural.nih.gov/search/searchview.taf?ipid=108536
240,BC011109-12,"October 01, 2018 -  September 30, 2019",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD,Arun  Ghosh|Kenji  Maeda (National Center For Global Health And Medicine)|Shigeyoshi  Harada|Matsuda  Koki (National Center For Global Health & Medicine)|Hirotomo  Nakata|Kazuhisa  Yoshimura (National Institute Of Infectious Diseases),NULL,NULL,"1. Nakata H, Maeda K, Das D, Chang SB, Matsuda K, Rao KV, Harada S, Yoshimura K, Ghosh AK, Mitsuya H (2019). Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s. Sci Rep  9, 4828.   https://doi.org/10.1038/s41598-019-41080-w",https://intramural.nih.gov/search/searchview.taf?ipid=108533
241,BC011111-12,"October 01, 2018 -  September 30, 2019",Cytokine signaling in developing thymocytes and T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Jennifer Marie Ashe|Mohamedelsherif G Gadelhaq Badr|Abhisek  Bhattacharya; PhD|Terry I Guinter|Yasuko Mary Mano|Show all 12,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108486
242,BC011112-12,"October 01, 2018 -  September 30, 2019",Development and function of regulatory T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Jennifer Marie Ashe|Mohamedelsherif G Gadelhaq Badr|Abhisek  Bhattacharya; PhD|Terry I Guinter|Yasuko Mary Mano|Show all 12,NULL,Naomi  Taylor (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108482
243,BC011113-12,"October 01, 2018 -  September 30, 2019",T cell survival,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Jennifer Marie Ashe|Mohamedelsherif G Gadelhaq Badr|Abhisek  Bhattacharya; PhD|Terry I Guinter|Yasuko Mary Mano|Show all 12,NULL,Naomi  Taylor (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108483
244,BC011114-12,"October 01, 2018 -  September 30, 2019",Role of microRNAs in T cell development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Jennifer Marie Ashe|Mohamedelsherif G Gadelhaq Badr|Abhisek  Bhattacharya; PhD|Terry I Guinter|Yasuko Mary Mano|Show all 11,NULL,NULL,"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108484
245,BC011115-12,"October 01, 2018 -  September 30, 2019",Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Julie A Hong|Yi  Liu; PhD|Vivek  Shukla; BSc, MSc|Sichuan  Xi|Mary R Zhang","Xinmin  Li (Functional Genomics, University of Chicago)|Raphael  Bueno (Brigham and Women's Hosp)|David  Beer (Thoracic Surgery, University of Michigan)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)",NULL,"1. Xi S, Payabyab EC, Straughan DM, Reardon ES, Zhang M, Hong JA, Ripley RT, Hoang CD, Schrump DS (2018). Asbestos Induces Epigenetic Repression of Ras Association Domain-Containing Protein 1, p16 Kinase 4a Inhibitor, and p14 Alternative Reading Frame in Normal Human Mesothelial Cells. Ann Am Thorac Soc  15, S123.   https://doi.org/10.1513/AnnalsATS.201707-609MG|2. Xiong Y, Xi S, Shan J, Hekimoglu E, Hsiao SH, Zhang M, Hong JA, Tao C, Chen H, Ripley RT, Hoang CD, Schrump DS (2018). Epigenomic Alterations and Gene Expression Profiles in Human Respiratory Epithelial Cells Mediated by Hookah and Cigarette Smoke. Ann Am Thorac Soc  15, S124-S125.   https://doi.org/10.1513/AnnalsATS.201707-611MG",https://intramural.nih.gov/search/searchview.taf?ipid=108476
246,BC011116-12,"October 01, 2018 -  September 30, 2019",MHC-independent T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Jennifer Marie Ashe|Mohamedelsherif G Gadelhaq Badr|Abhisek  Bhattacharya; PhD|Terry I Guinter|Yasuko Mary Mano|Show all 12,Batu M Erman|Gunter  Bernhardt (Hannover Medical School),NULL,NULL,"1. Gegonne A, Chen QR, Dey A, Etzensperger R, Tai X, Singer A, Meerzaman D, Ozato K, Singer DS (2018). Immature CD8 Single-Positive Thymocytes Are a Molecularly Distinct Subpopulation, Selectively Dependent on BRD4 for Their Differentiation. Cell Rep  24, 117-129.   https://doi.org/10.1016/j.celrep.2018.06.007|2. Hong J, Ge C, Jothikumar P, Yuan Z, Liu B, Bai K, Li K, Rittase W, Shinzawa M, Zhang Y, Palin A, Love P, Yu X, Salaita K, Evavold BD, Singer A, Zhu C (2018). A TCR mechanotransduction signaling loop induces negative selection in the thymus. Nat Immunol  19, 1379-1390.   https://doi.org/10.1038/s41590-018-0259-z|3. Kadakia T, Tai X, Kruhlak M, Wisniewski J, Hwang IY, Roy S, Guinter TI, Alag A, Kehrl JH, Zhuang Y, Singer A (2019). E-protein-regulated expression of CXCR4 adheres preselection thymocytes to the thymic cortex. J Exp Med  216, 1749-1761.   https://doi.org/10.1084/jem.20182285|4. Kimura MY, Igi A, Hayashizaki K, Mita Y, Shinzawa M, Kadakia T, Endo Y, Ogawa S, Yagi R, Motohashi S, Singer A, Nakayama T (2018). CD69 prevents PLZFhi innate precursors from prematurely exiting the thymus and aborting NKT2 cell differentiation. Nat Commun  9, 3749.   https://doi.org/10.1038/s41467-018-06283-1|5. Lu J, Van Laethem F, Bhattacharya A, Craveiro M, Saba I, Chu J, Love NC, Tikhonova A, Radaev S, Sun X, Ko A, Arnon T, Shifrut E, Friedman N, Weng NP, Singer A, Sun PD (2019). Molecular constraints on CDR3 for thymic selection of MHC-restricted TCRs from a random pre-selection repertoire. Nat Commun  10, 1019.   https://doi.org/10.1038/s41467-019-08906-7",https://intramural.nih.gov/search/searchview.taf?ipid=108480
247,BC011117-12,"October 01, 2018 -  September 30, 2019",T cell receptor regulation of cytokine signaling,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|Jennifer Marie Ashe|Mohamedelsherif G Gadelhaq Badr|Abhisek  Bhattacharya; PhD|Terry I Guinter|Yasuko Mary Mano|Show all 11,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108481
248,BC011118-12,"October 01, 2018 -  September 30, 2019",Role of Shh in developmental patterning and growth of digit skeleton,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Rashmi  Patel|Jianjian  Zhu,"Steve  Vokes (U. Texas, Austin)|Brian  Harfe; PhD (Molecular Genetics and Microbiology, University of Florida)",Stephen J Lockett; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108528
249,BC011119-12,"October 01, 2018 -  September 30, 2019",Hoxd and Gli3-Hoxd interaction roles in Hedgehog regulated digit morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Rashmi  Patel|Jianjian  Zhu,"Makoto  Taketo (Orthopedics, Kyoto University)|Steve  Vokes (U. Texas, Austin)|Marian  Ros; PhD (Universidad de Cantabria)|H  Stadler (Shriner's Hospital For Children, Oregon Health & Science University)","Martin John Schnermann; PhD (Chemical Biology Laboratory)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Mark B Lewandoski (Genetics of Vertebrate Development Section)","Richa  Agarwala; BTech, MS, PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108529
250,BC011120-12,"October 01, 2018 -  September 30, 2019",Genome-wide target analysis of Shh-activated transcription network in limb bud,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Rashmi  Patel|Jianjian  Zhu,"Steve  Vokes (U. Texas, Austin)|Marian  Ros; PhD (Universidad de Cantabria)|H  Stadler (Shriner's Hospital For Children, Oregon Health & Science University)","Sean Richard Davis; MD, PhD (Cancer Genetics Branch)","Richa  Agarwala; BTech, MS, PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108526
251,BC011121-12,"October 01, 2018 -  September 30, 2019",Role of Brachyury in regulating notochord development and neoplasia,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Jianjian  Zhu,NULL,Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108527
252,BC011124-12,"October 01, 2018 -  September 30, 2019",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Dinuka Mihirani de Silva; PhD|Molly Marie Lee|Arpita Avijit Roy; PhD|Cathy  Vocke; PhD|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD|Show all 8","Angela  Coxon (Amgen)|Regina  Day (NCI)|Irmgard  Irminger (Clinical Development, University Hospitals Geneva HUG)|Anne-Marie  Martin (GlaxoSmithKline)|Freidmann  Muller (Curacyte AG)|Andreas  van de Locht (Department of Pathology, Curacyte AG)|Show all 15","Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Melinda  Hollingshead (Biological Testing Branch)|Gary Leonard Griffiths; BSc, PhD (Molecular Imaging Program)|Ralph  Parchment (Office of the Director)",Rolf Eric Swenson; PhD (NHLBI),"1. Msaouel P, Hong AL, Mullen EA, Atkins MB, Walker CL, Lee CH, Carden MA, Genovese G, Linehan WM, Rao P, Merino MJ, Grodman H, Dome JS, Fernandez CV, Geller JI, Apolo AB, Daw NC, Hodges HC, Moxey-Mims M, Wei D, Bottaro DP, Staehler M, Karam JA, Rathmell WK, Tannir NM (2019). Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. Clin Genitourin Cancer  17, 1-6.   https://doi.org/10.1016/j.clgc.2018.09.005|2. Navas T, Pfister TD, Colantonio S, Aziz A, Dieckman L, Saul RG, Kaczmarczyk J, Borgel S, Alcoser SY, Hollingshead MG, Lee YH, Bottaro DP, Hiltke T, Whiteley G, Takebe N, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH (2018). Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. PLoS One  13, e0199361.   https://doi.org/10.1371/journal.pone.0199361|3. Srivastava AK, Hollingshead MG, Govindharajulu JP, Covey JM, Liston D, Simpson MA, Peggins JO, Bottaro DP, Wright JJ, Kinders RJ, Doroshow JH, Parchment RE (2018). Molecular Pharmacodynamics-Guided Scheduling of Biologically Effective Doses: A Drug Development Paradigm Applied to MET Tyrosine Kinase Inhibitors. Mol Cancer Ther  17, 698-709.   https://doi.org/10.1158/1535-7163.MCT-17-0552",https://intramural.nih.gov/search/searchview.taf?ipid=108441
253,BC011126-12,"October 01, 2018 -  September 30, 2019",Development of rationally designed HIV vaccines,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Massimiliano  Bissa; MBA|Melvin Nelson Doster|Veronica  Galli|Ramona  Moles|Luca  Schifanella|Isabela  Silva De Castro|Show all 12,"Donald  Forthal (School of Medicine, Univ of CA)|Chris  Miller; MS|Guido  Ferrari (Duke University)|Rafick  Sekaly; PhD (Vaccine & Gene Therapy Institute)|Elias  Haddad (VGTI-Florida)|Georgia Doris Tomaras; PhD|Show all 18",Brandon Frank Keele (Office Of The Director)|David J Venzon; PhD (Biostatistics and Data Management Section)|Giorgio  Trinchieri (Cancer Inflammation Program)|Margaret  Cam; PhD (Office of the Director)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|John Anthony McCulloch; PhD (Cancer Inflammation Program),Nancy R Miller (NIAID) |Steven J Jacobson; PhD (NINDS) |Mario  Roederer; PhD (NIAID) |Richard A Koup; MD (NIAID) |James  Arthos; PhD (NIAID) |Claudia  Cicala (NIAID),"1. Auclair S, Liu F, Niu Q, Hou W, Churchyard G, Morgan C, Frahm N, Nitayaphan S, Pitisuthithum P, Rerks-Ngarm S, Kimata JT, Soong L, Franchini G, Robb M, Kim J, Michael N, Hu H (2018). Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. PLoS Pathog  14, e1006888.   https://doi.org/10.1371/journal.ppat.1006888|2. Helmold Hait S, Vargas-Inchaustegui DA, Musich T, Mohanram V, Tuero I, Venzon DJ, Bear J, Rosati M, Vaccari M, Franchini G, Felber BK, Pavlakis GN, Robert-Guroff M (2019). Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques. J Virol  93.   https://doi.org/10.1128/JVI.01687-18|3. Lertjuthaporn S, Cicala C, Van Ryk D, Liu M, Yolitz J, Wei D, Nawaz F, Doyle A, Horowitch B, Park C, Lu S, Lou Y, Wang S, Pan R, Jiang X, Villinger F, Byrareddy SN, Santangelo PJ, Morris L, Wibmer CK, Biris K, Mason RD, Gorman J, Hiatt J, Martinelli E, et al. [10 more authors] (2018). Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7. PLoS Pathog  14, e1007278.   https://doi.org/10.1371/journal.ppat.1007278|4. Musich T, Rahman MA, Mohanram V, Miller-Novak L, Demberg T, Venzon DJ, Felber BK, Franchini G, Pavlakis GN, Robert-Guroff M (2018). Neutrophil Vaccination Dynamics and Their Capacity To Mediate B Cell Help in Rhesus Macaques. J Immunol  201, 2287-2302.   https://doi.org/10.4049/jimmunol.1800677|5. Vaccari M, Fourati S, Brown DR, Silva de Castro I, Bissa M, Schifanella L, Doster MN, Foulds KE, Roederer M, Koup RA, Sui Y, Berzofsky JA, Sekaly RP, Franchini G (2019). Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate. Front Immunol  10, 1072.   https://doi.org/10.3389/fimmu.2019.01072|6. Vaccari M, Fourati S, Gordon SN, Brown DR, Bissa M, Schifanella L, Silva de Castro I, Doster MN, Galli V, Omsland M, Fujikawa D, Gorini G, Liyanage NPM, Trinh HV, McKinnon KM, Foulds KE, Keele BF, Roederer M, Koup RA, Shen X, Tomaras GD, Wong MP, Munoz KJ, Gach JS, Forthal DN, et al. [8 more authors] (2018). HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition. Nat Med  24, 847-856.   https://doi.org/10.1038/s41591-018-0025-7|7. Vaccari M, Franchini G (2018). T Cell Subsets in the Germinal Center: Lessons from the Macaque Model. Front Immunol  9, 348.   https://doi.org/10.3389/fimmu.2018.00348",https://intramural.nih.gov/search/searchview.taf?ipid=108457
254,BC011131-12,"October 01, 2018 -  September 30, 2019",Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Fa-An  Chao|Domarin  Khago|Jess R Li,NULL,Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108444
255,BC011132-12,"October 01, 2018 -  September 30, 2019",Methods Development,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Fa-An  Chao|Jess R Li|Olivier Francois Andre  Soubias; PhD|Yue  Zhang,NULL,NULL,Nico  Tjandra; PhD (NHLBI),"1. Byrd R, Chao F (2018). Protein dynamics revealed by NMR relaxation methods. Emerging Topics in Life Sciences  2, 93-105.",https://intramural.nih.gov/search/searchview.taf?ipid=108443
256,BC011150-11,"October 01, 2018 -  September 30, 2019",Chronic Inflammation and Carcinogenesis,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI","Caroline Elizabeth Salter|Julie  Hixon|Wenqing  Li|Howard A Young; PhD|Ji Ming  Wang; MD, PhD",Lothar  Steidler (ActoGenix)|Mairi Hall McLean,NULL,Sandip  Datta (NIAID),"1. Andrews C, McLean MH, Durum SK (2018). Cytokine Tuning of Intestinal Epithelial Function. Front Immunol  9, 1270.   https://doi.org/10.3389/fimmu.2018.01270|2. Porter RJ, Andrews C, Brice DP, Durum SK, McLean MH (2018). Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? Inflamm Bowel Dis  24, 2123-2134.   https://doi.org/10.1093/ibd/izy230|3. Rodriguez-Palacios A, Harding A, Menghini P, Himmelman C, Retuerto M, Nickerson KP, Lam M, Croniger CM, McLean MH, Durum SK, Pizarro TT, Ghannoum MA, Ilic S, McDonald C, Cominelli F (2018). The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis. Inflamm Bowel Dis  24, 1005-1020.   https://doi.org/10.1093/ibd/izy060",https://intramural.nih.gov/search/searchview.taf?ipid=108554
257,BC011152-11,"October 01, 2018 -  September 30, 2019",Regulation of human dendritic cell activation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Sharon A Bargo|Amiran  Dzutsev; PhD|Rodrigo  Xavier Das Neves,NULL,NULL,NULL,"1. Abdi K, Laky K, Padhan K, Petrovas C, Skinner J, Kabat J, Dorward DW, Brzostowski J, Long EO, Trinchieri G, Varma R (2018). Cutting Edge: Quantitative Determination of CD40L Threshold for IL-12 and IL-23 Production from Dendritic Cells. J Immunol  201, 2879-2884.   https://doi.org/10.4049/jimmunol.1800721",https://intramural.nih.gov/search/searchview.taf?ipid=108575
258,BC011153-11,"October 01, 2018 -  September 30, 2019",Role of microbiome in cancer and inflammation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jonathan Harold Badger|Sharon A Bargo|Pramita  Chatterjee|Amiran  Dzutsev; PhD|April Michele Huang|John Anthony McCulloch; PhD|Show all 16,"Sergei A. Nedospasov; PhD, DSc|Marilia  Seelaender (University of Sao Paulo)|Sergey  Grivennikov (Fox Chase Cancer Center)",Li  Yang; PhD (Laboratory of Cancer Biology and Genetics)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Heidi H Kong (Office of the Director),"Yasmine  Belkaid; PhD (NIAID) |Karen Moore Frank; MD, PhD (CC)","1. Bodogai M, O'Connell J, Kim K, Kim Y, Moritoh K, Chen C, Gusev F, Vaughan K, Shulzhenko N, Mattison JA, Lee-Chang C, Chen W, Carlson O, Becker KG, Gurung M, Morgun A, White J, Meade T, Perdue K, Mack M, Ferrucci L, Trinchieri G, de Cabo R, Rogaev E, Egan J, et al. [2 more authors] (2018). Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells. Sci Transl Med  10.   https://doi.org/10.1126/scitranslmed.aat4271|2. Costa RGF, Caro PL, de Matos-Neto EM, Lima JDCC, Radloff K, Alves MJ, Camargo RG, Pessoa AFM, Simoes E, Gama P, Cara DC, da Silva ASF, O Pereira W, Maximiano LF, de Alcântara PSM, Otoch JP, Trinchieri G, Laviano A, Muscaritoli M, Seelaender M (2019). Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa. J Cachexia Sarcopenia Muscle  10, 1116-1127.   https://doi.org/10.1002/jcsm.12449|3. Dutzan N, Kajikawa T, Abusleme L, Greenwell-Wild T, Zuazo CE, Ikeuchi T, Brenchley L, Abe T, Hurabielle C, Martin D, Morell RJ, Freeman AF, Lazarevic V, Trinchieri G, Diaz PI, Holland SM, Belkaid Y, Hajishengallis G, Moutsopoulos NM (2018). A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans. Sci Transl Med  10.   https://doi.org/10.1126/scitranslmed.aat0797|4. Elinav E, Garrett WS, Trinchieri G, Wargo J (2019). The cancer microbiome. Nat Rev Cancer  19, 371-376.   https://doi.org/10.1038/s41568-019-0155-3|5. Plantamura E, Dzutsev A, Chamaillard M, Djebali S, Moudombi L, Boucinha L, Grau M, Macari C, Bauché D, Dumitrescu O, Rasigade JP, Lippens S, Plateroti M, Kress E, Cesaro A, Bondu C, Rothermel U, Heikenwälder M, Lina G, Bentaher-Belaaouaj A, Marie JC, Caux C, Trinchieri G, Marvel J, Michallet MC (2018). MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype. Proc Natl Acad Sci U S A  115, 10404-10409.   https://doi.org/10.1073/pnas.1722372115|6. Smith CK, Trinchieri G (2018). The interplay between neutrophils and microbiota in cancer. J Leukoc Biol  104, 701-715.   https://doi.org/10.1002/JLB.4RI0418-151R|7. Sui Y, Lewis GK, Wang Y, Berckmueller K, Frey B, Dzutsev A, Vargas-Inchaustegui D, Mohanram V, Musich T, Shen X, DeVico A, Fouts T, Venzon D, Kirk J, Waters RC, Talton J, Klinman D, Clements J, Tomaras GD, Franchini G, Robert-Guroff M, Trinchieri G, Gallo RC, Berzofsky JA (2019). Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response. J Clin Invest  129, 1314-1328.   https://doi.org/10.1172/JCI122110|8. Vetizou M, Trinchieri G (2018). Anti-PD1 in the wonder-gut-land. Cell Res  28, 263-264.   https://doi.org/10.1038/cr.2018.12",https://intramural.nih.gov/search/searchview.taf?ipid=108574
259,BC011154-11,"October 01, 2018 -  September 30, 2019",Biological Functions of Chromosomal Proteins,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI","Takashi  Furusawa|Ravikanth  Nanduri; PhD|Yuri  Postnikov; MD, PhD|Shaofei  Zhang",NULL,Joost J Oppenheim; MD (Cancer Inflammation Program),NULL,"1. Mowery CT, Reyes JM, Cabal-Hierro L, Higby KJ, Karlin KL, Wang JH, Kimmerling RJ, Cejas P, Lim K, Li H, Furusawa T, Long HW, Pellman D, Chapuy B, Bustin M, Manalis SR, Westbrook TF, Lin CY, Lane AA (2018). Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression. Cell Rep  25, 1898-1911.e5.   https://doi.org/10.1016/j.celrep.2018.10.061|2. Zhang S, Deng T, Tang W, He B, Furusawa T, Ambs S, Bustin M (2019). Epigenetic regulation of REX1 expression and chromatin binding specificity by HMGNs. Nucleic Acids Res  47, 4449-4461.   https://doi.org/10.1093/nar/gkz161",https://intramural.nih.gov/search/searchview.taf?ipid=108549
260,BC011158-11,"October 01, 2018 -  September 30, 2019",Stress responses in embryonic stem cellsvvvv,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Shunlin  Jiang|Young Im  Kim|Hualong  Yan,NULL,NULL,Chengyu  Liu; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108559
261,BC011162-11,"October 01, 2018 -  September 30, 2019",Integrative Molecular Profiling of Human Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Shouhui  Yang; PhD,"Jochen  Gaedcke|Frank  Bergmann (University of Heidelberg)|Michael  Ghadimi (Surgery, U. of Goettingen)|H Richard  Alexander (University of Maryland Medical System)|Gaida  Matthias (University of Heidelberg)",Karl Thomas Ried; MD (Cancer Genetics Branch)|David Anderson Wink (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108560
262,BC011163-11,"October 01, 2018 -  September 30, 2019",Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Feng  Leng|Earni Varaha Trinadha Rao Sornapudi|Sara  Zahraeifard,NULL,Ashish Kumar Lal (Cancer Genetics Branch)|Tim Friedrich Greten (Thoracic and GI Malignancies Branch)|Pengnian Charles Lin; PhD (Cancer Inflammation Program)|Giorgio  Trinchieri (Cancer Inflammation Program),Lawrence L Latour; PhD (NINDS) |Manfred  Boehm; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108577
263,BC011165-11,"October 01, 2018 -  September 30, 2019",Role of inflammation in epigenetic alterations of metastatic cancer cells,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Justin Matthew Gray|Woo Yong  Park|Jae Young  So|Maxwell P Lee; PhD,NULL,NULL,Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108578
264,BC011167-11,"October 01, 2018 -  September 30, 2019",Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day|Eva Eugenia Perez Guijarro,"Thomas  Tuting (Dermatology, University of Bonn)|Marcus  Bosenberg (Yale University)|Keith  Flaherty (Harvard Medical School)|Jennifer A Wargo|Jedd  Wolchok (Memorial Sloan Kettering)",Melinda  Hollingshead (Biological Testing Branch)|Dominic  Esposito; PhD (Office Of The Director)|Nicholas Phillip Restifo; MD (Surgery Branch)|Norman Edward Sharpless; MD (Office Of The Director)|Silvana Romina Goldszmid (Cancer Inflammation Program)|Patricia  Steeg; PhD (Womens Malignancies Branch),NULL,"1. Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, Sahu A, Zarecki R, Marie K, Feng Y, Khateb A, Frederick DT, Ashkenazi SK, Kim H, Perez EG, Day CP, Segura Muñoz RS, Schmaltz R, Yooseph S, Tam MA, Zhang T, Avitan-Hersh E, Tzur L, Roizman S, Boyango I, et al. [17 more authors] (2019). Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice. Nat Commun  10, 1492.   https://doi.org/10.1038/s41467-019-09525-y|2. Michael HT, Graff-Cherry C, Chin S, Rauck C, Habtemichael AD, Bunda P, Smith T, Campos MM, Bharti K, Arnheiter H, Merlino G, Day CP (2018). Partial Rescue of Ocular Pigment Cells and Structure by Inducible Ectopic Expression of Mitf-M in MITF-Deficient Mice. Invest Ophthalmol Vis Sci  59, 6067-6073.   https://doi.org/10.1167/iovs.18-25186",https://intramural.nih.gov/search/searchview.taf?ipid=108564
265,BC011168-11,"October 01, 2018 -  September 30, 2019",Physiological and pathological functions of E3 ubiquitin ligases Smurfs,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Christina  Stuelten|Liuya  Tang|Yi  Tang|Xuan  Xu,NULL,Kunio  Nagashima (Office of the Director)|Lisa Marie Jenkins (Laboratory of Cell Biology)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis),Chengyu  Liu; PhD (NHLBI),"1. Tang Y, Tang LY, Xu X, Li C, Deng C, Zhang YE (2018). Generation of Smurf2 Conditional Knockout Mice. Int J Biol Sci  14, 542-548.   https://doi.org/10.7150/ijbs.24303|2. Zhu K, Tang Y, Xu X, Dang H, Tang LY, Wang X, Wang XW, Zhang YE (2018). Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis. PLoS Biol  16, e3000091.   https://doi.org/10.1371/journal.pbio.3000091",https://intramural.nih.gov/search/searchview.taf?ipid=108579
266,BC011176-11,"October 01, 2018 -  September 30, 2019",Functions of KSHV microRNAs and circular RNAs,Joseph M Ziegelbauer|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Insun  Kook|Anna  Serquina|Tagawa  Takanobu,"Craig  McCormick (Dalhousie University)|Nicholas  Conrad (Ut Southwestern)|Ivan  Martinez (Dept. Of Microbiology, Immunology And Cell Biology)|Thomas  Uldrick (Fred Hutchinson Cancer Research Center)",Yun Xing M Wang (Structural Biophysics Laboratory)|Denise  Whitby (Office Of The Director),"John Lawrence Spouge; MD, PhD (NLM)","1. Tagawa T, Gao S, Koparde VN, Gonzalez M, Spouge JL, Serquiña AP, Lurain K, Ramaswami R, Uldrick TS, Yarchoan R, Ziegelbauer JM (2018). Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA. Proc Natl Acad Sci U S A  115, 12805-12810.   https://doi.org/10.1073/pnas.1816183115|2. Ziegelbauer JM (2018). Sequence variation in the microRNA region of a cancer virus. Oncotarget  9, 37272-37273.   https://doi.org/10.18632/oncotarget.26471",https://intramural.nih.gov/search/searchview.taf?ipid=108580
267,BC011181-11,"October 01, 2018 -  September 30, 2019",Functional Analysis of Human Breast Cancer Susceptibility Gene Variants,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",Kajal  Biswas|Linda S Cleveland|Betty K Martin|Arun Prakash Mishra|Sounak  Sahu|Stacey S Stauffer|Show all 7,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)|Stefan  Meyer (Manchester Academic Health Science Centre, University Of Manchester)|Edwin  Iversen (Duke University)",NULL,NULL,"1. Toland AE, Forman A, Couch FJ, Culver JO, Eccles DM, Foulkes WD, Hogervorst FBL, Houdayer C, Levy-Lahad E, Monteiro AN, Neuhausen SL, Plon SE, Sharan SK, Spurdle AB, Szabo C, Brody LC, BIC Steering Committee (2018). Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices. NPJ Genom Med  3, 7.   https://doi.org/10.1038/s41525-018-0046-7",https://intramural.nih.gov/search/searchview.taf?ipid=108570
268,BC011185-11,"October 01, 2018 -  September 30, 2019",Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Shouhui  Yang; PhD,Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Richard  Bucala (Yale University)|Fleming  Jason (MD Anderson Cancer Center)|Diane  Simeone (University of Michigan),Karl Thomas Ried; MD (Cancer Genetics Branch)|Christine Campo Alewine (Laboratory of Molecular Biology)|David Anderson Wink (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108561
269,BC011187-11,"October 01, 2018 -  September 30, 2019",Sphingolipid Signaling in Mammals,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI",Thiruvaimozhi  Abimannan|Parthibane  Velayoudame,NULL,Sarangan  Ravichandran (Office Of The Director)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Lino  Tessarollo (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108546
270,BC011190-11,"October 01, 2018 -  September 30, 2019",Chemical Biology of Nitroxyl (HNO),David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Debashree  Basudhar|Luiz Gonzaga De Franca Lopes|Joseph  Saavedra|Eduardo H S Sousa,"Bruce  King (Department of Chemistry, Wake Forest University)|Jon  Fukuto (UCLA)|Nazerano  Paolocci (Department of Cardiology, Johns Hopkins University Medical School)",Murali  Krishna; PhD (Radiation Biology Branch),NULL,"1. Fukuto JM, Ignarro LJ, Nagy P, Wink DA, Kevil CG, Feelisch M, Cortese-Krott MM, Bianco CL, Kumagai Y, Hobbs AJ, Lin J, Ida T, Akaike T (2018). Biological hydropersulfides and related polysulfides - a new concept and perspective in redox biology. FEBS Lett  592, 2140-2152.   https://doi.org/10.1002/1873-3468.13090",https://intramural.nih.gov/search/searchview.taf?ipid=108576
271,BC011191-11,"October 01, 2018 -  September 30, 2019",Preclinical Mouse Models of Thyroid Cancer,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Sunmi  Park|Li  Zhao|Xuguang  Zhu,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Cheng SY (2018). Interplay between TRα1 and Wnt signaling: A dangerous liaison. Oncotarget  9, 31939-31940.   https://doi.org/10.18632/oncotarget.25807|2. Fozzatti L, Alamino VA, Park S, Giusiano L, Volpini X, Zhao L, Stempin CC, Donadio AC, Cheng SY, Pellizas CG (2019). Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression. Sci Rep  9, 8028.   https://doi.org/10.1038/s41598-019-44361-6|3. Kim WG, Cheng SY (2018). Mechanisms Linking Obesity and Thyroid Cancer Development and Progression in Mouse Models. Horm Cancer  9, 108-116.   https://doi.org/10.1007/s12672-017-0320-7|4. Park S, Willingham MC, Qi J, Cheng SY (2018). Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer. Endocr Relat Cancer  25, 865-877.   https://doi.org/10.1530/ERC-18-0071",https://intramural.nih.gov/search/searchview.taf?ipid=108550
272,BC011197-11,"October 01, 2018 -  September 30, 2019",Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Subrata  Debnath; PhD|Jay Prakash  Kumar|Sharlyn  Mazur; PhD|Jonathan Lawrence Smisson|Harichandra Dnyaneshwar Tagad; PhD,Oleg  Demidov|Barbara  Stecca (Istituto Toscano Tumori Azienda),Stewart  Durell (Laboratory of Cell Biology)|Lisa Marie Jenkins (Laboratory of Cell Biology),Daniel  Appella; PhD (NIDDK) |Frederick P Dyda; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108547
273,BC011202-11,"October 01, 2018 -  September 30, 2019",Mechanism of transcription-coupled DNA repair and transcription mutagenesis,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Lucyna E Lubkowska|Alexander Victorovich Yakhnin,NULL,NULL,NULL,"1. Wang W, Walmacq C, Chong J, Kashlev M, Wang D (2018). Structural basis of transcriptional stalling and bypass of abasic DNA lesion by RNA polymerase II. Proc Natl Acad Sci U S A  115, E2538-E2545.   https://doi.org/10.1073/pnas.1722050115",https://intramural.nih.gov/search/searchview.taf?ipid=108563
274,BC011203-11,"October 01, 2018 -  September 30, 2019",Proteolysis and Regulation of Bacterial Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Kylie Suzanne Borden|Nadim  Majdalani|Song  Tong|Arti  Tripathi,Alexandra Monica Deaconescu (BIOCHEMISTRY & BIOPHYSICS CENTER)|Aurelia  Battesti,Sue H Wickner; PhD (DNA Molecular Biology Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Dorich V, Brugger C, Tripathi A, Hoskins JR, Tong S, Suhanovsky MM, Sastry A, Wickner S, Gottesman S, Deaconescu AM (2019). Structural basis for inhibition of a response regulator of σS stability by a ClpXP antiadaptor. Genes Dev  33, 718-732.   https://doi.org/10.1101/gad.320168.118|2. Gottesman S (2019). Trouble is coming: Signaling pathways that regulate general stress responses in bacteria. J Biol Chem  294, 11685-11700.   https://doi.org/10.1074/jbc.REV119.005593|3. Hamdallah I, Torok N, Bischof KM, Majdalani N, Chadalavada S, Mdluli N, Creamer KE, Clark M, Holdener C, Basting PJ, Gottesman S, Slonczewski JL (2018). Experimental Evolution of Escherichia coli K-12 at High pH and with RpoS Induction. Appl Environ Microbiol  84.   https://doi.org/10.1128/AEM.00520-18",https://intramural.nih.gov/search/searchview.taf?ipid=108555
275,BC011204-11,"October 01, 2018 -  September 30, 2019",Development of TIMP-2 derivatives or strategies as biologic therapies for cancer,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Alex S Kuznetsov|David  Peeney; PhD|Beiyang  Wei|Maryalice  Stetler-Stevenson; MD, PhD",John  Caterina; PhD (NIDR)|Robert G Brinson; PhD,Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Shyam K Sharan (Genetics of Cancer Susceptibility Section),Rolf Eric Swenson; PhD (NHLBI) |Olga  Vasalatiy; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108573
276,BC011206-11,"October 01, 2018 -  September 30, 2019",Genome wide profiling of histone variants in tumors,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Arun Kumar  Ganesan; PhD|Ankita  Saha,NULL,NULL,Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Nye J, Sturgill D, Athwal R, Dalal Y (2018). HJURP antagonizes CENP-A mislocalization driven by the H3.3 chaperones HIRA and DAXX. PLoS One  13, e0205948.   https://doi.org/10.1371/journal.pone.0205948",https://intramural.nih.gov/search/searchview.taf?ipid=108551
277,BC011207-11,"October 01, 2018 -  September 30, 2019",Analysis of centromere identity and structure in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Daniel Patrick Melters|Farzanna Aliyah Mohamed|Mary Elizabeth Pitman,NULL,NULL,Emilios K Dimitriadis; PhD (NIBIB) |Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Zhao H, Winogradoff D, Dalal Y, Papoian GA (2019). The Oligomerization Landscape of Histones. Biophys J  116, 1845-1855.   https://doi.org/10.1016/j.bpj.2019.03.021",https://intramural.nih.gov/search/searchview.taf?ipid=108552
278,BC011208-11,"October 01, 2018 -  September 30, 2019",Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Vanivilasini  Balachandran|Jothy  Dhakshnamoorthy|Amber Rae Cutter|Hernan Diego Folco|Brent Joseph Groubert|Sahana  Holla|Show all 15,NULL,NULL,NULL,"1. Folco HD, McCue A, Balachandran V, Grewal SIS (2019). Cohesin Impedes Heterochromatin Assembly in Fission Yeast Cells Lacking Pds5. Genetics  213, 127-141.   https://doi.org/10.1534/genetics.119.302256|2. Gallagher PS, Larkin M, Thillainadesan G, Dhakshnamoorthy J, Balachandran V, Xiao H, Wellman C, Chatterjee R, Wheeler D, Grewal SIS (2018). Iron homeostasis regulates facultative heterochromatin assembly in adaptive genome control. Nat Struct Mol Biol  25, 372-383.   https://doi.org/10.1038/s41594-018-0056-2|3. Xie G, Vo TV, Thillainadesan G, Holla S, Zhang B, Jiang Y, Lv M, Xu Z, Wang C, Balachandran V, Shi Y, Li F, Grewal SIS (2019). A conserved dimer interface connects ERH and YTH family proteins to promote gene silencing. Nat Commun  10, 251.   https://doi.org/10.1038/s41467-018-08273-9",https://intramural.nih.gov/search/searchview.taf?ipid=108556
279,BC011209-11,"October 01, 2018 -  September 30, 2019",Formation of Centromeres in vivo,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Arun Kumar  Ganesan; PhD|Minh  Bui,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Nye J, Melters DP, Dalal Y (2018). The Art of War: harnessing the epigenome against cancer. F1000Res  7, 141.   https://doi.org/10.12688/f1000research.12833.1",https://intramural.nih.gov/search/searchview.taf?ipid=108553
280,BC011211-11,"October 01, 2018 -  September 30, 2019",Subcellular protein localization in B. subtilis,Kumaran S Ramamurthi|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Brandon Ramal Anjuwon-Foster|Carissa M Chan|Thomas  Delerue|Haoyuan  Jing|Minsuk  Kong|Emily Ann Peluso|Show all 7,"Jodi  Camberg|Siddhartha  Das; Ph.D. (Mechanical  Engineering, University of Marlyand)|Kit  Pogliano (University Of California, San Diego)|Karl  Thompson",David J Fitzgerald; PhD (Biotherapy Section)|Kandice Danielle Tanner; PhD (Laboratory of Cell Biology),Hari  Shroff; PhD (NIBIB) |Aravind L Iyer; PhD (NLM),"1. Eswara PJ, Brzozowski RS, Viola MG, Graham G, Spanoudis C, Trebino C, Jha J, Aubee JI, Thompson KM, Camberg JL, Ramamurthi KS (2018). An essential Staphylococcus aureus cell division protein directly regulates FtsZ dynamics. Elife  7.   https://doi.org/10.7554/eLife.38856|2. Karauzum H, Updegrove TB, Kong M, Wu IL, Datta SK, Ramamurthi KS (2018). Vaccine display on artificial bacterial spores enhances protective efficacy against Staphylococcus aureus infection. FEMS Microbiol Lett  365.   https://doi.org/10.1093/femsle/fny190",https://intramural.nih.gov/search/searchview.taf?ipid=108569
281,BC011212-11,"October 01, 2018 -  September 30, 2019",Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jami D Willette brown|Feng  Zhu; PhD|Giorgio  Trinchieri,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108558
282,BC011214-11,"October 01, 2018 -  September 30, 2019",Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Megan A Luckey|Juliet  Fink|Hilary Rachel Keller|Tae Hyoun  Kim|Juntae  Kwon; PhD|Shunqun  Luo|Show all 9,Batu M Erman|Youngnim  Choi (Seoul National University)|Changwan  Hong|Carmen  Molina-paris (University Of Leeds),Ronald E Gress; MD (Experimental Transplantation and Immunology Branch),NULL,"1. Kim HK, Chung H, Kwon J, Castro E, Johns C, Hawk NV, Hwang S, Park JH, Gress RE (2019). Differential Cytokine Utilization and Tissue Tropism Results in Distinct Repopulation Kinetics of Naïve vs. Memory T Cells in Mice. Front Immunol  10, 355.   https://doi.org/10.3389/fimmu.2019.00355|2. Park JH, Waickman AT, Reynolds J, Castro M, Molina-París C (2019). IL7 receptor signaling in T cells: A mathematical modeling perspective. Wiley Interdiscip Rev Syst Biol Med  11, e1447.   https://doi.org/10.1002/wsbm.1447|3. Park JY, Ligons DL, Park JH (2018). Out-sourcing for Trans-presentation: Assessing T Cell Intrinsic and Extrinsic IL-15 Expression with Il15 Gene Reporter Mice. Immune Netw  18, e13.   https://doi.org/10.4110/in.2018.18.e13",https://intramural.nih.gov/search/searchview.taf?ipid=108567
283,BC011215-11,"October 01, 2018 -  September 30, 2019",Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Megan A Luckey|Juliet  Fink|Hilary Rachel Keller|Tae Hyoun  Kim|Juntae  Kwon; PhD|Shunqun  Luo|Show all 8,Youngnim  Choi (Seoul National University)|Batu M Erman|Changwan  Hong,Ronald E Gress; MD (Experimental Transplantation and Immunology Branch),NULL,"1. Park JY, Chung H, DiPalma DT, Tai X, Park JH (2018). Immune quiescence in the oral mucosa is maintained by a uniquely large population of highly activated Foxp3+ regulatory T cells. Mucosal Immunol  11, 1092-1102.   https://doi.org/10.1038/s41385-018-0027-2|2. Park JY, Kwon J, Kim EY, Fink J, Kim HK, Park JH (2019). CD24+ Cell Depletion Permits Effective Enrichment of Thymic iNKT Cells While Preserving Their Subset Composition. Immune Netw  19, e14.   https://doi.org/10.4110/in.2019.19.e14",https://intramural.nih.gov/search/searchview.taf?ipid=108568
284,BC011222-11,"October 01, 2018 -  September 30, 2019",CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra  Lin|Nihar Jaydeep Mehta,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108572
285,BC011232-11,"October 01, 2018 -  September 30, 2019",A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Brandon Manhay Liu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108548
286,BC011255-10,"October 01, 2018 -  September 30, 2019",Genetic Modifiers of Initiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Md Ruhul Amin|Randall Andrew Dass|Sarah Kimberly Deasy|Ngoc-Han  Ha|Devin Eugene Jackson|Megan  Majocha|Show all 14,"Yijun  Ruan; PhD (Department of Genetic and Development Biology, Jackson Laboratory for Genomic Medicine)|Michael  Lewis (Baylor University)|Sophia  Lunt (Michigan State University)|Eran  Andrecheck (Michigan State University)","Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)",NULL,"1. Ross C, Hunter K (2018) Metastasis signatures  The tell-tale signs of metastasis, in Encyclopedia of Cancer, in press.|2. Hunter KW, Amin R, Deasy S, Ha NH, Wakefield L (2018). Genetic insights into the morass of metastatic heterogeneity. Nat Rev Cancer  18, 211-223.   https://doi.org/10.1038/nrc.2017.126|3. Rennhack J, Swiatnicki M, Zhang Y, Caralynn L, Bylett E, Ross C, Szczepanek K, Hanrahan W, Jantissa M, Hunter K, Andrechek E (2019) Integrated sequence and gene expression analysis of mouse models of breast cancer reveals critical events with human parallels. Nature Communications, in press.|4. Teoh ST, Ogrodzinski MP, Ross C, Hunter KW, Lunt SY (2018). Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics. Front Oncol  8, 174.   https://doi.org/10.3389/fonc.2018.00174|5. Vera-Ramirez L, Vodnala SK, Nini R, Hunter KW, Green JE (2018). Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence. Nat Commun  9, 1944.   https://doi.org/10.1038/s41467-018-04070-6",https://intramural.nih.gov/search/searchview.taf?ipid=108582
287,BC011264-10,"October 01, 2018 -  September 30, 2019",Glucocorticoids and T cell development and function,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Paul  Mittelstadt; PhD|Matthew Donald Taves,NULL,Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Giardino Torchia ML, Ashwell JD (2018). Getting MAD at MYC. Proc Natl Acad Sci U S A  115, 9821-9823.   https://doi.org/10.1073/pnas.1813867115|2. Mittelstadt PR, Taves MD, Ashwell JD (2018). Cutting Edge: De Novo Glucocorticoid Synthesis by Thymic Epithelial Cells Regulates Antigen-Specific Thymocyte Selection. J Immunol  200, 1988-1994.   https://doi.org/10.4049/jimmunol.1701328|3. Taves MD, Mittelstadt PR, Presman DM, Hager GL, Ashwell JD (2019). Single-Cell Resolution and Quantitation of Targeted Glucocorticoid Delivery in the Thymus. Cell Rep  26, 3629-3642.e4.   https://doi.org/10.1016/j.celrep.2019.02.108",https://intramural.nih.gov/search/searchview.taf?ipid=108583
288,BC011267-10,"October 01, 2018 -  September 30, 2019",Preclinical drug development in pancreatic cancer,Udo  Rudloff|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI","Yansong  Bian; MD, PhD|Zachary Daniel Knotts|Dandan  Li|Victoria Thanh Nguyen|Rushikesh Vilas Sable; PhD",Duncan  Jodrell (CRUK Cambridge Research Institute)|Jesse  Jaynes (Tuskegee University)|Sui  Huang (Northwestern University)|Clayton  Yates (Tuskegee University)|Michael  Baltezor (University of Kansas)|Chan-young  Ock (Seoul National University Hospital)|Show all 7,"Thorkell  Andresson (Office Of The Director)|Serguei V Kozlov (Office of the Director)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Sarangan  Ravichandran (Office Of The Director)|Natalia  De Val Alda; PhD (Office of the Director)|Nathan Michael Pate; DVM, DACVP (Office of the Director)",Juan  Marugan (NCATS) |Xin  Xu (NCATS) |Marc  Ferrer-Alegre (NCATS) |Xin  Hu; PhD (NCATS) |Craig Joseph Thomas (NCATS) |Bolormaa  Baljinnyam (NCATS),"1. Bian Y, Teper Y, Mathews Griner LA, Aiken TJ, Shukla V, Guha R, Shinn P, Xin HW, Pflicke H, Powers AS, Li D, Jiang JK, Patel P, Rogers SA, Aubé J, Ferrer M, Thomas CJ, Rudloff U (2019). Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype. Mol Cancer Ther  18, 2097-2110.   https://doi.org/10.1158/1535-7163.MCT-18-1011|2. Li D, Lo W, Rudloff U (2018). Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk. Clin Transl Med  7, 7.   https://doi.org/10.1186/s40169-018-0184-7|3. Li D, Mullinax JE, Aiken T, Xin H, Wiegand G, Anderson A, Thorgeirsson S, Avital I, Rudloff U (2018). Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. BMC Cancer  18, 772.   https://doi.org/10.1186/s12885-018-4690-1|4. Rudloff U (2018). Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectives. Clin Exp Gastroenterol  11, 447-459.   https://doi.org/10.2147/CEG.S163227|5. Straughan DM, McLoughlin KC, Mullinax JE, Marciano BE, Freeman AF, Anderson VL, Uzel G, Azoury SC, Sorber R, Quadri HS, Malech HL, DeRavin SS, Kamal N, Koh C, Zerbe CS, Kuhns DB, Gallin JI, Heller T, Holland SM, Rudloff U (2018). The Changing Paradigm of Management of Liver Abscesses in Chronic Granulomatous Disease. Clin Infect Dis  66, 1427-1434.   https://doi.org/10.1093/cid/cix1012|6. Vilimas T, Wang AQ, Patnaik S, Hughes EA, Singleton MD, Knotts Z, Li D, Frankowski K, Schlomer JJ, Guerin TM, Springer S, Drennan C, Dextras C, Wang C, Gilbert D, Southall N, Ferrer M, Huang S, Kozlov S, Marugan J, Xu X, Rudloff U (2018). Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-KrasG12D/+;Tp53R172H/+ (KPC) mice, a genetically engineered model of pancreatic cancer. Cancer Chemother Pharmacol  82, 1067-1080.   https://doi.org/10.1007/s00280-018-3699-0",https://intramural.nih.gov/search/searchview.taf?ipid=108585
289,BC011283-10,"October 01, 2018 -  September 30, 2019","Investigating the link between DNA damage, chromatin and nuclear dysfunction",Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Robin  Sebastian|Andy Dong-Anh Tran; PhD,"David  Sinclair (Harvard Medical School)|karolin  Luger (Biochemsitry, Univ. of Colorado)|Richard  Gibbons; MD (Clinical Laboratory of Sciences, University of Oxford)|Matthew  Gamble (Albert Einstein College Of Medicine)",Mirit I Aladjem; PhD (Developmental Therapeutics Branch),Yie  Liu; PhD (NIA),"1. Kim J, Oberdoerffer P, Khurana S (2018). The histone variant macroH2A1 is a splicing-modulated caretaker of genome integrity and tumor growth. Mol Cell Oncol  5, e1441629.   https://doi.org/10.1080/23723556.2018.1441629|2. Kim J, Sun C, Tran AD, Chin PJ, Ruiz PD, Wang K, Gibbons RJ, Gamble MJ, Liu Y, Oberdoerffer P (2019). The macroH2A1.2 histone variant links ATRX loss to alternative telomere lengthening. Nat Struct Mol Biol  26, 213-219.   https://doi.org/10.1038/s41594-019-0192-3|3. Sun J, He X, Zhu Y, Ding Z, Dong H, Feng Y, Du J, Wang H, Wu X, Zhang L, Yu X, Lin A, McDonald T, Zhao D, Wu H, Hua WK, Zhang B, Feng L, Tohyama K, Bhatia R, Oberdoerffer P, Chung YJ, Aplan PD, Boultwood J, Pellagatti A, et al. [8 more authors] (2018). SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function. Cell Stem Cell  23, 355-369.e9.   https://doi.org/10.1016/j.stem.2018.07.018",https://intramural.nih.gov/search/searchview.taf?ipid=108587
290,BC011286-10,"October 01, 2018 -  September 30, 2019",Therapeutic targets and novel anticancer agents for endocrine cancers,Naris  Nilubol; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Myriem  Boufraqech; PhD|Dipranjan  Laha; PhD,"Steven  Libutti; MD (Office Of The Director)|Nancy  Perrier (University Of Texas Md Anderson Cancer Center)|Lawrence  Tamarkin (President, Cytimmune Sciences)",Samira Mercedes Sadowski (Endocrine Oncology Branch),"Karel  Pacak; MD, PhD (NICHD) |Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Babic B, De Roulet A, Volpe A, Nilubol N (2019). Is VTE Prophylaxis Necessary on Discharge for Patients Undergoing Adrenalectomy for Cushing Syndrome? J Endocr Soc  3, 304-313.   https://doi.org/10.1210/js.2018-00278|2. Boufraqech M, Patel D, Nilubol N, Powers A, King T, Shell J, Lack J, Zhang L, Gara SK, Gunda V, Klubo-Gwiezdzinska J, Kumar S, Fagin J, Knauf J, Parangi S, Venzon D, Quezado M, Kebebew E (2019). Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness. Thyroid  29, 79-92.   https://doi.org/10.1089/thy.2018.0424|3. El Lakis M, Gianakou A, Nockel P, Wiseman D, Tirosh A, Quezado MA, Patel D, Nilubol N, Pacak K, Sadowski SM, Kebebew E (2019). Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors. JAMA Surg  154, 40-45.   https://doi.org/10.1001/jamasurg.2018.3475|4. El Lakis M, Giannakou A, Nockel PJ, Wiseman D, Gara SK, Patel D, Sater ZA, Kushchayeva YY, Klubo-Gwiezdzinska J, Nilubol N, Merino MJ, Kebebew E (2019). Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment. Surgery  165, 50-57.   https://doi.org/10.1016/j.surg.2018.05.075|5. El Lakis M, Nockel P, Gaitanidis A, Guan B, Agarwal S, Welch J, Simonds WF, Weinstein L, Marx S, Nilubol N, Patel D, Merkel R, Tirosh A, Kebebew E (2018). Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. J Am Coll Surg  226, 933-938.   https://doi.org/10.1016/j.jamcollsurg.2018.01.007|6. El Lakis M, Nockel P, Guan B, Agarwal S, Welch J, Simonds WF, Marx S, Li Y, Nilubol N, Patel D, Yang L, Merkel R, Kebebew E (2018). Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure. Surgery  163, 31-34.   https://doi.org/10.1016/j.surg.2017.04.027|7. Gaitanidis A, Patel D, Nilubol N, Tirosh A, Kebebew E (2018). A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors. J Clin Endocrinol Metab  103, 187-195.   https://doi.org/10.1210/jc.2017-01791|8. Libutti SK, Tamarkin L, Nilubol N (2018). Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure. Oncotarget  9, 35723-35725.   https://doi.org/10.18632/oncotarget.26267|9. Mamilla D, Araque KA, Brofferio A, Gonzales MK, Sullivan JN, Nilubol N, Pacak K (2019). Postoperative Management in Patients with Pheochromocytoma and Paraganglioma. Cancers (Basel)  11.   https://doi.org/10.3390/cancers11070936|10. Nilubol N, Boufraqech M, Zhang L, Gaskins K, Shen M, Zhang YQ, Gara SK, Austin CP, Kebebew E (2018). Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response. Oncotarget  9, 33030-33042.   https://doi.org/10.18632/oncotarget.26050|11. Nilubol N, Yuan Z, Paciotti GF, Tamarkin L, Sanchez C, Gaskins K, Freedman EM, Cao S, Zhao J, Kingston DGI, Libutti SK, Kebebew E (2018). Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors. J Natl Cancer Inst  110, 1019-1029.   https://doi.org/10.1093/jnci/djy003|12. Nockel P, El Lakis M, Gaitanidis A, Yang L, Merkel R, Patel D, Nilubol N, Prodanov T, Pacak K, Kebebew E (2018). Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery. Surgery  163, 191-196.   https://doi.org/10.1016/j.surg.2017.05.025|13. Shell J, Keutgen XM, Millo C, Nilubol N, Patel D, Sadowski S, Boufraqech M, Yang L, Merkel R, Atallah C, Herscovitch P, Kebebew E (2018). 68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor. Int J Endocr Oncol  5, IJE04.   https://doi.org/10.2217/ije-2017-0005|14. Tirosh A, Papadakis GZ, Millo C, Hammoud D, Sadowski SM, Herscovitch P, Pacak K, Marx SJ, Yang L, Nockel P, Shell J, Green P, Keutgen XM, Patel D, Nilubol N, Kebebew E (2018). Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors. Gastroenterology  154, 998-1008.e1.   https://doi.org/10.1053/j.gastro.2017.11.008",https://intramural.nih.gov/search/searchview.taf?ipid=108589
291,BC011293-10,"October 01, 2018 -  September 30, 2019",Cytidine modifications in mRNA processing and function,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Daniel Alejandro Arango Tamayo|Austin Michael Chiappetta|Masaki  Hosogane|Maria Fernanda Prigge|David  Sturgill,NULL,NULL,NULL,"1. Nanan KK, Sturgill DM, Prigge MF, Thenoz M, Dillman AA, Mandler MD, Oberdoerffer S (2019). TET-Catalyzed 5-Carboxylcytosine Promotes CTCF Binding to Suboptimal Sequences Genome-wide. iScience  19, 326-339.   https://doi.org/10.1016/j.isci.2019.07.041",https://intramural.nih.gov/search/searchview.taf?ipid=108592
292,BC011298-10,"October 01, 2018 -  September 30, 2019",Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Sean Joseph Hipp|Mark  Atlas (Cohen Children's Medical Center)|Jason  Fangusaro (Lurie Children's Hospital)|Adam  Levy",Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108594
293,BC011299-10,"October 01, 2018 -  September 30, 2019",Noninvasive Evaluation of Pediatric CNS Tumors-RAPNO,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Roger  Packer (CNMC)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Darren  Hargrave (Great ormond Street Hospital for Children)|Gilbert  Vezina (Children's National Medical Center)|Tina  Young Poussaint (Children's Hospital)|Mark  Kieran (Children's Hospital)|Show all 10",NULL,"Eva Halle Baker; MD, PhD (CC) |Peter  Herscovitch; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108595
294,BC011303-10,"October 01, 2018 -  September 30, 2019",Role of the protein SUMOylation pathway in Ras-driven oncogenesis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Haibo  Zhang; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108596
295,BC011304-10,"October 01, 2018 -  September 30, 2019",Methods for mammalian genetic analysis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Fehad Jamil Khan|Chih-Shia  Lee|Kent W Hunter; PhD|Glenn  Merlino; PhD|Li  Yang; PhD|Stuart H Yuspa; MD,NULL,Tim Friedrich Greten (Thoracic and GI Malignancies Branch)|Udayan  Guha (Thoracic and GI Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Eytan  Ruppin (Cancer Data Science Laboratory)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis),NULL,"1. Khan FJ, Yuen G, Luo J (2019). Multiplexed CRISPR/Cas9 gene knockout with simple crRNA:tracrRNA co-transfection. Cell Biosci  9, 41.   https://doi.org/10.1186/s13578-019-0304-0",https://intramural.nih.gov/search/searchview.taf?ipid=108597
296,BC011306-10,"October 01, 2018 -  September 30, 2019",Inhibitors of protein-protein interactions,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Pedro Felipe Andrade Bonilla|Lyuba Aleksandrovna Khavrutskii|Karen Marie Stefanisko|Joshua Hoyoung Yu|Ruth  Nussinov; PhD|Howard A Young; PhD|Show all 7,Vadim  Gaponenko|Alla  Ivanova|Olga  Timofeeva (Georgetown University)|Mercedes  Gonzalez-Juarrero (Colorado State University)|Philip  Kim (University of Toronto)|Anatoly  Drischilo (Georgetown University),Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Sergey G Tarasov (Structural Biophysics Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)|Kylie Janice Walters (Structural Biophysics Laboratory)|Michael  Dean; PhD (Laboratory Translational Genomics)|Peter F Johnson; PhD (Mouse Cancer Genetics Program),NULL,"1. Upadhyay R, Sanchez-Hidalgo A, Wilusz CJ, Lenaerts AJ, Arab J, Yeh J, Stefanisko K, Tarasova NI, Gonzalez-Juarrero M (2018). Host Directed Therapy for Chronic Tuberculosis via Intrapulmonary Delivery of Aerosolized Peptide Inhibitors Targeting the IL-10-STAT3 Pathway. Sci Rep  8, 16610.   https://doi.org/10.1038/s41598-018-35023-0",https://intramural.nih.gov/search/searchview.taf?ipid=108598
297,BC011307-10,"October 01, 2018 -  September 30, 2019",Self-assembling protoviral nanoparticles,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Karen Marie Stefanisko|Joshua Hoyoung Yu|Joost J Oppenheim; MD,Vadim  Gaponenko|Mattheas  Majestachak (Loyola University Chicago)|Steven  Ackerman; PhD (University of Illinois at Chicago),Sergey G Tarasov (Structural Biophysics Laboratory)|Raul Eduardo Cachau (Office Of The Director)|Natalia  De Val Alda; PhD (Office of the Director),NULL,"1. Grozdanovic M, Laffey KG, Abdelkarim H, Hitchinson B, Harijith A, Moon HG, Park GY, Rousslang LK, Masterson JC, Furuta GT, Tarasova NI, Gaponenko V, Ackerman SJ (2019). Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness. J Allergy Clin Immunol  143, 669-680.e12.   https://doi.org/10.1016/j.jaci.2018.05.003|2. Hitchinson B, Eby JM, Gao X, Guite-Vinet F, Ziarek JJ, Abdelkarim H, Lee Y, Okamoto Y, Shikano S, Majetschak M, Heveker N, Volkman BF, Tarasova NI, Gaponenko V (2018). Biased antagonism of CXCR4 avoids antagonist tolerance. Sci Signal  11.   https://doi.org/10.1126/scisignal.aat2214",https://intramural.nih.gov/search/searchview.taf?ipid=108599
298,BC011311-10,"October 01, 2018 -  September 30, 2019",Identification of genetic interactors of Brca2,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",Kajal  Biswas|Suhas Sampat Kharat; PhD|Betty K Martin|Satheesh Kumar Sengodan,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",NULL,NULL,"1. Biswas K, Philip S, Yadav A, Martin BK, Burkett S, Singh V, Babbar A, North SL, Chang S, Sharan SK (2018). BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage. Nat Commun  9, 537.   https://doi.org/10.1038/s41467-018-03020-6|2. Kim S, Lee E, Jung J, Lee JW, Kim HJ, Kim J, Yoo HJ, Lee HJ, Chae SY, Jeon SM, Son BH, Gong G, Sharan SK, Chang S (2018). microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer. Oncogene  37, 2982-2991.   https://doi.org/10.1038/s41388-018-0124-4",https://intramural.nih.gov/search/searchview.taf?ipid=108602
299,BC011313-10,"October 01, 2018 -  September 30, 2019",Design and Utility of Novel Proteinaceous Biomaterials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Galit  Fichman|Poulami  Majumder|Scott Thomas Walsh,Darrin  Pochan (University of Delaware)|Gerald  Brandacher (Johns Hopkins University)|Eric  Furst (University of Delaware),"Scott K Durum; PhD (Cancer Inflammation Program)|William G Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",Robert  Tycko; PhD (NIDDK),"1. Majumder P, Baxa U, Walsh STR, Schneider JP (2018). Design of a Multicompartment Hydrogel that Facilitates Time-Resolved Delivery of Combination Therapy and Synergized Killing of Glioblastoma. Angew Chem Int Ed Engl  57, 15040-15044.   https://doi.org/10.1002/anie.201806483|2. Nagarkar RP, Miller SE, Zhong S, Pochan DJ, Schneider JP (2018). Dynamic protein folding at the surface of stimuli-responsive peptide fibrils. Protein Sci  27, 1243-1251.   https://doi.org/10.1002/pro.3394|3. Yamada Y, Chowdhury A, Schneider JP, Stetler-Stevenson WG (2018). Macromolecule-Network Electrostatics Controlling Delivery of the Biotherapeutic Cell Modulator TIMP-2. Biomacromolecules  19, 1285-1293.   https://doi.org/10.1021/acs.biomac.8b00107",https://intramural.nih.gov/search/searchview.taf?ipid=108603
300,BC011314-10,"October 01, 2018 -  September 30, 2019",Development of antibacterial agents and materials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Stephen Edward Miller; PhD|Scott Thomas Walsh|Martin John Schnermann; PhD,Darrin  Pochan (University of Delaware)|Gerald  Brandacher (Johns Hopkins University)|Brian  Bush (NIST)|Hedi  Mattoussi (The Florida State University),NULL,NULL,"1. Gril B, Paranjape AN, Woditschka S, Hua E, Dolan EL, Hanson J, Wu X, Kloc W, Izycka-Swieszewska E, Duchnowska R, Pęksa R, Biernat W, Jassem J, Nayyar N, Brastianos PK, Hall OM, Peer CJ, Figg WD, Pauly GT, Robinson C, Difilippantonio S, Bialecki E, Metellus P, Schneider JP, Steeg PS (2018). Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases. Nat Commun  9, 2705.   https://doi.org/10.1038/s41467-018-05030-w|2. Kapur A, Medina SH, Wang W, Palui G, Ji X, Schneider JP, Mattoussi H (2018). Enhanced Uptake of Luminescent Quantum Dots by Live Cells Mediated by a Membrane-Active Peptide. ACS Omega  3, 17164-17172.   https://doi.org/10.1021/acsomega.8b02918|3. Kapur A, Medina SH, Wang W, Palui G, Schneider JP, Mattoussi H (2018). Intracellular Delivery of Gold Nanocolloids Promoted by a Chemically Conjugated Anticancer Peptide. ACS Omega  3, 12754-12762.   https://doi.org/10.1021/acsomega.8b02276|4. Shi J, Fichman G, Schneider JP (2018). Enzymatic Control of the Conformational Landscape of Self-Assembling Peptides. Angew Chem Int Ed Engl  57, 11188-11192.   https://doi.org/10.1002/anie.201803983",https://intramural.nih.gov/search/searchview.taf?ipid=108604
301,BC011319-10,"October 01, 2018 -  September 30, 2019",Role of FIR in limb morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang,NULL,David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108606
302,BC011321-10,"October 01, 2018 -  September 30, 2019",Identification and characterization of FGF target genes,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Michael Graham Stanley Boylan|Cynthia M Elder|Salvia  Misaghian,NULL,NULL,NULL,"1. Rodgers HM, Huffman VJ, Voronina VA, Lewandoski M, Mathers PH (2018). The role of the Rx homeobox gene in retinal progenitor proliferation and cell fate specification. Mech Dev  151, 18-29.   https://doi.org/10.1016/j.mod.2018.04.003",https://intramural.nih.gov/search/searchview.taf?ipid=108607
303,BC011325-10,"October 01, 2018 -  September 30, 2019",Retrovirus Biology,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Banhi  Biswas|Demetria P Harvin|Tomas  Kroupa; PhD|Kin Kui  Lai|Alex  Compton,Stephen P Goff|Heinrich  Gottlinger (University of Massachusetts Medical School)|Sara  Sukumar (Johns Hopkins Oncology Center)|Ina  O'Carroll|Elizabeth  Yates (United States Naval Academy)|John  Coffin (Tufts University)|Show all 8,Kunio  Nagashima (Office of the Director)|Thorkell  Andresson (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Ulrich  Baxa; PhD (Office Of The Director)|Eric O Freed; PhD (HIV Drug Resistance Program)|Yun Xing M Wang (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108609
304,BC011328-10,"October 01, 2018 -  September 30, 2019",Characterization of the Osteosarcoma Genome,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","James Leland Thomas Dalgleish|Sean Richard Davis; MD, PhD|Arthur A Glatfelter; MS|John E Lueders|Marbin A Pineda|Robert L Walker; BS|Show all 7","Ching  Lau (Ped Heme/Onc, Texas Children's Hospital)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|John  Healey (Memorial Sloan Kettering Cancer Center)|Lee Jay Helman; MD (NCI)",Sharon Ann Savage (Clinical Genetics Branch)|Lisa  Mirabello (Clinical Genetics Branch)|Amy Kathleen Leblanc; DVM (Molecular Imaging Program),NULL,"1. Ma X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, Zhou X, Li Y, Rusch MC, Easton J, Huether R, Gonzalez-Pena V, Wilkinson MR, Hermida LC, Davis S, Sioson E, Pounds S, Cao X, Ries RE, Wang Z, Chen X, Dong L, Diskin SJ, Smith MA, Guidry Auvil JM, et al. [8 more authors] (2018). Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature  555, 371-376.   https://doi.org/10.1038/nature25795|2. Morrow JJ, Bayles I, Funnell APW, Miller TE, Saiakhova A, Lizardo MM, Bartels CF, Kapteijn MY, Hung S, Mendoza A, Dhillon G, Chee DR, Myers JT, Allen F, Gambarotti M, Righi A, DiFeo A, Rubin BP, Huang AY, Meltzer PS, Helman LJ, Picci P, Versteeg HH, Stamatoyannopoulos JA, Khanna C, et al. [1 more author] (2018). Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat Med  24, 176-185.   https://doi.org/10.1038/nm.4475|3. Roberts RD, Lizardo MM, Reed DR, Hingorani P, Glover J, Allen-Rhoades W, Fan T, Khanna C, Sweet-Cordero EA, Cash T, Bishop MW, Hegde M, Sertil AR, Koelsche C, Mirabello L, Malkin D, Sorensen PH, Meltzer PS, Janeway KA, Gorlick R, Crompton BD (2019). Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group. Cancer  125, 3514-3525.   https://doi.org/10.1002/cncr.32351|4. Yost KE, Clatterbuck Soper SF, Walker RL, Pineda MA, Zhu YJ, Ester CD, Showman S, Roschke AV, Waterfall JJ, Meltzer PS (2019). Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells. Sci Rep  9, 4544.   https://doi.org/10.1038/s41598-019-41058-8",https://intramural.nih.gov/search/searchview.taf?ipid=108610
305,BC011332-10,"October 01, 2018 -  September 30, 2019",Tumor Microenvironment in Cancer Progression,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Daniel Wirth Beury|Wei  Ju|Sabina Anna Kaczanowska|Meera  Murgai|Shil  Patel|Carol J Thiele,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|David  Lyden (Weill Cornell Medical Center)|Shahin  Rafii (Weill Cornell Medical Center)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Show all 8",Javed  Khan; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108612
306,BC011333-10,"October 01, 2018 -  September 30, 2019",Neuropsychological outcome measures in patients receiving whole brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108613
307,BC011334-10,"October 01, 2018 -  September 30, 2019",Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Daniel Wirth Beury|Wei  Ju|Sabina Anna Kaczanowska|Meera  Murgai|Shil  Patel|Katherine Elizabeth Warren; MD|Show all 7,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Paul  Meyers (Memorial Sloan Kettering Cancer Center)|Peter  Steinherz (Memorial Sloan Kettering Cancer Center)|Show all 8",Sharon Ann Savage (Clinical Genetics Branch)|Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Cornetta K, Duffy L, Feldman SA, Mackall CL, Davila ML, Curran KJ, Junghans RP, Tang JY, Kochenderfer JN, O'Cearbhaill R, Archer G, Kiem HP, Shah NN, Delbrook C, Kaplan R, Brentjens RJ, Rivière I, Sadelain M, Rosenberg SA (2018). Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience. Mol Ther Methods Clin Dev  10, 371-378.   https://doi.org/10.1016/j.omtm.2018.08.006",https://intramural.nih.gov/search/searchview.taf?ipid=108614
308,BC011336-10,"October 01, 2018 -  September 30, 2019",Tools for Prediction of ADME-Tox Properties,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach,"Ann  Richard (EPA)|Antony  Williams|Huixiao  Hong (NCI)|Kamel  Mansouri (EPA)|Barry  Bunin (Collaborative Drug Discovery (CDD), Inc.)|Alex  Clark (Molecular Materials Informatics, Inc.)",NULL,"Christopher P Austin; AB, MD (NCATS)","1. Pogodin PV, Lagunin AA, Rudik AV, Filimonov DA, Druzhilovskiy DS, Nicklaus MC, Poroikov VV (2018). How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors. Front Chem  6, 133.   https://doi.org/10.3389/fchem.2018.00133",https://intramural.nih.gov/search/searchview.taf?ipid=108615
309,BC011337-10,"October 01, 2018 -  September 30, 2019",Generation of T-cell receptors recognizing antigens on non-melanoma tumors,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Kenichi  Hanada|Amanda Jayne Lyon; PhD,NULL,William Marston Linehan; MD (Urologic Oncology Branch),NULL,"1. Jafferji MS, Yang JC (2019). Adoptive T-Cell Therapy for Solid Malignancies. Surg Oncol Clin N Am  28, 465-479.   https://doi.org/10.1016/j.soc.2019.02.012|2. Jin L, Ge H, Long Y, Yang C, Chang YE, Mu L, Sayour EJ, De Leon G, Wang QJ, Yang JC, Kubilis PS, Bao H, Xia S, Lu D, Kong Y, Hu L, Shang Y, Jiang C, Nie J, Li S, Gu Y, Sun J, Mitchell DA, Lin Z, Huang J (2018). CD70, a novel target of CAR T-cell therapy for gliomas. Neuro Oncol  20, 55-65.   https://doi.org/10.1093/neuonc/nox116|3. Jin L, Tao H, Karachi A, Long Y, Hou A, Na M, Dyson K, Grippin A, Deleyrolle L, Zhang W, Rajon D, Wang Q, Yang J, Kresak J, Sayour E, Rahman M, Bova F, Lin Z (2019) CXCR1- or CXCR2-Modified CAR T cells Co-opt IL-8 for Maximal Antitumor Efficacy in Solid Tumors. Nature Communications, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=108616
310,BC011340-10,"October 01, 2018 -  September 30, 2019",Preclinical evaluation of novel therapeutics for CNS tumor therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Rafael  Cruz Garcia|Cynthia M Lester mccully|Robert F Murphy|Srivandana  Akshintala|Andrea Michelle Gross; MD,"Dannis  van Vuurden (VU University medical Center)|Eric H Raabe|Javad  Nazarian (Children's National Medical Center)|Paul  Hergenrother (Chemistry, University of Illinois)|Nicholas  Vitanza (Seattle Children's Hospital)|Jeffrey Aaron Rubens (PEDIATRIC ONCOLOGY BRANCH)|Show all 9",William D Figg; PharmD (Genitourinary Malignancies Branch)|Cody John Peer (Office Of The Clinical Director)|Simone  Difilippantonio (Office Of The Director),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108617
311,BC011343-10,"October 01, 2018 -  September 30, 2019",Clinical protocols for the treatment of gastrointestinal cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Donna  Mabry|Chunhui  Wang|Haleluya Gedlu Yimamu,NULL,"Seth M Steinberg; PhD (Office Of The Clinical Director)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Douglas K Price (Genitourinary Malignancies Branch)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Bradford J Wood; MD (Office of the Director)",Theo  Heller; MD (NIDDK) |Venkatesh P Krishnasamy (CC) |Elliot Brian Levy (CC),"1. Alter H, Block T, Brown N, Brownstein A, Brosgart C, Chang KM, Chen PJ, Chisari FV, Cohen C, El-Serag H, Feld J, Gish R, Glenn J, Greten T, Guo H, Guo JT, Hoshida Y, Hu J, Kowdley KV, Li W, Liang J, Locarnini S, Lok AS, Mason W, McMahon B, et al. [10 more authors] (2018). A research agenda for curing chronic hepatitis B virus infection. Hepatology  67, 1127-1131.   https://doi.org/10.1002/hep.29509|2. Block TM, Alter H, Brown N, Brownstein A, Brosgart C, Chang KM, Chen PJ, Cohen C, El-Serag H, Feld J, Gish R, Glenn J, Greten TF, Guo JT, Hoshida Y, Kowdley KV, Li W, Lok AS, McMahon B, Mehta A, Perrillo R, Rice CM, Rinaudo J, Schinazi RF, Shetty K (2018). Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop. Antiviral Res  150, 93-100.   https://doi.org/10.1016/j.antiviral.2017.12.006|3. Brar G, Greten TF, Brown ZJ (2018). Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapy. Therap Adv Gastroenterol  11, 1756284818808086.   https://doi.org/10.1177/1756284818808086|4. Floudas CS, Brar G, Greten TF (2019). Immunotherapy: Current Status and Future Perspectives. Dig Dis Sci  64, 1030-1040.   https://doi.org/10.1007/s10620-019-05516-7|5. Gerbes A, Zoulim F, Tilg H, Dufour JF, Bruix J, Paradis V, Salem R, Peck-Radosavljevic M, Galle PR, Greten TF, Nault JC, Avila MA (2018). Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut  67, 380-388.   https://doi.org/10.1136/gutjnl-2017-315068|6. Greten TF, Lai CW, Li G, Staveley-O'Carroll KF (2019). Targeted and Immune-Based Therapies for Hepatocellular Carcinoma. Gastroenterology  156, 510-524.   https://doi.org/10.1053/j.gastro.2018.09.051|7. Levy EB, Peer C, Sissung TM, Venkatesan A, Pandalai P, Greten T, Hughes MS, Garcia C, Peretti J, Figg W, Lewis A, Wood B (2019). Pilot Study Comparing Systemic and Tissue Pharmacokinetics of Irinotecan and Metabolites after Hepatic Drug-Eluting Chemoembolization. J Vasc Interv Radiol  30, 19-22.   https://doi.org/10.1016/j.jvir.2018.06.023",https://intramural.nih.gov/search/searchview.taf?ipid=108618
312,BC011344-10,"October 01, 2018 -  September 30, 2019",Immune suppressor mechanisms in patients with GI cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Bernd  Heinrich|Varun Kumar Subramanyam|Chunhui  Wang,NULL,Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis),NULL,"1. Greten TF (2018). The ABC of adaptive immunity in liver cancer. Hepatology  68, 777-779.   https://doi.org/10.1002/hep.29839|2. Greten TF, Korangy F (2018). CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC. Gut  67, 783-784.   https://doi.org/10.1136/gutjnl-2017-315091|3. Ma C, Zhang Q, Greten TF (2018). Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes. FEBS J  285, 752-762.   https://doi.org/10.1111/febs.14209|4. Ziegler PK, Bollrath J, Pallangyo CK, Matsutani T, Canli Ö, De Oliveira T, Diamanti MA, Müller N, Gamrekelashvili J, Putoczki T, Horst D, Mankan AK, Öner MG, Müller S, Müller-Höcker J, Kirchner T, Slotta-Huspenina J, Taketo MM, Reinheckel T, Dröse S, Larner AC, Wels WS, Ernst M, Greten TF, Arkan MC, et al. [3 more authors] (2018). Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis. Cell  174, 88-101.e16.   https://doi.org/10.1016/j.cell.2018.05.028",https://intramural.nih.gov/search/searchview.taf?ipid=108619
313,BC011345-10,"October 01, 2018 -  September 30, 2019",Analysis of cancer-related immune suppressor mechanisms in mice,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Linda Leyi Cui|Bernd  Heinrich|Chi  Ma|Umberto  Rosato|Benjamin  Ruf|Simon Franz Fredrich Wabitsch|Show all 7,NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|William G Telford (Experimental Transplantation and Immunology Branch)|Masaki  Terabe (Neuro-Oncology Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)",NULL,"1. Brown ZJ, Fu Q, Ma C, Kruhlak M, Zhang H, Luo J, Heinrich B, Yu SJ, Zhang Q, Wilson A, Shi ZD, Swenson R, Greten TF (2018). Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development. Cell Death Dis  9, 620.   https://doi.org/10.1038/s41419-018-0687-6|2. Brown ZJ, Heinrich B, Greten TF (2018). Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research. Nat Rev Gastroenterol Hepatol  15, 536-554.   https://doi.org/10.1038/s41575-018-0033-6|3. Brown ZJ, Yu SJ, Heinrich B, Ma C, Fu Q, Sandhu M, Agdashian D, Zhang Q, Korangy F, Greten TF (2018). Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma. Cancer Immunol Immunother  67, 1305-1315.   https://doi.org/10.1007/s00262-018-2190-4|4. Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, Agdashian D, Terabe M, Berzofsky JA, Fako V, Ritz T, Longerich T, Theriot CM, McCulloch JA, Roy S, Yuan W, Thovarai V, Sen SK, Ruchirawat M, Korangy F, Wang XW, Trinchieri G, Greten TF (2018). Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science  360.   https://doi.org/10.1126/science.aan5931|5. Yu SJ, Ma C, Heinrich B, Brown ZJ, Sandhu M, Zhang Q, Fu Q, Agdashian D, Rosato U, Korangy F, Greten TF (2019). Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. J Hepatol  70, 449-457.   https://doi.org/10.1016/j.jhep.2018.10.040",https://intramural.nih.gov/search/searchview.taf?ipid=108620
314,BC011351-10,"October 01, 2018 -  September 30, 2019",Bladder Cancer Program,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","James L Gulley; MD, PhD",Dean  Bajorin (MSKCC)|Matthew  Galsky (Mount Sinai)|Dan  Theodorescu (University of Colorado)|Jean  Hoffman-Censits (Jefferson University Hospital)|Sumanta  Pal (City of Hope)|Arthur  DeCillis (Exelixis),Maria  Merino; PhD (Laboratory of Pathology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Mark  Raffeld; MD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),Les Roger Folio (CC) |Ashkan A Malayeri (CC),"1. Amara CS, Ambati CR, Vantaku V, Badrajee Piyarathna DW, Donepudi SR, Ravi SS, Arnold JM, Putluri V, Chatta G, Guru KA, Badr H, Terris MK, Bollag RJ, Sreekumar A, Apolo AB, Putluri N (2019). Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival. Cancer Epidemiol Biomarkers Prev  28, 770-781.   https://doi.org/10.1158/1055-9965.EPI-18-0936|2. Harshman LC, Tripathi A, Kaag M, Efstathiou JA, Apolo AB, Hoffman-Censits JH, Stadler WM, Yu EY, Bochner BH, Skinner EC, Downs T, Kiltie AE, Bajorin DF, Guru K, Shipley WU, Steinberg GD, Hahn NM, Sridhar SS (2018). Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer. Clin Genitourin Cancer  16, 213-218.   https://doi.org/10.1016/j.clgc.2017.11.004|3. Merseburger AS, Apolo AB, Chowdhury S, Hahn NM, Galsky MD, Milowsky MI, Petrylak D, Powles T, Quinn DI, Rosenberg JE, Siefker-Radtke A, Sonpavde G, Sternberg CN (2019). SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer. World J Urol  37, 95-105.   https://doi.org/10.1007/s00345-018-2486-1|4. Nadal R, Apolo AB (2018). Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma. Curr Treat Options Oncol  19, 36.   https://doi.org/10.1007/s11864-018-0551-z|5. Powles T, Necchi A, Rosen G, Hariharan S, Apolo AB (2018). Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development. Clin Genitourin Cancer  16, 117-129.   https://doi.org/10.1016/j.clgc.2017.11.002|6. Siefker-Radtke AO, Apolo AB, Bivalacqua TJ, Spiess PE, Black PC (2018). Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial Carcinoma. J Urol  199, 1129-1142.   https://doi.org/10.1016/j.juro.2017.10.041|7. Vantaku V, Donepudi SR, Piyarathna DWB, Amara CS, Ambati CR, Tang W, Putluri V, Chandrashekar DS, Varambally S, Terris MK, Davies K, Ambs S, Bollag R, Apolo AB, Sreekumar A, Putluri N (2019). Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival. Cancer  125, 921-932.   https://doi.org/10.1002/cncr.31890|8. Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, Putluri V, Ravi SS, Robertson MJ, Piyarathna DWB, Villanueva M, von Rundstedt FC, Karanam B, Ballester LY, Terris MK, Bollag RJ, Lerner SP, Apolo AB, Villanueva H, Lee M, Sikora AG, Lotan Y, Sreekumar A, Coarfa C, Putluri N (2019). Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer. Clin Cancer Res  25, 3689-3701.   https://doi.org/10.1158/1078-0432.CCR-18-1515",https://intramural.nih.gov/search/searchview.taf?ipid=108621
315,BC011354-10,"October 01, 2018 -  September 30, 2019",BCR Signaling in ABC DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Christopher Joseph Melani|Saleema  Osman|Louis  Staudt; MD,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Younes A, Sehn LH, Johnson P, Zinzani PL, Hong X, Zhu J, Patti C, Belada D, Samoilova O, Suh C, Leppä S, Rai S, Turgut M, Jurczak W, Cheung MC, Gurion R, Yeh SP, Lopez-Hernandez A, Dührsen U, Thieblemont C, Chiattone CS, Balasubramanian S, Carey J, Liu G, Shreeve SM, PHOENIX investigators, et al. [5 more authors] (2019). Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. J Clin Oncol  37, 1285-1295.   https://doi.org/10.1200/JCO.18.02403",https://intramural.nih.gov/search/searchview.taf?ipid=108622
316,BC011372-09,"October 01, 2018 -  September 30, 2019",Microenvironmental regulation of glioblastoma radiosensitivity,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Stacey Lynne Lehman|Joseph Hiram McAbee|Debasish  Sarkar|Cindy Rishma Timme|Theresa Faith Wechsler|Kevin A Camphausen; MD|Show all 7,NULL,NULL,NULL,"1. Krauze AV, Mackey M, Rowe L, Chang MG, Holdford DJ, Cooley T, Shih J, Tofilon PJ, Camphausen K (2018). Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma. Neurooncol Pract  5, 246-250.   https://doi.org/10.1093/nop/npy009|2. Rath BH, Waung I, Camphausen K, Tofilon PJ (2018). Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity. Mol Cancer Ther  17, 1070-1078.   https://doi.org/10.1158/1535-7163.MCT-17-1053|3. Timme CR, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ (2018). The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and as Orthotopic Xenografts. Mol Cancer Ther  17, 1207-1216.   https://doi.org/10.1158/1535-7163.MCT-17-1267",https://intramural.nih.gov/search/searchview.taf?ipid=108623
317,BC011373-09,"October 01, 2018 -  September 30, 2019",Radiation-induced translational control of gene expression,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Stacey Lynne Lehman|Joseph Hiram McAbee|Debasish  Sarkar|Cindy Rishma Timme|Theresa Faith Wechsler|Kevin A Camphausen; MD|Show all 7,NULL,NULL,NULL,"1. Wahba A, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ (2018). The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo. Mol Cancer Ther  17, 1717-1726.   https://doi.org/10.1158/1535-7163.MCT-17-1303|2. Wahba A, Ryan MC, Shankavaram UT, Camphausen K, Tofilon PJ (2018). Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA. Oncotarget  9, 691-705.   https://doi.org/10.18632/oncotarget.21672|3. Wang Z, Feng X, Molinolo AA, Martin D, Vitale-Cross L, Nohata N, Ando M, Wahba A, Amornphimoltham P, Wu X, Gilardi M, Allevato M, Wu V, Steffen DJ, Tofilon P, Sonenberg N, Califano J, Chen Q, Lippman SM, Gutkind JS (2019). 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Res  79, 1438-1450.   https://doi.org/10.1158/0008-5472.CAN-18-1220",https://intramural.nih.gov/search/searchview.taf?ipid=108624
318,BC011374-09,"October 01, 2018 -  September 30, 2019",Allotransplant for DOCK8 deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,"Steven M Holland; MD (NIAID) |Helen C Su; MD, PhD (NIAID)","1. Aydin SE, Freeman AF, Al-Herz W, Al-Mousa HA, Arnaout RK, Aydin RC, Barlogis V, Belohradsky BH, Bonfim C, Bredius RG, Chu JI, Ciocarlie OC, Doğu F, Gaspar HB, Geha RS, Gennery AR, Hauck F, Hawwari A, Hickstein DD, Hoenig M, Ikinciogullari A, Klein C, Kumar A, Ifversen MRS, Matthes S, Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and the European Society for Primary Immunodeficiencies, et al. [17 more authors] (2019). Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency. J Allergy Clin Immunol Pract  7, 848-855.   https://doi.org/10.1016/j.jaip.2018.10.035|2. Freeman AF, Yazigi N, Shah NN, Kleiner DE, Parta M, Atkinson P, Heller T, Holland SM, Kaufman SS, Khan KM, Hickstein DD (2019). Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency. Transplantation  103, 2144-2149.   https://doi.org/10.1097/TP.0000000000002649|3. Shah NN, Freeman AF, Hickstein DD (2019). Addendum to: Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency Using Post-Transplantation Cyclophosphamide. Biol Blood Marrow Transplant  25, e65-e67.   https://doi.org/10.1016/j.bbmt.2018.11.014",https://intramural.nih.gov/search/searchview.taf?ipid=108625
319,BC011378-09,"October 01, 2018 -  September 30, 2019",Studies of amplification in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Bishwanath  Chatterjee; PhD|Thanh Hung Nguyen|Wenyue  Sun|Stephen M Hewitt; MD, PhD",NULL,John Frederick Shern (Pediatric Oncology Branch)|Javed  Khan; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108626
320,BC011379-09,"October 01, 2018 -  September 30, 2019",Inhibitor Development Against the Wip1 Phosphatase,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Ettore  Appella; MD,NULL,NULL,Daniel  Appella; PhD (NIDDK),"1. Debnath S, Kosek D, Tagad HD, Durell SR, Appella DH, Acevedo R, Grishaev A, Dyda F, Appella E, Mazur SJ (2018). A trapped human PPM1A-phosphopeptide complex reveals structural features critical for regulation of PPM protein phosphatase activity. J Biol Chem  293, 7993-8008.   https://doi.org/10.1074/jbc.RA117.001213",https://intramural.nih.gov/search/searchview.taf?ipid=108627
321,BC011381-09,"October 01, 2018 -  September 30, 2019",Brd4 is an atypical kinase that regulates transcription,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Devaiah Nanjappa Ballachanda|Jie  Mu|Amit Kumar Singh; PhD|Jocelyn D Weissman,NULL,Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Peter W Schuck; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108629
322,BC011382-09,"October 01, 2018 -  September 30, 2019",Systems-level analysis of the regulation and function of p53 dynamics,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Ryan Lee Hanson; PhD|Marie Deborah Gaynelle Harton; PhD|Woo Seuk  Koh|Zhilin  Yang|Ettore  Appella; MD|Pedro Jorge De Oliveira Rodrigues Batista; PhD|Show all 9,Klaus  Hahn (UNC-Chapel Hill)|Richard  Anderson (University Of Wisconsin - Madison)|Abhyudai  Singh (University Of Delaware),NULL,"Perry Justin Blackshear; MD, DPhil (NIEHS)","1. Hanson RL, Porter JR, Batchelor E (2019). Protein stability of p53 targets determines their temporal expression dynamics in response to p53 pulsing. J Cell Biol  218, 1282-1297.   https://doi.org/10.1083/jcb.201803063|2. Koh WS, Porter JR, Batchelor E (2019). Tuning of mRNA stability through altering 3'-UTR sequences generates distinct output expression in a synthetic circuit driven by p53 oscillations. Sci Rep  9, 5976.   https://doi.org/10.1038/s41598-019-42509-y",https://intramural.nih.gov/search/searchview.taf?ipid=108630
323,BC011383-09,"October 01, 2018 -  September 30, 2019",Transcription and Splicing Dynamics in Single Cells,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Abdalla Mahmoud Akef|Gloria Rene Garcia|Murali  Palangat; PhD|Simona Saiprasad Patange|Yihan  Wan; PhD,Harold  Varmus; MD (OD)|Siddhartha  Mukherjee (Columbia University Medical Center)|Michael  Poirier (Ohio State University),David  Levens; PhD (Laboratory of Pathology),"Carson C Chow; BASc, PhD (NIDDK) |Markus  Hafner (NIAMS)","1. Donovan BT, Huynh A, Ball DA, Patel HP, Poirier MG, Larson DR, Ferguson ML, Lenstra TL (2019). Live-cell imaging reveals the interplay between transcription factors, nucleosomes, and bursting. EMBO J  38.   https://doi.org/10.15252/embj.2018100809|2. Palangat M, Anastasakis DG, Fei DL, Lindblad KE, Bradley R, Hourigan CS, Hafner M, Larson DR (2019). The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation. Genes Dev  33, 482-497.   https://doi.org/10.1101/gad.319590.118|3. Patange S, Girvan M, Larson DR (2018). Single-cell systems biology: probing the basic unit of information flow. Curr Opin Syst Biol  8, 7-15.   https://doi.org/10.1016/j.coisb.2017.11.011|4. Rodriguez J, Ren G, Day CR, Zhao K, Chow CC, Larson DR (2019). Intrinsic Dynamics of a Human Gene Reveal the Basis of Expression Heterogeneity. Cell  176, 213-226.e18.   https://doi.org/10.1016/j.cell.2018.11.026|5. Tsai PF, Dell'Orso S, Rodriguez J, Vivanco KO, Ko KD, Jiang K, Juan AH, Sarshad AA, Vian L, Tran M, Wangsa D, Wang AH, Perovanovic J, Anastasakis D, Ralston E, Ried T, Sun HW, Hafner M, Larson DR, Sartorelli V (2018). A Muscle-Specific Enhancer RNA Mediates Cohesin Recruitment and Regulates Transcription In trans. Mol Cell  71, 129-141.e8.   https://doi.org/10.1016/j.molcel.2018.06.008|6. Wan Y, Larson DR (2018). Splicing heterogeneity: separating signal from noise. Genome Biol  19, 86.   https://doi.org/10.1186/s13059-018-1467-4",https://intramural.nih.gov/search/searchview.taf?ipid=108631
324,BC011387-09,"October 01, 2018 -  September 30, 2019",Studies of gene fusions in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Salah  Boudjadi|Bishwanath  Chatterjee; PhD|Thanh Hung Nguyen|Wenyue  Sun|Stephen M Hewitt; MD, PhD|Svetlana Dmitriyevna Pack; PhD","Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Stephen  Skapek (The University of Chicago)|Lisa  Teot (Children's Hospital)|Erin  Rudzinski (Oregon Health and Science University)|Julie  Gastier-Foster (Nationwide Children's Hospital)|Michael  Arnold (Nationwide Childrenâ€™s Hospital)|Show all 10",John Frederick Shern (Pediatric Oncology Branch)|Javed  Khan; MD (Cancer Genetics Branch)|Christine Marie Heske (Pediatric Oncology Branch),NULL,"1. Bharathy N, Berlow NE, Wang E, Abraham J, Settelmeyer TP, Hooper JE, Svalina MN, Ishikawa Y, Zientek K, Bajwa Z, Goros MW, Hernandez BS, Wolff JE, Rudek MA, Xu L, Anders NM, Pal R, Harrold AP, Davies AM, Ashok A, Bushby D, Mancini M, Noakes C, Goodwin NC, Ordentlich P, et al. [13 more authors] (2018). The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma. Sci Signal  11.   https://doi.org/10.1126/scisignal.aau7632|2. Boudjadi S, Chatterjee B, Sun W, Vemu P, Barr FG (2018). The expression and function of PAX3 in development and disease. Gene  666, 145-157.   https://doi.org/10.1016/j.gene.2018.04.087|3. Nguyen TH, Barr FG (2018). Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma. Molecules  23.   https://doi.org/10.3390/molecules23112798|4. Skapek SX, Ferrari A, Gupta AA, Lupo PJ, Butler E, Shipley J, Barr FG, Hawkins DS (2019). Rhabdomyosarcoma. Nat Rev Dis Primers  5, 1.   https://doi.org/10.1038/s41572-018-0051-2",https://intramural.nih.gov/search/searchview.taf?ipid=108633
325,BC011390-09,"October 01, 2018 -  September 30, 2019",Vascular Biology Section,Pengnian Charles Lin; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jae Woo Hong|Wooram  Jung|Yongfen  Min|Peng  Qu|Howard A Young; PhD,"Michelle A. Petri; MD (Internal Medicine, Johns Hopkins University)|Dan  Berkowitz; MD (Johns Hopkins School of Medicine)|S  Wang (Adimmune Corporation)|Peter  Zhou (UNiversity of Kentuky)|Chuanshu  Huang (Nelson Institute of Environmental Medicine, New York University)",Li  Yang; PhD (Laboratory of Cancer Biology and Genetics)|Shyam K Sharan (Genetics of Cancer Susceptibility Section),Ilias  Alevizos; DMD (NIDCR),"1. Hong J, Kim S, Lin PC (2019). Interleukin-33 and ST2 Signaling in Tumor Microenvironment. J Interferon Cytokine Res  39, 61-71.   https://doi.org/10.1089/jir.2018.0044|2. Liu J, Duan Z, Guo W, Zeng L, Wu Y, Chen Y, Tai F, Wang Y, Lin Y, Zhang Q, He Y, Deng J, Stewart RL, Wang C, Lin PC, Ghaffari S, Evers BM, Liu S, Zhou MM, Zhou BP, Shi J (2018). Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer. Nat Commun  9, 5200.   https://doi.org/10.1038/s41467-018-07258-y",https://intramural.nih.gov/search/searchview.taf?ipid=108634
326,BC011391-09,"October 01, 2018 -  September 30, 2019",Role of IKK alpha in lung cancer development,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Sayantan  Banerjee|Gongping  Shi|Jami D Willette brown|Giorgio  Trinchieri,Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Nancy  Jenkins (Houston Methodist Research Institute),Curtis  Harris; MD (Laboratory of Human Carcinogenesis),NULL,"1. Gray Z, Shi G, Wang X, Hu Y (2018). Macrophage inducible nitric oxide synthase promotes the initiation of lung squamous cell carcinoma by maintaining circulated inflammation. Cell Death Dis  9, 642.   https://doi.org/10.1038/s41419-018-0653-3|2. Wang X, Gray Z, Willette-Brown J, Zhu F, Shi G, Jiang Q, Song NY, Dong L, Hu Y (2018). Macrophage inducible nitric oxide synthase circulates inflammation and promotes lung carcinogenesis. Cell Death Discov  4, 46.   https://doi.org/10.1038/s41420-018-0046-5|3. Zhu F, Hu Y (2018). Integrity of IKK/NF-κB Shields Thymic Stroma That Suppresses Susceptibility to Autoimmunity, Fungal Infection, and Carcinogenesis. Bioessays  40, e1700131.   https://doi.org/10.1002/bies.201700131",https://intramural.nih.gov/search/searchview.taf?ipid=108635
327,BC011393-09,"October 01, 2018 -  September 30, 2019",Development and regulation of stem cell lineages in skin,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Amy B Coxon|Lingling  Miao|Keisuke  Nagao,Sunny  Wong (University of Michigan)|Radhika  Atit (Case Western Reserve University),Natalie  Porat-Shliom (Thoracic and GI Malignancies Branch),Matthew William Kelley; PhD (NIDCD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108636
328,BC011394-09,"October 01, 2018 -  September 30, 2019",Molecular pathogenesis and therapy innovation for Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Amy B Coxon|Natasha Tremayne Hill; PhD|Lingling  Miao|Heidi H Kong,"Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Emily Yu-Kuang Chu; MD, PhD|Clayton  Green (Marshfield Clinic)|Bahar  Dasgeb (Memorial Sloan Ketting Cancer Center)|Show all 10","Christopher  Buck (Laboratory of Cellular Oncology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",Jay Robert Knutson; PhD (NHLBI) |Amir Hossein Gandjbakhche; PhD (NICHD) |Matthew David Hall (NCATS),"1. Gaiser MR, Weis CA, Gaiser T, Jiang H, Buder-Bakhaya K, Herpel E, Warth A, Xiao Y, Miao L, Brownell I (2018). Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells. Oncoimmunology  7, e1426517.   https://doi.org/10.1080/2162402X.2018.1426517|2. Pastrana DV, Peretti A, Welch NL, Borgogna C, Olivero C, Badolato R, Notarangelo LD, Gariglio M, FitzGerald PC, McIntosh CE, Reeves J, Starrett GJ, Bliskovsky V, Velez D, Brownell I, Yarchoan R, Wyvill KM, Uldrick TS, Maldarelli F, Lisco A, Sereti I, Gonzalez CM, Androphy EJ, McBride AA, Van Doorslaer K, et al. [7 more authors] (2018). Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency. mSphere  3.   https://doi.org/10.1128/mSphereDirect.00645-18|3. Paulson KG, Lahman MC, Chapuis AG, Brownell I (2019). Immunotherapy for skin cancer. Int Immunol  31, 465-475.   https://doi.org/10.1093/intimm/dxz012",https://intramural.nih.gov/search/searchview.taf?ipid=108637
329,BC011398-09,"October 01, 2018 -  September 30, 2019",Regulation of Ciliogenesis and Ciliary-related signaling,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Quanlong  Lu; PhD|Mihindukulasuriya Weliweriyage Sumeth Perera; DPHIL|Huijie  Zhao|Deborah K Morrison,Andrew  Peden (University of Sheffield)|Esben  Lorentzen (Max Plank Institute for  Biochemistry)|Lotte  Pedersen (University Of Copenhagen)|Matthew  Summer (The Ohio State University)|Chad  Pearson (University Of Colorado),Kedar  Narayan (Office of the Director),Anand  Swaroop; PhD (NEI),"1. Insinna C, Lu Q, Teixeira I, Harned A, Semler EM, Stauffer J, Magidson V, Tiwari A, Kenworthy AK, Narayan K, Westlake CJ (2019). Investigation of F-BAR domain PACSIN proteins uncovers membrane tubulation function in cilia assembly and transport. Nat Commun  10, 428.   https://doi.org/10.1038/s41467-018-08192-9|2. May-Simera HL, Wan Q, Jha BS, Hartford J, Khristov V, Dejene R, Chang J, Patnaik S, Lu Q, Banerjee P, Silver J, Insinna-Kettenhofen C, Patel D, Lotfi M, Malicdan M, Hotaling N, Maminishkis A, Sridharan R, Brooks B, Miyagishima K, Gunay-Aygun M, Pal R, Westlake C, Miller S, Sharma R, et al. [1 more author] (2018). Primary Cilium-Mediated Retinal Pigment Epithelium Maturation Is Disrupted in Ciliopathy Patient Cells. Cell Rep  22, 189-205.   https://doi.org/10.1016/j.celrep.2017.12.038|3. Nesmith JE, Hostelley TL, Leitch CC, Matern MS, Sethna S, McFarland R, Lodh S, Westlake CJ, Hertzano R, Ahmed ZM, Zaghloul NA (2019). Genomic knockout of alms1 in zebrafish recapitulates Alström syndrome and provides insight into metabolic phenotypes. Hum Mol Genet  28, 2212-2223.   https://doi.org/10.1093/hmg/ddz053",https://intramural.nih.gov/search/searchview.taf?ipid=108638
330,BC011405-09,"October 01, 2018 -  September 30, 2019",microRNA Profiling in the Spectrum of Kidney Tumors,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Xu  Naizhen|Rafael Santiago Parra Medina|Mark  Raffeld; MD|Jennifer Clare Jones; MD, PhD",NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|Mark Wayne Ball (Urologic Oncology Branch)|Vladmir Alexander Valera Romero; MD, PhD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Carlo MI, Hakimi AA, Stewart GD, Bratslavsky G, Brugarolas J, Chen YB, Linehan WM, Maher ER, Merino MJ, Offit K, Reuter VE, Shuch B, Coleman JA (2019). Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights. Eur Urol  76, 754-764.   https://doi.org/10.1016/j.eururo.2019.06.015",https://intramural.nih.gov/search/searchview.taf?ipid=108639
331,BC011406-09,"October 01, 2018 -  September 30, 2019",miRNA profiling of prostate cancer in young and older male patients,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Xu  Naizhen|David D Roberts; PhD|Jennifer Clare Jones; MD, PhD",NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Vladmir Alexander Valera Romero; MD, PhD (Urologic Oncology Branch)",NULL,"1. Merino MJ, Gil S, Macias CG, Lara K (2018). The Unknown microRNA Expression of Male Breast Cancer. Similarities and Differences with Female Ductal Carcinoma. Their Role as Tumor Biomarker. J Cancer  9, 450-459.   https://doi.org/10.7150/jca.23151",https://intramural.nih.gov/search/searchview.taf?ipid=108640
332,BC011407-09,"October 01, 2018 -  September 30, 2019",The International DIPG Registry,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Maryam  Fouladi (Cincinnati Children's Hospital Center)|Dannis  van Vuurden (VU University medical Center)|Darren  Hargrave (Great ormond Street Hospital for Children)|Chris  Jones (Institute of Cancer Research)|Ute  Bartels (Hospital for Sick Children),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108641
333,BC011410-09,"October 01, 2018 -  September 30, 2019",Protein phosphorylation downstream of mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Tsige Kidanemaryam Bahta|Constance M Cultraro|Tapan Kumar Maity|Yue  Qi|Abhilash  Venugopalan|Xu  Zhang,"Cathy  Wu (Protein Information Resource, Georgetown University)|Teresa  Fan (University of Louisville)",NULL,NULL,"1. Awasthi S, Maity T, Oyler BL, Zhang X, Goodlett DR, Guha U (2018). Dataset describing the development, optimization and application of SRM/MRM based targeted proteomics strategy for quantification of potential biomarkers of EGFR TKI sensitivity. Data Brief  19, 424-436.   https://doi.org/10.1016/j.dib.2018.04.086",https://intramural.nih.gov/search/searchview.taf?ipid=108643
334,BC011415-09,"October 01, 2018 -  September 30, 2019",Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Surgery Branch, NCI","Jennifer  Brudno|Jo Hannah Hurtt|Steven Aaron Rosenberg; MD, PhD",NULL,Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Luca  Gattinoni (Experimental Transplantation and Immunology Branch),NULL,"1. Rossi J, Paczkowski P, Shen YW, Morse K, Flynn B, Kaiser A, Ng C, Gallatin K, Cain T, Fan R, Mackay S, Heath JR, Rosenberg SA, Kochenderfer JN, Zhou J, Bot A (2018). Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL. Blood  132, 804-814.   https://doi.org/10.1182/blood-2018-01-828343",https://intramural.nih.gov/search/searchview.taf?ipid=108646
335,BC011417-09,"October 01, 2018 -  September 30, 2019",Improved Chimeric Antigen Receptor Therapies B-cell Malignancies,James N Kochenderfer|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Christina  Amatya|Jennifer  Brudno|Kathryn Marie Cappell|Norris Lio Lam|Danielle Anne Vanasse|Shicheng  Yang|Show all 7,"Adrian  Bot (Kite Pharma, Inc.)|Scott  Rodig (Brigham And Women's Hospital)",NULL,David F Stroncek; MD (CC),"1. Boyiadzis MM, Dhodapkar MV, Brentjens RJ, Kochenderfer JN, Neelapu SS, Maus MV, Porter DL, Maloney DG, Grupp SA, Mackall CL, June CH, Bishop MR (2018). Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance. J Immunother Cancer  6, 137.   https://doi.org/10.1186/s40425-018-0460-5|2. Brudno JN, Kochenderfer JN (2018). Chimeric antigen receptor T-cell therapies for lymphoma. Nat Rev Clin Oncol  15, 31-46.   https://doi.org/10.1038/nrclinonc.2017.128|3. Brudno JN, Kochenderfer JN (2019). Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management. Blood Rev  34, 45-55.   https://doi.org/10.1016/j.blre.2018.11.002|4. Panch SR, Srivastava SK, Elavia N, McManus A, Liu S, Jin P, Highfill SL, Li X, Dagur P, Kochenderfer JN, Fry TJ, Mackall CL, Lee D, Shah NN, Stroncek DF (2019). Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics. Mol Ther  27, 1275-1285.   https://doi.org/10.1016/j.ymthe.2019.05.015",https://intramural.nih.gov/search/searchview.taf?ipid=108647
336,BC011418-09,"October 01, 2018 -  September 30, 2019",Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Sudheer Kumar Gara|Julie A Hong|Vivek  Shukla; BSc, MSc|Rui-Hong  Wang|Yuan  Xu; PhD|Mary R Zhang",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Karl Thomas Ried; MD (Cancer Genetics Branch)",NULL,"1. Zhang MR, Xi S, Shukla V, Hong JA, Chen H, Xiong Y, Ripley RT, Hoang CD, Schrump DS (2018). The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy. Ann Am Thorac Soc  15, S124.   https://doi.org/10.1513/AnnalsATS.201707-608MG",https://intramural.nih.gov/search/searchview.taf?ipid=108648
337,BC011419-09,"October 01, 2018 -  September 30, 2019",Structural Biology of GTPase Activating Proteins,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Olivier Francois Andre  Soubias; PhD|Yue  Zhang,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Di S Xia; PhD, MS, BS (Crystallography Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108649
338,BC011422-08,"October 01, 2018 -  September 30, 2019",Role of IKK alpha in lymphoid organ development,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jami D Willette brown|Feng  Zhu; PhD|Giorgio  Trinchieri,Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Florian  Greten (The International Max Planck Research School for Molecular and Cellular Life Sciences),NULL,NULL,"1. Ramakrishnan SK, Zhang H, Ma X, Jung I, Schwartz AJ, Triner D, Devenport SN, Das NK, Xue X, Zeng MY, Hu Y, Mortensen RM, Greenson JK, Cascalho M, Wobus CE, Colacino JA, Nunez G, Rui L, Shah YM (2019). Intestinal non-canonical NFκB signaling shapes the local and systemic immune response. Nat Commun  10, 660.   https://doi.org/10.1038/s41467-019-08581-8",https://intramural.nih.gov/search/searchview.taf?ipid=108666
339,BC011423-08,"October 01, 2018 -  September 30, 2019",Epigenetic studies in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Bishwanath  Chatterjee; PhD|Wenyue  Sun|Stephen M Hewitt; MD, PhD","Corinne  Linardic (Duke University)|Peter  Houghton (Greehey Children's Cancer Research Institute)|Bruce  Pawel (Children's Hospital of Philadelphia)|Yueh-yun  Chi (University Of Florida)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Charles  Keller (University of Texas)|Show all 8","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|John Frederick Shern (Pediatric Oncology Branch)|Javed  Khan; MD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108672
340,BC011426-08,"October 01, 2018 -  September 30, 2019",HIV-1 Integrase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Dimiter  Demirov; PhD|Andrea L Ferris|Shuang  Guo; PhD|Steven J Smith|David  Wells|Katharine Kim Hewlett,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Alan  Engelman; PhD (Dana-Farber, Harvard University)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Peter  Cherepanov (Imperial College London)|John  Coffin (Tufts University (and HIV Drug Resistance Program))|Show all 9",Frank  Maldarelli (Host Virus Interaction Branch)|Xiaolin  Wu; PhD (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Mary  Kearney (Host Virus Interaction Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Henry L Levin; PhD (NICHD) |Daniel C Douek; MD (NIAID) |Eli  Boritz (NIAID),"1. Achuthan V, Perreira JM, Sowd GA, Puray-Chavez M, McDougall WM, Paulucci-Holthauzen A, Wu X, Fadel HJ, Poeschla EM, Multani AS, Hughes SH, Sarafianos SG, Brass AL, Engelman AN (2018). Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration. Cell Host Microbe  24, 392-404.e8.   https://doi.org/10.1016/j.chom.2018.08.002|2. Ferris AL, Wells DW, Guo S, Del Prete GQ, Swanstrom AE, Coffin JM, Wu X, Lifson JD, Hughes SH (2019). Clonal expansion of SIV-infected cells in macaques on antiretroviral therapy is similar to that of HIV-infected cells in humans. PLoS Pathog  15, e1007869.   https://doi.org/10.1371/journal.ppat.1007869|3. Roth TL, Puig-Saus C, Yu R, Shifrut E, Carnevale J, Li PJ, Hiatt J, Saco J, Krystofinski P, Li H, Tobin V, Nguyen DN, Lee MR, Putnam AL, Ferris AL, Chen JW, Schickel JN, Pellerin L, Carmody D, Alkorta-Aranburu G, Del Gaudio D, Matsumoto H, Morell M, Mao Y, Cho M, et al. [20 more authors] (2018). Reprogramming human T cell function and specificity with non-viral genome targeting. Nature  559, 405-409.   https://doi.org/10.1038/s41586-018-0326-5|4. Smith SJ, Zhao XZ, Burke TR, Hughes SH (2018). Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants. Retrovirology  15, 37.   https://doi.org/10.1186/s12977-018-0420-7|5. Smith SJ, Zhao XZ, Burke TR, Hughes SH (2018). HIV-1 Integrase Inhibitors That Are Broadly Effective against Drug-Resistant Mutants. Antimicrob Agents Chemother  62.   https://doi.org/10.1128/AAC.01035-18",https://intramural.nih.gov/search/searchview.taf?ipid=108650
341,BC011427-08,"October 01, 2018 -  September 30, 2019",Immunohistochemical and genomic analysis of tumors,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jerzy P Lasota,"John  Fetsch (Joint Pathology Center)|Shingo  Inaguma; MD, PhD (Laboratory Of Pathology)|Alejandro  Luina-contreras (Joint Pathology Center)|Lester  Thompson (Kaiser Permanente Medical Group)","Raffit  Hassan (Thoracic and GI Malignancies Branch)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch)",NULL,"1. Abdul Sater Z, Jha A, Mandl A, Mangelen SK, Carrasquillo JA, Ling A, Gonzales MK, Lopes Abath Neto O, Miettinen M, Adams KT, Nockel P, El Lakis M, Pacak K (2019). Gallbladder Paraganglioma Associated with SDHD Mutation: a Potential Pitfall on 18F-FDOPA PET Imaging. Nucl Med Mol Imaging  53, 144-147.   https://doi.org/10.1007/s13139-018-0558-1|2. Caisova V, Li L, Gupta G, Jochmanova I, Jha A, Uher O, Huynh TT, Miettinen M, Pang Y, Abunimer L, Niu G, Chen X, Ghayee HK, Taïeb D, Zhuang Z, Zenka J, Pacak K (2019). The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40. Cancers (Basel)  11.   https://doi.org/10.3390/cancers11050654|3. Felisiak-Goląbek A, Inaguma S, Kowalik A, Wasąg B, Wang ZF, Zięba S, Pięciak L, Ryś J, Kopczynski J, Sarlomo-Rikala M, Góźdź S, Lasota J, Miettinen M (2018). SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma. Appl Immunohistochem Mol Morphol  26, 40-45.   https://doi.org/10.1097/PAI.0000000000000500|4. Higham CS, Dombi E, Rogiers A, Bhaumik S, Pans S, Connor SEJ, Miettinen M, Sciot R, Tirabosco R, Brems H, Baldwin A, Legius E, Widemann BC, Ferner RE (2018). The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors. Neuro Oncol  20, 818-825.   https://doi.org/10.1093/neuonc/noy013|5. Inaguma S, Lasota J, Wang Z, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Miettinen M (2018). Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma. Hum Pathol  71, 1-7.   https://doi.org/10.1016/j.humpath.2017.04.032|6. Lo W, Zhu B, Sabesan A, Wu HH, Powers A, Sorber RA, Ravichandran S, Chen I, McDuffie LA, Quadri HS, Beane JD, Calzone K, Miettinen MM, Hewitt SM, Koh C, Heller T, Wacholder S, Rudloff U (2019). Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). J Med Genet  56, 370-379.   https://doi.org/10.1136/jmedgenet-2018-105361|7. Murai J, Thomas A, Miettinen M, Pommier Y (2019). Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies. Pharmacol Ther  201, 94-102.   https://doi.org/10.1016/j.pharmthera.2019.05.009|8. Pemov A, Hansen NF, Sindiri S, Patidar R, Higham CS, Dombi E, Miettinen MM, Fetsch P, Brems H, Chandrasekharappa S, Jones K, Zhu B, Wei JS, NISC Comparative Sequencing Program, NCI DCEG Cancer Genomics Research Laboratory, Mullikin JC, Wallace MR, Khan J, Legius E, Widemann BC, Stewart DR (2019) Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define pre-malignant neurofibromatosis type 1-associated atypical neurofibromas. Neuro Oncol, in press (e-pub ahead of print)  https://doi.org/10.1093/neuonc/noz028|9. Shukla V, Rao M, Zhang H, Beers J, Wangsa D, Wangsa D, Buishand FO, Wang Y, Yu Z, Stevenson H, Reardon E, McLoughlin KC, Kaufman A, Payabyab E, Hong JA, Zhang M, Davis SR, Edelman DC, Chen G, Miettinen M, Restifo N, Ried T, Meltzer PS, Schrump DS (2018). Identification of Novel Targets for Lung Cancer Therapy Using an Induced Pluripotent Stem Cell Model. Ann Am Thorac Soc  15, S127-S128.   https://doi.org/10.1513/AnnalsATS.201707-610MG|10. Thompson LDR, Jo VY, Agaimy A, Llombart-Bosch A, Morales GN, Machado I, Flucke U, Wakely PE, Miettinen M, Bishop JA (2018). Sinonasal Tract Alveolar Rhabdomyosarcoma in Adults: A Clinicopathologic and Immunophenotypic Study of Fifty-Two Cases with Emphasis on Epithelial Immunoreactivity. Head Neck Pathol  12, 181-192.   https://doi.org/10.1007/s12105-017-0851-9",https://intramural.nih.gov/search/searchview.taf?ipid=108673
342,BC011431-08,"October 01, 2018 -  September 30, 2019",Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yukun  Guan; PhD|Camille Anne Spinner; PhD|Yan  Wang,NULL,NULL,Dorian  McGavern (NINDS),"1. Loo TT, Gao Y, Lazarevic V (2018). Transcriptional regulation of CD4+ TH  cells that mediate tissue inflammation. J Leukoc Biol  104, 1069-1085.   https://doi.org/10.1002/JLB.1RI0418-152RR",https://intramural.nih.gov/search/searchview.taf?ipid=108676
343,BC011433-08,"October 01, 2018 -  September 30, 2019",The Role of Coherent Rotation in Adult Tissue Remodeling,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Maira  Alves Constantino|Milos  Nikolic|Woong Young  So|Colin Dowlin Paul; PhD,"Guiliano  Scarcelli (University Of Maryland, College Park)|Anna  Tesei (Irst Irccs)",NULL,NULL,"1. Paul CD, Hruska A, Staunton JR, Burr HA, Daly KM, Kim J, Jiang N, Tanner K (2019). Probing cellular response to topography in three dimensions. Biomaterials  197, 101-118.   https://doi.org/10.1016/j.biomaterials.2019.01.009|2. Ricca BL, Venugopalan G, Furuta S, Tanner K, Orellana WA, Reber CD, Brownfield DG, Bissell MJ, Fletcher DA (2018). Transient external force induces phenotypic reversion of malignant epithelial structures via nitric oxide signaling. Elife  7.   https://doi.org/10.7554/eLife.26161|3. Staunton JR, So WY, Paul CD, Tanner K (2019). High-frequency microrheology in 3D reveals mismatch between cytoskeletal and extracellular matrix mechanics. Proc Natl Acad Sci U S A  116, 14448-14455.   https://doi.org/10.1073/pnas.1814271116",https://intramural.nih.gov/search/searchview.taf?ipid=108678
344,BC011436-08,"October 01, 2018 -  September 30, 2019",Retroviral Replication and Interactions with Host Factors,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ryan C Burdick|Krista A Delviks-Frankenberry|Chenglei  Li; PhD|Mohamed Husen Mohamedhabib Munshi; PhD|Rokeya I Have No Middle Name Siddiqui|Wei-Shau  Hu; PhD,NULL,Eric O Freed; PhD (HIV Drug Resistance Program),NULL,"1. Liu Y, Chen J, Nikolaitchik OA, Desimmie BA, Busan S, Pathak VK, Weeks KM, Hu WS (2018). The roles of five conserved lentiviral RNA structures in HIV-1 replication. Virology  514, 1-8.   https://doi.org/10.1016/j.virol.2017.10.020|2. Rawson JMO, Nikolaitchik OA, Keele BF, Pathak VK, Hu WS (2018). Recombination is required for efficient HIV-1 replication and the maintenance of viral genome integrity. Nucleic Acids Res  46, 10535-10545.   https://doi.org/10.1093/nar/gky910",https://intramural.nih.gov/search/searchview.taf?ipid=108653
345,BC011437-08,"October 01, 2018 -  September 30, 2019",Combinatorial genetic analysis using validated siRNA libraries,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chih-Shia  Lee,Frank  McCormick (UCSF School of Medicine)|Scott  Lowe (Cold Spring Harbor Laboratory)|Michael  Gutschow (University of Bonn),Natasha  Caplen (Cancer Genetics Branch),NULL,"1. Lee CS, Lee LC, Yuan TL, Chakka S, Fellmann C, Lowe SW, Caplen NJ, McCormick F, Luo J (2019). MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival. Proc Natl Acad Sci U S A  116, 4508-4517.   https://doi.org/10.1073/pnas.1817494116|2. Yuan TL, Amzallag A, Bagni R, Yi M, Afghani S, Burgan W, Fer N, Strathern LA, Powell K, Smith B, Waters AM, Drubin D, Thomson T, Liao R, Greninger P, Stein GT, Murchie E, Cortez E, Egan RK, Procter L, Bess M, Cheng KT, Lee CS, Lee LC, Fellmann C, et al. [5 more authors] (2018). Differential Effector Engagement by Oncogenic KRAS. Cell Rep  22, 1889-1902.   https://doi.org/10.1016/j.celrep.2018.01.051",https://intramural.nih.gov/search/searchview.taf?ipid=108668
346,BC011438-08,"October 01, 2018 -  September 30, 2019",Genetic screens for target discovery in cancer,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Haibo  Zhang; PhD|Glenn  Merlino; PhD|Li  Yang; PhD|Stuart H Yuspa; MD,NULL,Yves  Pommier; PhD (Developmental Therapeutics Branch)|Eytan  Ruppin (Cancer Data Science Laboratory),NULL,"1. Sahu AD, S Lee J, Wang Z, Zhang G, Iglesias-Bartolome R, Tian T, Wei Z, Miao B, Nair NU, Ponomarova O, Friedman AA, Amzallag A, Moll T, Kasumova G, Greninger P, Egan RK, Damon LJ, Frederick DT, Jerby-Arnon L, Wagner A, Cheng K, Park SG, Robinson W, Gardner K, Boland G, et al. [7 more authors] (2019). Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy. Mol Syst Biol  15, e8323.   https://doi.org/10.15252/msb.20188323",https://intramural.nih.gov/search/searchview.taf?ipid=108669
347,BC011439-08,"October 01, 2018 -  September 30, 2019",Development of Chimeric Antigen Receptors Targeting Multiple Myeloma,James N Kochenderfer|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Christina  Amatya|Jennifer  Brudno|Norris Lio Lam|Jennifer Amy Mann|Lekha  Mikkilineni; MD|Danielle Anne Vanasse,NULL,"Philippe Bijin Youkharibache; PhD (Cancer Data Science Laboratory)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",David F Stroncek; MD (CC) |Irina  Maric; MD (CC),"1. Brudno JN, Maric I, Hartman SD, Rose JJ, Wang M, Lam N, Stetler-Stevenson M, Salem D, Yuan C, Pavletic S, Kanakry JA, Ali SA, Mikkilineni L, Feldman SA, Stroncek DF, Hansen BG, Lawrence J, Patel R, Hakim F, Gress RE, Kochenderfer JN (2018). T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma. J Clin Oncol  36, 2267-2280.   https://doi.org/10.1200/JCO.2018.77.8084|2. Raje N, Hege K, Kochenderfer JN (2019). Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma. Reply. N Engl J Med  381, e6.   https://doi.org/10.1056/NEJMc1907520",https://intramural.nih.gov/search/searchview.taf?ipid=108665
348,BC011441-08,"October 01, 2018 -  September 30, 2019",Cell density effects on therapeutic sensitivity,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kevin A Camphausen; MD,NULL,Natasha  Caplen (Cancer Genetics Branch)|Ettore  Appella; MD (Laboratory of Cell Biology)|Eric  Batchelor; PhD (Laboratory of Cell Biology)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,"1. Ahmad F, Sun Q, Patel D, Stommel JM (2019). Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma. Cancers (Basel)  11.   https://doi.org/10.3390/cancers11020146|2. Eke I, Makinde AY, Aryankalayil MJ, Sandfort V, Palayoor ST, Rath BH, Liotta L, Pierobon M, Petricoin EF, Brown MF, Stommel JM, Ahmed MM, Coleman CN (2018). Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example. Mol Cancer Ther  17, 355-367.   https://doi.org/10.1158/1535-7163.MCT-17-0262",https://intramural.nih.gov/search/searchview.taf?ipid=108670
349,BC011447-08,"October 01, 2018 -  September 30, 2019",Early Clinical Trials for Children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",John Walter Glod|Pamela  Wolters,"Roger  Packer (CNMC)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Maryam  Fouladi (Cincinnati Children's Hospital Center)|Mark  Kieran (Children's Hospital)|Michelle  Monje-Deisseroth (Stanford)|Sean Joseph Hipp|Show all 8",William D Figg; PharmD (Genitourinary Malignancies Branch),"Eva Halle Baker; MD, PhD (CC) |John D Heiss; MD (NINDS)","1. Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, Wen PY (2018). Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro Oncol  20, 897-906.   https://doi.org/10.1093/neuonc/noy056|2. Dang Do AN, Baker EH, Warren KE, Bianconi SE, Porter FD (2018). Spontaneously regressing brain lesions in Smith-Lemli-Opitz syndrome. Am J Med Genet A  176, 386-390.   https://doi.org/10.1002/ajmg.a.38563|3. Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, et al. [48 more authors] (2018). Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. J Clin Oncol  36, 1963-1972.   https://doi.org/10.1200/JCO.2017.75.9308|4. Jones DTW, Kieran MW, Bouffet E, Alexandrescu S, Bandopadhayay P, Bornhorst M, Ellison D, Fangusaro J, Fisher MJ, Foreman N, Fouladi M, Hargrave D, Hawkins C, Jabado N, Massimino M, Mueller S, Perilongo G, Schouten van Meeteren AYN, Tabori U, Warren K, Waanders AJ, Walker D, Weiss W, Witt O, Wright K, et al. [4 more authors] (2018). Pediatric low-grade gliomas: next biologically driven steps. Neuro Oncol  20, 160-173.   https://doi.org/10.1093/neuonc/nox141|5. Morales La Madrid A, Ranjan S, Warren KE (2018). Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USA. J Neurooncol  140, 1-4.   https://doi.org/10.1007/s11060-018-2938-x|6. Nellan A, McCully CML, Cruz Garcia R, Jayaprakash N, Widemann BC, Lee DW, Warren KE (2018). Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques. Blood  132, 662-666.   https://doi.org/10.1182/blood-2018-05-846428|7. Nellan A, Rota C, Majzner R, Lester-McCully CM, Griesinger AM, Mulcahy Levy JM, Foreman NK, Warren KE, Lee DW (2018). Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells. J Immunother Cancer  6, 30.   https://doi.org/10.1186/s40425-018-0340-z|8. Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, Magge SN, Gupta N, Myseros JS, Hwang EI, Kline C, Crawford JR, Warren KE, Cha S, Liang WS, Berens ME, Packer RJ, Resnick AC, Prados M, Mueller S, Nazarian J (2018). Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. Clin Cancer Res  24, 5850-5859.   https://doi.org/10.1158/1078-0432.CCR-18-1345|9. Warren KE (2018). Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma. Front Oncol  8, 239.   https://doi.org/10.3389/fonc.2018.00239|10. Warren KE, Vezina G, Poussaint TY, Warmuth-Metz M, Chamberlain MC, Packer RJ, Brandes AA, Reiss M, Goldman S, Fisher MJ, Pollack IF, Prados MD, Wen PY, Chang SM, Dufour C, Zurakowski D, Kortmann RD, Kieran MW (2018). Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol  20, 13-23.   https://doi.org/10.1093/neuonc/nox087|11. Warren KE, Vezina G, Poussaint TY, Warmuth-Metz M, Packer RJ, Kieran MW (2018). Response to Harreld re: ""Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee"". Neuro Oncol  20, 144-145.   https://doi.org/10.1093/neuonc/nox219|12. Withrow DR, de Gonzalez AB, Lam CJK, Warren KE, Shiels MS (2019). Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998-2013. Cancer Epidemiol Biomarkers Prev  28, 522-530.   https://doi.org/10.1158/1055-9965.EPI-18-0784|13. Yuan Y, Lin R, Li D, Nie L, Warren KE (2018). Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials. Clin Cancer Res  24, 4921-4930.   https://doi.org/10.1158/1078-0432.CCR-18-0246",https://intramural.nih.gov/search/searchview.taf?ipid=108663
350,BC011449-08,"October 01, 2018 -  September 30, 2019",Identification of Inhibitors of Protein Sumoylation,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,NULL,David S Waugh; PhD (Protein Engineering Section)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108674
351,BC011450-08,"October 01, 2018 -  September 30, 2019",Clinical treatment of advanced Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Heidi H Kong,Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Sandra  D'Angelo (Memorial Sloan-Kettering Cancer Center)|Sacha  Gnjatic (Icahn School of Medicine Mount Sinai),"Christopher  Buck (Laboratory of Cellular Oncology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Cardis MA, Jiang H, Strauss J, Gulley JL, Brownell I (2019). Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report. BMC Cancer  19, 539.   https://doi.org/10.1186/s12885-019-5759-1|2. D'Angelo SP, Hunger M, Brohl AS, Nghiem P, Bhatia S, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbé C, Lewis KD, Linette GP, Milella M, Schlichting M, Hennessy MH, Bharmal M (2019). Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma. Cancer Immunol Immunother  68, 609-618.   https://doi.org/10.1007/s00262-018-02295-4|3. Gaiser MR, Bongiorno M, Brownell I (2018). PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma. Expert Rev Clin Pharmacol  11, 345-359.   https://doi.org/10.1080/17512433.2018.1445966|4. Harms PW, Harms KL, Moore PS, DeCaprio JA, Nghiem P, Wong MKK, Brownell I, International Workshop on Merkel Cell Carcinoma Research (IWMCC) Working Group (2018). The biology and treatment of Merkel cell carcinoma: current understanding and research priorities. Nat Rev Clin Oncol  15, 763-776.   https://doi.org/10.1038/s41571-018-0103-2|5. Kaufman HL, Russell JS, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Milella M, Brownell I, Lewis KD, Lorch JH, von Heydebreck A, Hennessy M, Nghiem P (2018). Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial. J Immunother Cancer  6, 7.   https://doi.org/10.1186/s40425-017-0310-x",https://intramural.nih.gov/search/searchview.taf?ipid=108671
352,BC011458-08,"October 01, 2018 -  September 30, 2019",Molecular Targeted Photoimmunotherapy for Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Reema Sunil Railkar,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Peter L Choyke; MD (Molecular Imaging Program)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Martin John Schnermann; PhD (Chemical Biology Laboratory)|Anu  Puri; PhD (Rna Biology Laboratory),NULL,"1. Agarwal PK, Sternberg CN (2018). Clinical Trials Corner. Bladder Cancer  4, 133-136.   https://doi.org/10.3233/BLC-189028|2. Agarwal PK, Sternberg CN (2018). Clinical Trials Corner. Bladder Cancer  4, 347-350.   https://doi.org/10.3233/BLC-189036|3. Aleksic I, Rais-Bahrami S, Daugherty M, Agarwal PK, Vourganti S, Bratslavsky G (2018). Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survival. Urol Ann  10, 170-174.   https://doi.org/10.4103/UA.UA_136_17|4. Hale GR, Teplitsky S, Truong H, Gold SA, Bloom JB, Agarwal PK (2018). Lymph node imaging in testicular cancer. Transl Androl Urol  7, 864-874.   https://doi.org/10.21037/tau.2018.07.18|5. Monteiro LL, Witjes JA, Agarwal PK, Anderson CB, Bivalacqua TJ, Bochner BH, Boormans JL, Chang SS, Domínguez-Escrig JL, McKiernan JM, Dinney C, Godoy G, Kulkarni GS, Mariappan P, O'Donnell MA, Rentsch CA, Shah JB, Solsona E, Svatek RS, van der Heijden AG, van Valenberg FJP, Kassouf W (2019). ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer. World J Urol  37, 51-60.   https://doi.org/10.1007/s00345-018-2438-9|6. Railkar R, Agarwal PK (2018). Photodynamic Therapy in the Treatment of Bladder Cancer: Past Challenges and Current Innovations. Eur Urol Focus  4, 509-511.   https://doi.org/10.1016/j.euf.2018.08.005|7. Rayn KN, Hale GR, Bloom JB, Gold SA, Carvalho FLF, Mehralivand S, Czarniecki M, Wood BJ, Merino MJ, Choyke P, Türkbey B, Pinto PA, Agarwal PK (2018). Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience. Diagn Interv Radiol  24, 316-320.   https://doi.org/10.5152/dir.2018.18102",https://intramural.nih.gov/search/searchview.taf?ipid=108677
353,BC011459-08,"October 01, 2018 -  September 30, 2019",Control of centrosome biogenesis,Jadranka  Loncarek|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Dong  Kong; PhD|Kimberly Racine Lukasik|Catherine Elaine Sullenberger|Alejandra  Vasquez Limeta; PhD|Allan M Weissman; MD,"Haixin  Sui (Wadsworth Center)|Tomer  Avidor-Reiss; PhD (Department of Cell Biology, Harvard Medical School)|Moe  Mahjoub (Washington University)",NULL,NULL,"1. Bowler M, Kong D, Sun S, Nanjundappa R, Evans L, Farmer V, Holland A, Mahjoub MR, Sui H, Loncarek J (2019). High-resolution characterization of centriole distal appendage morphology and dynamics by correlative STORM and electron microscopy. Nat Commun  10, 993.   https://doi.org/10.1038/s41467-018-08216-4|2. Fishman EL, Jo K, Nguyen QPH, Kong D, Royfman R, Cekic AR, Khanal S, Miller AL, Simerly C, Schatten G, Loncarek J, Mennella V, Avidor-Reiss T (2018). A novel atypical sperm centriole is functional during human fertilization. Nat Commun  9, 2210.   https://doi.org/10.1038/s41467-018-04678-8|3. Garcia EB, Alms C, Hinman AW, Kelly C, Smith A, Vance M, Loncarek J, Marr LC, Cimini D (2019). Single-Cell Analysis Reveals that Chronic Silver Nanoparticle Exposure Induces Cell Division Defects in Human Epithelial Cells. Int J Environ Res Public Health  16.   https://doi.org/10.3390/ijerph16112061|4. Loncarek J, Bettencourt-Dias M (2018). Building the right centriole for each cell type. J Cell Biol  217, 823-835.   https://doi.org/10.1083/jcb.201704093|5. Montenegro Gouveia S, Zitouni S, Kong D, Duarte P, Ferreira Gomes B, Sousa AL, Tranfield EM, Hyman A, Loncarek J, Bettencourt-Dias M (2018). PLK4 is a microtubule-associated protein that self-assembles promoting de novo MTOC formation. J Cell Sci  132.   https://doi.org/10.1242/jcs.219501|6. Nanjundappa R, Kong D, Shim K, Stearns T, Brody SL, Loncarek J, Mahjoub MR (2019). Regulation of cilia abundance in multiciliated cells. Elife  8.   https://doi.org/10.7554/eLife.44039|7. Simerly C, Manil-Ségalen M, Castro C, Hartnett C, Kong D, Verlhac MH, Loncarek J, Schatten G (2018). Separation and Loss of Centrioles From Primordidal Germ Cells To Mature Oocytes In The Mouse. Sci Rep  8, 12791.   https://doi.org/10.1038/s41598-018-31222-x",https://intramural.nih.gov/search/searchview.taf?ipid=108675
354,BC011460-08,"October 01, 2018 -  September 30, 2019",BKV and JCV vaccine development,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana,NULL,NULL,NULL,"1. Gupta G, Kuppachi S, Kalil RS, Buck CB, Lynch CF, Engels EA (2018). Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States. Am J Transplant  18, 245-252.   https://doi.org/10.1111/ajt.14530|2. Starrett GJ, Buck CB (2019) The case for BK polyomavirus as a cause of bladder cancer. Curr Opin Virol, in press (e-pub ahead of print)  https://doi.org/10.1016/j.coviro.2019.06.009",https://intramural.nih.gov/search/searchview.taf?ipid=108655
355,BC011461-08,"October 01, 2018 -  September 30, 2019",HIV-1 evasion of cytosolic factors,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Szu-Wei  Huang; PhD|Kyeongeun  Lee|Sorin Ophelie Miller|Sekou-Tidiane T Yoda,Jeremy  Luban (Columbia University)|Irene  Pedersen (University of California - Irvine)|Paul  Bieniasz (Rockefeller University)|Theodora  Hatziioannou (Aaron Diamond AIDS Research Center),Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Schmidt F, Keele BF, Del Prete GQ, Voronin D, Fennessey CM, Soll S, Kane M, Raymond A, Gifford RJ, KewalRamani V, Lifson JD, Bieniasz PD, Hatziioannou T (2019). Derivation of simian tropic HIV-1 infectious clone reveals virus adaptation to a new host. Proc Natl Acad Sci U S A  116, 10504-10509.   https://doi.org/10.1073/pnas.1818059116",https://intramural.nih.gov/search/searchview.taf?ipid=108651
356,BC011464-08,"October 01, 2018 -  September 30, 2019",Clinical Interventional Studies of HIV Reservoirs,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Jennifer Marie Bell|Shawn A Hill|Kristi  Huik; PhD|James Quinn Virga|Mary  Kearney,Anuradha  Ganesan (Henry M. Jackson Foundation)|John W Mellors|Deborah  McMahon (University of Pittsburgh)|Erin  Reid (University of California San Diego)|John  Coffin (Tufts University)|John A Zaia|Show all 10,"Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Robert  Gorelick (Office Of The Director)|Bradford J Wood; MD (Office of the Director)",Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID) |Dean  Follmann; PhD (NIAID) |Irini  Sereti; MD (NIAID),"1. George JM, Kuriakose SS, Dee N, Stoll P, Lalani T, Dewar R, Khan MA, Rehman MT, Grossman Z, Maldarelli F, Pau AK (2018). Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir. Open Forum Infect Dis  5, ofy221.   https://doi.org/10.1093/ofid/ofy221|2. Winchester NE, Maldarelli F, Mejia Y, Dee N, Dewar R, Laidlaw E, Kuriakose SS, Stoll P, Proschan M, Lane HC, Pau AK (2019) 8-Day Inpatient Directly Observed Therapy for ART Failure: A Tool For Preventing Unnecessary ART Changes and Optimizing Adherence Support. Clin Infect Dis, in press (e-pub ahead of print)  https://doi.org/10.1093/cid/ciz590",https://intramural.nih.gov/search/searchview.taf?ipid=108656
357,BC011465-08,"October 01, 2018 -  September 30, 2019",c-Myc Function,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Fedor Edmundovich Kouzine|Suzanne Laurie Sanford|Ying  Zheng|Brian  Lewis|Zuqin  Nie; PhD,NULL,Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch),Keji  Zhao; PhD (NHLBI) |Craig Joseph Thomas (NCATS) |Rafael Cristian Casellas; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108654
358,BC011466-08,"October 01, 2018 -  September 30, 2019",HIV Persistence During Suppressive Antiretroviral Therapy,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Jennifer Marie Bell|Pamela Jo Harris|Shawn A Hill|Kristi  Huik; PhD|Camille Marie Lange; PhD|Natalie Alexandria Lindo|Show all 7,Anuradha  Ganesan (Henry M. Jackson Foundation)|John W Mellors|Deborah  McMahon (University of Pittsburgh)|John  Coffin (Tufts University),Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |Michael  Polis; MD (NIAID) |Mark  Connors; MD (NIAID) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID),"1. Anderson EM, Maldarelli F (2018). Quantification of HIV DNA Using Droplet Digital PCR Techniques. Curr Protoc Microbiol  51, e62.   https://doi.org/10.1002/cpmc.62|2. Anderson EM, Maldarelli F (2018). The role of integration and clonal expansion in HIV infection: live long and prosper. Retrovirology  15, 71.   https://doi.org/10.1186/s12977-018-0448-8|3. Fennessey CM, Camus C, Immonen TT, Reid C, Maldarelli F, Lifson JD, Keele BF (2019). Low-level alternative tRNA priming of reverse transcription of HIV-1 and SIV in vivo. Retrovirology  16, 11.   https://doi.org/10.1186/s12977-019-0473-2|4. Reid EG, Looney D, Maldarelli F, Noy A, Henry D, Aboulafia D, Ramos JC, Sparano J, Ambinder RF, Lee J, Cesarman E, Yahyaei S, Mitsuyasu R, Wachsman W, AIDS Malignancy Consortium (2018). Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas. Blood Adv  2, 3618-3626.   https://doi.org/10.1182/bloodadvances.2018022095",https://intramural.nih.gov/search/searchview.taf?ipid=108657
359,BC011469-08,"October 01, 2018 -  September 30, 2019",Building Libraries with Chemical Diversity for Screening,John A Beutler,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",Ekaterina  Goncharo|Cheryl L Thomas,John  Porco (Boston University)|Laila  Espindola (University of Brasilia)|Mahmut  Miski (Istanbul University)|Matthew  Todd (Baruch S. Blumberg Institute),NULL,NULL,"1. Tosun F, Beutler JA, Ransom TT, Miski M (2019). Anatolicin, a Highly Potent and Selective Cytotoxic Sesquiterpene Coumarin from the Root Extract of Heptaptera anatolica. Molecules  24.   https://doi.org/10.3390/molecules24061153",https://intramural.nih.gov/search/searchview.taf?ipid=108659
360,BC011470-08,"October 01, 2018 -  September 30, 2019",Development of Natural Product Leads as Anticancer Therapeutics,John A Beutler,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",Dayani Senadeera Sarath Parakumge; PhD|Dongdong  Wang,"William  Chain (University of Hawaii)|Kathlyn  Parker (Stony Brook University)|Antonio  Echavarren (Institute of Chemical Research of Catalonia)|Ryan  Murelli (Brooklyn College)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)|David  Beech (University of Leeds School of Medicine)","William Marston Linehan; MD (Urologic Oncology Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Karlyne M Reilly; BS, PhD (Pediatric Oncology Branch)",Alexander Theodore Chesler; PhD (NCCIH),"1. Grant CV, Carver CM, Hastings SD, Ramachandran K, Muniswamy M, Risinger AL, Beutler JA, Mooberry SL (2019). Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype. Breast Cancer Res Treat  177, 345-355.   https://doi.org/10.1007/s10549-019-05324-7|2. Miller JT, Zhao H, Masaoka T, Varnado B, Cornejo Castro EM, Marshall VA, Kouhestani K, Lynn AY, Aron KE, Xia A, Beutler JA, Hirsch DR, Tang L, Whitby D, Murelli RP, Le Grice SFJ (2018). Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands. Antimicrob Agents Chemother  62.   https://doi.org/10.1128/AAC.00233-18|3. Rubaiy HN, Ludlow MJ, Siems K, Norman K, Foster R, Wolf D, Beutler JA, Beech DJ (2018). Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels. Br J Pharmacol  175, 3361-3368.   https://doi.org/10.1111/bph.14379",https://intramural.nih.gov/search/searchview.taf?ipid=108660
361,BC011471-08,"October 01, 2018 -  September 30, 2019",Cell-free assay technologies for the identification of active compounds,Barry R O'Keefe,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",Tadeusz P Guszczynski|Shilpa R Kurian|Joe Sumagang Matarlo; PhD|Brice Alexander Pitt Wilson|Kirk R Gustafson; PhD,NULL,"Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Kylie Janice Walters (Structural Biophysics Laboratory)|Ping  Zhang (Structural Biophysics Laboratory)|Louis  Staudt; MD (Lymphoid Malignancies Branch)",NULL,"1. Matarlo JS, Krumpe LRH, Heinz WF, Oh D, Shenoy SR, Thomas CL, Goncharova EI, Lockett SJ, O'Keefe BR (2019). The Natural Product Butylcycloheptyl Prodiginine Binds Pre-miR-21, Inhibits Dicer-Mediated Processing of Pre-miR-21, and Blocks Cellular Proliferation. Cell Chem Biol  26, 1133-1142.e4.   https://doi.org/10.1016/j.chembiol.2019.04.011",https://intramural.nih.gov/search/searchview.taf?ipid=108661
362,BC011472-08,"October 01, 2018 -  September 30, 2019",Isolation of bioactive proteins from natural product extracts,Barry R O'Keefe,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",Lauren R Haugh Krumpe|Carter Alexander Mitchell; PhD|Tadeusz P Guszczynski|Shilpa R Kurian,"Kenneth E. Palmer; PhD (Department of Pharmacology and Toxicology, University of Louisville)|Elibio  Rech (Embrapa, Brasil)|Paul  Christou (Universitat de Lleida)|Robert Walter Buckheit (RETROVIRAL REPLICATION LABORATORY)|Romero  Jose (The Population Council)|John  Samuelson (Boston University)|Show all 10",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Aimaiti S, Suzuki A, Saito Y, Fukuyoshi S, Goto M, Miyake K, Newman DJ, O'Keefe BR, Lee KH, Nakagawa-Goto K (2018). Corymbulosins I-W, Cytotoxic Clerodane Diterpenes from the Bark of Laetia corymbulosa. J Org Chem  83, 951-963.   https://doi.org/10.1021/acs.joc.7b02951|2. Derby N, Lal M, Aravantinou M, Kizima L, Barnable P, Rodriguez A, Lai M, Wesenberg A, Ugaonkar S, Levendosky K, Mizenina O, Kleinbeck K, Lifson JD, Peet MM, Lloyd Z, Benson M, Heneine W, O'Keefe BR, Robbiani M, Martinelli E, Grasperge B, Blanchard J, Gettie A, Teleshova N, Fernández-Romero JA, et al. [1 more author] (2018). Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo. Nat Commun  9, 3881.   https://doi.org/10.1038/s41467-018-06349-0|3. Takeuchi M, Saito Y, Goto M, Miyake K, Newman DJ, O'Keefe BR, Lee KH, Nakagawa-Goto K (2018). Antiproliferative Alkaloids from Alangium longiflorum, an Endangered Tropical Plant Species. J Nat Prod  81, 1884-1891.   https://doi.org/10.1021/acs.jnatprod.8b00411|4. Tsurumi F, Miura Y, Saito Y, Miyake K, Fujie T, Newman DJ, O'Keefe BR, Lee KH, Nakagawa-Goto K (2018). Secondary Metabolites, Monoterpene-Polyketides Containing a Spiro[3.5]nonane from Cryptocarya laevigata. Org Lett  20, 2282-2286.   https://doi.org/10.1021/acs.orglett.8b00624|5. Vamvaka E, Farré G, Molinos-Albert LM, Evans A, Canela-Xandri A, Twyman RM, Carrillo J, Ordóñez RA, Shattock RJ, O'Keefe BR, Clotet B, Blanco J, Khush GS, Christou P, Capell T (2018). Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm. Proc Natl Acad Sci U S A  115, E7854-E7862.   https://doi.org/10.1073/pnas.1806022115|6. White JD, O'Keefe BR, Sharma J, Javed G, Nukala V, Ganguly A, Khan IA, Kumar NB, Mukhtar H, Pauli GF, Walker L, Sivaram S, Rajaraman P, Trimble EL (2018). India-United States Dialogue on Traditional Medicine: Toward Collaborative Research and Generation of an Evidence Base. J Glob Oncol  4, 1-10.   https://doi.org/10.1200/JGO.17.00099",https://intramural.nih.gov/search/searchview.taf?ipid=108662
363,BC011476-07,"October 01, 2018 -  September 30, 2019",Studies of the fate of environmental contaminants in humans and animals,Linda Silber Birnbaum; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Sherry Jones Coulter; BS|Christopher T Juberg|Gabriel Arther Knudsen|Andrew William Trexler,Marian  Pavuk (CDC)|Arnold  Schecter (NIEHS)|Hoang  Quynh (University of Hanoi)|Steven T Szabo|Michael  Hughes (U.S. Environmental Protection Agency),NULL,"Gaylia Jean Harry; PhD (NIEHS) |Stavros  Garantziotis; MD (NIEHS) |Suzanne Elizabeth Fenton; MS, PhD (NIEHS) |Shepherd H Schurman; MD (NIEHS) |Douglas  Bell; PhD (NIEHS)","1. Cannon RE, Trexler AW, Knudsen GA, Evans RA, Birnbaum LS (2019). Tetrabromobisphenol A (TBBPA) Alters ABC Transport at the Blood-Brain Barrier. Toxicol Sci  169, 475-484.   https://doi.org/10.1093/toxsci/kfz059|2. Emond C, DeVito MJ, Diliberto JJ, Birnbaum LS (2018). The Influence of Obesity on the Pharmacokinetics of Dioxin in Mice: An Assessment Using Classical and PBPK Modeling. Toxicol Sci  164, 218-228.   https://doi.org/10.1093/toxsci/kfy078|3. Knudsen GA, Hall SM, Richards AC, Birnbaum LS (2018). TBBPA disposition and kinetics in pregnant and nursing Wistar Han IGS rats. Chemosphere  192, 5-13.   https://doi.org/10.1016/j.chemosphere.2017.10.122|4. Knudsen GA, Hughes MF, Birnbaum LS (2019). Dermal disposition of Tetrabromobisphenol A Bis(2,3-dibromopropyl) ether (TBBPA-BDBPE) using rat and human skin. Toxicol Lett  301, 108-113.   https://doi.org/10.1016/j.toxlet.2018.11.011|5. Knudsen GA, Trexler AW, Richards AC, Hall SM, Hughes MF, Birnbaum LS (2019). 2,4,6-Tribromophenol Disposition and Kinetics in Rodents: Effects of Dose, Route, Sex, and Species. Toxicol Sci  169, 167-179.   https://doi.org/10.1093/toxsci/kfz044|6. Petriello MC, Charnigo R, Sunkara M, Soman S, Pavuk M, Birnbaum L, Morris AJ, Hennig B (2018). Relationship between serum trimethylamine N-oxide and exposure to dioxin-like pollutants. Environ Res  162, 211-218.   https://doi.org/10.1016/j.envres.2018.01.007|7. Schecter A, Kincaid J, Quynh HT, Lanceta J, Tran HTT, Crandall R, Shropshire W, Birnbaum LS (2018). Biomonitoring of Metals, Polybrominated Diphenyl Ethers, Polychlorinated Biphenyls, and Persistent Pesticides in Vietnamese Female Electronic Waste Recyclers. J Occup Environ Med  60, 191-197.   https://doi.org/10.1097/JOM.0000000000001200|8. Shipkowski KA, Betz JM, Birnbaum LS, Bucher JR, Coates PM, Hopp DC, MacKay D, Oketch-Rabah H, Walker NJ, Welch C, Rider CV (2018). Naturally complex: Perspectives and challenges associated with Botanical Dietary Supplement Safety assessment. Food Chem Toxicol  118, 963-971.   https://doi.org/10.1016/j.fct.2018.04.007|9. Werder EJ, Gam KB, Engel LS, Kwok RK, Ekenga CC, Curry MD, Chambers DM, Blair A, Miller AK, Birnbaum LS, Sandler DP (2018). Predictors of blood volatile organic compound levels in Gulf coast residents. J Expo Sci Environ Epidemiol  28, 358-370.   https://doi.org/10.1038/s41370-017-0010-0",https://intramural.nih.gov/search/searchview.taf?ipid=108713
364,BC011479-07,"October 01, 2018 -  September 30, 2019",T-cell receptor gene therapy for cancer,Christian S Hinrichs|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",John Stephen Davies; BS|Nikolaos  Gkitsas|Benjamin Yongzhu Jin|Nisha Bharat Nagarsheth|Carylinda  Serna|Andrew Lawrence Sinkoe|Show all 7,NULL,NULL,David F Stroncek; MD (CC) |Clint Tanner Allen (NIDCD) |Nicole Cherie Schmitt (NIDCD),"1. Helman SR, Stevanovic S, Campbell TE, Kwong MLM, Doran SL, Faquin WC, Hinrichs CS (2018). Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial Design. JAMA Netw Open  1, e180706.   https://doi.org/10.1001/jamanetworkopen.2018.0706|2. Hinrichs CS (2018). Cell-based molecularly targeted therapy: targeting oncoproteins with T cell receptor gene therapy. J Clin Invest  128, 1261-1263.   https://doi.org/10.1172/JCI120386|3. Jin BY, Campbell TE, Draper LM, Stevanović S, Weissbrich B, Yu Z, Restifo NP, Rosenberg SA, Trimble CL, Hinrichs CS (2018). Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model. JCI Insight  3.   https://doi.org/10.1172/jci.insight.99488|4. Jin J, Gkitsas N, Fellowes VS, Ren J, Feldman SA, Hinrichs CS, Stroncek DF, Highfill SL (2018). Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules. J Transl Med  16, 13.   https://doi.org/10.1186/s12967-018-1384-z",https://intramural.nih.gov/search/searchview.taf?ipid=108698
365,BC011480-07,"October 01, 2018 -  September 30, 2019",Programming T Cell Fates for Therapeutic Use,Luca  Gattinoni|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Ping  Chen|Jessica  Fioravanti; PhD|Sanjivan  Gautam|Patrick Joseph Grandinetti|Jinhui  Hu|Neal Edward Lacey,"Pedro  Romero; MD (Ludwig Center for Cancer Research, University of Lausanne)|Yi  Zhang (Temple University)|Timothy  Bender (University of Virginia)|Terry J Fry (NCI)",James N Kochenderfer (Surgery Branch)|Nicholas Phillip Restifo; MD (Surgery Branch),David F Stroncek; MD (CC) |Mario  Roederer; PhD (NIAID) |Stefan Adi Muljo; PhD (NIAID),"1. Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall JB, Yang X, Hocker JD, Escobar TM, He S, Dell'Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L (2019). miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate. Nat Commun  10, 2157.   https://doi.org/10.1038/s41467-019-09882-8|2. Mousset CM, Hobo W, Ji Y, Fredrix H, De Giorgi V, Allison RD, Kester MGD, Falkenburg JHF, Schaap NPM, Jansen JH, Gattinoni L, Dolstra H, van der Waart AB (2018). Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy. Oncoimmunology  7, e1488565.   https://doi.org/10.1080/2162402X.2018.1488565|3. Pilipow K, Scamardella E, Puccio S, Gautam S, De Paoli F, Mazza EM, De Simone G, Polletti S, Buccilli M, Zanon V, Di Lucia P, Iannacone M, Gattinoni L, Lugli E (2018). Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity. JCI Insight  3.   https://doi.org/10.1172/jci.insight.122299|4. Yamamoto TN, Lee PH, Vodnala SK, Gurusamy D, Kishton RJ, Yu Z, Eidizadeh A, Eil R, Fioravanti J, Gattinoni L, Kochenderfer JN, Fry TJ, Aksoy BA, Hammerbacher JE, Cruz AC, Siegel RM, Restifo NP, Klebanoff CA (2019). T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest  129, 1551-1565.   https://doi.org/10.1172/JCI121491|5. Yao C, Sun HW, Lacey NE, Ji Y, Moseman EA, Shih HY, Heuston EF, Kirby M, Anderson S, Cheng J, Khan O, Handon R, Reilley J, Fioravanti J, Hu J, Gossa S, Wherry EJ, Gattinoni L, McGavern DB, O'Shea JJ, Schwartzberg PL, Wu T (2019). Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection. Nat Immunol  20, 890-901.   https://doi.org/10.1038/s41590-019-0403-4",https://intramural.nih.gov/search/searchview.taf?ipid=108685
366,BC011486-07,"October 01, 2018 -  September 30, 2019",Development of Novel Agents Active against Hepatitis B Virus,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD,"Nobuyo  Kuwata (National Center for Global Health & Medicine)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Satoru  Kohgo (National Center for Global Health & Medicine)|Yasuhito  Tanaka (na)|Sanae  Hayashi (Nagoya City University Graduate School of Medical Sciences)|Hiroki  Kumamoto (Showa University)|Show all 8",David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Hashimoto M, Taguchi K, Ishiguro T, Kohgo S, Imoto S, Yamasaki K, Mitsuya H, Otagiri M (2018). Pharmacokinetic properties of a novel inosine analog, 4'-cyano-2'-deoxyinosine, after oral administration in rats. PLoS One  13, e0198636.   https://doi.org/10.1371/journal.pone.0198636|2. Higashi-Kuwata N, Hayashi S, Das D, Kohgo S, Murakami S, Hattori SI, Imoto S, Venzon DJ, Singh K, Sarafianos SG, Tanaka Y, Mitsuya H (2019). CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus. Antimicrob Agents Chemother  63.   https://doi.org/10.1128/AAC.02143-18|3. Yasutake Y, Hattori SI, Hayashi H, Matsuda K, Tamura N, Kohgo S, Maeda K, Mitsuya H (2018). HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir. Sci Rep  8, 1624.   https://doi.org/10.1038/s41598-018-19602-9",https://intramural.nih.gov/search/searchview.taf?ipid=108680
367,BC011487-07,"October 01, 2018 -  September 30, 2019",Systems-level analysis of the regulation and function of MYC,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Woo Seuk  Koh|Zhilin  Yang,Chi  Dang (Ludwig Cancer Research Center)|Martin  Eilers (University Of Wuerzburg),David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108700
368,BC011488-07,"October 01, 2018 -  September 30, 2019",Defining and Manipulating Epigenomic Regulators in Endogenous Systems,Jordan Leslie Meier; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Sarah Elizabeth Bergholtz|Chloe Ann Briney|Jeffrey Eduardo Lopez|Kellie D'Nee Nance|Jonathan Harold Shrimp|Justin Mcintyre Thomas|Show all 7,"Eric  Verdin (Gladstone Institutes, University of California at San Francisco)|Peter  Carmeliet (Vib Center For Cancer Biology (ccb))|Jerome  Cavaille (Laboratoire De Biologie Mol�culaire Eucaryote)|Emily  Dykhuizen (Purdue University)|Michael  Washburn (Stowers Institute For Medical Research)|Eranthie  Weerapana (Boston College)",Shalini  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Carol J Thiele (Pediatric Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Pedro Jorge De Oliveira Rodrigues Batista; PhD (Laboratory of Cell Biology),Rolf Eric Swenson; PhD (NHLBI),"1. Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, Hosogane M, Sinclair WR, Nanan KK, Mandler MD, Fox SD, Zengeya TT, Andresson T, Meier JL, Coller J, Oberdoerffer S (2018). Acetylation of Cytidine in mRNA Promotes Translation Efficiency. Cell  175, 1872-1886.e24.   https://doi.org/10.1016/j.cell.2018.10.030|2. Kulkarni RA, Bak DW, Wei D, Bergholtz SE, Briney CA, Shrimp JH, Alpsoy A, Thorpe AL, Bavari AE, Crooks DR, Levy M, Florens L, Washburn MP, Frizzell N, Dykhuizen EC, Weerapana E, Linehan WM, Meier JL (2019). A chemoproteomic portrait of the oncometabolite fumarate. Nat Chem Biol  15, 391-400.   https://doi.org/10.1038/s41589-018-0217-y|3. Kulkarni RA, Montgomery DC, Meier JL (2019). Epigenetic regulation by endogenous metabolite pharmacology. Curr Opin Chem Biol  51, 30-39.   https://doi.org/10.1016/j.cbpa.2019.02.002|4. Meier JL, Schnermann MJ (2018). Pharmacology by Chemical Biology. Mol Pharm  15, 703-704.   https://doi.org/10.1021/acs.molpharmaceut.8b00067|5. Shrimp JH, Garlick JM, Tezil T, Sorum AW, Worth AJ, Blair IA, Verdin E, Snyder NW, Meier JL (2018). Defining Metabolic and Nonmetabolic Regulation of Histone Acetylation by NSAID Chemotypes. Mol Pharm  15, 729-736.   https://doi.org/10.1021/acs.molpharmaceut.7b00943|6. Shrimp JH, Grose C, Widmeyer SRT, Thorpe AL, Jadhav A, Meier JL (2018). Chemical Control of a CRISPR-Cas9 Acetyltransferase. ACS Chem Biol  13, 455-460.   https://doi.org/10.1021/acschembio.7b00883|7. Sinclair WR, Shrimp JH, Zengeya TT, Kulkarni RA, Garlick JM, Luecke H, Worth AJ, Blair IA, Snyder NW, Meier JL (2018). Bioorthogonal pro-metabolites for profiling short chain fatty acylation. Chem Sci  9, 1236-1241.   https://doi.org/10.1039/c7sc00247e",https://intramural.nih.gov/search/searchview.taf?ipid=108709
369,BC011490-07,"October 01, 2018 -  September 30, 2019",Ubiquitin signaling for protein degradation,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Xiang  Chen|Danielle  Ebelle|Olumide R Kayode|Xiuxiu  Lu|Brandon Jarrod Wright; PhD|Sergey G Tarasov,Daniel  Finley (Harvard Medical School)|Richard  Roden (The Johns Hopkins University)|Lan  Huang,Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,"1. Anchoori RK, Jiang R, Peng S, Soong RS, Algethami A, Rudek MA, Anders N, Hung CF, Chen X, Lu X, Kayode O, Dyba M, Walters KJ, Roden RBS (2018). Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer. ACS Omega  3, 11917-11929.   https://doi.org/10.1021/acsomega.8b01479|2. Chen X, Ebelle DL, Wright BJ, Sridharan V, Hooper E, Walters KJ (2019). Structure of hRpn10 Bound to UBQLN2 UBL Illustrates Basis for Complementarity between Shuttle Factors and Substrates at the Proteasome. J Mol Biol  431, 939-955.   https://doi.org/10.1016/j.jmb.2019.01.021|3. Walters KJ (2019). Ubiquitin in disguise unveils a cryptic binding site in 1.2-MDa anaphase-promoting complex/cyclosome. Proc Natl Acad Sci U S A  116, 17142-17144.   https://doi.org/10.1073/pnas.1911388116",https://intramural.nih.gov/search/searchview.taf?ipid=108710
370,BC011491-07,"October 01, 2018 -  September 30, 2019",Role of kinetochore proteins in chromosome segregation,Alexander Ernest Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Mary Kate  Bonner; PhD|Richard Tin-Wei Chen|Hindol  Gupta|Julian Bernd Haase|Yawen  Bai; PhD,NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),NULL,"1. Bonner M, Haase J, Swinderman J, Halas H, Jenkins L, Kelly A (2019) Enrichment of Aurora B Kinase at the Inner Kinetochore Controls Outer Kinetochore Assembly. Journal of Cell Biology, in press.|2. Chittori S, Hong J, Saunders H, Feng H, Ghirlando R, Kelly AE, Bai Y, Subramaniam S (2018). Structural mechanisms of centromeric nucleosome recognition by the kinetochore protein CENP-N. Science  359, 339-343.   https://doi.org/10.1126/science.aar2781",https://intramural.nih.gov/search/searchview.taf?ipid=108708
371,BC011492-07,"October 01, 2018 -  September 30, 2019","Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Masaru  Matsumoto|Daxeshkumar Prahladbhai Patel|Elisa A Spillare|Kyra Kathleen Ungerleider|Show all 8,"Ping  Yang; MD, PhD (Mayo Clinic)|Wataru  Yasui (Hiroshima University)","Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Kenneth Dean Aldape; MD (Laboratory of Pathology)|Eytan  Ruppin (Cancer Data Science Laboratory)",NULL,"1. Brenner DR, Fehringer G, Zhang ZF, Lee YA, Meyers T, Matsuo K, Ito H, Vineis P, Stucker I, Boffetta P, Brennan P, Christiani DC, Diao N, Hong YC, Landi MT, Morgenstern H, Schwartz AG, Rennert G, Saliba W, McLaughlin JR, Harris CC, Orlow I, Barros Dios JM, Ruano Raviña A, Siemiatycki J, et al. [14 more authors] (2019). Alcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study. Cancer Epidemiol  58, 25-32.   https://doi.org/10.1016/j.canep.2018.10.006|2. Gardner LD, Loffredo PhD CA, Langenberg P, George DMS, Deepak J, Harris CC, Amr S (2018). Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race. Ann Epidemiol  28, 543-548.   https://doi.org/10.1016/j.annepidem.2018.04.012|3. Harris CC (2018). Tobacco smoking, E-cigarettes, and nicotine harm. Proc Natl Acad Sci U S A  115, 1406-1407.   https://doi.org/10.1073/pnas.1722636115|4. Haznadar M, Krausz KW, Margono E, Diehl CM, Bowman ED, Manna SK, Robles AI, Ryan BM, Gonzalez FJ, Harris CC (2018). Inverse association of vitamin D3 levels with lung cancer mediated by genetic variation. Cancer Med  7, 2764-2775.   https://doi.org/10.1002/cam4.1444|5. Jones CC, Bradford Y, Amos CI, Blot WJ, Chanock SJ, Harris CC, Schwartz AG, Spitz MR, Wiencke JK, Wrensch MR, Wu X, Aldrich MC (2019). Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans. Cancer Epidemiol Biomarkers Prev  28, 715-723.   https://doi.org/10.1158/1055-9965.EPI-18-0935|6. Mehrian-Shai R, Reichardt JKV, Harris CC, Toren A (2019). The Gut-Brain Axis, Paving the Way to Brain Cancer. Trends Cancer  5, 200-207.   https://doi.org/10.1016/j.trecan.2019.02.008|7. Paschke S, Jafarov S, Staib L, Kreuser ED, Maulbecker-Armstrong C, Roitman M, Holm T, Harris CC, Link KH, Kornmann M (2018). Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer. Int J Mol Sci  19.   https://doi.org/10.3390/ijms19092577|8. Shepshelovich D, Xu W, Lu L, Fares A, Yang P, Christiani D, Zhang J, Shiraishi K, Ryan BM, Chen C, Schwartz AG, Tardon A, Wu X, Schabath MB, Teare MD, Le Marchand L, Zhang ZF, Field JK, Brenner H, Diao N, Xie J, Kohno T, Harris CC, Wenzlaff AS, Fernandez-Tardon G, et al. [12 more authors] (2019). Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium. J Thorac Oncol  14, 1594-1607.   https://doi.org/10.1016/j.jtho.2019.05.031",https://intramural.nih.gov/search/searchview.taf?ipid=108681
372,BC011495-07,"October 01, 2018 -  September 30, 2019",Integrative Molecular Epidemiology of Human Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI","Elise Dawn Bowman|Mohammed A. Khan; PhD|Daxeshkumar Prahladbhai Patel|Elisa A Spillare|Snorri S. Thorgeirsson; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108682
373,BC011496-07,"October 01, 2018 -  September 30, 2019","p53, Aging, and Cancer",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI","Jessica Ann Beck|Izumi  Horikawa|Sebastien Marc Raphael Jo; PhD|Delphine  Lissa; PHARMD, PhD|Elisa A Spillare|Kyra Kathleen Ungerleider","David  Lane (University of Dundee)|Varda  Rotter (Weizmann Institute Of Science)|Manuel  Serrano; PhD (Dept of Immunology and Oncology, National Center for Biotechnology)",Ettore  Appella; MD (Laboratory of Cell Biology),NULL,"1. Cooks T, Pateras IS, Jenkins LM, Patel KM, Robles AI, Morris J, Forshew T, Appella E, Gorgoulis VG, Harris CC (2018). Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. Nat Commun  9, 771.   https://doi.org/10.1038/s41467-018-03224-w|2. Fujiwara Y, Saito M, Robles AI, Nishida M, Takeshita F, Watanabe M, Ochiya T, Yokota J, Kohno T, Harris CC, Tsuchiya N (2018). A Nucleolar Stress-Specific p53-miR-101 Molecular Circuit Functions as an Intrinsic Tumor-Suppressor Network. EBioMedicine  33, 33-48.   https://doi.org/10.1016/j.ebiom.2018.06.031|3. Mondal AM, Zhou H, Horikawa I, Suprynowicz FA, Li G, Dakic A, Rosenthal B, Ye L, Harris CC, Schlegel R, Liu X (2018). Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells. Cell Death Dis  9, 750.   https://doi.org/10.1038/s41419-018-0767-7|4. Solomon H, Dinowitz N, Pateras IS, Cooks T, Shetzer Y, Molchadsky A, Charni M, Rabani S, Koifman G, Tarcic O, Porat Z, Kogan-Sakin I, Goldfinger N, Oren M, Harris CC, Gorgoulis VG, Rotter V (2018). Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Oncogene  37, 1669-1684.   https://doi.org/10.1038/s41388-017-0060-8|5. Turnquist C, Beck JA, Horikawa I, Obiorah IE, Von Muhlinen N, Vojtesek B, Lane DP, Grunseich C, Chahine JJ, Ames HM, Smart DD, Harris BT, Harris CC (2019). Radiation-induced astrocyte senescence is rescued by Δ133p53. Neuro Oncol  21, 474-485.   https://doi.org/10.1093/neuonc/noz001|6. von Muhlinen N, Horikawa I, Alam F, Isogaya K, Lissa D, Vojtesek B, Lane DP, Harris CC (2018). p53 isoforms regulate premature aging in human cells. Oncogene  37, 2379-2393.   https://doi.org/10.1038/s41388-017-0101-3",https://intramural.nih.gov/search/searchview.taf?ipid=108683
374,BC011501-07,"October 01, 2018 -  September 30, 2019",Regulation and functional effects of localized RNAs,Stavroula  Mili|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",George Constantine Chrisafis|Konstadinos  Moissoglu|Tianhong  Wang|Alexander Nicholas Gasparski|Rebecca A Moriarty,Helim  Aranda-Espinoza (University of Maryland)|Kimberly  Stroka (University Of Maryland),Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Moissoglu K, Yasuda K, Wang T, Chrisafis G, Mili S (2019). Translational regulation of protrusion-localized RNAs involves silencing and clustering after transport. Elife  8.   https://doi.org/10.7554/eLife.44752|2. Stueland M, Wang T, Park HY, Mili S (2019). RDI Calculator: An Analysis Tool to Assess RNA Distributions in Cells. Sci Rep  9, 8267.   https://doi.org/10.1038/s41598-019-44783-2",https://intramural.nih.gov/search/searchview.taf?ipid=108705
375,BC011502-07,"October 01, 2018 -  September 30, 2019",Characterization of Biological Nanoparticle Subsets,"Jennifer Clare Jones; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Julia Ann Kepley|Joshua Aden Welsh|Aleksandra Na Dakic|Bryce William Killingsworth|Jason E Savage|Timothy Ryan Traynor,Marty  Bigos (Stanford)|David  Park (Stanford)|Gordon  Freeman (Harvard)|Susan  Knox (Stanford)|Vasilis  Toxavidis (Beth Israel Deaconess Medical Center)|Tigges  John (BIDMC)|Show all 8,"Marjorie  Robert-Guroff; PhD (Vaccine Branch)|William G Telford (Experimental Transplantation and Immunology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Katherine M McKinnon (Vaccine Branch)",Marc  Ferrer-Alegre (NCATS),"1. Clayton A, Buschmann D, Byrd JB, Carter DRF, Cheng L, Compton C, Daaboul G, Devitt A, Falcon-Perez JM, Gardiner C, Gustafson D, Harrison P, Helmbrecht C, Hendrix A, Hill A, Hoffman A, Jones JC, Kalluri R, Kang JY, Kirchner B, Lässer C, Lawson C, Lenassi M, Levin C, Llorente A, et al. [12 more authors] (2018). Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. J Extracell Vesicles  7, 1473707.   https://doi.org/10.1080/20013078.2018.1473707|2. Görgens A, Bremer M, Ferrer-Tur R, Murke F, Tertel T, Horn PA, Thalmann S, Welsh JA, Probst C, Guerin C, Boulanger CM, Jones JC, Hanenberg H, Erdbrügger U, Lannigan J, Ricklefs FL, El-Andaloussi S, Giebel B (2019). Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. J Extracell Vesicles  8, 1587567.   https://doi.org/10.1080/20013078.2019.1587567|3. Jones J (2019). Glioblastoma single extracellular vesicle analysis profiles: wading into new oceans of tumor data. Neuro Oncol  21, 562-564.   https://doi.org/10.1093/neuonc/noz045|4. Murillo OD, Thistlethwaite W, Rozowsky J, Subramanian SL, Lucero R, Shah N, Jackson AR, Srinivasan S, Chung A, Laurent CD, Kitchen RR, Galeev T, Warrell J, Diao JA, Welsh JA, Hanspers K, Riutta A, Burgstaller-Muehlbacher S, Shah RV, Yeri A, Jenkins LM, Ahsen ME, Cordon-Cardo C, Dogra N, Gifford SM, et al. [33 more authors] (2019). exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids. Cell  177, 463-477.e15.   https://doi.org/10.1016/j.cell.2019.02.018|5. Watson DC, Yung BC, Bergamaschi C, Chowdhury B, Bear J, Stellas D, Morales-Kastresana A, Jones JC, Felber BK, Chen X, Pavlakis GN (2018). Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes. J Extracell Vesicles  7, 1442088.   https://doi.org/10.1080/20013078.2018.1442088|6. Wiklander OPB, Bostancioglu RB, Welsh JA, Zickler AM, Murke F, Corso G, Felldin U, Hagey DW, Evertsson B, Liang XM, Gustafsson MO, Mohammad DK, Wiek C, Hanenberg H, Bremer M, Gupta D, Björnstedt M, Giebel B, Nordin JZ, Jones JC, El Andaloussi S, Görgens A (2018). Systematic Methodological Evaluation of a Multiplex Bead-Based Flow Cytometry Assay for Detection of Extracellular Vesicle Surface Signatures. Front Immunol  9, 1326.   https://doi.org/10.3389/fimmu.2018.01326",https://intramural.nih.gov/search/searchview.taf?ipid=108706
376,BC011503-07,"October 01, 2018 -  September 30, 2019",Novel Combinations of Radiation and Immunotherapy,"Jennifer Clare Jones; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Aleksandra Na Dakic|Julia Ann Kepley|Bryce William Killingsworth|Jason E Savage|Timothy Ryan Traynor|Joshua Aden Welsh,Gordon  Freeman (Harvard)|Rosemarie  DeKruyff (Children's Hospital Boston)|Susan  Knox (Stanford),"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Kevin Charles Conlon (Lymphoid Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108707
377,BC011504-07,"October 01, 2018 -  September 30, 2019",Vulnerabilities in osteosarcoma and breast cancer,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Gamze  Ayaz Sen|Navdeep  Malik|Yu-Chou  Tseng|Shunlin  Jiang|Beverly  Mock; PhD|Maxwell P Lee; PhD|Show all 8,NULL,Rosandra N Kaplan (Pediatric Oncology Branch)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),Chengyu  Liu; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108692
378,BC011506-07,"October 01, 2018 -  September 30, 2019",New Synthetic Approaches to Small Molecules for Imaging,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Venu Gopal Bandi|Michael Philip Luciano; PhD|Saghar  Nourian,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling)|Kirk R Gustafson; PhD (Molecular Targets Laboratory),NULL,"1. Cha J, Nani RR, Luciano MP, Kline G, Broch A, Kim K, Namgoong JM, Kulkarni RA, Meier JL, Kim P, Schnermann MJ (2018). A chemically stable fluorescent marker of the ureter. Bioorg Med Chem Lett  28, 2741-2745.   https://doi.org/10.1016/j.bmcl.2018.02.040|2. Luciano MP, Crooke SN, Nourian S, Dingle I, Nani RR, Kline G, Patel NL, Robinson CM, Difilippantonio S, Kalen JD, Finn MG, Schnermann MJ (2019). A Nonaggregating Heptamethine Cyanine for Building Brighter Labeled Biomolecules. ACS Chem Biol  14, 934-940.   https://doi.org/10.1021/acschembio.9b00122",https://intramural.nih.gov/search/searchview.taf?ipid=108704
379,BC011511-07,"October 01, 2018 -  September 30, 2019",Chemical Targeting of Multi-Protein Complexes,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Francisco Antonio Aguilar Alonso; PhD,NULL,NULL,NULL,"1. Aguilar-Alonso F, Whiting AL, Kim YJ, Bernal F (2018). Biophysical and biological evaluation of optimized stapled peptide inhibitors of the linear ubiquitin chain assembly complex (LUBAC). Bioorg Med Chem  26, 1179-1188.   https://doi.org/10.1016/j.bmc.2017.11.047|2. Fujita H, Tokunaga A, Shimizu S, Whiting AL, Aguilar-Alonso F, Takagi K, Walinda E, Sasaki Y, Shimokawa T, Mizushima T, Ohki I, Ariyoshi M, Tochio H, Bernal F, Shirakawa M, Iwai K (2018). Cooperative Domain Formation by Homologous Motifs in HOIL-1L and SHARPIN Plays A Crucial Role in LUBAC Stabilization. Cell Rep  23, 1192-1204.   https://doi.org/10.1016/j.celrep.2018.03.112|3. Payne SR, Pau DI, Whiting AL, Kim YJ, Pharoah BM, Moi C, Boddy CN, Bernal F (2018). Inhibition of Bacterial Gene Transcription with an RpoN-Based Stapled Peptide. Cell Chem Biol  25, 1059-1066.e4.   https://doi.org/10.1016/j.chembiol.2018.05.007",https://intramural.nih.gov/search/searchview.taf?ipid=108697
380,BC011512-07,"October 01, 2018 -  September 30, 2019",Activatable molecular cancer imaging probe,Hisataka  Kobayashi|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Fusa Ogata Motoki,Yasuteru  Urano|Marcin  Ptaszek (UMBC)|Yu  Chen (Univ of Maryland)|Neil  Bander (Cornell Univ),Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,"1. Mochida A, Ogata F, Maruoka Y, Nagaya T, Okada R, Inagaki F, Fujimura D, Choyke PL, Kobayashi H (2018). Pitfalls on sample preparation for ex vivo imaging of resected cancer tissue using enzyme-activatable fluorescent probes. Oncotarget  9, 36039-36047.   https://doi.org/10.18632/oncotarget.26320|2. Mochida A, Ogata F, Nagaya T, Choyke PL, Kobayashi H (2018). Activatable fluorescent probes in fluorescence-guided surgery: Practical considerations. Bioorg Med Chem  26, 925-930.   https://doi.org/10.1016/j.bmc.2017.12.002",https://intramural.nih.gov/search/searchview.taf?ipid=108690
381,BC011513-07,"October 01, 2018 -  September 30, 2019",Cancer-cell specific therapy: photo-immunotherapy,Hisataka  Kobayashi|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI","Daiki  Fujimura|Fuyuki  Inagaki; PhD, MD|Yasuhiro  Maruoka|Ryuhei  Okada",Mikako  Ogawa|Yu  Chen (Univ of Maryland)|Peter  Marinkovich (Stnford Univ)|Zaver  Bhujwalla (Johns Hopkins)|Toshiyoshi  Fujiwara (Okayama Univ),Mitchell  Ho (Laboratory of Molecular Biology)|Ira H Pastan; MD (Molecular Biology Section)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,"1. Kobayashi H, Choyke PL (2019). Near-Infrared Photoimmunotherapy of Cancer. Acc Chem Res  52, 2332-2339.   https://doi.org/10.1021/acs.accounts.9b00273|2. Nagaya T, Gorka AP, Nani RR, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Schnermann MJ, Kobayashi H (2018). Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate. Mol Cancer Ther  17, 661-670.   https://doi.org/10.1158/1535-7163.MCT-17-0851|3. Nagaya T, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H (2018). Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer. Cancer Sci  109, 1902-1908.   https://doi.org/10.1111/cas.13621|4. Nakajima K, Kimura T, Takakura H, Yoshikawa Y, Kameda A, Shindo T, Sato K, Kobayashi H, Ogawa M (2018). Implantable wireless powered light emitting diode (LED) for near-infrared photoimmunotherapy: device development and experimental assessment in vitro and in vivo. Oncotarget  9, 20048-20057.   https://doi.org/10.18632/oncotarget.25068|5. Okuyama S, Nagaya T, Sato K, Ogata F, Maruoka Y, Choyke PL, Kobayashi H (2018). Interstitial near-infrared photoimmunotherapy: effective treatment areas and light doses needed for use with fiber optic diffusers. Oncotarget  9, 11159-11169.   https://doi.org/10.18632/oncotarget.24329|6. Sato K, Ando K, Okuyama S, Moriguchi S, Ogura T, Totoki S, Hanaoka H, Nagaya T, Kokawa R, Takakura H, Nishimura M, Hasegawa Y, Choyke PL, Ogawa M, Kobayashi H (2018). Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy. ACS Cent Sci  4, 1559-1569.   https://doi.org/10.1021/acscentsci.8b00565|7. Tang Q, Nagaya T, Liu Y, Horng H, Lin J, Sato K, Kobayashi H, Chen Y (2018). 3D mesoscopic fluorescence tomography for imaging micro-distribution of antibody-photon absorber conjugates during near infrared photoimmunotherapy in vivo. J Control Release  279, 171-180.   https://doi.org/10.1016/j.jconrel.2018.04.027",https://intramural.nih.gov/search/searchview.taf?ipid=108691
382,BC011514-07,"October 01, 2018 -  September 30, 2019",Investigating Pediatric CNS tumor biology,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Charles  Eberhart (Pathology, Johns Hopkins University School of Medicine)|Eric H Raabe|Javad  Nazarian (Children's National Medical Center)|Michelle  Monje-Deisseroth (Stanford)|Nada  Jabado (McGill University)",Martha Maria Nicacio Quezado; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108689
383,BC011518-07,"October 01, 2018 -  September 30, 2019",Molecular basis of centriole duplication,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jong Il  Ahn|Seongjin  Choe|Jung Eun  Park|Zhuang  Wei|Liang  Zhang; PhD,NULL,Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling)|Yun Xing M Wang (Structural Biophysics Laboratory),Rodolfo  Ghirlando; PhD (NIDDK),"1. Lee KH, Hwang JA, Kim SO, Kim JH, Shin SC, Kim EE, Lee KS, Rhee K, Jeon BH, Bang JK, Cha-Molstad H, Soung NK, Jang JH, Ko SK, Lee HG, Ahn JS, Kwon YT, Kim BY (2018). Phosphorylation of human enhancer filamentation 1 (HEF1) stimulates interaction with Polo-like kinase 1 leading to HEF1 localization to focal adhesions. J Biol Chem  293, 847-862.   https://doi.org/10.1074/jbc.M117.802587|2. Soung NK, Kim HM, Asami Y, Kim DH, Cho Y, Naik R, Jang Y, Jang K, Han HJ, Ganipisetti SR, Cha-Molstad H, Hwang J, Lee KH, Ko SK, Jang JH, Ryoo IJ, Kwon YT, Lee KS, Osada H, Lee K, Kim BY, Ahn JS (2019). Mechanism of the natural product moracin-O derived MO-460 and its targeting protein hnRNPA2B1 on HIF-1α inhibition. Exp Mol Med  51, 10.   https://doi.org/10.1038/s12276-018-0200-4",https://intramural.nih.gov/search/searchview.taf?ipid=108684
384,BC011519-07,"October 01, 2018 -  September 30, 2019",Telomere Biology,Julia Promisel Cooper|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Manasi Sadanand Apte; PhD|Adenrele Madeline Gleason; PhD|Haitong  Hou|Hirohisa  Masuda; PhD|Rishi Kumar  Nageshan; PhD|Rahul Rajan Thadani; PhD|Show all 7,"Nevan  Krogan (Univ of California, San Francisco)|Geeta  Narlikar (UC San Francisco)",Eros  Lazzerini Denchi (Laboratory Of Genome Integrity),NULL,"1. Begnis M, Apte MS, Masuda H, Jain D, Wheeler DL, Cooper JP (2018). RNAi drives nonreciprocal translocations at eroding chromosome ends to establish telomere-free linear chromosomes. Genes Dev  32, 537-554.   https://doi.org/10.1101/gad.311712.118|2. Ebrahimi H, Masuda H, Jain D, Cooper JP (2018). Distinct 'safe zones' at the nuclear envelope ensure robust replication of heterochromatic chromosome regions. Elife  7.   https://doi.org/10.7554/eLife.32911|3. Greenwood J, Patel H, Cech TR, Cooper JP (2018). Fission yeast telosomes: non-canonical histone-containing chromatin structures dependent on shelterin and RNA. Nucleic Acids Res  46, 8865-8875.   https://doi.org/10.1093/nar/gky605|4. Hou H, Cooper JP (2018). Stretching, scrambling, piercing and entangling: Challenges for telomeres in mitotic and meiotic chromosome segregation. Differentiation  100, 12-20.   https://doi.org/10.1016/j.diff.2018.01.002",https://intramural.nih.gov/search/searchview.taf?ipid=108711
385,BC011524-07,"October 01, 2018 -  September 30, 2019",Mechanical regulation of the microenvironmental niche in skin tumorigenesis,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Maira  Alves Constantino|Woong Young  So,NULL,NULL,NULL,"1. Tanner K (2018). Perspective: The role of mechanobiology in the etiology of brain metastasis. APL Bioeng  2, 031801.   https://doi.org/10.1063/1.5024394",https://intramural.nih.gov/search/searchview.taf?ipid=108703
386,BC011525-07,"October 01, 2018 -  September 30, 2019",Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,Jung-Min  Lee|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Daniel  An|Tzu-Ting  Huang|Jayakumar Ramachandran Nair|Erin Kathleen Manricks,NULL,William D Figg; PharmD (Genitourinary Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch),Craig Joseph Thomas (NCATS),"1. Haynes B, Murai J, Lee JM (2018). Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition. Cancer Treat Rev  71, 1-7.   https://doi.org/10.1016/j.ctrv.2018.09.003|2. Karzai F, VanderWeele D, Madan RA, Owens H, Cordes LM, Hankin A, Couvillon A, Nichols E, Bilusic M, Beshiri ML, Kelly K, Krishnasamy V, Lee S, Lee MJ, Yuno A, Trepel JB, Merino MJ, Dittamore R, Marté J, Donahue RN, Schlom J, Killian KJ, Meltzer PS, Steinberg SM, Gulley JL, et al. [2 more authors] (2018). Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations. J Immunother Cancer  6, 141.   https://doi.org/10.1186/s40425-018-0463-2|3. Lee J, Minasian L, Kohn E (2019) New Strategies in Ovarian Cancer Treatment. Cancer, in press.|4. Liu JF, Barry WT, Birrer M, Lee JM, Buckanovich RJ, Fleming GF, Rimel BJ, Buss MK, Nattam SR, Hurteau J, Luo W, Curtis J, Whalen C, Kohn EC, Ivy SP, Matulonis UA (2019). Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer. Ann Oncol  30, 551-557.   https://doi.org/10.1093/annonc/mdz018|5. Pettitt SJ, Krastev DB, Brandsma I, Dréan A, Song F, Aleksandrov R, Harrell MI, Menon M, Brough R, Campbell J, Frankum J, Ranes M, Pemberton HN, Rafiq R, Fenwick K, Swain A, Guettler S, Lee JM, Swisher EM, Stoynov S, Yusa K, Ashworth A, Lord CJ (2018). Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance. Nat Commun  9, 1849.   https://doi.org/10.1038/s41467-018-03917-2|6. Rice CM, Davies LC, Subleski JJ, Maio N, Gonzalez-Cotto M, Andrews C, Patel NL, Palmieri EM, Weiss JM, Lee JM, Annunziata CM, Rouault TA, Durum SK, McVicar DW (2018). Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression. Nat Commun  9, 5099.   https://doi.org/10.1038/s41467-018-07505-2|7. Suffredini DA, Lee JM, Peer CJ, Pratt D, Kleiner DE, Elinoff JM, Solomon MA (2018). Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab. BMC Pulm Med  18, 112.   https://doi.org/10.1186/s12890-018-0681-x|8. Thomas A, Vilimas R, Trindade C, Erwin-Cohen R, Roper N, Xi L, Krishnasamy V, Levy E, Mammen A, Nichols S, Chen Y, Velcheti V, Yin F, Szabo E, Pommier Y, Steinberg SM, Trepel JB, Raffeld M, Young HA, Khan J, Hewitt S, Lee JM (2019). Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study. J Thorac Oncol  14, 1447-1457.   https://doi.org/10.1016/j.jtho.2019.04.026|9. Zimmer AS, Gillard M, Lipkowitz S, Lee JM (2018). Update on PARP Inhibitors in Breast Cancer. Curr Treat Options Oncol  19, 21.   https://doi.org/10.1007/s11864-018-0540-2",https://intramural.nih.gov/search/searchview.taf?ipid=108695
387,BC011528-07,"October 01, 2018 -  September 30, 2019","A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus",Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Julian  Custer|Rebecca Christine Dolan|Nida T Hussain,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)",NULL,"1. Agarwal PK, Sternberg CN (2018). Clinical Trials Corner. Bladder Cancer  4, 243-244.   https://doi.org/10.3233/BLC-189033|2. Agarwal PK, Sternberg CN (2018). Clinical Trials Corner. Bladder Cancer  4, 447-449.   https://doi.org/10.3233/BLC-189040",https://intramural.nih.gov/search/searchview.taf?ipid=108701
388,BC011529-07,"October 01, 2018 -  September 30, 2019",In-patient hospice and rapid autopsy to interrogate tumor heterogeneity,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Constance M Cultraro|Tapan Kumar Maity|Abhilash  Venugopalan|Xu  Zhang,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Javed  Khan; MD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108699
389,BC011547-06,"October 01, 2018 -  September 30, 2019",Cancer Immunotherapy Clinical Trials,Julius Yehuda Strauss; MD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Bonnie L Casey|Cynthia Ann Moye|Camilo  Pacheco|Renee Nicole Donahue,"Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|Paul  Chaplin (Bavarian Nordic, Inc.)|Frank E Jones; PhD (Tulane School of Medicine)|Shahrooz  Rabizadeh (Nantbioscience/nantomics)|Helen B Sabzevari|Patrick  Soon-shiong (Nantbioscience)|Show all 7","William Laurence Dahut; MD (Genitourinary Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Ravi  Madan (Genitourinary Malignancies Branch)|Peter A Pinto; MD (Urologic Oncology Branch)","Lisa Marie Cordes; PHARMD, BCACP (OD) |Clint Tanner Allen (NIDCD) |Andrew Lee Mammen (NIAMS)","1. Allen CT, Lee S, Norberg SM, Kovalovsky D, Ye H, Clavijo PE, Hu-Lieskovan S, Schlegel R, Schlom J, Strauss J, Gulley JL, Trepel J, Hinrichs CS (2019). Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis. J Immunother Cancer  7, 119.   https://doi.org/10.1186/s40425-019-0603-3|2. Gatti-Mays ME, Strauss J, Donahue RN, Palena C, Del Rivero J, Redman JM, Madan RA, Marté JL, Cordes LM, Lamping E, Orpia A, Burmeister A, Wagner E, Pico Navarro C, Heery CR, Schlom J, Gulley JL (2019). A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules. Clin Cancer Res  25, 4933-4944.   https://doi.org/10.1158/1078-0432.CCR-19-0183|3. Strauss J, Heery CR, Kim JW, Jochems C, Donahue RN, Montgomery AS, McMahon S, Lamping E, Marté JL, Madan RA, Bilusic M, Silver MR, Bertotti E, Schlom J, Gulley JL (2019). First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors. Clin Cancer Res  25, 99-109.   https://doi.org/10.1158/1078-0432.CCR-18-1512|4. Zhao C, Tella SH, Del Rivero J, Kommalapati A, Ebenuwa I, Gulley J, Strauss J, Brownell I (2018). Anti-PD-L1 Treatment Induced Central Diabetes Insipidus. J Clin Endocrinol Metab  103, 365-369.   https://doi.org/10.1210/jc.2017-01905",https://intramural.nih.gov/search/searchview.taf?ipid=108738
390,BC011549-06,"October 01, 2018 -  September 30, 2019",Chronic graft-versus-host disease,Edward W Cowen|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108735
391,BC011550-06,"October 01, 2018 -  September 30, 2019",Anakinra for neutrophilic pustular skin disease,Edward W Cowen|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,"Nehal N Mehta (NHLBI) |Raphaela  Goldbach-Mansky; MD, MHS (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108736
392,BC011552-06,"October 01, 2018 -  September 30, 2019",Targeting mechanisms of radiation resistance,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Jessica Leigh Reedy|Bradley T Scroggins|Ayla Oksuz White|Hong G Zhang; PhD,NULL,James B Mitchell; PhD (Radiation Biology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Murali  Krishna; PhD (Radiation Biology Branch)|Adam G Sowalsky (Laboratory Of Genitourinary Cancer Pathogenesis)|Bradford J Wood; MD (Office of the Director),NULL,"1. Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, et al. [2 more authors] (2018). Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint. Cancer Res  78, 2166-2170.   https://doi.org/10.1158/0008-5472.CAN-17-3760|2. Eke I, Makinde AY, Aryankalayil MJ, Reedy JL, Citrin DE, Chopra S, Ahmed MM, Coleman CN (2018). Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer. Mol Cancer Res  16, 1855-1864.   https://doi.org/10.1158/1541-7786.MCR-18-0232|3. Scroggins BT, Burkeen J, White AO, Chung EJ, Wei D, Chung SI, Valle LF, Patil SS, McKay-Corkum G, Hudak KE, Linehan WM, Citrin DE (2018). Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage. Int J Radiat Oncol Biol Phys  100, 344-352.   https://doi.org/10.1016/j.ijrobp.2017.09.049",https://intramural.nih.gov/search/searchview.taf?ipid=108734
393,BC011554-06,"October 01, 2018 -  September 30, 2019",Lung Cancer Health Disparities,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Rony F Arauz|Emily Louise Rossi|Sanju  Sinha|Adriana  Zingone; MD|Curtis  Harris; MD|Julian Marcelo Candia,Pine  Sharon (Rutgers Cancer Institute of New Jersey)|Rick  Kittles (University of Arizona Cancer Center)|Keisha  Houston (Centers for Disease Control and Prevention)|Ann  Schwartz (Karmanos Cancer Center)|Isidore  Rigoutsos (Thomas Jefferson University),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Daniel C Edelman (Cancer Genetics Branch)|Bin  Zhu (Biostatistics Branch)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)|Maki  Inoue Choi (Hormonal and Reproductive Epidemiology Branch)",Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS),"1. Brown D, Zingone A, Yu Y, Zhu B, Candia J, Cao L, Ryan BM (2019). Relationship between Circulating Inflammation Proteins and Lung Cancer Diagnosis in the National Lung Screening Trial. Cancer Epidemiol Biomarkers Prev  28, 110-118.   https://doi.org/10.1158/1055-9965.EPI-18-0598|2. Erickson P, Gardner LD, Loffredo CA, St George DM, Bowman ED, Deepak J, Mitchell K, Meaney CL, Langenberg P, Bernat DH, Amr S, Ryan BM (2018). Racial and Ethnic Differences in the Relationship between Aspirin Use and Non-Small Cell Lung Cancer Risk and Survival. Cancer Epidemiol Biomarkers Prev  27, 1518-1526.   https://doi.org/10.1158/1055-9965.EPI-18-0366|3. Houston KA, Mitchell KA, King J, White A, Ryan BM (2018). Histologic Lung Cancer Incidence Rates and Trends Vary by Race/Ethnicity and Residential County. J Thorac Oncol  13, 497-509.   https://doi.org/10.1016/j.jtho.2017.12.010|4. Meaney CL, Mitchell KA, Zingone A, Brown D, Bowman E, Yu Y, Wenzlaff AS, Neslund-Dudas C, Pine SR, Cao L, Schwartz AG, Ryan BM (2019). Circulating Inflammation Proteins Associated With Lung Cancer in African Americans. J Thorac Oncol  14, 1192-1203.   https://doi.org/10.1016/j.jtho.2019.03.014|5. Minas TZ, Tang W, Smith CJ, Onabajo OO, Obajemu A, Dorsey TH, Jordan SV, Obadi OM, Ryan BM, Prokunina-Olsson L, Loffredo CA, Ambs S (2018). IFNL4-ΔG is associated with prostate cancer among men at increased risk of sexually transmitted infections. Commun Biol  1, 191.   https://doi.org/10.1038/s42003-018-0193-5|6. Ryan BM (2018). Lung cancer health disparities. Carcinogenesis  39, 741-751.   https://doi.org/10.1093/carcin/bgy047|7. Yu Y, Ryan BM, Thomas A, Morrow B, Zhang J, Kang Z, Zingone A, Onda M, Hassan R, Pastan I, Cao L (2018). Elevated Serum Megakaryocyte Potentiating Factor as a Predictor of Poor Survival in Patients with Mesothelioma and Primary Lung Cancer. J Appl Lab Med  3, 166-177.   https://doi.org/10.1373/jalm.2017.025015",https://intramural.nih.gov/search/searchview.taf?ipid=108732
394,BC011555-06,"October 01, 2018 -  September 30, 2019",Gene-Environment Interactions in Lung Cancer,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Christopher Edward Grant|Emily Louise Rossi|Leila Bahadori Toulabi; PhD|Adriana  Zingone; MD,Ann  Schwartz (Karmanos Cancer Center)|Pine  Sharon (Rutgers Cancer Institute of New Jersey),Rachael Zoe Solomon (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Hung RJ, Spitz MR, Houlston RS, Schwartz AG, Field JK, Ying J, Li Y, Han Y, Ji X, Chen W, Wu X, Gorlov IP, Na J, de Andrade M, Liu G, Brhane Y, Diao N, Wenzlaff A, Davies MPA, Liloglou T, Timofeeva M, Muley T, Rennert H, Saliba W, Ryan BM, et al. [41 more authors] (2019). Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. J Thorac Oncol  14, 1360-1369.   https://doi.org/10.1016/j.jtho.2019.04.008|2. Pine SR, Ryan BM (2018). Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach. Transl Lung Cancer Res  7, S265-S269.   https://doi.org/10.21037/tlcr.2018.09.10|3. Ryan BM, Robles AI (2019). Prenatal smoke exposure, DNA methylation and a link between DRD1 and lung cancer. Int J Epidemiol  48, 1377-1378.   https://doi.org/10.1093/ije/dyz035|4. Toulabi L, Ryan BM (2018). Stressing the need to overcome EGFR tyrosine kinase inhibitor resistance. Transl Lung Cancer Res  7, S123-S126.   https://doi.org/10.21037/tlcr.2018.03.05",https://intramural.nih.gov/search/searchview.taf?ipid=108733
395,BC011558-06,"October 01, 2018 -  September 30, 2019",Effects of systemic and topical perturbations on human microbes,Heidi H Kong|IRP Faculty Profile,NULL,"Office of the Director, NCI","Iryna Leonidivna Chub|Jay Hyun  Jo; PhD|Valentina Shobhana Pillai; CRNP|Nicole Helen Schwardt|Monica Elizabeth Taylor|Isaac Franklin Brownell; MD, PhD|Show all 8",Carsten  Flohr (St. John's College)|Lora  Hooper (UT Southwestern)|Lloyd  Miller (Johns Hopkins),"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Ravi  Madan (Genitourinary Malignancies Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)","Julia A Segre; PhD (NHGRI) |Alexandra  Freeman (NIAID) |Steven M Holland; MD (NIAID) |Michail S Lionakis (NIAID) |Niki  Moutsopoulos; DDS, PhD (NIDCR) |Philip M Murphy; MD (NIAID)","1. Abusleme L, Diaz PI, Freeman AF, Greenwell-Wild T, Brenchley L, Desai JV, Ng WI, Holland SM, Lionakis MS, Segre JA, Kong HH, Moutsopoulos NM (2018). Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis. JCI Insight  3.   https://doi.org/10.1172/jci.insight.122061|2. Archer NK, Jo JH, Lee SK, Kim D, Smith B, Ortines RV, Wang Y, Marchitto MC, Ravipati A, Cai SS, Dillen CA, Liu H, Miller RJ, Ashbaugh AG, Uppal AS, Oyoshi MK, Malhotra N, Hoff S, Garza LA, Kong HH, Segre JA, Geha RS, Miller LS (2019). Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1α release. J Allergy Clin Immunol  143, 1426-1443.e6.   https://doi.org/10.1016/j.jaci.2018.08.042|3. Sinha R, Ahsan H, Blaser M, Caporaso JG, Carmical JR, Chan AT, Fodor A, Gail MH, Harris CC, Helzlsouer K, Huttenhower C, Knight R, Kong HH, Lai GY, Hutchinson DLS, Le Marchand L, Li H, Orlich MJ, Shi J, Truelove A, Verma M, Vogtmann E, White O, Willett W, Zheng W, et al. [2 more authors] (2018). Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16-17, 2017. Microbiome  6, 210.   https://doi.org/10.1186/s40168-018-0596-z|4. Tirosh O, Conlan S, Deming C, Lee-Lin SQ, Huang X, NISC Comparative Sequencing Program, Su HC, Freeman AF, Segre JA, Kong HH (2018). Expanded skin virome in DOCK8-deficient patients. Nat Med  24, 1815-1821.   https://doi.org/10.1038/s41591-018-0211-7",https://intramural.nih.gov/search/searchview.taf?ipid=108731
396,BC011559-06,"October 01, 2018 -  September 30, 2019",The role of the tumor biofilm in determining tissue tropism,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Maira  Alves Constantino|Colin Dowlin Paul; PhD|Joanna Ruth Thomas|Michael Marc Gottesman; MD,NULL,Kumaran S Ramamurthi (Laboratory of Molecular Biology)|David J Fitzgerald; PhD (Biotherapy Section)|Zhenggang  Liu; PhD (Laboratory of Immune Cell Biology),NULL,"1. Paul C, Bishop K, Devine A, Paine E, Staunton J, Thomas S, Thomas J, Jenkins L, Morgan N, Sood R, Tanner K (2019) Tissue architectural cues drive organ targeting of human tumor cells in zebrafish. Cell Systems, in press.|2. Paul CD, Devine A, Bishop K, Xu Q, Wulftange WJ, Burr H, Daly KM, Lewis C, Green DS, Staunton JR, Choksi S, Liu ZG, Sood R, Tanner K (2019). Human macrophages survive and adopt activated genotypes in living zebrafish. Sci Rep  9, 1759.   https://doi.org/10.1038/s41598-018-38186-y",https://intramural.nih.gov/search/searchview.taf?ipid=108730
397,BC011561-06,"October 01, 2018 -  September 30, 2019",Exploring mechanisms that govern immune homeostasis in skin,Keisuke  Nagao|IRP Faculty Profile,NULL,"Office of the Director, NCI",Benjamin  Voisin|Thomas  Doebel|Tetsuro  Kobayashi|Bao D Quoe  Tran|Michael Christopher Kelly; PhD|Heidi H Kong,Daniel M Kaplan|Masayuki  Amagai (Keio University School of Medicine)|Moro  Kazuyo (Riken Institute),Stefania  Pittaluga (Laboratory of Pathology)|Chunhua  Yan (Cancer Informatics Branch),Julia A Segre; PhD (NHGRI) |Warren J Leonard; MD (NHLBI) |Matthew William Kelley; PhD (NIDCD) |Alexandra  Freeman (NIAID) |Fred Pejman Davis (NIAMS) |Gary A Fahle (CC),"1. Fujita K, Chakarov S, Kobayashi T, Sakamoto K, Voisin B, Duan K, Nakagawa T, Horiuchi K, Amagai M, Ginhoux F, Nagao K (2019). Cell-autonomous FLT3L shedding via ADAM10 mediates conventional dendritic cell development in mouse spleen. Proc Natl Acad Sci U S A  116, 14714-14723.   https://doi.org/10.1073/pnas.1818907116|2. Kim D, Kobayashi T, Nagao K (2019). Research Techniques Made Simple: Mouse Models of Atopic Dermatitis. J Invest Dermatol  139, 984-990.e1.   https://doi.org/10.1016/j.jid.2019.02.014|3. Kitashima DY, Kobayashi T, Woodring T, Idouchi K, Doebel T, Voisin B, Adachi T, Ouchi T, Takahashi H, Nishifuji K, Kaplan DH, Clausen BE, Amagai M, Nagao K (2018). Langerhans Cells Prevent Autoimmunity via Expansion of Keratinocyte Antigen-Specific Regulatory T Cells. EBioMedicine  27, 293-303.   https://doi.org/10.1016/j.ebiom.2017.12.022|4. Kobayashi T, Nagao K (2018). Mapping regulatory circuits in allergic skin inflammation. Sci Immunol  3.   https://doi.org/10.1126/sciimmunol.aar7655|5. Kobayashi T, Nagao K (2019). Host-microbial dialogues in atopic dermatitis. Int Immunol  31, 449-456.   https://doi.org/10.1093/intimm/dxz026|6. Kobayashi T, Naik S, Nagao K (2019). Choreographing Immunity in the Skin Epithelial Barrier. Immunity  50, 552-565.   https://doi.org/10.1016/j.immuni.2019.02.023|7. Kobayashi T, Voisin B, Kim DY, Kennedy EA, Jo JH, Shih HY, Truong A, Doebel T, Sakamoto K, Cui CY, Schlessinger D, Moro K, Nakae S, Horiuchi K, Zhu J, Leonard WJ, Kong HH, Nagao K (2019). Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium. Cell  176, 982-997.e16.   https://doi.org/10.1016/j.cell.2018.12.031|8. Larsen BM, Cowan JE, Wang Y, Tanaka Y, Zhao Y, Voisin B, Constantinides MG, Nagao K, Belkaid Y, Awasthi P, Takahama Y, Bhandoola A (2019). Identification of an Intronic Regulatory Element Necessary for Tissue-Specific Expression of Foxn1 in Thymic Epithelial Cells. J Immunol  203, 686-695.   https://doi.org/10.4049/jimmunol.1801540",https://intramural.nih.gov/search/searchview.taf?ipid=108728
398,BC011564-06,"October 01, 2018 -  September 30, 2019",Near-IR Photorelease Chemistry: Discovery and Applications,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Michael Philip Luciano; PhD,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,"1. Anderson ED, Sova S, Ivanic J, Kelly L, Schnermann MJ (2018). Defining the conditional basis of silicon phthalocyanine near-IR ligand exchange. Phys Chem Chem Phys  20, 19030-19036.   https://doi.org/10.1039/c8cp03842b|2. Fu Y, Urban DJ, Nani RR, Zhang YF, Li N, Fu H, Shah H, Gorka AP, Guha R, Chen L, Hall MD, Schnermann MJ, Ho M (2019). Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma. Hepatology  70, 563-576.   https://doi.org/10.1002/hep.30326|3. Gorka AP, Yamamoto T, Zhu J, Schnermann MJ (2018). Cyanine Photocages Enable Spatial Control of Inducible Cre-Mediated Recombination. Chembiochem  19, 1239-1243.   https://doi.org/10.1002/cbic.201800061",https://intramural.nih.gov/search/searchview.taf?ipid=108729
399,BC011566-06,"October 01, 2018 -  September 30, 2019","Mechanism, Regulation and Application of miRNA pathway in cancer",Shuo  Gu|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Ben  Birkenfeld|Francesc Xavier  Bofill De Ros|Lisheng  Dai|Lillian Faye Hallmark|Chuanjiang  Lian|Acong  Yang|Show all 8,NULL,Xinhua  Ji; PhD (Biomolecular Structure Section)|Yun Xing M Wang (Structural Biophysics Laboratory),NULL,"1. Bindewald E, Dai L, Kasprzak WK, Kim T, Gu S, Shapiro BA (2018). RNA⁻Protein Interactions Prevent Long RNA Duplex Formation: Implications for the Design of RNA-Based Therapeutics. Molecules  23.   https://doi.org/10.3390/molecules23123329|2. Bofill-De Ros X, Chen K, Chen S, Tesic N, Randjelovic D, Skundric N, Nesic S, Varjacic V, Williams EH, Malhotra R, Jiang M, Gu S (2019). QuagmiR: a cloud-based application for isomiR big data analytics. Bioinformatics  35, 1576-1578.   https://doi.org/10.1093/bioinformatics/bty843|3. Bofill-De Ros X, Kasprzak WK, Bhandari Y, Fan L, Cavanaugh Q, Jiang M, Dai L, Yang A, Shao TJ, Shapiro BA, Wang YX, Gu S (2019). Structural Differences between Pri-miRNA Paralogs Promote Alternative Drosha Cleavage and Expand Target Repertoires. Cell Rep  26, 447-459.e4.   https://doi.org/10.1016/j.celrep.2018.12.054|4. Bofill-De Ros X, Yang A, Gu S (2019) IsomiRs: Expanding the miRNA repression toolbox beyond the seed. Biochim Biophys Acta Gene Regul Mech, in press (e-pub ahead of print)  https://doi.org/10.1016/j.bbagrm.2019.03.005|5. Jin L, Song H, Tropea JE, Needle D, Waugh DS, Gu S, Ji X (2019). The molecular mechanism of dsRNA processing by a bacterial Dicer. Nucleic Acids Res  47, 4707-4720.   https://doi.org/10.1093/nar/gkz208|6. Yang A, Bofill-De Ros X, Shao TJ, Jiang M, Li K, Villanueva P, Dai L, Gu S (2019). 3' Uridylation Confers miRNAs with Non-canonical Target Repertoires. Mol Cell  75, 511-522.e4.   https://doi.org/10.1016/j.molcel.2019.05.014",https://intramural.nih.gov/search/searchview.taf?ipid=108724
400,BC011568-06,"October 01, 2018 -  September 30, 2019",Natural Products Discovery and Characterization Through Network Collaborations,Kirk R Gustafson; PhD|IRP Faculty Profile,NULL,"Molecular Targets Laboratory, NCI",Heidi  Bokesch|Richard W Fuller|Unwoo  Kang|Chang-Kwon  Kim; PhD,NULL,William D Figg; PharmD (Genitourinary Malignancies Branch)|Martin John Schnermann; PhD (Chemical Biology Laboratory)|David  Covell (Screening Technologies Branch)|Megan L Peach (Chemical Biology Laboratory),NULL,"1. Espindola LS, Dusi RG, Demarque DP, Braz-Filho R, Yan P, Bokesch HR, Gustafson KR, Beutler JA (2018). Cytotoxic Triterpenes from Salacia crassifolia and Metabolite Profiling of Celastraceae Species. Molecules  23.   https://doi.org/10.3390/molecules23061494|2. Harris EM, Strope JD, Beedie SL, Huang PA, Goey AKL, Cook KM, Schofield CJ, Chau CH, Cadelis MM, Copp BR, Gustafson KR, Figg WD (2018). Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models. Mar Drugs  16.   https://doi.org/10.3390/md16070241|3. Kim HJ, Yim SH, Han F, Kang BY, Choi HJ, Jung DW, Williams DR, Gustafson KR, Kennelly EJ, Lee IS (2019). Biotransformed Metabolites of the Hop Prenylflavanone Isoxanthohumol. Molecules  24.   https://doi.org/10.3390/molecules24030394|4. Liu Y, Cohen RD, Gustafson KR, Martin GE, Williamson RT (2018). Enhanced measurement of residual chemical shift anisotropy for small molecule structure elucidation. Chem Commun (Camb)  54, 4254-4257.   https://doi.org/10.1039/c8cc00552d|5. Milanowski DJ, Oku N, Cartner LK, Bokesch HR, Williamson RT, Saurí J, Liu Y, Blinov KA, Ding Y, Li XC, Ferreira D, Walker LA, Khan S, Davies-Coleman MT, Kelley JA, McMahon JB, Martin GE, Gustafson KR (2018). Unequivocal determination of caulamidines A and B: application and validation of new tools in the structure elucidation tool box. Chem Sci  9, 307-314.   https://doi.org/10.1039/c7sc01996c|6. Singh AJ, Gorka AP, Bokesch HR, Wamiru A, O'Keefe BR, Schnermann MJ, Gustafson KR (2018). Harnessing Natural Product Diversity for Fluorophore Discovery: Naturally Occurring Fluorescent Hydroxyanthraquinones from the Marine Crinoid Pterometra venusta. J Nat Prod  81, 2750-2755.   https://doi.org/10.1021/acs.jnatprod.8b00761|7. Tian XR, Tang HF, Tian XL, Hu JJ, Huang LL, Gustafson KR (2018). Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery. Future Med Chem  10, 1497-1514.   https://doi.org/10.4155/fmc-2018-0012|8. Valdeira ASC, Ritt DA, Morrison DK, McMahon JB, Gustafson KR, Salvador JAR (2018). Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling. Front Chem  6, 434.   https://doi.org/10.3389/fchem.2018.00434",https://intramural.nih.gov/search/searchview.taf?ipid=108726
401,BC011584-06,"October 01, 2018 -  September 30, 2019",Clinical trials in womens cancers,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Michelle K Ozaki|Stanley  Lipkowitz; MD, PhD|Jung-Min  Lee",NULL,Jinqiu  Chen (Office of the Director),"Carter  Van Waes; MD, PhD (NIDCD) |Diana Willa Bianchi; MD (NICHD)","1. Annunziata CM, Kohn EC (2018). Clinical trials in gynecologic oncology: Past, present, and future. Gynecol Oncol  148, 393-402.   https://doi.org/10.1016/j.ygyno.2017.11.026|2. Disis ML, Taylor MH, Kelly K, Beck JT, Gordon M, Moore KM, Patel MR, Chaves J, Park H, Mita AC, Hamilton EP, Annunziata CM, Grote HJ, von Heydebreck A, Grewal J, Chand V, Gulley JL (2019). Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial. JAMA Oncol  5, 393-401.   https://doi.org/10.1001/jamaoncol.2018.6258|3. Green DS, Nunes AT, David-Ocampo V, Ekwede IB, Houston ND, Highfill SL, Khuu H, Stroncek DF, Steinberg SM, Zoon KC, Annunziata CM (2018). A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer. J Transl Med  16, 196.   https://doi.org/10.1186/s12967-018-1569-5|4. Lampert EJ, Hays JL, Kohn EC, Annunziata CM, Minasian L, Yu M, Gordon N, Sissung TM, Chiou VL, Figg WD, Houston N, Lee JM (2019). Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk. Oncotarget  10, 2855-2868.   https://doi.org/10.18632/oncotarget.26869|5. Zimmer AS, Nichols E, Cimino-Mathews A, Peer C, Cao L, Lee MJ, Kohn EC, Annunziata CM, Lipkowitz S, Trepel JB, Sharma R, Mikkilineni L, Gatti-Mays M, Figg WD, Houston ND, Lee JM (2019). A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses. J Immunother Cancer  7, 197.   https://doi.org/10.1186/s40425-019-0680-3",https://intramural.nih.gov/search/searchview.taf?ipid=108717
402,BC011585-06,"October 01, 2018 -  September 30, 2019",Identification of Nucleic Acid Binding Small Molecules,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Robert Edward Boer|David Raymond Calabrese; PhD|Colleen Marie Connelly|Zachary Robert Torrey|Sumirtha  Balaratnam; PhD|Desta Doro Bume; PhD|Show all 8,NULL,Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Thomas A Misteli; PhD (Office of the Director)|Natasha  Caplen (Cancer Genetics Branch)|Kylie Janice Walters (Structural Biophysics Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory),Adrian Riu Ferre-D'Amare (NHLBI),"1. Abulwerdi FA, Xu W, Ageeli AA, Yonkunas MJ, Arun G, Nam H, Schneekloth JS, Dayie TK, Spector D, Baird N, Le Grice SFJ (2019). Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1. ACS Chem Biol  14, 223-235.   https://doi.org/10.1021/acschembio.8b00807|2. Calabrese DR, Zlotkowski K, Alden S, Hewitt WM, Connelly CM, Wilson RM, Gaikwad S, Chen L, Guha R, Thomas CJ, Mock BA, Schneekloth JS (2018). Characterization of clinically used oral antiseptics as quadruplex-binding ligands. Nucleic Acids Res  46, 2722-2732.   https://doi.org/10.1093/nar/gky084|3. Connelly CM, Numata T, Boer RE, Moon MH, Sinniah RS, Barchi JJ, Ferré-D'Amaré AR, Schneekloth JS (2019). Synthetic ligands for PreQ1 riboswitches provide structural and mechanistic insights into targeting RNA tertiary structure. Nat Commun  10, 1501.   https://doi.org/10.1038/s41467-019-09493-3|4. Gunther EC, Smith LM, Kostylev MA, Cox TO, Kaufman AC, Lee S, Folta-Stogniew E, Maynard GD, Um JW, Stagi M, Heiss JK, Stoner A, Noble GP, Takahashi H, Haas LT, Schneekloth JS, Merkel J, Teran C, Naderi ZK, Supattapone S, Strittmatter SM (2019). Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists. Cell Rep  26, 1368.   https://doi.org/10.1016/j.celrep.2019.01.064|5. Gunther EC, Smith LM, Kostylev MA, Cox TO, Kaufman AC, Lee S, Folta-Stogniew E, Maynard GD, Um JW, Stagi M, Heiss JK, Stoner A, Noble GP, Takahashi H, Haas LT, Schneekloth JS, Merkel J, Teran C, Naderi ZK, Supattapone S, Strittmatter SM (2019). Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists. Cell Rep  26, 145-158.e8.   https://doi.org/10.1016/j.celrep.2018.12.021|6. Journey SN, Alden SL, Hewitt WM, Peach ML, Nicklaus MC, Schneekloth JS (2018). Probing the hras-1Y i-motif with small molecules. Medchemcomm  9, 2000-2007.   https://doi.org/10.1039/c8md00311d|7. Moon MH, Hilimire TA, Sanders AM, Schneekloth JS (2018). Measuring RNA-Ligand Interactions with Microscale Thermophoresis. Biochemistry  57, 4638-4643.   https://doi.org/10.1021/acs.biochem.7b01141|8. Yan P, Ritt DA, Zlotkowski K, Bokesch HR, Reinhold WC, Schneekloth JS, Morrison DK, Gustafson KR (2018). Macrophilones from the Marine Hydroid Macrorhynchia philippina Can Inhibit ERK Cascade Signaling. J Nat Prod  81, 1666-1672.   https://doi.org/10.1021/acs.jnatprod.8b00343",https://intramural.nih.gov/search/searchview.taf?ipid=108718
403,BC011593-06,"October 01, 2018 -  September 30, 2019",Investigation of Epigenetic Modifiers in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Leonard  Neckers; PhD,NULL,Jane Beth Trepel (Developmental Therapeutics Branch),Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108716
404,BC011594-06,"October 01, 2018 -  September 30, 2019",Targeting the MET Pathway in Urothelial Carcinoma,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Rene A Costello; MT|Gloria L Jackson|Yang-Min  Ning,NULL,Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108715
405,BC011627-05,"October 01, 2018 -  September 30, 2019",Mechanisms of function and targeting for complexes relevant to cancer biology,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Gwen Rebecca Buel|Xiang  Chen,NULL,Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|John Stephen Schneekloth (Chemical Biology Laboratory),NULL,"1. Calabrese DR, Chen X, Leon EC, Gaikwad SM, Phyo Z, Hewitt WM, Alden S, Hilimire TA, He F, Michalowski AM, Simmons JK, Saunders LB, Zhang S, Connors D, Walters KJ, Mock BA, Schneekloth JS (2018). Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex. Nat Commun  9, 4229.   https://doi.org/10.1038/s41467-018-06315-w",https://intramural.nih.gov/search/searchview.taf?ipid=108757
406,BC011633-05,"October 01, 2018 -  September 30, 2019",T cell Development and Regeneration,"Avinash  Bhandoola; MD, PhD|IRP Faculty Profile",NULL,"Laboratory Of Genome Integrity, NCI",Jennifer Elizabeth Cowan|Arundhoti  Das|Xiao  Lu; PhD|Justin Lewis Malin; PhD|Yongge  Zhao|Yi  Ding; PhD|Show all 8,"Anjana  Rao (La Jolla Institute For Allergy And Immunology)|Jonathan  Kaye (Cedars Sinai Medical Center)|Hai-Hui  Xue; MD, PhD (University of Iowa)","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)",John Allan Hanover; PhD (NIDDK) |Keji  Zhao; PhD (NHLBI) |Luigi Daniele Notarangelo (NIAID) |Jinfang  Zhu; PhD (NIAID),"1. Das A, Harly C, Yang Q, Bhandoola A (2018). Lineage specification in innate lymphocytes. Cytokine Growth Factor Rev  42, 20-26.   https://doi.org/10.1016/j.cytogfr.2018.01.005|2. Gautam S, Fioravanti J, Zhu W, Le Gall JB, Brohawn P, Lacey NE, Hu J, Hocker JD, Hawk NV, Kapoor V, Telford WG, Gurusamy D, Yu Z, Bhandoola A, Xue HH, Roychoudhuri R, Higgs BW, Restifo NP, Bender TP, Ji Y, Gattinoni L (2019). The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity. Nat Immunol  20, 337-349.   https://doi.org/10.1038/s41590-018-0311-z|3. Harly C, Cam M, Kaye J, Bhandoola A (2018). Development and differentiation of early innate lymphoid progenitors. J Exp Med  215, 249-262.   https://doi.org/10.1084/jem.20170832|4. Hsu AP, Donkó A, Arrington ME, Swamydas M, Fink D, Das A, Escobedo O, Bonagura V, Szabolcs P, Steinberg HN, Bergerson J, Skoskiewicz A, Makhija M, Davis J, Foruraghi L, Palmer C, Fuleihan RL, Church JA, Bhandoola A, Lionakis MS, Campbell S, Leto TL, Kuhns DB, Holland SM (2019). Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects. Blood  133, 1977-1988.   https://doi.org/10.1182/blood-2018-11-886028|5. Johnson JL, Georgakilas G, Petrovic J, Kurachi M, Cai S, Harly C, Pear WS, Bhandoola A, Wherry EJ, Vahedi G (2018). Lineage-Determining Transcription Factor TCF-1 Initiates the Epigenetic Identity of T Cells. Immunity  48, 243-257.e10.   https://doi.org/10.1016/j.immuni.2018.01.012|6. Richardson LA, Schmid SL, Bhandoola A, Harly C, Hedenström A, Laub MT, Mace GM, Sengupta P, Stock AM, Read AF, Malik HS, Estelle M, Lowell S, Kimmelman J (2019). The PLOS Biology XV Collection: 15 Years of Exceptional Science Highlighted across 12 Months. PLoS Biol  17, e3000180.   https://doi.org/10.1371/journal.pbio.3000180|7. Seo H, Chen J, González-Avalos E, Samaniego-Castruita D, Das A, Wang YH, López-Moyado IF, Georges RO, Zhang W, Onodera A, Wu CJ, Lu LF, Hogan PG, Bhandoola A, Rao A (2019). TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion. Proc Natl Acad Sci U S A  116, 12410-12415.   https://doi.org/10.1073/pnas.1905675116|8. Shen X, Liang M, Chen X, Pasha MA, D'Souza SS, Hidde K, Howard J, Sultana DA, Fung ITH, Ye L, Pan J, Liu G, Drake JR, Drake LA, Zhu J, Bhandoola A, Yang Q (2019). Cutting Edge: Core Binding Factor β Is Required for Group 2 Innate Lymphoid Cell Activation. J Immunol  202, 1669-1673.   https://doi.org/10.4049/jimmunol.1800852",https://intramural.nih.gov/search/searchview.taf?ipid=108753
407,BC011640-05,"October 01, 2018 -  September 30, 2019",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Jinkyu  Jung|Aiguo  Li|Virginia W Rodriguez|Hua  Song|Wei  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108764
408,BC011643-05,"October 01, 2018 -  September 30, 2019",Rare Central Nervous System Cancers Initiative,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Orwa  Aboud|Susie  Ahn|Ramya  Parthasarathy|Lisa Marie Boris|Nicole Johana Briceno|Christine Alexis Cordova|Show all 19,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Rosandra N Kaplan (Pediatric Oncology Branch)|Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Markku Martti Miettinen (Laboratory of Pathology),"John D Heiss; MD (NINDS) |Kareem Amir Zaghloul; MD, PhD (NINDS) |Prashant  Chittiboina; MD (NINDS) |Abhik  Ray-Chaudhury; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108763
409,BC011646-05,"October 01, 2018 -  September 30, 2019",Role of long non-coding RNAs in p53 signaling,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Emily Ann Dangelmaier|Sarah Bayla Lazar|Xiao Ling  Li|Xing  Lu|Bruna Rodrigues Muys,NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Stefan  Ambs (Laboratory of Human Carcinogenesis),NULL,"1. Dangelmaier E, Lal A (2019) Adaptor proteins in long noncoding RNA biology. Biochim Biophys Acta Gene Regul Mech, in press (e-pub ahead of print)  https://doi.org/10.1016/j.bbagrm.2019.03.003|2. Dangelmaier E, Lazar SB, Lal A (2019). Long noncoding RNAs: p53's secret weapon in the fight against cancer? PLoS Biol  17, e3000143.   https://doi.org/10.1371/journal.pbio.3000143|3. Ishii H, Vodnala SK, Achyut BR, So JY, Hollander MC, Greten TF, Lal A, Yang L (2018). miR-130a and miR-145 reprogram Gr-1+CD11b+ myeloid cells and inhibit tumor metastasis through improved host immunity. Nat Commun  9, 2611.   https://doi.org/10.1038/s41467-018-05023-9|4. Jadaliha M, Gholamalamdari O, Tang W, Zhang Y, Petracovici A, Hao Q, Tariq A, Kim TG, Holton SE, Singh DK, Li XL, Freier SM, Ambs S, Bhargava R, Lal A, Prasanth SG, Ma J, Prasanth KV (2018). A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability. PLoS Genet  14, e1007802.   https://doi.org/10.1371/journal.pgen.1007802|5. Meyer SE, Muench DE, Rogers AM, Newkold TJ, Orr E, O'Brien E, Perentesis JP, Doench JG, Lal A, Morris PJ, Thomas CJ, Lieberman J, McGlinn E, Aronow BJ, Salomonis N, Grimes HL (2018). miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. J Exp Med  215, 2115-2136.   https://doi.org/10.1084/jem.20171312|6. Muys BR, Sousa JF, Plaça JR, de Araújo LF, Sarshad AA, Anastasakis DG, Wang X, Li XL, de Molfetta GA, Ramão A, Lal A, Vidal DO, Hafner M, Silva WA (2019). miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism. Cancer Res  79, 3294-3305.   https://doi.org/10.1158/0008-5472.CAN-19-0490|7. Sun Q, Tripathi V, Yoon JH, Singh DK, Hao Q, Min KW, Davila S, Zealy RW, Li XL, Polycarpou-Schwarz M, Lehrmann E, Zhang Y, Becker KG, Freier SM, Zhu Y, Diederichs S, Prasanth SG, Lal A, Gorospe M, Prasanth KV (2018). MIR100 host gene-encoded lncRNAs regulate cell cycle by modulating the interaction between HuR and its target mRNAs. Nucleic Acids Res  46, 10405-10416.   https://doi.org/10.1093/nar/gky696",https://intramural.nih.gov/search/searchview.taf?ipid=108774
410,BC011647-05,"October 01, 2018 -  September 30, 2019",Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Orieta  Celiku|Lee Sun Hwang; MD|Jinkyu  Jung|Aiguo  Li|Virginia W Rodriguez|Show all 13,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108773
411,BC011648-05,"October 01, 2018 -  September 30, 2019",Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC,"Ramaprasad  Srinivasan; MD, PhD|IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI",Donna  Drake|Julia C Friend; PA|Janet  Gichonge|Lisa Marie Mac|Roma  Pahwa|Sameer Haleem Issaq|Show all 10,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|John Walter Glod (Pediatric Oncology Branch)|Joanna H Shih (Biostatistics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)","Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NINDS) |Wadih Michel Zein; MD (NEI) |Ashkan A Malayeri (CC) |Clara Chi Chen; MD (CC) |Emily Y Chew; MD (NEI)","1. Linehan WM, Schmidt LS, Crooks DR, Wei D, Srinivasan R, Lang M, Ricketts CJ (2019). The Metabolic Basis of Kidney Cancer. Cancer Discov  9, 1006-1021.   https://doi.org/10.1158/2159-8290.CD-18-1354|2. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Cancer Genome Atlas Research Network, et al. [20 more authors] (2018). The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep  23, 313-326.e5.   https://doi.org/10.1016/j.celrep.2018.03.075",https://intramural.nih.gov/search/searchview.taf?ipid=108772
412,BC011649-05,"October 01, 2018 -  September 30, 2019",The Hippo Pathway in Human Gliomas,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kevin A Camphausen; MD,NULL,Natasha  Caplen (Cancer Genetics Branch)|Ettore  Appella; MD (Laboratory of Cell Biology)|Eric  Batchelor; PhD (Laboratory of Cell Biology)|Ji  Luo (Laboratory of Cancer Biology and Genetics)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108771
413,BC011650-05,"October 01, 2018 -  September 30, 2019",Genomic characterization of breast cancer in high risk subsets of breast cancer,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Alexandra Dos Santos Zimmer|Patricia  Steeg; PhD,Hai  Hu (Windber Research Institute)|Kangmin  Zhu|Jeremy  Perkins|Craig David Shriver (Office Of The Clinical Director),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108769
414,BC011651-05,"October 01, 2018 -  September 30, 2019",Laboratory and Clinical studies on T-cells recognizing NSCLC,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Kenichi  Hanada|Chihao  Zhao,NULL,Udayan  Guha (Thoracic and GI Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108770
415,BC011652-05,"October 01, 2018 -  September 30, 2019",Mesothelin-targeted immunotoxins in Pancreatic Cancer,Christine Campo Alewine|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Leela Rani  Avula|Sarah Mary Joseph|Xianyu  Zhang; MS,NULL,Ira H Pastan; MD (Molecular Biology Section)|Serguei V Kozlov (Office of the Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Seth M Steinberg; PhD (Office Of The Clinical Director)|Liang  Cao (Cancer Genetics Branch)|David J Fitzgerald; PhD (Biotherapy Section),NULL,"1. El-Behaedi S, Landsman R, Rudloff M, Kolyvas E, Albalawy R, Zhang X, Bera T, Collins K, Kozlov S, Alewine C (2018). Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors. Toxins (Basel)  10.   https://doi.org/10.3390/toxins10110447|2. Simon N, Antignani A, Hewitt SM, Gadina M, Alewine C, FitzGerald D (2019). Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cells. JCI Insight  4.   https://doi.org/10.1172/jci.insight.123281",https://intramural.nih.gov/search/searchview.taf?ipid=108768
416,BC011654-05,"October 01, 2018 -  September 30, 2019",TEDDI-R in PCNSL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Christopher Joseph Melani|Saleema  Osman|Louis  Staudt; MD,NULL,"Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108767
417,BC011655-05,"October 01, 2018 -  September 30, 2019",Targeting protein-DNA interactions in prokaryotic systems,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108750
418,BC011657-05,"October 01, 2018 -  September 30, 2019",microRNA regulatory networks in thoracic cancers,Chuong Dinh Hoang|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",James Patrick Madigan|Nathanael David Pruett; PhD|Anand  Singh; PhD|David  Schrump; MD,NULL,"Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Eytan  Ruppin (Cancer Data Science Laboratory)",NULL,"1. Bakr S, Gevaert O, Echegaray S, Ayers K, Zhou M, Shafiq M, Zheng H, Benson JA, Zhang W, Leung ANC, Kadoch M, Hoang CD, Shrager J, Quon A, Rubin DL, Plevritis SK, Napel S (2018). A radiogenomic dataset of non-small cell lung cancer. Sci Data  5, 180202.   https://doi.org/10.1038/sdata.2018.202|2. Padda SK, Terrone D, Tian L, Khuong A, Neal JW, Riess JW, Berry MF, Hoang CD, Burt BM, Leung AN, Schwartz EJ, Shrager JB, Wakelee HA (2018). Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors. J Thorac Imaging  33, 176-183.   https://doi.org/10.1097/RTI.0000000000000310|3. Singh A, Bhattacharyya N, Srivastava A, Pruett N, Ripley RT, Schrump DS, Hoang CD (2019). MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis. Mol Ther  27, 1665-1680.   https://doi.org/10.1016/j.ymthe.2019.05.020|4. Zhang L, Singh A, Plaisier C, Pruett N, Ripley RT, Schrump DS, Hoang CD (2019). Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling. Transl Oncol  12, 859-870.   https://doi.org/10.1016/j.tranon.2019.03.005",https://intramural.nih.gov/search/searchview.taf?ipid=108752
419,BC011659-05,"October 01, 2018 -  September 30, 2019",Deciphering the efficacy of posttransplant cyclophosphamide in haplo transplant,Christopher George Kanakry|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Rochelle Elayne Fletcher|Suresh Kumar Mendu; PhD|Michael Tyrone Patterson|Natalia  Schneider Nunes,NULL,David J Venzon; PhD (Biostatistics and Data Management Section),Michael  Eckhaus; DVM (OD),"1. Acevedo MJ, Wilder JS, Adams S, Davis J, Kelly C, Hilligoss D, Carroll E, Blacklock-Schuver B, Cole K, Kang EM, Hsu AP, Kanakry CG, Dimitrova D, Kanakry JA (2019). Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant  25, 1666-1673.   https://doi.org/10.1016/j.bbmt.2019.04.008|2. Bejanyan N, Zhang MJ, Wang HL, Lazaryan A, de Lima M, Marks DI, Sandmaier BM, Bachanova V, Rowe J, Tallman M, Kebriaei P, Kharfan-Dabaja M, Peter Gale R, Lazarus HM, Ustun C, Copelan E, Ky Hamilton B, Schiller G, Hogan W, Hashmi S, Seftel M, Kanakry CG, Olsson RF, Martino R, Saber W, et al. [2 more authors] (2018). Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation. Biol Blood Marrow Transplant  24, 945-955.   https://doi.org/10.1016/j.bbmt.2017.12.784|3. Manion M, Dimitrova D, Pei L, Gea-Banacloche J, Zelazny A, Lisco A, Zerbe C, Freeman AF, Holland SM, Kanakry CG, Kanakry JA, Sereti I (2019) IRIS as a post-transplantation complication in primary immunodeficiency with disseminated M. avium. Clin Infect Dis, in press (e-pub ahead of print)  https://doi.org/10.1093/cid/ciz507|4. Rashidi A, Hamadani M, Zhang MJ, Wang HL, Abdel-Azim H, Aljurf M, Assal A, Bajel A, Bashey A, Battiwalla M, Beitinjaneh AM, Bejanyan N, Bhatt VR, Bolaños-Meade J, Byrne M, Cahn JY, Cairo M, Ciurea S, Copelan E, Cutler C, Daly A, Diaz MA, Farhadfar N, Gale RP, Ganguly S, et al. [45 more authors] (2019). Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood Adv  3, 1826-1836.   https://doi.org/10.1182/bloodadvances.2019000050",https://intramural.nih.gov/search/searchview.taf?ipid=108748
420,BC011660-05,"October 01, 2018 -  September 30, 2019",Development of fully-human anti-CD30 chimeric antigen receptors,James N Kochenderfer|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Stephanie  Choi|Jo Hannah Hurtt|Jennifer Amy Mann,NULL,Ronald E Gress; MD (Experimental Transplantation and Immunology Branch),David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108749
421,BC011666-05,"October 01, 2018 -  September 30, 2019",Synthetically Accessible Virtual Inventory (SAVI),Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Hitesh Jayantilal Patel; PhD,"Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Peter  Ertl (Novartis)|Martin  Ott (Lhasa Limited)|Philip  Judson (Lhasa Limited)|Alex  Sukharevsky (LHASA, LLC)|Alan  Long (LHASA, LLC)|Show all 11",Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108747
422,BC011669-05,"October 01, 2018 -  September 30, 2019",NCI X-ray free electron laser (XFEL) initiative,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108746
423,BC011670-05,"October 01, 2018 -  September 30, 2019",Role of the microbiota in regulating the mononuclear phagocyte system,Silvana Romina Goldszmid|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Romina Elizabeth Araya|Quanyi  Chen|Khiem Chi Lam|Amelie Jacqueline Denise Lopes; PhD|Gregoire Yves Altan-Bonnet,NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),Mariana Julieta Kaplan (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108745
424,BC011672-04,"October 01, 2018 -  September 30, 2019",Clinical Protocols in the Cancer Signaling Networks Section,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Tsige Kidanemaryam Bahta|Constance M Cultraro|Tapan Kumar Maity|Nitin  Roper; MD|Xu  Zhang,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Javed  Khan; MD (Cancer Genetics Branch)",NULL,"1. Roper N, Gao S, Maity TK, Banday AR, Zhang X, Venugopalan A, Cultraro CM, Patidar R, Sindiri S, Brown AL, Goncearenco A, Panchenko AR, Biswas R, Thomas A, Rajan A, Carter CA, Kleiner DE, Hewitt SM, Khan J, Prokunina-Olsson L, Guha U (2019). APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors. Cell Rep  26, 2651-2666.e6.   https://doi.org/10.1016/j.celrep.2019.02.028|2. Zhang X, Nguyen KD, Rudnick PA, Roper N, Kawaler E, Maity TK, Awasthi S, Gao S, Biswas R, Venugopalan A, Cultraro CM, Fenyö D, Guha U (2019). Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879V. Mol Cell Proteomics  18, 622-641.   https://doi.org/10.1074/mcp.RA118.001266",https://intramural.nih.gov/search/searchview.taf?ipid=108776
425,BC011679-04,"October 01, 2018 -  September 30, 2019",Molecular alterations driving the development of primary prostate cancers,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",John Robert Bright|Nicholas Taylor Terrigino|Shana Y Trostel|Nichelle Chantil Whitlock; PhD|Scott Christopher Wilkinson|Huihui  Ye|Show all 9,NULL,William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Ismail Baris Turkbey (Molecular Imaging Program)|Guinevere Joy Ng Chun (Office Of The Clinical Director),NULL,"1. Alsinnawi M, Zhang A, Bianchi-Frias D, Burns J, Cho E, Zhang X, Sowalsky A, Ye H, Slee AE, True L, Porter C, Taplin ME, Balk S, Nelson PS, Montgomery RB, Mostaghel EA (2019). Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy. Prostate Cancer Prostatic Dis  22, 560-568.   https://doi.org/10.1038/s41391-019-0141-6|2. Carneiro A, Barbosa ÁRG, Takemura LS, Kayano PP, Moran NKS, Chen CK, Wroclawski ML, Lemos GC, da Cunha IW, Obara MT, Tobias-Machado M, Sowalsky AG, Bianco B (2018). The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature. Front Oncol  8, 377.   https://doi.org/10.3389/fonc.2018.00377|3. Carneiro A, Priante Kayano P, Gomes Barbosa ÁR, Langer Wroclawski M, Ko Chen C, Cavlini GC, Reche GJ, Sanchez-Salas R, Tobias-Machado M, Sowalsky AG, Bianco B (2018). Are localized prostate cancer biomarkers useful in the clinical practice? Tumour Biol  40, 1010428318799255.   https://doi.org/10.1177/1010428318799255|4. Sowalsky AG, Ye H, Bhasin M, Van Allen EM, Loda M, Lis RT, Montaser-Kouhsari L, Calagua C, Ma F, Russo JW, Schaefer RJ, Voznesensky OS, Zhang Z, Bubley GJ, Montgomery B, Mostaghel EA, Nelson PS, Taplin ME, Balk SP (2018). Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations. Cancer Res  78, 4716-4730.   https://doi.org/10.1158/0008-5472.CAN-18-0610|5. Ye H, Sowalsky AG (2018). Molecular correlates of intermediate- and high-risk localized prostate cancer. Urol Oncol  36, 368-374.   https://doi.org/10.1016/j.urolonc.2017.12.022",https://intramural.nih.gov/search/searchview.taf?ipid=108777
426,BC011680-04,"October 01, 2018 -  September 30, 2019",Detection of prostate cancer using circulating tumor DNA,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",John Robert Bright|Nicholas Taylor Terrigino|Shana Y Trostel|Scott Christopher Wilkinson|Huihui  Ye,Steven  Balk (Beth Israel Deaconess Medical Center)|Glenn  Bubley (Beth Israel Deaconess Medical Center),Peter A Pinto; MD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108778
427,BC011681-04,"October 01, 2018 -  September 30, 2019",Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy,Mary  Kearney|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",NULL,"John  Coffin (Tufts University)|Mark  Cotton (Stellenbosch University)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|John W Mellors|Gert  van Zyl (Stellenbosch University)|Deanna  Kulpa (Emory University)|Show all 7",Michael Javier Bale (Host Virus Interaction Branch)|Valerie F Boltz (Host Virus Interaction Branch)|Jennifer Louise Groebner; PhD (Host Virus Interaction Branch)|Jenna Mohammad Hasson (Host Virus Interaction Branch)|Andrew Timothy Rajendra Musick (Host Virus Interaction Branch)|Aurelie  Niyongabo (Host Virus Interaction Branch),NULL,"1. Bale MJ, Kearney MF (2019). Review: HIV-1 phylogeny during suppressive antiretroviral therapy. Curr Opin HIV AIDS  14, 188-193.   https://doi.org/10.1097/COH.0000000000000535|2. Bozzi G, Simonetti F, Watters S, Anderson E, Gouzoulis M, Kearney M, Rote P, Lange C, Shao W, Gorelick R, Fullmer B, Kumar S, Wank S, Hattori J, Hill S, Bell J, Rehm C, Grossman Z, Yarchoan R, Uldrick T, Maldarelli F (2019) No evidence of ongoing HIV-1 replication in tissue compartments during cART. Sci Adv, in press.|3. Capoferri AA, Bale MJ, Simonetti FR, Kearney MF (2019). Phylogenetic inference for the study of within-host HIV-1 dynamics and persistence on antiretroviral therapy. Lancet HIV  6, e325-e333.   https://doi.org/10.1016/S2352-3018(19)30051-7|4. McManus WR, Bale MJ, Spindler J, Wiegand A, Musick A, Patro SC, Sobolewski MD, Musick VK, Anderson EM, Cyktor JC, Halvas EK, Shao W, Wells D, Wu X, Keele BF, Milush JM, Hoh R, Mellors JW, Hughes SH, Deeks SG, Coffin JM, Kearney MF (2019). HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy. J Clin Invest  130, 4629-4642.   https://doi.org/10.1172/JCI126714|5. van Zyl G, Bale MJ, Kearney MF (2018). HIV evolution and diversity in ART-treated patients. Retrovirology  15, 14.   https://doi.org/10.1186/s12977-018-0395-4",https://intramural.nih.gov/search/searchview.taf?ipid=108779
428,BC011682-04,"October 01, 2018 -  September 30, 2019",Molecular mechanisms of membrane remodeling,"Roberto  Weigert; MSc Chemistry, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Desu  Chen|Seham  Ebrahim; PhD|Ian Haywood Mather|Nicolas Gregory Emile Alain Melis|Yeap Shen Ng|Bhagawat Chandrasekar  Subramanian; PhD|Show all 7,Marino  Zerial (Max Planck Institute)|Peter  Gunning (University of New South Wales)|Douglas  Brooks (University of South Australia)|Alexander  Sorkin (Univeristy of Pittsburgh),NULL,"Kelly G Ten Hagen; BS, PhD (NIDCR)","1. Ebrahim S, Liu J, Weigert R (2018). The Actomyosin Cytoskeleton Drives Micron-Scale Membrane Remodeling In Vivo Via the Generation of Mechanical Forces to Balance Membrane Tension Gradients. Bioessays  40, e1800032.   https://doi.org/10.1002/bies.201800032|2. Ebrahim S, Weigert R (2019). Intravital microscopy in mammalian multicellular organisms. Curr Opin Cell Biol  59, 97-103.   https://doi.org/10.1016/j.ceb.2019.03.015|3. Masedunskas A, Appaduray MA, Lucas CA, Lastra Cagigas M, Heydecker M, Holliday M, Meiring JCM, Hook J, Kee A, White M, Thomas P, Zhang Y, Adelstein RS, Meckel T, Böcking T, Weigert R, Bryce NS, Gunning PW, Hardeman EC (2018). Parallel assembly of actin and tropomyosin, but not myosin II, during de novo actin filament formation in live mice. J Cell Sci  131.   https://doi.org/10.1242/jcs.212654|4. Porat-Shliom N, Harding OJ, Malec L, Narayan K, Weigert R (2019). Mitochondrial Populations Exhibit Differential Dynamic Responses to Increased Energy Demand during Exocytosis In Vivo. iScience  11, 440-449.   https://doi.org/10.1016/j.isci.2018.12.036|5. Shitara A, Malec L, Ebrahim S, Chen D, Bleck C, Hoffman MP, Weigert R (2019). Cdc42 negatively regulates endocytosis during apical membrane maintenance in live animals. Mol Biol Cell  30, 324-332.   https://doi.org/10.1091/mbc.E18-10-0615",https://intramural.nih.gov/search/searchview.taf?ipid=108828
429,BC011684-04,"October 01, 2018 -  September 30, 2019",Chemo-sensitizing IDH1-mutated glioma by molecular targeting,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Yang  Liu|Mingyu  Qian|Jing  Wu; MD, PhD",NULL,NULL,NULL,"1. Lu Y, Liu Y, Pang Y, Pacak K, Yang C (2018). Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy. Pharmacol Ther  188, 168-175.   https://doi.org/10.1016/j.pharmthera.2018.03.006|2. Pang Y, Liu Y, Pacak K, Yang C (2019). Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies. Cancers (Basel)  11.   https://doi.org/10.3390/cancers11040436",https://intramural.nih.gov/search/searchview.taf?ipid=108781
430,BC011686-04,"October 01, 2018 -  September 30, 2019",Modulating BBB Permeability in Malignant Glioma,Sadhana  Jackson|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Caitlin Bryanna Meeks|Amelie  Vezina,NULL,Kunio  Nagashima (Office of the Director),"Kenneth A Jacobson; BA, MS, PhD (NIDDK) |Dorian  McGavern (NINDS) |Christina Margaret Van Itallie; PhD (NHLBI) |Marsha J Merrill; PhD (NINDS) |Patricia M Zerfas (OD)","1. Jackson S, Meeks C, Vézina A, Robey RW, Tanner K, Gottesman MM (2019). Model systems for studying the blood-brain barrier: Applications and challenges. Biomaterials  214, 119217.   https://doi.org/10.1016/j.biomaterials.2019.05.028",https://intramural.nih.gov/search/searchview.taf?ipid=108783
431,BC011687-04,"October 01, 2018 -  September 30, 2019",Dysregulation of Antigen Presenting Cell Function in Cancer,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Joanna Marta Bandola-Simon; PhD,NULL,NULL,NULL,"1. Bandola-Simon J, Roche PA (2019). Dysfunction of antigen processing and presentation by dendritic cells in cancer. Mol Immunol  113, 31-37.   https://doi.org/10.1016/j.molimm.2018.03.025",https://intramural.nih.gov/search/searchview.taf?ipid=108784
432,BC011688-04,"October 01, 2018 -  September 30, 2019",In vivo function of BRD4,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Devaiah Nanjappa Ballachanda|Anne G M Gegonne Bosselut|Jie  Mu|Alfred  Singer; MD,NULL,Daoud M Meerzaman (Cancer Informatics Branch)|Qingrong  Chen (Cancer Informatics Branch)|Xuguang C Tai (Lymphocyte Development Section),Keiko  Ozato; PhD (NICHD) |Jinfang  Zhu; PhD (NIAID) |Anup  Dey; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108786
433,BC011690-04,"October 01, 2018 -  September 30, 2019",Novel Tumor Suppressing Kinases in Cancer,John Fickes Brognard; MS|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Elvira  An|Christina  Walker,Alexandra  Newton (University of California at San Diego)|Tony C Hunter,NULL,NULL,"1. An E, Brognard J (2019). Orange is the new black: Kinases are the new master regulators of tumor suppression. IUBMB Life  71, 738-748.   https://doi.org/10.1002/iub.1981",https://intramural.nih.gov/search/searchview.taf?ipid=108788
434,BC011691-04,"October 01, 2018 -  September 30, 2019",Oncogenic Kinases in Cancer,John Fickes Brognard; MS|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Elvira  An|Van Tuyet Hoang|Amy Lynn Funk|Katherine M Nyswaner|Pedro  Torres-Ayuso|Christina  Walker|Show all 7,"Richard  Marais (CRUK Manchester Institute)|Ivan  Ahel; PhD (Cancer Research UK, Paterson Institute for Cancer Research)",NULL,Rolf Eric Swenson; PhD (NHLBI) |Craig Joseph Thomas (NCATS),"1. Callender JA, Yang Y, Lordén G, Stephenson NL, Jones AC, Brognard J, Newton AC (2018). Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation. Proc Natl Acad Sci U S A  115, E5497-E5505.   https://doi.org/10.1073/pnas.1805046115|2. Marusiak AA, Prelowska MK, Mehlich D, Lazniewski M, Kaminska K, Gorczynski A, Korwat A, Sokolowska O, Kedzierska H, Golab J, Biernat W, Plewczynski D, Brognard J, Nowis D (2019). Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells. Oncogene  38, 2860-2875.   https://doi.org/10.1038/s41388-018-0618-0|3. Torres-Ayuso P, Sahoo S, Ashton G, An E, Simms N, Galvin M, Leong HS, Frese KK, Simpson K, Cook N, Hughes A, Miller CJ, Marais R, Dive C, Krebs MG, Brognard J (2018). Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin. NPJ Genom Med  3, 15.   https://doi.org/10.1038/s41525-018-0055-6",https://intramural.nih.gov/search/searchview.taf?ipid=108789
435,BC011692-04,"October 01, 2018 -  September 30, 2019",Comparative Oncology Program Laboratory,Amy Kathleen Leblanc; DVM|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Christina  Mazcko|Ling  Ren|Peter L Choyke; MD|Hisataka  Kobayashi|Elaine Marie Jagoda; MS,"Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Louis  Stancato (NCI)|Cheryl  London (Center for Comparative Medicine, University Of California)|Doug  Thamm (Colorado State University)|John  Rossmeisl (Virginia Polytechnical University)|Shruthi  Naik (Mayo Clinic - Rochester)|Show all 8","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Rosandra N Kaplan (Pediatric Oncology Branch)|Lawrence R Sternberg (Office Of The Director)|Jiuping  Ji (Office of the Director)",Gregory James Tawa (NCATS) |Matthew David Hall (NCATS) |Rolf Eric Swenson; PhD (NHLBI) |Xiang  Zhang; PhD (NHLBI),"1. Nagaya T, Okuyama S, Ogata F, Maruoka Y, Knapp DW, Karagiannis SN, Fazekas-Singer J, Choyke PL, LeBlanc AK, Jensen-Jarolim E, Kobayashi H (2018). Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody. Oncotarget  9, 19026-19038.   https://doi.org/10.18632/oncotarget.24876|2. Rowe JA, Morandi F, Osborne DR, Wall JS, Kennel SJ, Reed RB, LeBlanc AK (2019). Relative skeletal distribution of proliferating marrow in the adult dog determined using 3'-deoxy-3'-[18 F]fluorothymidine. Anat Histol Embryol  48, 46-52.   https://doi.org/10.1111/ahe.12410",https://intramural.nih.gov/search/searchview.taf?ipid=108787
436,BC011696-04,"October 01, 2018 -  September 30, 2019",Comparative Brain Tumor Consortium,Amy Kathleen Leblanc; DVM|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Christina  Mazcko|Peter L Choyke; MD,"Matthew  Breen; PhD (Veterinary Medicine, North Carolina State University)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Michael  Kent (UC Davis)|William  Kisseberth (Veterinary Medicine, Ohio State University)|John  Rossmeisl (Virginia Polytechnical University)|Drew  Miller (Cornell University College of Veterinary Medicine)|Show all 17","Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",Gregory James Tawa (NCATS) |Matthew David Hall (NCATS) |Rolf Eric Swenson; PhD (NHLBI),"1. Koehler JW, Miller AD, Miller CR, Porter B, Aldape K, Beck J, Brat D, Cornax I, Corps K, Frank C, Giannini C, Horbinski C, Huse JT, O'Sullivan MG, Rissi DR, Mark Simpson R, Woolard K, Shih JH, Mazcko C, Gilbert MR, LeBlanc AK (2018). A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma. J Neuropathol Exp Neurol  77, 1039-1054.   https://doi.org/10.1093/jnen/nly085|2. Leblanc A, Packer R, Kent M, Rossmeisl J, Griffin J, Mazcko C (2018). Consensus recommendations for harmonized imaging standards for multicenter canine brain tumor clinical trials. Veterinary Radiology and Ultrasound  59, 261-271.|3. Schlein LJ, Fadl-Alla B, Pondenis HC, Lezmi S, Eberhart CG, LeBlanc AK, Dickinson PJ, Hergenrother PJ, Fan TM (2019). Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers. Front Oncol  9, 96.   https://doi.org/10.3389/fonc.2019.00096",https://intramural.nih.gov/search/searchview.taf?ipid=108790
437,BC011697-04,"October 01, 2018 -  September 30, 2019",Effects of Antiretroviral Therapy on Transcriptional Activity of HIV Proviruses,Mary  Kearney|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",NULL,"John  Coffin (Tufts University)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|John W Mellors|Anna  Aldovini (Harvard Medical School)",Michael Javier Bale (Host Virus Interaction Branch)|Valerie F Boltz (Host Virus Interaction Branch)|Jennifer Louise Groebner; PhD (Host Virus Interaction Branch)|Andrew Timothy Rajendra Musick (Host Virus Interaction Branch)|Jonathan E Spindler (Host Virus Interaction Branch)|Ann P Wiegand (Host Virus Interaction Branch),Eli  Boritz (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108791
438,BC011698-04,"October 01, 2018 -  September 30, 2019",Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression,Mary  Kearney|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",NULL,"Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|John W Mellors|John  Coffin (Tufts University)|Timothy  Henrich (University Of California, San Francisco)",Jennifer Louise Groebner; PhD (Host Virus Interaction Branch)|Sean Christopher Patro (Host Virus Interaction Branch)|Ann P Wiegand (Host Virus Interaction Branch)|Eric O Freed; PhD (HIV Drug Resistance Program),Eli  Boritz (NIAID),"1. Coffin JM, Wells DW, Zerbato JM, Kuruc JD, Guo S, Luke BT, Eron JJ, Bale M, Spindler J, Simonetti FR, Hill S, Kearney MF, Maldarelli F, Wu X, Mellors JW, Hughes SH (2019). Clones of infected cells arise early in HIV-infected individuals. JCI Insight  4.   https://doi.org/10.1172/jci.insight.128432|2. Cohen SE, Sachdev D, Lee SA, Scheer S, Bacon O, Chen MJ, Okochi H, Anderson PL, Kearney MF, Coffey S, Scott H, Grant RM, Havlir D, Gandhi M (2018) Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV, in press (e-pub ahead of print)  https://doi.org/10.1016/S2352-3018(18)30288-1|3. Gay CL, DeBenedette MA, Tcherepanova IY, Gamble A, Lewis WE, Cope AB, Kuruc JD, McGee KS, Kearney MF, Coffin JM, Archin NM, Hicks CB, Eron JJ, Nicolette CA, Margolis DM (2018). Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection. AIDS Res Hum Retroviruses  34, 111-122.   https://doi.org/10.1089/aid.2017.0071",https://intramural.nih.gov/search/searchview.taf?ipid=108775
439,BC011699-04,"October 01, 2018 -  September 30, 2019",Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution,Mary  Kearney|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",NULL,John  Coffin (Tufts University)|Michael  Hughes (U.S. Environmental Protection Agency)|Shahin  Lockman (Harvard University)|John W Mellors|Sharon  Riddler (University of Pittsburgh)|Gert  van Zyl (Stellenbosch University)|Show all 7,Michael Javier Bale (Host Virus Interaction Branch)|Valerie F Boltz (Host Virus Interaction Branch)|Wei  Shao; PhD (Host Virus Interaction Branch),NULL,"1. Boltz V, Shao W, Halvas E, Bale M, McIntyre J, Schooley R, Lockman S, Currier J, Sawe F, Hogg E, Hughes M, Kearney M, Coffin J, Mellors J (2019) Rare HIV variants with linked dual-class resistance mutations are associated with failure of combination antiretroviral therapy. JCI Insight, in press.|2. Kearney MF, Spindler J, Wiegand A, Shao W, Haubrich R, Riddler S, Lalama CM, Hughes MD, Coffin JM, Mellors JW (2018). Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults. PLoS One  13, e0190438.   https://doi.org/10.1371/journal.pone.0190438",https://intramural.nih.gov/search/searchview.taf?ipid=108792
440,BC011701-04,"October 01, 2018 -  September 30, 2019",Metabolic characterization of FH- and SDH-deficient RCC cell lines,Jeffrey Arnold Moscow,NULL,"Urologic Oncology Branch, NCI","Rony  Panarsky; PhD, BPHARM|William Marston Linehan; MD",NULL,NULL,NULL,"1. Lim B, Murthy RK, Lee J, Jackson SA, Iwase T, Davis DW, Willey JS, Wu J, Shen Y, Tripathy D, Alvarez R, Ibrahim NK, Brewster AM, Barcenas CH, Brown PH, Giordano SH, Moulder SL, Booser DJ, Moscow JA, Piekarz R, Valero V, Ueno NT (2019). A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment. Br J Cancer  120, 1105-1112.   https://doi.org/10.1038/s41416-019-0473-y|2. Moscow JA, Fojo T, Schilsky RL (2018). The evidence framework for precision cancer medicine. Nat Rev Clin Oncol  15, 183-192.   https://doi.org/10.1038/nrclinonc.2017.186|3. Wu TH, Karim N, Moscow JA (2018). Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs. Oncotarget  9, 32404-32405.   https://doi.org/10.18632/oncotarget.25968|4. Yarana C, Carroll D, Chen J, Chaiswing L, Zhao Y, Noel T, Alstott M, Bae Y, Dressler EV, Moscow JA, Butterfield DA, Zhu H, St Clair DK (2018). Extracellular Vesicles Released by Cardiomyocytes in a Doxorubicin-Induced Cardiac Injury Mouse Model Contain Protein Biomarkers of Early Cardiac Injury. Clin Cancer Res  24, 1644-1653.   https://doi.org/10.1158/1078-0432.CCR-17-2046",https://intramural.nih.gov/search/searchview.taf?ipid=108793
441,BC011704-04,"October 01, 2018 -  September 30, 2019",Discovery of genes required for expression or activity of fusion oncogenes,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Nicholas Gabriel Aboreden|Allison Margarethe Cross; PhD|Tamara L Jones|Katelyn Rose Ludwig|Carla Maya Neckles; PhD|Soumya  Sundara Rajan|Show all 7,Philip L Lorenzi|Amanda  Hummon,John Stephen Schneekloth (Chemical Biology Laboratory),NULL,"1. Sen N, Cross AM, Lorenzi PL, Khan J, Gryder BE, Kim S, Caplen NJ (2018). EWS-FLI1 reprograms the metabolism of Ewing sarcoma cells via positive regulation of glutamine import and serine-glycine biosynthesis. Mol Carcinog  57, 1342-1357.   https://doi.org/10.1002/mc.22849",https://intramural.nih.gov/search/searchview.taf?ipid=108795
442,BC011707-04,"October 01, 2018 -  September 30, 2019",The effect of therapeutics on mutated IDH1 cell lines and mice tumor models,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Lumin  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108796
443,BC011708-04,"October 01, 2018 -  September 30, 2019",Targeted and untargeted metabolomics in IDH1 mutated xenografts in mice,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Tyrone Maurice Dowdy|Victor  Ruiz Rodado,NULL,Kylie Janice Walters (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108797
444,BC011709-04,"October 01, 2018 -  September 30, 2019","Metabolite profiling of patients blood, urine, cerebrospinal fluid and tissue",Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Tyrone Maurice Dowdy|Victor  Ruiz Rodado|Deric Minwoo Park|Mark Richard Gilbert; MD|Jing  Wu; MD, PhD|Sadhana  Jackson",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108798
445,BC011710-04,"October 01, 2018 -  September 30, 2019",In vivo and in vitro metabolic flux analysis in preclinical mouse models,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Tyrone Maurice Dowdy|Adrian  Lita,NULL,Murali  Krishna; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108799
446,BC011711-04,"October 01, 2018 -  September 30, 2019",Develop RAMAN imaging to visualize metabolism in cell lines and tissue,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Adrian  Lita|Deric Minwoo Park|Jing  Wu; MD, PhD",NULL,NULL,NULL,"1. Kuzmin AN, Pliss A, Rzhevskii A, Lita A, Larion M (2018). BCAbox Algorithm Expands Capabilities of Raman Microscope for Single Organelles Assessment. Biosensors (Basel)  8.   https://doi.org/10.3390/bios8040106",https://intramural.nih.gov/search/searchview.taf?ipid=108800
447,BC011714-04,"October 01, 2018 -  September 30, 2019",Brain Tumor Immunotherapy,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Orieta  Celiku|Amber Jin Giles|Nivedita Mohan Ratnam|Wei  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108802
448,BC011715-04,"October 01, 2018 -  September 30, 2019",T cell receptor proximal signaling,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Debjani  Dutta; PhD|Shizuka  Otsuka,NULL,Lawrence Elliot Samelson; MD (Laboratory of Cellular and Molecular Biology)|Ettore  Appella; MD (Laboratory of Cell Biology),NULL,"1. Giardino Torchia ML, Dutta D, Mittelstadt PR, Guha J, Gaida MM, Fish K, Barr VA, Akpan IO, Samelson LE, Tagad HD, Debnath S, Miller Jenkins LM, Appella E, Ashwell JD (2018). Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70T293 and destabilization of the signalosome. Proc Natl Acad Sci U S A  115, 2174-2179.   https://doi.org/10.1073/pnas.1713301115",https://intramural.nih.gov/search/searchview.taf?ipid=108803
449,BC011718-04,"October 01, 2018 -  September 30, 2019",Breast cancer aggressiveness in young patients,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Alex Man Lai Wu|Stanley  Lipkowitz; MD, PhD|Alexandra Dos Santos Zimmer",NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Simone  Difilippantonio (Office Of The Director),Dorian  McGavern (NINDS),"1. Zimmer AS, Zhu K, Steeg PS, Wu A, Gatti-Mays ME, Soltani S, Perkins JG, Shao S, Brown D, Georg M, Hu H, Shriver CD, Lipkowitz S (2018). Analysis of breast cancer in young women in the Department of Defense (DOD) database. Breast Cancer Res Treat  168, 501-511.   https://doi.org/10.1007/s10549-017-4615-8",https://intramural.nih.gov/search/searchview.taf?ipid=108805
450,BC011720-04,"October 01, 2018 -  September 30, 2019","Gag Trafficking, Assembly, and Release",Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",Sherimay  Ablan|Melissa Victoria Fernandez; PhD|James Kiprotich Kirui|Cheng Man  Lun|Ahlam Amelia Majadly|Phuong Nhat Pham|Show all 9,"Michael  Summers (University of Maryland, Baltimore County)|Asim  Debnath (Lindsley F. Kimball Research Institute of the New York Blood Center)|James  Hurley (University of California, Berkeley)|Shan-Lu  Liu (University of Missouri)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Schuyler Bergren van Engelenburg|Show all 10",Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Vineet Narain KewalRamani; PhD (Basic Research Laboratory)|Natalia  De Val Alda; PhD (Office of the Director)|Kedar  Narayan (Office of the Director)|Vinay K Pathak; PhD (Retroviral Replication Laboratory),Juan S Bonifacino; PhD (NICHD),"1. Buttler CA, Pezeshkian N, Fernandez MV, Aaron J, Norman S, Freed EO, van Engelenburg SB (2018). Single molecule fate of HIV-1 envelope reveals late-stage viral lattice incorporation. Nat Commun  9, 1861.   https://doi.org/10.1038/s41467-018-04220-w|2. Li M, Waheed AA, Yu J, Zeng C, Chen HY, Zheng YM, Feizpour A, Reinhard BM, Gummuluru S, Lin S, Freed EO, Liu SL (2019). TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins. Proc Natl Acad Sci U S A  116, 5705-5714.   https://doi.org/10.1073/pnas.1819475116|3. Mailler E, Waheed AA, Park SY, Gershlick DC, Freed EO, Bonifacino JS (2019). The autophagy protein ATG9A promotes HIV-1 infectivity. Retrovirology  16, 18.   https://doi.org/10.1186/s12977-019-0480-3|4. Novikova M, Adams LJ, Fontana J, Gres AT, Balasubramaniam M, Winkler DC, Kudchodkar SB, Soheilian F, Sarafianos SG, Steven AC, Freed EO (2018). Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation. MBio  9.   https://doi.org/10.1128/mBio.01567-18|5. Novikova M, Zhang Y, Freed EO, Peng K (2019). Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle. Virol Sin  34, 119-134.   https://doi.org/10.1007/s12250-019-00095-3|6. Uhl J, Gujarathi S, Waheed AA, Gordon A, Freed EO, Gousset K (2019). Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes. J Cell Commun Signal  13, 209-224.   https://doi.org/10.1007/s12079-018-0493-z|7. Van Duyne R, Freed EO (2018). HIV-1 packs in PACSIN2 for cell-to-cell spread. Proc Natl Acad Sci U S A  115, 6885-6887.   https://doi.org/10.1073/pnas.1808821115|8. Waheed AA, Gitzen A, Swiderski M, Freed EO (2018). High-Mannose But Not Complex-Type Glycosylation of Tetherin Is Required for Restriction of HIV-1 Release. Viruses  10.   https://doi.org/10.3390/v10010026|9. Zheng Z, Lan K, Freed E, Shi Z (2019). Preface to special issue of Virologica Sinica commemorating the first joint SKLV NIH Virology Symposium. Virol Sin  34, 117-118.",https://intramural.nih.gov/search/searchview.taf?ipid=108807
451,BC011721-04,"October 01, 2018 -  September 30, 2019",Envelope Glycoprotein Incorporation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",Sherimay  Ablan|Melissa Victoria Fernandez; PhD|Cheng Man  Lun|Phuong Nhat Pham|Abdul Latheef Abdul Waheed|Yuta  Hikichi; MSC|Show all 8,"Michael  Summers (University of Maryland, Baltimore County)|Simon  Cocklin (Drexel University)|Eric  Barklis (University of Oregon)|Zandrea  Ambrose (University Of Pittsburgh)|Zabrina  Brumme (Simon Fraser University)|Gregory  Milikian (Emory University)|Show all 8",Mary  Kearney (Host Virus Interaction Branch)|Jeffrey D Lifson; MD (Office Of The Director),Mario J Borgnia; PhD (NIEHS),"1. Fernandez MV, Freed EO (2018). Meeting Review: 2018 International Workshop on Structure and Function of the Lentiviral gp41 Cytoplasmic Tail. Viruses  10.   https://doi.org/10.3390/v10110613|2. Van Duyne R, Kuo LS, Pham P, Fujii K, Freed EO (2019). Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle. Proc Natl Acad Sci U S A  116, 9040-9049.   https://doi.org/10.1073/pnas.1820333116|3. Zheng Z, Lan K, Freed E, Shi Z (2019). Preface to special issue of Virologica Sinica commemorating the first joint SKLV NIH Virology Symposium. Virol Sin  34, 117-118.",https://intramural.nih.gov/search/searchview.taf?ipid=108809
452,BC011722-04,"October 01, 2018 -  September 30, 2019",Genomic characterization and development of therapies for pediatric sarcoma,John Frederick Shern|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Xiyuan  Zhang|Haiyan  Lei,NULL,Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Gryder BE, Wu L, Woldemichael GM, Pomella S, Quinn TR, Park PMC, Cleveland A, Stanton BZ, Song Y, Rota R, Wiest O, Yohe ME, Shern JF, Qi J, Khan J (2019). Chemical genomics reveals histone deacetylases are required for core regulatory transcription. Nat Commun  10, 3004.   https://doi.org/10.1038/s41467-019-11046-7",https://intramural.nih.gov/search/searchview.taf?ipid=108808
453,BC011725-04,"October 01, 2018 -  September 30, 2019",Immunometabolism and metabolic imaging of graft-versus-host disease,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Julian Christopher Assmann,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Daniel  Crooks (Urologic Oncology Branch)|Carole  Sourbier (Urologic Oncology Branch)|Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch)|Peter L Choyke; MD (Molecular Imaging Program),"Hellmut  Merkle; MS, PHD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108811
454,BC011726-04,"October 01, 2018 -  September 30, 2019",Phenotypic variability within isogenic population of lymphocytes,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Sooraj Raghavendra Achar|Emanuel  Salazar Cavazos; PhD,Lia  Palomba (Memorial Sloan Kettering)|Paul  Franois (McGill University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108812
455,BC011728-04,"October 01, 2018 -  September 30, 2019",Cell-cell communications create robust collective immunological responses,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Ratnadeep  Mukherjee; PhD,Laurent  Lauvau (Albert Einstein College of Medicine)|Paul  Franois (McGill University),NULL,Nihal  Altan-Bonnet; PhD (NHLBI),"1. Altan-Bonnet G, Mukherjee R (2019). Cytokine-mediated communication: a quantitative appraisal of immune complexity. Nat Rev Immunol  19, 205-217.   https://doi.org/10.1038/s41577-019-0131-x|2. Erez A, Mukherjee R, Altan-Bonnet G (2019). Quantifying the Dynamics of Hematopoiesis by In Vivo IdU Pulse-Chase, Mass Cytometry, and Mathematical Modeling. Cytometry A  95, 1075-1084.   https://doi.org/10.1002/cyto.a.23799",https://intramural.nih.gov/search/searchview.taf?ipid=108814
456,BC011730-04,"October 01, 2018 -  September 30, 2019",Studies on drug resistance in HIV-related Kaposi sarcoma,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Fatima Ghazanfar Ali-Rahmani,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108816
457,BC011732-04,"October 01, 2018 -  September 30, 2019",Discovery of combination therapy for KRAS mutant cancer,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Shinjen  Lin,NULL,Zhenggang  Liu; PhD (Laboratory of Immune Cell Biology),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108818
458,BC011733-04,"October 01, 2018 -  September 30, 2019",Mechanism of anchorage independent growth driven by the KRAS oncogene,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chih-Shia  Lee|Haibo  Zhang; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108819
459,BC011734-04,"October 01, 2018 -  September 30, 2019",Genomic dissection of tumor heterogeneity and progression,John Frederick Shern|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Haiyan  Lei|Carly Meyer Sayers|Xiyuan  Zhang|Brigitte  Widemann; MD,NULL,"Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)",NULL,"1. Beltrán D, Anderson ME, Bharathy N, Settelmeyer TP, Svalina MN, Bajwa Z, Shern JF, Gultekin SH, Cuellar MA, Yonekawa T, Keller C, Campbell KP (2019). Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma. Skelet Muscle  9, 11.   https://doi.org/10.1186/s13395-019-0195-0|2. Fry TJ, Shah NN, Orentas RJ, Stetler-Stevenson M, Yuan CM, Ramakrishna S, Wolters P, Martin S, Delbrook C, Yates B, Shalabi H, Fountaine TJ, Shern JF, Majzner RG, Stroncek DF, Sabatino M, Feng Y, Dimitrov DS, Zhang L, Nguyen S, Qin H, Dropulic B, Lee DW, Mackall CL (2018). CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med  24, 20-28.   https://doi.org/10.1038/nm.4441|3. Heitzeneder S, Sotillo E, Shern JF, Sindiri S, Xu P, Jones R, Pollak M, Noer PR, Lorette J, Fazli L, Alag A, Meltzer P, Lau C, Conover CA, Oxvig C, Sorensen PH, Maris JM, Khan J, Mackall CL (2019). Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion. J Natl Cancer Inst  111, 970-982.   https://doi.org/10.1093/jnci/djy209|4. Qin H, Ramakrishna S, Nguyen S, Fountaine TJ, Ponduri A, Stetler-Stevenson M, Yuan CM, Haso W, Shern JF, Shah NN, Fry TJ (2018). Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22. Mol Ther Oncolytics  11, 127-137.   https://doi.org/10.1016/j.omto.2018.10.006|5. Shalabi H, Kraft IL, Wang HW, Yuan CM, Yates B, Delbrook C, Zimbelman JD, Giller R, Stetler-Stevenson M, Jaffe ES, Lee DW, Shern JF, Fry TJ, Shah NN (2018). Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma. Haematologica  103, e215-e218.   https://doi.org/10.3324/haematol.2017.183459",https://intramural.nih.gov/search/searchview.taf?ipid=108820
460,BC011736-04,"October 01, 2018 -  September 30, 2019",Preclinical Development of Therapeutics in Murine Models of Lung Cancer,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Devon Ashley Atkinson|Wendi Raye Custer Lawrence|Catherine I Drennan|Rajaa  Elmeskini|Theresa Mae Guerin|Deborah B Householder|Show all 11,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Hisataka  Kobayashi (Molecular Imaging Program)|Udayan  Guha (Thoracic and GI Malignancies Branch)|Azam  Ghafoor (Thoracic and GI Malignancies Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108822
461,BC011737-04,"October 01, 2018 -  September 30, 2019",Therapeutic evaluation in ovarian and breast cancer GEM-GDA models,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI","Wendi Raye Custer Lawrence|Catherine I Drennan|Melanie  Gordon|Theresa Mae Guerin|Xiuyun  Lu|Nathan Michael Pate; DVM, DACVP|Show all 9",NULL,Yves  Pommier; PhD (Developmental Therapeutics Branch)|Robert  Shoemaker (Chemopreventive Agent Development Research Group)|Laura  Schmidt (Urologic Oncology Branch)|Christina M Annunziata (Womens Malignancies Branch),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108823
462,BC011738-04,"October 01, 2018 -  September 30, 2019",Preclinical GEM and GDA Models of Primary and Metastatic Melanoma,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Devon Ashley Atkinson|Wendi Raye Custer Lawrence|Catherine I Drennan|Rajaa  Elmeskini|Theresa Mae Guerin|Deborah B Householder|Show all 11,NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Chi-Ping  Day (Laboratory of Cancer Biology and Genetics)|Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108824
463,BC011739-04,"October 01, 2018 -  September 30, 2019",Development and Preclinical Applications of Pancreatic Adenocarcinoma Models,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",N Keith Collins|Wendi Raye Custer Lawrence|Catherine I Drennan|Debra J Gilbert|Theresa Mae Guerin|Theresa N O'Sullivan|Show all 8,"Frank  McCormick (UCSF School of Medicine)|Ruihong  Chen (K-Gen, Inc.)|Vincent  Bond (Morehouse School Of Medicine)",Ira H Pastan; MD (Molecular Biology Section)|Christine Campo Alewine (Laboratory of Molecular Biology)|James Halpern Doroshow (Developmental Therapeutics Branch)|Bradley D St Croix (Mouse Cancer Genetics Program)|Peter F Johnson; PhD (Mouse Cancer Genetics Program)|Martin John Schnermann; PhD (Chemical Biology Laboratory),Juan  Marugan (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108825
464,BC011740-04,"October 01, 2018 -  September 30, 2019",Inhibitors of Viral Membrane Fusion,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",NULL,NULL,Eric  Batchelor; PhD (Laboratory of Cell Biology),Peter  Jahrling (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108826
465,BC011741-04,"October 01, 2018 -  September 30, 2019",Targeting Metabolic Pathways in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Michelle Ann Bylicky|Leonard  Neckers; PhD,NULL,NULL,NULL,"1. Leko V, McDuffie LA, Zheng Z, Gartner JJ, Prickett TD, Apolo AB, Agarwal PK, Rosenberg SA, Lu YC (2019). Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer. J Immunol  202, 3458-3467.   https://doi.org/10.4049/jimmunol.1801022|2. Rayn KN, Hale GR, Grave GP, Agarwal PK (2018). New therapies in nonmuscle invasive bladder cancer treatment. Indian J Urol  34, 11-19.   https://doi.org/10.4103/iju.IJU_296_17|3. Sanford T, Meng MV, Railkar R, Agarwal PK, Porten SP (2018). Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma. Clin Epigenetics  10, 19.   https://doi.org/10.1186/s13148-018-0451-x|4. Siddiqui MR, Railkar R, Sanford T, Crooks DR, Eckhaus MA, Haines D, Choyke PL, Kobayashi H, Agarwal PK (2019). Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT). Sci Rep  9, 2084.   https://doi.org/10.1038/s41598-019-38575-x",https://intramural.nih.gov/search/searchview.taf?ipid=108827
466,BC011743-04,"October 01, 2018 -  September 30, 2019",NIH Chronic GVHD Study Group,"Steven  Pavletic; MD, MS|IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI",Shaneil Patrica Flucker|Sencer  Goklemez|Annie  Im|Filip  Pirsl|Dana Angelina Schaar,Paul  Martin|Daniel  Weisdorf (University of Minnesota)|J Doug  Rizzo (Medical College of Wisconsin)|Mary  Horawitz (Medical College of Wisconsin)|Georgia  Vogelsang (Johns Hopkins University)|Stephanie  Lee (University of Washington-Fred Hutchinson CRC)|Show all 12,"Daoud M Meerzaman (Cancer Informatics Branch)|Sandra  Mitchell (Outcomes Research Branch)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Seth M Steinberg; PhD (Office Of The Clinical Director)|Liang  Cao (Cancer Genetics Branch)|Edward W Cowen (Office of the Director)","Jacqueline W Mays; DDS, PhD (NIDCR) |Ann M Cohen-Berger; MD (CC) |Galen O Joe (CC) |Manuel B Datiles; MD (NEI) |Rachel Jessica Bishop; MD (NEI) |Theo  Heller; MD (NIDDK)","1. Bojanic I, Mravak Stipetic M, Pulanic D, Desnica L, Mazic S, Golubic Cepulic B, Serventi Seiwerth R, Vrhovac R, Nemet D, Pavletic SZ (2018). Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease. Transfusion  58, 1494-1499.   https://doi.org/10.1111/trf.14594|2. Buxbaum NP, Robinson C, Sinaii N, Ling A, Curtis LM, Pavletic SZ, Baird K, Lodish MB (2018). Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant  24, 1415-1423.   https://doi.org/10.1016/j.bbmt.2018.02.019|3. Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, Lazaryan A, Wu J, Nemecek ER, Pavletic SZ, Cutler CS, Horowitz MM, Arora M, BMT CTN. (2018). A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801. Haematologica  103, 1915-1924.   https://doi.org/10.3324/haematol.2018.195123|4. Hakim A, Cooke KR, Pavletic SZ, Khalid M, Williams KM, Hashmi SK (2019). Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally. Bone Marrow Transplant  54, 383-392.   https://doi.org/10.1038/s41409-018-0266-6|5. Melendez-Munoz R, Marchalik R, Jerussi T, Dimitrova D, Nussenblatt V, Beri A, Rai K, Wilder JS, Barrett AJ, Battiwalla M, Childs RW, Fitzhugh CD, Fowler DH, Fry TJ, Gress RE, Hsieh MM, Ito S, Kang EM, Pavletic SZ, Shah NN, Tisdale JF, Gea-Banacloche J, Kanakry CG, Kanakry JA (2019). Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution. Biol Blood Marrow Transplant  25, 577-586.   https://doi.org/10.1016/j.bbmt.2018.10.011|6. Paczesny S, Pavletic SZ, Bollard CM (2018). Introduction to a review series on emerging immunotherapies for hematologic diseases. Blood  131, 2617-2620.   https://doi.org/10.1182/blood-2018-04-840793|7. Peric Z, Skegro I, Durakovic N, Desnica L, Pulanic D, Serventi-Seiwerth R, Petricek I, Pavletic SZ, Vrhovac R (2018). Amniotic membrane transplantation-a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease. Bone Marrow Transplant  53, 1466-1469.   https://doi.org/10.1038/s41409-018-0140-6|8. Schoemans HM, Goris K, Van Durm R, Fieuws S, De Geest S, Pavletic SZ, Im A, Wolff D, Lee SJ, Greinix H, Duarte RF, Poiré X, Selleslag D, Lewalle P, Kerre T, Graux C, Baron F, Maertens JA, Dobbels F, EBMT Transplantation Complications Working party (2018). The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial. Haematologica  103, 1698-1707.   https://doi.org/10.3324/haematol.2018.190777|9. Schoemans HM, Goris K, Van Durm R, Vanbrabant K, De Geest S, Maertens J, Wolff D, Greinix H, Ruutu T, Pavletic SZ, Im A, Lee SJ, Basak GW, Duarte RF, Dobbels F, Complications and Quality of Life Working Party of the EBMT (2018). Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress. Bone Marrow Transplant  53, 490-494.   https://doi.org/10.1038/s41409-017-0017-0|10. Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, Shaw BE, Flowers ME, Ruutu T, Greinix H, Holler E, Basak G, Duarte RF, Pavletic SZ, EBMT (European Society for Blood and Marrow Transplantation) Transplant Complications Working Party and the “EBMT−NIH (National Institutes of Health)−CIBMTR (Center for International Blood and Marrow Transplant Research) GvHD Task Force” (2018). EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transplant  53, 1401-1415.   https://doi.org/10.1038/s41409-018-0204-7",https://intramural.nih.gov/search/searchview.taf?ipid=108829
467,BC011744-03,"October 01, 2018 -  September 30, 2019",Oncogenic Kinase complexes,Ping  Zhang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Baohua  Cao; PhD|Jeneffer Patricia England; PhD|Juliana Andrea Martinez Fiesco; PhD,Sanford  Simon (Rockefeller University)|Susan S Taylor,NULL,NULL,"1. Cao B, Lu TW, Martinez Fiesco JA, Tomasini M, Fan L, Simon SM, Taylor SS, Zhang P (2019). Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα. Structure  27, 816-828.e4.   https://doi.org/10.1016/j.str.2019.03.001|2. Lu TW, Wu J, Aoto PC, Weng JH, Ahuja LG, Sun N, Cheng CY, Zhang P, Taylor SS (2019). Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP. Proc Natl Acad Sci U S A  116, 16347-16356.   https://doi.org/10.1073/pnas.1906036116",https://intramural.nih.gov/search/searchview.taf?ipid=108831
468,BC011745-03,"October 01, 2018 -  September 30, 2019",Development of biologic based therapies for rhabdomyosarcoma,Christine Marie Heske|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Grace B McKay-Corkum|Choh L Yeung,Lee Jay Helman; MD (NCI)|Fariba  Navid; MD (NCI),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108830
469,BC011746-03,"October 01, 2018 -  September 30, 2019",Development Therapeutics Branch Clinical Trials,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",James Halpern Doroshow|Jane Beth Trepel|Anish  Thomas; MD,NULL,"Andrea Borghese Apolo (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Raffit  Hassan (Thoracic and GI Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108864
470,BC011754-03,"October 01, 2018 -  September 30, 2019","Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1","Karlyne M Reilly; BS, PhD",Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI",Robert  Tuskan|John Frederick Shern,NULL,Fathi  Elloumi (Developmental Therapeutics Branch)|Margaret  Cam; PhD (Office of the Director)|John A Beutler (Molecular Targets Laboratory),Kapil  Bharti; PhD (NEI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108834
471,BC011755-03,"October 01, 2018 -  September 30, 2019",The role of Foxo1 for intestinal epithelial cells during mucosal immune response,Chuan  Wu|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Zuojia  Chen; PhD|Girak  Kim|Jialie  Luo|Jian  Li,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108835
472,BC011756-03,"October 01, 2018 -  September 30, 2019",An Intrinsic Link between the Metabolic and Antiviral States of the Cell,Alex  Compton|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Charles A Coomer|Kazi Mohammad Mostafizur Rahman|Guoli  Shi,Bruce  Torbett (The Scripps Research Institute)|Sergi  Padilla-Parra (University of Oxford),Peter F Johnson; PhD (Mouse Cancer Genetics Program)|Stephen J Lockett; PhD (Office Of The Director)|Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling),Juan S Bonifacino; PhD (NICHD),"1. Ozog S, Timberlake ND, Hermann K, Garijo O, Haworth KG, Shi G, Glinkerman CM, Schefter LE, D'Souza S, Simpson E, Sghia-Hughes G, Carillo RR, Boger DL, Kiem HP, Slukvin I, Ryu BY, Sorrentino BP, Adair JE, Snyder SA, Compton AA, Torbett BE (2019). Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes. Blood  134, 1298-1311.   https://doi.org/10.1182/blood.2019000040",https://intramural.nih.gov/search/searchview.taf?ipid=108833
473,BC011757-03,"October 01, 2018 -  September 30, 2019","Biogenesis, Function and Turnover of Noncoding RNAs","Sandra Lynn Wolin; MD, PhD|IRP Faculty Profile",NULL,"Rna Biology Laboratory, NCI",Cedric  Belair; PhD|Marco Elio Boccitto; PhD|Xinguo  Chen; PhD|Kevin James Hughes|Yuanyuan  Leng|Lily Elizabeth O'Connor|Show all 7,NULL,NULL,Eric Paul Nawrocki; PhD (NLM) |Eugene Victor Koonin; PhD (NLM) |Kira Semenovna Makarova; PhD (NLM) |Aravind L Iyer; PhD (NLM) |Alexander  Burroughs (NLM),"1. Belair C, Sim S, Kim KY, Tanaka Y, Park IH, and, Wolin SL (2019). The RNA exosome nuclease complex regulates human embryonic stem cell differentiation. J Cell Biol  218, 2564-2582.   https://doi.org/10.1083/jcb.201811148|2. Boccitto M, Wolin SL (2019). Ro60 and Y RNAs: structure, functions, and roles in autoimmunity. Crit Rev Biochem Mol Biol  54, 133-152.   https://doi.org/10.1080/10409238.2019.1608902|3. Glauzy S, Boccitto M, Bannock JM, Delmotte FR, Saadoun D, Cacoub P, Ice JA, Sivils KL, James JA, Wolin SL, Meffre E (2018). Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21-/low B Cells From Patients With Sjögren's Syndrome. Arthritis Rheumatol  70, 298-307.   https://doi.org/10.1002/art.40352|4. Greiling TM, Dehner C, Chen X, Hughes K, Iñiguez AJ, Boccitto M, Ruiz DZ, Renfroe SC, Vieira SM, Ruff WE, Sim S, Kriegel C, Glanternik J, Chen X, Girardi M, Degnan P, Costenbader KH, Goodman AL, Wolin SL, Kriegel MA (2018). Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med  10.   https://doi.org/10.1126/scitranslmed.aan2306|5. Itano MS, Arnion H, Wolin SL, Simon SM (2018). Recruitment of 7SL RNA to assembling HIV-1 virus-like particles. Traffic  19, 36-43.   https://doi.org/10.1111/tra.12536|6. Sim S, Wolin SL (2018). Bacterial Y RNAs: Gates, Tethers, and tRNA Mimics. Microbiol Spectr  6.   https://doi.org/10.1128/microbiolspec.RWR-0023-2018|7. Wang W, Chen X, Wolin SL, Xiong Y (2018). Structural Basis for tRNA Mimicry by a Bacterial Y RNA. Structure  26, 1635-1644.e3.   https://doi.org/10.1016/j.str.2018.09.001",https://intramural.nih.gov/search/searchview.taf?ipid=108832
474,BC011758-03,"October 01, 2018 -  September 30, 2019",Predicting the probabilistic complex invasive map of GBM cells,Orit  Lavi; PhD,Michael Marc Gottesman; MD,"Multidrug Resistence Section, NCI",Jeremiah Ogheneochuko Emidih|Pierre-Emmanuel J Jabin; PhD|Spencer Anthony Teolis|Trevor James Teolis|Junxi  Zhu,"Pierre  Jabin (University Of Maryland)|Wojtek  Czaja (University Of Maryland)|Amy  Tabb (United States Department Of Agriculture, Agricultural Research Service)",NULL,Nadia Madelaine Biassou (CC) |Joelle  Sarlls; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108837
475,BC011759-03,"October 01, 2018 -  September 30, 2019",Interrogating the molecular underpinnings of metastatic colonization,Jonathan Matthew Hernandez|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Imani Akili Alexander|Alok  Ranjan|Kirsten  Remmert|Surajit  Sinha; PhD,NULL,NULL,"Kamille Aisha West (CC) |Ronald N Germain; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108836
476,BC011761-03,"October 01, 2018 -  September 30, 2019",Nrf2-goverened metabolic reprogram in IDH1-mutated glioma,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Sue  Han|Yang  Liu|Yiqiang  Zhou; MD,NULL,NULL,NULL,"1. Cai SJ, Liu Y, Han S, Yang C (2019). Brusatol, an NRF2 inhibitor for future cancer therapeutic. Cell Biosci  9, 45.   https://doi.org/10.1186/s13578-019-0309-8|2. Liu Y, Lu Y, Celiku O, Li A, Wu Q, Zhou Y, Yang C (2019). Targeting IDH1-Mutated Malignancies with NRF2 Blockade. J Natl Cancer Inst  111, 1033-1041.   https://doi.org/10.1093/jnci/djy230",https://intramural.nih.gov/search/searchview.taf?ipid=108838
477,BC011762-03,"October 01, 2018 -  September 30, 2019",Screening to identify protectors and mitigators of Radiation GI Syndrome,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Seok Joo  Kwon; PhD|Bradley T Scroggins|Ayla Oksuz White,NULL,NULL,NULL,"1. Sei Y, Feng J, Samsel L, White A, Zhao X, Yun S, Citrin D, McCoy JP, Sundaresan S, Hayes MM, Merchant JL, Leiter A, Wank SA (2018). Mature enteroendocrine cells contribute to basal and pathological stem cell dynamics in the small intestine. Am J Physiol Gastrointest Liver Physiol  315, G495-G510.   https://doi.org/10.1152/ajpgi.00036.2018",https://intramural.nih.gov/search/searchview.taf?ipid=108839
478,BC011763-03,"October 01, 2018 -  September 30, 2019",Signaling pathways regulating stem cell fate decisions,Ramiro  Iglesias-Bartolome; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Maria Del Pilar Pedro; PhD|Natalia Fernanda Salinas Parra|Yao  Yuan,NULL,NULL,NULL,"1. Zhao X, Deng P, Iglesias-Bartolome R, Amornphimoltham P, Steffen DJ, Jin Y, Molinolo AA, de Castro LF, Ovejero D, Yuan Q, Chen Q, Han X, Bai D, Taylor SS, Yang Y, Collins MT, Gutkind JS (2018). Expression of an active Gαs mutant in skeletal stem cells is sufficient and necessary for fibrous dysplasia initiation and maintenance. Proc Natl Acad Sci U S A  115, E428-E437.   https://doi.org/10.1073/pnas.1713710115",https://intramural.nih.gov/search/searchview.taf?ipid=108843
479,BC011764-03,"October 01, 2018 -  September 30, 2019",G-protein-coupled receptor signaling in cancer development and treatment,Ramiro  Iglesias-Bartolome; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",James Joseph Hoy|Natalia Fernanda Salinas Parra,NULL,NULL,NULL,"1. Martin D, Degese MS, Vitale-Cross L, Iglesias-Bartolome R, Valera JLC, Wang Z, Feng X, Yeerna H, Vadmal V, Moroishi T, Thorne RF, Zaida M, Siegele B, Cheong SC, Molinolo AA, Samuels Y, Tamayo P, Guan KL, Lippman SM, Lyons JG, Gutkind JS (2018). Assembly and activation of the Hippo signalome by FAT1 tumor suppressor. Nat Commun  9, 2372.   https://doi.org/10.1038/s41467-018-04590-1",https://intramural.nih.gov/search/searchview.taf?ipid=108844
480,BC011765-03,"October 01, 2018 -  September 30, 2019",Transcriptional regulation of inflammatory and autoimmune responses,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yuanyuan  Gao; PhD|Yan  Wang,NULL,NULL,Dorian  McGavern (NINDS) |Yasmine  Belkaid; PhD (NIAID),"1. Dutta DJ, Woo DH, Lee PR, Pajevic S, Bukalo O, Huffman WC, Wake H, Basser PJ, SheikhBahaei S, Lazarevic V, Smith JC, Fields RD (2018). Regulation of myelin structure and conduction velocity by perinodal astrocytes. Proc Natl Acad Sci U S A  115, 11832-11837.   https://doi.org/10.1073/pnas.1811013115",https://intramural.nih.gov/search/searchview.taf?ipid=108845
481,BC011766-03,"October 01, 2018 -  September 30, 2019",Regulation of RNA biogenesis and function by RNA modifications,Pedro Jorge De Oliveira Rodrigues Batista; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Christina Marie Fitzsimmons; PhD|Mariana D Mandler|Dalen  Chan,NULL,William Marston Linehan; MD (Urologic Oncology Branch),NULL,"1. Fitzsimmons CM, Batista PJ (2019). It's complicated… m6A-dependent regulation of gene expression in cancer. Biochim Biophys Acta Gene Regul Mech  1862, 382-393.   https://doi.org/10.1016/j.bbagrm.2018.09.010",https://intramural.nih.gov/search/searchview.taf?ipid=108842
482,BC011767-03,"October 01, 2018 -  September 30, 2019",Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1,Chengkai  Dai|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Adam Mohammad Ibrahimi|Meng  Xu|Kuo-Hui  Su,NULL,Shyam K Sharan (Genetics of Cancer Susceptibility Section)|William Frederick Heinz (Office of the Director)|Valentin  Magidson (Office of the Director),NULL,"1. Dai C (2018). The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis. Philos Trans R Soc Lond B Biol Sci  373.   https://doi.org/10.1098/rstb.2016.0525",https://intramural.nih.gov/search/searchview.taf?ipid=108840
483,BC011768-03,"October 01, 2018 -  September 30, 2019",Natural History and Specimen Banking for Patients with CNS Tumors,Terri Sue Armstrong; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Alvina A Acquaye|Nicole Marie Leggiero|Elizabeth  Vera|Mark Richard Gilbert; MD|Jing  Wu; MD, PhD|Tito Reyes Mendoza",NULL,Kenneth Dean Aldape; MD (Laboratory of Pathology)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108841
484,BC011772-03,"October 01, 2018 -  September 30, 2019",The role of Galpha13 signaling in suppression of lymphoma,Jagan Reddy Muppidi|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Anne Robins Albright|Moyi  Li|Hang T Nguyen|Raud  Razzaghi|Louis  Staudt; MD,Jason  Cyster; PhD (UCSF)|Thomas Michael Oellerich (Lymphoid Malignancies Branch)|Andrea  Reboldi (University Of Massachusetts Medical School),NULL,"Juraj  Kabat; PhD (NIAID) |Adrian Bernard McDermott; PhD (NIAID) |Richard M Siegel; MD, PhD (NIAMS)","1. Lu E, Wolfreys FD, Muppidi JR, Xu Y, Cyster JG (2019). S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8. Nature  567, 244-248.   https://doi.org/10.1038/s41586-019-1003-z",https://intramural.nih.gov/search/searchview.taf?ipid=108847
485,BC011773-03,"October 01, 2018 -  September 30, 2019",Hypoxia signaling in cancer development,"Zhengping  Zhuang; MD, PhD|IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",Jing  Cui|Yan-Ling  Feng; MD|Jared  Rosenblum|Herui  Wang; PhD|Timothy James Westlake|Chun Zhang  Yang; PhD,Graeme  Eisenhofer; PhD (NINDS)|Josef  Prchal; MD (Baylor College of Medicine)|Alexander Oliver Vortmeyer; MD (NINDS),William Marston Linehan; MD (Urologic Oncology Branch)|Svetlana Dmitriyevna Pack; PhD (Laboratory of Pathology),"Karel  Pacak; MD, PhD (NICHD) |John D Heiss; MD (NINDS) |Emily Y Chew; MD (NEI) |Jiansen  Jiang (NHLBI) |Beth A Kozel (NHLBI)","1. Cui J, Zhang Q, Song Q, Wang H, Dmitriev P, Sun MY, Cao X, Wang Y, Guo L, Indig IH, Rosenblum JS, Ji C, Cao D, Yang K, Gilbert MR, Yao Y, Zhuang Z (2019). Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma. Neuro Oncol  21, 1436-1446.   https://doi.org/10.1093/neuonc/noz117|2. Musolf AM, Ho WSC, Long KA, Zhuang Z, Argersinger DP, Sun H, Moiz BA, Simpson CL, Mendelevich EG, Bogdanov EI, Bailey-Wilson JE, Heiss JD (2019). Small posterior fossa in Chiari I malformation affected families is significantly linked to 1q43-44 and 12q23-24.11 using whole exome sequencing. Eur J Hum Genet  27, 1599-1610.   https://doi.org/10.1038/s41431-019-0457-7|3. Pang Y, Gupta G, Jha A, Yue X, Wang H, Huynh TT, Li A, Li L, Baker E, Chew E, Feelders RA, Korpershoek E, Zhuang Z, Yang C, Pacak K (2019). Nonmosaic somatic HIF2A mutations associated with late onset polycythemia-paraganglioma syndrome: Newly recognized subclass of polycythemia-paraganglioma syndrome. Cancer  125, 1258-1266.   https://doi.org/10.1002/cncr.31839|4. Rosenblum JS, Maggio D, Pang Y, Nazari MA, Gonzales MK, Lechan RM, Smirniotopoulos JG, Zhuang Z, Pacak K, Heiss JD (2019). Chiari Malformation Type 1 in EPAS1-Associated Syndrome. Int J Mol Sci  20.   https://doi.org/10.3390/ijms20112819|5. Wang H, Shepard MJ, Zhang C, Dong L, Walker D, Guedez L, Park S, Wang Y, Chen S, Pang Y, Zhang Q, Gao C, Wong WT, Wiley H, Pacak K, Chew EY, Zhuang Z, Chan CC (2018). Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina. Cancer Res  78, 1266-1274.   https://doi.org/10.1158/0008-5472.CAN-17-1718|6. Wang H, Zhuang Z, Chan CC (2018). Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome. Oncoscience  5, 212-213.   https://doi.org/10.18632/oncoscience.447",https://intramural.nih.gov/search/searchview.taf?ipid=108848
486,BC011774-03,"October 01, 2018 -  September 30, 2019",Development and translation of novel therapies for pediatric sarcoma,Christine Marie Heske|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Victor Jared Collins|Choh L Yeung|Anna Elizabeth Gibson|Grace B McKay-Corkum,NULL,Leonard  Neckers; PhD (Urologic Oncology Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)|Natasha  Caplen (Cancer Genetics Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108849
487,BC011775-03,"October 01, 2018 -  September 30, 2019",Immune cell control of ovarian cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Anna Rose Duemler|Daniel Saul Green|Lidia F Hernandez|Jung-Min  Lee|Stanley  Lipkowitz; MD, PhD",NULL,NULL,NULL,"1. Fantini M, David JM, Wong HC, Annunziata CM, Arlen PM, Tsang KY (2019). An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells. Cancer Biother Radiopharm  34, 147-159.   https://doi.org/10.1089/cbr.2018.2628",https://intramural.nih.gov/search/searchview.taf?ipid=108853
488,BC011777-03,"October 01, 2018 -  September 30, 2019",Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Julian Christopher Assmann,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|Keita  Saito (Office Of The Director)|Jeffrey Robert Brender (Radiation Biology Branch)|Shun Kishimoto Kishimoto (Radiation Biology Branch),"Hellmut  Merkle; MS, PHD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108850
489,BC011778-03,"October 01, 2018 -  September 30, 2019",Quantitative Single-Cell Assessment of Lentivirus Susceptibility Determinants,Alex  Compton|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Charles A Coomer|Saliha  Majdoul,NULL,Stephen J Lockett; PhD (Office Of The Director),"Richard  Pastor; PhD (NHLBI) |Joshua  Zimmerberg; PhD, MD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108851
490,BC011779-03,"October 01, 2018 -  September 30, 2019",Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry,Alex  Compton|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kazi Mohammad Mostafizur Rahman|Guoli  Shi|Alexis Marie Schirling|Alan  Rein; PhD,Chen  Liang (McGill University)|Olivier  Schwartz (Institut Pasteur)|Jacob  Yount (The Ohio State University)|Rajini  Mudhasani (Usamriid),Thorkell  Andresson (Office Of The Director)|Eric O Freed; PhD (HIV Drug Resistance Program)|Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Shi G, Ozog S, Torbett BE, Compton AA (2018). mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3. Proc Natl Acad Sci U S A  115, E10069-E10078.   https://doi.org/10.1073/pnas.1811892115",https://intramural.nih.gov/search/searchview.taf?ipid=108852
491,BC011780-03,"October 01, 2018 -  September 30, 2019",Clinical development of mechanism-based lymphoma therapies,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Wyndham H Wilson; MD, PhD|Mark Jason Roschewski",NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, Reddy NM, Winter JN, Chang JE, Gopal AK, Chadburn A, Mathew S, Fisher RI, Richards KL, Schöder H, Zelenetz AD, et al. [1 more author] (2019). Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303. J Clin Oncol  37, 1790-1799.   https://doi.org/10.1200/JCO.18.01994",https://intramural.nih.gov/search/searchview.taf?ipid=108854
492,BC011781-03,"October 01, 2018 -  September 30, 2019",Dynamics of hematopoietic differentiation,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Ratnadeep  Mukherjee; PhD,Frdric  Geissman (Memorial Sloan Kettering)|Pankaj  Mehta (Boston University),Jung-Hyun  Park (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108856
493,BC011782-03,"October 01, 2018 -  September 30, 2019",Mechanisms of pathogenesis in patient derived organoid models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Supreet  Agarwal|Aian Neil Seno Alilin|Michael Louis Beshiri; PhD|Keith Henry Jansson|Julianna Cassandra Kostas|Morgan Nicole Riba; BS|Show all 13,Eva  Corey (University of Washington)|Hong-sheng  Lin (Guanganmen Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Peter L Choyke; MD (Molecular Imaging Program)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Fatima Hafiz Karzai; MD (Genitourinary Malignancies Branch)",Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108855
494,BC011784-03,"October 01, 2018 -  September 30, 2019",Bioinformatics: Characterizing Brain Tumor Data,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Orieta  Celiku|Aiguo  Li|Xinyi  Li|Terri Sue Armstrong; PhD|Zhengping  Zhuang; MD, PhD|Sadhana  Jackson|Show all 9",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108857
495,BC011785-03,"October 01, 2018 -  September 30, 2019",Better Understanding and Handling of Tautomerism,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Devendra Kumar  Dhaked,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Steve  Heller (NIST),NULL,NULL,"1. Cachau RE, Zhu J, Nicklaus MC (2019). The upcoming subatomic resolution revolution. Curr Opin Struct Biol  58, 53-58.   https://doi.org/10.1016/j.sbi.2019.05.013",https://intramural.nih.gov/search/searchview.taf?ipid=108858
496,BC011786-03,"October 01, 2018 -  September 30, 2019",A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Rebecca Christine Dolan|Nida T Hussain|Yvonne  Wall,Greg  Adams (Fox Chase Cancer Center)|Zenta  Tsuchihashi (Astrazeneca),"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Jane Beth Trepel (Developmental Therapeutics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108859
497,BC011787-03,"October 01, 2018 -  September 30, 2019",Predictive biomarker of BET bromodomain inhibitor in Small cell lung cancer,Haobin  Chen|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Anju  Kumari|David  Schrump; MD,Charles  Rudin (MSKCC)|John  Poirier (MSKCC)|Nenghui  Wang (Ningbo Wenda Pharma)|Ulrike  Tontsch-grunt (Boehringer Ingelheim),NULL,Kai  Ge; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108860
498,BC011789-03,"October 01, 2018 -  September 30, 2019",Phase 2 study of Lu-177-DOTATATE in inoperable paraganglioma - pheochromocytoa,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Jyoti  Roy|Jorge Amilcar Carrasquillo,Emily  Bergsland (University Of California - San Francisco)|Daniel  Pryma (University Of Pennsylvania),Jaydira  del Rivero; MD (Pediatric Oncology Branch),"Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108861
499,BC011790-03,"October 01, 2018 -  September 30, 2019",Metabolic imaging of the effects of brain radiotherapy,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Nihar Jaydeep Mehta,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108862
500,BC011793-02,"October 01, 2018 -  September 30, 2019",Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies,Anish  Thomas; MD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Samantha Krystle Nichols|Yang  Zhang|Yves  Pommier; PhD|Jane Beth Trepel,NULL,"Javed  Khan; MD (Cancer Genetics Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Mark  Raffeld; MD (Laboratory of Pathology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Jung-Min  Lee (Womens Malignancies Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)",NULL,"1. Davis JS, Prophet E, Peng HL, Lee HY, Tidwell RSS, Lee JJ, Thomas A, Szabo E, Chang S (2019). Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer. JNCI Cancer Spectr  3, pkz010.   https://doi.org/10.1093/jncics/pkz010|2. Thomas A, Murai J, Pommier Y (2018). The evolving landscape of predictive biomarkers of response to PARP inhibitors. J Clin Invest  128, 1727-1730.   https://doi.org/10.1172/JCI120388|3. Thomas A, Pattanayak P, Szabo E, Pinsky P (2018). Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening. Chest  154, 1284-1290.   https://doi.org/10.1016/j.chest.2018.07.029|4. Thomas A, Pommier Y (2019). Targeting Topoisomerase I in the Era of Precision Medicine. Clin Cancer Res  25, 6581-6589.   https://doi.org/10.1158/1078-0432.CCR-19-1089",https://intramural.nih.gov/search/searchview.taf?ipid=108906
501,BC011798-02,"October 01, 2018 -  September 30, 2019",Identification of genomic regulatory elements in pancreas cells,Hatice Efsun Arda|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Elizabeth Ridgely Duvall|Sandeep  Nadella|Thucnhi  Truongvo|Li  Wang|John Alan Wildenthal,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108907
502,BC011800-02,"October 01, 2018 -  September 30, 2019",Engineering HCC-selective PET agent,"Freddy Enrique Escorcia; MD, PhD|IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI",Meghan Martha Bell|Nicholas Tang Gutsche,NULL,Mitchell  Ho (Laboratory of Molecular Biology),Rolf Eric Swenson; PhD (NHLBI),"1. Escorcia FE, Steckler JM, Abdel-Atti D, Price EW, Carlin SD, Scholz WW, Lewis JS, Houghton JL (2018). Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model. Mol Imaging Biol  20, 808-815.   https://doi.org/10.1007/s11307-018-1177-z",https://intramural.nih.gov/search/searchview.taf?ipid=108908
503,BC011801-02,"October 01, 2018 -  September 30, 2019",CD101 controls intraepithelial cells (IELs) for intestinal barrier integrity,Chuan  Wu|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Zuojia  Chen; PhD|Girak  Kim|Jian  Li|Jialie  Luo,NULL,NULL,NULL,"1. Biton M, Haber AL, Rogel N, Burgin G, Beyaz S, Schnell A, Ashenberg O, Su CW, Smillie C, Shekhar K, Chen Z, Wu C, Ordovas-Montanes J, Alvarez D, Herbst RH, Zhang M, Tirosh I, Dionne D, Nguyen LT, Xifaras ME, Shalek AK, von Andrian UH, Graham DB, Rozenblatt-Rosen O, Shi HN, et al. [4 more authors] (2018). T Helper Cell Cytokines Modulate Intestinal Stem Cell Renewal and Differentiation. Cell  175, 1307-1320.e22.   https://doi.org/10.1016/j.cell.2018.10.008|2. Wu C, Chen Z, Xiao S, Thalhamer T, Madi A, Han T, Kuchroo V (2018). SGK1 Governs the Reciprocal Development of Th17 and Regulatory T Cells. Cell Rep  22, 653-665.   https://doi.org/10.1016/j.celrep.2017.12.068",https://intramural.nih.gov/search/searchview.taf?ipid=108909
504,BC011802-02,"October 01, 2018 -  September 30, 2019",Discovery of genetic interactions in cancer,Eytan  Ruppin|IRP Faculty Profile,NULL,"Cancer Data Science Laboratory, NCI",Kuoyuan  Cheng|Joo Sang  Lee|Nishanth Ulhas Nair|Kun  Wang,NULL,Kenneth Dean Aldape; MD (Laboratory of Pathology)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Alon M, Arafeh R, Lee JS, Madan S, Kalaora S, Nagler A, Abgarian T, Greenberg P, Ruppin E, Samuels Y (2018). CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma. Oncotarget  9, 31264-31277.   https://doi.org/10.18632/oncotarget.25805|2. Auslander N, Zhang G, Lee JS, Frederick DT, Miao B, Moll T, Tian T, Wei Z, Madan S, Sullivan RJ, Boland G, Flaherty K, Herlyn M, Ruppin E (2018). Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat Med  24, 1545-1549.   https://doi.org/10.1038/s41591-018-0157-9|3. Feng X, Arang N, Rigiracciolo DC, Lee JS, Yeerna H, Wang Z, Lubrano S, Kishore A, Pachter JA, König GM, Maggiolini M, Kostenis E, Schlaepfer DD, Tamayo P, Chen Q, Ruppin E, Gutkind JS (2019). A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK. Cancer Cell  35, 457-472.e5.   https://doi.org/10.1016/j.ccell.2019.01.009|4. Lee JS, Adler L, Karathia H, Carmel N, Rabinovich S, Auslander N, Keshet R, Stettner N, Silberman A, Agemy L, Helbling D, Eilam R, Sun Q, Brandis A, Malitsky S, Itkin M, Weiss H, Pinto S, Kalaora S, Levy R, Barnea E, Admon A, Dimmock D, Stern-Ginossar N, Scherz A, et al. [9 more authors] (2018). Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures. Cell  174, 1559-1570.e22.   https://doi.org/10.1016/j.cell.2018.07.019|5. Nair NU, Das A, Rogkoti VM, Fokkelman M, Marcotte R, de Jong CG, Koedoot E, Lee JS, Meilijson I, Hannenhalli S, Neel BG, de Water BV, Le Dévédec SE, Ruppin E (2019). Migration rather than proliferation transcriptomic signatures are strongly associated with breast cancer patient survival. Sci Rep  9, 10989.   https://doi.org/10.1038/s41598-019-47440-w|6. Pathria G, Scott DA, Feng Y, Sang Lee J, Fujita Y, Zhang G, Sahu AD, Ruppin E, Herlyn M, Osterman AL, Ronai ZA (2018). Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival. EMBO J  37.   https://doi.org/10.15252/embj.201899735|7. Persi E, Duran-Frigola M, Damaghi M, Roush WR, Aloy P, Cleveland JL, Gillies RJ, Ruppin E (2018). Systems analysis of intracellular pH vulnerabilities for cancer therapy. Nat Commun  9, 2997.   https://doi.org/10.1038/s41467-018-05261-x|8. Persi E, Wolf YI, Leiserson MDM, Koonin EV, Ruppin E (2018). Criticality in tumor evolution and clinical outcome. Proc Natl Acad Sci U S A  115, E11101-E11110.   https://doi.org/10.1073/pnas.1807256115|9. Silberman A, Goldman O, Boukobza Assayag O, Jacob A, Rabinovich S, Adler L, Lee JS, Keshet R, Sarver A, Frug J, Stettner N, Galai S, Persi E, Halpern KB, Zaltsman-Amir Y, Pode-Shakked B, Eilam R, Anikster Y, Nagamani SCS, Ulitsky I, Ruppin E, Erez A (2019). Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer. Cancer Res  79, 518-533.   https://doi.org/10.1158/0008-5472.CAN-18-1062|10. Styr B, Gonen N, Zarhin D, Ruggiero A, Atsmon R, Gazit N, Braun G, Frere S, Vertkin I, Shapira I, Harel M, Heim LR, Katsenelson M, Rechnitz O, Fadila S, Derdikman D, Rubinstein M, Geiger T, Ruppin E, Slutsky I (2019). Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility. Neuron  102, 1009-1024.e8.   https://doi.org/10.1016/j.neuron.2019.03.045|11. Tang W, Zhou M, Dorsey TH, Prieto DA, Wang XW, Ruppin E, Veenstra TD, Ambs S (2018). Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival. Genome Med  10, 94.   https://doi.org/10.1186/s13073-018-0602-x",https://intramural.nih.gov/search/searchview.taf?ipid=108905
505,BC011803-02,"October 01, 2018 -  September 30, 2019",Cancer immunotherapy,Eytan  Ruppin|IRP Faculty Profile,NULL,"Cancer Data Science Laboratory, NCI",Kuoyuan  Cheng|David Robert Crawford|Joo Sang  Lee|Sushant Anant Patkar|Wells Ivens Robinson|Alejandro Alberto Schaffer; PhD,NULL,Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108903
506,BC011804-02,"October 01, 2018 -  September 30, 2019",Dual Blockade of IGF1R and MEK synergistically inhibits RMS cell growth,Marielle Elizabeth Yohe|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Xiaolin  Wan,NULL,Javed  Khan; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108904
507,BC011805-02,"October 01, 2018 -  September 30, 2019",Defining the Mechanism of Action of Rigosertib in Pediatric Cancers,Marielle Elizabeth Yohe|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Edjay Ralph Agustin Hernandez,NULL,Deborah K Morrison (Laboratory of Cell and Developmental Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108902
508,BC011806-02,"October 01, 2018 -  September 30, 2019",Thymus biology,Yousuke  Takahama; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Alison Kristin Jacques|Amy Colleen Palin|Melina Maria Frantzeskakis|Kenta  Kondo|Yu  Tanaka|Xuan  Xie; PhD,Izumi  Ohigashi (University Of Tokushima)|Graham  Anderson (University Of Birmingham)|Georg  Hollander (University of Oxford)|Shigeo  Murata (University Of Tokyo)|Keiji  Tanaka (Tokyo Metropolitan Institute Of Medical Science),NULL,NULL,"1. Cosway EJ, Ohigashi I, Schauble K, Parnell SM, Jenkinson WE, Luther S, Takahama Y, Anderson G (2018). Formation of the Intrathymic Dendritic Cell Pool Requires CCL21-Mediated Recruitment of CCR7+ Progenitors to the Thymus. J Immunol  201, 516-523.   https://doi.org/10.4049/jimmunol.1800348|2. Kasahara M, Flajnik MF, Takahama Y (2019). Biology, evolution, and history of antigen processing and presentation: Immunogenetics special issue 2019. Immunogenetics  71, 137-139.   https://doi.org/10.1007/s00251-019-01107-y|3. Khanom US, Ohigashi I, Fujimori S, Kondo K, Takada K, Takahama Y (2019). TCR Affinity for In Vivo Peptide-Induced Thymic Positive Selection Fine-Tunes TCR Responsiveness of Peripheral CD8+ T Cells. J Immunol  203, 881-887.   https://doi.org/10.4049/jimmunol.1900097|4. Kondo K, Ohigashi I, Takahama Y (2019). Thymus machinery for T-cell selection. Int Immunol  31, 119-125.   https://doi.org/10.1093/intimm/dxy081|5. Murata S, Takahama Y, Kasahara M, Tanaka K (2018). The immunoproteasome and thymoproteasome: functions, evolution and human disease. Nat Immunol  19, 923-931.   https://doi.org/10.1038/s41590-018-0186-z|6. Takahama Y, Ohigashi I, Murata S, Tanaka K (2019). Thymoproteasome and peptidic self. Immunogenetics  71, 217-221.   https://doi.org/10.1007/s00251-018-1081-3|7. Takeuchi A, Ozawa M, Kanda Y, Kozai M, Ohigashi I, Kurosawa Y, Rahman MA, Kawamura T, Shichida Y, Umemoto E, Miyasaka M, Ludewig B, Takahama Y, Nagasawa T, Katakai T (2018). A Distinct Subset of Fibroblastic Stromal Cells Constitutes the Cortex-Medulla Boundary Subcompartment of the Lymph Node. Front Immunol  9, 2196.   https://doi.org/10.3389/fimmu.2018.02196",https://intramural.nih.gov/search/searchview.taf?ipid=108901
509,BC011807-02,"October 01, 2018 -  September 30, 2019",Immunophenotyping by CyTOF and machine learning,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Sooraj Raghavendra Achar,Pankaj  Mehta (Boston University)|Hassane  Zarour (University Of Pittsburgh),NULL,Michael J Lenardo; MD (NIAID) |Mariana Julieta Kaplan (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108899
510,BC011808-02,"October 01, 2018 -  September 30, 2019",Role of ETS-Transcription Factors in Regulating Cell Fate,Sergio  Ruiz Macias; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Nancy Suyeon Lee|Teresa  Olbrich|Maria  Vega Sendino,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108900
511,BC011809-02,"October 01, 2018 -  September 30, 2019",Identification of molecular pathways regulating quiescence in pluripotent cells,Sergio  Ruiz Macias; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Nancy Suyeon Lee|Teresa  Olbrich|Maria  Vega Sendino,NULL,Steven David Cappell (Laboratory of Cancer Biology and Genetics)|Gianluca  Pegoraro (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108897
512,BC011810-02,"October 01, 2018 -  September 30, 2019",Canonical and non-canonical roles of Argonaute proteins in mammals,Joana  De Campos Alves Vidigal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Srividya  Chandrasekhar|Stephen Joshua Moore|Mahendra Kumar Prajapat|Laura  Sala,NULL,NULL,NULL,"1. Sala L, Chandrasekhar S, De Campos Alves Vidigal J (2019) AGO Unchained:  Canonical and non-canonical roles of Argonaute  proteins in mammals. Frontiers in Bioscience, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=108898
513,BC011811-02,"October 01, 2018 -  September 30, 2019",CRISPR tools to dissect the coding and non-coding genome,Joana  De Campos Alves Vidigal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Stephen Joshua Moore|Alexender Reinaldo Perez,Ralph  Garippa (Memorial Sloan Kettering Cancer Center)|Scott  Lowe (Cold Spring Harbor Laboratory),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108895
514,BC011812-02,"October 01, 2018 -  September 30, 2019",Dissecting the roles of Vault RNAs in mammals,Joana  De Campos Alves Vidigal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Laura  Sala,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108896
515,BC011813-02,"October 01, 2018 -  September 30, 2019",Molecular Determinants of Totipotency,Sergio  Ruiz Macias; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Nancy Suyeon Lee|Teresa  Olbrich|Maria  Vega Sendino,NULL,Gianluca  Pegoraro (Laboratory of Receptor Biology and Gene Expression)|Lino  Tessarollo (Mouse Cancer Genetics Program),Nicole Yen-I Morgan; PhD (NIBIB) |Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108893
516,BC011814-02,"October 01, 2018 -  September 30, 2019",RNA methylation as a modulator of cancer genome instability,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",William Walter Hannon|Andy Dong-Anh Tran; PhD,NULL,Pedro Jorge De Oliveira Rodrigues Batista; PhD (Laboratory of Cell Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108894
517,BC011815-02,"October 01, 2018 -  September 30, 2019",Investigate the mechanism of action of the novel telomere length regulator TZAP,Eros  Lazzerini Denchi|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Maria Soledad Ivaldi; PhD,Michael  Boddy (The Scripps Research Institute)|Jan  Karlseder (Salk),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108891
518,BC011816-02,"October 01, 2018 -  September 30, 2019",Determine how telomere dysfunction impacts neuronal function,Eros  Lazzerini Denchi|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Benura  Azeroglu Jaramillo Riveri; PhD|Anisha Mallika Loeb|Marta Aleksandra Markiewicz-Potoczny; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108892
519,BC011819-02,"October 01, 2018 -  September 30, 2019",Mechanisms of multi-species bacterial interactions,Anupama  Khare|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Sara Ann Alexander|Tiffany Marie Zarrella,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108888
520,BC011821-02,"October 01, 2018 -  September 30, 2019",Evolution of antibiotic resistance,Anupama  Khare|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Ganesh  Sundar,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108890
521,BC011823-01,"October 01, 2018 -  September 30, 2019",Immunotherapeutic approaches to treat pediatric hematologic malignancies,Nirali Niranjan Shah|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Haris Ahmed Qureshi|Bonnie Dolores Yates|Brigitte  Widemann; MD|John Frederick Shern|Naomi  Taylor,Richard  Aplenc (Children's Hospital Of Philadelphia)|Terry J Fry (NCI)|Crystal L. Mackall; MD (NCI)|Michael  Pulsipher (Children's Hospital Los Angeles)|Sarah  Tasian (Children's Hospital of Philadelphia),James N Kochenderfer (Surgery Branch),Omar Iqbal Khan; MD (NINDS) |Vandana Y Sachdev; MD (NHLBI),"1. Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, et al. [14 more authors] (2019). The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time. Biol Blood Marrow Transplant  25, 1325-1330.   https://doi.org/10.1016/j.bbmt.2019.01.034|2. Qin H, Ishii K, Nguyen S, Su PP, Burk CR, Kim BH, Duncan BB, Tarun S, Shah NN, Kohler ME, Fry TJ (2018). Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor. Blood  132, 1899-1910.   https://doi.org/10.1182/blood-2017-12-815548|3. Shah NN, Fry TJ (2019). Mechanisms of resistance to CAR T cell therapy. Nat Rev Clin Oncol  16, 372-385.   https://doi.org/10.1038/s41571-019-0184-6",https://intramural.nih.gov/search/searchview.taf?ipid=112254
522,BC011824-02,"October 01, 2018 -  September 30, 2019",Structural studies with regulatory RNAs,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Regan Michael Leblanc|Jennifer T Miller|Julie Marie Nyman|Monalisa  Swain; PhD|Samantha Beatrice Gacasan|Stefano  Ginocchio|Show all 8,Ryan  Murelli (Brooklyn College)|Peter  Stockley (University of Leeds),John Stephen Schneekloth (Chemical Biology Laboratory)|John A Beutler (Molecular Targets Laboratory),NULL,"1. Dai Y, Peralta AN, Wynn JE, Sherpa C, Li H, Verma A, Le Grice SFJ, Santos WL (2019). Molecular recognition of a branched peptide with HIV-1 Rev Response Element (RRE) RNA. Bioorg Med Chem  27, 1759-1765.   https://doi.org/10.1016/j.bmc.2019.03.016|2. Dai Y, Wynn JE, Peralta AN, Sherpa C, Jayaraman B, Li H, Verma A, Frankel AD, Le Grice SF, Santos WL (2018). Discovery of a Branched Peptide That Recognizes the Rev Response Element (RRE) RNA and Blocks HIV-1 Replication. J Med Chem  61, 9611-9620.   https://doi.org/10.1021/acs.jmedchem.8b01076|3. Marshall VA, Labo N, Sztuba-Solinska J, Cornejo Castro EM, Aleman K, Wyvill KM, McNamara L, Le Grice SFJ, Yarchoan R, Uldrick TS, MacPhail P, Polizzotto MN, Whitby D (2018). Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions. Oncotarget  9, 35856-35869.   https://doi.org/10.18632/oncotarget.26321|4. Shilo A, Tosto FA, Rausch JW, Le Grice SFJ, Misteli T (2019). Interplay of primary sequence, position and secondary RNA structure determines alternative splicing of LMNA in a pre-mature aging syndrome. Nucleic Acids Res  47, 5922-5935.   https://doi.org/10.1093/nar/gkz259",https://intramural.nih.gov/search/searchview.taf?ipid=108885
523,BC011825-02,"October 01, 2018 -  September 30, 2019",Th227-mesothelin and Zr89-mesothelin antibody conjugate in mesothelin tumors,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Jyoti  Roy|Peter L Choyke; MD|Elaine Marie Jagoda; MS,NULL,Raffit  Hassan (Thoracic and GI Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108886
524,BC011826-02,"October 01, 2018 -  September 30, 2019",Protection of Salivary Gland in PSMA-targeted radioligand therapy,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Jyoti  Roy|Peter L Choyke; MD|Elaine Marie Jagoda; MS,NULL,NULL,"Blake Matthew Warner; DDS, PhD (NIDCR) |Jay A Chiorini; PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108883
525,BC011827-02,"October 01, 2018 -  September 30, 2019",Phase 1-2 study of Lu177-DOTATATE and olaparib in neuroendocrine tumors,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Jyoti  Roy|Maria Liza Lindenberg|Esther  Mena Gonzalez,NULL,Jaydira  del Rivero; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108884
526,BC011828-02,"October 01, 2018 -  September 30, 2019",Mitochondrial metabolism in normal and transformed cells,Natalie  Porat-Shliom|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Suehelay  Acevedo Acevedo|Daniel  Feliciano|Megan Lynn Stefkovich,NULL,"Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108880
527,BC011830-02,"October 01, 2018 -  September 30, 2019",Control of cell cycle commitment by APC-C-Cdh1,Steven David Cappell|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Marwa Mounir Afifi; PhD|James Anthony Cornwell|Jenny Elana Frieder Nathans|Debasish  Paul,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108881
528,BC011831-02,"October 01, 2018 -  September 30, 2019",The Role of Protein Methylation in Squamous Cell Carcinoma of the Head and Neck,Vassiliki  Saloura; MD|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Sheila  Alvarez-Fernandez,Yusuke  Nakamura (University Of Chicago)|Robert  Macleod (Ionis Pharmaceuticals Inc)|Yo  Matsuo; PhD|Tanguy  Seiwert (Johns Hopkins),Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression),"Carter  Van Waes; MD, PhD (NIDCD) |Clint Tanner Allen (NIDCD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108882
529,BC011832-02,"October 01, 2018 -  September 30, 2019",Study cell cycle regulation in dormant tumor cells,Steven David Cappell|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Marwa Mounir Afifi; PhD|James Anthony Cornwell|Jenny Elana Frieder Nathans|Debasish  Paul|Li  Yang; PhD,NULL,NULL,NULL,"1. Cappell SD, Mark KG, Garbett D, Pack LR, Rape M, Meyer T (2018). EMI1 switches from being a substrate to an inhibitor of APC/CCDH1 to start the cell cycle. Nature  558, 313-317.   https://doi.org/10.1038/s41586-018-0199-7",https://intramural.nih.gov/search/searchview.taf?ipid=108878
530,BC011833-02,"October 01, 2018 -  September 30, 2019",The DIPG All-In Initiative,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Cynthia M Lester mccully,"Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Michelle  Monje-Deisseroth (Stanford)|Nicholas  Vitanza (Seattle Children's Hospital)|Patricia  Baxter (Texas Children's Cancer Center)|Sri  Gururangan (Duke University medical Center)|Duane A Mitchell|Show all 11",Cody John Peer (Office Of The Clinical Director)|Simone  Difilippantonio (Office Of The Director)|Rafael  Cruz Garcia (Office Of The Director),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108879
531,BC011835-02,"October 01, 2018 -  September 30, 2019",Minimal Myc functional threshold for tumorigenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao,NULL,David  Levens; PhD (Laboratory of Pathology)|Svetlana Dmitriyevna Pack; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108876
532,BC011837-02,"October 01, 2018 -  September 30, 2019",Outcomes and Risk of Rare Tumors,Terri Sue Armstrong; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Alvina A Acquaye|Elizabeth  Vera|Mark Richard Gilbert; MD,NULL,NULL,NULL,"1. Armstrong TS (2018). Survivorship in Neuro-Oncology. Neuro Oncol  20, vii4-vii5.   https://doi.org/10.1093/neuonc/noy173|2. Dirven L, Armstrong TS, Blakeley JO, Brown PD, Grant R, Jalali R, Leeper H, Mendoza T, Nayak L, Reijneveld JC, Le Rhun E, Walbert T, Weller M, Wen PY, Taphoorn MJB (2018). Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative. Lancet Oncol  19, e173-e180.   https://doi.org/10.1016/S1470-2045(18)30004-4|3. Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE (2018). Quality improvement in neurology: Neuro-Oncology Quality Measurement Set. Neuro Oncol  20, 531-537.   https://doi.org/10.1093/neuonc/nox245|4. Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS, Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM, Bates A, Doherty L, Galanis E, Gaffey S, Halkin T, Friday BE, Fouladi M, Lin NU, Macdonald D, Mehta MP, Penas-Prado M, Vogelbaum MA, et al. [6 more authors] (2019) Barriers to Accrual and Enrollment in Brain Tumor Trials. Neuro Oncol, in press (e-pub ahead of print)  https://doi.org/10.1093/neuonc/noz104|5. Milbury K, Mallaiah S, Mahajan A, Armstrong T, Weathers SP, Moss KE, Goktepe N, Spelman A, Cohen L (2018). Yoga Program for High-Grade Glioma Patients Undergoing Radiotherapy and Their Family Caregivers. Integr Cancer Ther  17, 332-336.   https://doi.org/10.1177/1534735417689882|6. Siegel C, Armstrong TS (2018). Nursing Guide to Management of Major Symptoms in Patients with Malignant Glioma. Semin Oncol Nurs  34, 513-527.   https://doi.org/10.1016/j.soncn.2018.10.014",https://intramural.nih.gov/search/searchview.taf?ipid=108873
533,BC011838-02,"October 01, 2018 -  September 30, 2019",Mechanisms of resistance to treatment in aggressive prostate cancers,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",John Robert Bright|Nicholas Taylor Terrigino|Shana Y Trostel|Scott Christopher Wilkinson|Huihui  Ye|Kathleen  Kelly; PhD|Show all 9,Steven  Balk (Beth Israel Deaconess Medical Center)|Mary-ellen  Taplin (Dana-farber Cancer Institute)|Glenn  Bubley (Beth Israel Deaconess Medical Center)|Angelo  DeMarzo (Johns Hopkins U),"William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Ismail Baris Turkbey (Molecular Imaging Program)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Guinevere Joy Ng Chun (Office Of The Clinical Director)",NULL,"1. Chen S, Cai C, Sowalsky AG, Ye H, Ma F, Yuan X, Simon NI, Gray NS, Balk SP (2018). BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer. Cancer Res  78, 5203-5215.   https://doi.org/10.1158/0008-5472.CAN-17-3615",https://intramural.nih.gov/search/searchview.taf?ipid=108874
534,BC011839-02,"October 01, 2018 -  September 30, 2019",Developing an Effective BET bromodomain inhibitor Drug Combo to Target SCLC,Haobin  Chen|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Anju  Kumari|David  Schrump; MD,Nenghui  Wang (Ningbo Wenda Pharma)|Ulrike  Tontsch-grunt (Boehringer Ingelheim),Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108875
535,BC011840-02,"October 01, 2018 -  September 30, 2019",Discovering novel therapies for glioma patients,"Jing  Wu; MD, PhD|IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",Funita Pindria Phan; PhD|Yu-Ting  Su|Mark Richard Gilbert; MD|Terri Sue Armstrong; PhD,NULL,William D Figg; PharmD (Genitourinary Malignancies Branch),Doug B Kuhns; PhD (NIAID),"1. Lukas RV, Wu J, Dey M, Buerki RA, Byrne RW, Dohrmann GJ (2018). A Survey of the Neuro-Oncology Landscape. J Clin Neurol  14, 8-15.   https://doi.org/10.3988/jcn.2018.14.1.8",https://intramural.nih.gov/search/searchview.taf?ipid=108871
536,BC011841-02,"October 01, 2018 -  September 30, 2019",Understanding IDH mutant gliomas,"Jing  Wu; MD, PhD|IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",Yu-Ting  Su|Funita Pindria Phan; PhD|Mark Richard Gilbert; MD|Terri Sue Armstrong; PhD,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Javed  Khan; MD (Cancer Genetics Branch)|Kenneth Dean Aldape; MD (Laboratory of Pathology),Jun  Shen; PhD (NIMH),"1. Waddle MR, Oudenhoven MD, Farin CV, Deal AM, Hoffman R, Yang H, Peterson J, Armstrong TS, Ewend MG, Wu J (2019). Impacts of Surgery on Symptom Burden and Quality of Life in Pituitary Tumor Patients in the Subacute Post-operative Period. Front Oncol  9, 299.   https://doi.org/10.3389/fonc.2019.00299",https://intramural.nih.gov/search/searchview.taf?ipid=108872
537,BC011843-02,"October 01, 2018 -  September 30, 2019",Identification and use of T-cell receptors recognizing common tumor mutations,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Catherine Marie Ade|Kenichi  Hanada|Chihao  Zhao,NULL,Udayan  Guha (Thoracic and GI Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108866
538,BC011846-02,"October 01, 2018 -  September 30, 2019",Single-cell DNA methylation analysis of human cancer,Kenneth Dean Aldape; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung|Bharati  Mehani|Zhichao  Wu; PhD,NULL,Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Eytan  Ruppin (Cancer Data Science Laboratory),NULL,"1. Bunda S, Heir P, Metcalf J, Li ASC, Agnihotri S, Pusch S, Yasin M, Li M, Burrell K, Mansouri S, Singh O, Wilson M, Alamsahebpour A, Nejad R, Choi B, Kim D, von Deimling A, Zadeh G, Aldape K (2019). CIC protein instability contributes to tumorigenesis in glioblastoma. Nat Commun  10, 661.   https://doi.org/10.1038/s41467-018-08087-9|2. Mansouri A, Hachem LD, Mansouri S, Nassiri F, Laperriere NJ, Xia D, Lindeman NI, Wen PY, Chakravarti A, Mehta MP, Hegi ME, Stupp R, Aldape KD, Zadeh G (2019). MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges. Neuro Oncol  21, 167-178.   https://doi.org/10.1093/neuonc/noy132",https://intramural.nih.gov/search/searchview.taf?ipid=108867
539,BC011847-02,"October 01, 2018 -  September 30, 2019",Development and validation of a predictor of meningioma recurrence,Kenneth Dean Aldape; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung|Bharati  Mehani|Zhichao  Wu; PhD,NULL,Eytan  Ruppin (Cancer Data Science Laboratory),NULL,"1. Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR, International Consortium on Meningiomas (2019). Advances in multidisciplinary therapy for meningiomas. Neuro Oncol  21, i18-i31.   https://doi.org/10.1093/neuonc/noy136|2. Chen H, Thomas C, Munoz FA, Alexandrescu S, Horbinski CM, Olar A, McGuone D, Camelo-Piragua S, Wang L, Pentsova E, Phillips J, Aldape K, Chen W, Iafrate AJ, Chi AS, Zagzag D, Golfinos JG, Placantonakis DG, Rosenblum M, Ohman-Strickland P, Hameed M, Snuderl M (2019) Polysomy is associated with poor outcome in 1p19q co-deleted oligodendroglial tumors. Neuro Oncol, in press (e-pub ahead of print)  https://doi.org/10.1093/neuonc/noz098|3. Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF, International Consortium on Meningiomas (2019). Imaging and diagnostic advances for intracranial meningiomas. Neuro Oncol  21, i44-i61.   https://doi.org/10.1093/neuonc/noy143|4. Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Ng HK, Noushmehr H, Harter P, Baumgarten P, Weller M, Preusser M, Herold-Mende C, Tatagiba M, Tabatabai G, Sahm F, von Deimling A, Zadeh G, Aldape KD, International Consortium on Meningiomas (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro Oncol, in press (e-pub ahead of print)  https://doi.org/10.1093/neuonc/noz061|5. Nassiri F, Tabatabai G, Aldape K, Zadeh G (2019). Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas. Neuro Oncol  21, i2-i3.   https://doi.org/10.1093/neuonc/noy181|6. Olar A, Tran D, Mehta VP, Reinhardt A, Manekia JH, Garnovskaya M, Ellezam B, Luthra R, Sulman EP, Mohila CA, Campbell GA, Powell SZ, Fuller GN, Aldape KD, Adesina AM (2019). ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features. Clin Neuropathol  38, 59-73.   https://doi.org/10.5414/NP301105|7. Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H, Perry A, Sahm F, Sloan A, Von Deimling A, Wen PY, Aldape K, Zadeh G, International Consortium on Meningiomas (2019). Molecular and translational advances in meningiomas. Neuro Oncol  21, i4-i17.   https://doi.org/10.1093/neuonc/noy178",https://intramural.nih.gov/search/searchview.taf?ipid=108868
540,BC011848-02,"October 01, 2018 -  September 30, 2019",Preclinical Modelling and Therapeutic Development for Other Cancer Indications,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Devon Ashley Atkinson|N Keith Collins|Wendi Raye Custer Lawrence|Catherine I Drennan|Rajaa  Elmeskini|Debra J Gilbert|Show all 18,NULL,Carol J Thiele (Pediatric Oncology Branch)|John Frederick Shern (Pediatric Oncology Branch)|Laura  Schmidt (Urologic Oncology Branch)|Marielle Elizabeth Yohe (Pediatric Oncology Branch)|Sheueyann  Cheng; PhD (Gene Regulation Section)|James Halpern Doroshow (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108869
541,BC011850-01,"October 01, 2018 -  September 30, 2019",Genomic Biomarkers of Cancer,Kenneth Dean Aldape; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung|Bharati  Mehani|Zhichao  Wu; PhD,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Eytan  Ruppin (Cancer Data Science Laboratory),NULL,"1. Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M (2018). cIMPACT-NOW update 3: recommended diagnostic criteria for ""Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"". Acta Neuropathol  136, 805-810.   https://doi.org/10.1007/s00401-018-1913-0|2. Chen S, Dickson BC, Mohammed S, Aldape K, Swanson D, Coulombe J, Zakhari N, Karimi S, Nassiri F, Zadeh G, Mamatjan Y, Wang T, Lo B, Woulfe J (2019) A dural-based spindle cell neoplasm characterized by a novel MN1-KMT2A fusion gene. Neuro Oncol, in press (e-pub ahead of print)  https://doi.org/10.1093/neuonc/noz091|3. Louis DN, Ellison DW, Brat DJ, Aldape K, Capper D, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D, von Deimling A, Wesseling P (2019). cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates. Brain Pathol  29, 469-472.   https://doi.org/10.1111/bpa.12732|4. Suppiah S, Aldape K, Zadeh G (2019) Needle in a Haystack: Identifying Drivers of Malignant Transformation in Neurofibromas. Neuro Oncol, in press (e-pub ahead of print)  https://doi.org/10.1093/neuonc/noz086",https://intramural.nih.gov/search/searchview.taf?ipid=112253
542,BC011852-02,"October 01, 2018 -  September 30, 2019",MyPART: My Pediatric and Adult Rare Tumor Network - Cures,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Crystal  Flowers|Sarah Noel Fuller|Susan Mary Hughes|Maran Ganesh Ilanchezhian|Margarita J Raygada; PhD|Abby  Sandler|Show all 10,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108911
543,BC011853-02,"October 01, 2018 -  September 30, 2019",CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Brittany Brelle Cordeiro|Nicole Marie Leggiero|Kristin Rae Odom|Marta  Penas-Prado; MD|Dorela Doris Shuboni-Mulligan; PhD|Yamini  Vyas|Show all 9,Nicholas  Avgeropoulos (Orlando Health)|George  Bobustuc (Aurora Health Care)|Daniela  Bota (University Of California Irvine)|David  Cachia (Medical University Of South Carolina)|Jian  Campian (Washington University)|Howard  Colman (University Of Utah Huntsman Cancer Institute)|Show all 31,Kenneth Dean Aldape; MD (Laboratory of Pathology)|Brett James Theeler (Neuro-Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108913
544,BC011854-02,"October 01, 2018 -  September 30, 2019",NCI Program for Natural Products Discovery - Cures,Barry R O'Keefe,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,James Halpern Doroshow (Developmental Therapeutics Branch),NULL,"1. Grkovic T, Evans JR, Akee RK, Guo L, Davis M, Jato J, Grothaus PG, Ahalt-Gottholm M, Hollingshead M, Collins JM, Newman DJ, O'Keefe BR (2019). Erythrofordins D and E, two new cassaine-type diterpenes from Erythrophleum suaveolens. Bioorg Med Chem Lett  29, 134-137.   https://doi.org/10.1016/j.bmcl.2018.12.019",https://intramural.nih.gov/search/searchview.taf?ipid=108910
545,BC011855-02,"October 01, 2018 -  September 30, 2019",Center for Cell-based Therapy - Cures,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Meghan Lyn Good; MD|S M Rafiqul  Islam; PhD|Takuya  Maeda|Taisuke  Kondo,NULL,NULL,NULL,"1. Hanada KI, Yu Z, Chappell GR, Park AS, Restifo NP (2019). An effective mouse model for adoptive cancer immunotherapy targeting neoantigens. JCI Insight  4.   https://doi.org/10.1172/jci.insight.124405",https://intramural.nih.gov/search/searchview.taf?ipid=108912
546,BC011859-01,"October 01, 2018 -  September 30, 2019",IMRRT for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma,Vassiliki  Saloura; MD|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",NULL,NULL,NULL,"Carter  Van Waes; MD, PhD (NIDCD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112251
547,BC011861-01,"October 01, 2018 -  September 30, 2019",Evaluating outcomes for patients with primary-metastatic gastrointestinal cancer,Jonathan Matthew Hernandez|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,Jeremy Lee Davis; MD (Endocrine Oncology Branch),NULL,"1. Coit DG, Hernandez J, Schoder H, Goldman D (2018). Response to the Letter to the Editor by CM den Bakker and DL van Der Peet. Ann Surg  268, e79-e80.   https://doi.org/10.1097/SLA.0000000000002676|2. Hernandez JM, Beylergil V, Goldman DA, van Beek E, Gonen M, Tang L, Downey R, Rizk N, Shah M, Strong V, Janjigian Y, Schöder H, Coit DG (2018). Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma. Ann Surg  267, 898-904.   https://doi.org/10.1097/SLA.0000000000002306|3. Kariya CM, Wach MM, Ruff SM, Ayabe RI, Lo WM, Torres MB, Petrick JL, McNeel TS, Davis JL, McGlynn KA, Hernandez JM (2019). Postbiliary drainage rates of cholangitis are impacted by procedural technique for patients with supra-ampullary cholangiocarcinoma: A SEER-Medicare analysis. J Surg Oncol  120, 249-255.   https://doi.org/10.1002/jso.25485|4. Martin SP, Drake J, Wach MM, Ruff SM, Diggs LP, Wan JY, Good ML, Dominguez DA, Ayabe RI, Glazer ES, Dickson PV, Davis JL, Deneve JL, Hernandez JM (2019) Resection and chemotherapy is the optimal treatment approach for patients with clinically node positive intrahepatic cholangiocarcinoma. HPB (Oxford), in press (e-pub ahead of print)  https://doi.org/10.1016/j.hpb.2019.06.007|5. Ruff SM, Ayabe RI, Wach MM, Diggs LP, Martin SP, Davis JL, Hernandez JM (2019). Practice patterns of VTE chemoprophylaxis after discharge following hepatic and pancreatic resections for cancer: A survey of hepatopancreatobiliary surgeons. J Thromb Thrombolysis  48, 119-124.   https://doi.org/10.1007/s11239-019-01834-9|6. van Beek EJAH, Hernandez JM, Goldman DA, Davis JL, McLaughlin K, Ripley RT, Kim TS, Tang LH, Hechtman JF, Zheng J, Capanu M, Schultz N, Hyman DM, Ladanyi M, Berger MF, Solit DB, Janjigian YY, Strong VE (2018). Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer. Ann Surg Oncol  25, 2027-2033.   https://doi.org/10.1245/s10434-018-6502-x|7. Wach MM, Ayabe RI, Ruff SM, D'Angelica M, Dineen SP, Grubbs EG, Shibata D, Shirley L, Weiss MJ, Davis JL, Hernandez JM (2019). A Survey of the Complex General Surgical Oncology Fellowship Programs Regarding Applicant Selection and Rank. Ann Surg Oncol  26, 2675-2681.   https://doi.org/10.1245/s10434-019-07372-1|8. Zheng J, Hernandez JM, Doussot A, Bojmar L, Zambirinis CP, Costa-Silva B, van Beek EJAH, Mark MT, Molina H, Askan G, Basturk O, Gonen M, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Lyden D, Jarnagin WR (2018). Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer. HPB (Oxford)  20, 597-604.   https://doi.org/10.1016/j.hpb.2017.12.010",https://intramural.nih.gov/search/searchview.taf?ipid=112252
548,BC011865-01,"October 01, 2018 -  September 30, 2019",Breast and Other Carcinoma Clinical Trials Using Immunotherapies,Margaret Elena Gatti-Mays,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Bonnie L Casey|Cynthia Ann Moye|Camilo  Pacheco|Renee Nicole Donahue|Sofia Ribeiro Gameiro|James W Hodge; PhD|Show all 7,"Sylvia  Adams (Perlmutter Cancer Center, Nyu School Of Medicine)|Paul  Chaplin (Bavarian Nordic, Inc.)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|Frank E Jones; PhD (Tulane School of Medicine)|Elizabeth  Mittendorf (Dana-farber/brigham And Women's Cancer Center)|Shahrooz  Rabizadeh (Nantbioscience/nantomics)|Show all 9","Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Marijo  Bilusic (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|William Douglas Figg Ii (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Fatima Hafiz Karzai; MD (Genitourinary Malignancies Branch)","Clint Tanner Allen (NIDCD) |Lisa Marie Cordes; PHARMD, BCACP (OD)","1. Gatti-Mays ME, Gulley JL (2018). M7824: A promising new strategy to combat cancer immune evasion. Oncoscience  5, 269-270.   https://doi.org/10.18632/oncoscience.451",https://intramural.nih.gov/search/searchview.taf?ipid=112249
549,BC011869-01,"October 01, 2018 -  September 30, 2019",Advancing RAS and RASopathy Therapies,Marielle Elizabeth Yohe|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Andrea Michelle Gross; MD|Brigitte  Widemann; MD,NULL,"Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Sharon Ann Savage (Clinical Genetics Branch)|Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112248
550,BC011870-01,"October 01, 2018 -  September 30, 2019",Liver Cancer Program,Anuradha Samantha Budhu,Tim Friedrich Greten,"Laboratory of Human Carcinogenesis, NCI",NULL,"Ghassan  Abou-Alfa (Gastrointestinal Medical Oncology, Memorial Sloan-Kettering Cancer Center)|Anthony  Bejjani (David Geffen School Of Medicine At Ucla)|Anthony  El-khoueiry (Usc Norris Comprehensive Cancer Center)|Richard  Finn (David Geffen School Of Medicine At Ucla)|Lipika  Goyal (Massachusetts General Hospital)|Aiwu  He (Georgetown University)|Show all 14","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Giorgio  Trinchieri (Cancer Inflammation Program)|Bradford J Wood; MD (Office of the Director)|Ying  Zhang (Laboratory of Cellular and Molecular Biology)",NULL,"1. Dang H, Pomyen Y, Martin SP, Dominguez DA, Yim SY, Lee JS, Budhu A, Shah AP, Bodzin AS, Wang XW (2019). NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma. Sci Rep  9, 3369.   https://doi.org/10.1038/s41598-019-39727-9",https://intramural.nih.gov/search/searchview.taf?ipid=112246
551,BC011871-01,"October 01, 2018 -  September 30, 2019",T-Cell Receptor Gene Therapy for Human Cancers-Cures,Christian S Hinrichs|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI","Tejas Bharat Kadakia|Xiang  Liu; PhD, BS|Brigitte Oneida Osorio",NULL,NULL,Clint Tanner Allen (NIDCD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112247
552,BC011872-01,"October 01, 2018 -  September 30, 2019",PSMA-PET Imaging of High Risk Prostate Cancer-Cures,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112242
553,BC011874-01,"October 01, 2018 -  September 30, 2019",Graft-Versus-Host Disease Symptom Management-Cures,"Lori  Wiener; PhD, LCSW-C",Thomas A Misteli; PhD,"Office of the Director, NCI",Abigail Bess Baruch Fry,Amy  Amy Keating (Children's  Hospital Colorado)|Kenneth  Cook (Johns Hopkins)|Jacobsohn  David (Children's National Medical Center)|Deena  Levine|Margaret  Macmillan (University Of Minnesota)|Eneida  Nemecek (Doernbecher Children’s Hospital)|Show all 7,"Nataliya Prokopenko Buxbaum (Experimental Transplantation and Immunology Branch)|Sandra  Mitchell (Outcomes Research Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112244
554,BC011876-01,"October 01, 2018 -  September 30, 2019",Establish Preclinical Model for IDH-mutated Glioma,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Sue  Han,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112240
555,BC011877-01,"October 01, 2018 -  September 30, 2019",Immunological Analysis of Brain Cancer,Masaki  Terabe|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112241
556,BC011880-01,"October 01, 2018 -  September 30, 2019",Structural Analysis of Antiviral Activity of Novel Agents against HIV,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Hiromi  Aoki|Manabu  Aoki; PhD|Haydar  Bulut; PhD|Debananda  Das; PhD|David A Davis; MD,Masayuki  Amano (Kumamoto University School Of Medicine)|Nicole  Delino (HIV & AIDS MALIGNANCY BRANCH)|Arun  Ghosh|Hironori  Hayashi; MA|Matsuda  Koki (National Center For Global Health & Medicine)|Ladislau Christopher Kovari (Hiv & Aids Malignancy Branch)|Show all 8,David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Aoki M, Das D, Hayashi H, Aoki-Ogata H, Takamatsu Y, Ghosh AK, Mitsuya H (2018). Mechanism of Darunavir (DRV)'s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance. MBio  9.   https://doi.org/10.1128/mBio.02425-17|2. Delino NS, Aoki M, Hayashi H, Hattori SI, Chang SB, Takamatsu Y, Martyr CD, Das D, Ghosh AK, Mitsuya H (2018). GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants. Antimicrob Agents Chemother  62.   https://doi.org/10.1128/AAC.02060-17|3. Ghosh AK, Jadhav RD, Simpson H, Kovela S, Osswald H, Agniswamy J, Wang YF, Hattori SI, Weber IT, Mitsuya H (2018). Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors incorporating aminothiochromane and aminotetrahydronaphthalene carboxamide derivatives as the P2 ligands. Eur J Med Chem  160, 171-182.   https://doi.org/10.1016/j.ejmech.2018.09.046|4. Ghosh AK, R Nyalapatla P, Kovela S, Rao KV, Brindisi M, Osswald HL, Amano M, Aoki M, Agniswamy J, Wang YF, Weber IT, Mitsuya H (2018). Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis. J Med Chem  61, 4561-4577.   https://doi.org/10.1021/acs.jmedchem.8b00298|5. Ghosh AK, Rao KV, Nyalapatla PR, Kovela S, Brindisi M, Osswald HL, Sekhara Reddy B, Agniswamy J, Wang YF, Aoki M, Hattori SI, Weber IT, Mitsuya H (2018). Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants. ChemMedChem  13, 803-815.   https://doi.org/10.1002/cmdc.201700824|6. Ghosh AK, Williams JN, Ho RY, Simpson HM, Hattori SI, Hayashi H, Agniswamy J, Wang YF, Weber IT, Mitsuya H (2018). Design and Synthesis of Potent HIV-1 Protease Inhibitors Containing Bicyclic Oxazolidinone Scaffold as the P2 Ligands: Structure-Activity Studies and Biological and X-ray Structural Studies. J Med Chem  61, 9722-9737.   https://doi.org/10.1021/acs.jmedchem.8b01227|7. Hattori SI, Matsuda K, Tsuchiya K, Gatanaga H, Oka S, Yoshimura K, Mitsuya H, Maeda K (2018). Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro. Front Microbiol  9, 2022.   https://doi.org/10.3389/fmicb.2018.02022|8. Takamatsu Y, Das D, Kohgo S, Hayashi H, Delino NS, Sarafianos SG, Mitsuya H, Maeda K (2018). The High Genetic Barrier of EFdA/MK-8591 Stems from Strong Interactions with the Active Site of Drug-Resistant HIV-1 Reverse Transcriptase. Cell Chem Biol  25, 1268-1278.e3.   https://doi.org/10.1016/j.chembiol.2018.07.014",https://intramural.nih.gov/search/searchview.taf?ipid=112237
557,BC011881-01,"October 01, 2018 -  September 30, 2019",Investigating the microbiome in persons living with HIV,Heidi H Kong|IRP Faculty Profile,NULL,"Office of the Director, NCI",Iryna Leonidivna Chub|Valentina Shobhana Pillai; CRNP,NULL,NULL,Julia A Segre; PhD (NHGRI) |Irini  Sereti; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112239
558,BC011882-01,"October 01, 2018 -  September 30, 2019",Interactions Between MYC and BRD4 Result in Their Reciprocal Regulation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Devaiah Nanjappa Ballachanda|Dan  Cheng|Jie  Mu|Jocelyn D Weissman,NULL,Laura  Baranello (Laboratory of Pathology)|David  Levens; PhD (Laboratory of Pathology)|Zuqin  Nie; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112238
559,BC011883-01,"October 01, 2018 -  September 30, 2019",BRD4 Contributes to the Regulation of Alternative Splicing,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Dan  Cheng|Anne G M Gegonne Bosselut|Jie  Mu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112235
560,BC011884-01,"October 01, 2018 -  September 30, 2019",The dynamics of chromatin topology in human cells,Chongyi  Chen; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Jun  Lyu|Yun  Shen; PhD|Qian  Yao,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112236
561,BC011886-01,"October 01, 2018 -  September 30, 2019","First in Human Trials of ProAgio, a Cytotoxin",Christine Campo Alewine|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Xianyu  Zhang; MS|Jian  Xu,NULL,William D Figg; PharmD (Genitourinary Malignancies Branch)|Serguei V Kozlov (Office of the Director)|Ira H Pastan; MD (Molecular Biology Section)|Seth M Steinberg; PhD (Office Of The Clinical Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112233
562,BC011888-01,"October 01, 2018 -  September 30, 2019",Cancer Stem Cells in Cholangiocarcinoma,Changqing  Xie|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Tim Friedrich Greten,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112231
563,BC011889-01,"October 01, 2018 -  September 30, 2019",Data-driven inference of regulators for cytokine-mediated tumor killing,Peng  Jiang|IRP Faculty Profile,NULL,"Cancer Data Science Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112232
564,BC011890-01,"October 01, 2018 -  September 30, 2019",Computational approaches for the analyses of spatial profiling technologies,Peng  Jiang|IRP Faculty Profile,NULL,"Cancer Data Science Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112234
565,BC011892-01,"October 01, 2018 -  September 30, 2019",Targeting RAS in Pediatric Cancer,Marielle Elizabeth Yohe|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Edjay Ralph Agustin Hernandez|Xiaolin  Wan|Carol J Thiele,Benjamin  Braun (Ucsf)|Meredith  Irwin (Universtiy Of Toronto)|Christine  Pratilas (Johns Hopkins University)|Angelina  Vaseva (Greehy Children's Cancer Research Institute),Robert W Robey (Laboratory of Cell Biology),Craig Joseph Thomas (NCATS),"1. Sztul E, Chen PW, Casanova JE, Cherfils J, Dacks JB, Lambright DG, Lee FS, Randazzo PA, Santy LC, Schürmann A, Wilhelmi I, Yohe ME, Kahn RA (2019). ARF GTPases and their GEFs and GAPs: concepts and challenges. Mol Biol Cell  30, 1249-1271.   https://doi.org/10.1091/mbc.E18-12-0820",https://intramural.nih.gov/search/searchview.taf?ipid=112225
566,BC011893-01,"October 01, 2018 -  September 30, 2019",Exploring Behavioral Correlates of a Mouse Model of Central Nervous System Radia,Terri Sue Armstrong; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Dorela Doris Shuboni-Mulligan; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112226
567,BC011894-01,"October 01, 2018 -  September 30, 2019",Biology of Virus-associated Cancers,Gabriel James Starrett; PhD,Christopher  Buck,"Laboratory of Cellular Oncology, NCI",NULL,"James  Decaprio (Dana-farber Cancer Institute)|Reuben  Harris (Biochemistry, University of Minnesota)",Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Michael Robert Sargen (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112222
568,BC011895-01,"October 01, 2018 -  September 30, 2019",Improving PSMA-based radioligand therapy via combination radioligand therapy,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Jyoti  Roy|Jorge Amilcar Carrasquillo,NULL,Ravi  Madan (Genitourinary Malignancies Branch)|Maria  Merino; PhD (Laboratory of Pathology),Rolf Eric Swenson; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112223
569,BC011896-01,"October 01, 2018 -  September 30, 2019",Evaluation of immunotherapy-novel treatments in biochemically recurrent prostate,Ravi  Madan|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Moniquea L Smith|Marijo  Bilusic|William Laurence Dahut; MD|William D Figg; PharmD|James L Gulley; MD, PhD|Fatima Hafiz Karzai; MD",Lauren  Harshman (Dana Farber)|Philip  Kantoff (Dana-Farber Cancer Institute)|Nima  Sharifi (Cleveland Clinic)|Susan  Slovin (Sloan Kettering),Peter L Choyke; MD (Molecular Imaging Program)|Deborah E Citrin (Radiation Oncology Branch)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Peter A Pinto; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Ismail Baris Turkbey (Molecular Imaging Program),NULL,"1. Aragon-Ching JB, Madan RA (2018). The path forward in prostate cancer therapeutics. Asian J Androl  20, 213-214.   https://doi.org/10.4103/aja.aja_3_18|2. Madan RA, Gulley JL (2019). Finding an Immunologic Beachhead in the Prostate Cancer Microenvironment. J Natl Cancer Inst  111, 219-220.   https://doi.org/10.1093/jnci/djy145",https://intramural.nih.gov/search/searchview.taf?ipid=112224
570,BC011897-01,"October 01, 2018 -  September 30, 2019",Evaluation of Immune-based Combinations in Metastatic Prostate Cancer,Ravi  Madan|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Moniquea L Smith|Marijo  Bilusic|William Laurence Dahut; MD|William D Figg; PharmD|James L Gulley; MD, PhD|Fatima Hafiz Karzai; MD",NULL,James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology),NULL,"1. Cordes LM, Gulley JL, Madan RA (2018). Perspectives on the clinical development of immunotherapy in prostate cancer. Asian J Androl  20, 253-259.   https://doi.org/10.4103/aja.aja_9_18|2. Marciscano AE, Madan RA (2018). Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies. Curr Treat Options Oncol  19, 16.   https://doi.org/10.1007/s11864-018-0523-3|3. Pezaro CJ, Marciscano AE, Madan RA (2018). The Winds of Change: Emerging Therapeutics in Prostate Cancer. Am Soc Clin Oncol Educ Book  38, 382-390.   https://doi.org/10.1200/EDBK_201295",https://intramural.nih.gov/search/searchview.taf?ipid=112218
571,BC011898-01,"October 01, 2018 -  September 30, 2019",Development of Immunotherapy for Medullary Thyroid Cancer,Ravi  Madan|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Moniquea L Smith|James L Gulley; MD, PhD",NULL,Jaydira  del Rivero; MD (Pediatric Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology),NULL,"1. Del Rivero J, Edgerly M, Ward J, Madan RA, Balasubramaniam S, Fojo T, Gramza AW (2019). Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer. Oncologist  24, 16-e14.   https://doi.org/10.1634/theoncologist.2018-0452",https://intramural.nih.gov/search/searchview.taf?ipid=112219
572,BC011899-01,"October 01, 2018 -  September 30, 2019",Targeted Therapy in Neuroendocrine Cancer,Samira Mercedes Sadowski|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Akhilendra Kumar Maurya,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112220
573,BC011900-01,"October 01, 2018 -  September 30, 2019",Pilot Study of Avelumab in Thymic Epithelial Tumors,Arun  Rajan|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Emerson Baes Padiernos|Susan C Sansone|Raffit  Hassan,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)","Andrew Lee Mammen (NIAMS) |Blake Matthew Warner; DDS, PhD (NIDCR)","1. Achhal El Kadmiri MA, Rajan A (2018). Uncommon efforts for an uncommon tumor: the case for development of newer systemic therapies for advanced thymic epithelial tumors. Mediastinum  2.   https://doi.org/10.21037/med.2018.03.04|2. El Kadmiri MAA, Rajan A (2018). Neoadjuvant immunotherapy for non-small cell lung cancer: can early intervention result in durable clinical benefit? J Thorac Dis  10, S3203-S3206.   https://doi.org/10.21037/jtd.2018.08.39|3. Mammen AL, Rajan A, Pak K, Lehky T, Casciola-Rosen L, Donahue RN, Lepone LM, Zekeridou A, Pittock SJ, Hassan R, Schlom J, Gulley JL (2019). Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1. Ann Rheum Dis  78, 150-152.   https://doi.org/10.1136/annrheumdis-2018-213777|4. Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, Bowlby R, Matthew T, Danilova L, Hegde AM, Kim J, Leiserson MDM, Sethi G, Lu C, Ryan M, Su X, Cherniack AD, Robertson G, Akbani R, Spellman P, Weinstein JN, Cancer Genome Atlas Network, et al. [22 more authors] (2018). The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell  33, 244-258.e10.   https://doi.org/10.1016/j.ccell.2018.01.003|5. Takahashi N, Zhao C, Rajan A (2019). WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity. Mediastinum  3.   https://doi.org/10.21037/med.2019.03.03|6. Zhao C, Takahashi N, Rajan A (2018). Sleep better on combination therapy: SLFN11 predicts response to veliparib and temozolomide in recurrent small cell lung cancer. Transl Lung Cancer Res  7, S308-S311.   https://doi.org/10.21037/tlcr.2018.12.11",https://intramural.nih.gov/search/searchview.taf?ipid=112221
574,BC011901-01,"October 01, 2018 -  September 30, 2019","New regulatory mechanisms of WNT signaling in development, stem cells and cancer",Andres Matias Lebensohn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Courtney Rose Quick,NULL,Mitchell  Ho (Laboratory of Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112211
575,BC011902-01,"October 01, 2018 -  September 30, 2019",Anetumab in Thymic Carcinoma,Arun  Rajan|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Emerson Baes Padiernos|Susan C Sansone|Raffit  Hassan,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112212
576,BC011903-01,"October 01, 2018 -  September 30, 2019",Synthetic bacteria as a targeted delivery system for small molecule therapeutics,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Joanna Ruth Thomas,NULL,David J Fitzgerald; PhD (Biotherapy Section)|Kumaran S Ramamurthi (Laboratory of Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112213
577,BC011904-01,"October 01, 2018 -  September 30, 2019",Assay development and screening for molecular targets and discovery,Barry R O'Keefe,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",Mohammadnabi  Asmani|Curtis  Henrich|Nirmala D Sharma|Emily Ann Smith|Anthony  Wamiru|Jennifer A Wilson|Show all 7,NULL,Stuart F J Le Grice; PhD (Basic Research Laboratory)|Daniel  McVicar; PhD (Cancer Inflammation Program)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Kylie Janice Walters (Structural Biophysics Laboratory)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Ping  Zhang (Structural Biophysics Laboratory),Myriam  Gorospe; PhD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112214
578,BC011905-01,"October 01, 2018 -  September 30, 2019",Anti-PD-L1-TGFb antibody (M7824) in advanced non-small cell lung cancer,Arun  Rajan|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Emerson Baes Padiernos|Susan C Sansone,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112215
579,BC011906-01,"October 01, 2018 -  September 30, 2019",CV301 and Anti-PD-1 Therapy in Non-Small Cell Lung Cancer,Arun  Rajan|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Emerson Baes Padiernos|Susan C Sansone,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112216
580,BC011907-01,"October 01, 2018 -  September 30, 2019",Durvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer,Arun  Rajan|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Emerson Baes Padiernos|Susan C Sansone,NULL,Jung-Min  Lee (Womens Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112217
581,BC011914-01,"October 01, 2018 -  September 30, 2019",Molecular Biology of Lymphoma,Mark Jason Roschewski|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Lydia L Yee|Jaime Piercey Gastwirt|Christopher Joseph Melani|Jagan Reddy Muppidi|Arthur L Shaffer|Louis  Staudt; MD|Show all 7,Ash  Alizadeh (Stanford University)|Jason  Cyster; PhD (UCSF)|Allison  Jacob (Adaptive Biotechnologies),Elaine S Jaffe; MD (Laboratory of Pathology)|Jane Beth Trepel (Developmental Therapeutics Branch)|Stefania  Pittaluga (Laboratory of Pathology),"Ronald N Germain; MD, PhD (NIAID) |Adrian U Wiestner; MD, PhD (NHLBI)","1. Gastwirt JP, Roschewski M (2018). Management of adults with Burkitt lymphoma. Clin Adv Hematol Oncol  16, 812-822.|2. Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, Newman AM, Dührsen U, Hüttmann A, Meignan M, Casasnovas RO, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, et al. [2 more authors] (2018). Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. J Clin Oncol  36, 2845-2853.   https://doi.org/10.1200/JCO.2018.78.5246|3. Melani C, Wilson WH, Roschewski M (2018). Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA. Best Pract Res Clin Haematol  31, 285-292.   https://doi.org/10.1016/j.beha.2018.07.004|4. Melani C, Wilson WH, Roschewski M (2019). Liquid biopsy in non-Hodgkin's lymphoma. Hematol Oncol  37 Suppl 1, 70-74.   https://doi.org/10.1002/hon.2587|5. Miljkovic MD, Roschewski M, Dunleavy K, Wilson WH (2019) Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma. Leuk Lymphoma, in press (e-pub ahead of print)  https://doi.org/10.1080/10428194.2019.1627540",https://intramural.nih.gov/search/searchview.taf?ipid=112208
582,BC011916-01,"October 01, 2018 -  September 30, 2019",Pathway inhibitors in Lymphomas,Mark Jason Roschewski|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Lydia L Yee|Jaime Piercey Gastwirt|Christopher Joseph Melani|Louis  Staudt; MD|Wyndham H Wilson; MD, PhD|Jagan Reddy Muppidi|Show all 7",Ash  Alizadeh (Stanford University)|Matthias  Holdhoff (Johns Hopkins)|Allison  Jacob (Adaptive Biotechnologies),"Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Jane Beth Trepel (Developmental Therapeutics Branch)","Michail S Lionakis (NIAID) |Ronald N Germain; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112205
583,BC011919-01,"October 01, 2018 -  September 30, 2019",Identifying genetic vulnerabilities in neuroendocrine prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Sonam  Raj; PhD,NULL,Berkley Eric Gryder (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112206
584,BC011920-01,"October 01, 2018 -  September 30, 2019",Novel Approaches to Targeting Cancers Associated with VHL Mutations,"Ramaprasad  Srinivasan; MD, PhD|IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI",Donna  Drake|Julia C Friend; PA|Janet  Gichonge|Lisa Marie Mac|Donald P Bottaro; PhD|William Marston Linehan; MD,NULL,Marijo  Bilusic (Genitourinary Malignancies Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology),Emily Y Chew; MD (NEI) |Ashkan A Malayeri (CC) |Henry Ernest Wiley; MD (NEI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112203
585,BC011923-01,"October 01, 2018 -  September 30, 2019",Metabolic regulation of T cell effector function and anti-tumor immunotherapy,Naomi  Taylor|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christopher Daniel Chien; PhD|Taisuke  Kondo|Marie Charlotte Chantal Pouzolles|Angela Hui Su|John Walter Glod|Nirali Niranjan Shah,"Hinrich  Abken (Centre for Molecular Medicine, Universit�t zu K�ln)|Valrie  Dardalhon (University Of Montpellier/ Institut De G�n�tique Mol�culaire De Montpellier/ Cnrs)|Philippe  Jay (University Of Montpellier/ Institute Of Functional Genomics/ Cnrs)|David  Klatzmann (University Of Paris)|Cdric  Mongellaz (University Of Montpellier/ Institut De G�n�tique Mol�culaire De Montpellier/ Cnrs)|Vincent  Petit (Metafora)|Show all 7",Gregoire Yves Altan-Bonnet (Cancer Inflammation Program)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Khamous Marc Sitbon; PhD (Experimental Immunology Branch),Steven Lorenz Highfill (CC) |David F Stroncek; MD (CC),"1. Clerc I, Abba Moussa D, Vahlas Z, Tardito S, Oburoglu L, Hope T, Sitbon M, Dardalhon V, Mongellaz C, Taylor N (2019). Entry of glucose- and glutamine-derived carbons into the citric acid cycle supports early steps of HIV-1 infection in CD4 T cells. Nature Metabolism  1, 717-730.|2. Gonzalez-Menendez P, Hevia D, Alonso-Arias R, Alvarez-Artime A, Rodriguez-Garcia A, Kinet S, Gonzalez-Pola I, Taylor N, Mayo JC, Sainz RM (2018). GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress. Redox Biol  17, 112-127.   https://doi.org/10.1016/j.redox.2018.03.017",https://intramural.nih.gov/search/searchview.taf?ipid=112204
586,BC011924-01,"October 01, 2018 -  September 30, 2019",Enhancing HSC differentiation via metabolic conditioning and thymus-targeting,Naomi  Taylor|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christopher Daniel Chien; PhD|Taisuke  Kondo|Marie Charlotte Chantal Pouzolles|Angela Hui Su|Nirali Niranjan Shah,Jakub  Abramson (Weizmman Institute)|Patrick G Gallagher (Yale University)|Philippe  Jay (University Of Montpellier/ Institute Of Functional Genomics/ Cnrs)|Sandrina  Kinet (University Of Montpellier/ Institut De G�n�tique Mol�culaire De Montpellier/ Cnrs)|David  Klatzmann (University Of Paris)|Narla  Mohandas; DSc. (New York Blood Center)|Show all 8,Leonard  Neckers; PhD (Urologic Oncology Branch)|Khamous Marc Sitbon; PhD (Experimental Immunology Branch),David F Stroncek; MD (CC) |Luigi Daniele Notarangelo (NIAID),"1. Yan H, Hale J, Jaffray J, Li J, Wang Y, Huang Y, An X, Hillyer C, Wang N, Kinet S, Taylor N, Mohandas N, Narla A, Blanc L (2018). Developmental differences between neonatal and adult human erythropoiesis. Am J Hematol  93, 494-503.   https://doi.org/10.1002/ajh.25015",https://intramural.nih.gov/search/searchview.taf?ipid=112202
587,BC011926-01,"October 01, 2018 -  September 30, 2019",Predicting the adaptation processes of GBM cells due to spatiotemporal stimuli,Orit  Lavi; PhD,Michael Marc Gottesman; MD,"Multidrug Resistence Section, NCI",Vinodh  Rajapakse|Alex Hunter Rodriguez|Max Stephen Springer,NULL,Orieta  Celiku (Neuro-Oncology Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112200
588,BC011927-01,"October 01, 2018 -  September 30, 2019",Clinical Development of Novel Agents for Relapsed Acute Lymphoblastic Leukemia,Nirali Niranjan Shah|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Bonnie Dolores Yates|Brigitte  Widemann; MD,Deepa  Bhojwani (Children's Hospital Los Angeles)|Maureen Megan O'Brien|Alan S Wayne; MD,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Hao-Wei  Wang (Laboratory of Pathology)|Constance M Yuan (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112201
589,BC011928-01,"October 01, 2018 -  September 30, 2019",Rare GU tumors projects,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Rene A Costello; MT|Gloria L Jackson|Yang-Min  Ning|William D Figg; PharmD,NULL,Donald P Bottaro; PhD (Urologic Oncology Branch)|Maria Liza Lindenberg (Molecular Imaging Program)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology),Les Roger Folio (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112230
590,BC011930-01,"October 01, 2018 -  September 30, 2019",Investigation of skin disease,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Christopher  Buck (Laboratory of Cellular Oncology)","Alexandra  Freeman (NIAID) |Andrea  Lisco; MD, PhD (NIAID)","1. Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett DL (2018). Colchicine: an ancient drug with novel applications. Br J Dermatol  178, 350-356.   https://doi.org/10.1111/bjd.15896",https://intramural.nih.gov/search/searchview.taf?ipid=112229
591,CP000101-15,"October 01, 2018 -  September 30, 2019",Human Studies of Diet and Nutrition,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  | |Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Terryl  Hartman (Penn State University)|David  Baer (BHNRC, USDA)|Joanne  Dorgan; PhD (NCI)|Jerry  Combs (USDA)|Meryl  Wastney (Metabolic Modeling Services)",Ruth  Pfeiffer; PhD (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108958
592,CP000112-15,"October 01, 2018 -  September 30, 2019",Nutrition Intervention Trials,"Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Nan  Hu|Neal David Freedman|Gwen  Murphy,"You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Wen-Qiang  Wei (Cancer Institute, Chinese Academy of Medical Sciences)",Alisa  Goldstein; PhD (Clinical Genetics Branch)|Kai  Yu (Biostatistics Branch)|Paula L Hyland (Genetic Epidemiology Branch),NULL,"1. Epplein M, Butt J, Zhang Y, Hendrix LH, Abnet CC, Murphy G, Zheng W, Shu XO, Tsugane S, Qiao YL, Taylor PR, Shimazu T, Yoo KY, Park SK, Kim J, Jee SH, Waterboer T, Pawlita M, You WC, Pan KF (2018). Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer. Cancer Epidemiol Biomarkers Prev  27, 1472-1479.   https://doi.org/10.1158/1055-9965.EPI-18-0582|2. Thistle JE, Yang B, Petrick JL, Fan JH, Qiao YL, Abnet CC, Taylor PR, McGlynn KA (2018). Association of tooth loss with liver cancer incidence and chronic liver disease mortality in a rural Chinese population. PLoS One  13, e0203926.   https://doi.org/10.1371/journal.pone.0203926|3. Wang SM, Abnet CC, Qiao YL (2019). What have we learned from Linxian esophageal cancer etiological studies? Thorac Cancer  10, 1036-1042.   https://doi.org/10.1111/1759-7714.13058",https://intramural.nih.gov/search/searchview.taf?ipid=108957
593,CP000176-15,"October 01, 2018 -  September 30, 2019",Biologic Specimen Bank for Early Lung Cancer Markers,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Nan  Hu,You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|George M Weinstock|Jie  He (CICAMS)|Bert R Vogelstein,"Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108959
594,CP000185-15,"October 01, 2018 -  September 30, 2019",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Michael Blaise Cook|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Gwen  Murphy|Arash  Etemadi|Nan  Hu,"Paolo  Boffetta (International Agency for Research on Cancer)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Renato  Fagundes|David  Fleischer (Mayo Clinic (Scottsdale))|Ning  Lu (Cancer Institute, Chinese Academy of Medical Sciences)|Reza  Malekzadeh (Digestive Disease Research Center, Tehran University of Medical Sciences)|Show all 11",NULL,NULL,"1. Choi K, Inoue-Choi M, McNeel TS, Freedman ND (2019) Mortality Risks of Dual- and Poly-Tobacco Product Users in the United States. Am J Epidemiol, in press (e-pub ahead of print)  https://doi.org/10.1093/aje/kwz143|2. Etemadi A, Poustchi H, Chang CM, Blount BC, Calafat AM, Wang L, De Jesus VR, Pourshams A, Shakeri R, Shiels MS, Inoue-Choi M, Ambrose BK, Christensen CH, Wang B, Murphy G, Ye X, Bhandari D, Feng J, Xia B, Sosnoff CS, Kamangar F, Brennan P, Boffetta P, Dawsey SM, Abnet CC, et al. [2 more authors] (2019). Urinary Biomarkers of Carcinogenic Exposure among Cigarette, Waterpipe, and Smokeless Tobacco Users and Never Users of Tobacco in the Golestan Cohort Study. Cancer Epidemiol Biomarkers Prev  28, 337-347.   https://doi.org/10.1158/1055-9965.EPI-18-0743|3. Hashemian M, Farvid MS, Poustchi H, Murphy G, Etemadi A, Hekmatdoost A, Kamangar F, Sheikh M, Pourshams A, Sepanlou SG, Fazeltabar Malekshah A, Khoshnia M, Gharavi A, Brennan PJ, Boffetta P, Dawsey SM, Reedy J, Subar AF, Abnet CC, Malekzadeh R (2019). The application of six dietary scores to a Middle Eastern population: a comparative analysis of mortality in a prospective study. Eur J Epidemiol  34, 371-382.   https://doi.org/10.1007/s10654-019-00508-3|4. Inoue-Choi M, Hartge P, Park Y, Abnet CC, Freedman ND (2019). Association Between Reductions of Number of Cigarettes Smoked per Day and Mortality Among Older Adults in the United States. Am J Epidemiol  188, 363-371.   https://doi.org/10.1093/aje/kwy227|5. Inoue-Choi M, Hartge P, Park Y, Abnet CC, Freedman ND (2019). THE AUTHORS REPLY. Am J Epidemiol  188, 1.   https://doi.org/10.1093/aje/kwz155|6. Inoue-Choi M, Shiels MS, McNeel TS, Graubard BI, Hatsukami D, Freedman ND (2019). Contemporary Associations of Exclusive Cigarette, Cigar, Pipe, and Smokeless Tobacco Use With Overall and Cause-Specific Mortality in the United States. JNCI Cancer Spectr  3, pkz036.   https://doi.org/10.1093/jncics/pkz036|7. Mokhtari Z, Sharafkhah M, Poustchi H, Sepanlou SG, Khoshnia M, Gharavi A, Sohrabpour AA, Sotoudeh M, Dawsey SM, Boffetta P, Abnet CC, Kamangar F, Etemadi A, Pourshams A, FazeltabarMalekshah A, Islami F, Brennan P, Malekzadeh R, Hekmatdoost A (2019) Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet and risk of total and cause-specific mortality: results from the Golestan Cohort Study. Int J Epidemiol, in press (e-pub ahead of print)  https://doi.org/10.1093/ije/dyz079|8. Mwachiro MM, Parker RK, Pritchett NR, Lando JO, Ranketi S, Murphy G, Chepkwony R, Burgert SL, Abnet CC, Topazian MD, Dawsey SM, White RE (2019). Investigating tea temperature and content as risk factors for esophageal cancer in an endemic region of Western Kenya: Validation of a questionnaire and analysis of polycyclic aromatic hydrocarbon content. Cancer Epidemiol  60, 60-66.   https://doi.org/10.1016/j.canep.2019.03.010|9. Oranuba E, Deng H, Peng J, Dawsey SM, Kamangar F (2019). Polycyclic aromatic hydrocarbons as a potential source of carcinogenicity of mate. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev  37, 26-41.   https://doi.org/10.1080/10590501.2019.1555323|10. Sayed S, Field A, Rajab J, Mutuiri A, Githanga J, Mungania M, Okinda N, Moloo Z, Abdillah A, Ayara B, Chesori E, Muthua J, Obosy L, Massawa T, Obiero O, Kagotho E, Shikuku PK, Gachii AK, Migide E, Muninzwa D, Dawsey SM, Muchiri L (2018). Task Sharing and Shifting to Provide Pathology Diagnostic Services: The Kenya Fine-Needle Aspiration Biopsy Cytology and Bone Marrow Aspiration and Trephine Biopsy Training Program. J Glob Oncol  4, 1-11.   https://doi.org/10.1200/JGO.18.00094|11. Xue LY, Qin XM, Liu Y, Liang J, Lin H, Xue XM, Zou SM, Zhang MY, Zhang BH, Hui ZG, Zhao ZT, Ren LQ, Zhang YM, Liu XY, Yuan YL, Ying JM, Gao SG, Song YM, Wang GQ, Dawsey SM, Lu N (2018). Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma. World J Gastroenterol  24, 5154-5166.   https://doi.org/10.3748/wjg.v24.i45.5154",https://intramural.nih.gov/search/searchview.taf?ipid=108960
595,CP004410-43,"October 01, 2018 -  September 30, 2019",Family Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Alisa  Goldstein; PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI",June  Peters|Mary Louise McMaster; MD,Janis  Beach (Information Management Systems)|Donato  Calista (Bufalini Hospital)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Michael  Kelley (Duke University Medical Center)|Jeannette  Korczak (Karmanos Cancer Institute)|Yvonne  Reid (American Type Culture Collection)|Show all 11,NULL,NULL,"1. Gianferante DM, Rotunno M, Dean M, Zhou W, Hicks BD, Wyatt K, Jones K, Wang M, Zhu B, Goldstein AM, Mirabello L (2018). Whole-exome sequencing of nevoid basal cell carcinoma syndrome families and review of Human Gene Mutation Database PTCH1 mutation data. Mol Genet Genomic Med  6, 1168-1180.   https://doi.org/10.1002/mgg3.498|2. Goldstein AM, Stidd KC, Yang XR, Fraser MC, Tucker MA (2018). Pediatric melanoma in melanoma-prone families. Cancer  124, 3715-3723.   https://doi.org/10.1002/cncr.31641|3. McMaster ML, Berndt SI, Zhang J, Slager SL, Li SA, Vajdic CM, Smedby KE, Yan H, Birmann BM, Brown EE, Smith A, Kleinstern G, Fansler MM, Mayr C, Zhu B, Chung CC, Park JH, Burdette L, Hicks BD, Hutchinson A, Teras LR, Adami HO, Bracci PM, McKay J, Monnereau A, et al. [56 more authors] (2018). Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia. Nat Commun  9, 4182.   https://doi.org/10.1038/s41467-018-06541-2|4. McMaster ML, Sun C, Landi MT, Savage SA, Rotunno M, Yang XR, Jones K, Vogt A, Hutchinson A, Zhu B, Wang M, Hicks B, Thirunavukarason A, Stewart DR, Koutros S, Goldstein AM, Chanock SJ, Caporaso NE, Tucker MA, Goldin LR, Liu Y (2018). Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma. Br J Haematol  181, 372-377.   https://doi.org/10.1111/bjh.15203|5. Pugh J, Khan SG, Tamura D, Goldstein AM, Landi MT, DiGiovanna JJ, Kraemer KH (2019). Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population. JAMA Dermatol  155, 72-78.   https://doi.org/10.1001/jamadermatol.2018.4473",https://intramural.nih.gov/search/searchview.taf?ipid=108932
596,CP005782-25,"October 01, 2018 -  September 30, 2019",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Mahale P, Aka P, Chen X, Pfeiffer RM, Liu P, Groover S, Mendy M, Njie R, Goedert JJ, Kirk GD, Glenn JS, O'Brien TR (2019). Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia. J Viral Hepat  26, 738-749.   https://doi.org/10.1111/jvh.13065|2. O'Brien TR, Jackson SS (2019). What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection? J Interferon Cytokine Res  39, 618-626.   https://doi.org/10.1089/jir.2019.0048|3. O'Brien TR, Yang HI, Groover S, Jeng WJ (2019). Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression. Gastroenterology  156, 400-417.   https://doi.org/10.1053/j.gastro.2018.09.052|4. O'Brien TR, Young HA, Donnelly RP, Prokunina-Olsson L (2019). Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential. J Interferon Cytokine Res  39, 586-591.   https://doi.org/10.1089/jir.2019.0018|5. Vergara C, Thio CL, Johnson E, Kral AH, O'Brien TR, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Busch MP, Alexander G, Rosen HR, Murphy EL, Latanich R, et al. [5 more authors] (2019). Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. Gastroenterology  156, 1496-1507.e7.   https://doi.org/10.1053/j.gastro.2018.12.014",https://intramural.nih.gov/search/searchview.taf?ipid=108931
597,CP005803-25,"October 01, 2018 -  September 30, 2019",Genetic Epidemiology,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Alisa  Goldstein; PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI",Mary Louise McMaster; MD|Dilys  Parry; PhD,"Tim  Bishop (Institute for Cancer Research)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Jorgen  Olsen (Danish Cancer Society)|Lene  Mellemkjaer (Danish Cancer Society)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Donato  Calista (Bufalini Hospital)","Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Margaret Anne Tucker (Human Genetics Program)",NULL,"1. Gu F, Chen TH, Pfeiffer RM, Fargnoli MC, Calista D, Ghiorzo P, Peris K, Puig S, Menin C, De Nicolo A, Rodolfo M, Pellegrini C, Pastorino L, Evangelou E, Zhang T, Hua X, DellaValle CT, Timothy Bishop D, MacGregor S, Iles MI, Law MH, Cust A, Brown KM, Stratigos AJ, Nagore E, et al. [3 more authors] (2018). Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma. Hum Mol Genet  27, 4145-4156.   https://doi.org/10.1093/hmg/ddy282",https://intramural.nih.gov/search/searchview.taf?ipid=108930
598,CP005804-25,"October 01, 2018 -  September 30, 2019",Pharmacogenetic Studies,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Lynn Rachel Goldin; PhD,Janis  Beach (Information Management Systems)|Maria  Landi (DCEG),Alisa  Goldstein; PhD (Clinical Genetics Branch)|Margaret Anne Tucker (Human Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108929
599,CP010119-24,"October 01, 2018 -  September 30, 2019",Studies of Occupational Cancer (Pesticides),"Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Stella  Koutros|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Gabriella  Andreotti|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD",Lisbeth  Lopez-Carrillo (Mexican National Institute of Public Health)|Andrew  Olshan (University of North Carolina)|Sandra  Petralia (Roche Laboratories)|Dennis  Weisenburger (University of Nebraska Medical Center)|Jane  Hoppin (North Carolina State University),NULL,NULL,"1. Andreotti G, Lubin JH, Koutros S, Hofmann JN, Sandler DP, Lerro CC, Parks CG, Silverman DT, Beane Freeman LE (2019). Response to Sheppard and Shaffer. J Natl Cancer Inst  111, 216-218.   https://doi.org/10.1093/jnci/djy201|2. Shrestha S, Kamel F, Umbach DM, Freeman LEB, Koutros S, Alavanja M, Blair A, Sandler DP, Chen H (2019). High Pesticide Exposure Events and Olfactory Impairment among U.S. Farmers. Environ Health Perspect  127, 17005.   https://doi.org/10.1289/EHP3713|3. Shrestha S, Parks CG, Goldner WS, Kamel F, Umbach DM, Ward MH, Lerro CC, Koutros S, Hofmann JN, Beane Freeman LE, Sandler DP (2018). Pesticide Use and Incident Hypothyroidism in Pesticide Applicators in the Agricultural Health Study. Environ Health Perspect  126, 97008.   https://doi.org/10.1289/EHP3194",https://intramural.nih.gov/search/searchview.taf?ipid=108924
600,CP010120-24,"October 01, 2018 -  September 30, 2019",Studies of Occupational Cancer,"Laura Elizabeth Beane Freeman|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Joanne S Colt|Bu Tian  Ji|Mary Helen Ward; MS, PhD|Aaron E Blair; PhD, MPH|Lee Elizabeth Moore; PhD, MD|Wen-Yi  Huang|Show all 9",Paolo  Boffetta (International Agency for Research on Cancer)|Leon  Burmeister (University of Iowa)|Larwence  Figgs (St. Louis University)|Daniel  Lackland (Medical University of South Carolina)|J.  Nichols (Medical University of South Carolina)|Dennis  Zaebst (National Institute for Occupational Safety and Health)|Show all 21,"Jay  Lubin; PhD (Biostatistics Branch)|Louise  Brinton; PhD (Office of the Director)|Montserrat  Garcia-Closas; MD, PhD (Office of the Director)",NULL,"1. Silverman DT (2019). THE AUTHOR REPLIES. Am J Epidemiol  188, 491-492.   https://doi.org/10.1093/aje/kwy178",https://intramural.nih.gov/search/searchview.taf?ipid=108926
601,CP010121-24,"October 01, 2018 -  September 30, 2019",Molecular Epidemiology Studies of Occupational and Environmental Exposures,"Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Mary Helen Ward; MS, PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Lee Elizabeth Moore; PhD, MD|Mark  Purdue|Laura Elizabeth Beane Freeman","Stephen  Rappaport (School of Public Health, University of California)|Martyn  Smith (University of California at Berkeley)|Wei  Zheng (Vanderbilt University Medical Center)|John  Tessari (Colorado State University)|Xiao  Shu (Vanderbilt)|Robert  Branch (University of Pittsburgh)|Show all 13",NULL,NULL,"1. Purdue MP, Lan Q, Hoffman-Bolton J, Hildesheim A, Callahan CL, Strickland P, Visvanathan K, Rothman N (2019). Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk. Int J Cancer  144, 1780-1785.   https://doi.org/10.1002/ijc.31879",https://intramural.nih.gov/search/searchview.taf?ipid=108927
602,CP010122-24,"October 01, 2018 -  September 30, 2019",Occupational Exposure Assessment,Qing  Lan|IRP Faculty Profile  | |Melissa Charmaine Friesen|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Mary Helen Ward; MS, PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Mark  Purdue|Sarah J Locke|Debra  Silverman; ScD, ScM|Show all 9",NULL,NULL,NULL,"1. Friesen MC (2019). What Should We Do with Short-Term Jobs in Studies of Chronic Diseases? Ann Work Expo Health  63, 612-613.   https://doi.org/10.1093/annweh/wxz041|2. Ge CB, Friesen MC, Kromhout H, Peters S, Rothman N, Lan Q, Vermeulen R (2018). Use and Reliability of Exposure Assessment Methods in Occupational Case-Control Studies in the General Population: Past, Present, and Future. Ann Work Expo Health  62, 1047-1063.   https://doi.org/10.1093/annweh/wxy080|3. Sauvé JF, Friesen MC (2019). Using Decision Rules to Assess Occupational Exposure in Population-Based Studies. Curr Environ Health Rep  6, 148-159.   https://doi.org/10.1007/s40572-019-00240-w",https://intramural.nih.gov/search/searchview.taf?ipid=108925
603,CP010123-24,"October 01, 2018 -  September 30, 2019",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Melissa Charmaine Friesen|IRP Faculty Profile  | |Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Aaron E Blair; PhD, MPH|Bu Tian  Ji|Joanne S Colt",NULL,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108928
604,CP010124-24,"October 01, 2018 -  September 30, 2019",Human papillomavirus (HPV) infection and cervical and anal cancers,Mark  Schiffman; MD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Julia  Gage,Robert  Burk (Albert Einstein College of Medicine)|Michael  Gold MD (Vanderbilt University)|Patti  Gravitt (Johns Hopkins University)|Martha  Hutchinson (Brown University)|David  Scott (Kaiser Permanente)|Joan  Walker MD (University of Oklahoma Health Sciences Center)|Show all 27,Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Joshua Neil Sampson (Biostatistics Branch)|Hannah  Yang (Office of the Director)|Clara  Bodelon (Genetic Epidemiology Branch)|Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology),NULL,"1. Clarke MA, Wentzensen N (2018). Strategies for screening and early detection of anal cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers. Cancer Cytopathol  126, 447-460.   https://doi.org/10.1002/cncy.22018|2. Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, Massad LS, Parvu V, Perkins RB, Schiffman M, Smith KM, Wentzensen N (2018). Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis. Obstet Gynecol  132, 725-735.   https://doi.org/10.1097/AOG.0000000000002812",https://intramural.nih.gov/search/searchview.taf?ipid=108920
605,CP010125-24,"October 01, 2018 -  September 30, 2019",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Rena Rae Jones|Joanne S Colt|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH|Lee Elizabeth Moore; PhD, MD|Show all 9","James  Cerhan (Mayo Clinic)|Charles  Lynch (University of Iowa)|R William  Field (University of Iowa)|Manolis  Kogevinas|John W Brock (CDC)|Alexander  Parker (Mayo Clinic, Rochestor, NM)|Show all 28",Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Jones RR, VoPham T, Sevilla B, Airola M, Flory A, Deziel NC, Nuckols JR, Pronk A, Laden F, Ward MH (2019). Verifying locations of sources of historical environmental releases of dioxin-like compounds in the U.S.: implications for exposure assessment and epidemiologic inference. J Expo Sci Environ Epidemiol  29, 842-851.   https://doi.org/10.1038/s41370-018-0079-0|2. Sauvé JF, Ramsay JM, Locke SJ, Dopart PJ, Josse PR, Zaebst DD, Albert PS, Cantor KP, Baris D, Jackson BP, Karagas MR, Hosain GM, Schwenn M, Johnson A, Purdue MP, Koutros S, Silverman DT, Friesen MC (2019). Validity of retrospective occupational exposure estimates of lead and manganese in a case-control study. Occup Environ Med  76, 680-687.   https://doi.org/10.1136/oemed-2019-105744|3. Ward MH, Jones RR, Brender JD, de Kok TM, Weyer PJ, Nolan BT, Villanueva CM, van Breda SG (2018). Drinking Water Nitrate and Human Health: An Updated Review. Int J Environ Res Public Health  15.   https://doi.org/10.3390/ijerph15071557",https://intramural.nih.gov/search/searchview.taf?ipid=108933
606,CP010126-24,"October 01, 2018 -  September 30, 2019",Hormone-Related Cancers,"Louise  Brinton; PhD| | |Michael Blaise Cook|IRP Faculty Profile  | |Montserrat  Garcia-Closas; MD, PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Britton Lindsay Trabert|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Gretchen L Gierach|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI","Roni T Falk|Hannah  Yang|Stephen J Chanock; MD, PhD",David  Alberts (University of Arizona Cancer Center)|Douglas  Bauer (University of California at San Francisco)|Ralph  Coates (Centers for Disease Control and Prevention)|Joanne  Dorgan; PhD (NCI)|Kathleen  Egan (Harvard University)|R Loren  Erickson (Department of Defense)|Show all 11,"Barry Ira Graubard; PhD (Biostatistics Branch)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)",NULL,"1. Abubakar M, Chang-Claude J, Ali HR, Chatterjee N, Coulson P, Daley F, Blows F, Benitez J, Milne RL, Brenner H, Stegmaier C, Mannermaa A, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RAEM, Seynaeve C, Figueroa J, Lissowska J, Hewitt S, Hooning MJ, Hollestelle A, Foekens R, Koppert LB, et al. [12 more authors] (2018). Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. Int J Cancer  143, 746-757.   https://doi.org/10.1002/ijc.31352|2. Bodelon C, Ambatipudi S, Dugué PA, Johansson A, Sampson JN, Hicks B, Karlins E, Hutchinson A, Cuenin C, Chajès V, Southey MC, Romieu I, Giles GG, English D, Polidoro S, Assumma M, Baglietto L, Vineis P, Severi G, Herceg Z, Flanagan JM, Milne RL, Garcia-Closas M (2019). Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies. Breast Cancer Res  21, 62.   https://doi.org/10.1186/s13058-019-1145-9|3. Campbell PT, Ambrosone CB, Nishihara R, Aerts HJWL, Bondy M, Chatterjee N, Garcia-Closas M, Giannakis M, Golden JA, Heng YJ, Kip NS, Koshiol J, Liu XS, Lopes-Ramos CM, Mucci LA, Nowak JA, Phipps AI, Quackenbush J, Schoen RE, Sholl LM, Tamimi RM, Wang M, Weijenberg MP, Wu CJ, Wu K, et al. [5 more authors] (2019). Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control  30, 799-811.   https://doi.org/10.1007/s10552-019-01177-z|4. Clarke MA, Long BJ, Del Mar Morillo A, Arbyn M, Bakkum-Gamez JN, Wentzensen N (2018). Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis. JAMA Intern Med  178, 1210-1222.   https://doi.org/10.1001/jamainternmed.2018.2820|5. Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Zeleniuch-Jacquotte A, Liu M (2019). Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model. Breast Cancer Res  21, 42.   https://doi.org/10.1186/s13058-019-1126-z|6. Coburn SB, Stanczyk FZ, Falk RT, McGlynn KA, Brinton LA, Sampson J, Bradwin G, Xu X, Trabert B (2019). Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status. Cancer Causes Control  30, 75-86.   https://doi.org/10.1007/s10552-018-1105-1|7. Colombo M, Lòpez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meindl A, Montagna M, Niederacher D, Schmidt AY, Varesco L, Wappenschmidt B, Bolla MK, Dennis J, Michailidou K, Wang Q, Aittomäki K, Andrulis IL, kConFab/AOCS Investigators, et al. [89 more authors] (2018). The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Hum Mutat  39, 729-741.   https://doi.org/10.1002/humu.23411|8. Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, Beesley J, Lecarpentier J, Bolla MK, Wang Q, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Boeckx B, Bojesen SE, Bonanni B, Børresen-Dale AL, NBCS Collaborators, et al. [211 more authors] (2019). Genome-wide association study of germline variants and breast cancer-specific mortality. Br J Cancer  120, 647-657.   https://doi.org/10.1038/s41416-019-0393-x|9. Falk RT, Manson JE, Barnabei VM, Anderson GL, Brinton LA, Rohan TE, Cauley JA, Chen C, Coburn SB, Pfeiffer RM, Reding KW, Sarto GE, Wentzensen N, Chlebowski RT, Xu X, Trabert B (2019). Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone? Int J Cancer  144, 730-740.   https://doi.org/10.1002/ijc.31851|10. Felix AS, Brasky TM, Cohn DE, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel C, Boggess JF, Pearl ML, Ioffe OB, Deng W, Miller DS, Brinton LA (2018). Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study. Int J Cancer  142, 1102-1115.   https://doi.org/10.1002/ijc.31127|11. Florio AA, Graubard BI, Yang B, Thistle JE, Bradley MC, McGlynn KA, Petrick JL (2019). Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink. Eur J Epidemiol  34, 871-878.   https://doi.org/10.1007/s10654-019-00526-1|12. Hada M, Oh H, Pfeiffer RM, Falk RT, Fan S, Mullooly M, Pollak M, Geller B, Vacek PM, Weaver D, Shepherd J, Wang J, Fan B, Mahmoudzadeh AP, Malkov S, Herschorn S, Brinton LA, Sherman ME, Gierach GL (2019). Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy. Breast Cancer Res  21, 81.   https://doi.org/10.1186/s13058-019-1162-8|13. Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, Jensen A, Schildkraut JM, Berchuck A, Cramer DW, Bandera EV, Wentzensen N, Kotsopoulos J, Narod SA, Phelan CM, McLaughlin JR, Anton-Culver H, Ovarian Cancer Association Consortium, Australian Ovarian Cancer Study Group, et al. [4 more authors] (2018). Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev  27, 174-182.   https://doi.org/10.1158/1055-9965.EPI-17-0655|14. Heng YJ, Wang J, Ahearn TU, Brown SB, Zhang X, Ambrosone CB, de Andrade VP, Brufsky AM, Couch FJ, King TA, Modugno F, Vachon CM, DuPre NC, Garcia-Closas M, Troester MA, Hunter DJ, Eliassen AH, Tamimi RM, Hankinson SE, Beck AH (2019). Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues. Breast Cancer Res Treat  173, 667-677.   https://doi.org/10.1007/s10549-018-5034-1|15. Horne HN, Oh H, Sherman ME, Palakal M, Hewitt SM, Schmidt MK, Milne RL, Hardisson D, Benitez J, Blomqvist C, Bolla MK, Brenner H, Chang-Claude J, Cora R, Couch FJ, Cuk K, Devilee P, Easton DF, Eccles DM, Eilber U, Hartikainen JM, Heikkilä P, Holleczek B, Hooning MJ, Jones M, et al. [27 more authors] (2018). E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. Sci Rep  8, 6574.   https://doi.org/10.1038/s41598-018-23733-4|16. Kim S, Wang M, Tyrer JP, Jensen A, Wiensch A, Liu G, Lee AW, Ness RB, Salvatore M, Tworoger SS, Whittemore AS, Anton-Culver H, Sieh W, Olson SH, Berchuck A, Goode EL, Goodman MT, Doherty JA, Chenevix-Trench G, Rossing MA, Webb PM, Giles GG, Terry KL, Ziogas A, Fortner RT, et al. [25 more authors] (2019). A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants. Int J Cancer  144, 2192-2205.   https://doi.org/10.1002/ijc.32029|17. Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, Babb de Villiers C, Izquierdo A, Simard J, Schmidt MK, Walter FM, Chatterjee N, Garcia-Closas M, Tischkowitz M, Pharoah P, Easton DF, Antoniou AC (2019). BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med  21, 1708-1718.   https://doi.org/10.1038/s41436-018-0406-9|18. Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Auer PL, Auvinen P, Barrdahl M, Beane Freeman LE, Beckmann MW, ABCTB Investigators, kConFab/AOCS Investigators, NBCS Collaborators, et al. [244 more authors] (2019). Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet  104, 21-34.   https://doi.org/10.1016/j.ajhg.2018.11.002|19. Michels KA, Brinton LA, Wentzensen N, Pan K, Chen C, Anderson GL, Pfeiffer RM, Xu X, Rohan TE, Trabert B (2019). Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women's Health Initiative Observational Study. JNCI Cancer Spectr  3, pkz029.   https://doi.org/10.1093/jncics/pkz029|20. Mullooly M, Gierach GL (2018). The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response. JNCI Cancer Spectr  2, pky072.   https://doi.org/10.1093/jncics/pky072|21. Nyante SJ, Biritwum R, Figueroa J, Graubard B, Awuah B, Addai BW, Yarney J, Clegg-Lamptey JN, Ansong D, Nyarko K, Wiafe S, Oppong J, Boakye I, Brotzman M, Adjei R, Afriyie LT, Garcia-Closas M, Brinton LA (2019). Recruiting population controls for case-control studies in sub-Saharan Africa: The Ghana Breast Health Study. PLoS One  14, e0215347.   https://doi.org/10.1371/journal.pone.0215347|22. Shu X, Wu L, Khankari NK, Shu XO, Wang TJ, Michailidou K, Bolla MK, Wang Q, Dennis J, Milne RL, Schmidt MK, Pharoah PDP, Andrulis IL, Hunter DJ, Simard J, Easton DF, Zheng W, Breast Cancer Association Consortium (2019). Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. Int J Epidemiol  48, 795-806.   https://doi.org/10.1093/ije/dyy201|23. Trabert B, Michels KA, Anderson GL, Brinton LA, Falk RT, Geczik AM, Harris HR, Pan K, Pfeiffer RM, Qi L, Rohan T, Wentzensen N, Xu X (2019). Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Int J Cancer  145, 2051-2060.   https://doi.org/10.1002/ijc.32157|24. Webb PM, Na R, Weiderpass E, Adami HO, Anderson KE, Bertrand KA, Botteri E, Brasky TM, Brinton LA, Chen C, Doherty JA, Lu L, McCann SE, Moysich KB, Olson S, Petruzella S, Palmer JR, Prizment AE, Schairer C, Setiawan VW, Spurdle AB, Trabert B, Wentzensen N, Wilkens L, Yang HP, et al. [3 more authors] (2019). Use of aspirin, other nonsteroidal anti-inflammatory drugs and acetaminophen and risk of endometrial cancer: the Epidemiology of Endometrial Cancer Consortium. Ann Oncol  30, 310-316.   https://doi.org/10.1093/annonc/mdy541|25. Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, Al-Ejeh F, Rozali E, Wang Q, Dennis J, Li B, Zeng C, Feng H, Gusev A, Barfield RT, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Barrdahl M, NBCS Collaborators, kConFab/AOCS Investigators, et al. [185 more authors] (2018). A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nat Genet  50, 968-978.   https://doi.org/10.1038/s41588-018-0132-x",https://intramural.nih.gov/search/searchview.taf?ipid=108934
607,CP010127-24,"October 01, 2018 -  September 30, 2019",Etiologic Studies of Diet and Cancer,Eric Andrew Engels; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Loftfield E, Rothwell JA, Sinha R, Keski-Rahkonen P, Robinot N, Albanes D, Weinstein SJ, Derkach A, Sampson J, Scalbert A, Freedman ND (2019) Prospective investigation of serum metabolites, coffee drinking, liver cancer incidence, and liver disease mortality. J Natl Cancer Inst, in press (e-pub ahead of print)  https://doi.org/10.1093/jnci/djz122",https://intramural.nih.gov/search/searchview.taf?ipid=108952
608,CP010128-24,"October 01, 2018 -  September 30, 2019",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Louise  Brinton; PhD| | |Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Vikrant Vasant Sahasrabuddhe| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Britton Lindsay Trabert|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI

Breast and Gynecologic Cancer Research Group, NCI",Roni T Falk,Lenore  Buckley (Virginia Commonwealth University)|Theodore  Colton (Boston University School of Public Health)|Olga  Dvorkina (SUNY Health Sciences Center)|Susanne  Kruger-Kjaer (Danish Cancer Registry)|Emmet  Lamb (Stanford University)|Lene  Mellemkjaer (Danish Cancer Society)|Show all 10,NULL,NULL,"1. Aarestrup J, Trabert B, Ulrich LG, Wentzensen N, Sørensen TIA, Baker JL (2019). Childhood Overweight, Tallness, and Growth Increase Risks of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev  28, 183-188.   https://doi.org/10.1158/1055-9965.EPI-18-0024|2. Cabasag CJ, Arnold M, Butler J, Inoue M, Trabert B, Webb PM, Bray F, Soerjomataram I (2019) The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int J Cancer, in press (e-pub ahead of print)  https://doi.org/10.1002/ijc.32322|3. Samimi G, Trabert B, Geczik A, DUGGAN M, SHERMAN M (2018). Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice using SEE-Fim Protocol. JNCI Cancer Spectrum  2, pky061.|4. Trabert B, Troisi R, Grotmol T, Ekbom A, Engeland A, Gissler M, Glimelius I, Madanat-Harjuoja L, Sørensen HT, Tretli S, Gulbech Ording A, Bjørge T (2019) Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study. Int J Cancer, in press (e-pub ahead of print)  https://doi.org/10.1002/ijc.32494",https://intramural.nih.gov/search/searchview.taf?ipid=108935
609,CP010131-24,"October 01, 2018 -  September 30, 2019",Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"Amy  de Gonzalez|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Lindsay Mcomber Morton|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Daryl  Freedman|Maureen Cusack Hatch; MD,David  Abramson (New York Presbyterian Hospital)|Michael  Andersson (Danish Cancer Society)|Mary  Gospodarowicz (Princess Margaret Hospital)|Eric  Holowaty (Cancer Care Ontario)|Ann  Mertens (University of Minnesota)|Joseph  Neglia (University of Minnesota)|Show all 24,Steven L Simon (Epidemiology and Biostatistics Program)|Andre  Bouville (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Gramatges MM, Morton LM, Yasui Y, Arnold MA, Neglia JP, Leisenring WM, Machiela MJ, Dagnall CL, Chanock SJ, Armstrong GT, Robison LL, Bhatia S, Lupo PJ (2019). Telomere Length-Associated Genetic Variants and the Risk of Thyroid Cancer in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS). Cancer Epidemiol Biomarkers Prev  28, 417-419.   https://doi.org/10.1158/1055-9965.EPI-18-0972|2. Griffin KT, Mille MM, Pelletier C, Gopalakrishnan M, Jung JW, Lee C, Kalapurakal J, Pyakuryal A, Lee C (2019). Conversion of computational human phantoms into DICOM-RT for normal tissue dose assessment in radiotherapy patients. Phys Med Biol  64, 13NT02.   https://doi.org/10.1088/1361-6560/ab2670|3. Herr MM, Schonfeld SJ, Dores GM, Engels EA, Tucker MA, Curtis RE, Morton LM (2019). Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes. Blood Adv  3, 1961-1969.   https://doi.org/10.1182/bloodadvances.2019030924|4. Kalapurakal JA, Gopalakrishnan M, Mille M, Helenowski I, Peterson S, Rigsby C, Laurie F, Jung JW, Fitzgerald TJ, Lee C (2018). Feasibility and accuracy of UF/NCI phantoms and Monte Carlo retrospective dosimetry in children treated on National Wilms Tumor Study protocols. Pediatr Blood Cancer  65, e27395.   https://doi.org/10.1002/pbc.27395|5. Kleinerman RA, Tucker MA, Sigel BS, Abramson DH, Seddon JM, Morton LM (2019). Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914-2016. J Natl Cancer Inst  111, 961-969.   https://doi.org/10.1093/jnci/djy227|6. Kuzmin GA, Mille MM, Jung JW, Lee C, Pelletier C, Akabani G, Lee C (2018). A Novel Method to Extend a Partial-Body CT for the Reconstruction of Dose to Organs beyond the Scan Range. Radiat Res  189, 618-626.   https://doi.org/10.1667/RR14999.1|7. Little MP, Wakeford R, Borrego D, French B, Zablotska LB, Adams MJ, Allodji R, de Vathaire F, Lee C, Brenner AV, Miller JS, Campbell D, Pearce MS, Doody MM, Holmberg E, Lundell M, Sadetzki S, Linet MS, Berrington de González A (2018). Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies. Lancet Haematol  5, e346-e358.   https://doi.org/10.1016/S2352-3026(18)30092-9|8. Mille MM, Jung JW, Lee C, Kuzmin GA, Lee C (2018). Comparison of normal tissue dose calculation methods for epidemiological studies of radiotherapy patients. J Radiol Prot  38, 775-792.   https://doi.org/10.1088/1361-6498/aabd4f|9. Morton LM, Dores GM, Schonfeld SJ, Linet MS, Sigel BS, Lam CJK, Tucker MA, Curtis RE (2019). Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era. JAMA Oncol  5, 318-325.   https://doi.org/10.1001/jamaoncol.2018.5625|10. Morton LM, Kerns SL, Dolan ME (2018). Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment. Am Soc Clin Oncol Educ Book  38, 775-786.   https://doi.org/10.1200/EDBK_201391|11. Morton LM, Ricks-Santi L, West CML, Rosenstein BS (2018). Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy. Int J Part Ther  5, 103-113.   https://doi.org/10.14338/IJPT-18-00009.1|12. Moskowitz CS, Chou JF, Neglia JP, Partridge AH, Howell RM, Diller LR, Novetsky Friedman D, Barnea D, Morton LM, Turcotte LM, Arnold MA, Leisenring WM, Armstrong GT, Robison LL, Oeffinger KC, Henderson TO (2019). Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol  37, 2120-2130.   https://doi.org/10.1200/JCO.18.02219|13. Rühm W, Azizova T, Bouffler S, Cullings HM, Grosche B, Little MP, Shore RS, Walsh L, Woloschak GE (2018). Typical doses and dose rates in studies pertinent to radiation risk inference at low doses and low dose rates. J Radiat Res  59, ii1-ii10.   https://doi.org/10.1093/jrr/rrx093|14. Sapkota Y, Turcotte LM, Ehrhardt MJ, Howell RM, Arnold MA, Wilson CL, Leisenring W, Wang Z, Sampson J, Dagnall CL, Karlins E, Li SA, Hicks BD, Weathers R, Smith SA, Shelton K, Liu Q, Tucker MA, Chanock SJ, Zhang J, Hudson MM, Neglia JP, Armstrong GT, Robison LL, Morton LM, et al. [2 more authors] (2019). Genome-Wide Association Study in Irradiated Childhood Cancer Survivors Identifies HTR2A for Subsequent Basal Cell Carcinoma. J Invest Dermatol  139, 2042-2045.e8.   https://doi.org/10.1016/j.jid.2019.02.029",https://intramural.nih.gov/search/searchview.taf?ipid=108936
610,CP010132-24,"October 01, 2018 -  September 30, 2019",Studies of Populations Exposed to Environmental Sources of Radiation,"Amy  de Gonzalez|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Elizabeth  Cahoon|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Maureen Cusack Hatch; MD|Daryl  Freedman,Boris  Gusev (Kazakh Institute for Radiation Medicine and Ecology)|Terry  Hartman (Pennsylvania State University)|Alex  Romanukha (National Institute for Standards and Technology)|N.  Shilnikova (Biophysics Institute-Branch 1)|Alexander  Sekerbaev (Kazakhstan Research Institute of Radiation Medicine and Ecology)|Mykola  Tronko (Research Institute of Endocrinology and Metabolism)|Show all 10,NULL,NULL,"1. Hatch M, Brenner AV, Cahoon EK, Drozdovitch V, Little MP, Bogdanova T, Shpak V, Bolshova E, Zamotayeva G, Terekhova G, Shelkovoy E, Klochkova V, Mabuchi K, Tronko M (2019). Thyroid Cancer and Benign Nodules After Exposure In Utero to Fallout From Chernobyl. J Clin Endocrinol Metab  104, 41-48.   https://doi.org/10.1210/jc.2018-00847|2. Kendall GM, Little MP, Wakeford R (2018). Comment on ""Indoor terrestrial gamma dose rate mapping in France: A case study using two different geostatistical models"" by Warnery et al. (J. Environ. Radioact. 2015, 139, 140-148). J Environ Radioact  182, 172-173.   https://doi.org/10.1016/j.jenvrad.2017.11.031|3. Little MP (2018). Evidence for dose and dose rate effects in human and animal radiation studies. Ann ICRP  47, 97-112.   https://doi.org/10.1177/0146645318756235|4. Tronko M, Brenner AV, Bogdanova T, Shpak V, Cahoon EK, Drozdovitch V, Little MP, Tereshchenko V, Zamotayeva G, Terekhova G, Zurnadzhi L, Hatch M, Mabuchi K (2019). Reply to letter: Thyroid neoplasia after Chernobyl: A comment. Int J Cancer  144, 2898.   https://doi.org/10.1002/ijc.32213",https://intramural.nih.gov/search/searchview.taf?ipid=108921
611,CP010133-24,"October 01, 2018 -  September 30, 2019",Studies of Populations Exposed to Occupational Sources of Radiation,"Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Daryl  Freedman|Maureen Cusack Hatch; MD|Ethel S Gilbert|Steven L Simon,Bruce  Alexander (University of Minnesota)|Terry  Hartman (Pennsylvania State University)|Juozas  Kurtinaitis (Lithuanian Cancer Registry)|Dale  Preston (Hirosoft)|S.  Salomaa (Finnish Center for Radiation and Nuclear Safety)|N.  Shilnikova (Biophysics Institute-Branch 1)|Show all 16,NULL,NULL,"1. Elgart SR, Little MP, Chappell LJ, Milder CM, Shavers MR, Huff JL, Patel ZS (2018). Radiation Exposure and Mortality from Cardiovascular Disease and Cancer in Early NASA Astronauts. Sci Rep  8, 8480.   https://doi.org/10.1038/s41598-018-25467-9|2. Little MP, Fang M, Liu JJ, Weideman AM, Linet MS (2019). Inflammatory disease and C-reactive protein in relation to therapeutic ionising radiation exposure in the US Radiologic Technologists. Sci Rep  9, 4891.   https://doi.org/10.1038/s41598-019-41129-w|3. Little MP, Kitahara CM, Cahoon EK, Bernier MO, Velazquez-Kronen R, Doody MM, Borrego D, Miller JS, Alexander BH, Simon SL, Preston DL, Meyer C, Linet MS, Hamada N (2018). Occupational radiation exposure and glaucoma and macular degeneration in the US radiologic technologists. Sci Rep  8, 10481.   https://doi.org/10.1038/s41598-018-28620-6|4. Little MP, Lim H, Friesen MC, Preston DL, Doody MM, Sigurdson AJ, Neta G, Alexander BH, Chang LA, Cahoon EK, Simon SL, Linet MS, Kitahara CM (2018). Assessment of thyroid cancer risk associated with radiation dose from personal diagnostic examinations in a cohort study of US radiologic technologists, followed 1983-2014. BMJ Open  8, e021536.   https://doi.org/10.1136/bmjopen-2018-021536|5. Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, Jones ME, Adami HO, Baglietto L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Hoffman-Bolton J, Kaaks R, Key TJ, Kitahara CM, Larsson SC, Linet M, Merritt MA, et al. [18 more authors] (2019). Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies. Ann Intern Med  170, 22-30.   https://doi.org/10.7326/M18-1323|6. Ojha J, Dyagil I, Finch SC, Reiss RF, de Smith AJ, Gonseth S, Zhou M, Hansen HM, Sherborne AL, Nakamura J, Bracci PM, Gudzenko N, Hatch M, Babkina N, Little MP, Chumak VV, Walsh KM, Bazyka D, Wiemels JL, Zablotska LB (2018). Genomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers. Environ Health  17, 43.   https://doi.org/10.1186/s12940-018-0387-9|7. Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, et al. [25 more authors] (2018). Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncol  4, e181771.   https://doi.org/10.1001/jamaoncol.2018.1771",https://intramural.nih.gov/search/searchview.taf?ipid=108937
612,CP010134-23,"October 01, 2018 -  September 30, 2019",Studies of Atomic Bomb Survivors,"Amy  de Gonzalez|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Elizabeth  Cahoon|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",NULL,"Harry  Culling (Radiation Effects Research Foundation)|Kyoji  Furukawa; PhD|Eric Kobina Grant|Yuko  Hirai (Genetics, Radiation Effects Research Foundation)|Kazunori  Kodama (Radiation Effects Research Foundation, Japan)|Nori  Nakamwa (Radiation Effects Research Foundation)|Show all 9",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104293
613,CP010135-24,"October 01, 2018 -  September 30, 2019",Studies of Non-Ionizing Radiation-Related Cancer,Elizabeth  Cahoon|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Rochelle E Curtis|Daryl  Freedman,Peter  Black (Brigham and Women's Hospital & Dana Farber Cancer Center)|W.  Bleyer (Children's Cancer Group)|Howard  Fine (NYU Langone Medical Center)|Jay  Loeffler (Massachusetts General Hospital)|Bruce  Alexander (University of Minnesota)|Ann  Mertens (University of Minnesota)|Show all 13,Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Susan Shaw Devesa (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108938
614,CP010136-24,"October 01, 2018 -  September 30, 2019",Cancer Risk in Human Populations,"Sonja  Berndt|IRP Faculty Profile  | |Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Stella  Koutros|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Joanne S Colt|Mary Helen Ward; MS, PhD|Kenneth  Cantor; PhD|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH",NULL,Mark  Schiffman; MD (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108939
615,CP010142-21,"October 01, 2018 -  September 30, 2019",Genetic Modifiers of Cancer Risk,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Jennifer T Loud| | |Lisa  Mirabello|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI

Office of the Director, NCI",Anand  Pathak|Meredith  Yeager,Joseph  Constantino (National Surgical Adjuvant Breast & Bowel Project Statistical Center)|Larry  Wickerham (NSABP Group Headquarters)|Norman  Wolmark (National Surgical Adjuvant Breast and Bowel Project)|Phuong L Mai,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108940
616,CP010144-21,"October 01, 2018 -  September 30, 2019",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Blanche P Alter|IRP Faculty Profile  | |Shahinaz M Gadalla|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  |Jennifer T Loud| |Lisa James McReynolds| | |Lisa  Mirabello|IRP Faculty Profile  |Alexander  Pemov| | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Mitchell Henry Gail; PhD, MD|Renee C Bremer|Hormuzdiar Aspandiar Katki; MS|Neelam K Giri; MD|Mary Louise McMaster; MD|Payal Premchand Khincha|Show all 7",David  Alberts (University of Arizona Cancer Center)|Tim  Bishop (Institute for Cancer Research)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|Peter  Durie (Toronto Hospital for Sick Children)|M.  Elghetany (University of Texas)|Show all 51,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Margaret Anne Tucker (Human Genetics Program)|Stephen J Chanock; MD, PhD (Office of the Director)|Bari Jane Ballew (Office of the Director)",NULL,"1. AlDubayan SH, Pyle LC, Gamulin M, Kulis T, Moore ND, Taylor-Weiner A, Hamid AA, Reardon B, Wubbenhorst B, Godse R, Vaughn DJ, Jacobs LA, Meien S, Grgic M, Kastelan Z, Markt SC, Damrauer SM, Rader DJ, Kember RL, Loud JT, Kanetsky PA, Greene MH, Sweeney CJ, Kubisch C, Nathanson KL, Regeneron Genetics Center (RGC) Research Team, et al. [3 more authors] (2019). Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors. JAMA Oncol  5, 514-522.   https://doi.org/10.1001/jamaoncol.2018.6477|2. Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Wagner KR, Greene MH, Amr S, Gadalla SM (2018). Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity. JNCI Cancer Spectr  2, pky052.   https://doi.org/10.1093/jncics/pky052|3. Alter BP, Giri N (2019). Serum alpha fetoprotein levels in Fanconi anaemia. Br J Haematol  184, 1074-1076.   https://doi.org/10.1111/bjh.15517|4. Alter BP, Giri N, Savage SA, Rosenberg PS (2018). Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica  103, 30-39.   https://doi.org/10.3324/haematol.2017.178111|5. Ashizawa T, Gagnon C, Groh WJ, Gutmann L, Johnson NE, Meola G, Moxley R, Pandya S, Rogers MT, Simpson E, Angeard N, Bassez G, Berggren KN, Bhakta D, Bozzali M, Broderick A, Byrne JLB, Campbell C, Cup E, Day JW, De Mattia E, Duboc D, Duong T, Eichinger K, Ekstrom AB, et al. [41 more authors] (2018). Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract  8, 507-520.   https://doi.org/10.1212/CPJ.0000000000000531|6. Best AF, Hilbert JE, Wood L, Martens WB, Nikolenko N, Marini-Bettolo C, Lochmüller H, Rosenberg PS, Moxley RT, Greene MH, Gadalla SM (2019). Survival patterns and cancer determinants in families with myotonic dystrophy type 1. Eur J Neurol  26, 58-65.   https://doi.org/10.1111/ene.13763|7. Emparanza JI, López de Munain A, Greene MH, Matheu A, Fernández-Torrón R, Gadalla SM (2018). Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis. Muscle Nerve  58, 517-522.   https://doi.org/10.1002/mus.26194|8. Friebel TM, Andrulis IL, Balmaña J, Blanco AM, Couch FJ, Daly MB, Domchek SM, Easton DF, Foulkes WD, Ganz PA, Garber J, Glendon G, Greene MH, Hulick PJ, Isaacs C, Jankowitz RC, Karlan BY, Kirk J, Kwong A, Lee A, Lesueur F, Lu KH, Nathanson KL, Neuhausen SL, Offit K, et al. [18 more authors] (2019). BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry. Hum Mutat  40, 1781-1796.   https://doi.org/10.1002/humu.23804|9. Huryn LA, Turriff A, Harney LA, Carr AG, Chevez-Barrios P, Gombos DS, Ram R, Hufnagel RB, Hill DA, Zein WM, Schultz KAP, Bishop R, Stewart DR (2019). DICER1 Syndrome: Characterization of the Ocular Phenotype in a Family-Based Cohort Study. Ophthalmology  126, 296-304.   https://doi.org/10.1016/j.ophtha.2018.09.038|10. Kim J, Luo W, Wang M, Wegman-Ostrosky T, Frone MN, Johnston JJ, Nickerson ML, Rotunno M, Li SA, Achatz MI, Brodie SA, Dean M, de Andrade KC, Fortes FP, Gianferante M, Khincha P, McMaster ML, McReynolds LJ, Pemov A, Pinheiro M, Santiago KM, Alter BP, Caporaso NE, Gadalla SM, Goldin LR, et al. [25 more authors] (2018). Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls. Genome Med  10, 99.   https://doi.org/10.1186/s13073-018-0607-5|11. Kim J, Schultz KAP, Hill DA, Stewart DR (2019). The prevalence of germline DICER1 pathogenic variation in cancer populations. Mol Genet Genomic Med  7, e555.   https://doi.org/10.1002/mgg3.555|12. Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK, Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Benitez J, Bjorge L, Brenton J, Butzow R, Caldes T, Caligo MA, Campbell I, et al. [119 more authors] (2018). A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res  78, 5419-5430.   https://doi.org/10.1158/0008-5472.CAN-18-0951|13. Park JH, Li J, Starost MF, Liu C, Zhuang J, Chen J, Achatz MI, Kang JG, Wang PY, Savage SA, Hwang PM (2018). Mouse Homolog of the Human TP53 R337H Mutation Reveals Its Role in Tumorigenesis. Cancer Res  78, 5375-5383.   https://doi.org/10.1158/0008-5472.CAN-18-0016|14. Qian F, Rookus MA, Leslie G, Risch HA, Greene MH, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arnold N, Arun BK, Ausems MGEM, Azzollini J, Barrowdale D, Barwell J, Benitez J, Białkowska K, Bonadona V, Borde J, Borg A, Bradbury AR, Brunet J, KConFab Investigators, HEBON Investigators, GEMO Study Collaborators, EMBRACE Collaborators, CIMBA, et al. [113 more authors] (2019). Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. Br J Cancer  121, 180-192.   https://doi.org/10.1038/s41416-019-0492-8|15. Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Arun BK, Ausems MGEM, Azzollini J, Barouk-Simonet E, Barwell J, Belotti M, Benitez J, GEMO Study Collaborators, HEBON, EMBRACE, et al. [122 more authors] (2019). Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. J Natl Cancer Inst  111, 350-364.   https://doi.org/10.1093/jnci/djy132|16. Ratnasamy V, Navaneethakrishnan S, Sirisena ND, Grüning NM, Brandau O, Thirunavukarasu K, Dagnall CL, McReynolds LJ, Savage SA, Dissanayake VHW (2018). Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report. BMC Med Genet  19, 85.   https://doi.org/10.1186/s12881-018-0584-y|17. Savage SA, Walsh MF (2018). Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia. Hematol Oncol Clin North Am  32, 657-668.   https://doi.org/10.1016/j.hoc.2018.04.002|18. Schultz KAP, Williams GM, Kamihara J, Stewart DR, Harris AK, Bauer AJ, Turner J, Shah R, Schneider K, Schneider KW, Carr AG, Harney LA, Baldinger S, Frazier AL, Orbach D, Schneider DT, Malkin D, Dehner LP, Messinger YH, Hill DA (2018). DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res  24, 2251-2261.   https://doi.org/10.1158/1078-0432.CCR-17-3089|19. Ward SC, Savage SA, Giri N, Alter BP, Rosenberg PS, Pichard DC, Cowen EW (2018). Beyond the triad: Inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita. J Am Acad Dermatol  78, 804-806.   https://doi.org/10.1016/j.jaad.2017.10.017|20. Young JL, Pantaleao A, Zaspel L, Bayer J, Peters JA, Khincha PP, Bremer RC, Loud JT, Greene MH, Achatz MI, Savage SA, Werner-Lin A (2019). Couples coping with screening burden and diagnostic uncertainty in Li-Fraumeni syndrome: Connection versus independence. J Psychosoc Oncol  37, 178-193.   https://doi.org/10.1080/07347332.2018.1543376",https://intramural.nih.gov/search/searchview.taf?ipid=108941
617,CP010145-20,"October 01, 2018 -  September 30, 2019",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  |Jennifer T Loud| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",June  Peters,David  Alberts (University of Arizona Cancer Center)|Steven  Skates (Massachusetts General Hospital)|Marion  Piedmonte (GOG Statistical and Data Center)|Martee  Hensley (Memorial Sloan-Kettering Cancer Center)|Austin  Miller (GOG Statistical and Data Center)|Karen  Lu (MD Anderson Cancer Center)|Show all 15,Margaret Anne Tucker (Human Genetics Program),NULL,"1. Ersig AL, Werner-Lin A, Hoskins L, Young J, Loud JT, Peters J, Greene MH (2019). Legacies and Relationships: Diverse Social Networks and BRCA1/2 Risk Management Decisions and Actions. J Fam Nurs  25, 28-53.   https://doi.org/10.1177/1074840718815844|2. Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, Aldrich MC, Andrew AS, Andrulis IL, Anton-Culver H, Antoniou AC, Antonenkova NN, Arnold SM, Aronson KJ, Arun BK, Bandera EV, et al. [308 more authors] (2019). Shared heritability and functional enrichment across six solid cancers. Nat Commun  10, 431.   https://doi.org/10.1038/s41467-018-08054-4",https://intramural.nih.gov/search/searchview.taf?ipid=108942
618,CP010150-20,"October 01, 2018 -  September 30, 2019","Infections, immunity, and inflammation in cancer",Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Meredith Sarah Shiels|Jill Elizabeth Koshiol,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Anil Kumar Chaturvedi (Clinical Genetics Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|James Jerome Goedert; MD (Epidemiology and Biostatistics Program)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)|Joseph  Fraumeni; MD (Office of the Director),NULL,"1. Bernier MO, Withrow DR, Berrington de Gonzalez A, Lam CJK, Linet MS, Kitahara CM, Shiels MS (2019). Trends in pediatric thyroid cancer incidence in the United States, 1998-2013. Cancer  125, 2497-2505.   https://doi.org/10.1002/cncr.32125|2. Cahoon EK, Engels EA (2019). Reply to: Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR-inhibitors: 1997-2016. Int J Cancer  145, 599.   https://doi.org/10.1002/ijc.32096|3. D'Arcy M, Rivera DR, Grothen A, Engels EA (2019). Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United States. Cancer Epidemiol Biomarkers Prev  28, 741-750.   https://doi.org/10.1158/1055-9965.EPI-18-0887|4. D'Arcy ME, Coghill AE, Lynch CF, Koch LA, Li J, Pawlish KS, Morris CR, Rao C, Engels EA (2019). Survival after a cancer diagnosis among solid organ transplant recipients in the United States. Cancer  125, 933-942.   https://doi.org/10.1002/cncr.31782|5. Engels EA, Jennings LW, Everly MJ, Landgren O, Murata K, Yanik EL, Pfeiffer RM, Onaca N, Klintmalm GB (2018). Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients. Transplant Direct  4, e353.   https://doi.org/10.1097/TXD.0000000000000792|6. Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Althoff KN, Achenbach CJ, Hessol NA, D'Souza G, Gebo KA, Gill MJ, Grover S, Horberg MA, Li J, Mathews WC, Mayor AM, Park LS, Rabkin CS, Salters K, Justice AC, Moore RD, Engels EA, Silverberg MJ, Dubrow R, North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS (2019). Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study. Lancet HIV  6, e240-e249.   https://doi.org/10.1016/S2352-3018(18)30360-6|7. Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Althoff KN, Hessol NA, Achenbach CJ, Brooks JT, Gill MJ, Grover S, Horberg MA, Li J, Mathews WC, Mayor AM, Patel P, Rabkin CS, Rachlis A, Justice AC, Moore RD, Engels EA, Silverberg MJ, Dubrow R, North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS (2019) Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada. Clin Infect Dis, in press (e-pub ahead of print)  https://doi.org/10.1093/cid/ciz329|8. Khan SQ, Berrington de Gonzalez A, Best AF, Chen Y, Haozous EA, Rodriquez EJ, Spillane S, Thomas DA, Withrow D, Freedman ND, Shiels MS (2018). Infant and Youth Mortality Trends by Race/Ethnicity and Cause of Death in the United States. JAMA Pediatr  172, e183317.   https://doi.org/10.1001/jamapediatrics.2018.3317|9. Liu Z, Mahale P, Engels EA (2019). Sepsis and Risk of Cancer Among Elderly Adults in the United States. Clin Infect Dis  68, 717-724.   https://doi.org/10.1093/cid/ciy530|10. Mahale P, Engels EA, Lynch CF, Morton LM (2019). Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients. Br J Haematol  186, 347-351.   https://doi.org/10.1111/bjh.15828|11. Peprah S, Ogwang MD, Kerchan P, Reynolds SJ, Tenge CN, Were PA, Kuremu RT, Wekesa WN, Sumba PO, Masalu N, Kawira E, Magatti J, Kinyera T, Otim I, Legason ID, Nabalende H, Dhudha H, Ally H, Genga IO, Mumia M, Ayers LW, Pfeiffer RM, Biggar RJ, Bhatia K, Goedert JJ, et al. [1 more author] (2019) Risk factors for Burkitt lymphoma in East African children and minors: A case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya. Int J Cancer, in press (e-pub ahead of print)  https://doi.org/10.1002/ijc.32390|12. Shiels MS, Berrington de González A, Best AF, Chen Y, Chernyavskiy P, Hartge P, Khan SQ, Pérez-Stable EJ, Rodriquez EJ, Spillane S, Thomas DA, Withrow D, Freedman ND (2019). Premature mortality from all causes and drug poisonings in the USA according to socioeconomic status and rurality: an analysis of death certificate data by county from 2000-15. Lancet Public Health  4, e97-e106.   https://doi.org/10.1016/S2468-2667(18)30208-1|13. Shiels MS, Engels EA, Yanik EL, McGlynn KA, Pfeiffer RM, O'Brien TR (2019). Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013. Cancer  125, 2621-2630.   https://doi.org/10.1002/cncr.32129|14. Yanik EL, Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Horberg MA, Moore RD, Mathews WC, Justice AC, Hessol NA, Mayor AM, Gill MJ, Brooks JT, Sun J, Althoff KN, Engels EA, Silverberg MJ, Dubrow R (2018). Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr  78, 499-504.   https://doi.org/10.1097/QAI.0000000000001719",https://intramural.nih.gov/search/searchview.taf?ipid=108943
619,CP010152-20,"October 01, 2018 -  September 30, 2019",PLCO Trial Etiologic and Early Marker Study,"Sonja  Berndt|IRP Faculty Profile  | |Michael Blaise Cook|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI",Wen-Yi  Huang,"Mona  Fouad (University of Alabama, Birmingham)|Paul  Kvale (Extramural PLCO)|David T Crawford|Lance  Yokochi (Pacific Health Research Institute)|Doug  Reding (Marshfield Clinic Research Foundation)|Timothy R. Church; PhD (Environ & Occup Health, University of Minnesota School of Public Health)|Show all 11",Amanda  Black (Office of the Director)|Christine Dorothy Berg (Office of the Director),NULL,"1. Fortner RT, Poole EM, Wentzensen NA, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, Clendenen TV, Fournier A, Fraser G, Gapstur SM, Gaudet MM, Giles GG, Gram IT, Hartge P, Hoffman-Bolton J, Idahl A, et al. [29 more authors] (2019). Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium. Int J Cancer  145, 58-69.   https://doi.org/10.1002/ijc.32075|2. Hada M, Edin ML, Hartge P, Lih FB, Wentzensen N, Zeldin DC, Trabert B (2019). Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev  28, 189-197.   https://doi.org/10.1158/1055-9965.EPI-18-0392|3. Huang WY, Berndt SI, Shiels MS, Katki HA, Chaturvedi AK, Wentzensen N, Trabert B, Kemp TJ, Pinto LA, Hildesheim A, Rothman N, Purdue MP (2019). Circulating inflammation markers and colorectal adenoma risk. Carcinogenesis  40, 765-770.   https://doi.org/10.1093/carcin/bgz027|4. Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö S, Metter EJ, Mikami K, Milne RL, et al. [20 more authors] (2018). Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies. Eur Urol  74, 585-594.   https://doi.org/10.1016/j.eururo.2018.07.024|5. Watts EL, Perez-Cornago A, Appleby PN, Albanes D, Ardanaz E, Black A, Bueno-de-Mesquita HB, Chan JM, Chen C, Chubb SAP, Cook MB, Deschasaux M, Donovan JL, English DR, Flicker L, Freedman ND, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Häggström C, Haiman C, Hamdy FC, Hercberg S, et al. [39 more authors] (2019). The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies. Int J Cancer  145, 3244-3256.   https://doi.org/10.1002/ijc.32276|6. Wentzensen N, Berg CD (2018). Population Testing for High Penetrance Genes: Are We There Yet? J Natl Cancer Inst  110, 687-689.   https://doi.org/10.1093/jnci/djx282",https://intramural.nih.gov/search/searchview.taf?ipid=108944
620,CP010158-19,"October 01, 2018 -  September 30, 2019",Studies of Rare Cancers,Michael Blaise Cook|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Yu-Tang  Gao (Shanghai Cancer Institute)|Evelyene  Lennette (Virolab, Inc.)|Lene  Mellemkjaer (Danish Cancer Society)|Jorgen  Olsen (Danish Cancer Society)|Asif  Rashid (MD Anderson Cancer Center)|Juergen  Reichardt (University of Southern California)|Show all 12",NULL,NULL,"1. GOLONKA R, YEOH B, Petrick J, Weinstein S, Albanes D, GEWIRTZ A, McGlynn K, VIJAYKUMAR M (2019). Deoxyribonuclease I activity, cell-free DNA and risk of liver cancer in a prospective cohort. JNCI Cancer Spectrum  2, pky083.|2. Kariya CM, Wach MM, Ruff SM, Ayabe RI, Lo WM, Torres MB, Petrick JL, McNeel TS, Davis JL, McGlynn KA, Hernandez JM (2019). Postbiliary drainage rates of cholangitis are impacted by procedural technique for patients with supra-ampullary cholangiocarcinoma: A SEER-Medicare analysis. J Surg Oncol  120, 249-255.   https://doi.org/10.1002/jso.25485|3. Kroker-Lobos MF, Alvarez CS, Rivera-Andrade A, Smith JW, Egner P, Torres O, Lazo M, Freedman ND, Guallar E, Graubard BI, McGlynn KA, Ramírez-Zea M, Groopman JD (2019). Association between aflatoxin-albumin adduct levels and tortilla consumption in Guatemalan adults. Toxicol Rep  6, 465-471.   https://doi.org/10.1016/j.toxrep.2019.05.009|4. Petrick JL, McGlynn KA (2019). The changing epidemiology of primary liver cancer. Curr Epidemiol Rep  6, 104-111.   https://doi.org/10.1007/s40471-019-00188-3|5. Petrick JL, Thistle JE, Zeleniuch-Jacquotte A, Zhang X, Wactawski-Wende J, Van Dyke AL, Stampfer MJ, Sinha R, Sesso HD, Schairer C, Rosenberg L, Rohan TE, Robien K, Purdue MP, Poynter JN, Palmer JR, Newton CC, Linet MS, Liao LM, Lee IM, Koshiol J, Kitahara CM, Hofmann JN, Graubard BI, Giovannucci E, et al. [9 more authors] (2018). Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis. Am J Gastroenterol  113, 1494-1505.   https://doi.org/10.1038/s41395-018-0207-4|6. Rivera-Andrade A, Kroker-Lobos MF, Lazo M, Freedman ND, Smith JW, Torres O, McGlynn KA, Groopman JD, Guallar E, Ramirez-Zea M (2019). High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. Nutr Metab Cardiovasc Dis  29, 191-200.   https://doi.org/10.1016/j.numecd.2018.10.008",https://intramural.nih.gov/search/searchview.taf?ipid=108945
621,CP010167-19,"October 01, 2018 -  September 30, 2019",General Studies of Epidemiology,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi,Chester  Douglass (Harvard School of Dentistry)|Patricia  Hartge; ScD (NCI),Sharon Ann Savage (Clinical Genetics Branch)|Catherine G Schairer (Hormonal and Reproductive Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108946
622,CP010168-19,"October 01, 2018 -  September 30, 2019",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi,"Ervin  Adam (Baylor College of Medicine)|Elizabeth  Hatch (Boston University)|Arthur  Herbst (University of Chicago)|Julie  Palmer (Boston University)|Stanley  Robboy; MD (Pathology and Obstetrics & Gynecology, Duke University Medical Center)|William  Strohsnitter (University of Massachusetts)|Show all 11",NULL,NULL,"1. Cantonwine DE, McElrath TF, Trabert B, Xu X, Sampson J, Roberts JM, Hoover RN, Troisi R (2019). Estrogen metabolism pathways in preeclampsia and normal pregnancy. Steroids  144, 8-14.   https://doi.org/10.1016/j.steroids.2019.01.005|2. Sköld C, Bjørge T, Ekbom A, Engeland A, Gissler M, Grotmol T, Madanat-Harjuoja L, Gulbech Ording A, Stephansson O, Trabert B, Tretli S, Troisi R, Toft Sørensen H, Glimelius I (2018). Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. Int J Cancer  143, 1858-1867.   https://doi.org/10.1002/ijc.31581|3. Troisi R, Bjørge T, Gissler M, Grotmol T, Kitahara CM, Myrtveit Saether SM, Ording AG, Sköld C, Sørensen HT, Trabert B, Glimelius I (2018). The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. J Intern Med  283, 430-445.   https://doi.org/10.1111/joim.12747|4. Troisi R, Gulbech Ording A, Grotmol T, Glimelius I, Engeland A, Gissler M, Trabert B, Ekbom A, Madanat-Harjuoja L, Toft Sørensen H, Tretli S, Bjørge T (2018). Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study. Int J Cancer  143, 1904-1913.   https://doi.org/10.1002/ijc.31600|5. Troisi R, Hatch EE, Palmer JR, Titus L, Sampson JN, Xu X, Hoover RN (2018). Estrogen Metabolism in Postmenopausal Women Exposed In Utero to Diethylstilbestrol. Cancer Epidemiol Biomarkers Prev  27, 1208-1213.   https://doi.org/10.1158/1055-9965.EPI-18-0135",https://intramural.nih.gov/search/searchview.taf?ipid=108947
623,CP010169-18,"October 01, 2018 -  September 30, 2019","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Louise  Brinton; PhD|Mitchell Henry Gail; PhD, MD|Hormuzdiar Aspandiar Katki; MS","Lawrence  Kolonel (University of Hawaii)|Abraham  Nomura (School of Public Health, University of Hawaii)|Emanuel  Petricoin III (Food and Drug Administration)|Malcolm  Pike (University of Southern California)|Michael  Pollak (McGill University)|Frank  Stanczyk (University of Southern California)|Show all 11",Demetrius  Albanes; MD (Hormonal and Reproductive Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Catherine G Schairer (Hormonal and Reproductive Epidemiology Branch)|Stephanie Joan Weinstein (Hormonal and Reproductive Epidemiology Branch),NULL,"1. McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang WY, Jenab M, Jones ME, et al. [31 more authors] (2019). Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts. J Natl Cancer Inst  111, 158-169.   https://doi.org/10.1093/jnci/djy087",https://intramural.nih.gov/search/searchview.taf?ipid=108950
624,CP010170-19,"October 01, 2018 -  September 30, 2019",Multidisciplinary Studies of Hematopoietic Malignancies,Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Lindsay Mcomber Morton|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI

Radiation Epidemiology Branch, NCI","Joanne S Colt|Aaron E Blair; PhD, MPH|Mary Helen Ward; MS, PhD","Wendy  Cozen (Norris Comprehensive Cancer Center)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Richard  Severson (Barbara Karmanos Cancer Institute)|James  Cerhan (Mayo Clinic)|Anneclaire  De Roos (University of Washington, Seattle, WA)|Maryjean  Schenk (Barbara Karmanos Cancer Institute)",Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108948
625,CP010176-19,"October 01, 2018 -  September 30, 2019",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sam  Mbulaiteye|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI",Charles  Rabkin,"M  Eyster (Pennsylvania State University)|Angelos  Hatzakis (University of Athens Medical School)|Michael  Lederman; MD (Case Western Reserve University)|Nino  Romano (University of Palermo)|Cloe  Thio (Dept of Medicine, Johns Hopkins University School of Medicine)|David  Thomas (Johns Hopkins University)|Show all 7","Anil Kumar Chaturvedi (Clinical Genetics Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|James Jerome Goedert; MD (Epidemiology and Biostatistics Program)",NULL,"1. Derkach A, Otim I, Pfeiffer RM, Onabajo OO, Legason ID, Nabalende H, Ogwang MD, Kerchan P, Talisuna AO, Ayers LW, Reynolds SJ, Nkrumah F, Neequaye J, Bhatia K, Theander TG, Prokunina-Olsson L, Turner L, Goedert JJ, Lavstsen T, Mbulaiteye SM (2019). Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies. EBioMedicine  39, 358-368.   https://doi.org/10.1016/j.ebiom.2018.12.020|2. Gouveia MH, Bergen AW, Borda V, Nunes K, Leal TP, Ogwang MD, Yeboah ED, Mensah JE, Kinyera T, Otim I, Nabalende H, Legason ID, Mpoloka SW, Mokone GG, Kerchan P, Bhatia K, Reynolds SJ, Birtwum RB, Adjei AA, Tettey Y, Tay E, Hoover R, Pfeiffer RM, Biggar RJ, Goedert JJ, et al. [9 more authors] (2019). Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the ""endemic Burkitt Lymphoma belt"". PLoS Genet  15, e1008027.   https://doi.org/10.1371/journal.pgen.1008027|3. Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN, Mbulaiteye SM (2018). Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. Br J Haematol  181, 505-514.   https://doi.org/10.1111/bjh.15229|4. Peprah S, Dhudha H, Ally H, Masalu N, Kawira E, Chao CN, Genga IO, Mumia M, Were PA, Kinyera T, Otim I, Legason ID, Biggar RJ, Bhatia K, Goedert JJ, Pfeiffer RM, Mbulaiteye SM (2019). A population-based study of the prevalence and risk factors of low-grade Plasmodium falciparum malaria infection in children aged 0-15 years old in northern Tanzania. Trop Med Int Health  24, 571-585.   https://doi.org/10.1111/tmi.13225|5. Peprah S, Tenge C, Genga IO, Mumia M, Were PA, Kuremu RT, Wekesa WN, Sumba PO, Kinyera T, Otim I, Legason ID, Biddle J, Reynolds SJ, Talisuna AO, Biggar RJ, Bhatia K, Goedert JJ, Pfeiffer RM, Mbulaiteye SM (2019). A Cross-Sectional Population Study of Geographic, Age-Specific, and Household Risk Factors for Asymptomatic Plasmodium falciparum Malaria Infection in Western Kenya. Am J Trop Med Hyg  100, 54-65.   https://doi.org/10.4269/ajtmh.18-0481",https://intramural.nih.gov/search/searchview.taf?ipid=108949
626,CP010180-18,"October 01, 2018 -  September 30, 2019",Prostate Cancer Studies,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,Chu  Chen (University of Washington)|Yu-Tang  Gao (Shanghai Cancer Institute)|Juergen  Reichardt (University of Southern California)|Frank  Stanczyk (University of Southern California)|Paul  Levine (George Washington U)|Streamson  Chua (Columbia University)|Show all 15,NULL,NULL,"1. Andrews C, Fortier B, Hayward A, Lederman R, Petersen L, McBride J, Petersen DC, Ajayi O, Kachambwa P, Seutloali M, Shoko A, Mokhosi M, Hiller R, Adams M, Ongaco C, Pugh E, Romm J, Shelford T, Chinegwundoh F, Adusei B, Mante S, Snyper NY, Agalliu I, Lounsbury DW, Rohan T, et al. [54 more authors] (2018). Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate. J Glob Oncol  4, 1-14.   https://doi.org/10.1200/JGO.18.00063|2. Parlett LE, Beachler DC, Lanes S, Hoover RN, Cook MB (2019). Validation of an Algorithm for Claims-based Incidence of Prostate Cancer. Epidemiology  30, 466-471.   https://doi.org/10.1097/EDE.0000000000001007",https://intramural.nih.gov/search/searchview.taf?ipid=108962
627,CP010181-17,"October 01, 2018 -  September 30, 2019",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Joshua Neil Sampson|IRP Faculty Profile  | |Jianxin  Shi|IRP Faculty Profile  | |Kai  Yu|IRP Faculty Profile  | |Paul Stuart Albert|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",NULL,"Gang  Zheng (National Heart Lung and Blood Institute)|Efstathia  Bura (The George Washington University, Washington, DC)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Raymond  Carroll (Texas A&M University)|Cathy  Kronin (DCCPS, NCI, Rockville, MD)|Zhaohai  Li|Show all 13","Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)",NULL,"1. Albert PS (2018). Estimating recurrence and incidence of preterm birth subject to measurement error in gestational age: A hidden Markov modeling approach. Stat Med  37, 1973-1985.   https://doi.org/10.1002/sim.7624|2. Bokulich NA, Dillon MR, Zhang Y, Rideout JR, Bolyen E, Li H, Albert PS, Caporaso JG (2018). q2-longitudinal: Longitudinal and Paired-Sample Analyses of Microbiome Data. mSystems  3.   https://doi.org/10.1128/mSystems.00219-18|3. Chaurasia A, Liu D, Albert PS (2018). Pattern-mixture models with incomplete informative cluster size: Application to a repeated pregnancy study. J R Stat Soc Ser C Appl Stat  67, 255-273.   https://doi.org/10.1111/rssc.12226|4. Choo-Wosoba H, Albert PS, Zhu B (2018). hsegHMM: hidden Markov model-based allele-specific copy number alteration analysis accounting for hypersegmentation. BMC Bioinformatics  19, 424.   https://doi.org/10.1186/s12859-018-2412-y|5. Gail MH (2019). Performance of BCRAT in high-risk patients with breast cancer. Lancet Oncol  20, e285.   https://doi.org/10.1016/S1470-2045(19)30301-8|6. Gail MH, Haneuse S (2019). Power and sample size for multivariate logistic modeling of unmatched case-control studies. Stat Methods Med Res  28, 822-834.   https://doi.org/10.1177/0962280217737157|7. Gail MH, Pfeiffer RM (2018). Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening. J Natl Cancer Inst  110, 994-1002.   https://doi.org/10.1093/jnci/djy013|8. Hall IJ, Tangka FKL, Sabatino SA, Thompson TD, Graubard BI, Breen N (2018). Patterns and Trends in Cancer Screening in the United States. Prev Chronic Dis  15, E97.   https://doi.org/10.5888/pcd15.170465|9. Hinkle SN, Tsai MY, Rawal S, Albert PS, Zhang C (2018). HbA1c Measured in the First Trimester of Pregnancy and the Association with Gestational Diabetes. Sci Rep  8, 12249.   https://doi.org/10.1038/s41598-018-30833-8|10. Hyun N, Gastwirth JL, Graubard BI (2018). Grouping methods for estimating the prevalences of rare traits from complex survey data that preserve confidentiality of respondents. Stat Med  37, 2174-2186.   https://doi.org/10.1002/sim.7648|11. Jeffries N, Zaslavsky AM, Diez Roux AV, Creswell JW, Palmer RC, Gregorich SE, Reschovsky JD, Graubard BI, Choi K, Pfeiffer RM, Zhang X, Breen N (2019). Methodological Approaches to Understanding Causes of Health Disparities. Am J Public Health  109, S28-S33.   https://doi.org/10.2105/AJPH.2018.304843|12. Kant AK, Graubard BI (2018). Complementary and compensatory dietary changes associated with consumption or omission of plain water by US adults. Appetite  128, 255-262.   https://doi.org/10.1016/j.appet.2018.06.020|13. Kant AK, Graubard BI (2018). Secular trends in regional differences in nutritional biomarkers and self-reported dietary intakes among American adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 to 2009-2010. Public Health Nutr  21, 927-939.   https://doi.org/10.1017/S1368980017003743|14. Kant AK, Graubard BI (2019). Within-person compensation for snack energy by US adults, NHANES 2007-2014. Am J Clin Nutr  109, 1145-1153.   https://doi.org/10.1093/ajcn/nqy349|15. Katki HA (2019). Quantifying risk stratification provided by diagnostic tests and risk predictions: Comparison to AUC and decision curve analysis. Stat Med  38, 2943-2955.   https://doi.org/10.1002/sim.8163|16. Kim S, Albert PS (2018). Latent Variable Poisson Models for Assessing the Regularity of Circadian Patterns over Time. J Am Stat Assoc  113, 992-1002.   https://doi.org/10.1080/01621459.2017.1379402|17. Lobach I, Sampson J, Lobach S, Alekseyenko A, Piryatinska A, He T, Zhang L (2019). A simple approximation to the bias of gene-environment interactions in case-control studies with silent disease. Genet Epidemiol  43, 292-299.   https://doi.org/10.1002/gepi.22186|18. Lobach I, Sampson J, Lobach S, Zhang L (2018). Gene-environment interactions in case-control studies with silent disease. Genet Epidemiol  42, 551-558.   https://doi.org/10.1002/gepi.22135|19. Maziarz M, Pfeiffer RM, Wan Y, Gail MH (2018). Using standard microbiome reference groups to simplify beta-diversity analyses and facilitate independent validation. Bioinformatics  34, 3249-3257.   https://doi.org/10.1093/bioinformatics/bty297|20. Ortega-Villa AM, Albert PS (2018). Estimating onset time from longitudinal data in the presence of measurement error with application to estimating gestational age from maternal anthropometry during pregnancy. Stat Med  37, 4743-4757.   https://doi.org/10.1002/sim.7955|21. Ortega-Villa AM, Grantz KL, Albert PS (2018). Estimating onset time from longitudinal and cross-sectional data with an application to estimating gestational age from longitudinal maternal anthropometry during pregnancy and neonatal anthropometry at birth. J R Stat Soc Ser A Stat Soc  181, 825-842.   https://doi.org/10.1111/rssa.12312|22. Rawal S, Tsai MY, Hinkle SN, Zhu Y, Bao W, Lin Y, Panuganti P, Albert PS, Ma RCW, Zhang C (2018). A Longitudinal Study of Thyroid Markers Across Pregnancy and the Risk of Gestational Diabetes. J Clin Endocrinol Metab  103, 2447-2456.   https://doi.org/10.1210/jc.2017-02442|23. Robbins HA, Berg CD, Cheung LC, Chaturvedi AK, Katki HA (2019). Identification of Candidates for Longer Lung Cancer Screening Intervals Following a Negative Low-Dose Computed Tomography Result. J Natl Cancer Inst  111, 996-999.   https://doi.org/10.1093/jnci/djz041|24. Robbins HA, Katki HA, Cheung LC, Landy R, Berg CD (2019). Insights for Management of Ground-Glass Opacities From the National Lung Screening Trial. J Thorac Oncol  14, 1662-1665.   https://doi.org/10.1016/j.jtho.2019.05.012|25. Sampson JN, Hildesheim A, Herrero R, Gonzalez P, Kreimer AR, Gail MH (2018). Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine. Contemp Clin Trials  68, 35-44.   https://doi.org/10.1016/j.cct.2018.02.010|26. Sloan A, Song Y, Gail MH, Betensky R, Rosner B, Ziegler RG, Smith-Warner SA, Wang M (2019). Design and analysis considerations for combining data from multiple biomarker studies. Stat Med  38, 1303-1320.   https://doi.org/10.1002/sim.8052|27. Winer KK, Kelly A, Johns A, Zhang B, Dowdy K, Kim L, Reynolds JC, Albert PS, Cutler GB (2018). Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism. J Pediatr  203, 391-399.e1.   https://doi.org/10.1016/j.jpeds.2018.08.010|28. Yu K, Hyun N, Fetterman B, Lorey T, Raine-Bennett TR, Zhang H, Stamps RE, Poitras NE, Wheeler W, Befano B, Gage JC, Castle PE, Wentzensen N, Schiffman M (2018). Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology. J Natl Cancer Inst  110, 1222-1228.   https://doi.org/10.1093/jnci/djy044|29. Zhang H, Wheeler W, Song L, Yu K (2018). Proper joint analysis of summary association statistics requires the adjustment of heterogeneity in SNP coverage pattern. Brief Bioinform  19, 1337-1343.   https://doi.org/10.1093/bib/bbx072|30. Zhang W, Liu A, Albert PS, Ashmead RD, Schisterman EF, Mills JL (2018). A pooling strategy to effectively use genotype data in quantitative traits genome-wide association studies. Stat Med  37, 4083-4095.   https://doi.org/10.1002/sim.7898",https://intramural.nih.gov/search/searchview.taf?ipid=108923
628,CP010182-17,"October 01, 2018 -  September 30, 2019",Epidemiologic Field Studies,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,Wei-Cheng  You (Beijing Institute for Cancer Research)|Susan  Sturgeon (University of Massachusetts)|Paul  Levine (George Washington U)|Lian  Zhang|Amr  Soliman (M.D. Anderson Cancer Center)|Donghui  Li (M.D. Anderson Cancer Center)|Show all 7,"Joseph  Fraumeni; MD (Office of the Director)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"1. Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Pfeiffer RM, Gadalla SM, Swain SM, Merajver SD, Brown LM, Soliman AS (2019). Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa. Breast Cancer Res Treat  176, 407-417.   https://doi.org/10.1007/s10549-019-05237-5",https://intramural.nih.gov/search/searchview.taf?ipid=108953
629,CP010183-17,"October 01, 2018 -  September 30, 2019",Descriptive Studies and Record Linkage,Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Paul Stuart Albert|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Anil Kumar Chaturvedi|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD|Philip Samuel Rosenberg; PhD",Susan Shaw Devesa (NCI)|Ismail  Jatoi (US Army)|Ahmedin  Jemal (American Cancer Society)|Niels  Kroman (Danish Breast Cancer Group)|Timothy R Rebbeck|Rebecca B Siegel|Show all 9,"Louise  Brinton; PhD (Office of the Director)|Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Nilanjan  Chatterjee (Epidemiology and Biostatistics Program)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch)|Rochelle E Curtis (Radiation Epidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. Davis Lynn BC, Rosenberg PS, Anderson WF, Gierach GL (2019). Response to DeSantis and Jemal. J Natl Cancer Inst  111, 101-102.   https://doi.org/10.1093/jnci/djy163",https://intramural.nih.gov/search/searchview.taf?ipid=108922
630,CP010184-17,"October 01, 2018 -  September 30, 2019",Consultation and Collaboration,Barry Ira Graubard; PhD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI","Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD|Hormuzdiar Aspandiar Katki; MS|Joshua Neil Sampson|Jianxin  Shi|Bin  Zhu",Eleuterio  Bravo-Otero (University of Puerto Rico)|David  Brenner (Columbia University)|Robert  Burk (Albert Einstein College of Medicine)|Julianne  Byrne (Washington Children's hospital)|David  Camann (Southwest Research Institute)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Show all 78,"Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Wen-Yi  Huang (Occupational and Environmental Epidemiology Branch)|James Jerome Goedert; MD (Epidemiology and Biostatistics Program)|Thomas R O'Brien; BA, MPH, MD (Infection & Immunoepidemiology Branch)|Mark  Schiffman; MD (Clinical Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108955
631,CP010185-17,"October 01, 2018 -  September 30, 2019",Biodefense Project,Steven L Simon,"Robert  Hoover; MD, ScD","Epidemiology and Biostatistics Program, NCI",NULL,"Harold  Beck (DOE Environmental Measurements Laboratory (retired))|Victor  Kryuchkov (Institute of Biophysics)|Sergey  Shinkarev (Moscow Institute of Biophysics)|Sergey  Sholom (URPI)|Eduardo  Yukihara (Oklahoma State University)|Nikolai  Talerko (Scientific Center of Radiation Medicine, Ukraine)",Vladimir  Drozdovitch (Radiation Epidemiology Branch)|Amy  de Gonzalez (Radiation Epidemiology Branch)|Andre  Bouville (Epidemiology and Biostatistics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108954
632,CP010187-15,"October 01, 2018 -  September 30, 2019",Cancer Genetic Markers of Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI",NULL,NULL,Margaret Anne Tucker (Human Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108961
633,CP010188-15,"October 01, 2018 -  September 30, 2019",Risk prediction methods,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI",Nilanjan  Chatterjee,Garnet  Anderson (WHI Clinical Coordinating Center)|Heather  Feigelson (American Cancer Society)|David  Hunter (Harvard School of Public Health)|Mateo  Banegas (University of Washington)|Stephanie Ann Kovalchik|Ju-Hyun  Park,"Catherine G Schairer (Hormonal and Reproductive Epidemiology Branch)|Demetrius  Albanes; MD (Hormonal and Reproductive Epidemiology Branch)|Thomas R O'Brien; BA, MPH, MD (Infection & Immunoepidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108956
634,CP010190-14,"October 01, 2018 -  September 30, 2019",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,Shahinaz M Gadalla|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Lisa  Mirabello|Lisa James McReynolds|Neelam K Giri; MD|Payal Premchand Khincha|Blanche P Alter,"Immaculata  DeVivo (Harvard Medical School)|Steven  Artandi (Stanford University)|Judy  Wong (University of British Columbia)|Alison  Bertuch; MD, PhD (Pediatrics, Baylor College of Medicine)|Davide  Ruggero (University of California San Francisco)|Catherine  Keegan (University of Michigan)|Show all 10",NULL,NULL,"1. Alousi A, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Pidala J, Anderlini P, Boyiadzis M, Bredeson CN, Cahn JY, Cairo MS, Gadalla SM, Hashmi SK, Gale RP, Kanda J, Kamble RT, Kharfan-Dabaja MA, Litzow MR, Ringden O, Saad AA, Schultz KR, Verdonck LF, Waller EK, Yared JA, et al. [2 more authors] (2019). Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival. Biol Blood Marrow Transplant  25, 270-278.   https://doi.org/10.1016/j.bbmt.2018.09.004|2. Chhabra S, Ahn KW, Hu ZH, Jain S, Assal A, Cerny J, Copelan EA, Daly A, DeFilipp Z, Gadalla SM, Gale RP, Ganguly S, Hamilton BK, Hildebrandt GC, Hsu JW, Inamoto Y, Kanate AS, Khoury HJ, Lazarus HM, Litzow MR, Nathan S, Olsson RF, Pawarode A, Ringden O, Rowe JM, et al. [15 more authors] (2018). Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. Blood Adv  2, 2922-2936.   https://doi.org/10.1182/bloodadvances.2018024844|3. Gadalla SM, Wang T, Loftus D, Friedman L, Dagnall C, Haagenson M, Spellman SR, Buturovic L, Blauwkamp M, Shelton J, Fleischhauer K, Hsu KC, Verneris MR, Krstajic D, Hicks B, Jones K, Lee SJ, Savage SA (2018). No association between donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia. Bone Marrow Transplant  53, 383-391.   https://doi.org/10.1038/s41409-017-0029-9|4. Gallicchio L, Gadalla SM, Murphy JD, Simonds NI (2018). The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature. J Natl Cancer Inst  110, 1048-1058.   https://doi.org/10.1093/jnci/djy189|5. Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, et al. [29 more authors] (2019). GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. Blood Adv  3, 1441-1449.   https://doi.org/10.1182/bloodadvances.2018030171|6. Parikh SH, Satwani P, Ahn KW, Sahr NA, Fretham C, Abraham AA, Agrawal V, Auletta JJ, Abdel-Azim H, Copelan E, Diaz MA, Dvorak CC, Frangoul HA, Freytes CO, Gadalla SM, Gale RP, George B, Gergis U, Hashmi S, Hematti P, Hildebrandt GC, Keating AK, Lazarus HM, Myers KC, Olsson RF, et al. [8 more authors] (2019). Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant. JAMA Pediatr  173, e190081.   https://doi.org/10.1001/jamapediatrics.2019.0081|7. Wang Y, Savage SA, Alsaggaf R, Aubert G, Dagnall CL, Spellman SR, Lee SJ, Hicks B, Jones K, Katki HA, Gadalla SM (2018). Telomere Length Calibration from qPCR Measurement: Limitations of Current Method. Cells  7.   https://doi.org/10.3390/cells7110183",https://intramural.nih.gov/search/searchview.taf?ipid=108963
635,CP010193-13,"October 01, 2018 -  September 30, 2019",Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan),"Laufey Thora Amundadottir|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI",NULL,"Charles  Fuchs (Harvard)|Alan  Arslan (NYU)|Eric  Jacobs (American Cancer Society)|H  Bueno-de-Mesquita (Dept of Chronic Dis Epidemiology, Natl Inst for Pub Health and the Environ)|Wei  Zheng (Vanderbilt University Medical Center)|Andrea  LaCroix (Fred Hutchinson Cancer Research Center)|Show all 17",Geoffrey Scott Tobias (Office of the Director)|Kai  Yu (Biostatistics Branch)|Amy  Hutchinson (Office of the Director),NULL,"1. Walsh N, Zhang H, Hyland PL, Yang Q, Mocci E, Zhang M, Childs EJ, Collins I, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Brennan P, Canzian F, Duell EJ, Gallinger S, Giles GG, Goggins M, Goodman GE, Goodman PJ, Hung RJ, Kooperberg C, Kurtz RC, Malats N, LeMarchand L, PanScan and PanC4 consortia, et al. [78 more authors] (2018) Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. J Natl Cancer Inst, in press (e-pub ahead of print)  https://doi.org/10.1093/jnci/djy155",https://intramural.nih.gov/search/searchview.taf?ipid=108964
636,CP010195-13,"October 01, 2018 -  September 30, 2019","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study","Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Stephanie Joan Weinstein|Michael Blaise Cook,David  Hunter (Harvard School of Public Health)|Brian  Henderson (University of Southern California)|Elio  Riboli (International Agency for Research on Cancer)|Peter  Kraft|Tim  Key (Oxford University)|Laurence N Kolonel|Show all 26,"Stephen J Chanock; MD, PhD (Office of the Director)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Qing  Lan (Occupational and Environmental Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"1. Adams CD, Richmond R, Ferreira DLS, Spiller W, Tan V, Zheng J, Würtz P, Donovan J, Hamdy F, Neal D, Lane JA, Smith GD, Relton C, Eeles RA, Haiman CA, Kote-Jarai Z, Schumacher FR, Olama AAA, Benlloch S, Muir K, Berndt SI, Conti DV, Wiklund F, Chanock SJ, Gapstur S, PRACTICAL consortium, et al. [51 more authors] (2019). Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study. Cancer Epidemiol Biomarkers Prev  28, 208-216.   https://doi.org/10.1158/1055-9965.EPI-18-0079|2. Fanidi A, Carreras-Torres R, Larose TL, Yuan JM, Stevens VL, Weinstein SJ, Albanes D, Prentice R, Pettinger M, Cai Q, Blot WJ, Arslan AA, Zeleniuch-Jacquotte A, McCullough ML, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Stampfer MJ, Smith-Warner SA, Giovannucci E, Giles GG, Hodge AM, Severi G, Johansson M, LC3 consortium and the TRICL consortium, et al. [31 more authors] (2019). Is high vitamin B12 status a cause of lung cancer? Int J Cancer  145, 1499-1503.   https://doi.org/10.1002/ijc.32033|3. Ferreiro-Iglesias A, Lesseur C, McKay J, Hung RJ, Han Y, Zong X, Christiani D, Johansson M, Xiao X, Li Y, Qian DC, Ji X, Liu G, Caporaso N, Scelo G, Zaridze D, Mukeriya A, Kontic M, Ognjanovic S, Lissowska J, Szołkowska M, Swiatkowska B, Janout V, Holcatova I, Bolca C, et al. [48 more authors] (2018). Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nat Commun  9, 3927.   https://doi.org/10.1038/s41467-018-05890-2|4. Hall KT, Buring JE, Mukamal KJ, Vinayaga Moorthy M, Wayne PM, Kaptchuk TJ, Battinelli EM, Ridker PM, Sesso HD, Weinstein SJ, Albanes D, Cook NR, Chasman DI (2019) COMT and Alpha-Tocopherol Effects in Cancer Prevention: Gene-Supplement Interactions in Two Randomized Clinical Trials. J Natl Cancer Inst, in press (e-pub ahead of print)  https://doi.org/10.1093/jnci/djy204|5. Hashemian M, Sinha R, Murphy G, Weinstein SJ, Liao LM, Freedman ND, Abnet CC, Albanes D, Loftfield E (2019). Coffee and tea drinking and risk of cancer of the urinary tract in male smokers. Ann Epidemiol  34, 33-39.   https://doi.org/10.1016/j.annepidem.2019.03.014|6. Huang J, Mondul AM, Weinstein SJ, Derkach A, Moore SC, Sampson JN, Albanes D (2019). Prospective serum metabolomic profiling of lethal prostate cancer. Int J Cancer  145, 3231-3243.   https://doi.org/10.1002/ijc.32218|7. Huang J, Weinstein SJ, Yu K, Männistö S, Albanes D (2018). Serum Beta Carotene and Overall and Cause-Specific Mortality. Circ Res  123, 1339-1349.   https://doi.org/10.1161/CIRCRESAHA.118.313409|8. Huang J, Weinstein SJ, Yu K, Männistö S, Albanes D (2019) A Prospective Study of Serum Vitamin E and 28-Year Risk of Lung Cancer. J Natl Cancer Inst, in press (e-pub ahead of print)  https://doi.org/10.1093/jnci/djz077|9. Ji X, Bossé Y, Landi MT, Gui J, Xiao X, Qian D, Joubert P, Lamontagne M, Li Y, Gorlov I, de Biasi M, Han Y, Gorlova O, Hung RJ, Wu X, McKay J, Zong X, Carreras-Torres R, Christiani DC, Caporaso N, Johansson M, Liu G, Bojesen SE, Le Marchand L, Albanes D, et al. [99 more authors] (2018). Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun  9, 3221.   https://doi.org/10.1038/s41467-018-05074-y|10. Kachuri L, Saarela O, Bojesen SE, Davey Smith G, Liu G, Landi MT, Caporaso NE, Christiani DC, Johansson M, Panico S, Overvad K, Trichopoulou A, Vineis P, Scelo G, Zaridze D, Wu X, Albanes D, Diergaarde B, Lagiou P, Macfarlane GJ, Aldrich MC, Tardón A, Rennert G, Olshan AF, Weissler MC, et al. [45 more authors] (2019). Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers. Int J Epidemiol  48, 751-766.   https://doi.org/10.1093/ije/dyy140|11. Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, et al. [52 more authors] (2018). Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun  9, 4616.   https://doi.org/10.1038/s41467-018-06863-1|12. McNabb S, Harrison TA, Albanes D, Berndt SI, Brenner H, Caan BJ, Campbell PT, Cao Y, Chang-Claude J, Chan A, Chen Z, English DR, Giles GG, Giovannucci EL, Goodman PJ, Hayes RB, Hoffmeister M, Jacobs EJ, Joshi AD, Larsson SC, Le Marchand L, Li L, Lin Y, Männistö S, Milne RL, et al. [17 more authors] (2019) Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. Int J Cancer, in press (e-pub ahead of print)  https://doi.org/10.1002/ijc.32377|13. Muller DC, Larose TL, Hodge A, Guida F, Langhammer A, Grankvist K, Meyer K, Cai Q, Arslan AA, Zeleniuch-Jacquotte A, Albanes D, Giles GG, Sesso HD, Lee IM, Gaziano JM, Yuan JM, Hoffman Bolton J, Buring JE, Visvanathan K, Le Marchand L, Purdue MP, Caporaso NE, Midttun Ø, Ueland PM, Prentice RL, et al. [20 more authors] (2019). Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium. BMJ  364, k4981.   https://doi.org/10.1136/bmj.k4981|14. Rosenberger A, Hung RJ, Christiani DC, Caporaso NE, Liu G, Bojesen SE, Le Marchand L, Haiman CA, Albanes D, Aldrich MC, Tardon A, Fernández-Tardón G, Rennert G, Field JK, Kiemeney B, Lazarus P, Haugen A, Zienolddiny S, Lam S, Schabath MB, Andrew AS, Brunnsstöm H, Goodman GE, Doherty JA, Chen C, et al. [14 more authors] (2018). Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. Int Arch Occup Environ Health  91, 937-950.   https://doi.org/10.1007/s00420-018-1334-3|15. Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sánchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P, et al. [41 more authors] (2019). A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk. Cancer Res  79, 274-285.   https://doi.org/10.1158/0008-5472.CAN-18-2318|16. Wang X, Dai JY, Albanes D, Arndt V, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Butterbach K, Caan B, Casey G, Campbell PT, Chan AT, Chen Z, Chang-Claude J, Cotterchio M, Easton DF, Giles GG, Giovannucci E, Grady WM, Hoffmeister M, Hopper JL, Hsu L, Jenkins MA, Joshi AD, et al. [31 more authors] (2019). Mendelian randomization analysis of C-reactive protein on colorectal cancer risk. Int J Epidemiol  48, 767-780.   https://doi.org/10.1093/ije/dyy244|17. Zuo H, Ueland PM, Midttun Ø, Tell GS, Fanidi A, Zheng W, Shu X, Xiang Y, Wu J, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, Blot WJ, Johansson M, Hultdin J, Grankvist K, Stevens VL, McCullough ML, Weinstein SJ, Albanes D, Ziegler RG, Freedman ND, et al. [24 more authors] (2019). Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3). Ann Oncol  30, 478-485.   https://doi.org/10.1093/annonc/mdz002",https://intramural.nih.gov/search/searchview.taf?ipid=108965
637,CP010196-13,"October 01, 2018 -  September 30, 2019",Prospective Studies of Diet and Cancer in the AARP Cohort,Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Rachael Zoe Solomon|Neal David Freedman|Steven  Moore|Christian Cormac Abnet; PhD, MPH",NULL,Louise  Brinton; PhD (Office of the Director),NULL,"1. DiPietro L, Jin Y, Talegawkar S, Matthews CE (2018). The Joint Associations of Sedentary Time and Physical Activity With Mobility Disability in Older People: The NIH-AARP Diet and Health Study. J Gerontol A Biol Sci Med Sci  73, 532-538.   https://doi.org/10.1093/gerona/glx122|2. Hashemian M, Murphy G, Etemadi A, Liao LM, Dawsey SM, Malekzadeh R, Abnet CC (2019). Potato consumption and the risk of overall and cause specific mortality in the NIH-AARP study. PLoS One  14, e0216348.   https://doi.org/10.1371/journal.pone.0216348|3. Kelly SP, Lennon H, Sperrin M, Matthews C, Freedman ND, Albanes D, Leitzmann MF, Renehan AG, Cook MB (2019). Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study. Int J Epidemiol  48, 464-473.   https://doi.org/10.1093/ije/dyy219|4. Kuan AS, Green J, Kitahara CM, Berrington de González A, Key T, Reeves G, Floud S, Balkwill A, Bradbury K, Liao LM, Freedman ND, Beral V, Sweetland S, collaborators of the Million Women Study, NIH-AARP Study, PLCO Study (2019) Diet and risk of glioma: combined analysis of three large prospective studies in the UK and USA. Neuro Oncol, in press (e-pub ahead of print)  https://doi.org/10.1093/neuonc/noz013|5. Liao LM, Loftfield E, Etemadi A, Graubard BI, Sinha R (2019). Substitution of dietary protein sources in relation to colorectal cancer risk in the NIH-AARP cohort study. Cancer Causes Control  30, 1127-1135.   https://doi.org/10.1007/s10552-019-01210-1|6. Saint-Maurice PF, Coughlan D, Kelly SP, Keadle SK, Cook MB, Carlson SA, Fulton JE, Matthews CE (2019). Association of Leisure-Time Physical Activity Across the Adult Life Course With All-Cause and Cause-Specific Mortality. JAMA Netw Open  2, e190355.   https://doi.org/10.1001/jamanetworkopen.2019.0355|7. Schmid D, Matthews CE, Leitzmann MF (2018). Physical activity and sedentary behavior in relation to mortality among renal cell cancer survivors. PLoS One  13, e0198995.   https://doi.org/10.1371/journal.pone.0198995|8. Xiao Q, Berrigan D, Powell-Wiley TM, Matthews CE (2018). Ten-Year Change in Neighborhood Socioeconomic Deprivation and Rates of Total, Cardiovascular Disease, and Cancer Mortality in Older US Adults. Am J Epidemiol  187, 2642-2650.   https://doi.org/10.1093/aje/kwy181|9. Zheng J, Wirth MD, Merchant AT, Zhang J, Shivappa N, Stolzenberg-Solomon RZ, Hebert JR, Steck SE (2019). Inflammatory Potential of Diet, Inflammation-Related Lifestyle Factors, and Risk of Pancreatic Cancer: Results from the NIH-AARP Diet and Health Study. Cancer Epidemiol Biomarkers Prev  28, 1266-1270.   https://doi.org/10.1158/1055-9965.EPI-19-0250",https://intramural.nih.gov/search/searchview.taf?ipid=108971
638,CP010197-13,"October 01, 2018 -  September 30, 2019","Physical Activity, Energy Balance, and Cancer",Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Steven  Moore,NULL,NULL,NULL,"1. Chu SH, Huang M, Kelly RS, Benedetti E, Siddiqui JK, Zeleznik OA, Pereira A, Herrington D, Wheelock CE, Krumsiek J, McGeachie M, Moore SC, Kraft P, Mathé E, Lasky-Su J, Consortium of Metabolomics Studies Statistics Working Group (2019). Integration of Metabolomic and Other Omics Data in Population-Based Study Designs: An Epidemiological Perspective. Metabolites  9.   https://doi.org/10.3390/metabo9060117|2. Gu Q, Spinelli JJ, Dummer TBJ, McDonald TE, Moore SC, Murphy RA (2018). Metabolic profiling of adherence to diet, physical activity and body size recommendations for cancer prevention. Sci Rep  8, 16293.   https://doi.org/10.1038/s41598-018-34662-7|3. Keadle SK, Kravitz ES, Matthews CE, Tseng M, Carroll RJ (2019). Development and Testing of an Integrated Score for Physical Behaviors. Med Sci Sports Exerc  51, 1759-1766.   https://doi.org/10.1249/MSS.0000000000001955|4. Lee IM, Shiroma EJ, Kamada M, Bassett DR, Matthews CE, Buring JE (2019) Association of Step Volume and Intensity With All-Cause Mortality in Older Women. JAMA Intern Med, in press (e-pub ahead of print)  https://doi.org/10.1001/jamainternmed.2019.0899|5. Marron MM, Harris TB, Boudreau RM, Clish CB, Moore SC, Murphy RA, Murthy VL, Sanders JL, Shah RV, Tseng GC, Wendell SG, Zmuda JM, Newman AB (2019). Metabolites Associated with Vigor to Frailty Among Community-Dwelling Older Black Men. Metabolites  9.   https://doi.org/10.3390/metabo9050083|6. Mazzilli KM, Matthews CE, Salerno EA, Moore SC (2019). Weight Training and Risk of 10 Common Types of Cancer. Med Sci Sports Exerc  51, 1845-1851.   https://doi.org/10.1249/MSS.0000000000001987|7. Playdon MC, Joshi AD, Tabung FK, Cheng S, Henglin M, Kim A, Lin T, van Roekel EH, Huang J, Krumsiek J, Wang Y, Mathé E, Temprosa M, Moore S, Chawes B, Eliassen AH, Gsur A, Gunter MJ, Harada S, Langenberg C, Oresic M, Perng W, Seow WJ, Zeleznik OA (2019). Metabolomics Analytics Workflow for Epidemiological Research: Perspectives from the Consortium of Metabolomics Studies (COMETS). Metabolites  9.   https://doi.org/10.3390/metabo9070145|8. Rothwell JA, Loftfield E, Wedekind R, Freedman N, Kambanis C, Scalbert A, Sinha R (2019). A Metabolomic Study of the Variability of the Chemical Composition of Commonly Consumed Coffee Brews. Metabolites  9.   https://doi.org/10.3390/metabo9010017|9. Shaw PA, McMurray R, Butte N, Sotres-Alvarez D, Sun H, Stoutenberg M, Evenson KR, Wong WW, Moncrieft AE, Sanchez-Johnsen LAP, Carnethon MR, Arredondo E, Kaplan RC, Matthews CE, Mossavar-Rahmani Y (2019). Calibration of activity-related energy expenditure in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). J Sci Med Sport  22, 300-306.   https://doi.org/10.1016/j.jsams.2018.07.021|10. Wu J, Cai H, Xiang YB, Matthews CE, Ye F, Zheng W, Cai Q, Shu XO (2018). Intra-individual variation of miRNA expression levels in human plasma samples. Biomarkers  23, 339-346.   https://doi.org/10.1080/1354750X.2018.1427794|11. Xiao Q, Blot WJ, Matthews CE (2019). Weekday and weekend sleep duration and mortality among middle-to-older aged White and Black adults in a low-income southern US cohort. Sleep Health  5, 521-527.   https://doi.org/10.1016/j.sleh.2019.04.008|12. Yang L, Cao C, Kantor ED, Nguyen LH, Zheng X, Park Y, Giovannucci EL, Matthews CE, Colditz GA, Cao Y (2019). Trends in Sedentary Behavior Among the US Population, 2001-2016. JAMA  321, 1587-1597.   https://doi.org/10.1001/jama.2019.3636|13. Yu B, Zanetti KA, Temprosa M, Albanes D, Appel N, Barrera CB, Ben-Shlomo Y, Boerwinkle E, Casas JP, Clish C, Dale C, Dehghan A, Derkach A, Eliassen AH, Elliott P, Fahy E, Gieger C, Gunter MJ, Harada S, Harris T, Herr DR, Herrington D, Hirschhorn JN, Hoover E, Hsing AW, et al. [49 more authors] (2019). The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort Studies. Am J Epidemiol  188, 991-1012.   https://doi.org/10.1093/aje/kwz028|14. Zhao H, Shen J, Moore SC, Ye Y, Wu X, Esteva FJ, Tripathy D, Chow WH (2019). Breast cancer risk in relation to plasma metabolites among Hispanic and African American women. Breast Cancer Res Treat  176, 687-696.   https://doi.org/10.1007/s10549-019-05165-4",https://intramural.nih.gov/search/searchview.taf?ipid=108966
639,CP010198-13,"October 01, 2018 -  September 30, 2019",Lower Gastrointestinal Cancer Studies,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Gwen  Murphy,NULL,NULL,NULL,"1. Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, Bai Y, Bisanz JE, Bittinger K, Brejnrod A, Brislawn CJ, Brown CT, Callahan BJ, Caraballo-Rodríguez AM, Chase J, Cope EK, Da Silva R, Diener C, Dorrestein PC, Douglas GM, Durall DM, et al. [87 more authors] (2019). Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol  37, 852-857.   https://doi.org/10.1038/s41587-019-0209-9|2. Shi J, Sinha R, Goedert JJ (2019). THREE AUTHORS REPLY. Am J Epidemiol  188, 308-309.   https://doi.org/10.1093/aje/kwz022|3. Sinha R, Ahsan H, Blaser M, Caporaso JG, Carmical JR, Chan AT, Fodor A, Gail MH, Harris CC, Helzlsouer K, Huttenhower C, Knight R, Kong HH, Lai GY, Hutchinson DLS, Le Marchand L, Li H, Orlich MJ, Shi J, Truelove A, Verma M, Vogtmann E, White O, Willett W, Zheng W, et al. [2 more authors] (2018). Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16-17, 2017. Microbiome  6, 210.   https://doi.org/10.1186/s40168-018-0596-z|4. Vogtmann E, Chen J, Kibriya MG, Amir A, Shi J, Chen Y, Islam T, Eunes M, Ahmed A, Naher J, Rahman A, Barmon B, Knight R, Chia N, Ahsan H, Abnet CC, Sinha R (2019). Comparison of Oral Collection Methods for Studies of Microbiota. Cancer Epidemiol Biomarkers Prev  28, 137-143.   https://doi.org/10.1158/1055-9965.EPI-18-0312",https://intramural.nih.gov/search/searchview.taf?ipid=108967
640,CP010199-13,"October 01, 2018 -  September 30, 2019",Methods for Etiologic Studies of Diet and Cancer,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Charles E Matthews,NULL,NULL,NULL,"1. Matthews CE, Berrigan D, Fischer B, Gomersall SR, Hillreiner A, Kim Y, Leitzmann MF, Saint-Maurice P, Olds TS, Welk GJ (2019). Use of previous-day recalls of physical activity and sedentary behavior in epidemiologic studies: results from four instruments. BMC Public Health  19, 478.   https://doi.org/10.1186/s12889-019-6763-8",https://intramural.nih.gov/search/searchview.taf?ipid=108968
641,CP010200-12,"October 01, 2018 -  September 30, 2019",GEI - Genome-Wide Association Studies,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI

Office of the Director, NCI",Mark  Purdue,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108970
642,CP010201-10,"October 01, 2018 -  September 30, 2019",Laboratory of Translational Genomics,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory Translational Genomics, NCI",Laufey Thora Amundadottir|Liudmila  Prokunina-Olsson; PhD|Kevin Michael Brown,NULL,NULL,NULL,"1. Roper N, Gao S, Maity TK, Banday AR, Zhang X, Venugopalan A, Cultraro CM, Patidar R, Sindiri S, Brown AL, Goncearenco A, Panchenko AR, Biswas R, Thomas A, Rajan A, Carter CA, Kleiner DE, Hewitt SM, Khan J, Prokunina-Olsson L, Guha U (2019). APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors. Cell Rep  26, 2651-2666.e6.   https://doi.org/10.1016/j.celrep.2019.02.028",https://intramural.nih.gov/search/searchview.taf?ipid=108975
643,CP010202-11,"October 01, 2018 -  September 30, 2019","Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO",Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,Brietta M Oaks|K  Dodd (DCCPS/NCI),"Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108919
644,CP010206-10,"October 01, 2018 -  September 30, 2019","Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment",Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Mark H Greene; MD|Nicolas Albert Hermann Wentzensen|Julia  Gage|Lisa  Mirabello,Robert  Burk (Albert Einstein College of Medicine)|Rodney D Long|Attila  Lorincz (Digene)|Walter  Kinney (Kaiser Permanente Northern California)|Tina  Raine-Bennett (Kaiser Permanente Northern California)|Cosette  Wheeler (University of New Mexico)|Show all 11,Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Meredith  Yeager (Office of the Director)|Douglas  Lowy; MD (Office Of The Director),NULL,"1. Clarke MA, Gradissimo A, Schiffman M, Lam J, Sollecito CC, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Castle PE, Wentzensen N, Burk RD (2018). Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women. Clin Cancer Res  24, 2194-2202.   https://doi.org/10.1158/1078-0432.CCR-17-3251|2. Demarco M, Cheung LC, Kinney WK, Wentzensen N, Lorey TS, Fetterman B, Poitras NE, Befano B, Castle PE, Schiffman M (2018). Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy. J Low Genit Tract Dis  22, 97-103.   https://doi.org/10.1097/LGT.0000000000000382|3. Hu L, Bell D, Antani S, Xue Z, Yu K, Horning MP, Gachuhi N, Wilson B, Jaiswal MS, Befano B, Long LR, Herrero R, Einstein MH, Burk RD, Demarco M, Gage JC, Rodriguez AC, Wentzensen N, Schiffman M (2019). An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening. J Natl Cancer Inst  111, 923-932.   https://doi.org/10.1093/jnci/djy225",https://intramural.nih.gov/search/searchview.taf?ipid=108976
645,CP010207-10,"October 01, 2018 -  September 30, 2019",PLCO EEMS and Extended Follow Up,"Neal David Freedman|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",NULL,NULL,Amanda  Black (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108977
646,CP010209-10,"October 01, 2018 -  September 30, 2019",HPV and cancer at multiple anatomic sites,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108979
647,CP010210-10,"October 01, 2018 -  September 30, 2019","HPV, cervical neoplasia, and vaccination",Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Aimee Rebecca Kreimer,L  Pinto (SAIC-NCI)|Mary  Carrington (SAIC Frederick),Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108980
648,CP010211-10,"October 01, 2018 -  September 30, 2019",Viral and Host Factors Associated with NPC,Alisa  Goldstein; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Kelly Jen-Yi Yu,Chen-Jen  Chen (Academia Sinica in Taiwan)|ChenPing  Wang (National Taiwan University),Ruth  Pfeiffer; PhD (Biostatistics Branch)|Kai  Yu (Biostatistics Branch),NULL,"1. Coghill AE, Bu W, Hsu WL, Nguyen H, Yu KJ, Chien YC, Chen CJ, Cohen JI, Hildesheim A (2018). Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk. J Infect Dis  218, 886-891.   https://doi.org/10.1093/infdis/jiy250|2. Coghill AE, Hsu WL, Yang Q, Wang CP, Lou PJ, Yu KJ, Yu G, Diehl SR, Chen CJ, Goldstein AM, Hildesheim A (2018). Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants. J Gen Virol  99, 1268-1273.   https://doi.org/10.1099/jgv.0.001115",https://intramural.nih.gov/search/searchview.taf?ipid=108981
649,CP010212-10,"October 01, 2018 -  September 30, 2019",Molecular mechanisms of infection-related cancer,Charles  Rabkin|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, Lucas GM, Klein MB, Kitahata MM, Crane H, Silverberg MJ, Gill MJ, Mathews WC, Dubrow R, Horberg MA, Rabkin CS, Klein DB, Lo Re V, Sterling TR, Desir FA, Lichtenstein K, Willig J, Rachlis AR, Kirk GD, Anastos K, North American AIDS Cohort Collaboration on Research and Design, et al. [11 more authors] (2019). Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. Lancet HIV  6, e93-e104.   https://doi.org/10.1016/S2352-3018(18)30295-9|2. Desir FA, Lesko CR, Moore RD, Horberg MA, Wong C, Crane HM, Silverberg M, Thorne JE, Rachlis B, Rabkin C, Mayor AM, Mathews WC, Althoff KN, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Region of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium (2019). One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States. Clin Infect Dis  68, 795-802.   https://doi.org/10.1093/cid/ciy556|3. Grover S, Desir F, Jing Y, Bhatia RK, Trifiletti DM, Swisher-McClure S, Kobie J, Moore RD, Rabkin CS, Silverberg MJ, Salters K, Mathews WC, Gill MJ, Thorne JE, Castilho J, Kitahata MM, Justice A, Horberg MA, Achenbach CJ, Mayor AM, Althoff KN, North American AIDS Cohort Collaboration on Research and Design (2018). Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr  79, 421-429.   https://doi.org/10.1097/QAI.0000000000001842|4. Song M, Latorre G, Ivanovic-Zuvic D, Camargo MC, Rabkin CS (2019). Autoimmune Diseases and Gastric Cancer Risk: A Systematic Review and Meta-Analysis. Cancer Res Treat  51, 841-850.   https://doi.org/10.4143/crt.2019.151|5. Song M, Rabkin CS, Camargo MC (2018). Gastric Cancer: an Evolving Disease. Curr Treat Options Gastroenterol  16, 561-569.   https://doi.org/10.1007/s11938-018-0203-1",https://intramural.nih.gov/search/searchview.taf?ipid=108982
650,CP010213-10,"October 01, 2018 -  September 30, 2019",Studies of Head and Neck Cancers,Anil Kumar Chaturvedi|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108983
651,CP010214-10,"October 01, 2018 -  September 30, 2019",Microbes and Human Malignancies,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Jacques  Ravel; PhD (Microbial Genomics, The Institute for Genomic Research (TIGR))|Jeffrey  Gordon (WUSTL)|Wendy  Cozen (Norris Comprehensive Cancer Center)|Heather  Feigelson (American Cancer Society)|Dominique  Costagliola (INSERM, U943)|Nino  Romano (University of Palermo)|Show all 9",Rashmi P Sinha; PhD (Hormonal and Reproductive Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108984
652,CP010215-10,"October 01, 2018 -  September 30, 2019",Human microbiome and cancer,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108985
653,CP010216-10,"October 01, 2018 -  September 30, 2019",Immune responses to HPV infection and HPV vaccination,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108986
654,CP010217-09,"October 01, 2018 -  September 30, 2019",HPV Vaccine Trial,Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Aimee Rebecca Kreimer|IRP Faculty Profile  | |Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",Nicolas Albert Hermann Wentzensen|Anil Kumar Chaturvedi|Ligia  Pinto,Rolando  Herrero (IARC)|Douglas  Lowy; MD (NCI)|Ana-Cecilia  Rodriguez (Proyecto Epidemiologico Guanacaste)|John  Schiller; PhD (NCI)|Diane  Solomon; PhD (NCI)|Wim  Quint (Delft Diagnostic Laboratory),NULL,NULL,"1. Beachler DC, Pinto LA, Kemp TJ, Nyitray AG, Hildesheim A, Viscidi R, Schussler J, Kreimer AR, Giuliano AR (2018). An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study. Cancer Epidemiol Biomarkers Prev  27, 496-502.   https://doi.org/10.1158/1055-9965.EPI-17-0853|2. Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, Pinto LA, Hildesheim A, Gonzalez P, Costa Rica HPV Vaccine Trial (CVT) Group (2018). Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine  36, 4774-4782.   https://doi.org/10.1016/j.vaccine.2017.12.078|3. Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio González Losa M, Kojic EM, Schim van der Loeff MF, Wei F, Longatto-Filho A, Mbulawa ZA, Palefsky JM, Sohn AH, Hernandez BY, Robison K, Simpson S, Conley LJ, et al. [18 more authors] (2019). Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. Lancet Infect Dis  19, 880-891.   https://doi.org/10.1016/S1473-3099(19)30164-1",https://intramural.nih.gov/search/searchview.taf?ipid=108987
655,CP010218-09,"October 01, 2018 -  September 30, 2019",Etiology of Biliary Tract Cancer,Jill Elizabeth Koshiol|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch),NULL,"1. Liu Z, Alsaggaf R, McGlynn KA, Anderson LA, Tsai HT, Zhu B, Zhu Y, Mbulaiteye SM, Gadalla SM, Koshiol J (2019). Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink. Gut  68, 1458-1464.   https://doi.org/10.1136/gutjnl-2018-317504|2. McGee EE, Jackson SS, Petrick JL, Van Dyke AL, Adami HO, Albanes D, Andreotti G, Beane-Freeman LE, de Gonzalez AB, Buring JE, Chan AT, Chen Y, Fraser GE, Freedman ND, Gao YT, Gapstur SM, Gaziano JM, Giles GG, Grant EJ, Grodstein F, Hartge P, Jenab M, Kitahara CM, Knutsen SF, Koh WP, et al. [32 more authors] (2019) Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies. J Natl Cancer Inst, in press (e-pub ahead of print)  https://doi.org/10.1093/jnci/djz103",https://intramural.nih.gov/search/searchview.taf?ipid=108988
656,CP010219-09,"October 01, 2018 -  September 30, 2019",Studies of other risk factors for radiosensitive tumors,Amy  de Gonzalez|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kitahara CM, K Rmendiné Farkas D, Jørgensen JOL, Cronin-Fenton D, Sørensen HT (2018). Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study. J Clin Endocrinol Metab  103, 2216-2224.   https://doi.org/10.1210/jc.2017-02599",https://intramural.nih.gov/search/searchview.taf?ipid=108989
657,CP010220-09,"October 01, 2018 -  September 30, 2019",Barretts Esophagus,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Michael Blaise Cook|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Cook MB, Barnett MJ, Bock CH, Cross AJ, Goodman PJ, Goodman GE, Haiman CA, Khaw KT, McCullough ML, Newton CC, Boutron-Ruault MC, Lund E, Rutegård M, Thornquist MD, Spriggs M, Giffen C, Freedman ND, Kemp T, Kroenke CH, Le Marchand L, Park JY, Simon M, Wilkens LR, Pinto L, Hildesheim A, et al. [1 more author] (2019). Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium. Gut  68, 960-968.   https://doi.org/10.1136/gutjnl-2018-316678",https://intramural.nih.gov/search/searchview.taf?ipid=108990
658,CP010221-09,"October 01, 2018 -  September 30, 2019",Etiologic Studies of Prostate Cancer,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Office of the Director, NCI",Mark  Purdue|Stephanie Joan Weinstein|Meredith  Yeager|Zhaoming  Wang,"David  Hunter (Harvard School of Public Health)|Peter  Kraft|Laurence N Kolonel|Susan  Gapstur (American Cancer Society)|Margie  Wright; PhD (Queensland Institute of Medical Research, Brisbane, Australia)","Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108991
659,CP010222-09,"October 01, 2018 -  September 30, 2019",Studies of Populations Exposed to Diagnostic Medical Radiation,Cari Meinhold Kitahara|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Kiyohiko  Mabuchi; MD, DPhil|Martha S Linet; PhD|Daryl  Freedman",David  Abramson (New York Presbyterian Hospital)|Johanna  Seddon (Massachusetts Eye and Ear Infirmary)|Marilyn  Stovall (The University of Texas MD Anderson Cancer Center)|Neal Andrew Naito|Ritsu  Sakata; PhD|Eve  Roman (University of York)|Show all 14,Steven L Simon (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Chang LA, Borrego D, Lee C (2018). Body-weight dependent dose coefficients for adults exposed to idealised external photon fields. J Radiol Prot  38, 1441-1453.   https://doi.org/10.1088/1361-6498/aae66e|2. Lee C, Journy N, Moroz BE, Little M, Harbron R, McHugh K, Pearce M, Berrington de Gonzalez A (2019). ORGAN DOSE ESTIMATION ACCOUNTING FOR UNCERTAINTY FOR PEDIATRIC AND YOUNG ADULT CT SCANS IN THE UNITED KINGDOM. Radiat Prot Dosimetry  184, 44-53.   https://doi.org/10.1093/rpd/ncy184|3. Lee C, Kuzmin GA, Bae J, Yao J, Mosher E, Folio LR (2019). Automatic Mapping of CT Scan Locations on Computational Human Phantoms for Organ Dose Estimation. J Digit Imaging  32, 175-182.   https://doi.org/10.1007/s10278-018-0119-2",https://intramural.nih.gov/search/searchview.taf?ipid=108992
660,CP010224-08,"October 01, 2018 -  September 30, 2019",Esophageal cancer genetic project,Alisa  Goldstein; PhD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,"TI  Ding (DEPT OF THORACIC SURGERY, SCHI)|LiDong  Wang (Zhengzhou Medical University)|DongXin  Lin (CICAMS)|Wei  Zheng (Vanderbilt University)|XiaoOu  Shu (Vanderbilt University)|JianMin  Yuan (University of Pittsburgh)","Nan  Hu (Hormonal and Reproductive Epidemiology Branch)|Christian Cormac Abnet; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)|Sanford Martin Dawsey; MD (Hormonal and Reproductive Epidemiology Branch)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)|Paula L Hyland (Genetic Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108994
661,CP010225-08,"October 01, 2018 -  September 30, 2019",Barretts esophagus early detection project,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Nan  Hu|Sanford Martin Dawsey; MD|Christian Cormac Abnet; PhD, MPH",Ming  Zhou (SAIC)|Patrick  Young (WRNMMC),Paula L Hyland (Genetic Epidemiology Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108995
662,CP010227-05,"October 01, 2018 -  September 30, 2019",Laboratory of Genetic Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,"Chris  Amos (Dartmouth University)|Smita  Bhatia (University of Alabama School of Medicine)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|James  Cerhan (Mayo Clinic)|Fergus  Couch; PhD (Dept of Laboratory Medicine & Pathology, Mayo Clinic)|Olivier  Delattre (Institut Curie, Paris, France)|Show all 20",Leandro Machado Colli (Laboratory Of Genetic Susceptibility)|Lea  Jessop (Laboratory Of Genetic Susceptibility)|Roelof  Koster (Laboratory Of Genetic Susceptibility)|Mitchell John Machiela; PhD (Genetic Epidemiology Branch)|Timothy A Myers (Laboratory Of Genetic Susceptibility),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108997
663,CP010228-04,"October 01, 2018 -  September 30, 2019",Human Papillomavirus (HPV) Genomics Project,Mark  Schiffman; MD|IRP Faculty Profile  | |Lisa  Mirabello|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Nicolas Albert Hermann Wentzensen|Yanzi  Xiao|Maisa  Pinheiro,NULL,Meredith  Yeager (Office of the Director)|Joseph  Boland (Office of the Director)|Kai  Yu (Biostatistics Branch)|Bin  Zhu (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108998
664,CP010229-02,"October 01, 2018 -  September 30, 2019",Clinical Epidemiology,Anil Kumar Chaturvedi|IRP Faculty Profile  | |Mark  Schiffman; MD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Megan A Clarke-Corso|Maria  Demarco|Julia  Gage|Joseph Emilio Tota,NULL,Tamara Rae Litwin (Cancer Prevention Fellowship Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108999
665,CP010230-02,"October 01, 2018 -  September 30, 2019",Cervical Cancer Moonshot,Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109000
666,CP101231-02,"October 01, 2018 -  September 30, 2019",Studies of Genetic and Environmental Epidemiology,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Consonni D, Carugno M, De Matteis S, Nordio F, Randi G, Bazzano M, Caporaso NE, Tucker MA, Bertazzi PA, Pesatori AC, Lubin JH, Landi MT (2018). Outdoor particulate matter (PM10) exposure and lung cancer risk in the EAGLE study. PLoS One  13, e0203539.   https://doi.org/10.1371/journal.pone.0203539",https://intramural.nih.gov/search/searchview.taf?ipid=109001
667,CP101232-02,"October 01, 2018 -  September 30, 2019",HPV Vaccine Moonshot - Cures,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109002
668,SC000550-39,"October 01, 2018 -  September 30, 2019",Lymphoma Disease Discovery and Definition,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Julie Catalina Alejo|Jinjun  Cheng|Theresa M Davies Hill|Caoimhe Mary Egan; MD|Ivo  Francischetti; MD, PhD|Pallavi Kanwar  Galera|Show all 9","Wing  Chan (Pathology, University of Nebraska)|Elias  Campo (University of Barcelona)|Steven  Swerdlow (University of Pittsburgh Med Center)|Reiner  Siebert (University of Kiel)|Lisa  Rimsza (University of Arizona Cancer Center)|Falko  Fend|Show all 8","George W Wright (Computational & Systems Biology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)",Jeffrey  Cohen; MD (NIAID),"1. Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J, Balagué O, Celis V, Verdu-Amoros J, Nadeu F, Sábado C, Ferrández A, Garrido M, García-Bragado F, de la Maya MD, Vagace JM, Panizo CM, Astigarraga I, Andrés M, Jaffe ES, Campo E, Salaverria I (2019). Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Haematologica  104, 1822-1829.   https://doi.org/10.3324/haematol.2018.207928",https://intramural.nih.gov/search/searchview.taf?ipid=109012
669,SC000892-36,"October 01, 2018 -  September 30, 2019",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Imran  Khan; PhD,NULL,Simone  Difilippantonio (Office Of The Director),NULL,"1. Brooks D, Zimmer A, Wakefield L, Lyle LT, Difilippantonio S, Tucci FC, Illiano S, Annunziata CM, Steeg PS (2018). Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target. Oncotarget  9, 23462-23481.   https://doi.org/10.18632/oncotarget.25231|2. Khan I, Steeg PS (2018). Metastasis suppressors: functional pathways. Lab Invest  98, 198-210.   https://doi.org/10.1038/labinvest.2017.104|3. Khan I, Steeg PS (2018). The relationship of NM23 (NME) metastasis suppressor histidine phosphorylation to its nucleoside diphosphate kinase, histidine protein kinase and motility suppression activities. Oncotarget  9, 10185-10202.   https://doi.org/10.18632/oncotarget.23796",https://intramural.nih.gov/search/searchview.taf?ipid=109014
670,SC004002-50,"October 01, 2018 -  September 30, 2019",IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Olga Maria Anton Hurtado|Yuquan  Lin|Juergen R Mueller; PhD|Masao  Nakagawa,Richard  Bamford; PhD|Georgy  Vamosi (University of Debrecen),NULL,NULL,"1. Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, Cwynarski K, Taylor G, Waldmann TA, Bittencourt A, Marcais A, Suarez F, Sibon D, Phillips A, Lunning M, Farid R, Imaizumi Y, Choi I, Ishida T, Ishitsuka K, Fukushima T, et al. [7 more authors] (2019). Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report. J Clin Oncol  37, 677-687.   https://doi.org/10.1200/JCO.18.00501|2. Lu L, Zhu F, Zhang M, Li Y, Drennan AC, Kimpara S, Rumball I, Selzer C, Cameron H, Kellicut A, Kelm A, Wang F, Waldmann TA, Rui L (2018). Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A  115, E498-E505.   https://doi.org/10.1073/pnas.1715118115|3. Nagy É, Mocsár G, Sebestyén V, Volkó J, Papp F, Tóth K, Damjanovich S, Panyi G, Waldmann TA, Bodnár A, Vámosi G (2018). Membrane Potential Distinctly Modulates Mobility and Signaling of IL-2 and IL-15 Receptors in T Cells. Biophys J  114, 2473-2482.   https://doi.org/10.1016/j.bpj.2018.04.038|4. Waldmann TA (2019). Making discoveries in immunology. Hum Vaccin Immunother  15, 280-282.   https://doi.org/10.1080/21645515.2018.1549830",https://intramural.nih.gov/search/searchview.taf?ipid=109015
671,SC004020-42,"October 01, 2018 -  September 30, 2019","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Julian Demond Burks|Lee Chrisman England|Laurel  Lagenaur; PhD|John Sangmin Lee|Jianping  Li|Hoyoung  Maeng; MD|Show all 19,"David  Carbone (Vanderbilt University)|Guido  Forni (Clinical and Biological Sciences, University of Turin)|Dale  Godfrey (Immunolgy, University of Melbourne)|Wayne M. Yokoyama; MD (Rheumatology Division, Washington University)|Yoran  Reiter (Immunology, Technion-Israel Institue of Technology)|Geoffrey  Shapiro (Dana Farber Cancer Institute)|Show all 31",William Marston Linehan; MD (Urologic Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David J Venzon; PhD (Biostatistics and Data Management Section)|Hisataka  Kobayashi (Molecular Imaging Program)|Joseph John Barchi (Chemical Biology Laboratory),"Brian  Kelsall; MD (NIAID) |David Harvey Margulies; MD, PhD (NIAID) |Warren  Strober; MD (NIAID) |Patricia  Earl; PhD (NIAID) |Warren J Leonard; MD (NHLBI) |Hee-Yong  Kim; PhD (NIAAA)","1. Billeskov R, Beikzadeh B, Berzofsky JA (2019). The effect of antigen dose on T cell-targeting vaccine outcome. Hum Vaccin Immunother  15, 407-411.   https://doi.org/10.1080/21645515.2018.1527496|2. Bloom A, Bender L, Tiwary S, Pasquet L, Clark K, Jiang T, Xia Z, MoralesKastresana A, Jones J, Walters I, Terabe M, Berzofsky J (2019) Intratumorally delivered formulation, INT230-6, containing potent anticancer agents induces protective T cell immunity and memory. OncoImmunology, in press.|3. Frey BF, Jiang J, Sui Y, Boyd LF, Yu B, Tatsuno G, Billeskov R, Solaymani-Mohammadi S, Berman PW, Margulies DH, Berzofsky JA (2018). Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity. J Immunol  200, 1853-1864.   https://doi.org/10.4049/jimmunol.1701523|4. Jin P, Chen W, Ren J, Chen S, Wood L, Zhao Y, Remaley A, Pham C, Lian S, Liu S, Liu H, Highfill S, Berzofsky JA, Stroncek DF (2018). Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells. Cytotherapy  20, 728-739.   https://doi.org/10.1016/j.jcyt.2018.03.001|5. Kato S, Berzofsky JA, Terabe M (2018). Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity. Front Immunol  9, 314.   https://doi.org/10.3389/fimmu.2018.00314|6. Maeng H, Terabe M, Berzofsky JA (2018). Cancer vaccines: translation from mice to human clinical trials. Curr Opin Immunol  51, 111-122.   https://doi.org/10.1016/j.coi.2018.03.001|7. Maeng HM, Berzofsky JA (2019). Strategies for developing and optimizing cancer vaccines. F1000Res  8.   https://doi.org/10.12688/f1000research.18693.1|8. O'Konek JJ, Ambrosino E, Bloom AC, Pasquet L, Massilamany C, Xia Z, Terabe M, Berzofsky JA (2018). Differential Regulation of T-cell mediated anti-tumor memory and cross-protection against the same tumor in lungs versus skin. Oncoimmunology  7, e1439305.   https://doi.org/10.1080/2162402X.2018.1439305|9. Paquin-Proulx D, Greenspun BC, Pasquet L, Strunz B, Aleman S, Falconer K, Terabe M, Berzofsky JA, Sandberg JK, Melum E, Nixon DF, Björkström NK (2018). IL13Rα2 expression identifies tissue-resident IL-22-producing PLZF+ innate T cells in the human liver. Eur J Immunol  48, 1329-1335.   https://doi.org/10.1002/eji.201747334|10. Solaymani-Mohammadi S, Berzofsky JA (2019). Interleukin 21 collaborates with interferon-γ for the optimal expression of interferon-stimulated genes and enhances protection against enteric microbial infection. PLoS Pathog  15, e1007614.   https://doi.org/10.1371/journal.ppat.1007614|11. Terabe M, Berzofsky JA (2018). Tissue-Specific Roles of NKT Cells in Tumor Immunity. Front Immunol  9, 1838.   https://doi.org/10.3389/fimmu.2018.01838",https://intramural.nih.gov/search/searchview.taf?ipid=109016
672,SC006321-40,"October 01, 2018 -  September 30, 2019",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|Janet W Gamson|Sangeeta  Gohain|Askale Y Mathias|Chandrasek N. Nagineni; PhD|Show all 9,NULL,Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch),"Carter  Van Waes; MD, PhD (NIDCD) |Clint Tanner Allen (NIDCD)","1. Naz S, Cook JA, Mitchell JB (2019). Abemaciclib: A multi-functional radiation modifier. Oncotarget  10, 1230-1232.   https://doi.org/10.18632/oncotarget.26652|2. Naz S, Sowers A, Choudhuri R, Wissler M, Gamson J, Mathias A, Cook JA, Mitchell JB (2018). Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell Lung Cancer In Vitro and In Vivo. Clin Cancer Res  24, 3994-4005.   https://doi.org/10.1158/1078-0432.CCR-17-3575|3. Patel P, Sun L, Robbins Y, Clavio P, Friedman J, Silvin C, Van Waes C, Cook J, Mitchell J, Allen C (2019) Enhancing direct cytotoxicity and response to immune checkpoint blockage following ionizing radiation with Wee1 kinase inhibition. Oncoimmunology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=109017
673,SC006330-39,"October 01, 2018 -  September 30, 2019",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Jason Yulin Cheng; PhD|Peter  Guion|Holly  Ning|Ying  Zhuge|Barbara Chin Arora|Norman Norman Coleman; MD,"Chang-Ming  Ma (Radiation Oncology Department, Fox Chase Cancer Center)|Wei  Chen (University Of Texas)","Jeffrey Craig Buchsbaum; MD, PhD, AM (Radiation Research Program)|Bradford J Wood; MD (Office of the Director)",NULL,"1. Zeng R, Torkaman M, Ning H, Zhuge Y, Miller R, Myers KJ (2019). A data-efficient method for local noise power spectrum (NPS) estimation in FDK-reconstructed 3D cone-beam CT. Med Phys  46, 1634-1647.   https://doi.org/10.1002/mp.13428",https://intramural.nih.gov/search/searchview.taf?ipid=109007
674,SC006387-32,"October 01, 2018 -  September 30, 2019",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|Sangeeta  Gohain|Anastasia L Sowers|Murali  Krishna; PhD,NULL,Frank Jess Gonzalez; PhD (Laboratory of Metabolism),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109018
675,SC006538-26,"October 01, 2018 -  September 30, 2019",Development of Angiogenesis Inhibitors,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Cindy Huong-Bich Chau|Matthew Keen Collins|Douglas K Price|James L Gulley; MD, PhD|William Laurence Dahut; MD|Ravi  Madan|Show all 8","Neil  Vargesson; PhD (University of Aberdeen)|Christopher  Schofield (University of Oxford)|Brent R Copp; PhD (Chemistry, University of Auckland)|Michael  Gutschow (University of Bonn)|C  Landgren (Memorial Sloan Kettering Cancer Center)",David J Venzon; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Ismail Baris Turkbey (Molecular Imaging Program)|Liang  Cao (Cancer Genetics Branch)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Heidi H Kong (Office of the Director),Nigel H Greig; PhD (NIA),"1. Luo W, Tweedie D, Beedie SL, Vargesson N, Figg WD, Greig NH, Scerba MT (2018). Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities. Bioorg Med Chem  26, 1547-1559.   https://doi.org/10.1016/j.bmc.2018.01.032|2. Mahony C, McMenemy S, Rafipay AJ, Beedie SL, Fraga LR, Gütschow M, Figg WD, Erskine L, Vargesson N (2018). CPS49-induced neurotoxicity does not cause limb patterning anomalies in developing chicken embryos. J Anat  232, 568-574.   https://doi.org/10.1111/joa.12712|3. Steinebach C, Ambrożak A, Dosa S, Beedie SL, Strope JD, Schnakenburg G, Figg WD, Gütschow M (2018). Synthesis, Structural Characterization, and Antiangiogenic Activity of Polyfluorinated Benzamides. ChemMedChem  13, 2080-2089.   https://doi.org/10.1002/cmdc.201800263",https://intramural.nih.gov/search/searchview.taf?ipid=109019
676,SC006663-30,"October 01, 2018 -  September 30, 2019",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,"Armando  Filie (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Sheila Ann Prindiville (Office Of The Director)",NULL,"1. Danforth D (2018). Risk assessment for sporadic breast cancer: The need for a molecular profile. Clinics in Surgery  3, 1-4.|2. Danforth DN (2018). Molecular profile of atypical hyperplasia of the breast. Breast Cancer Res Treat  167, 9-29.   https://doi.org/10.1007/s10549-017-4488-x",https://intramural.nih.gov/search/searchview.taf?ipid=109020
677,SC006737-28,"October 01, 2018 -  September 30, 2019",Development of Novel Therapies for HIV Infection,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI","David A Davis; MD|Prabha  Shrestha; PhD|Kathryn Anne Lurain; MD, MPH|Ramya Meenakshi Ramaswami|Hiroaki  Mitsuya",Mac  Cheever (Fred Hutchinson Cancer Research Center)|Thomas  Uldrick (Fred Hutchinson Cancer Center),Marjorie  Robert-Guroff; PhD (Vaccine Branch)|Frank  Maldarelli (Host Virus Interaction Branch)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Eric O Freed; PhD (HIV Drug Resistance Program),NULL,"1. Davis DA, Shrestha P, Aisabor AI, Stream A, Galli V, Pise-Masison CA, Tagawa T, Ziegelbauer JM, Franchini G, Yarchoan R (2019). Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells. Oncoimmunology  8, e1546544.   https://doi.org/10.1080/2162402X.2018.1546544|2. Uldrick TS, Gonçalves PH, Abdul-Hay M, Claeys AJ, Emu B, Ernstoff MS, Fling SP, Fong L, Kaiser JC, Lacroix AM, Lee SY, Lundgren LM, Lurain K, Parsons CH, Peeramsetti S, Ramaswami R, Sharon E, Sznol M, Wang CJ, Yarchoan R, Cheever MA, Cancer Immunotherapy Trials Network (CITN)-12 Study Team (2019) Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study. JAMA Oncol, in press (e-pub ahead of print)  https://doi.org/10.1001/jamaoncol.2019.2244",https://intramural.nih.gov/search/searchview.taf?ipid=109021
678,SC006738-28,"October 01, 2018 -  September 30, 2019",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Hiromi  Aoki|Manabu  Aoki; PhD|Haydar  Bulut; PhD|Debananda  Das; PhD|Robert  Yarchoan; MD|David A Davis; MD,Arun  Ghosh|Yasuhiro  Koh (Kumamoto University School of Medicine)|Masayuki  Amano (Kumamoto University School of Medicine)|Hironori  Hayashi; MA|Nobuyo  Kuwata (National Center for Global Health & Medicine)|Kenji  Maeda (National Center For Global Health And Medicine)|Show all 11,David J Venzon; PhD (Biostatistics and Data Management Section),Paul T Wingfield; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109008
679,SC006741-27,"October 01, 2018 -  September 30, 2019",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Christopher Joseph Melani|Louis  Staudt; MD,NULL,"Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Ben-Yakov G, Alao H, Haydek JP, Fryzek N, Cho MH, Hemmati M, Samala V, Shovlin M, Dunleavy K, Wilson W, Jones EC, Rotman Y (2019). Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma. Hepatol Commun  3, 220-226.   https://doi.org/10.1002/hep4.1304|2. Melani C, Roschewski M, Wilson WH (2018). End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams et al. Haematologica  103, e382.   https://doi.org/10.3324/haematol.2018.199547|3. Melani C, Wilson WH, Roschewski M (2019). What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R? Br J Haematol  184, 836-838.   https://doi.org/10.1111/bjh.15185|4. Miljkovic MD, Roschewski M, Dunleavy K, Wilson WH (2019) Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma. Leuk Lymphoma, in press (e-pub ahead of print)  https://doi.org/10.1080/10428194.2019.1627540|5. Strati P, Fanale MA, Oki Y, Turturro F, Fayad LE, Bartlett NL, Gladstone DE, Kasamon YL, Portlock CS, Wilson WH, Goy A, Younes A, Lee HJ (2019). ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study. Haematologica  104, e65-e67.   https://doi.org/10.3324/haematol.2018.199844|6. Wilson WH (2019). Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care - Authors' reply. Lancet Haematol  6, e120.   https://doi.org/10.1016/S2352-3026(19)30020-1",https://intramural.nih.gov/search/searchview.taf?ipid=109009
680,SC007263-27,"October 01, 2018 -  September 30, 2019",Activating Cell Death Pathways in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Yoshimi Endo Greer|Donna M Voeller|Manjari  Kundu|Alexandra Dos Santos Zimmer|Patricia  Steeg; PhD|Jung-Min  Lee|Show all 7,"David  Tice (MedImmune)|Doron  Levy (University Of Maryland)|Lee  Graves (University Of North Carolina)|Edwin  Iwanowicz (Maadera Therapeutics, Llc)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Seth M Steinberg; PhD (Office Of The Clinical Director)|Anand S Merchant (Cancer Diagnosis Program)|Bao D Quoe  Tran (Office of the Director)|Margaret  Cam; PhD (Office of the Director)|William Marston Linehan; MD (Urologic Oncology Branch)",Markus  Hafner (NIAMS) |Matthew David Hall (NCATS),"1. Greer YE, Gilbert SF, Gril B, Narwal R, Peacock Brooks DL, Tice DA, Steeg PS, Lipkowitz S (2019). MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. Breast Cancer Res  21, 27.   https://doi.org/10.1186/s13058-019-1116-1",https://intramural.nih.gov/search/searchview.taf?ipid=109022
681,SC007281-26,"October 01, 2018 -  September 30, 2019",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Yuk Sing Robert Cheng|Lisa Ann Ridnour|Veena  Somasundaram|Daniel  McVicar; PhD|Howard A Young; PhD,NULL,"Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Terry  Moody; PhD (Office Of Training & Education)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Stephen J Lockett; PhD (Office Of The Director)|Stefan  Ambs (Laboratory of Human Carcinogenesis)",NULL,"1. Basudhar D, Bharadwaj G, Somasundaram V, Cheng RYS, Ridnour LA, Fujita M, Lockett SJ, Anderson SK, McVicar DW, Wink DA (2019). Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective. Br J Pharmacol  176, 155-176.   https://doi.org/10.1111/bph.14488|2. Fujita M, Somasundaram V, Basudhar D, Cheng RYS, Ridnour LA, Higuchi H, Imadome K, No JH, Bharadwaj G, Wink DA (2019). Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype. Redox Biol  22, 101158.   https://doi.org/10.1016/j.redox.2019.101158|3. Somasundaram V, Basudhar D, Bharadwaj G, No JH, Ridnour LA, Cheng RYS, Fujita M, Thomas DD, Anderson SK, McVicar DW, Wink DA (2019). Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism. Antioxid Redox Signal  30, 1124-1143.   https://doi.org/10.1089/ars.2018.7527",https://intramural.nih.gov/search/searchview.taf?ipid=109023
682,SC009144-35,"October 01, 2018 -  September 30, 2019",Mechanisms of transcription factor integration at the c-myc promoter,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Brian  Lewis|Emil Francis Michelotti; PhD|Suzanne Laurie Sanford|Ying  Zheng,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch),Keji  Zhao; PhD (NHLBI) |Teresa M Przytycka (NLM) |Rafael Cristian Casellas; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109024
683,SC009172-31,"October 01, 2018 -  September 30, 2019",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Joshua David Amason|Rajdeep  Banerjee|Alejandra  Cavazos Saldana|Kun  Dong|Sukhbir  Kaur|Thomas W Miller; PhD|Show all 9,Jeff  Isenberg (University of Pittsburgh)|Thomas  Miller (Paradigm Shift Therapeutics)|David  Soto-Pantoja (Wake Forest University School of Medicine)|Katherine  Cook (Georgetown University Medical Center)|Joanne  Murphy-ullrich (University Of Alabama At Birminghan),Margaret  Cam; PhD (Office of the Director)|Nancy J Emenaker (Nutritional Science Research Group),Abdel G Elkahloun; PhD (NHGRI) |Satya P Singh; PhD (NIAID) |Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS) |Ethan M Shevach; MD (NIAID) |James  Inglese (NCATS),"1. Kaur S, Elkahloun AG, Arakelyan A, Young L, Myers TG, Otaizo-Carrasquero F, Wu W, Margolis L, Roberts DD (2018). CD63, MHC class 1, and CD47 identify subsets of extracellular vesicles containing distinct populations of noncoding RNAs. Sci Rep  8, 2577.   https://doi.org/10.1038/s41598-018-20936-7|2. Miller TW, Amason JD, Garcin ED, Lamy L, Dranchak PK, Macarthur R, Braisted J, Rubin JS, Burgess TL, Farrell CL, Roberts DD, Inglese J (2019). Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors. PLoS One  14, e0218897.   https://doi.org/10.1371/journal.pone.0218897|3. Sipes JM, Murphy-Ullrich JE, Roberts DD (2018). Thrombospondins: Purification of human platelet thrombospondin-1. Methods Cell Biol  143, 347-369.   https://doi.org/10.1016/bs.mcb.2017.08.021|4. Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, et al. [357 more authors] (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles  7, 1535750.   https://doi.org/10.1080/20013078.2018.1535750",https://intramural.nih.gov/search/searchview.taf?ipid=109005
684,SC009174-31,"October 01, 2018 -  September 30, 2019",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Dipasmita  Pal Nath; PhD|John M Sipes,Jeff  Isenberg (University of Pittsburgh)|Thomas  Miller (Paradigm Shift Therapeutics)|David  Soto-Pantoja (Wake Forest University School of Medicine),David Anderson Wink (Cancer Inflammation Program),NULL,"1. Feliz-Mosquea YR, Christensen AA, Wilson AS, Westwood B, Varagic J, Meléndez GC, Schwartz AL, Chen QR, Mathews Griner L, Guha R, Thomas CJ, Ferrer M, Merino MJ, Cook KL, Roberts DD, Soto-Pantoja DR (2018). Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy. Breast Cancer Res Treat  172, 69-82.   https://doi.org/10.1007/s10549-018-4884-x|2. Isenberg JS, Roberts DD (2019). The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury. Pediatr Nephrol  34, 2479-2494.   https://doi.org/10.1007/s00467-018-4123-z|3. Kaur S, Elkahloun AG, Singh SP, Arakelyan A, Roberts DD (2018). A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells. J Cell Commun Signal  12, 157-170.   https://doi.org/10.1007/s12079-017-0428-0|4. Ramirez MU, Stirling ER, Emenaker NJ, Roberts DD, Soto-Pantoja DR (2018). Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation. Cancer Metastasis Rev  37, 469-476.   https://doi.org/10.1007/s10555-018-9737-x",https://intramural.nih.gov/search/searchview.taf?ipid=109004
685,SC009179-31,"October 01, 2018 -  September 30, 2019","The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis","William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Alex S Kuznetsov|David  Peeney; PhD|Beiyang  Wei|Maryalice  Stetler-Stevenson; MD, PhD",John  Caterina; PhD (NIDR)|Dimitra  Bourboulia|Evette  Radisky (Mayo Clinic Cancer Center),NULL,Paul T Wingfield; PhD (NIAMS),"1. Sánchez-Pozo J, Baker-Williams AJ, Woodford MR, Bullard R, Wei B, Mollapour M, Stetler-Stevenson WG, Bratslavsky G, Bourboulia D (2018). Extracellular Phosphorylation of TIMP-2 by Secreted c-Src Tyrosine Kinase Controls MMP-2 Activity. iScience  1, 87-96.   https://doi.org/10.1016/j.isci.2018.02.004",https://intramural.nih.gov/search/searchview.taf?ipid=109025
686,SC009389-26,"October 01, 2018 -  September 30, 2019",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Aian Neil Seno Alilin|Adam G Sowalsky,NULL,Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109026
687,SC010074-24,"October 01, 2018 -  September 30, 2019",HSP90 Chaperone Proteins and Interactors in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Li  Dai|Joe K Jackson|Marisa Sakarin Maisiak|Marianne  Poruchynsky|Genesis Mayliz Rivera-Marquez|Show all 8,"Brian  Blagg (Chemistry, University of Kansas)|Laurence  Pearl (University of Sussex)|Matthias  Mayer (University of Heidelberg)|Marc  Cox (University of Texas at El Paso)|Gabriela X Chiosis|Timothy  Haystead (Duke University)|Show all 16",Christine Marie Heske (Pediatric Oncology Branch)|Jane Beth Trepel (Developmental Therapeutics Branch),Daniel C Masison; PhD (NIDDK) |Yihong  Ye (NIDDK),"1. Calderwood SK, Repasky EA, Neckers L, Hightower LE (2019). The IXth CSSI international symposium on heat shock proteins in biology and medicine: stress responses in health and disease : Alexandria Old Town, Alexandria, Virginia, November 10-13, 2018. Cell Stress Chaperones  24, 1-6.   https://doi.org/10.1007/s12192-018-00966-w|2. Kijima T, Prince TL, Tigue ML, Yim KH, Schwartz H, Beebe K, Lee S, Budzynski MA, Williams H, Trepel JB, Sistonen L, Calderwood S, Neckers L (2018). HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation. Sci Rep  8, 6976.   https://doi.org/10.1038/s41598-018-25404-w|3. Neckers L, Blagg B, Haystead T, Trepel JB, Whitesell L, Picard D (2018). Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development. Cell Stress Chaperones  23, 467-482.   https://doi.org/10.1007/s12192-018-0877-2",https://intramural.nih.gov/search/searchview.taf?ipid=109027
688,SC010093-23,"October 01, 2018 -  September 30, 2019",Epigenetic Therapy for Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Colleen Donahue Bond|Claudia Lissette Espinoza|Julie A Hong|Cheryl L Warga|Mary R Zhang|Chuong Dinh Hoang,"Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Xinmin  Li (Functional Genomics, University of Chicago)|Sacha  Ghnatic (Ludwig Cancer Inst)",William D Figg; PharmD (Genitourinary Malignancies Branch)|Raffit  Hassan (Thoracic and GI Malignancies Branch),NULL,"1. Schrump DS, Hong JA (2018). Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer. J Thorac Cardiovasc Surg  155, 2632-2633.   https://doi.org/10.1016/j.jtcvs.2018.01.060",https://intramural.nih.gov/search/searchview.taf?ipid=109011
689,SC010098-17,"October 01, 2018 -  September 30, 2019",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Philip M Arlen; MD|Anna C Couvillon; NP,Phil  Kantoff (DFCI)|Joseph  KIm (Yale)|Howard  Scher (Mskcc),"William Marston Linehan; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Seth M Steinberg; PhD (Office Of The Clinical Director)|Peter A Pinto; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)",NULL,"1. Armstrong AJ, Antonarakis ES, Taplin ME, Kelly WK, Beltran H, Fizazi K, Dahut WL, Shore N, Slovin S, George D, Carducci MA, Corn P, Danila D, Dreicer R, Heath E, Rathkopf D, Liu G, Nanus D, Stein M, Smith MR, Sternberg C, Wilding G, Nelson PS, Halabi S, Kantoff P, et al. [7 more authors] (2018). Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. Ann Oncol  29, 23-25.   https://doi.org/10.1093/annonc/mdx648",https://intramural.nih.gov/search/searchview.taf?ipid=109043
690,SC010354-20,"October 01, 2018 -  September 30, 2019",Research and Development of Effective Therapies for Patients with Rare Tumors,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Julia Wanda Cohen|Eva  Dombi|Andrea Michelle Gross; MD|Souvik  Karmakar|Robert F Murphy|Haiying  Qin|Show all 13,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|AeRang  Kim (Children's National Medical Center)|Lee Jay Helman; MD (NCI)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Alice Pinting Chen (Office of the Director)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Cody John Peer (Office Of The Clinical Director)","Karel  Pacak; MD, PhD (NICHD)","1. Chuk MK, Widemann BC, Minard CG, Liu X, Kim A, Bernhardt MB, Kudgus RA, Reid JM, Voss SD, Blaney S, Fox E, Weigel BJ (2018). A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group. Pediatr Blood Cancer  65, e27077.   https://doi.org/10.1002/pbc.27077|2. Ramsey LB, Balis FM, O'Brien MM, Schmiegelow K, Pauley JL, Bleyer A, Widemann BC, Askenazi D, Bergeron S, Shirali A, Schwartz S, Vinks AA, Heldrup J (2018). Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. Oncologist  23, 52-61.   https://doi.org/10.1634/theoncologist.2017-0243|3. Widemann B, Lu Y, Reinke D, Okuno S, Meyer C, Cote G, Milhelm M, Hirbe A, Kim A, Turoin B, Pressey J, Dombi E, Jayaprakash N, Helman L, Onduwine N, Cichowksi K, Perentesis J (2019) SARC016: Phase II Study of Everolimus Combined with Bevacizumab in Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST). Sarcoma, in press.|4. Widemann BC, Italiano A (2018). Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives. J Clin Oncol  36, 160-167.   https://doi.org/10.1200/JCO.2017.75.3467",https://intramural.nih.gov/search/searchview.taf?ipid=109028
691,SC010355-20,"October 01, 2018 -  September 30, 2019",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Taekyu  Ha|Yuyi  Wang,Maria  Cid (Univ. of Barcelona Medical School)|Amparo  Acher-Palmer (University of Frankfurt)|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Ira  Daar; PhD (Cancer and Developmental Biology Laboratory),Manfred  Boehm; MD (NHLBI) |Yosuke  Mukoyama; PhD (NHLBI),"1. Ha T, Ohnuki H, Tosato G (2018). Novel insights into endothelial cell malignancies. Oncotarget  9, 37468-37470.   https://doi.org/10.18632/oncotarget.26516",https://intramural.nih.gov/search/searchview.taf?ipid=109029
692,SC010356-20,"October 01, 2018 -  September 30, 2019",A Role for KSHV in the Pathogenesis of Malignancies,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Michael Joseph Diprima|Jing-Xin  Feng,Frederick  Wang (Harvard Univ)|Stefan  Rose-John (Univ. of Kiel)|Thomas  Uldrick (Fred Hutchinson Cancer Research Center),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Manfred  Boehm; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109030
693,SC010357-20,"October 01, 2018 -  September 30, 2019",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"Rna Biology Laboratory, NCI",Beatriz  Alvarado Hernandez; PhD|Deanna R Gotte|Mina Katariina Griffioen|Haibin  Liu|Vladimir  Majerciak|Lulu  Yu; PhD|Show all 7,"Craig  Meyers (Microbiology and Immunology, Penn State University College of Medicine)|Louise T Chow|Xing  Xie (Zhejiang University)|Thomas  Tuschl (Rockefeller University)|Paul  Lambert (University of Wisconsin School of Medicine)|John  Doorbar (National Institute for Medical Research)|Show all 8",Xinhua  Ji; PhD (Biomolecular Structure Section),Jun  Zhu; PhD (NHLBI),"1. BeltCappellino A, Majerciak V, Lobanov A, Lack J, Cam M, Zheng ZM (2019). CRISPR/Cas9-Mediated Knockout and In Situ Inversion of the ORF57 Gene from All Copies of the Kaposi's Sarcoma-Associated Herpesvirus Genome in BCBL-1 Cells. J Virol  93.   https://doi.org/10.1128/JVI.00628-19|2. Brant AC, Majerciak V, Moreira MAM, Zheng ZM (2019). HPV18 Utilizes Two Alternative Branch Sites for E6*I Splicing to Produce E7 Protein. Virol Sin  34, 211-221.   https://doi.org/10.1007/s12250-019-00098-0|3. Cladel NM, Jiang P, Li JJ, Peng X, Cooper TK, Majerciak V, Balogh KK, Meyer TJ, Brendle SA, Budgeon LR, Shearer DA, Munden R, Cam M, Vallur R, Christensen ND, Zheng ZM, Hu J (2019). Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models. Emerg Microbes Infect  8, 1108-1121.   https://doi.org/10.1080/22221751.2019.1637072|4. Jia R, Ajiro M, Yu L, McCoy P, Zheng ZM (2019). Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation. RNA  25, 630-644.   https://doi.org/10.1261/rna.068619.118|5. Majerciak V, Yang W, Zheng J, Zhu J, Zheng ZM (2019). A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA. J Virol  93.   https://doi.org/10.1128/JVI.01593-18|6. Sharma NR, Majerciak V, Kruhlak MJ, Yu L, Kang JG, Yang A, Gu S, Fritzler MJ, Zheng ZM (2019). KSHV RNA-binding protein ORF57 inhibits P-body formation to promote viral multiplication by interaction with Ago2 and GW182. Nucleic Acids Res  47, 9368-9385.   https://doi.org/10.1093/nar/gkz683|7. Yan L, Majerciak V, Zheng ZM, Lan K (2019). Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis. Virol Sin  34, 135-161.   https://doi.org/10.1007/s12250-019-00114-3|8. Yuan F, Gao ZQ, Majerciak V, Bai L, Hu ML, Lin XX, Zheng ZM, Dong YH, Lan K (2018). The crystal structure of KSHV ORF57 reveals dimeric active sites important for protein stability and function. PLoS Pathog  14, e1007232.   https://doi.org/10.1371/journal.ppat.1007232|9. Zhang Q, Sharma NR, Zheng ZM, Chen M (2019). Viral Regulation of RNA Granules in Infected Cells. Virol Sin  34, 175-191.   https://doi.org/10.1007/s12250-019-00122-3|10. Zheng Z, Lan K, Freed E, Shi Z (2019). Preface  to special issue of Virologica Sinica commemorating the first joint SKLV NIH Virology Symposium. Virol Sin  34, 117-118.|11. Zheng ZM (2019). Circular RNAs and RNase L in PKR activation and virus infection. Cell Biosci  9, 43.   https://doi.org/10.1186/s13578-019-0307-x",https://intramural.nih.gov/search/searchview.taf?ipid=109031
694,SC010366-19,"October 01, 2018 -  September 30, 2019",Identification of Genes for Predicting Prognosis in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Andrew Scott Brohl|Berkley Eric Gryder|Igor Borisovich Kuznetsov|Sivasish  Sindiri|Young K Song|Jun S Wei|Show all 8,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Stephen  Skapek (The University of Chicago)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Janet  Shipley (The Institute of Cancer Research)|Show all 7","Carol J Thiele (Pediatric Oncology Branch)|Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109032
695,SC010372-19,"October 01, 2018 -  September 30, 2019",Pre-clinical Development of Radiation Sensitizers for Patients with Glioblastoma,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Juliana  Ferreira de Sousa; MSC|Tamalee  Scott|Jennifer Amy Lee|Mary T Sproull|Hong Shik  Yun; PhD|Philip Jeffrey Tofilon,NULL,James B Mitchell; PhD (Radiation Biology Branch),Craig Joseph Thomas (NCATS),"1. Das S, Deng X, Camphausen K, Shankavaram U (2019). DiscoverSL: an R package for multi-omic data driven prediction of synthetic lethality in cancers. Bioinformatics  35, 701-702.   https://doi.org/10.1093/bioinformatics/bty673|2. Loo HK, Mathen P, Lee J, Camphausen K (2019). Circulating biomarkers for high-grade glioma. Biomark Med  13, 161-165.   https://doi.org/10.2217/bmm-2018-0463",https://intramural.nih.gov/search/searchview.taf?ipid=109033
696,SC010373-19,"October 01, 2018 -  September 30, 2019",The Synergy Between Radiotherapy and Molecularly Targeted Agents,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Tamalee  Scott|Mary T Sproull|Hong Shik  Yun; PhD|Philip Jeffrey Tofilon,NULL,Mark Richard Gilbert; MD (Neuro-Oncology Branch),NULL,"1. Kil WJ, Camphausen K, Cho IH (2019). Clinical and radiobiological consideration of cyclical hypofractionated radiation therapy also known as QUAD Shot for neglected skin cancer disfiguring the face of a non-compliant patient who was refusing surgery and protracted radiation therapy: case report. Radiat Oncol J  37, 143-148.   https://doi.org/10.3857/roj.2019.00248",https://intramural.nih.gov/search/searchview.taf?ipid=109034
697,SC010375-19,"October 01, 2018 -  September 30, 2019",TAF7: A Check-point Regulator in Transcription Initiation and Translation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Dan  Cheng|Anne G M Gegonne Bosselut,NULL,Qingrong  Chen (Cancer Informatics Branch)|Daoud M Meerzaman (Cancer Informatics Branch),Markus  Hafner (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109035
698,SC010376-19,"October 01, 2018 -  September 30, 2019","TNF Signaling, Cell Death and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Jin Young  Baik|Swati Suresh Choksi|Delong  Jiao; PhD|Chamila Charthuranga Kadigamuwa|Hyung Joon  Kwon; PhD|Zhao-Shan  Liu|Show all 7,"Brian  Rowan (School of Medicine, Tulane University)|Jennifer  Yu (Cleveland Clinic)|Tao  Li (National Center Of Biomedical Analysis)",NULL,Richard James Youle; PhD (NINDS) |Chengyu  Liu; PhD (NHLBI),"1. Chen X, Zhuang C, Ren Y, Zhang H, Qin X, Hu L, Fu J, Miao Z, Chai Y, Liu ZG, Zhang H, Cai Z, Wang HY (2019). Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3. Br J Pharmacol  176, 2095-2108.   https://doi.org/10.1111/bph.14653|2. Dowling JP, Alsabbagh M, Del Casale C, Liu ZG, Zhang J (2019). TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3. Nat Commun  10, 705.   https://doi.org/10.1038/s41467-019-08584-5|3. Kadigamuwa C, Choksi S, Xu Q, Cataisson C, Greenbaum SS, Yuspa SH, Liu ZG (2019). Role of Retinoic Acid Receptor-γ in DNA Damage-Induced Necroptosis. iScience  17, 74-86.   https://doi.org/10.1016/j.isci.2019.06.019|4. Man J, Yu X, Huang H, Zhou W, Xiang C, Huang H, Miele L, Liu Z, Bebek G, Bao S, Yu JS (2018). Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells. Cell Stem Cell  22, 104-118.e6.   https://doi.org/10.1016/j.stem.2017.10.005",https://intramural.nih.gov/search/searchview.taf?ipid=109036
699,SC010378-19,"October 01, 2018 -  September 30, 2019",Activation of Proto-Oncogenes by Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Yang-Jo  Chung|Toshihiro  Matsukawa|Vijay  Negi|Mianmian  Yin|Zhenhua  Zhang|Paul S Meltzer; MD, PhD",Trang  Hoang (U. Montreal)|Laura  Schuettpelz (Washington University)|Ling  Li (City Of Hope)|Chris  Slape (Monash University)|Amit  Verma (Alberrt Einstein),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109037
700,SC010379-19,"October 01, 2018 -  September 30, 2019",Mechanisms of Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Toshihiro  Matsukawa|Mianmian  Yin|Zhenhua  Zhang,Masahiro  Onozawa|Steven  Pruitt (Rpci),Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109038
701,SC010384-19,"October 01, 2018 -  September 30, 2019",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Thomas R Bauer,David  Russell (University of Washington)|Punam  Malik,NULL,NULL,"1. Goodman MA, Arumugam P, Pillis DM, Loberg A, Nasimuzzaman M, Lynn D, van der Loo JCM, Dexheimer PJ, Keddache M, Bauer TR, Hickstein DD, Russell DW, Malik P (2018). Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential. J Virol  92.   https://doi.org/10.1128/JVI.01639-17",https://intramural.nih.gov/search/searchview.taf?ipid=109039
702,BC010906-12,"October 01, 2018 -  September 30, 2019",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Nancy  Beltran|Bonita R Bryant|Kevin Charles Conlon|Sigrid Priscilla Dubois|Liyanage P Perera; PhD|Michael N Petrus,"Nicole  Urquhart (Dept of, University of the West Indies)|Joseph  Murray (Department of Gastroenterology, Mayo Clinic)|Jeffrey  Miller (University of Minnesota)",Jason L Yovandich (Biological Resources Branch),NULL,"1. Conlon KC, Miljkovic MD, Waldmann TA (2019). Cytokines in the Treatment of Cancer. J Interferon Cytokine Res  39, 6-21.   https://doi.org/10.1089/jir.2018.0019|2. Miller JS, Morishima C, McNeel DG, Patel MR, Kohrt HEK, Thompson JA, Sondel PM, Wakelee HA, Disis ML, Kaiser JC, Cheever MA, Streicher H, Creekmore SP, Waldmann TA, Conlon KC (2018). A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors. Clin Cancer Res  24, 1525-1535.   https://doi.org/10.1158/1078-0432.CCR-17-2451|3. Ratner L, Waldmann TA, Janakiram M, Brammer JE (2018). Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy. N Engl J Med  378, 1947-1948.   https://doi.org/10.1056/NEJMc1803181|4. Waldmann TA (2018). Cytokines in Cancer Immunotherapy. Cold Spring Harb Perspect Biol  10.   https://doi.org/10.1101/cshperspect.a028472|5. Wang TT, Yang J, Zhang Y, Zhang M, Dubois S, Conlon KC, Tagaya Y, Hamele CE, Dighe S, Olson TL, Feith DJ, Azimi N, Waldmann TA, Loughran TP (2019). IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability. Leukemia  33, 1243-1255.   https://doi.org/10.1038/s41375-018-0290-y|6. Zhang M, Wen B, Anton OM, Yao Z, Dubois S, Ju W, Sato N, DiLillo DJ, Bamford RN, Ravetch JV, Waldmann TA (2018). IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages. Proc Natl Acad Sci U S A  115, E10915-E10924.   https://doi.org/10.1073/pnas.1811615115",https://intramural.nih.gov/search/searchview.taf?ipid=108500
703,BC009255-45,"October 01, 2018 -  September 30, 2019",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Anthony J Adams|Assiatu Jalloh Crossman|Lawrence G Granger|Donald G Plugge,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108237
704,BC010517-17,"October 01, 2018 -  September 30, 2019",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Devendra Kumar  Dhaked|Hitesh Jayantilal Patel; PhD,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ann  Richard (EPA)|Stephen  Boyer|Lawrence  Callahan (FDA)|Eugene  Demchuk (CDC)|Antony  Williams|Show all 9,NULL,"Evan  Bolton; PhD (NLM) |Igor V Filippov (NLM) |Christopher P Austin; AB, MD (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108351
705,BC010639-16,"October 01, 2018 -  September 30, 2019",In Silico Screening for Cancer Targets,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach|John Stephen Schneekloth|Jordan Leslie Meier; PhD|Jeffrey  Gildersleeve,"Iwona Elzbieta Weidlich|Julieta  Comin (University of Buenos Aires)|Kevin  Gardner; MD, PhD (NCI)",Donald P Bottaro; PhD (Urologic Oncology Branch)|Kyung  Lee; PhD (Laboratory of Metabolism)|David D Roberts; PhD (Laboratory of Pathology)|Sergey G Tarasov (Structural Biophysics Laboratory)|Terry  Moody; PhD (Office Of Training & Education)|Kylie Janice Walters (Structural Biophysics Laboratory),"Paul P. Liu; MD, PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108360
706,BC010685-15,"October 01, 2018 -  September 30, 2019",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI","Willie J Young|Stephen M Hewitt; MD, PhD",NULL,Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Udayan  Guha (Thoracic and GI Malignancies Branch)|Frank  Maldarelli (Host Virus Interaction Branch),"Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Kenneth  Olivier; MD, MPH (NHLBI)","1. Agdashian D, ElGindi M, Xie C, Sandhu M, Pratt D, Kleiner DE, Figg WD, Rytlewski JA, Sanders C, Yusko EC, Wood B, Venzon D, Brar G, Duffy AG, Greten TF, Korangy F (2019). The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma. Cancer Immunol Immunother  68, 599-608.   https://doi.org/10.1007/s00262-019-02299-8|2. Ahmad J, Rossi S, Rodgers SK, Ghabril M, Fontana RJ, Stolz A, Hayashi PH, Barnhart H, Kleiner DE, Bjornsson ES (2019). Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury. Clin Gastroenterol Hepatol  17, 789-790.   https://doi.org/10.1016/j.cgh.2018.06.035|3. Ajmera V, Belt P, Wilson LA, Gill RM, Loomba R, Kleiner DE, Neuschwander-Tetri BA, Terrault N, Nonalcoholic Steatohepatitis Clinical Research Network (2018). Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis. Clin Gastroenterol Hepatol  16, 1511-1520.e5.   https://doi.org/10.1016/j.cgh.2018.01.026|4. Almeida LEF, Damsker JM, Albani S, Afsar N, Kamimura S, Pratt D, Kleiner DE, Quezado M, Gordish-Dressman H, Quezado ZMN (2018). The corticosteroid compounds prednisolone and vamorolone do not alter the nociception phenotype and exacerbate liver injury in sickle cell mice. Sci Rep  8, 6081.   https://doi.org/10.1038/s41598-018-24274-6|5. Brunt EM, Kleiner DE, Wilson LA, Sanyal AJ, Neuschwander-Tetri BA, Nonalcoholic Steatohepatitis Clinical Research Network (2019). Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials. Hepatology  70, 522-531.   https://doi.org/10.1002/hep.30418|6. Chen Z, Diaz G, Pollicino T, Zhao H, Engle RE, Schuck P, Shen CH, Zamboni F, Long Z, Kabat J, De Battista D, Bock KW, Moore IN, Wollenberg K, Soto C, Govindarajan S, Kwong PD, Kleiner DE, Purcell RH, Farci P (2018). Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure. Proc Natl Acad Sci U S A  115, E11369-E11378.   https://doi.org/10.1073/pnas.1809028115|7. Corey KE, Wilson LA, Altinbas A, Yates KP, Kleiner DE, Chung RT, Krauss RM, Chalasani N, NASH Clinical Research Network (2019). Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial. Aliment Pharmacol Ther  49, 1205-1213.   https://doi.org/10.1111/apt.15216|8. DiPaola F, Molleston JP, Gu J, Cirulli ET, Chalasani N, Barnhart H, Kleiner DE, Hoofnagle JH, Fontana RJ, US Drug Induced Liver Injury Network (2019). Antimicrobials and Antiepileptics Are the Leading Causes of Idiosyncratic Drug-induced Liver Injury in American Children. J Pediatr Gastroenterol Nutr  69, 152-159.   https://doi.org/10.1097/MPG.0000000000002383|9. Etzion O, Takyar V, Novack V, Gharib AM, Canales R, Adebogun A, Matsumoto E, Eccleston JL, Kleiner DE, Rosenzweig SD, Gunay-Aygun M, Uzel G, Fuss I, Childs R, Holland SM, Levy EB, Liang TJ, Heller T, Koh C (2018). Spleen and Liver Volumetrics as Surrogate Markers of Hepatic Venous Pressure Gradient in Patients With Noncirrhotic Portal Hypertension. Hepatol Commun  2, 919-928.   https://doi.org/10.1002/hep4.1198|10. Ferré EMN, Break TJ, Burbelo PD, Allgäuer M, Kleiner DE, Jin D, Xu Z, Folio LR, Mollura DJ, Swamydas M, Gu W, Hunsberger S, Lee CR, Bondici A, Hoffman KW, Lim JK, Dobbs K, Niemela JE, Fleisher TA, Hsu AP, Snow LN, Darnell DN, Ojaimi S, Cooper MA, Bozzola M, et al. [12 more authors] (2019). Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance. Sci Transl Med  11.   https://doi.org/10.1126/scitranslmed.aav5597|11. Fontana RJ, Cirulli ET, Gu J, Kleiner D, Ostrov D, Phillips E, Schutte R, Barnhart H, Chalasani N, Watkins PB, Hoofnagle JH (2018). The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. J Hepatol  69, 1317-1325.   https://doi.org/10.1016/j.jhep.2018.08.004|12. Haroutunian SG, O'Brien KJ, Estrada-Veras JI, Yao J, Boyd LC, Mathur K, Gahl WA, Mirmomen SM, Malayeri AA, Kleiner DE, Jaffe ES, Gochuico BR (2018). Clinical and Histopathologic Features of Interstitial Lung Disease in Erdheim⁻Chester Disease. J Clin Med  7.   https://doi.org/10.3390/jcm7090243|13. Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS, Hepatitis B Research Network (HBRN), Harvard Consortium (2018). Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes Care  41, 1251-1259.   https://doi.org/10.2337/dc18-0040|14. Kleiner DE (2018). Hepatocellular carcinoma: Liver biopsy in the balance. Hepatology  68, 13-15.   https://doi.org/10.1002/hep.29831|15. Kleiner DE (2018). Histopathological challenges in suspected drug-induced liver injury. Liver Int  38, 198-209.   https://doi.org/10.1111/liv.13584|16. Kleiner DE (2018). Histopathology, grading and staging of nonalcoholic fatty liver disease. Minerva Gastroenterol Dietol  64, 28-38.   https://doi.org/10.23736/S1121-421X.17.02445-X|17. Kleiner DE (2018). Recent Advances in the Histopathology of Drug-Induced Liver Injury. Surg Pathol Clin  11, 297-311.   https://doi.org/10.1016/j.path.2018.02.009|18. Li Y, Xia Y, Cheng X, Kleiner DE, Hewitt SM, Sproch J, Li T, Zhuang H, Liang TJ (2019). Hepatitis B Surface Antigen Activates Unfolded Protein Response in Forming Ground Glass Hepatocytes of Chronic Hepatitis B. Viruses  11.   https://doi.org/10.3390/v11040386|19. Ma Y, Belyaeva OV, Brown PM, Fujita K, Valles K, Karki S, de Boer YS, Koh C, Chen Y, Du X, Handelman SK, Chen V, Speliotes EK, Nestlerode C, Thomas E, Kleiner DE, Zmuda JM, Sanyal AJ, (for the Nonalcoholic Steatohepatitis Clinical Research Network), Kedishvili NY, Liang TJ, Rotman Y (2019). 17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease. Hepatology  69, 1504-1519.   https://doi.org/10.1002/hep.30350|20. Manoli I, Sysol JR, Epping MW, Li L, Wang C, Sloan JL, Pass A, Gagné J, Ktena YP, Li L, Trivedi NS, Ouattara B, Zerfas PM, Hoffmann V, Abu-Asab M, Tsokos MG, Kleiner DE, Garone C, Cusmano-Ozog K, Enns GM, Vernon HJ, Andersson HC, Grunewald S, Elkahloun AG, Girard CL, et al. [6 more authors] (2018). FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia. JCI Insight  3.   https://doi.org/10.1172/jci.insight.124351|21. Middleton MS, Van Natta ML, Heba ER, Alazraki A, Trout AT, Masand P, Brunt EM, Kleiner DE, Doo E, Tonascia J, Lavine JE, Shen W, Hamilton G, Schwimmer JB, Sirlin CB, NASH Clinical Research Network (2018). Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology  67, 858-872.   https://doi.org/10.1002/hep.29596|22. Pacheco GG, Jones AM, Yao J, Kleiner DE, Taveira-DaSilva AM, Moss J (2018). Mounier-Kuhn Syndrome Mimicking Lymphangioleiomyomatosis. Chest  153, e19-e23.   https://doi.org/10.1016/j.chest.2017.10.024|23. Sakiani S, Kleiner DE, Heller T, Koh C (2019). Hepatic Manifestations of Cystic Fibrosis. Clin Liver Dis  23, 263-277.   https://doi.org/10.1016/j.cld.2018.12.008|24. Siddiqui MS, Harrison SA, Abdelmalek MF, Anstee QM, Bedossa P, Castera L, Dimick-Santos L, Friedman SL, Greene K, Kleiner DE, Megnien S, Neuschwander-Tetri BA, Ratziu V, Schabel E, Miller V, Sanyal AJ, Liver Forum Case Definitions Working Group (2018). Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science. Hepatology  67, 2001-2012.   https://doi.org/10.1002/hep.29607|25. Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Brandman D, Doo E, Tonascia JA, Kleiner DE, Chalasani N, Sanyal AJ, NASH Clinical Research Network (2019). Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol  17, 156-163.e2.   https://doi.org/10.1016/j.cgh.2018.04.043|26. Springer JM, Gierer SA, Jiang H, Kleiner D, Deuitch N, Ombrello AK, Grayson PC, Aksentijevich I (2018). Deficiency of Adenosine Deaminase 2 in Adult Siblings: Many Years of a Misdiagnosed Disease With Severe Consequences. Front Immunol  9, 1361.   https://doi.org/10.3389/fimmu.2018.01361|27. Stolz A, Navarro V, Hayashi PH, Fontana RJ, Barnhart HX, Gu J, Chalasani NP, Vega MM, Bonkovsky HL, Seeff LB, Serrano J, Avula B, Khan IA, Cirulli ET, Kleiner DE, Hoofnagle JH, DILIN Investigators (2019). Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors. Aliment Pharmacol Ther  49, 1195-1204.   https://doi.org/10.1111/apt.15211|28. Surana P, Kapuria D, Broadwell C, Wright EC, Takyar V, Kleiner DE, Ghany MG, Ben-Yakov G, Heller T, Liang TJ, Koh C (2019). Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years. Antiviral Res  168, 61-67.   https://doi.org/10.1016/j.antiviral.2019.05.007|29. Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Abdelmalek M, Doo E, Tonascia JA, Kleiner DE, Sanyal AJ, Chalasani N, NASH Clinical Research Network (2018). Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology  67, 134-144.   https://doi.org/10.1002/hep.29489|30. Warner BM, Baer AN, Lipson EJ, Allen C, Hinrichs C, Rajan A, Pelayo E, Beach M, Gulley JL, Madan RA, Feliciano J, Grisius M, Long L, Powers A, Kleiner DE, Cappelli L, Alevizos I (2019). Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy. Oncologist  24, 1259-1269.   https://doi.org/10.1634/theoncologist.2018-0823|31. Xie C, Duffy AG, Mabry-Hrones D, Wood B, Levy E, Krishnasamy V, Khan J, Wei JS, Agdashian D, Tyagi M, Gangalapudi V, Fioravanti S, Walker M, Anderson V, Venzon D, Figg WD, Sandhu M, Kleiner DE, Morelli MP, Floudas CS, Brar G, Steinberg SM, Korangy F, Greten TF (2019). Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer. Hepatology  69, 2048-2060.   https://doi.org/10.1002/hep.30482",https://intramural.nih.gov/search/searchview.taf?ipid=108372
707,BC010687-15,"October 01, 2018 -  September 30, 2019",Histology Core Laboratory,Joseph  Chinquee,Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",NULL,NULL,Tashanda Renee Ashford (Laboratory of Pathology)|Lisandra Danielle Cavins (Laboratory of Pathology)|Makda Tesfai Gebregziabher (Laboratory of Pathology)|Terrica Shuntay Johnson (Laboratory of Pathology)|Michael Kanwolo Newford (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108374
708,BC010858-13,"October 01, 2018 -  September 30, 2019",CCR Microscopy Core,Michael John Kruhlak; PhD,Kent W Hunter; PhD,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,Weiye  Wang (Laboratory of Cellular and Molecular Biology)|Sarwat  Naz; PhD (Radiation Biology Branch)|Tim Friedrich Greten (Thoracic and GI Malignancies Branch)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Nicholas Phillip Restifo; MD (Surgery Branch)|Alfred  Singer; MD (Experimental Immunology Branch),Sarah Elizabeth May Herman; PhD (NHLBI),"1. Petrovic J, Zhou Y, Fasolino M, Goldman N, Schwartz GW, Mumbach MR, Nguyen SC, Rome KS, Sela Y, Zapataro Z, Blacklow SC, Kruhlak MJ, Shi J, Aster JC, Joyce EF, Little SC, Vahedi G, Pear WS, Faryabi RB (2019). Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques. Mol Cell  73, 1174-1190.e12.   https://doi.org/10.1016/j.molcel.2019.01.006",https://intramural.nih.gov/search/searchview.taf?ipid=108428
709,BC010903-12,"October 01, 2018 -  September 30, 2019",Transgenic Core Facility,Deborah A Swing,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Robert H Koogle|Holly Marie Morris,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108495
710,BC010905-12,"October 01, 2018 -  September 30, 2019",Surgery Branch Cell Prep Core,John R Wunderlich,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,Michelle  Pelletier (Surgery Branch)|Tangying  Lu (Surgery Branch)|Azam V Nahvi (Surgery Branch)|Thomas E Shelton (Surgery Branch)|Graeme Alex Fenton (Surgery Branch)|Zulmarie  Franco; MSc (Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108506
711,BC010915-12,"October 01, 2018 -  September 30, 2019",EIB Microscopy Core Facility,Jan  Wisniewski,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Dinah  Singer; PhD|Vanja  Lazarevic|Jung-Hyun  Park|Richard J Hodes; MD,NULL,Philip Jeffrey Tofilon (Radiation Oncology Branch)|Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Peter D Aplan; MD (Cancer Genetics Branch)|Raul Eduardo Vizcardo Sakoda (Surgery Branch)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Rosandra N Kaplan (Pediatric Oncology Branch),"Elissa P Lei; BS, PhD (NIDDK) |Richard D Leapman; PhD (NIBIB) |Rafael Cristian Casellas; PhD (NIAMS) |Myung Hee  Park; PhD (NIDCR) |David Barry Sacks (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108518
712,BC010934-12,"October 01, 2018 -  September 30, 2019",Immune reconstitution following autologous and allogeneic stem cell transplant,Jeremy J Rose,Christian S Hinrichs,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,Alexander Thomas De Almeida (Experimental Transplantation and Immunology Branch)|Cara Marie Pardon (Experimental Transplantation and Immunology Branch)|Xiao Y Yan (Experimental Transplantation and Immunology Branch)|Libsework Muluneh Belete (Experimental Transplantation and Immunology Branch)|Nicole A Crofton (Experimental Transplantation and Immunology Branch)|Divya Lakshmi Deverakonda (Experimental Transplantation and Immunology Branch),Dominique C Pichard (NIAMS),"1. Dimitrova D, Rose JJ, Uzel G, Cohen JI, Rao KV, Bleesing JH, Kanakry CG, Kanakry JA (2019). Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered. J Clin Immunol  39, 1-3.   https://doi.org/10.1007/s10875-018-0573-0",https://intramural.nih.gov/search/searchview.taf?ipid=108462
713,BC010936-12,"October 01, 2018 -  September 30, 2019",CCR Vaccine Branch FACS Core,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI",Sophia Nadine Brown|Marjorie  Robert-Guroff; PhD|Genoveffa  Franchini; MD|Monica  Vaccari|Yongjun  Sui|Barbara K Felber|Show all 9,Kent  Weinhold (DUMC)|Cliburn  Chan (Duke University)|Marcin  Moniuszko|Jason  Warfal (FDA),Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Charles  Vinson; PhD (Nucleic Acids Section)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Philipp  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Shalini  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Munira A Basrai; PhD (Cancer Genetics Branch),NULL,"1. McKinnon KM (2018). Flow Cytometry: An Overview. Curr Protoc Immunol  120, 5.1.1-5.1.11.   https://doi.org/10.1002/cpim.40",https://intramural.nih.gov/search/searchview.taf?ipid=108530
714,BC010937-12,"October 01, 2018 -  September 30, 2019",Novel Targets for Immunotherapy,Claudia Mercedes Palena|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Kristen Nicole Fousek|Heidi A Hempel|Lucas Alan Horn|Hanne Thor Lind|Kristen Koenig McCampbell|Jeffrey Charles Riskin|Show all 7,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",Clint Tanner Allen (NIDCD),"1. Hamilton DH, McCampbell KK, Palena C (2018). Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack. Front Oncol  8, 143.   https://doi.org/10.3389/fonc.2018.00143|2. Sun L, Clavijo PE, Robbins Y, Patel P, Friedman J, Greene S, Das R, Silvin C, Van Waes C, Horn LA, Schlom J, Palena C, Maeda D, Zebala J, Allen CT (2019). Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight  4.   https://doi.org/10.1172/jci.insight.126853",https://intramural.nih.gov/search/searchview.taf?ipid=108539
715,BC010947-12,"October 01, 2018 -  September 30, 2019",Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility,Ross G Lake,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,"Haydn  Kissick (Emory University School Of Medicine)|Emeline  Tabouret; MD, PhD (Neuro-Oncology Branch)",Zhenggang  Liu; PhD (Laboratory of Immune Cell Biology)|Adam G Sowalsky (Laboratory Of Genitourinary Cancer Pathogenesis)|Kandice Danielle Tanner; PhD (Laboratory of Cell Biology)|Philip Jeffrey Tofilon (Radiation Oncology Branch)|David James Vanderweele (Laboratory Of Genitourinary Cancer Pathogenesis)|Giorgio  Trinchieri (Cancer Inflammation Program),Lynne Ann A Holtzclaw; BS (NICHD) |David Lozoff Brody (NINDS),"1. Jiao D, Cai Z, Choksi S, Ma D, Choe M, Kwon HJ, Baik JY, Rowan BG, Liu C, Liu ZG (2018). Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis. Cell Res  28, 868-870.   https://doi.org/10.1038/s41422-018-0058-y|2. Li L, Ameri AH, Wang S, Jansson KH, Casey OM, Yang Q, Beshiri ML, Fang L, Lake RG, Agarwal S, Alilin AN, Xu W, Yin J, Kelly K (2019). EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene  38, 6241-6255.   https://doi.org/10.1038/s41388-019-0873-8|3. Ward Y, Lake R, Faraji F, Sperger J, Martin P, Gilliard C, Ku KP, Rodems T, Niles D, Tillman H, Yin J, Hunter K, Sowalsky AG, Lang J, Kelly K (2018). Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration. Cell Rep  23, 808-822.   https://doi.org/10.1016/j.celrep.2018.03.092|4. Xu Q, Choksi S, Liu Z (2018). Switching from TNF-induced inflammation to death signaling. Mol Cell Oncol  5, e1392402.   https://doi.org/10.1080/23723556.2017.1392402",https://intramural.nih.gov/search/searchview.taf?ipid=108503
716,BC010948-12,"October 01, 2018 -  September 30, 2019",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Shahram S Farid|Jared Joseph Gartner|Victoria Kate Hill|Li  Jia|Yili  Li|Arnold L Mixon|Show all 8,Yardena  Samuel (Weizmann Institute of Science)|Cyrille  Cohen,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108466
717,BC010953-12,"October 01, 2018 -  September 30, 2019",Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Hibret Amare Adissu|Jennifer B Dwyer|John  Hickerson|Shelley B Hoover|Munish  Puri|Bih-Rong  Wei|Show all 12,brandon  gallas (Food and Drug Administration)|Charles Harrison Castle Halsey (LABORATORY CANCER BIOLOGY & GENETICS)|Kevin D Woolard,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Natasha  Caplen (Cancer Genetics Branch)|Josip  Blonder (Office Of The Director)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Udayan  Guha (Thoracic and GI Malignancies Branch)",NULL,"1. Hernandez B, Adissu HA, Wei BR, Michael HT, Merlino G, Simpson RM (2018). Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas. Int J Mol Sci  19.   https://doi.org/10.3390/ijms19020394|2. Jansson KH, Tucker JB, Stahl LE, Simmons JK, Fuller C, Beshiri ML, Agarwal S, Fang L, Hynes PG, Alilin AN, Lake R, Abbey YC, Cawley J, Tice CM, Yin J, McKnight C, Klummp-Thomas C, Zhang X, Guha R, Hoover S, Simpson RM, Nguyen HM, Corey E, Thomas CJ, Proia DA, et al. [1 more author] (2018). High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer. Sci Rep  8, 17239.   https://doi.org/10.1038/s41598-018-35417-0",https://intramural.nih.gov/search/searchview.taf?ipid=108479
718,BC010965-12,"October 01, 2018 -  September 30, 2019",CCR Biophysics Resource Core,Sergey G Tarasov,Kylie Janice Walters,"Structural Biophysics Laboratory, NCI",Marzeena  Dyba|Robert Andrew Byrd,NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108496
719,BC010978-12,"October 01, 2018 -  September 30, 2019",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI","Itoro O Akpan|Paul A Randazzo; MD, PhD|Ying  Zhang|Ramiro  Iglesias-Bartolome; PhD",Wolfgang  Losert (University of Maryland)|Stephen  Bunnell (Tufts University School of Medicine)|Eilon  Sherman,"Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)","Paul E Love; MD, PhD (NICHD)","1. Dimitriou ID, Lee K, Akpan I, Lind EF, Barr VA, Ohashi PS, Samelson LE, Rottapel R (2018). Timed Regulation of 3BP2 Induction Is Critical for Sustaining CD8+ T Cell Expansion and Differentiation. Cell Rep  24, 1123-1135.   https://doi.org/10.1016/j.celrep.2018.06.075|2. Guittard G, Dios-Esponera A, Palmer DC, Akpan I, Barr VA, Manna A, Restifo NP, Samelson LE (2018). The Cish SH2 domain is essential for PLC-γ1 regulation in TCR stimulated CD8+ T cells. Sci Rep  8, 5336.   https://doi.org/10.1038/s41598-018-23549-2",https://intramural.nih.gov/search/searchview.taf?ipid=108439
720,BC010981-12,"October 01, 2018 -  September 30, 2019",Biomarker Investigations for Clinical Trials,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu|Javed  Khan; MD,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Jung-Min  Lee (Womens Malignancies Branch)|Christina M Annunziata (Womens Malignancies Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)",NULL,"1. Cao L, Yu Y, Thomas A, Zhang J, Onda M, Meltzer P, Hassan R, Pastan I (2018). Megakaryocyte Potentiating Factor as a Predictive Biomarker for Therapies Against Malignant Mesothelioma. JCO Precis Oncol  2018.   https://doi.org/10.1200/PO.17.00282",https://intramural.nih.gov/search/searchview.taf?ipid=108447
721,BC010989-12,"October 01, 2018 -  September 30, 2019",Clinical production of viral vectors for cancer gene therapy,Rachel  Beyer,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Anila  Afzal|Pearl  Queen|Adrian Alejandro Cuenca; MHS, PhD|Jonathan Henry Halmo|Ryan Alexandria Lee Shepherd|Suad  Diglisic|Show all 9",NULL,Ira H Pastan; MD (Molecular Biology Section),Joseph  Shiloach; PhD (NIDDK) |Harry Lewis Malech; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108455
722,BC010991-12,"October 01, 2018 -  September 30, 2019",Radiation Oncology Branch - Microarray Facility,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Shaoli  Das; PhD|Xiang  Deng|Uma  Shankavaram; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108445
723,BC011016-12,"October 01, 2018 -  September 30, 2019",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",Scott R Cherry; BS|Janet R Fields,"Jozsef  Tozser|Robert  Ulrich (Molecular Immunology, USAMRIID)|Vaclav  Veverka (Institute of Organic Chemistry and Biochemistry of the ASCR, v.v.i.)|Lesley-Ann  Giddings",David S Waugh; PhD (Protein Engineering Section)|Zbigniew  Dauter (Synchrotron Radiation Research Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Donald L Court; PhD (Rna Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Terrence R Burke; PhD (Chemical Biology Laboratory),NULL,"1. Gumpena R, Lountos GT, Raran-Kurussi S, Tropea JE, Cherry S, Waugh DS (2018). Crystal structure of the human dual specificity phosphatase 1 catalytic domain. Protein Sci  27, 561-567.   https://doi.org/10.1002/pro.3328|2. Lountos GT, Zhao XZ, Kiselev E, Tropea JE, Needle D, Pommier Y, Burke TR, Waugh DS (2019). Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening. Nucleic Acids Res  47, 10134-10150.   https://doi.org/10.1093/nar/gkz515",https://intramural.nih.gov/search/searchview.taf?ipid=108497
724,BC011021-11,"October 01, 2018 -  September 30, 2019",Basic Research Support for the CCR,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108227
725,BC011029-12,"October 01, 2018 -  September 30, 2019",Preclinical development and clinical monitoring of adoptive immune therapy,Jeremy J Rose,Christian S Hinrichs,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,Alexander Thomas De Almeida (Experimental Transplantation and Immunology Branch)|Vicki  Fellowes (Experimental Transplantation and Immunology Branch)|Cara Marie Pardon (Experimental Transplantation and Immunology Branch)|Xiao Y Yan (Experimental Transplantation and Immunology Branch)|Libsework Muluneh Belete (Experimental Transplantation and Immunology Branch)|Nicole A Crofton (Experimental Transplantation and Immunology Branch),David F Stroncek; MD (CC) |Clint Tanner Allen (NIDCD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108463
726,BC011030-12,"October 01, 2018 -  September 30, 2019",The Antigen Targeting Core,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Scott Harrison Kivitz|Nicholas Phillip Restifo; MD|Paul  Robbins,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108540
727,BC011040-12,"October 01, 2018 -  September 30, 2019",Molecular Profiling of Clinical Specimens,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",NULL,NULL,David  Petersen (Cancer Genetics Branch)|Jennifer  Walling (Cancer Genetics Branch)|Yonghong  Wang (Cancer Genetics Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|John Walter Glod (Pediatric Oncology Branch),NULL,"1. HernandezRamon E, Si N, Lachir Y, Cline J, Wood C, Asaki E, Edelman D, Petersen D, Sanchez V, Woodward R, Wang Y, Poirier M (2019) Transcriptional regulation of Tamoxifen in human and non-human primate endometrium and cultured breast and endometrial cells. Current Topics in Toxicology, in press.|2. Oltmann J, Heselmeyer-Haddad K, Hernandez LS, Meyer R, Torres I, Hu Y, Doberstein N, Killian JK, Petersen D, Zhu YJ, Edelman DC, Meltzer PS, Schwartz R, Gertz EM, Schäffer AA, Auer G, Habermann JK, Ried T (2018). Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients. Genes Chromosomes Cancer  57, 165-175.   https://doi.org/10.1002/gcc.22515",https://intramural.nih.gov/search/searchview.taf?ipid=108453
728,BC011041-12,"October 01, 2018 -  September 30, 2019",Technical Development of Molecular Profiling Technologies,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",NULL,NULL,David  Petersen (Cancer Genetics Branch)|Jennifer  Walling (Cancer Genetics Branch)|Yonghong  Wang (Cancer Genetics Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|John Walter Glod (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108454
729,BC011044-12,"October 01, 2018 -  September 30, 2019",Tissue Processing-Sequencing Facility,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Julian  Custer|Catherine  Wells|Robert A Worrell|Youfeng  Yang,William  Kaelin (Dana-Farber Cancer Institute)|Paul T Spellman|James  Brugarolas (University of Texas Southwestern Medical Center)|Maria  Czyzyk-Krzeska (University of Cincinnati)|Arul Moli Chinnaiyan|Elizabeth P Henske; MD (Brigham and Women's Hospital)|Show all 11,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Joel  Moss; MD, PhD (NHLBI) |Jeffrey Burnett Kopp; MD (NIDDK) |Ann C.M. Smith; MA, DSc (hon) (NHGRI) |Leslie Glenn Biesecker; MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108498
730,BC011047-12,"October 01, 2018 -  September 30, 2019",Animal Model and Genotyping Core Support Facility,Wendy Dianne Du Bois De Vroylande,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,Marta  Custer (Laboratory of Cancer Biology and Genetics)|Maudeline  Etienne (Laboratory of Cancer Biology and Genetics)|Dillon Selwyn Richardson (Laboratory of Cancer Biology and Genetics)|Anthony W Vieira (Laboratory of Cancer Biology and Genetics)|Susan  Walters (Laboratory of Cancer Biology and Genetics)|Tina M Wellington (Laboratory of Cancer Biology and Genetics),"Pamela Lee Schwartzberg; MD, PhD (NIAID) |Rafael Cristian Casellas; PhD (NIAMS) |Herbert Carpenter Morse; MD (NIAID) |Neal S Young; MD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108450
731,BC011052-12,"October 01, 2018 -  September 30, 2019",Cytopathology Core,Armando  Filie|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Dana K Erickson|May Ester Owens|Mark J Roth|Mark  Raffeld; MD|Stephen M Hewitt; MD, PhD|Svetlana Dmitriyevna Pack; PhD",NULL,Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Christina M Annunziata (Womens Malignancies Branch)|Raffit  Hassan (Thoracic and GI Malignancies Branch),Joanna  Klubo-Gwiezdzinska (NIDDK) |Natalie Dara Shaw; MD (NIEHS),"1. Lurain K, Polizzotto MN, Aleman K, Bhutani M, Wyvill KM, Gonçalves PH, Ramaswami R, Marshall VA, Miley W, Steinberg SM, Little RF, Wilson W, Filie AC, Pittaluga S, Jaffe ES, Whitby D, Yarchoan R, Uldrick TS (2019). Viral, immunologic, and clinical features of primary effusion lymphoma. Blood  133, 1753-1761.   https://doi.org/10.1182/blood-2019-01-893339",https://intramural.nih.gov/search/searchview.taf?ipid=108456
732,BC011075-12,"October 01, 2018 -  September 30, 2019",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Yinon  Shafrir,NULL,Suresh V Ambudkar; PhD (Viral Epidemiology Br),NULL,"1. Abel B, Tosh DK, Durell SR, Murakami M, Vahedi S, Jacobson KA, Ambudkar SV (2019). Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1). Mol Pharmacol  96, 180-192.   https://doi.org/10.1124/mol.118.115295|2. Vahedi S, Lusvarghi S, Pluchino K, Shafrir Y, Durell SR, Gottesman MM, Ambudkar SV (2018). Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein. Sci Rep  8, 12716.   https://doi.org/10.1038/s41598-018-30984-8",https://intramural.nih.gov/search/searchview.taf?ipid=108451
733,BC011077-12,"October 01, 2018 -  September 30, 2019",Molecular Modeling of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Ettore  Appella; MD,NULL,NULL,Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108452
734,BC011079-12,"October 01, 2018 -  September 30, 2019",Molecular Diagnostics Core Laboratory,Liqiang  Xi; MD,Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",Sodgerel  Batmunkh|Francine  Blumental De Abreu; PhD|Vineela  Gangalapudi|Gloria Mawufakor Gblokpor|Yoon Jeong  Jang; MS|Jung A Kim|Show all 17,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)","Steven M Holland; MD (NIAID) |Amy D Klion; MD (NIAID) |William A Gahl; MD, PhD (NHGRI) |Adrian U Wiestner; MD, PhD (NHLBI) |Irina  Maric; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108545
735,BC011093-12,"October 01, 2018 -  September 30, 2019",Flow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",Truc Thanh Ho|Catharine S Mccoy|Aaron Richard Nelson|Dalia Abdel-Raouf Salem|Hao-Wei  Wang|Linda Shonk Weaver|Show all 7,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Nirali Niranjan Shah (Pediatric Oncology Branch)|Ramya Meenakshi Ramaswami (HIV and AIDS Malignancy Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108494
736,BC011104-12,"October 01, 2018 -  September 30, 2019",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",Truc Thanh Ho|Catharine S Mccoy|Hao-Wei  Wang|Linda Shonk Weaver|Constance M Yuan,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ira H Pastan; MD (Molecular Biology Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|James N Kochenderfer (Surgery Branch)|Nirali Niranjan Shah (Pediatric Oncology Branch)|Christian S Hinrichs (Experimental Transplantation and Immunology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Bhojwani D, Sposto R, Shah NN, Rodriguez V, Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer JL, Quereshi A, Cabannes A, Schlegel P, Rossig C, Dalla-Pozza L, August K, Alexander S, Bourquin JP, Zwaan M, Raetz EA, Loh ML, Rheingold SR (2019). Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia  33, 884-892.   https://doi.org/10.1038/s41375-018-0265-z|2. Khanna S, Graef S, Mussai F, Thomas A, Wali N, Yenidunya BG, Yuan C, Morrow B, Zhang J, Korangy F, Greten TF, Steinberg SM, Stetler-Stevenson M, Middleton G, De Santo C, Hassan R (2018). Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients. Clin Cancer Res  24, 2859-2872.   https://doi.org/10.1158/1078-0432.CCR-17-3757|3. Salem DA, Korde N, Venzon DJ, Liewehr DJ, Maric I, Calvo KR, Braylan R, Tembhare PR, Yuan CM, Landgren CO, Stetler-Stevenson M (2018). Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma. Leuk Lymphoma  59, 178-186.   https://doi.org/10.1080/10428194.2017.1321746",https://intramural.nih.gov/search/searchview.taf?ipid=108493
737,BC011138-12,"October 01, 2018 -  September 30, 2019",ETIB FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Nga  Voong|Veena N Kapoor,NULL,NULL,NULL,"1. Telford WG (2018). Overview of Lasers for Flow Cytometry. Methods Mol Biol  1678, 447-479.   https://doi.org/10.1007/978-1-4939-7346-0_19",https://intramural.nih.gov/search/searchview.taf?ipid=108543
738,BC011139-12,"October 01, 2018 -  September 30, 2019",Application of novel laser technology for flow cytometric analysis,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)|Awtar  Krishan (University of Miami School of Medicine)|Fetah  Benabid (University of Limoges)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108544
739,BC011236-11,"October 01, 2018 -  September 30, 2019",CCR-Frederick Flow Cytometry Core,Kimberly D Klarmann,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",NULL,NULL,Jeffrey Alan Carrell (Cancer Inflammation Program)|Megan  Whang (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108565
740,BC011237-11,"October 01, 2018 -  September 30, 2019",CIP Microbiome and Genetics Core,Colm  Ohuigin,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",NULL,Effie  Petersdorf (Fred Hutchinson)|Robert  Lanford (Texas Biomedical Research Institute),Sonia Vikas Ahluwalia (Cancer Inflammation Program)|Tatyana Y Fuksenko (Cancer Inflammation Program)|Shurjo  Sen; PhD (Cancer Inflammation Program)|Vishal Vijayan Thovarai (Cancer Inflammation Program)|Wuxing  Yuan (Cancer Inflammation Program)|Scott K Durum; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108566
741,BC011265-10,"October 01, 2018 -  September 30, 2019",Gene Targeting Facility,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Mary Ellen  Palko|Susan W Reid|Bradley D St Croix|Jonathan  Keller; PhD,NULL,"Jairaj K Acharya; MBBS, PhD (Cancer and Developmental Biology Laboratory)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Ji Ming  Wang; MD, PhD (Cancer Inflammation Program)",NULL,"1. Chen K, Tang P, Bao Z, He T, Xiang Y, Gong W, Yoshimura T, Le Y, Tessarollo L, Chen X, Wang JM (2018). Deficiency in Fpr2 results in reduced numbers of Lin-cKit+Sca1+ myeloid progenitor cells. J Biol Chem  293, 13452-13463.   https://doi.org/10.1074/jbc.RA118.002683|2. Singh SK, Singh S, Gadomski S, Sun L, Pfannenstein A, Magidson V, Chen X, Kozlov S, Tessarollo L, Klarmann KD, Keller JR (2018). Id1 Ablation Protects Hematopoietic Stem Cells from Stress-Induced Exhaustion and Aging. Cell Stem Cell  23, 252-265.e8.   https://doi.org/10.1016/j.stem.2018.06.001|3. Yoshimura T, McLean MH, Dzutsev AK, Yao X, Chen K, Huang J, Gong W, Zhou J, Xiang Y, H Badger J, O'hUigin C, Thovarai V, Tessarollo L, Durum SK, Trinchieri G, Bian XW, Wang JM (2018). The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance. J Immunol  200, 2174-2185.   https://doi.org/10.4049/jimmunol.1602073",https://intramural.nih.gov/search/searchview.taf?ipid=108584
742,BC011309-10,"October 01, 2018 -  September 30, 2019",DNA Extraction Service,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Experimental Immunology Branch)|Paul A Roche; PhD (Experimental Immunology Branch)|Richard J Hodes; MD (Experimental Immunology Branch)|Jung-Hyun  Park (Experimental Immunology Branch)|Vanja  Lazarevic (Experimental Immunology Branch)|Chuan  Wu (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108600
743,BC011310-10,"October 01, 2018 -  September 30, 2019",Hollow Fiber Production of Monoclonal Antibodies,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Experimental Immunology Branch)|Jung-Hyun  Park (Experimental Immunology Branch)|Vanja  Lazarevic (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108601
744,BC011331-10,"October 01, 2018 -  September 30, 2019",CCR Sequencing Facility,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",Vicky  Chen; PhD|Xiongfong  Chen|Oksana  German|Sujatha B Gowda|Parimal  Kumar|Yelena  Levin|Show all 19,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108611
745,BC011380-09,"October 01, 2018 -  September 30, 2019",HIV NCp7 inhibitors and Multivalent Inhibition of Membrane Receptors,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Ettore  Appella; MD,NULL,NULL,Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108628
746,BC011428-08,"October 01, 2018 -  September 30, 2019","CCR, LGI, Flow Cytometry Core",Ferenc  Livak,Andre A Nussenzweig; PhD,"Laboratory Of Genome Integrity, NCI",Subhadra  Banerjee|Caiyi  Li|Shafiuddin  Siddiqui|Karen Marie Wolcott,NULL,NULL,NULL,"1. He B, Deng T, Zhu I, Furusawa T, Zhang S, Tang W, Postnikov Y, Ambs S, Li CC, Livak F, Landsman D, Bustin M (2018). Binding of HMGN proteins to cell specific enhancers stabilizes cell identity. Nat Commun  9, 5240.   https://doi.org/10.1038/s41467-018-07687-9|2. Joshi SS, Tandukar B, Pan L, Huang JM, Livak F, Smith BJ, Hodges T, Mahurkar AA, Hornyak TJ (2019). CD34 defines melanocyte stem cell subpopulations with distinct regenerative properties. PLoS Genet  15, e1008034.   https://doi.org/10.1371/journal.pgen.1008034|3. Zheng H, Pomyen Y, Hernandez MO, Li C, Livak F, Tang W, Dang H, Greten TF, Davis JL, Zhao Y, Mehta M, Levin Y, Shetty J, Tran B, Budhu A, Wang XW (2018). Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology  68, 127-140.   https://doi.org/10.1002/hep.29778",https://intramural.nih.gov/search/searchview.taf?ipid=108679
747,BC011430-08,"October 01, 2018 -  September 30, 2019",CPTR - Mass Spectrometry Unit,Lisa Marie Jenkins,Suresh V Ambudkar; PhD,"Laboratory of Cell Biology, NCI",Michael Marc Gottesman; MD|Ettore  Appella; MD|Kandice Danielle Tanner; PhD|Pedro Jorge De Oliveira Rodrigues Batista; PhD,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Ashish Kumar Lal (Cancer Genetics Branch)|David D Roberts; PhD (Laboratory of Pathology)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Natasha  Caplen (Cancer Genetics Branch)",Lisa Lynn Cunningham (NIDCD),"1. Alam MS, Gaida MM, Debnath S, Tagad HD, Miller Jenkins LM, Appella E, Rahman MJ, Ashwell JD (2018). Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation. PLoS Biol  16, e2004111.   https://doi.org/10.1371/journal.pbio.2004111|2. Kriebel PW, Majumdar R, Jenkins LM, Senoo H, Wang W, Ammu S, Chen S, Narayan K, Iijima M, Parent CA (2018). Extracellular vesicles direct migration by synthesizing and releasing chemotactic signals. J Cell Biol  217, 2891-2910.   https://doi.org/10.1083/jcb.201710170|3. Luo R, Chen PW, Kuo JC, Jenkins L, Jian X, Waterman CM, Randazzo PA (2018). ARAP2 inhibits Akt independently of its effects on focal adhesions. Biol Cell  110, 257-270.   https://doi.org/10.1111/boc.201800044|4. Madigan JP, Hou F, Ye L, Hu J, Dong A, Tempel W, Yohe ME, Randazzo PA, Jenkins LMM, Gottesman MM, Tong Y (2018). The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding. J Biol Chem  293, 16142-16159.   https://doi.org/10.1074/jbc.RA118.003525|5. Murai J, Tang SW, Leo E, Baechler SA, Redon CE, Zhang H, Al Abo M, Rajapakse VN, Nakamura E, Jenkins LMM, Aladjem MI, Pommier Y (2018). SLFN11 Blocks Stressed Replication Forks Independently of ATR. Mol Cell  69, 371-384.e6.   https://doi.org/10.1016/j.molcel.2018.01.012",https://intramural.nih.gov/search/searchview.taf?ipid=108664
748,BC011434-08,"October 01, 2018 -  September 30, 2019",Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section,Jinqiu  Chen,Thomas A Misteli; PhD,"Office of the Director, NCI",Noemi  Kedei|Xiaoling  Luo,"Richard  Bryant (Oxford Cancer Research Centre, University Of Oxford)|Melissa  Ratner (Cincinnati Children's Hospital)","Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Javed  Khan; MD (Cancer Genetics Branch)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Christina M Annunziata (Womens Malignancies Branch)","Perry Justin Blackshear; MD, DPhil (NIEHS) |Robert Simon Adelstein; MD (NHLBI) |Mark Robert Cookson; PhD (NIA) |Andrew  Redd; PhD (NIAID)","1. Knudson KM, Hicks KC, Luo X, Chen JQ, Schlom J, Gameiro SR (2018). M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine. Oncoimmunology  7, e1426519.   https://doi.org/10.1080/2162402X.2018.1426519|2. Liyasova MS, Ma K, Voeller D, Ryan PE, Chen J, Klevit RE, Lipkowitz S (2019). Cbl interacts with multiple E2s in vitro and in cells. PLoS One  14, e0216967.   https://doi.org/10.1371/journal.pone.0216967|3. Takai A, Dang H, Oishi N, Khatib S, Martin SP, Dominguez DA, Luo J, Bagni R, Wu X, Powell K, Ye QH, Jia HL, Qin LX, Chen J, Mitchell GA, Luo X, Thorgeirsson SS, Wang XW (2019). Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma. Cancer Res  79, 2379-2391.   https://doi.org/10.1158/0008-5472.CAN-18-3015|4. Zhovmer AS, Tabdanov ED, Miao H, Wen H, Chen J, Luo X, Ma X, Provenzano PP, Adelstein RS (2019). The role of nonmuscle myosin 2A and 2B in the regulation of mesenchymal cell contact guidance. Mol Biol Cell  30, 1961-1973.   https://doi.org/10.1091/mbc.E19-01-0071",https://intramural.nih.gov/search/searchview.taf?ipid=108667
749,BC011475-07,"October 01, 2018 -  September 30, 2019",Genomics and Bioinformatics Group web site development and maintenance,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch)|Yanghsin  Wang (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108688
750,BC011497-07,"October 01, 2018 -  September 30, 2019",RNA sequencing (RNA-Seq) of the NCI-60,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,"Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch)|Yanghsin  Wang (Developmental Therapeutics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108686
751,BC011509-07,"October 01, 2018 -  September 30, 2019",Comparison of molecular factors to drug activities,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,Ruedi  Aebersold (Institute for Systems Biology)|Mathew  Garnett (Wellcome Trust Sanger Institute)|Tiannan  Guo (Institute Of Biotechnology At The Swiss Federal Institute Of Technology)|Augustin  Luna|Chris  Sander (Dana-Farber Cancer Institute),"Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|David Jay Goldstein (Office of the Director)|Mirit I Aladjem; PhD (Developmental Therapeutics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108687
752,BC011515-07,"October 01, 2018 -  September 30, 2019",Chemical Synthesis Core,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Gary T Pauly,NULL,Patricia  Steeg; PhD (Womens Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108696
753,BC011531-07,"October 01, 2018 -  September 30, 2019",High Throughput Screening of Agents in Bladder Cancer Cell Lines,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Qingdi Q Li|Reema Sunil Railkar,NULL,Andrea Borghese Apolo (Genitourinary Malignancies Branch),Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108702
754,BC011532-07,"October 01, 2018 -  September 30, 2019",CCR Collaborative Bioinformatics Resource,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",Parthav A Jailwala|Vishal Nitinchandra Koparde; PhD|Skyler Alexander Kuhn|Alexei Viktorovich Lobanov|Ajeet  Mandal; PhD|Thomas Joshua Meyer; PhD|Show all 10,NULL,"Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Cheryl Ann Winkler (Basic Research Laboratory)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Dennis D Hickstein (Experimental Transplantation and Immunology Branch)|Carol J Thiele (Pediatric Oncology Branch)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Greer YE, Porat-Shliom N, Nagashima K, Stuelten C, Crooks D, Koparde VN, Gilbert SF, Islam C, Ubaldini A, Ji Y, Gattinoni L, Soheilian F, Wang X, Hafner M, Shetty J, Tran B, Jailwala P, Cam M, Lang M, Voeller D, Reinhold WC, Rajapakse V, Pommier Y, Weigert R, Linehan WM, et al. [1 more author] (2018). ONC201 kills breast cancer cells in vitro by targeting mitochondria. Oncotarget  9, 18454-18479.   https://doi.org/10.18632/oncotarget.24862",https://intramural.nih.gov/search/searchview.taf?ipid=108712
755,BC011535-06,"October 01, 2018 -  September 30, 2019",SAXS Core,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Angel  Cantero-Camacho|Lixin  Fan; PhD,NULL,NULL,NULL,"1. Kim TS, Zhang L, Il Ahn J, Meng L, Chen Y, Lee E, Bang JK, Lim JM, Ghirlando R, Fan L, Wang YX, Kim BY, Park JE, Lee KS (2019). Molecular architecture of a cylindrical self-assembly at human centrosomes. Nat Commun  10, 1151.   https://doi.org/10.1038/s41467-019-08838-2",https://intramural.nih.gov/search/searchview.taf?ipid=108743
756,BC011567-06,"October 01, 2018 -  September 30, 2019",HiTIF Microscopy Core Facility,Gianluca  Pegoraro,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Adrian Alejandro Carcamo|Prabhakar R Gudla; PhD|Daniel Robert Larson; PhD|Thomas A Misteli; PhD|Yamini Praful Dalal,NULL,"Munira A Basrai; PhD (Cancer Genetics Branch)|Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Sergio  Ruiz Macias; PhD (Laboratory Of Genome Integrity)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Yousuke  Takahama; PhD (Experimental Immunology Branch)","Iain  Fraser (NIAID) |Luis Miguel Franco (NIAMS) |Elissa P Lei; BS, PhD (NIDDK) |Kapil  Bharti; PhD (NEI)","1. Adriaens C, Serebryannyy LA, Feric M, Schibler A, Meaburn KJ, Kubben N, Trzaskoma P, Shachar S, Vidak S, Finn EH, Sood V, Pegoraro G, Misteli T (2018). Blank spots on the map: some current questions on nuclear organization and genome architecture. Histochem Cell Biol  150, 579-592.   https://doi.org/10.1007/s00418-018-1726-1|2. Finn EH, Pegoraro G, Brandão HB, Valton AL, Oomen ME, Dekker J, Mirny L, Misteli T (2019). Extensive Heterogeneity and Intrinsic Variation in Spatial Genome Organization. Cell  176, 1502-1515.e10.   https://doi.org/10.1016/j.cell.2019.01.020|3. Jevtić P, Schibler AC, Wesley CC, Pegoraro G, Misteli T, Levy DL (2019). The nucleoporin ELYS regulates nuclear size by controlling NPC number and nuclear import capacity. EMBO Rep  20.   https://doi.org/10.15252/embr.201847283|4. Jowhar Z, Gudla PR, Shachar S, Wangsa D, Russ JL, Pegoraro G, Ried T, Raznahan A, Misteli T (2018). HiCTMap: Detection and analysis of chromosome territory structure and position by high-throughput imaging. Methods  142, 30-38.   https://doi.org/10.1016/j.ymeth.2018.01.013|5. Jowhar Z, Shachar S, Gudla PR, Wangsa D, Torres E, Russ JL, Pegoraro G, Ried T, Raznahan A, Misteli T (2018). Effects of human sex chromosome dosage on spatial chromosome organization. Mol Biol Cell  29, 2458-2469.   https://doi.org/10.1091/mbc.E18-06-0359|6. Stavreva DA, Garcia DA, Fettweis G, Gudla PR, Zaki GF, Soni V, McGowan A, Williams G, Huynh A, Palangat M, Schiltz RL, Johnson TA, Presman DM, Ferguson ML, Pegoraro G, Upadhyaya A, Hager GL (2019). Transcriptional Bursting and Co-bursting Regulation by Steroid Hormone Release Pattern and Transcription Factor Mobility. Mol Cell  75, 1161-1177.e11.   https://doi.org/10.1016/j.molcel.2019.06.042",https://intramural.nih.gov/search/searchview.taf?ipid=108725
757,BC011569-06,"October 01, 2018 -  September 30, 2019",Cell Production Core Facility,Robert P Somerville,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",James N Kochenderfer,NULL,Christian S Hinrichs (Experimental Transplantation and Immunology Branch),NULL,"1. Deniger DC, Pasetto A, Robbins PF, Gartner JJ, Prickett TD, Paria BC, Malekzadeh P, Jia L, Yossef R, Langhan MM, Wunderlich JR, Danforth DN, Somerville RPT, Rosenberg SA (2018). T-cell Responses to TP53 ""Hotspot"" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers. Clin Cancer Res  24, 5562-5573.   https://doi.org/10.1158/1078-0432.CCR-18-0573|2. Malekzadeh P, Pasetto A, Robbins PF, Parkhurst MR, Paria BC, Jia L, Gartner JJ, Hill V, Yu Z, Restifo NP, Sachs A, Tran E, Lo W, Somerville RP, Rosenberg SA, Deniger DC (2019). Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers. J Clin Invest  129, 1109-1114.   https://doi.org/10.1172/JCI123791|3. Stevanović S, Helman SR, Wunderlich JR, Langhan MM, Doran SL, Kwong MLM, Somerville RPT, Klebanoff CA, Kammula US, Sherry RM, Yang JC, Rosenberg SA, Hinrichs CS (2019). A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers. Clin Cancer Res  25, 1486-1493.   https://doi.org/10.1158/1078-0432.CCR-18-2722|4. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu YC, Zheng Z, Pasetto A, Langhan M, Shelton T, Prickett T, Gartner J, Jia L, Trebska-McGowan K, Somerville RP, Robbins PF, Rosenberg SA, Goff SL, Feldman SA (2018). Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med  24, 724-730.   https://doi.org/10.1038/s41591-018-0040-8",https://intramural.nih.gov/search/searchview.taf?ipid=108723
758,BC011571-06,"October 01, 2018 -  September 30, 2019",Transcription factor mobility,Tatiana  Karpova,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,Gunjan Deepakkumar Mehta; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Mehta GD, Ball DA, Eriksson PR, Chereji RV, Clark DJ, McNally JG, Karpova TS (2018). Single-Molecule Analysis Reveals Linked Cycles of RSC Chromatin Remodeling and Ace1p Transcription Factor Binding in Yeast. Mol Cell  72, 875-887.e9.   https://doi.org/10.1016/j.molcel.2018.09.009|2. Serebryannyy LA, Ball DA, Karpova TS, Misteli T (2019). Single molecule analysis of lamin dynamics. Methods  157, 56-65.   https://doi.org/10.1016/j.ymeth.2018.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=108719
759,BC011574-06,"October 01, 2018 -  September 30, 2019",LRBGE Optical Microscopy Core,Tatiana  Karpova,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,John S Choy|Jeffrey  Rothstein (Johns Hopkins University School of Medicine),"David Allan Ball (Laboratory of Receptor Biology and Gene Expression)|Munira A Basrai; PhD (Cancer Genetics Branch)|Genoveffa  Franchini; MD (Vaccine Branch)|Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)|Kyung  Lee; PhD (Laboratory of Metabolism)|Karl Thomas Ried; MD (Cancer Genetics Branch)","Marta Liliana Catalfamo; PhD (NIAID) |Edward  Giniger; BS, MS, PHD (NINDS)","1. Kim J, Sturgill D, Sebastian R, Khurana S, Tran AD, Edwards GB, Kruswick A, Burkett S, Hosogane EK, Hannon WW, Weyemi U, Bonner WM, Luger K, Oberdoerffer P (2018). Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic Regions. Mol Cell  69, 36-47.e7.   https://doi.org/10.1016/j.molcel.2017.11.021|2. Lee NCO, Kim JH, Petrov NS, Lee HS, Masumoto H, Earnshaw WC, Larionov V, Kouprina N (2018). Method to Assemble Genomic DNA Fragments or Genes on Human Artificial Chromosome with Regulated Kinetochore Using a Multi-Integrase System. ACS Synth Biol  7, 63-74.   https://doi.org/10.1021/acssynbio.7b00209|3. Pesenti E, Kouprina N, Liskovykh M, Aurich-Costa J, Larionov V, Masumoto H, Earnshaw WC, Molina O (2018). Generation of a Synthetic Human Chromosome with Two Centromeric Domains for Advanced Epigenetic Engineering Studies. ACS Synth Biol  7, 1116-1130.   https://doi.org/10.1021/acssynbio.8b00018|4. Rahman MA, McKinnon KM, Karpova TS, Ball DA, Venzon DJ, Fan W, Kang G, Li Q, Robert-Guroff M (2018). Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8+ T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control. J Immunol  200, 2714-2726.   https://doi.org/10.4049/jimmunol.1701403|5. Shah SB, Parmiter D, Constantine C, Elizalde P, Naldrett M, Karpova TS, Choy JS (2019). Glucose Signaling Is Connected to Chromosome Segregation Through Protein Kinase A Phosphorylation of the Dam1 Kinetochore Subunit in Saccharomycescerevisiae. Genetics  211, 531-547.   https://doi.org/10.1534/genetics.118.301727",https://intramural.nih.gov/search/searchview.taf?ipid=108722
760,BC011596-06,"October 01, 2018 -  September 30, 2019",CCR Dedicated Cores,Robin T Winkler Pickett,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108714
761,BC011622-05,"October 01, 2018 -  September 30, 2019",Development of novel molecular or phenotypic databases,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,Mathew  Garnett (Wellcome Trust Sanger Institute)|Ruedi  Aebersold (Institute for Systems Biology),"Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch)|Yanghsin  Wang (Developmental Therapeutics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)",NULL,"1. Rajapakse VN, Luna A, Yamade M, Loman L, Varma S, Sunshine M, Iorio F, Sousa FG, Elloumi F, Aladjem MI, Thomas A, Sander C, Kohn KW, Benes CH, Garnett M, Reinhold WC, Pommier Y (2018). CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines. iScience  10, 247-264.   https://doi.org/10.1016/j.isci.2018.11.029|2. Reinhold WC, Varma S, Sunshine M, Elloumi F, Ofori-Atta K, Lee S, Trepel JB, Meltzer PS, Doroshow JH, Pommier Y (2019). RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB. Cancer Res  79, 3514-3524.   https://doi.org/10.1158/0008-5472.CAN-18-2047",https://intramural.nih.gov/search/searchview.taf?ipid=108761
762,BC011623-05,"October 01, 2018 -  September 30, 2019",CCR Genomics Core,Elizabeth A Conner,Javed  Khan; MD,"Cancer Genetics Branch, NCI",NULL,NULL,Steven W Shema (Cancer Genetics Branch)|Qin  Wei (Cancer Genetics Branch),NULL,"1. Yim SY, Shim JJ, Shin JH, Jeong YS, Kang SH, Kim SB, Eun YG, Lee DJ, Conner EA, Factor VM, Moore DD, Johnson RL, Thorgeirsson SS, Lee JS (2018). Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer. Mol Cancer Res  16, 1713-1723.   https://doi.org/10.1158/1541-7786.MCR-18-0313",https://intramural.nih.gov/search/searchview.taf?ipid=108760
763,BC011638-05,"October 01, 2018 -  September 30, 2019",Experimental Pathology Laboratory (EPL),"Stephen M Hewitt; MD, PhD",Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",Joon Yong Chung|Jeffrey C Hanson|Kristofferson R Ylaya|Elaine S Jaffe; MD|Frederic Glenn Barr|David  Levens; PhD|Show all 9,NULL,NULL,NULL,"1. Abubakar M, Chang-Claude J, Ali HR, Chatterjee N, Coulson P, Daley F, Blows F, Benitez J, Milne RL, Brenner H, Stegmaier C, Mannermaa A, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RAEM, Seynaeve C, Figueroa J, Lissowska J, Hewitt S, Hooning MJ, Hollestelle A, Foekens R, Koppert LB, et al. [12 more authors] (2018). Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. Int J Cancer  143, 746-757.   https://doi.org/10.1002/ijc.31352|2. Chung JY, Song JS, Ylaya K, Sears JD, Choi L, Cho H, Rosenberg AZ, Hewitt SM (2018). Histomorphological and Molecular Assessments of the Fixation Times Comparing Formalin and Ethanol-Based Fixatives. J Histochem Cytochem  66, 121-135.   https://doi.org/10.1369/0022155417741467|3. Dieci MV, Radosevic-Robin N, Fineberg S, van den Eynden G, Ternes N, Penault-Llorca F, Pruneri G, D'Alfonso TM, Demaria S, Castaneda C, Sanchez J, Badve S, Michiels S, Bossuyt V, Rojo F, Singh B, Nielsen T, Viale G, Kim SR, Hewitt S, Wienert S, Loibl S, Rimm D, Symmans F, Denkert C, International Immuno-Oncology Biomarker Working Group on Breast Cancer, et al. [3 more authors] (2018). Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. Semin Cancer Biol  52, 16-25.   https://doi.org/10.1016/j.semcancer.2017.10.003|4. Hewitt SM (2018). The Role of Extracellular Matrix in Innate Immunity, Fugues of Evolution. J Histochem Cytochem  66, 211.   https://doi.org/10.1369/0022155418761352|5. Horne HN, Oh H, Sherman ME, Palakal M, Hewitt SM, Schmidt MK, Milne RL, Hardisson D, Benitez J, Blomqvist C, Bolla MK, Brenner H, Chang-Claude J, Cora R, Couch FJ, Cuk K, Devilee P, Easton DF, Eccles DM, Eilber U, Hartikainen JM, Heikkilä P, Holleczek B, Hooning MJ, Jones M, et al. [27 more authors] (2018). E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. Sci Rep  8, 6574.   https://doi.org/10.1038/s41598-018-23733-4|6. Ko A, Han SY, Choi CH, Cho H, Lee MS, Kim SY, Song JS, Hong KM, Lee HW, Hewitt SM, Chung JY, Song J (2018). Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF. Cell Death Differ  25, 1050-1062.   https://doi.org/10.1038/s41418-018-0072-0|7. Koutros S, Lenz P, Hewitt SM, Kida M, Jones M, Schned AR, Baris D, Pfeiffer R, Schwenn M, Johnson A, Karagas MR, Garcia-Closas M, Rothman N, Moore LE, Silverman DT (2018). RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic. J Natl Cancer Inst  110, 1273-1274.   https://doi.org/10.1093/jnci/djy045|8. Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, Palmer M, Rosenberg AZ, Lemley KV, Chien HP, Zee J, Smith A, Appel GB, Trachtman H, Hewitt SM, Kretzler M, Bagnasco SM (2018). Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Nephrol Dial Transplant  33, 310-318.   https://doi.org/10.1093/ndt/gfw443|9. Morfouace M, Hewitt SM, Salgado R, Hartmann K, Litiere S, Tejpar S, Golfinopoulos V, Lively T, Thurin M, Conley B, Lacombe D (2018). A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design. Semin Cancer Biol  52, 158-165.   https://doi.org/10.1016/j.semcancer.2018.01.003|10. Phelan JD, Young RM, Webster DE, Roulland S, Wright GW, Kasbekar M, Shaffer AL, Ceribelli M, Wang JQ, Schmitz R, Nakagawa M, Bachy E, Huang DW, Ji Y, Chen L, Yang Y, Zhao H, Yu X, Xu W, Palisoc MM, Valadez RR, Davies-Hill T, Wilson WH, Chan WC, Jaffe ES, et al. [15 more authors] (2018). A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature  560, 387-391.   https://doi.org/10.1038/s41586-018-0290-0|11. Zee J, Hodgin JB, Mariani LH, Gaut JP, Palmer MB, Bagnasco SM, Rosenberg AZ, Hewitt SM, Holzman LB, Gillespie BW, Barisoni L (2018). Reproducibility and Feasibility of Strategies for Morphologic Assessment of Renal Biopsies Using the Nephrotic Syndrome Study Network Digital Pathology Scoring System. Arch Pathol Lab Med  142, 613-625.   https://doi.org/10.5858/arpa.2017-0181-OA",https://intramural.nih.gov/search/searchview.taf?ipid=108756
764,BC011641-05,"October 01, 2018 -  September 30, 2019",Pre-clinical Translational Research Facility,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Dionne  Davis|Jinkyu  Jung|Hua  Song|Mei  Zhang; MD, PhD|Wei  Zhang|Aiguo  Li|Show all 12",NULL,James W Hodge; PhD (Laboratory of Tumor Immunology and Biology),NULL,"1. Giles AJ, Hutchinson MND, Sonnemann HM, Jung J, Fecci PE, Ratnam NM, Zhang W, Song H, Bailey R, Davis D, Reid CM, Park DM, Gilbert MR (2018). Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. J Immunother Cancer  6, 51.   https://doi.org/10.1186/s40425-018-0371-5|2. Hao S, Song H, Zhang W, Seldomridge A, Jung J, Giles AJ, Hutchinson MK, Cao X, Colwell N, Lita A, Larion M, Maric D, Abu-Asab M, Quezado M, Kramp T, Camphausen K, Zhuang Z, Gilbert MR, Park DM (2018). Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma. Neuro Oncol  20, 799-809.   https://doi.org/10.1093/neuonc/nox241|3. Larion M, Dowdy T, Ruiz-Rodado V, Meyer MW, Song H, Zhang W, Davis D, Gilbert MR, Lita A (2018). Detection of Metabolic Changes Induced via Drug Treatments in Live Cancer Cells and Tissue Using Raman Imaging Microscopy. Biosensors (Basel)  9.   https://doi.org/10.3390/bios9010005",https://intramural.nih.gov/search/searchview.taf?ipid=108765
765,BC011724-04,"October 01, 2018 -  September 30, 2019",Effects of Cytosine Modifications on Transcription Factor Binding,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Charles  Vinson; PhD (Nucleic Acids Section),NULL,"1. Ray S, Tillo D, Assad N, Ufot A, Deppmann C, Durell SR, Porollo A, Vinson C (2018). Replacing C189 in the bZIP domain of Zta with S, T, V, or A changes DNA binding specificity to four types of double-stranded DNA. Biochem Biophys Res Commun  501, 905-912.   https://doi.org/10.1016/j.bbrc.2018.05.080",https://intramural.nih.gov/search/searchview.taf?ipid=108810
766,BC011731-04,"October 01, 2018 -  September 30, 2019","Tissue Procurement, Processing Facility and Biorepository",Joseph  Chinquee,Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",NULL,NULL,Mohammad Javed Mahboob (Laboratory of Pathology)|Sarah Paige Young (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108817
767,BC011820-02,"October 01, 2018 -  September 30, 2019",DNA methylation data development and for small cell lung cancer,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch)|Yanghsin  Wang (Developmental Therapeutics Branch)|Beverly Ann Teicher (Molecular Pharmocology Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)|David Jay Goldstein (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108889
768,BC011842-02,"October 01, 2018 -  September 30, 2019",Molecular Mechanisms of Cancer Development,Svetlana Dmitriyevna Pack; PhD,Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",Ziedulla  Abdullaev|Shannon I Skarshaug|Valerie M Zgonc|Martha Maria Nicacio Quezado; MD|Frederic Glenn Barr|Elaine S Jaffe; MD|Show all 9,NULL,"Udayan  Guha (Thoracic and GI Malignancies Branch)|Raffit  Hassan (Thoracic and GI Malignancies Branch)|Nicholas Phillip Restifo; MD (Surgery Branch)|Zhengping  Zhuang; MD, PhD (Neuro-Oncology Branch)",NULL,"1. Pang Y, Gupta G, Yang C, Wang H, Huynh TT, Abdullaev Z, Pack SD, Percy MJ, Lappin TRJ, Zhuang Z, Pacak K (2018). A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: a case report. BMC Cancer  18, 286.   https://doi.org/10.1186/s12885-018-4127-x|2. Vizcardo R, Klemen ND, Islam SMR, Gurusamy D, Tamaoki N, Yamada D, Koseki H, Kidder BL, Yu Z, Jia L, Henning AN, Good ML, Bosch-Marce M, Maeda T, Liu C, Abdullaev Z, Pack S, Palmer DC, Stroncek DF, Ito F, Flomerfelt FA, Kruhlak MJ, Restifo NP (2018). Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System. Cell Rep  22, 3175-3190.   https://doi.org/10.1016/j.celrep.2018.02.087",https://intramural.nih.gov/search/searchview.taf?ipid=108865
769,BC011849-02,"October 01, 2018 -  September 30, 2019",Structural studies of biomolecules related to cancer and HIV-AIDS,Hiroshi  Matsuo; PhD,Joel Patrick Schneider; PhD,"Basic Research Laboratory, NCI",Tapan  Kanai|Atanu  Maiti; PhD,"Yuri  Lyubchenko; PhD (Pharmaceutical Sciences, Univ. of Nebraska Medical Center)|Celia  Schiffer (University of Massachusetts)",Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Sergey G Tarasov (Structural Biophysics Laboratory)|Marzeena  Dyba (Structural Biophysics Laboratory)|Krista A Delviks-Frankenberry (Retroviral Replication Laboratory),Eri  Miyagi; PhD (NIAID) |Klaus  Strebel; PhD (NIAID),"1. Maiti A, Myint W, Kanai T, Delviks-Frankenberry K, Sierra Rodriguez C, Pathak VK, Schiffer CA, Matsuo H (2018). Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA. Nat Commun  9, 2460.   https://doi.org/10.1038/s41467-018-04872-8|2. Silvas TV, Hou S, Myint W, Nalivaika E, Somasundaran M, Kelch BA, Matsuo H, Kurt Yilmaz N, Schiffer CA (2018). Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions. Sci Rep  8, 7511.   https://doi.org/10.1038/s41598-018-25881-z|3. Solomon WC, Myint W, Hou S, Kanai T, Tripathi R, Kurt Yilmaz N, Schiffer CA, Matsuo H (2019). Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA. Nucleic Acids Res  47, 7676-7689.   https://doi.org/10.1093/nar/gkz550",https://intramural.nih.gov/search/searchview.taf?ipid=108870
770,BC011868-01,"October 01, 2018 -  September 30, 2019",Protein Engineering Core,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",NULL,NULL,Danielle  Needle (Protein Engineering Section)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Joseph Edward Tropea (Macromolecular Crystallography Laboratory),NULL,"1. Gumpena R, Lountos GT, Waugh DS (2018). MBP-binding DARPins facilitate the crystallization of an MBP fusion protein. Acta Crystallogr F Struct Biol Commun  74, 549-557.   https://doi.org/10.1107/S2053230X18009901",https://intramural.nih.gov/search/searchview.taf?ipid=112250
771,BC011891-01,"October 01, 2018 -  September 30, 2019",Antibody Engineering Program,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Hejiao  Bian|Zhijian  Duan|Jessica Diana Hong|Yaping  Sun,NULL,"Freddy Enrique Escorcia; MD, PhD (Molecular Imaging Program)|David J Fitzgerald; PhD (Biotherapy Section)|Christian S Hinrichs (Experimental Transplantation and Immunology Branch)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Ira H Pastan; MD (Molecular Biology Section)|James Chung-Yin Yang; MD, PhD (Surgery Branch)",NULL,"1. Feng M, Bian H, Wu X, Fu T, Fu Y, Hong J, Fleming BD, Flajnik MF, Ho M (2019). Construction and next-generation sequencing analysis of a large phage-displayed VNAR single-domain antibody library from six naïve nurse sharks. Antib Ther  2, 1-11.   https://doi.org/10.1093/abt/tby011|2. Ho M (2018). Inaugural Editorial: Searching for Magic Bullets. Antib Ther  1, 1-5.   https://doi.org/10.1093/abt/tby001|3. Weiss E, Sarnovsky R, Ho M, Arons E, Kreitman R, Angelus E, Antignani A, FitzGerald D (2019). Generation of antibody-based therapeutics targeting the Idiotype of B-cell Malignancies. Antib Ther  2, 1-10.   https://doi.org/10.1093/abt/tby012|4. Zhang H, Deng M, Lin P, Liu J, Liu C, Strohl WR, Wang S, Ho M (2018). Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society. Antib Ther  1, 65-74.   https://doi.org/10.1093/abt/tby009",https://intramural.nih.gov/search/searchview.taf?ipid=112227
772,CO020007-11,"October 01, 2018 -  September 30, 2019",NCI-Frederick Support and Technical Services,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",NULL,NULL,Kristin L Komschlies McConville; PhD  (NCI Frederick Office Scientific Operations),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108917
773,CP010178-18,"October 01, 2018 -  September 30, 2019",Cancer Genomics Research Laboratory,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Meredith  Yeager|Michael  Beerman|Laura Ann Burdett|Salma  Chowdhury; MS|Casey  Dagnall|Belynda D Hicks|Show all 11,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108951
774,CP010192-12,"October 01, 2018 -  September 30, 2019","Biorepository Processing, Storage, and Research","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Amanda  Black|Marianne  Henderson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108969
775,CP010203-11,"October 01, 2018 -  September 30, 2019",Applied Molecular Pathology Laboratory,"Montserrat  Garcia-Closas; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108972
776,CP010223-08,"October 01, 2018 -  September 30, 2019",Endogenous Hormone Measurement Production Assay Infrastructure at the FNLCR,"Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Regina Gale Ziegler; PhD, MPH|Marianne  Henderson",Timothy  Veenstra (SAIC)|Xia  Xu (SAIC frederick),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108993
777,CP010226-06,"October 01, 2018 -  September 30, 2019",Cohort and Biobank Development,"Amy  de Gonzalez|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Radiation Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI",Hannah  Yang|Amanda  Black|Catherine G Schairer,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108996
778,SC006536-26,"October 01, 2018 -  September 30, 2019",Biospecimen Processing and Biorepository,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Paula A Carter|Justin Keyan Hassani|Veronica  Krevinko|Brenna Marie Noone|Trung C Pham|Diana  Roame|Show all 8,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Ismail Baris Turkbey (Molecular Imaging Program)","Forbes D Porter; MD, PhD (NICHD)","1. Balasubramaniam S, Redon CE, Peer CJ, Bryla C, Lee MJ, Trepel JB, Tomita Y, Rajan A, Giaccone G, Bonner WM, Figg WD, Fojo T, Piekarz RL, Bates SE (2018). Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung. Anticancer Drugs  29, 457-465.   https://doi.org/10.1097/CAD.0000000000000596|2. Conlon KC, Potter EL, Pittaluga S, Lee CR, Miljkovic MD, Fleisher TA, Dubois S, Bryant BR, Petrus M, Perera LP, Hsu J, Figg WD, Peer CJ, Shih JH, Yovandich JL, Creekmore SP, Roederer M, Waldmann TA (2019). IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion. Clin Cancer Res  25, 4945-4954.   https://doi.org/10.1158/1078-0432.CCR-18-3468|3. Floudas CS, Brar G, Mabry-Hrones D, Duffy AG, Wood B, Levy E, Krishnasamy V, Fioravanti S, Bonilla CM, Walker M, Morelli MP, Kleiner DE, Steinberg SM, Figg WD, Greten TF, Xie C (2019) A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer. Clin Colorectal Cancer, in press (e-pub ahead of print)  https://doi.org/10.1016/j.clcc.2019.06.004|4. Kazandjian D, Korde N, Mailankody S, Hill E, Figg WD, Roschewski M, Landgren O (2018). Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone: Five-Year Follow-up of a Phase 2 Clinical Trial. JAMA Oncol  4, 1781-1783.   https://doi.org/10.1001/jamaoncol.2018.5457",https://intramural.nih.gov/search/searchview.taf?ipid=109041
779,SC006537-26,"October 01, 2018 -  September 30, 2019",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI","Roberto Hugo Barbier|Lisa Marie Cordes; PHARMD, BCACP|Phoebe Ao-Xue Huang|Jessica Diane Kindrick|Cody John Peer|Keith Thomas Schmidt|Show all 9",C  Landgren (Memorial Sloan Kettering Cancer Center)|Susan  Bates (Columbia University)|William  Chain (University of Hawaii)|Kim  Dao (University Of Lausanne)|Tito  Fojo (Columbia University)|Daniel Michael Goldstein; MPAS (CARDIOVASCULAR & PULMONARY BRANCH)|Show all 11,"Peter L Choyke; MD (Molecular Imaging Program)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Richard Lawrence Piekarz (Investigational Drug Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Ismail Baris Turkbey (Molecular Imaging Program)","Forbes D Porter; MD, PhD (NICHD)","1. Bergamaschi C, Watson DC, Valentin A, Bear J, Peer CJ, Figg WD, Felber BK, Pavlakis GN (2018). Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques. Cytokine  108, 213-224.   https://doi.org/10.1016/j.cyto.2018.01.011|2. Hall OM, Peer CJ, Figg WD (2018). Tissue preservation with mass spectroscopic analysis: Implications for cancer diagnostics. Cancer Biol Ther  19, 953-955.   https://doi.org/10.1080/15384047.2018.1456610|3. Hall OM, Peer CJ, Fitzhugh CD, Figg WD (2018). A sensitive and rapid ultra high-performance liquid chromatography with tandem mass spectrometric assay for the simultaneous quantitation of cyclophosphamide and the 4-hydroxycyclophosphamide metabolite in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci  1086, 56-62.   https://doi.org/10.1016/j.jchromb.2018.04.016|4. Jackson S, Weingart J, Nduom EK, Harfi TT, George RT, McAreavey D, Ye X, Anders NM, Peer C, Figg WD, Gilbert M, Rudek MA, Grossman SA (2018). The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma. Fluids Barriers CNS  15, 2.   https://doi.org/10.1186/s12987-017-0088-8|5. Kurmasheva RT, Bandyopadhyay A, Favours E, Del Pozo V, Ghilu S, Phelps DA, Erickson SW, Peer CJ, Figg WD, Smith MA, Houghton PJ (2019). Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models. Pediatr Blood Cancer  66, e27820.   https://doi.org/10.1002/pbc.27820|6. Levy EB, Peer C, Sissung TM, Venkatesan A, Pandalai P, Greten T, Hughes MS, Garcia C, Peretti J, Figg W, Lewis A, Wood B (2019). Pilot Study Comparing Systemic and Tissue Pharmacokinetics of Irinotecan and Metabolites after Hepatic Drug-Eluting Chemoembolization. J Vasc Interv Radiol  30, 19-22.   https://doi.org/10.1016/j.jvir.2018.06.023|7. Li M, Nguyen L, Subramaniyan B, Bio M, Peer CJ, Kindrick J, Figg WD, Woo S, You Y (2019). PBPK modeling-based optimization of site-specific chemo-photodynamic therapy with far-red light-activatable paclitaxel prodrug. J Control Release  308, 86-97.   https://doi.org/10.1016/j.jconrel.2019.07.010",https://intramural.nih.gov/search/searchview.taf?ipid=109042
780,SC006743-26,"October 01, 2018 -  September 30, 2019",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Jonathan Michael Baker|Min Jung Lee|Sunmin T Lee|Ayzhan J Murphy|Akira  Yuno|Anish  Thomas; MD,Marc  Cox (University of Texas at El Paso)|Robert Taylor Ripley; MD,"Leonard  Neckers; PhD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)",NULL,"1. Christenson JL, Trepel JB, Ali HY, Lee S, Eisner JR, Baskin-Bey ES, Elias AD, Richer JK (2018). Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer. Horm Cancer  9, 82-94.   https://doi.org/10.1007/s12672-017-0314-5|2. Jaeger AM, Stopfer L, Lee S, Gaglia G, Sandel D, Santagata S, Lin NU, Trepel JB, White F, Jacks T, Lindquist S, Whitesell L (2019). Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation. Clin Cancer Res  25, 6392-6405.   https://doi.org/10.1158/1078-0432.CCR-19-0596|3. Morgensztern D, Rose M, Waqar SN, Morris J, Ma PC, Reid T, Brzezniak CE, Zeman KG, Padmanabhan A, Hirth J, I Spira A, Trepel JB, Padda SK (2019). RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer. Br J Cancer  121, 211-217.   https://doi.org/10.1038/s41416-019-0504-8|4. Ojemuyiwa M, Zeman K, Spira A, Oronsky B, Ray C, Trepel JB, Lee MJ, Onyiuke I, Brzezniak C (2018). Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets. Clin Case Rep  6, 2478-2481.   https://doi.org/10.1002/ccr3.1880|5. Tang SW, Thomas A, Murai J, Trepel JB, Bates SE, Rajapakse VN, Pommier Y (2018). Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (SLFN11) Expression with Class I Histone Deacetylase Inhibitors. Clin Cancer Res  24, 1944-1953.   https://doi.org/10.1158/1078-0432.CCR-17-0443",https://intramural.nih.gov/search/searchview.taf?ipid=109040
781,SC009372-28,"October 01, 2018 -  September 30, 2019",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",Truc Thanh Ho|Catharine S Mccoy|Aaron Richard Nelson|Dalia Abdel-Raouf Salem|Hao-Wei  Wang|Linda Shonk Weaver|Show all 7,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ira H Pastan; MD (Molecular Biology Section)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|James N Kochenderfer (Surgery Branch)|Nirali Niranjan Shah (Pediatric Oncology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Ahn IE, Farooqui MZH, Tian X, Valdez J, Sun C, Soto S, Lotter J, Housel S, Stetler-Stevenson M, Yuan CM, Maric I, Calvo KR, Nierman P, Hughes TE, Saba NS, Marti GE, Pittaluga S, Herman SEM, Niemann CU, Pedersen LB, Geisler CH, Childs R, Aue G, Wiestner A (2018). Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study. Blood  131, 2357-2366.   https://doi.org/10.1182/blood-2017-12-820910|2. Aue G, Sun C, Liu D, Park JH, Pittaluga S, Tian X, Lee E, Soto S, Valdez J, Maric I, Stetler-Stevenson M, Yuan C, Nakamura Y, Muranski P, Wiestner A (2018). Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia. J Immunol  201, 1967-1974.   https://doi.org/10.4049/jimmunol.1800570|3. Cherian S, Stetler-Stevenson M (2018). Flow Cytometric Monitoring for Residual Disease in B Lymphoblastic Leukemia Post T Cell Engaging Targeted Therapies. Curr Protoc Cytom  86, e44.   https://doi.org/10.1002/cpcy.44|4. Kreitman RJ, Tallman MS, Robak T, Coutre S, Wilson WH, Stetler-Stevenson M, FitzGerald DJ, Santiago L, Gao G, Lanasa MC, Pastan I (2018). Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up. Blood  131, 2331-2334.   https://doi.org/10.1182/blood-2017-09-803072|5. Tageja N, Korde N, Kazandjian D, Panch S, Manasanch E, Bhutani M, Kwok M, Mailankody S, Yuan C, Stetler-Stevenson M, Leitman SF, Sportes C, Landgren O (2018). Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma. Bone Marrow Transplant  53, 1445-1449.   https://doi.org/10.1038/s41409-018-0170-0",https://intramural.nih.gov/search/searchview.taf?ipid=109010
782,BC010686-15,"October 01, 2018 -  September 30, 2019",Clinical Operations for Laboratory of Pathology,Joseph  Chinquee,Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",NULL,NULL,Tangi Y Howard (Laboratory of Pathology)|Neil J Hardegen (Laboratory of Pathology)|Mohammad Javed Mahboob (Laboratory of Pathology)|Michael Kanwolo Newford (Laboratory of Pathology)|Ralph Leon Nix (Laboratory of Pathology)|Kayla A O'Donnell (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108373
783,BC010882-12,"October 01, 2018 -  September 30, 2019",Center for Cancer Research Clinical Trials Support,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,Elena  Byrley (Office Of The Clinical Director)|Deborah Anne Grady (Office Of The Clinical Director)|Lisa R King (Office Of The Clinical Director)|Tracy Lea Kirby (Office Of The Clinical Director)|Elizabeth A Ness (Office Of The Clinical Director)|Martha B Shaw (Office Of The Clinical Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108491
784,BC010963-12,"October 01, 2018 -  September 30, 2019",ETIB Clinical Research Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Judy Liliana Baruffaldi|Tracey N Chinn|Megan Irene Kenyon|Sarfraz A Memon|Eun Soo  Paek|Lauren R Skeffington|Show all 7,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108459
785,BC010987-12,"October 01, 2018 -  September 30, 2019",Center for Cancer Research Patient Travel,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108492
786,BC010990-12,"October 01, 2018 -  September 30, 2019",Radiation Oncology Branch - Radiation Clinic,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra Kay Brennan|Kelli Michelle Brown Winstead|Michael Mann Chamberlin|Angela Clayborne Combs|May H Garcia|Andrew Eckhardt Graff|Show all 15,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108446
787,BC011022-11,"October 01, 2018 -  September 30, 2019",Clinical Research Support for the CCR,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108228
788,BC011089-12,"October 01, 2018 -  September 30, 2019",Clinical Nursing and Data Management Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Michael Andrew Ahdoot|Jonathan Barrett Bloom|Jamie Lee Bullock|Kristin K Shouck|Patrick Theodore Gomella; MD, MPH|Sandeep  Gurram|Show all 10",NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108521
789,BC011092-12,"October 01, 2018 -  September 30, 2019",Urologic Oncology Branch Consult Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Jonathan Barrett Bloom|Jamie Lee Bullock|Patrick Theodore Gomella; MD, MPH|Sandeep  Gurram|Amir Hossien Lebastchi|Gustavo Emilio Pene La Grave; MD|Show all 7",NULL,Maria  Merino; PhD (Laboratory of Pathology),"Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108522
790,BC011242-11,"October 01, 2018 -  September 30, 2019",Center for Interventional Oncology,Bradford J Wood; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Mark  Dewhirst (Duke)|Russel  Taylor (Johns Hopkins University)|Emad  Boctor (Johns Hopkins University)|Umar  Mahmood (Harvard / Massachusetts General Hospital)|Luigi  Solbiati (Busto Arsizio)|Thierry  de Bare (Institut de Cancrologie Gustave Roussy)|Show all 35,Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Ismail Baris Turkbey (Molecular Imaging Program),Elliot Brian Levy (CC) |Karun  Sharma (CC) |Andrew J Mannes; MD (CC) |Sheng  Xu (CC) |Theo  Heller; MD (NIDDK) |Henry  Masur; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108581
791,BC011291-10,"October 01, 2018 -  September 30, 2019",General Surgical Pathology,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jerzy P Lasota,"John  Fetsch (Joint Pathology Center)|Shingo  Inaguma; MD, PhD (Laboratory Of Pathology)",Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch)|Raffit  Hassan (Thoracic and GI Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108591
792,BC011317-10,"October 01, 2018 -  September 30, 2019",Dermatology Consultation Service,Edward W Cowen|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108605
793,BC011517-07,"October 01, 2018 -  September 30, 2019",Pediatric Oncology Branch Behavioral Science Core,John Walter Glod,Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI","Stacia Martin Peron; PhD|Lori  Wiener; PhD, LCSW-C|Pamela  Wolters|Katherine Elizabeth Warren; MD|Rosandra N Kaplan|Nirali Niranjan Shah",NULL,"Kevin A Camphausen; MD (Radiation Oncology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)","Courtney Dayle Fitzhugh (NHLBI) |John F Tisdale; MD (NHLBI) |Margaret Frances Bevans; RN, PhD (OD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108694
794,BC011540-06,"October 01, 2018 -  September 30, 2019",Thoracic and Gastrointestinal Malignancies Branch Clinical Core,Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic and GI Malignancies Branch, NCI",Gideon Michael Blumenthal|Idrees Mohamed Mian; MD,NULL,Ira H Pastan; MD (Molecular Biology Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Javed  Khan; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108742
795,BC011543-06,"October 01, 2018 -  September 30, 2019",Medical Oncology Service Clinical Core,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI","Jeannette Christine Nashed|Heaven Damitrius Russell|Daniel Hicks Johnson|Atul  Rohatgi|Caryn  Steakley; BA, BSN, MSW",NULL,Ravi  Madan (Genitourinary Malignancies Branch)|Christina M Annunziata (Womens Malignancies Branch)|Mark Jason Roschewski (Lymphoid Malignancies Branch)|Jennifer Ann Kanakry (Experimental Transplantation and Immunology Branch)|Fatima Hafiz Karzai; MD (Genitourinary Malignancies Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),Ekene  Monyei (CC) |Pius Ayodele Aiyelawo (CC) |James Kevin Gilman (CC) |Deborah A Kolakowski (CC) |Linda A Tondreau (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108739
796,BC011642-05,"October 01, 2018 -  September 30, 2019",Brain Tumor Clinical and Clinical Research Program,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Orwa  Aboud|Tracy D Ani|Ramya  Parthasarathy|Katherine Elizabeth Blackburn|Lisa Marie Boris|Brittany Brelle Cordeiro|Show all 18,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Kenneth Dean Aldape; MD (Laboratory of Pathology),"John Anthony Butman; MD, PhD (CC) |John D Heiss; MD (NINDS) |Kareem Amir Zaghloul; MD, PhD (NINDS) |Edjah K Nduom (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108762
797,BC011683-04,"October 01, 2018 -  September 30, 2019",Medical Oncology HIV-AIDS Clinical Research,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI",NULL,NULL,Mark Jason Roschewski (Lymphoid Malignancies Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Ekene  Monyei (CC) |Deborah A Kolakowski (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108780
798,BC011716-04,"October 01, 2018 -  September 30, 2019",CCR Research Nursing,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,Molly Beth Adamek (Office Of The Clinical Director)|Mehwish  Ahmad (Office Of The Clinical Director)|Elizabeth Queenvalle Akoth (Office Of The Clinical Director)|Deborah E Allen (Office Of The Clinical Director)|Sonia Elisa Bellfield (Office Of The Clinical Director)|Arlene Wendy Berman (Office Of The Clinical Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108804
799,BC011729-04,"October 01, 2018 -  September 30, 2019",Chronic graft-versus-host disease in children and young adults,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI","Steven  Pavletic; MD, MS",Kristen  Baird (FDA)|Maya Beth Lodish,"Edward W Cowen (Office of the Director)|Lori  Wiener; PhD, LCSW-C (Pediatric Oncology Branch)","Jacqueline W Mays; DDS, PhD (NIDCR) |Ninet  Sinaii (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108815
800,BC011792-03,"October 01, 2018 -  September 30, 2019",Development of FISH Molecular Diagnostics to support Clinical Trials at NCI,Svetlana Dmitriyevna Pack; PhD,Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",Ziedulla  Abdullaev|Shannon I Skarshaug|Valerie M Zgonc|Martha Maria Nicacio Quezado; MD|Armando  Filie|Elaine S Jaffe; MD|Show all 10,NULL,Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Udayan  Guha (Thoracic and GI Malignancies Branch)|Raffit  Hassan (Thoracic and GI Malignancies Branch)|Hoyoung  Maeng; MD (Vaccine Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108863
801,BC011856-02,"October 01, 2018 -  September 30, 2019",Rare Tumor Patient Engagement Network - Cures,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108914
802,BC011875-01,"October 01, 2018 -  September 30, 2019",Office of Sponsor and Regulatory Oversight,Shy  Shorer,NULL,"Office Of The Clinical Director, NCI",Barbara Ann Butler|Trinka Susan Coster|Hilda Elena Grabczewski|Santhosh No Middle Name Karunakaran|Joni R Love|Rohini  Misra|Show all 10,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112245
803,BC011908-01,"October 01, 2018 -  September 30, 2019",Clinical Cancer Genomics Program,Kathleen A Calzone,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",NULL,NULL,Grace-ann  Olayinka (Cancer Genetics Branch)|Alexandra Perez Lebensohn (Cancer Genetics Branch)|Jeremy Lee Davis; MD (Endocrine Oncology Branch)|Raffit  Hassan (Thoracic and GI Malignancies Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Clesson  Turner (Cancer Genetics Branch),Lori Ann Hamby Erby (NHGRI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112209
804,BC011911-01,"October 01, 2018 -  September 30, 2019",Thoracic Surgery Consultative Services,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Colleen Donahue Bond|Claudia Lissette Espinoza|Cheryl L Warga|Chuong Dinh Hoang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112210
805,BC011929-01,"October 01, 2018 -  September 30, 2019",Methylation Array Profiling as a New Clinical Diagnostic Test,Svetlana Dmitriyevna Pack; PhD,Kenneth Dean Aldape; MD,"Laboratory of Pathology, NCI",Ziedulla  Abdullaev|Shannon I Skarshaug|Valerie M Zgonc|Frederic Glenn Barr|Martha Maria Nicacio Quezado; MD,NULL,"Terri Sue Armstrong; PhD (Neuro-Oncology Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Jing  Wu; MD, PhD (Neuro-Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=112228
806,SC006329-39,"October 01, 2018 -  September 30, 2019",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Barbara Chin Arora|Jason Yulin Cheng; PhD|Peter  Guion|Mary Kathleen Hawes|Holly  Ning|Ying  Zhuge|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109006
807,SC007202-36,"October 01, 2018 -  September 30, 2019",Biostatistics and Data Management Section,Seth M Steinberg; PhD|IRP Faculty Profile,NULL,"Biostatistics and Data Management Section, NCI",David J Liewehr|David J Venzon; PhD,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=109003
808,BC010843-13,"October 01, 2018 -  September 30, 2019",NIH Hematology Oncology Fellowship Program,Marijo  Bilusic,"James L Gulley; MD, PhD","Genitourinary Malignancies Branch, NCI","Maria Del Carmen Bonilla|Kyunghee  Burkitt; DO, PhD|Jennifer Marquita Carter|Peter Joseph Demaria; MD|Charalampos  Floudas; MD|Andy  Itsara; MD|Show all 9",NULL,"Kathryn Anne Lurain; MD, MPH (HIV and AIDS Malignancy Branch)","Charles  Bolan; BS, MS, MD (NHLBI)","1. Anari F, O'Neill J, Choi W, Chen DYT, Haseebuddin M, Kutikov A, Dulaimi E, Alpaugh RK, Devarajan K, Greenberg RE, Bilusic M, Wong YN, Viterbo R, Hoffman-Censits JH, Lallas CD, Trabulsi EJ, Smaldone M, Geynisman DM, Zibelman M, Lin J, Kelly WK, Uzzo R, McConkey D, Plimack ER (2018). Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial. Eur Urol Oncol  1, 54-60.   https://doi.org/10.1016/j.euo.2018.02.007|2. DeMaria PJ, Bilusic M (2019). Cancer Vaccines. Hematol Oncol Clin North Am  33, 199-214.   https://doi.org/10.1016/j.hoc.2018.12.001|3. Grenga I, Donahue RN, Gargulak ML, Lepone LM, Roselli M, Bilusic M, Schlom J (2018). Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis. Urol Oncol  36, 93.e1-93.e11.   https://doi.org/10.1016/j.urolonc.2017.09.027",https://intramural.nih.gov/search/searchview.taf?ipid=108400
809,BC011023-12,"October 01, 2018 -  September 30, 2019",Clinical Fellowship Training Program,Peter A Pinto; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",John Michael  Dibianco,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology)|Ismail Baris Turkbey (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),NULL,"1. Ahdoot M, Lebastchi AH, Turkbey B, Wood B, Pinto PA (2019). Contemporary treatments in prostate cancer focal therapy. Curr Opin Oncol  31, 200-206.   https://doi.org/10.1097/CCO.0000000000000515",https://intramural.nih.gov/search/searchview.taf?ipid=108541
810,BC011241-11,"October 01, 2018 -  September 30, 2019",Hematopathology Fellowship,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Jinjun  Cheng|Princess Yah Dorley|Ivo  Francischetti; MD, PhD|Pallavi Kanwar  Galera|Gaurav Kumar Gupta; MD, PhD|Stefania  Pittaluga|Show all 12",Donald  Karcher (George Washington University Medical Center)|Michael  Borowitz (Johns Hopkins Medical School),NULL,Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Raul Cipriano Braylan; MD (CC),"1. Balakrishna JP, Bhavsar T, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S (2018). Human Herpes Virus 6 (HHV-6)-associated Lymphadenitis: Pitfalls in Diagnosis in Benign and Malignant Settings. Am J Surg Pathol  42, 1402-1408.   https://doi.org/10.1097/PAS.0000000000001121|2. Balakrishna JP, Raffeld M, Jaffe ES, Pittaluga S (2019). Lymphoid hyperplasia with atypical dendritic/Langerhans cell proliferation mimicking Hodgkin lymphoma. Histopathology  74, 797-799.   https://doi.org/10.1111/his.13795|3. Gong S, Crane GM, McCall CM, Xiao W, Ganapathi KA, Cuka N, Davies-Hill T, Xi L, Raffeld M, Pittaluga S, Duffield AS, Jaffe ES (2018). Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings. Am J Surg Pathol  42, 1306-1316.   https://doi.org/10.1097/PAS.0000000000001113|4. Gupta GK, Jaffe ES, Pittaluga S (2019). A study of PD-L1 expression in intravascular large B cell lymphoma: correlation with clinical and pathological features. Histopathology  75, 282-286.   https://doi.org/10.1111/his.13870|5. Raess PW, Wang HW, Pack SD, Jaffe ES (2019). CD30+ large B cell lymphoma with anaplastic features and complete loss of B cell marker expression arising from follicular lymphoma. Histopathology  75, 602-605.   https://doi.org/10.1111/his.13919|6. Wang HW, Balakrishna JP, Pittaluga S, Jaffe ES (2019). Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol  184, 45-59.   https://doi.org/10.1111/bjh.15614|7. Wang HY, Jaffe ES (2018). An anaplastic T-cell lymphoma mimicking classical Hodgkin lymphoma. Blood  131, 1262.   https://doi.org/10.1182/blood-2017-12-819987",https://intramural.nih.gov/search/searchview.taf?ipid=108562
811,BC011384-09,"October 01, 2018 -  September 30, 2019",Anatomic Pathology Residency Program,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Billel  Gasmi|Hong  Jiang|Osorio  Lopes Abath Neto; MD, PhD|Irena  Manukyan|Cara Estelle Monroe; MD, MSPH|Neval  Ozkaya|Show all 9",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108632
812,BC011516-07,"October 01, 2018 -  September 30, 2019",Pediatric Oncology Branch Clinical Care and Education,John Walter Glod,Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI",Taryn Margaret Allen|Michael Isaac Barbato; MD|Katherine Kelly Barnett|Sima Lehimgar Zadeh|Lingling  Chen|Julia Wanda Cohen|Show all 29,NULL,NULL,NULL,"1. Kraft IL, Akshintala S, Zhu Y, Lei H, Derse-Anthony C, Dombi E, Steinberg SM, Lodish M, Waguespack SG, Kapustina O, Fox E, Balis FM, Merino MJ, Meltzer PS, Glod JW, Shern JF, Widemann BC (2018). Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib. Clin Cancer Res  24, 753-765.   https://doi.org/10.1158/1078-0432.CCR-17-2101|2. Makri A, Akshintala S, Derse-Anthony C, Del Rivero J, Widemann B, Stratakis CA, Glod J, Lodish M (2019). Pheochromocytoma in Children and Adolescents With Multiple Endocrine Neoplasia Type 2B. J Clin Endocrinol Metab  104, 7-12.   https://doi.org/10.1210/jc.2018-00705|3. Makri A, Akshintala S, Derse-Anthony C, Widemann B, Stratakis CA, Glod J, Lodish M (2018). Multiple Endocrine Neoplasia Type 2B Presents Early in Childhood but Often Is Undiagnosed for Years. J Pediatr  203, 447-449.   https://doi.org/10.1016/j.jpeds.2018.08.022|4. Sissung TM, Huang PA, Hauke RJ, McCrea EM, Peer CJ, Barbier RH, Strope JD, Ley AM, Zhang M, Hong JA, Venzon D, Jackson JP, Brouwer KR, Grohar P, Glod J, Widemann BC, Heller T, Schrump DS, Figg WD (2019). Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters. Mol Pharmacol  96, 158-167.   https://doi.org/10.1124/mol.118.114827|5. Thomas N, Glod J, Derse-Anthony C, Baple EL, Osborne N, Sturley R, Vaidya B, Newbold K, Brooke A (2018). Pregnancy on vandetanib in metastatic medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2B. Clin Endocrinol (Oxf)  88, 754-756.   https://doi.org/10.1111/cen.13577",https://intramural.nih.gov/search/searchview.taf?ipid=108693
813,BC011542-06,"October 01, 2018 -  September 30, 2019",Surgical Training Program,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108740
814,BC011653-05,"October 01, 2018 -  September 30, 2019",Clinical Support,Christine Campo Alewine|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,Anish  Thomas; MD (Developmental Therapeutics Branch)|Raffit  Hassan (Thoracic and GI Malignancies Branch)|Jeremy Lee Davis; MD (Endocrine Oncology Branch),NULL,"1. Hassan R, Morrow B, Thomas A, Walsh T, Lee MK, Gulsuner S, Gadiraju M, Panou V, Gao S, Mian I, Khan J, Raffeld M, Patel S, Xi L, Wei JS, Hesdorffer M, Zhang J, Calzone K, Desai A, Padiernos E, Alewine C, Schrump DS, Steinberg SM, Kindler HL, King MC, et al. [1 more author] (2019). Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy. Proc Natl Acad Sci U S A  116, 9008-9013.   https://doi.org/10.1073/pnas.1821510116|2. Thomas A, Redon CE, Sciuto L, Padiernos E, Ji J, Lee MJ, Yuno A, Lee S, Zhang Y, Tran L, Yutzy W, Rajan A, Guha U, Chen H, Hassan R, Alewine CC, Szabo E, Bates SE, Kinders RJ, Steinberg SM, Doroshow JH, Aladjem MI, Trepel JB, Pommier Y (2018). Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors. J Clin Oncol  36, 1594-1602.   https://doi.org/10.1200/JCO.2017.76.6915",https://intramural.nih.gov/search/searchview.taf?ipid=108766
815,BC011912-01,"October 01, 2018 -  September 30, 2019",Genomic Competency Initiative,Kathleen A Calzone,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Alexandra Perez Lebensohn,Lisa Beth Aiello; PhD (Division Of Intramural Research)|Laurie  Badzek (Penn State University)|Caroline  Benjamin (Liverpool & Cheshire Clinical Genetics Service)|Patricia  Brennan (Samuel Merritt University)|Sek Ying  Chair (Chinese University Of Hong Kong)|Bernice  Coleman (Cedars Sinai Medical Center)|Show all 16,NULL,Vence Lee Bonham; JD (NHGRI) |Susan J Persky; PhD (NHGRI) |Ann King Cashion (NINR) |Sharon L Flynn (CC) |Donna  Messersmith (NHGRI) |Lois Ann Tully (NINR),"1. McCormick K, Calzone K (2019) Genomics and Information Technology for Personalized Health, in Essentials of Nursing Informatics, Seventh Edition, in press.|2. Calzone KA, Kirk M, Tonkin E, Badzek L, Benjamin C, Middleton A (2018). Increasing nursing capacity in genomics: Overview of existing global genomics resources. Nurse Educ Today  69, 53-59.   https://doi.org/10.1016/j.nedt.2018.06.032|3. Calzone KA, Kirk M, Tonkin E, Badzek L, Benjamin C, Middleton A (2018). The Global Landscape of Nursing and Genomics. J Nurs Scholarsh  50, 249-256.   https://doi.org/10.1111/jnu.12380|4. Chair SY, Waye MMY, Calzone K, Chan CWH (2019). Genomics education in nursing in Hong Kong, Taiwan and Mainland China. Int Nurs Rev  66, 459-466.   https://doi.org/10.1111/inr.12537|5. Regan M, Engler MB, Coleman B, Daack-Hirsch S, Calzone KA (2019). Establishing the Genomic Knowledge Matrix for Nursing Science. J Nurs Scholarsh  51, 50-57.   https://doi.org/10.1111/jnu.12427",https://intramural.nih.gov/search/searchview.taf?ipid=112207
816,SC000853-66,"October 01, 2018 -  September 30, 2019",Translational Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Xu  Naizhen|Rafael Santiago Parra Medina|Mark  Raffeld; MD,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Hannah-Shmouni F, Moraitis AG, Romero VV, Faucz FR, Mastroyannis SA, Berthon A, Failor RA, Merino M, Demidowich AP, Stratakis CA (2018). Successful Treatment of Estrogen Excess in Primary Bilateral Macronodular Adrenocortical Hyperplasia with Leuprolide Acetate. Horm Metab Res  50, 124-132.   https://doi.org/10.1055/s-0043-122074|2. Le Gallo M, Rudd ML, Urick ME, Hansen NF, National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program, Merino MJ, Mutch DG, Goodfellow PJ, Mullikin JC, Bell DW (2018). The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas. Cancer  124, 65-73.   https://doi.org/10.1002/cncr.30971",https://intramural.nih.gov/search/searchview.taf?ipid=109013
817,BC010856-13,"October 01, 2018 -  September 30, 2019",Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research,Mary C Custer,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108427
818,BC010931-12,"October 01, 2018 -  September 30, 2019",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Hibret Amare Adissu|Jennifer B Dwyer|Amy Lynn Flis|Raisa Allie Glabman|John  Hickerson|Shelley B Hoover|Show all 12,"Siba  Samal; PhD (Virginia-Maryland Regional College of Vet Med, University of Maryland)|Matti  Kiupel; PhD|Margaret  Miller (Purdue)|John M Cullen; VMD, PhD","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Jonathan S Wiest; PhD (Center For Cancer Training)|Natasha  Caplen (Cancer Genetics Branch)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108478
819,BC011689-04,"October 01, 2018 -  September 30, 2019",Comparative Oncology Trials Consortium,Amy Kathleen Leblanc; DVM|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Christina  Mazcko,"Lisa  Barber (Veterinary Medicine, Tufts University)|Antonella  Borgatti (University of Minnesota)|E  Ehrhart (Colorado State University)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Carolyn  Henry (Veterinary Medicine, University of Missouri)|Michael  Kent (UC Davis)|Show all 32",James Halpern Doroshow (Developmental Therapeutics Branch),NULL,"1. Burton JH, Mazcko C, LeBlanc A, Covey JM, Ji J, Kinders RJ, Parchment RE, Khanna C, Paoloni M, Lana S, Weishaar K, London C, Kisseberth W, Krick E, Vail D, Childress M, Bryan JN, Barber L, Ehrhart EJ, Kent M, Fan T, Kow K, Northup N, Wilson-Robles H, Tomaszewski J, et al. [6 more authors] (2018). NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma. Clin Cancer Res  24, 5830-5840.   https://doi.org/10.1158/1078-0432.CCR-18-1498|2. Dull AB, Wilsker D, Hollingshead M, Mazcko C, Annunziata CM, LeBlanc AK, Doroshow JH, Kinders RJ, Parchment RE (2018). Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug-induced DNA double strand breaks from DNA double strand breaks associated with apoptosis. Oncotarget  9, 17104-17116.   https://doi.org/10.18632/oncotarget.24936|3. Mochel JP, Ekker SC, Johannes CM, Jergens AE, Allenspach K, Bourgois-Mochel A, Knouse M, Benzekry S, Wierson W, LeBlanc AK, Kenderian SS (2019). CAR T Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds Against Hematological Malignancies. AAPS J  21, 50.   https://doi.org/10.1208/s12248-019-0322-1|4. Naik S, Galyon GD, Jenks NJ, Steele MB, Miller AC, Allstadt SD, Suksanpaisan L, Peng KW, Federspiel MJ, Russell SJ, LeBlanc AK (2018). Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer. Mol Cancer Ther  17, 316-326.   https://doi.org/10.1158/1535-7163.MCT-17-0432",https://intramural.nih.gov/search/searchview.taf?ipid=108785
820,BC011735-04,"October 01, 2018 -  September 30, 2019",Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Devon Ashley Atkinson|N Keith Collins|Wendi Raye Custer Lawrence|Catherine I Drennan|Rajaa  Elmeskini|Debra J Gilbert|Show all 18,NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Ira H Pastan; MD (Molecular Biology Section)|Christine Campo Alewine (Laboratory of Molecular Biology)|James Halpern Doroshow (Developmental Therapeutics Branch)|Chi-Ping  Day (Laboratory of Cancer Biology and Genetics)|Peter L Choyke; MD (Molecular Imaging Program),Craig Joseph Thomas (NCATS) |Juan  Marugan (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108821
821,BC011235-11,"October 01, 2018 -  September 30, 2019",Support of NCI CCR Clinical Research and Bioinformatics,Jason Edward Levine,Thomas A Misteli; PhD,"Office of the Director, NCI",Ming  Ji|Richard J Moon|Rohit  Paul|Jeffrey David Saxe|James  Waters|Heidi H Kong,NULL,Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Pamela  Wolters (Pediatric Oncology Branch)|Stacia Martin Peron; PhD (Pediatric Oncology Branch),Jon W McKeeby (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108571
822,BC011703-04,"October 01, 2018 -  September 30, 2019","Integrated analyses of genetics, epigenetics, and gene expression",Maxwell P Lee; PhD,Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI",Huaitian  Liu|Howard H Yang|Lalage  Wakefield; PhD|Kent W Hunter; PhD|Glenn  Merlino; PhD|Beverly  Mock; PhD|Show all 11,Kathleen  Arcaro (University of Massachusetts)|Hai  Hu (Windber Research Institute)|Sulma Ibrahim Mohammed,"Dinah  Singer; PhD (Experimental Immunology Branch)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Philip  Taylor; MD, ScD (Hormonal and Reproductive Epidemiology Branch)|Alisa  Goldstein; PhD (Clinical Genetics Branch)|Ronald  Lubet (Chemopreventive Agent Development Research Group)|Robert  Shoemaker (Chemopreventive Agent Development Research Group)",NULL,"1. Cataisson C, Salcedo R, Michalowski AM, Klosterman M, Naik S, Li L, Pan MJ, Sweet A, Chen JQ, Kostecka LG, Karwan M, Smith L, Dai RM, Stewart CA, Lyakh L, Hsieh WT, Khan A, Yang H, Lee M, Trinchieri G, Yuspa SH (2019). T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis. Mol Cancer Res  17, 1759-1773.   https://doi.org/10.1158/1541-7786.MCR-19-0227|2. Deasy SK, Uehara R, Vodnala SK, Yang HH, Dass RA, Hu Y, Lee MP, Crouch RJ, Hunter KW (2019). Aicardi-Goutières syndrome gene Rnaseh2c is a metastasis susceptibility gene in breast cancer. PLoS Genet  15, e1008020.   https://doi.org/10.1371/journal.pgen.1008020|3. Malik N, Yan H, Moshkovich N, Palangat M, Yang H, Sanchez V, Cai Z, Peat TJ, Jiang S, Liu C, Lee M, Mock BA, Yuspa SH, Larson D, Wakefield LM, Huang J (2019). The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription. Nat Commun  10, 2071.   https://doi.org/10.1038/s41467-019-10102-6|4. Puri M, Hoover SB, Hewitt SM, Wei BR, Adissu HA, Halsey CHC, Beck J, Bradley C, Cramer SD, Durham AC, Esplin DG, Frank C, Lyle LT, McGill LD, Sánchez MD, Schaffer PA, Traslavina RP, Buza E, Yang HH, Lee MP, Dwyer JE, Simpson RM (2019). Automated Computational Detection, Quantitation, and Mapping of Mitosis in Whole-Slide Images for Clinically Actionable Surgical Pathology Decision Support. J Pathol Inform  10, 4.   https://doi.org/10.4103/jpi.jpi_59_18|5. Tayyari F, Gowda GAN, Olopade OF, Berg R, Yang HH, Lee MP, Ngwa WF, Mittal SK, Raftery D, Mohammed SI (2018). Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences. Oncotarget  9, 11677-11690.   https://doi.org/10.18632/oncotarget.24433|6. Wangsa D, Braun R, Stuelten CH, Brown M, Bauer KM, Emons G, Weston LA, Hu Y, Yang HH, Vila-Casadesús M, Lee MP, Brauer P, Warner L, Upender M, Hummon AB, Camps J, Ried T (2019). Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer Cells. Neoplasia  21, 721-729.   https://doi.org/10.1016/j.neo.2019.04.009|7. Wei BR, Halsey CH, Hoover SB, Puri M, Yang HH, Gallas BD, Lee MP, Chen W, Durham AC, Dwyer JE, Sánchez MD, Traslavina RP, Frank C, Bradley C, McGill LD, Esplin DG, Schaffer PA, Cramer SD, Lyle LT, Beck J, Buza E, Gong Q, Hewitt SM, Simpson RM (2019). Agreement in Histological Assessment of Mitotic Activity Between Microscopy and Digital Whole Slide Images Informs Conversion for Clinical Diagnosis. Acad Pathol  6, 2374289519859841.   https://doi.org/10.1177/2374289519859841",https://intramural.nih.gov/search/searchview.taf?ipid=108794
823,CP010205-11,"October 01, 2018 -  September 30, 2019",Scientific Computing,"Jonas Silva De Almeida|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Geoffrey Scott Tobias|Amanda  Black,NULL,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108974
824,BC011234-11,"October 01, 2018 -  September 30, 2019",CCR New Space Activation,Darren W Henderson,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108557
825,CO020002-11,"October 01, 2018 -  September 30, 2019",Space and Facilities Management,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",NULL,NULL,NULL,Jean P Khoshbin (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108916
826,CO030001-02,"October 01, 2018 -  September 30, 2019",TIL Rosenberuge Modular Processing Facility,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",NULL,NULL,NULL,Jean P Khoshbin (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108918
827,BC011133-11,"October 01, 2018 -  September 30, 2019",CCR Office of Training and Education,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108229
828,BC011285-10,"October 01, 2018 -  September 30, 2019",CCR Education and Outreach,Melissa A Bronez,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108588
829,CP010204-11,"October 01, 2018 -  September 30, 2019","Communications, Education and Outreach","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Wendy  Schneider-Levinson|Jennifer K Loukissas|Victoria Anne McCallum|Jackie Ann Lavigne,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108973
830,CP010208-10,"October 01, 2018 -  September 30, 2019",Special Studies Institutional Review Board Support,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Catherine G Schairer,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108978
831,BC010857-13,"October 01, 2018 -  September 30, 2019",Science and Technology Resources,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",Ramalakshmi  Darbha|Peter C Fitzgerald|J  Foley|Scott Andrew Hannon|Mariam Q Malik|Carl E Mcintosh|Show all 10,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108429
832,CO020001-11,"October 01, 2018 -  September 30, 2019",Technology Transfer Center,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",Karen M Maurey,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=108915
